PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, HB; Plutzky, J; Shubina, M; Turchin, A				Zhang, Huabing; Plutzky, Jorge; Shubina, Maria; Turchin, Alexander			Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-TRIALS; BONFERRONI PROCEDURE; INVERSE PROBABILITY; PROPENSITY SCORE; LDL CHOLESTEROL; CLINICAL-TRIALS; MULTIPLE TESTS; THERAPY; DISCONTINUATION; METAANALYSIS	Background: Many patients discontinue statin treatment, often after having a possible adverse reaction. The risks and benefits of continued statin therapy after an adverse reaction are not known. Objective: To examine the relationship between continuation of statin therapy (any prescription within 12 months after an adverse reaction) and clinical outcomes. Design: Retrospective cohort study. Setting: Primary care practices affiliated with 2 academic medical centers. Participants: Patients with a presumed adverse reaction to a statin between 2000 and 2011. Measurements: Information on adverse reactions to statins was obtained from structured electronic medical record data or natural-language processing of narrative provider notes. The primary composite outcome was time to a cardiovascular event (myocardial infarction or stroke) or death. Results: Most (81%) of the adverse reactions to statins were identified from the text of electronic provider notes. Among 28 266 study patients, 19 989 (70.7%) continued receiving statin prescriptions after the adverse reaction. Four years after the presumed adverse event, the cumulative incidence of the composite primary outcome was 12.2% for patients with continued statin prescriptions, compared with 13.9% for those without them (difference, 1.7% [95% CI, 0.8% to 2.7%]; P < 0.001). In a secondary analysis of 7604 patients for whom a different statin was prescribed after the adverse reaction, 2014 (26.5%) had a documented adverse reaction to the second statin, but 1696 (84.2%) of those patients continued receiving statin prescriptions. Limitations: The risk for recurrent adverse reactions to statins could not be established for the entire sample. It was also not possible to determine whether patients actually took the statins. Conclusion: Continued statin prescriptions after an adverse reaction were associated with a lower incidence of death and cardiovascular events.	[Zhang, Huabing] Beijing Union Med Coll Hosp, Dept Endocrinol, 1 Shuaifuyuan, Beijing 100730, Peoples R China; Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; Baim Inst Clin Res, Boston, MA USA; [Shubina, Maria; Turchin, Alexander] Brigham & Womens Hosp, Div Endocrinol, 221 Longwood Ave, Boston, MA 02115 USA; [Plutzky, Jorge] Harvard New Res Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Turchin, A (corresponding author), Brigham & Womens Hosp, Div Endocrinol, 221 Longwood Ave, Boston, MA 02115 USA.	aturchin@bwh.harvard.edu	Plutzky, Jorge/V-3410-2019; Zhang, Huabing/ABD-6216-2020	Zhang, Huabing/0000-0001-6259-7584	Chinese National Key Program of Clinical Science; National Natural Science Foundation of China; Young Scientific Research Fund of Peking Union Medical College Hospital	Chinese National Key Program of Clinical Science; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scientific Research Fund of Peking Union Medical College Hospital	Chinese National Key Program of Clinical Science, National Natural Science Foundation of China, and Young Scientific Research Fund of Peking Union Medical College Hospital.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Degli Esposti L, 2012, CLIN THER, V34, P190, DOI 10.1016/j.clinthera.2011.12.011; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Haukka J, 2012, PHARMACOEPIDEM DR S, V21, P61, DOI 10.1002/pds.2255; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Joy TR, 2014, ANN INTERN MED, V160, P301, DOI 10.7326/M13-1921; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Phan K, 2014, CURR PHARM DESIGN, V20, P6314, DOI 10.2174/1381612820666140620162629; Lemstra M, 2012, CAN J CARDIOL, V28, P574, DOI 10.1016/j.cjca.2012.05.007; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Mampuya WM, 2013, AM HEART J, V166, P597, DOI 10.1016/j.ahj.2013.06.004; Mancini GBJ, 2013, CAN J CARDIOL, V29, P1553, DOI 10.1016/j.cjca.2013.09.023; Maningat P, 2011, NEW ENGL J MED, V365, P2250, DOI 10.1056/NEJMp1112023; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Morrison FJR, 2014, CARDIORENAL MED, V4, P225, DOI 10.1159/000368914; Naci H, 2013, CIRC-CARDIOVASC QUAL, V6, P390, DOI 10.1161/CIRCOUTCOMES.111.000071; Nissen SE, 2016, JAMA-J AM MED ASSOC, V315, P1580, DOI 10.1001/jama.2016.3608; Qu YM, 2009, STAT MED, V28, P1402, DOI 10.1002/sim.3549; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sandoval YHG, 2011, CURR PHARM DESIGN, V17, P3669, DOI 10.2174/138161211798220891; Schneeweiss S, 2005, EPIDEMIOLOGY, V16, P17, DOI 10.1097/01.ede.0000147164.11879.b5; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Skentzos Stephen, 2011, AMIA Annu Symp Proc, V2011, P1270; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tsuyuki RT, 2001, PHARMACOTHERAPY, V21, P576, DOI 10.1592/phco.21.6.576.34541; Wei MY, 2013, J CLIN LIPIDOL, V7, P472, DOI 10.1016/j.jacl.2013.03.001; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	35	66	67	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					221	+		10.7326/M16-0838	http://dx.doi.org/10.7326/M16-0838			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28738423				2022-12-28	WOS:000407797500010
J	Huybrechts, KF; Bateman, BT; Desai, RJ; Hernandez-Diaz, S; Rough, K; Mogun, H; Kerzner, LS; Davis, JM; Stover, M; Bartels, D; Cottral, J; Patorno, E				Huybrechts, Krista F.; Bateman, Brian T.; Desai, Rishi J.; Hernandez-Diaz, Sonia; Rough, Kathryn; Mogun, Helen; Kerzner, Leslie S.; Davis, Jonathan M.; Stover, Megan; Bartels, Devan; Cottral, Jennifer; Patorno, Elisabetta			Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ABSTINENCE SYNDROME; UNITED-STATES; GABAPENTIN; PREGNANCY; ADJUSTMENT; METHADONE	OBJECTIVES To assess the impact of in utero co-exposure to psychotropic medications and opioids on the incidence and severity of neonatal drug withdrawal. DESIGN Observational cohort study. SETTING Nationwide sample of pregnancies in publicly insured women in the US, nested in the Medicaid Analytic eXtract (2000-10). PARTICIPANTS 201 275 pregnant women with public insurance who were exposed to opioids around the time of delivery and their liveborn infants. INTERVENTIONS In utero exposure to psychotropic medications, in particular antidepressants, atypical antipsychotics, benzodiazepines, gabapentin, and non-benzodiazepine hypnotics (Z drugs), with prescriptions filled within the same time window as prescriptions for opioids. MAIN OUTCOME MEASURE Diagnosis of neonatal drug withdrawal in infants exposed in utero to opioids and psychotropic medications compared with opioids alone. RESULTS The absolute risk for neonatal drug withdrawal ranged from 1.0% in infants exposed in utero to prescription opioids alone to 11.4% for those exposed to opioids co-prescribed with gabapentin. Among neonates exposed in utero to prescription opioids, the relative risk adjusted for propensity score was 1.34 (95% confidence interval 1.22 to 1.47) with concomitant exposure to antidepressants, 1.49 (1.35 to 1.63) with benzodiazepines, 1.61 (1.26 to 2.06) with gabapentin, 1.20 (0.95 to 1.51) with antipsychotics, and 1.01 (0.88 to 1.15) with Z drugs. In utero exposure to two or more psychotropic medications along with opioids was associated with a twofold increased risk of withdrawal (2.05, 1.77 to 2.37). The severity of the withdrawal seemed increased in neonates exposed to both opioids and psychotropic medications compared with opioids alone. CONCLUSIONS During pregnancy, the use of psychotropic medications in addition to prescription opioids is common, despite a lack of safety data. The current findings suggest that these drugs could further increase the risk and severity of neonatal drug withdrawal.	[Huybrechts, Krista F.; Bateman, Brian T.; Desai, Rishi J.; Rough, Kathryn; Mogun, Helen; Patorno, Elisabetta] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Huybrechts, Krista F.; Bateman, Brian T.; Desai, Rishi J.; Rough, Kathryn; Mogun, Helen; Kerzner, Leslie S.; Bartels, Devan; Cottral, Jennifer; Patorno, Elisabetta] Harvard Med Sch, Boston, MA USA; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Hernandez-Diaz, Sonia; Rough, Kathryn] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Kerzner, Leslie S.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Davis, Jonathan M.] Tufts Med Ctr, Floating Hosp, Dept Pediat, Boston, MA USA; [Davis, Jonathan M.] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Stover, Megan] Tufts Med Ctr, Dept Obstet & Gynecol, Boston, MA USA; [Stover, Megan] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Bartels, Devan; Cottral, Jennifer] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Floating Hospital For Children; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Harvard University; Massachusetts General Hospital	Huybrechts, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	khuybrechts@bwh.harvard.edu	Desai, Rishi/AAH-8988-2021		National Institute of Mental Health [R01 MH100216, K01MH099141]; National Institute of Child Health and Human Development [K08HD075831]; National Institute of Drug Abuse [R01DA032889-04, R21DA041706-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA041706] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by an R01 grant (R01 MH100216) from the National Institute of Mental Health. KFH was supported by a career development grant K01MH099141 from the National Institute of Mental Health. BTB was supported by a career development grant K08HD075831 from the National Institute of Child Health and Human Development. JMD was supported by R01 (R01DA032889-04) and R21 (R21DA041706-01) grants from the National Institute of Drug Abuse. The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	[Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb; [Anonymous], 2016, CLIN PHARM DATABASE; Bateman BT, 2014, ANESTHESIOLOGY, V120, P1216, DOI 10.1097/ALN.0000000000000172; Carrasco M, 2015, PEDIATR NEUROL, V53, P445, DOI 10.1016/j.pediatrneurol.2015.06.023; Desai RJ, 2017, EPIDEMIOLOGY, V28, P249, DOI 10.1097/EDE.0000000000000595; Desai RJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2102; Desai RJ, 2014, OBSTET GYNECOL, V123, P997, DOI 10.1097/AOG.0000000000000208; Dryden C, 2009, BJOG-INT J OBSTET GY, V116, P665, DOI 10.1111/j.1471-0528.2008.02073.x; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; FDA Drug Safety Communication, 2011, ANT DRUG LAB UPD US; FINNEGAN LP, 1975, ADDICT DIS, V2, P141; Hanley GE, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-242; Hudak ML, 2012, PEDIATRICS, V129, pE540, DOI 10.1542/peds.2011-3212; Hwang CS, 2016, AM J PREV MED, V51, P151, DOI 10.1016/j.amepre.2016.02.014; Jansson LM, 2012, DRUG ALCOHOL DEPEN, V122, P213, DOI 10.1016/j.drugalcdep.2011.10.003; Loudin S, 2017, J PEDIATR-US, V181, P286, DOI 10.1016/j.jpeds.2016.11.004; Mercadante S, 2006, J PAIN SYMPTOM MANAG, V32, P175, DOI 10.1016/j.jpainsymman.2006.01.013; Mercadante S, 2013, CURR MED RES OPIN, V29, P661, DOI 10.1185/03007995.2013.791617; Mersfelder TL, 2016, ANN PHARMACOTHER, V50, P229, DOI 10.1177/1060028015620800; Norton JW, 2001, CLIN NEUROPHARMACOL, V24, P245, DOI 10.1097/00002826-200107000-00011; Patrick SW, 2015, J PERINATOL, V35, P650, DOI 10.1038/jp.2015.36; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Raffaeli G, 2017, PHARMACOTHERAPY, V37, P814, DOI 10.1002/phar.1954; van Amsterdam Jan, 2015, Curr Drug Abuse Rev, V8, P3; Volkow ND, 2014, AM ADDICTION OPIOIDS; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Wachman EM, 2011, J ADDICT MED, V5, P293, DOI 10.1097/ADM.0b013e3182266a3a	29	84	85	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2017	358								j3326	10.1136/bmj.j3326	http://dx.doi.org/10.1136/bmj.j3326			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CG	28768628	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000407206800002
J	Heeg, KP; Kaldun, A; Strohm, C; Reiser, P; Ott, C; Subramanian, R; Lentrodt, D; Haber, J; Wille, HC; Goerttler, S; Ruffer, R; Keitel, CH; Rohlsberger, R; Pfeifer, T; Evers, J				Heeg, K. P.; Kaldun, A.; Strohm, C.; Reiser, P.; Ott, C.; Subramanian, R.; Lentrodt, D.; Haber, J.; Wille, H. -C.; Goerttler, S.; Ruffer, R.; Keitel, C. H.; Roehlsberger, R.; Pfeifer, T.; Evers, J.			Spectral narrowing of x-ray pulses for precision spectroscopy with nuclear resonances	SCIENCE			English	Article							SINGLE; SHIFT	Spectroscopy of nuclear resonances offers a wide range of applications due to the remarkable energy resolution afforded by their narrow linewidths. However, progress toward higher resolution is inhibited at modern x-ray sources because they deliver only a tiny fraction of the photons on resonance, with the remainder contributing to an off-resonant background. We devised an experimental setup that uses the fast mechanical motion of a resonant target to manipulate the spectrum of a given x-ray pulse and to redistribute off-resonant spectral intensity onto the resonance. As a consequence, the resonant pulse brilliance is increased while the off-resonant background is reduced. Because our method is compatible with existing and upcoming pulsed x-ray sources, we anticipate that this approach will find applications that require ultranarrow x-ray resonances.	[Heeg, K. P.; Kaldun, A.; Reiser, P.; Ott, C.; Subramanian, R.; Lentrodt, D.; Goerttler, S.; Keitel, C. H.; Pfeifer, T.; Evers, J.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Strohm, C.; Haber, J.; Wille, H. -C.; Roehlsberger, R.] DESY, D-22607 Hamburg, Germany; [Ruffer, R.] ESRF European Synchrotron, CS40220, F-38043 Grenoble 9, France	Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Synchrotron Radiation Facility (ESRF)	Evers, J (corresponding author), Max Planck Inst Kernphys, D-69117 Heidelberg, Germany.	joerg.evers@mpi-hd.mpg.de	Röhlsberger, Ralf/J-4173-2013; Evers, Jörg/AAB-2018-2019; Ott, Christian/GXV-1144-2022	Röhlsberger, Ralf/0000-0001-6005-5183; Ott, Christian/0000-0003-4110-0916; Evers, Jorg/0000-0001-7864-6029; Lentrodt, Dominik/0000-0001-7400-9575; Goerttler, Stephan/0000-0002-6534-9735	Deutsche Forschungsgemeinschaft Collaborative Research Centre [SFB 1225]; European Research Council [X-MuSiC-616783]; Helmholtz Association	Deutsche Forschungsgemeinschaft Collaborative Research Centre(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Helmholtz Association(Helmholtz Association)	This work is part of and supported by the Deutsche Forschungsgemeinschaft Collaborative Research Centre "SFB 1225 (ISOQUANT)." Also part of and supported by European Research Council consolidator grant X-MuSiC-616783 and Helmholtz Association project-oriented funds. The authors declare no competing financial interest.	Baldwin GC, 1997, REV MOD PHYS, V69, P1085, DOI 10.1103/RevModPhys.69.1085; CHAMPENEY DC, 1963, NATURE, V198, P1186, DOI 10.1038/1981186b0; Glover TE, 2012, NATURE, V488, P603, DOI 10.1038/nature11340; Heeg KP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.207401; Heeg KP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.203601; Heeg KP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.073601; HELISTO P, 1991, PHYS REV LETT, V66, P2037, DOI 10.1103/PhysRevLett.66.2037; Kalvius M., 2012, R MOSSBAUER STORY; Lu J, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.11; Mukhopadhyay D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8057; Ott C, 2013, SCIENCE, V340, P716, DOI 10.1126/science.1234407; POUND RV, 1959, PHYS REV LETT, V3, P439, DOI 10.1103/PhysRevLett.3.439; Radeonychev YV, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.043808; Rohlsberger R, 2012, NATURE, V482, P199, DOI 10.1038/nature10741; Rohlsberger R, 2010, SCIENCE, V328, P1248, DOI 10.1126/science.1187770; Rohlsberger R., 2005, NUCL CONDENSED MATTE; Schindelmann P, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.023804; Schindelmann P., 1999, THESIS; Shakhmuratov RN, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.023836; Shakhmuratov RN, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013807; Shakhmuratov RN, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043820; Shwartz S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.163901; Tamasaku K, 2014, NAT PHOTONICS, V8, P313, DOI [10.1038/NPHOTON.2014.10, 10.1038/nphoton.2014.10]; Tkalya EV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.162501; Troyan I, 2016, SCIENCE, V351, P1303, DOI 10.1126/science.aac8176; TURNER KC, 1964, PHYS REV B, V134, pB252, DOI 10.1103/PhysRev.134.B252; Vagizov F, 2014, NATURE, V508, P80, DOI 10.1038/nature13018; Wang DW, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.093901; Weiner A M, 2009, ULTRAFAST OPTICS	29	33	33	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					376	+		10.1126/science.aan3512	http://dx.doi.org/10.1126/science.aan3512			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751603	Green Published			2022-12-28	WOS:000406362300038
J	Larson, DR; Misteli, T				Larson, Daniel R.; Misteli, Tom			The genome-seeing it clearly now	SCIENCE			English	Editorial Material							30-NM CHROMATIN FIBERS; IN-SITU; NUCLEOSOME		[Larson, Daniel R.; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Larson, DR (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	dan.larson@nih.gov; mistelit@mail.nih.gov	Larson, Daniel R/B-9829-2008	Larson, Daniel R/0000-0001-9253-3055	Intramural NIH HHS [ZIA BC010309-16] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025; Risca VI, 2017, NATURE, V541, P237, DOI 10.1038/nature20781; Scheffer MP, 2011, P NATL ACAD SCI USA, V108, P16992, DOI 10.1073/pnas.1108268108; Teves SS, 2016, ELIFE, V5, DOI 10.7554/eLife.22280	8	3	3	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					354	355		10.1126/science.aao1893	http://dx.doi.org/10.1126/science.aao1893			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751596	Green Accepted			2022-12-28	WOS:000406362300024
J	Newman, TH; Caine, EA; Lynes, K; Sebastian, J				Newman, Thomas H.; Caine, Eline A.; Lynes, Kathryn; Sebastian, Joseph			CASE REVIEW An uncommon right iliac fossa mass in an older woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPIGELIAN HERNIA REPAIR		[Newman, Thomas H.; Caine, Eline A.; Lynes, Kathryn; Sebastian, Joseph] East Kent Hosp Univ NHS Fdn Trust, Queen Elizabeth Queen Mother Hosp, Trust, England		Newman, TH (corresponding author), East Kent Hosp Univ NHS Fdn Trust, Queen Elizabeth Queen Mother Hosp, Trust, England.	thnewman@doctors.org.uk	Newman, Thomas/AAT-9918-2021					Barnes TG, 2016, SURG LAPARO ENDO PER, V26, P265, DOI 10.1097/SLE.0000000000000286; Bradley M, 2006, ANN ROY COLL SURG, V88, P165, DOI 10.1308/003588406X95110; Kelly ME, 2015, SURG LAPARO ENDO PER, V25, pe86, DOI 10.1097/SLE.0000000000000112; Moreno-Egea A, 2002, ARCH SURG-CHICAGO, V137, P1266, DOI 10.1001/archsurg.137.11.1266; Morrison CP, 2002, SURG ENDOSC, V358, P1364; Polistina FA, 2015, SURGERY, V157, P547, DOI 10.1016/j.surg.2014.09.027; Skandalakis PN, 2006, AM SURGEON, V72, P42; Skouras C, 2011, SURG LAPARO ENDO PER, V21, P76, DOI 10.1097/SLE.0b013e31820d66df; Srivastava KN, 2015, INDIAN J SURG, V77, pS35, DOI 10.1007/s12262-014-1085-7; Zachariah SK, 2011, CASE REP SURG, V2011, DOI 10.1155/2011/491802	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2017	358								j3279	10.1136/bmj.j3279	http://dx.doi.org/10.1136/bmj.j3279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UX	28751479				2022-12-28	WOS:000406766000004
J	Ramos, A; Hemann, MT				Ramos, Azucena; Hemann, Michael T.			Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer	CELL			English	Editorial Material							MICROENVIRONMENT		[Ramos, Azucena; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ramos, Azucena; Hemann, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Hemann, MT (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Hemann, MT (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	hemann@mit.edu						Alexander JL, 2017, NAT REV GASTRO HEPAT, V14, P356, DOI 10.1038/nrgastro.2017.20; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008	8	35	36	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					411	413		10.1016/j.cell.2017.07.018	http://dx.doi.org/10.1016/j.cell.2017.07.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753421	Bronze			2022-12-28	WOS:000406462400002
J	Rogers, G; Davies, D; Pink, J; Cooper, P				Rogers, Gabriel; Davies, Debbie; Pink, Joshua; Cooper, Paul			GUIDELINES Parkinson's disease: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rogers, Gabriel; Pink, Joshua] Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England; [Davies, Debbie] Aneurin Bevan Hlth Board, Newport, Shrops, England; [Cooper, Paul] Greater Manchester Neurosci Ctr, Salford, Lancs, England; [Cooper, Paul] Univ Manchester, Manchester, Lancs, England	National Institute for Health & Care Excellence; University of Manchester	Rogers, G (corresponding author), Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England.	Gabriel.Rogers@nice.org.uk	Cooper, Paul N/L-9819-2013	Cooper, Paul N/0000-0002-7232-3365; Pink, Joshua/0000-0002-7597-4198; Rogers, Gabriel/0000-0001-9339-7374	Department of Health	Department of Health	During the development of this work, GR and JP were both employees of NICE, which is commissioned and funded by the Department of Health to develop clinical guidelines. No authors received specific funding to write this summary.	General Medical Council, 2021, GOOD PRACT PRESCR MA; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; National Institute for Health and Care Excellence, 2017, PARK DIS AD DIAGN MA; National Institute for Health and Care Excellence, 2009, DEPR AD CHRON PHYS H; NHS England, 2015, CLIN COMM POL LEV CA; Parkinson's UK, 2009, PARK PREV UK 2009	6	46	46	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2017	358								j1951	10.1136/bmj.j1951	http://dx.doi.org/10.1136/bmj.j1951			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UX	28751362				2022-12-28	WOS:000406766000001
J	Schuchat, A				Schuchat, Anne			Deceptive Lyme Disease Diagnosis Linked with Serious Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					324	324		10.1001/jama.2017.8897	http://dx.doi.org/10.1001/jama.2017.8897			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742918				2022-12-28	WOS:000406296700005
J	Torjesen, I				Torjesen, Ingrid			Heavy drinking predicted to kill 63 000 people over the next five years	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Foundation for Liver Research, 2017, FIN CAS ACT LIV DIS	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2017	358								j3594	10.1136/bmj.j3594	http://dx.doi.org/10.1136/bmj.j3594			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UT	28743703				2022-12-28	WOS:000406765600007
J	Friedrich, MJ				Friedrich, M. J.			Drug-Resistant Tuberculosis Predicted to Increase in High-Burden Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					231	231		10.1001/jama.2017.9086	http://dx.doi.org/10.1001/jama.2017.9086			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719700				2022-12-28	WOS:000405775000026
J	Fuller, BM; Carpenter, CR				Fuller, Brian M.; Carpenter, Christopher R.			Pooled RCTs: Early goal-directed therapy does not reduce mortality more than usual care in early septic shock	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEVERE SEPSIS; RESUSCITATION; TRIAL		[Fuller, Brian M.; Carpenter, Christopher R.] Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Fuller, BM (corresponding author), Washington Univ, St Louis, MO 63130 USA.		Carpenter, Christopher R./E-3720-2013	Carpenter, Christopher R./0000-0002-2603-7157				Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Nguyen HB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1288-3; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	6	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC6	JC6		10.7326/ACPJC-2017-167-2-006	http://dx.doi.org/10.7326/ACPJC-2017-167-2-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715828				2022-12-28	WOS:000405573400007
J	Lagisetty, P; Bohnert, A				Lagisetty, Pooja; Bohnert, Amy			Inpatient Notes: The Opioid Epidemic-What's a Hospitalist to Do?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA; VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Lagisetty, P (corresponding author), Univ Michigan, North Campus Res Ctr, 3800 Plymouth Rd, Ann Arbor, MI 48109 USA.	lagiset@med.umich.edu						Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Liebschutz JM, 2014, JAMA INTERN MED, V174, P1369, DOI 10.1001/jamainternmed.2014.2556; Meltzer EC, 2011, PAIN, V152, P397, DOI 10.1016/j.pain.2010.11.006; Naeger S, 2016, PSYCHIAT SERV, V67, P1262, DOI 10.1176/appi.ps.201500538; Ronan MV, 2016, HEALTH AFFAIR, V35, P832, DOI 10.1377/hlthaff.2015.1424	5	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					HO2	HO3		10.7326/M17-1564	http://dx.doi.org/10.7326/M17-1564			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715839				2022-12-28	WOS:000405573400001
J	Halliday, JEB; Hampson, K; Hanley, N; Lembo, T; Sharp, JP; Haydon, DT; Cleaveland, S				Halliday, Jo E. B.; Hampson, Katie; Hanley, Nick; Lembo, Tiziana; Sharp, Joanne P.; Haydon, Daniel T.; Cleaveland, Sarah			Driving improvements in emerging disease surveillance through locally relevant capacity strengthening	SCIENCE			English	Review							NEGLECTED TROPICAL DISEASES; PATHOGENS; EMERGENCE	Emerging infectious diseases (EIDs) threaten the health of people, animals, and crops globally, but our ability to predict their occurrence is limited. Current public health capacity and ability to detect and respond to EIDs is typically weakest in low-and middle-income countries (LMICs). Many known drivers of EID emergence also converge in LMICs. Strengthening capacity for surveillance of diseases of relevance to local populations can provide a mechanism for building the cross-cutting and flexible capacities needed to tackle both the burden of existing diseases and EID threats. A focus on locally relevant diseases in LMICs and the economic, social, and cultural contexts of surveillance can help address existing inequalities in health systems, improve the capacity to detect and contain EIDs, and contribute to broader global goals for development.	[Halliday, Jo E. B.; Hampson, Katie; Lembo, Tiziana; Haydon, Daniel T.; Cleaveland, Sarah] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Hanley, Nick] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Sharp, Joanne P.] Univ Glasgow, Sch Geog & Earth Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of St Andrews; University of Glasgow	Halliday, JEB (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland.	jo.halliday@glasgow.ac.uk		Cleaveland, Sarah/0000-0002-0456-0959; Halliday, Jo/0000-0002-1329-9035; Lembo, Tiziana/0000-0002-6405-1849; Hanley, Nick/0000-0002-1362-3499; Hampson, Katie/0000-0001-5392-6884	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J010367/1]; UK Zoonoses and Emerging Livestock Systems Initiative [BB/L018845/1, BB/L018926/1]; Wellcome Trust [095787/Z/11/Z]; Economic and Social Research Council (ESRC) [RES-070-27-0039]; Leverhulme-Royal Society Africa Award [AA130131]; BBSRC [BB/L018926/1, BB/J010367/1, BB/L018845/1] Funding Source: UKRI; ESRC [ES/H041354/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L018845/1, BB/J010367/1, BB/L018926/1] Funding Source: researchfish; Economic and Social Research Council [ES/H041354/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Zoonoses and Emerging Livestock Systems Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme-Royal Society Africa Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) BB/J010367/1 (J.E.B.H., J.P.S., D.T.H., and S.C.), the UK Zoonoses and Emerging Livestock Systems Initiative grants BB/L018845/1 (J.E.B.H. and D.T.H.) and BB/L018926/1 (J.P.S. and S.C.), the Wellcome Trust 095787/Z/11/Z (K.H.), the Economic and Social Research Council (ESRC) RES-070-27-0039 (J.P.S.), and a Leverhulme-Royal Society Africa Award (AA130131). J.E.B.H., D.T.H., and S.C. conceptualized the project. J.E.B.H., N.H., J.P.S., and SC wrote the original draft. J.E.B.H., K.H., N.H., T.L., J.P.S., D.T.H., and S.C wrote, reviewed and edited the manuscript. The authors declare that they have no competing interests. All data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials.	[Anonymous], 2009, SUSTAINING GLOBAL SU; Bardosh K, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-35; Bogich TL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001354; Burkle FM, 2015, DISASTER MED PUBLIC, V9, P568, DOI 10.1017/dmp.2015.26; Cason TN, 2012, GAME ECON BEHAV, V76, P26, DOI 10.1016/j.geb.2012.05.001; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Chisha Z, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0735-y; Farmer P.E, 2001, INFECT INEQUALITIES; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Hitchcock P, 2007, BIOSECUR BIOTERROR, V5, P206, DOI 10.1089/bsp.2007.0041; Horan RD, 2007, AM J AGR ECON, V89, P1232, DOI 10.1111/j.1467-8276.2007.01089.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kabatereine NB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000755; Kluberg Sheryl A, 2016, Emerg Infect Dis, V22, pE1, DOI 10.3201/eid2210.151956; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Mariner JC, 2012, SCIENCE, V337, P1309, DOI 10.1126/science.1223805; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Mtema Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002002; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Swanson RC, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0090-3; UNU-IHDP and UNEP, 2014, INCL WEALTH REP 2014; Vaz R. G., J INFECT DIS S3, V213, pS140; White B, 2016, ENVIRON RESOUR ECON, V63, P765, DOI 10.1007/s10640-016-0002-x; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organisation, 2015, EB RESP WHAT NEEDS H; [World Organization for Animal Health World Health Organization], HDB ASS CAP HUM AN I	29	38	38	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		146	148		10.1126/science.aam8332	http://dx.doi.org/10.1126/science.aam8332			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706036	Green Accepted			2022-12-28	WOS:000405391700033
J	Ota, M				Ota, Mitsuhito			A rash localised around the eyes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ota, Mitsuhito] Chitose City Hosp Hokkou 2, Dept Dermatol, Chitose, Japan		Ota, M (corresponding author), Chitose City Hosp Hokkou 2, Dept Dermatol, Chitose, Japan.	ota@med.hokudai.ac.jp						Balta I, 2014, INT J DERMATOL, V53, pE134, DOI 10.1111/j.1365-4632.2012.05626.x; Cox NH, 2010, ROOKS TXB DERMATOLOG, P49, DOI [10.1002/9781444317633.ch49, DOI 10.1002/9781444317633.CH49]; Ozaslan E, 2010, Acta Dermatovenerol Alp Pannonica Adriat, V19, P21; RASMUSSEN JE, 1982, J AM ACAD DERMATOL, V6, P67, DOI 10.1016/S0190-9622(82)80202-8; Yuksel I, 2012, CHINESE MED J-PEKING, V125, P1520, DOI 10.3760/cma.j.issn.0366-6999.2012.08.030	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2017	358								j3148	10.1136/bmj.j3148	http://dx.doi.org/10.1136/bmj.j3148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MU	28705813				2022-12-28	WOS:000405770500003
J	Bel, S; Pendse, M; Wang, YH; Li, Y; Ruhn, KA; Hassell, B; Leal, T; Winter, SE; Xavier, RJ; Hooper, LV				Bel, Shai; Pendse, Mihir; Wang, Yuhao; Li, Yun; Ruhn, Kelly A.; Hassell, Brian; Leal, Tess; Winter, Sebastian E.; Xavier, Ramnik J.; Hooper, Lora V.			Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LINKS ER STRESS; GENE ATG16L1; DEFENSE	Intestinal Paneth cells limit bacterial invasion by secreting antimicrobial proteins, including lysozyme. However, invasive pathogens can disrupt the Golgi apparatus, interfering with secretion and compromising intestinal antimicrobial defense. Here we show that during bacterial infection, lysozyme is rerouted via secretory autophagy, an autophagy-based alternative secretion pathway. Secretory autophagy was triggered in Paneth cells by bacteria-induced endoplasmic reticulum (ER) stress, required extrinsic signals from innate lymphoid cells, and limited bacterial dissemination. Secretory autophagy was disrupted in Paneth cells of mice harboring a mutation in autophagy gene Atg16L1 that confers increased risk for Crohn's disease in humans. Our findings identify a role for secretory autophagy in intestinal defense and suggest why Crohn's disease is associated with genetic mutations that affect both the ER stress response and autophagy.	[Bel, Shai; Pendse, Mihir; Wang, Yuhao; Li, Yun; Ruhn, Kelly A.; Hassell, Brian; Leal, Tess; Hooper, Lora V.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Winter, Sebastian E.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Xavier, Ramnik J.] Broad Inst, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Med Sch, Gastrointestinal Unit, Boston, MA 02142 USA; [Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02142 USA; [Hooper, Lora V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.; Hooper, LV (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Bel, Shai/AAH-7870-2021; Winter, Sebastian E/A-4118-2009	Bel, Shai/0000-0002-7166-4870; Winter, Sebastian E/0000-0003-1532-9178	NIH [DK070855, AI118807, AI128151]; Burroughs Wellcome Foundation; Welch Foundation [I-1874, I-1858]; Howard Hughes Medical Institute; Gruss-Lipper postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284, R01AI118807, U19AI109725, R21AI128151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097485, R01DK070855, P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gruss-Lipper postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Levine for discussions and C. L. Behrendt-Boyd for assistance with mouse experiments. This work was supported by the NIH (grant DK070855 to L.V.H.; grants AI118807 and AI128151 to S.E.W.), the Burroughs Wellcome Foundation (Investigators in the Pathogenesis of Infectious Diseases Award to L.V.H.), the Welch Foundation (grant I-1874 to L.V.H.; grant I-1858 to S.E.W.), and the Howard Hughes Medical Institute (L.V.H.). S.B. was supported by a Gruss-Lipper postdoctoral fellowship.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Escoll P, 2016, NAT REV MICROBIOL, V14, P5, DOI 10.1038/nrmicro.2015.1; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; Preston AM, 2009, DIABETOLOGIA, V52, P2369, DOI 10.1007/s00125-009-1506-5; Ramanan D, 2016, CELL HOST MICROBE, V19, P434, DOI 10.1016/j.chom.2016.03.003; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Wang XZ, 1996, MOL CELL BIOL, V16, P4273	19	180	183	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1047	1051		10.1126/science.aal4677	http://dx.doi.org/10.1126/science.aal4677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28751470	Green Accepted			2022-12-28	WOS:000409455700047
J	Clarke, R				Clarke, Rachel			Cheap, undervalued, expendable: junior doctors in 2017?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rtsclarke@gmail.com						Confederation NHS, 2017, KEY STAT NHS; Moberly T., 2017, BMJ CAREERS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2017	358								j3651	10.1136/bmj.j3651	http://dx.doi.org/10.1136/bmj.j3651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CB	28760803				2022-12-28	WOS:000407206300004
J	Lyon, J				Lyon, Jeff			Cancer Project Speeding Along	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					322	322		10.1001/jama.2017.9616	http://dx.doi.org/10.1001/jama.2017.9616			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NN	28742892				2022-12-28	WOS:000426801700001
J	Sellers, MH; Dinner, SN				Sellers, Meredith H.; Dinner, Shira N.			Epistaxis, Ecchymoses, and an Abnormal White Blood Cell Count	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; ARSENIC TRIOXIDE		[Sellers, Meredith H.] Northwestern Univ, Feinberg Sch Med, Dept Med, 251 E Huron,Galter 3-150, Chicago, IL 60611 USA; [Dinner, Shira N.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Sellers, MH (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 251 E Huron,Galter 3-150, Chicago, IL 60611 USA.	meredith.sellers@northwestern.edu						Coombs CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.25; Kwaan HC, 2014, BEST PRACT RES CL HA, V27, P11, DOI 10.1016/j.beha.2014.04.005; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lo-Coco F, 2014, BEST PRACT RES CL HA, V27, P3, DOI 10.1016/j.beha.2014.04.006; National Comprehensive Cancer Network (NCCN), 2016, ACUT MY LEUK VERS 1; Nichol JN, 2014, BEST PRACT RES CL HA, V27, P19, DOI 10.1016/j.beha.2014.04.009; Park JH, 2011, BLOOD, V118, P1248, DOI 10.1182/blood-2011-04-346437; Tallman MS, 2009, BLOOD, V114, P5126, DOI 10.1182/blood-2009-07-216457; Watts JM, 2014, BLOOD REV, V28, P205, DOI 10.1016/j.blre.2014.07.001	9	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					383	384		10.1001/jama.2017.9020	http://dx.doi.org/10.1001/jama.2017.9020			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742885				2022-12-28	WOS:000406296700019
J	Mendelson, JR				Mendelson, Joseph R., III			The call of the wild	SCIENCE			English	Editorial Material								"Would you like to move to Atlanta?" asked the voice on the phone. Just a few months earlier, I had earned tenure-my primary goal for decades-at Utah State University. But rather than basking in my promotion, I was thinking, "So, this is what I do for the rest of my career?" Lecturing to huge auditoriums of freshman nonmajors exhausted me. Encouraging my graduate students to publish, only to send them into a dismal job market, felt duplicitous. Because my university's administration seemed to value funding more than publications, I found myself pursuing easy-to-get grants, sometimes on topics of only marginal interest to me. My tenure committee had pushed me to articulate a single central research theme, while I wanted to explore broadly in my area of amphibian and reptile studies. I was experiencing academic burnout.	[Mendelson, Joseph R., III] Zoo Atlanta, Res, Atlanta, GA 30315 USA; [Mendelson, Joseph R., III] Georgia Inst Technol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Mendelson, JR (corresponding author), Zoo Atlanta, Res, Atlanta, GA 30315 USA.; Mendelson, JR (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.								0	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					326	326		10.1126/science.357.6348.326	http://dx.doi.org/10.1126/science.357.6348.326			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729514				2022-12-28	WOS:000405901600045
J	Pavlov, V; Rosental, B; Hansen, NF; Beers, JM; Parish, G; Rowbotham, I; Block, BA				Pavlov, Vadim; Rosental, Benyamin; Hansen, Nathaniel F.; Beers, Jody M.; Parish, George; Rowbotham, Ian; Block, Barbara A.			Hydraulic control of tuna fins: A role for the lymphatic system in vertebrate locomotion (vol 357, pg 310, 2017)	SCIENCE			English	Article							SECONDARY CIRCULATION; METABOLIC-RATES; SKIPJACK TUNA; FISH; VESSELS; MECHANISMS; STABILITY; CENTERS; DESIGN	The lymphatic system in teleost fish has genetic and developmental origins similar to those of the mammalian lymphatic system, which is involved in immune response and fluid homeostasis. Here, we show that the lymphatic system of tunas functions in swimming hydrodynamics. Specifically, a musculo-vascular complex, consisting of fin muscles, bones, and lymphatic vessels, is involved in the hydraulic control of median fins. This specialization of the lymphatic system is associated with fish in the family Scombridae and may have evolved in response to the demand for swimming and maneuvering control in these high-performance species.	[Pavlov, Vadim; Rosental, Benyamin; Hansen, Nathaniel F.; Beers, Jody M.; Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Dept Biol, 120 Oceanview Blvd, Pacific Grove, CA 93950 USA; [Rosental, Benyamin] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Parish, George; Rowbotham, Ian] Monterey Bay Aquarium, Tuna Res & Conservat Ctr, Monterey, CA 93950 USA	Stanford University; Stanford University; Monterey Bay Aquarium Research Institute	Pavlov, V; Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, 120 Oceanview Blvd, Pacific Grove, CA 93950 USA.	pavlov.v.v@gmail.com; bblock@stanford.edu	Rosental, Benyamin/X-5400-2019	Rosental, Benyamin/0000-0002-3974-3296; Hansen, Nate/0000-0002-3368-9938	Office of Naval Research; Monterey Bay Aquarium; Human Frontier Science Program Organization; NIH [T32 HL120824-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120824] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); Monterey Bay Aquarium; Human Frontier Science Program Organization(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Tuna Research and Conservation Center staff for their assistance with the tuna experiments, including C. Farwell and A. Norton. We also thank M. Ezcurra and the staff of the Monterey Bay Aquarium for help in video recording of swimming tuna, and P. Chu, J. Tsai, I. Harel, and M. Dimitrov for technical assistance. High-speed video is courtesy of R. Kochevar, True Blue Films, and Discovery Communications. Additional appreciation is extended to J. Dabiri, J. Potvin, C. Lowe, D. Epel, C. Reeb, K. Palmeri, and N. Clarke for useful discussions. Supporting data are in the supplementary materials. This work was supported by the Office of Naval Research and Monterey Bay Aquarium. B.R. was supported by a postdoctoral fellowship from the Human Frontier Science Program Organization and the NIH hematology training grant T32 HL120824-03. The authors declare no competing financial interests.	Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Blank JM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P167, DOI 10.1086/510637; BRILL RW, 1987, FISH B-NOAA, V85, P25; BUSHNELL PG, 1992, J COMP PHYSIOL B, V162, P131, DOI 10.1007/BF00398338; CHAPMAN G, 1975, J EXP ZOOL, V194, P249, DOI 10.1002/jez.1401940118; Chopin LK, 1998, J ZOOL, V246, P105, DOI 10.1017/S0952836998009133; DEWAR H, 1994, J EXP ZOOL, V269, P566, DOI 10.1002/jez.1402690610; Donley JM, 2004, NATURE, V429, P61, DOI 10.1038/nature02435; ELLIS AE, 1976, J FISH BIOL, V8, P67, DOI 10.1111/j.1095-8649.1976.tb03908.x; Fish FE, 2006, ANNU REV FLUID MECH, V38, P193, DOI 10.1146/annurev.fluid.38.050304.092201; Graham JB, 2004, J EXP BIOL, V207, P4015, DOI 10.1242/jeb.01267; Jondeung A, 2010, MITOCHONDR DNA, V21, P36, DOI 10.3109/19401731003622529; Katz SL, 2001, NATURE, V410, P770, DOI 10.1038/35071170; Kier WM, 2012, J EXP BIOL, V215, P1247, DOI 10.1242/jeb.056549; Korsmeyer K.E., 2001, TUNA PHYSL ECOLOGY E, P35, DOI DOI 10.1016/S1546-5098(01)19003-5; KRANZ H, 1989, DIS AQUAT ORGAN, V6, P167, DOI 10.3354/dao006167; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; Miya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073535; MUIR BS, 1969, J EXP BIOL, V51, P271; Okuda KS, 2012, DEVELOPMENT, V139, P2381, DOI 10.1242/dev.077701; Olson KR, 1996, J EXP ZOOL, V275, P172, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<172::AID-JEZ9>3.3.CO;2-#; Pavlov V, 2017, SCIENCE, V357, P310, DOI 10.1126/science.aak9607; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rummer JL, 2014, J EXP BIOL, V217, P751, DOI 10.1242/jeb.086348; Shimoda H, 2012, ACTA HISTOCHEM CYTOC, V45, P335, DOI 10.1267/ahc.12027; Siddall R, 2017, INTERFACE FOCUS, V7, DOI 10.1098/rsfs.2016.0085; Skov PV, 2004, J EXP BIOL, V207, P3339, DOI 10.1242/jeb.01164; Steffensen J.F., 1992, P185; VOGEL WOP, 1981, Z NATURFORSCH C, V36, P490; Webb P.W., 1975, B FISH RES BOARD CAN, V190, P1, DOI DOI 10.1002/RRA.1371; Webb PW, 2015, INTEGR COMP BIOL, V55, P753, DOI 10.1093/icb/icv053; WEBB PW, 1984, AM ZOOL, V24, P107; Webb PW, 2002, INTEGR COMP BIOL, V42, P94, DOI 10.1093/icb/42.1.94; Weihs D, 2002, INTEGR COMP BIOL, V42, P127, DOI 10.1093/icb/42.1.127; Weihs D., 1993, CONTEMP MATH, V141, P443, DOI [10.1090/conm/141/19, DOI 10.1090/CONM/141/19]; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	37	22	22	4	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					310	314		10.1126/science.aak9607	http://dx.doi.org/10.1126/science.aak9607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729512	Green Accepted			2022-12-28	WOS:000405901600043
J	Hakim, J; Musiime, V; Szubert, AJ; Mallewa, J; Siika, A; Agutu, C; Walker, S; Pett, SL; Bwakura-Dangarembizi, M; Lugemwa, A; Kaunda, S; Karoney, M; Musoro, G; Kabahenda, S; Nathoo, K; Maitland, K; Griffiths, A; Thomason, MJ; Kityo, C; Mugyenyi, P; Prendergast, AJ; Walker, AS; Gibb, DM				Hakim, J.; Musiime, V.; Szubert, A. J.; Mallewa, J.; Siika, A.; Agutu, C.; Walker, S.; Pett, S. L.; Bwakura-Dangarembizi, M.; Lugemwa, A.; Kaunda, S.; Karoney, M.; Musoro, G.; Kabahenda, S.; Nathoo, K.; Maitland, K.; Griffiths, A.; Thomason, M. J.; Kityo, C.; Mugyenyi, P.; Prendergast, A. J.; Walker, A. S.; Gibb, D. M.		REALITY Trial Team	Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRYPTOCOCCAL MENINGITIS; DOUBLE-BLIND; OPEN-LABEL; TUBERCULOSIS; CHILDREN; PEOPLE; ADULTS; MORTALITY; WORLDWIDE	BACKGROUND In sub-Saharan Africa, among patients with advanced human immunodeficiency virus (HIV) infection, the rate of death from infection (including tuberculosis and cryptococcus) shortly after the initiation of antiretroviral therapy (ART) is approximately 10%. METHODS In this factorial open-label trial conducted in Uganda, Zimbabwe, Malawi, and Kenya, we enrolled HIV-infected adults and children 5 years of age or older who had not received previous ART and were starting ART with a CD4+ count of fewer than 100 cells per cubic millimeter. They underwent simultaneous randomization to receive enhanced antimicrobial prophylaxis or standard prophylaxis, adjunctive raltegravir or no raltegravir, and supplementary food or no supplementary food. Here, we report on the effects of enhanced antimicrobial prophylaxis, which consisted of continuous trimethoprim-sulfamethoxazole plus at least 12 weeks of isoniazid-pyridoxine (coformulated with trimethoprim-sulfamethoxazole in a single fixed-dose combination tablet), 12 weeks of fluconazole, 5 days of azithromycin, and a single dose of albendazole, as compared with standard prophylaxis (trimethoprim-sulfamethoxazole alone). The primary end point was 24-week mortality. RESULTS A total of 1805 patients (1733 adults and 72 children or adolescents) underwent randomization to receive either enhanced prophylaxis (906 patients) or standard prophylaxis (899 patients) and were followed for 48 weeks (loss to follow-up, 3.1%). The median baseline CD4+ count was 37 cells per cubic millimeter, but 854 patients (47.3%) were asymptomatic or mildly symptomatic. In the Kaplan-Meier analysis at 24 weeks, the rate of death with enhanced prophylaxis was lower than that with standard prophylaxis (80 patients [8.9% vs. 108 [12.2%]; hazard ratio, 0.73; 95% confidence interval [CI], 0.55 to 0.98; P = 0.03); 98 patients (11.0%) and 127 (14.4%), respectively, had died by 48 weeks (hazard ratio, 0.76; 95% CI, 0.58 to 0.99; P = 0.04). Patients in the enhanced-prophylaxis group had significantly lower rates of tuberculosis (P = 0.02), cryptococcal infection (P = 0.01), oral or esophageal candidiasis (P = 0.02), death of unknown cause (P = 0.03), and new hospitalization (P = 0.03). However, there was no significant between-group difference in the rate of severe bacterial infection (P = 0.32). There were nonsignificantly lower rates of serious adverse events and grade 4 adverse events in the enhanced-prophylaxis group (P = 0.08 and P = 0.09, respectively). Rates of HIV viral suppression and adherence to ART were similar in the two groups. CONCLUSIONS Among HIV-infected patients with advanced immunosuppression, enhanced antimicrobial prophylaxis combined with ART resulted in reduced rates of death at both 24 weeks and 48 weeks without compromising viral suppression or increasing toxic effects. (Funded by the Medical Research Council and others; REALITY Current Controlled Trials number, ISRCTN43622374.)	[Hakim, J.; Bwakura-Dangarembizi, M.; Musoro, G.; Nathoo, K.] Univ Zimbabwe, Clin Res Ctr, Harare, Zimbabwe; [Musiime, V.; Kityo, C.; Mugyenyi, P.] Joint Clin Res Ctr, Kampala, Uganda; [Lugemwa, A.] Joint Clin Res Ctr, Mbarara, Uganda; [Kabahenda, S.] Joint Clin Res Ctr, Ft Portal, Uganda; [Szubert, A. J.; Pett, S. L.; Griffiths, A.; Thomason, M. J.; Prendergast, A. J.; Walker, A. S.; Gibb, D. M.] UCL, Med Res Council Clin Trials Unit, London, England; [Maitland, K.] Imperial Coll, Wellcome Trust Ctr Clin Trop Med, London, England; [Maitland, K.] Imperial Coll, Dept Paediat, London, England; [Prendergast, A. J.] Queen Mary Univ London, London, England; [Walker, S.] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Mallewa, J.; Kaunda, S.] Dept Med, Blantyre, Malawi; [Mallewa, J.; Kaunda, S.] Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi	University of Zimbabwe; Joint Clinic Research Center - United Arab Emirates; Joint Clinic Research Center - United Arab Emirates; Medical Research Council Clinical Trials Unit; University of London; University College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; Queen Mary University London; University of York - UK; University of Malawi	Hakim, J (corresponding author), UCL, MRC Clin Trials Unit, Aviation House,125 Kingsway, London WC2B 6NH, England.	rmjlasw@ucl.ac.uk	Etyang, Anthony/AAJ-2704-2020; Lwande, Gerald O/I-3414-2013; Walker, Sarah/HDM-8717-2022; Bwakura-Dangarembizi, Mutsa/D-5686-2018	Etyang, Anthony/0000-0003-1267-6422; Lwande, Gerald O/0000-0003-0801-3028; Thomason, Margaret/0000-0003-3590-0140; Prendergast, Andrew/0000-0001-7904-7992; Jelagat Karoney, Mercy/0000-0003-0557-4188; Bwakura-Dangarembizi, Mutsa/0000-0001-7751-6177; O'Hare, Bernadette/0000-0003-1730-7941; Fitzgerald, Felicity/0000-0001-9594-3228; Walker, Simon Mark/0000-0002-5750-3691; Maitland, Kathryn/0000-0002-0007-0645; Arenas-Pinto, Alejandro/0000-0002-3368-5005	Medical Research Council; MRC [MC_EX_G1100693, MR/K023535/1] Funding Source: UKRI; Medical Research Council [G1100693, MC_EX_G1100693, MC_UU_12023/23] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W1068] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069911] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Medical Research Council and others; REALITY Current Controlled Trials number, ISRCTN43622374.	Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2004, DIV AIDS TABL GRAD S; [Anonymous], 2011, GUIDELINES FOR INTEN; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Coles CL, 2013, CLIN INFECT DIS, V56, P1519, DOI 10.1093/cid/cit137; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Ford N, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20714; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Gibb DM, 2015, 46 UN WORLD C LUNG H; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Grant A, C RETR OPP INF BOST; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Hosseinipour MC, 2016, LANCET, V387, P1198, DOI 10.1016/S0140-6736(16)00546-8; Jelsma Jennifer, 2003, Popul Health Metr, V1, P11, DOI 10.1186/1478-7954-1-11; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Parkes-Ratanshi R, 2011, LANCET INFECT DIS, V11, P933, DOI 10.1016/S1473-3099(11)70245-6; Paton NI, 2014, NEW ENGL J MED, V371, P234, DOI 10.1056/NEJMoa1311274; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; UNAIDS, 2015, GLOBAL AIDS RESPONSE; Walker AS, 2012, CLIN INFECT DIS, V55, P1707, DOI 10.1093/cid/cis797; Woods B, 2015, COUNTRY LEVEL COST E, V109, P1; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2016, CONS GUID US ANT DRU	29	109	111	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					233	245		10.1056/NEJMoa1615822	http://dx.doi.org/10.1056/NEJMoa1615822			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9PI	28723333	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000405777600007
J	Hofmann, B; Welch, HG				Hofmann, Bjorn; Welch, H. Gilbert			New diagnostic tests: more harm than good	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BIOMARKERS		[Hofmann, Bjorn] Norwegian Univ Sci & Technol, Dept Hlth Sci Gjovik, N-0318 Oslo, Norway; [Hofmann, Bjorn] Univ Oslo, Ctr Med Eth, POB 1130, N-0318 Oslo, Norway; [Welch, H. Gilbert] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	Norwegian University of Science & Technology (NTNU); University of Oslo; Dartmouth College	Hofmann, B (corresponding author), Norwegian Univ Sci & Technol, Dept Hlth Sci Gjovik, N-0318 Oslo, Norway.; Hofmann, B (corresponding author), Univ Oslo, Ctr Med Eth, POB 1130, N-0318 Oslo, Norway.	b.m.hofmann@medisin.uio.no	Hofmann, Bjørn/AAI-7121-2020	Hofmann, Bjørn/0000-0001-6709-4265	Commonwealth Fund through the Harkness Fellowship at the Dartmouth Institute of Health Policy and Clinical Practice	Commonwealth Fund through the Harkness Fellowship at the Dartmouth Institute of Health Policy and Clinical Practice	We have read and understood BMJ policy on declaration of interests and declare the following: BH has received funding from the Commonwealth Fund through the Harkness Fellowship at the Dartmouth Institute of Health Policy and Clinical Practice for part of this work. The views presented here are those of the author and not necessarily those of the Commonwealth Fund, their directors, officers, or staff or of the Dartmouth Institute. Neither BH or HGW have any relationships with any companies that might have an interest in the submitted work in the previous three years; their spouses, partners, or children have any financial relationships that may be relevant to the submitted work; and BH and HGW have no non-financial interests that may be relevant to the submitted work.	Coart E, 2015, J ALZHEIMERS DIS, V46, P889, DOI 10.3233/JAD-142886; Dent AG, 2013, J THORAC DIS, V5, pS540, DOI 10.3978/j.issn.2072-1439.2013.08.44; Dowling L., 2014, NANOSOMIX; Fung E, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00149; Gadsden G., 2014, CLICK ORLANDO   0910; Grand View Research, 2016, BREATH AN MARK SIZ R; Gregory A., 2015, MIRROR          0210; Hardesty LA, 2016, J AM COLL RADIOL, V13, P1032, DOI 10.1016/j.jacr.2016.03.016; Hasan N, 2014, LUNG, V192, P639, DOI 10.1007/s00408-014-9636-z; Hibbard C., 2016, HEALTHTELL INC COMPL; Highsmith J., 2014, BIOMARKERS TECHNOLOG; Highsmith J., 2016, BIOMARKERS TECHNOLOG; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Kiddle SJ, 2014, J ALZHEIMERS DIS, V38, P515, DOI 10.3233/JAD-130380; Krilaviciute A, 2015, ONCOTARGET, V6, P38643, DOI 10.18632/oncotarget.5938; Kronemeyer B., 2014, BLOOD TEST EARLY DET; Legutki JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5785; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; O'Bryant SE, 2017, ALZHEIMERS DEMENT, V13, P45, DOI 10.1016/j.jalz.2016.09.014; Qualcomm, 2014, INTR QUALC LIF MOB H; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Siontis KC, 2014, J CLIN EPIDEMIOL, V67, P612, DOI 10.1016/j.jclinepi.2013.12.008; Stafford P, 2014, P NATL ACAD SCI USA, V111, pE3072, DOI 10.1073/pnas.1409432111; Sykes KF, 2013, TRENDS BIOTECHNOL, V31, P45, DOI 10.1016/j.tibtech.2012.10.012; TellHealth, 2014, HEALTHTELL REACH 13; van Veldhuisen DJ, 2011, CIRCULATION, V124, P1719, DOI 10.1161/CIRCULATIONAHA.111.043042; Weinstein G, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt235; Welch GH, 2011, OVER DIAGNOSED MAKIN; Zephyr Technology, 2014, BIOPATCH WIR DEV	30	31	31	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2017	358								j3314	10.1136/bmj.j3314	http://dx.doi.org/10.1136/bmj.j3314			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7JY	28720607	Green Published			2022-12-28	WOS:000406318100004
J	McCracken, JL; Veeranki, SP; Ameredes, BT; Calhoun, WJ				McCracken, Jennifer L.; Veeranki, Sreenivas P.; Ameredes, Bill T.; Calhoun, William J.			Diagnosis and Management of Asthma in Adults A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							EOSINOPHILIC AIRWAY INFLAMMATION; EXHALED NITRIC-OXIDE; BRONCHIAL THERMOPLASTY; LUNG-FUNCTION; DOUBLE-BLIND; THERAPY; EXACERBATIONS; FLUTICASONE; MULTICENTER; SALMETEROL	IMPORTANCE Asthma affects about 7.5% of the adult population. Evidence-based diagnosis, monitoring, and treatment can improve functioning and quality of life in adult patients with asthma. OBSERVATIONS Asthma is a heterogeneous clinical syndrome primarily affecting the lower respiratory tract, characterized by episodic or persistent symptoms of wheezing, dyspnea, and cough. The diagnosis of asthma requires these symptoms and demonstration of reversible airway obstruction using spirometry. Identifying clinically important allergen sensitivities is useful. Inhaled short-acting beta(2)-agonists provide rapid relief of acute symptoms, but maintenance with daily inhaled corticosteroids is the standard of care for persistent asthma. Combination therapy, including inhaled corticosteroids and long-acting beta(2)-agonists, is effective in patients for whom inhaled corticosteroids alone are insufficient. The use of inhaled long-acting beta(2)-agonists alone is not appropriate. Other controller approaches include long-acting muscarinic antagonists (eg, tiotropium), and biological agents directed against proteins involved in the pathogenesis of asthma (eg, omalizumab, mepolizumab, reslizumab). CONCLUSIONS AND RELEVANCE Asthma is characterized by variable airway obstruction, airway hyperresponsiveness, and airway inflammation. Management of persistent asthma requires avoidance of aggravating environmental factors, use of short-acting beta(2)-agonists for rapid relief of symptoms, and daily use of inhaled corticosteroids. Other controller medications, such as long-acting bronchodilators and biologics, may be required in moderate and severe asthma. Patients with severe asthma generally benefit from consultation with an asthma specialist for consideration of additional treatment, including injectable biologic agents.	[McCracken, Jennifer L.; Calhoun, William J.] Univ Texas Med Branch, Div Allergy & Clin Immunol, Galveston, TX 77555 USA; [Veeranki, Sreenivas P.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Ameredes, Bill T.; Calhoun, William J.] Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Calhoun, WJ (corresponding author), Univ Texas Med Branch, 4-116 JSA,301 Univ Blvd, Galveston, TX 77555 USA.	william.calhoun@utmb.edu		Calhoun, William/0000-0001-7075-712X	Clinical and Translational Science Award from the National Center for Advancing Translational Sciences [UL1TR001439]	Clinical and Translational Science Award from the National Center for Advancing Translational Sciences	This work was supported in part by Clinical and Translational Science Award funding from the National Center for Advancing Translational Sciences (UL1TR001439).	Adams NP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003135.pub3; Amaral AFS, 2014, THORAX, V69, P558, DOI 10.1136/thoraxjnl-2013-204574; Ameredes Bill T, 2011, Front Biosci (Schol Ed), V3, P643, DOI 10.2741/s177; Anderson SD, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-4; [Anonymous], 2000, INT FORUM ALLERGY S1; Apter AJ, 1996, J ALLERGY CLIN IMMUN, V98, P295, DOI 10.1016/S0091-6749(96)70153-7; Barnig C, 2013, EXPERT REV CLIN IMMU, V9, P491, DOI [10.1586/eci.13.36, 10.1586/ECI.13.36]; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Busse WW, 1998, J ALLERGY CLIN IMMUN, V102, pS17, DOI 10.1016/S0091-6749(98)70002-8; Calhoun WJ, 2015, J ALLERGY CLIN IMMUN, V136, P1125, DOI 10.1016/j.jaci.2015.05.014; Calhoun WJ, 2012, JAMA-J AM MED ASSOC, V308, P987, DOI 10.1001/2012.jama.10893; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Cazzola M, 2016, J ALLERGY CLIN IMMUN, V138, P977, DOI 10.1016/j.jaci.2016.04.028; CDC, 2014, CURR ASTHM PREV PERC; Centers for Disease Control and Prevention (CDC), 2012, 20 LEAD PRIM DIAGN G; Centers for Disease Control and Prevention (CDC), 2010, RAT DISCH SHORT STAY; Centers for Disease Control and Prevention (CDC), 2014, UND CAUS DEATH 1999; Centers for Disease Control and Prevention (CDC), 2010, 20 LEAD PRIM DIAGN G; Centers for Disease Control and Prevention (CDC), 2011, 20 LEAD PRIM DIAGN P; CHERVINSKY P, 1994, J ALLERGY CLIN IMMUN, V94, P676, DOI 10.1016/0091-6749(94)90174-0; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; COCKCROFT DW, 1985, ANN ALLERGY, V55, P527; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Eaton T, 2000, CHEST, V118, P66, DOI 10.1378/chest.118.1.66; Freitas PD, 2017, AM J RESP CRIT CARE, V195, P32, DOI [10.1164/rccm.201603-0446OC, 10.1164/rccm.201603-0446oc]; Gauvreau GM, 2015, EUR RESPIR J, V46, DOI [10.1183/13993003.congress-2015.PA5091, 10.1183/13993003.00536-2015]; Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN; Goyal M, 2010, MED HYPOTHESES, V74, P661, DOI 10.1016/j.mehy.2009.11.011; Grigoras A, 2016, ROM J MORPHOL EMBRYO, V57, P115; Hansbro Philip M, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS297, DOI 10.1513/AnnalsATS.201402-086AW; Hosoki K, 2016, CURR OPIN ALLERGY CL, V16, P45, DOI 10.1097/ACI.0000000000000231; HUANG SK, 1995, J IMMUNOL, V155, P2688; Humbert M, 2014, J ALLER CL IMM-PRACT, V2, P525, DOI 10.1016/j.jaip.2014.03.010; Israel E, 1996, JAMA-J AM MED ASSOC, V275, P931, DOI 10.1001/jama.275.12.931; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; JOHANSSON SA, 1988, ALLERGY, V43, P173; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kerstjens HAM, 2016, EXPERT OPIN DRUG SAF, V15, P1115, DOI 10.1080/14740338.2016.1199682; Komarow HD, 2011, ANN ALLERG ASTHMA IM, V106, P191, DOI 10.1016/j.anai.2010.11.011; Lane SJ, 1996, J ALLERGY CLIN IMMUN, V98, pS67, DOI 10.1016/S0091-6749(96)80131-X; Laxmanan B, 2015, J ASTHMA ALLERGY, V8, P39, DOI 10.2147/JAA.S49306; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Leuppi JD, 2014, CURR OPIN PULM MED, V20, P31, DOI 10.1097/MCP.0000000000000009; Liu T, 2015, RESP MED, V109, P1391, DOI 10.1016/j.rmed.2015.09.016; Liu Y, 2014, DNA CELL BIOL, V33, P793, DOI 10.1089/dna.2013.2284; MARKETOS SG, 1982, J ASTHMA, V19, P263, DOI 10.3109/02770908209104771; McCracken JL, 2016, CURR OPIN ALLERGY CL, V16, P375, DOI 10.1097/ACI.0000000000000284; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Nakajima Hiroshi, 2010, Immune Netw, V10, P1, DOI 10.4110/in.2010.10.1.1; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Education and Prevention Program National Heart Lung and Blood Institute (NHLBI), 3 NHLBI; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Nicodemus-Johnson J, 2013, J ALLERGY CLIN IMMUN, V131, P1496, DOI 10.1016/j.jaci.2013.01.037; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; Ogawa Y, 2008, CURR MOL MED, V8, P437, DOI 10.2174/156652408785160907; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Papadopoulos NG, 2007, ALLERGY, V62, P457, DOI 10.1111/j.1398-9995.2007.01341.x; Peters SP, 2016, NEW ENGL J MED, V375, P850, DOI 10.1056/NEJMoa1511190; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Price D, 2011, NEW ENGL J MED, V364, P1695, DOI 10.1056/NEJMoa1010846; Ray A, 2015, AM J PHYSIOL-LUNG C, V308, pL130, DOI 10.1152/ajplung.00070.2014; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; Reno ANL, 2015, ENVIRON HEALTH INSIG, V9, DOI 10.4137/EHI.S15671; ROBINSON DS, 1993, THORAX, V48, P26, DOI 10.1136/thx.48.1.26; Roux E, 1998, GEN PHARMACOL, V31, P349, DOI 10.1016/S0306-3623(98)00007-X; Rubin Bruce K, 2014, Transl Respir Med, V2, P6, DOI 10.1186/2213-0802-2-6; Shapiro G, 2000, AM J RESP CRIT CARE, V161, P527, DOI 10.1164/ajrccm.161.2.9905091; Sokol K, 2014, ADV EXP MED BIOL, V795, P43, DOI 10.1007/978-1-4614-8603-9_4; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; vanNoord JA, 1996, EUR RESPIR J, V9, P1684, DOI 10.1183/09031936.96.09081684; Wechsler ME, 2013, J ALLERGY CLIN IMMUN, V132, P1295, DOI 10.1016/j.jaci.2013.08.009; White Carl W, 2010, Proc Am Thorac Soc, V7, P257, DOI 10.1513/pats.201001-008SM	78	109	116	0	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					279	290		10.1001/jama.2017.8372	http://dx.doi.org/10.1001/jama.2017.8372			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719697				2022-12-28	WOS:000405775000014
J	Voelker, R				Voelker, Rebecca			Opioid Should Come Off the Market	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					232	232		10.1001/jama.2017.8435	http://dx.doi.org/10.1001/jama.2017.8435			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719676				2022-12-28	WOS:000405775000004
J	Crow, D				Crow, Diana			Biology Gone Wild	CELL			English	Editorial Material								To study how genes, cells, or organisms operate in natural environments, researchers often need to leave the bench and venture into the field. Here are a few approaches that field biologists use in designing and conducting semi-wild experiments and the many challenges they face.											0	4	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					219	221		10.1016/j.cell.2017.06.043	http://dx.doi.org/10.1016/j.cell.2017.06.043			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708992	Bronze			2022-12-28	WOS:000405493900002
J	Wilt, TJ; Jones, KM; Barry, MJ; Andriole, GL; Culkin, D; Wheeler, T; Aronson, WJ; Brawer, MK				Wilt, Timothy J.; Jones, Karen M.; Barry, Michael J.; Andriole, Gerald L.; Culkin, Daniel; Wheeler, Thomas; Aronson, William J.; Brawer, Michael K.			Follow-up of Prostatectomy versus Observation for Early Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADICAL PROSTATECTOMY; ACTIVE-SURVEILLANCE; OBSERVATION TRIAL; COMPETING RISK; MEN; MANAGEMENT; COHORT; INTERVENTION; OUTCOMES; PROGRAM	BACKGROUND We previously found no significant differences in mortality between men who underwent surgery for localized prostate cancer and those who were treated with observation only. Uncertainty persists regarding nonfatal health outcomes and long-term mortality. METHODS From November 1994 through January 2002, we randomly assigned 731 men with localized prostate cancer to radical prostatectomy or observation. We extended follow-up through August 2014 for our primary outcome, all-cause mortality, and the main secondary outcome, prostate-cancer mortality. We describe disease progression, treatments received, and patient-reported outcomes through January 2010 (original follow-up). RESULTS During 19.5 years of follow-up (median, 12.7 years), death occurred in 223 of 364 men (61.3%) assigned to surgery and in 245 of 367 (66.8%) assigned to observation (absolute difference in risk, 5.5 percentage points; 95% confidence interval [CI], -1.5 to 12.4; hazard ratio, 0.84; 95% CI, 0.70 to 1.01; P = 0.06). Death attributed to prostate cancer or treatment occurred in 27 men (7.4%) assigned to surgery and in 42 men (11.4%) assigned to observation (absolute difference in risk, 4.0 percentage points; 95% CI, -0.2 to 8.3; hazard ratio, 0.63; 95% CI, 0.39 to 1.02; P = 0.06). Surgery may have been associated with lower all-cause mortality than observation among men with intermediate-risk disease (absolute difference, 14.5 percentage points; 95% CI, 2.8 to 25.6) but not among those with low-risk disease (absolute difference, 0.7 percentage points; 95% CI, -10.5 to 11.8) or high-risk disease (absolute difference, 2.3 percentage points; 95% CI, -11.5 to 16.1) (P = 0.08 for interaction). Treatment for disease progression was less frequent with surgery than with observation (absolute difference, 26.2 percentage points; 95% CI, 19.0 to 32.9); treatment was primarily for asymptomatic, local, or biochemical (prostate-specific antigen) progression. Urinary incontinence and erectile and sexual dysfunction were each greater with surgery than with observation through 10 years. Disease-related or treatment-related limitations in activities of daily living were greater with surgery than with observation through 2 years. CONCLUSIONS After nearly 20 years of follow-up among men with localized prostate cancer, surgery was not associated with significantly lower all-cause or prostate-cancer mortality than observation. Surgery was associated with a higher frequency of adverse events than observation but a lower frequency of treatment for disease progression, mostly for asymptomatic, local, or biochemical progression. (Funded by the Department of Veterans Affairs and others; PIVOT ClinicalTrials.gov number, NCT00007644.)	[Wilt, Timothy J.] Minneapolis Vet Affairs VA Hlth Care Syst, Minneapolis, MN USA; [Wilt, Timothy J.] Univ Minnesota, Sch Med, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55455 USA; [Wilt, Timothy J.] Univ Minnesota, Sch Med, Sect Gen Med, Minneapolis, MN 55455 USA; [Jones, Karen M.] VA Cooperat Studies Program Coordinating Ctr, Perry Point, MD USA; [Barry, Michael J.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Andriole, Gerald L.] Washington Univ, Sch Med, Div Urol, St Louis, MO USA; [Culkin, Daniel] Univ Oklahoma, Coll Med, Dept Urol, Oklahoma City, OK 73190 USA; [Wheeler, Thomas] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Aronson, William J.] Greater Los Angeles Healthcare Syst, VA Med Ctr, Los Angeles, CA USA; [Brawer, Michael K.] Myriad Genet Labs, Salt Lake City, UT USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; Baylor College of Medicine; Myriad Genetics, Inc	Wilt, TJ (corresponding author), Minneapolis VA Ctr Chron Dis Outcomes Res, 1 Vet Dr 111-0, Minneapolis, MN 55417 USA.	tim.wilt@va.gov			Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	Funded by the Department of Veterans Affairs and others; PIVOT ClinicalTrials.gov number, NCT00007644.	Albertsen PC, 2005, J NATL CANCER I, V97, P1248, DOI 10.1093/jnci/dji248; Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Allison P. D, 1995, SURVIVAL ANAL USING; [Anonymous], 1997, AJCC CANC STAGING MA; Barry MJ, 2013, CLIN TRIALS, V10, P907, DOI 10.1177/1740774513498008; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dall'Era MA, 2012, EUR UROL, V62, P976, DOI 10.1016/j.eururo.2012.05.072; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; Godtman RA, 2013, EUR UROL, V63, P101, DOI 10.1016/j.eururo.2012.08.066; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Hayes JH, 2013, ANN INTERN MED, V158, P853, DOI 10.7326/0003-4819-158-12-201306180-00002; Helpap B, 2006, VIRCHOWS ARCH, V449, P622, DOI 10.1007/s00428-006-0310-6; Hoffman KE, 2014, JAMA INTERN MED, V174, P1450, DOI 10.1001/jamainternmed.2014.3021; IVERSEN P, 1995, SCAND J UROL NEPHROL, P65; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Lin G., 2012, ANAL SURVIVAL DATA C; Maurice MJ, 2015, JAMA INTERN MED, V175, P1569, DOI 10.1001/jamainternmed.2015.2835; Maurice MJ, 2015, CUAJ-CAN UROL ASSOC, V9, pE193, DOI 10.5489/cuaj.2606; Newschaffer CJ, 2000, JNCI-J NATL CANCER I, V92, P613, DOI 10.1093/jnci/92.8.613; Pocock SJ, 2016, NEW ENGL J MED, V375, P971, DOI 10.1056/NEJMra1601511; Pocock SJ, 2016, NEW ENGL J MED, V375, P861, DOI 10.1056/NEJMra1510064; Sanyal C, 2016, CANCER-AM CANCER SOC, V122, P1085, DOI 10.1002/cncr.29892; Tosoian JJ, 2015, J CLIN ONCOL, V33, P3379, DOI 10.1200/JCO.2015.62.5764; US Preventive Services Task Force, PROST CANC SCREEN DR; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Wilt TJ, 2009, CONTEMP CLIN TRIALS, V30, P81, DOI 10.1016/j.cct.2008.08.002; Yamamoto T, 2016, J UROLOGY, V195, P1409, DOI 10.1016/j.juro.2015.11.075	36	334	338	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					132	142		10.1056/NEJMoa1615869	http://dx.doi.org/10.1056/NEJMoa1615869			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA2PC	28700844	Green Published, Bronze			2022-12-28	WOS:000405282300007
J	Livingston, G; Sommerlad, A; Orgeta, V; Costafreda, SG; Huntley, J; Ames, D; Ballard, C; Banerjee, S; Burns, A; Cohen-Mansfield, J; Cooper, C; Fox, N; Gitlin, LN; Howard, R; Kales, HC; Larson, EB; Ritchie, K; Rockwood, K; Sampson, EL; Samus, Q; Schneider, LS; Selbaek, G; Teri, L; Mukadam, N				Livingston, Gill; Sommerlad, Andrew; Orgeta, Vasiliki; Costafreda, Sergi G.; Huntley, Jonathan; Ames, David; Ballard, Clive; Banerjee, Sube; Burns, Alistair; Cohen-Mansfield, Jiska; Cooper, Claudia; Fox, Nick; Gitlin, Laura N.; Howard, Robert; Kales, Helen C.; Larson, Eric B.; Ritchie, Karen; Rockwood, Kenneth; Sampson, Elizabeth L.; Samus, Quincy; Schneider, Lon S.; Selbaek, Geir; Teri, Linda; Mukadam, Naaheed			Dementia prevention, intervention, and care	LANCET			English	Review							MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; SEVERE ALZHEIMERS-DISEASE; NURSING-HOME RESIDENTS; LONG-TERM-CARE; PLACEBO-CONTROLLED-TRIAL; COMMUNITY-DWELLING PERSONS; HEALTHY OLDER-ADULTS; ATYPICAL ANTIPSYCHOTIC MEDICATIONS		[Livingston, Gill; Sommerlad, Andrew; Orgeta, Vasiliki; Costafreda, Sergi G.; Huntley, Jonathan; Cooper, Claudia; Howard, Robert; Mukadam, Naaheed] UCL, Div Psychiat, London W1T 7NF, England; [Livingston, Gill; Costafreda, Sergi G.; Cooper, Claudia; Howard, Robert] Camden & Islington NHS Fdn Trust, London, England; [Huntley, Jonathan] Kings Coll London, Dept Old Age Psychiat, London, England; [Ames, David] Natl Ageing Res In, Parkville, Vic, Australia; [Ames, David] Univ Melbourne, Acad Unit Psychiat Old Age, Kew, Vic, Australia; [Ballard, Clive] Univ Exeter, Med Sch, Exeter, Devon, England; [Banerjee, Sube] Univ Sussex, Brighton & Sussex Med Sch, Ctr Dementia Studies, Brighton, E Sussex, England; [Banerjee, Sube] Univ Manchester, Ctr Dementia Studies, Manchester, Lancs, England; [Cohen-Mansfield, Jiska] Tel Aviv Univ, Dept Hlth Promot, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel; [Cohen-Mansfield, Jiska] Tel Aviv Univ, Heczeg Inst Aging, Tel Aviv, Israel; [Cohen-Mansfield, Jiska] Tel Aviv Univ, Minerva Ctr Interdisciplinary Study End Life, Tel Aviv, Israel; [Fox, Nick] UCL, Dementia Res Ctr, Inst Neurol, Natl Hosp Neurol & Neurosurg, London, England; [Gitlin, Laura N.] Johns Hopkins Univ, Ctr Innovat Care Aging, Baltimore, MD USA; [Kales, Helen C.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kales, Helen C.] VA Ctr Clin Management Res, Ann Arbor, MI USA; [Larson, Eric B.] Permanente Washington Hlth Res Inst, Seattle, WA USA; [Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Ritchie, Karen] Univ Montpellier, Colombiere Hosp, Neuropsychiat Epidemiol & Clin Res, Inserm,Unit 1061, Montpellier, France; [Ritchie, Karen] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Rockwood, Kenneth] Dalhousie Univ, Geriatr Med, Ctr Hlth Care Elderly People, Halifax, NS, Canada; [Sampson, Elizabeth L.] UCL, Div Psychiat, Marie Curie Palliat Care Res Dept, London, England; [Samus, Quincy] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Johns Hopkins Bayview, Baltimore, MD USA; [Schneider, Lon S.] Univ Southern Calif, Keck Sch Med, Dept Neurol, Leonard Davis Sch Gerontol, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Leonard Davis Sch Gerontol, Los Angeles, CA 90033 USA; [Selbaek, Geir] Vestfold Hlth Trust, Norwegian Natl Advisory Unit Aging & Hlth, Tonsberg, Norway; [Selbaek, Geir] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Selbaek, Geir] Innlandet Hosp Trust, Ctr Old Age Psychiat Res, Ottestad, Norway; [Teri, Linda] Univ Washington, Sch Nursing, Dept Psychosocial & Community Hlth, Washington, WA USA	University of London; University College London; University of London; King's College London; University of Melbourne; University of Exeter; University of Brighton; University of Sussex; University of Manchester; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Johns Hopkins University; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; University of Edinburgh; Dalhousie University; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; University of Southern California; University of Oslo; Innlandet Hospital Trust; University of Washington	Livingston, G (corresponding author), UCL, Div Psychiat, London W1T 7NF, England.	g.livingston@ucl.ac.uk	cohen-mansfield, jiska/AFS-8589-2022; Rockwood, Kenneth/AAD-8951-2019; Ritchie, Karen/G-3571-2013; Sampson, Elizabeth L/B-8647-2009; Fox, Nick C/B-1319-2009; Sommerlad, Andrew/Y-5517-2019; Cooper, Claudia/C-1556-2008	cohen-mansfield, jiska/0000-0003-0209-7304; Ritchie, Karen/0000-0002-0688-8982; Sampson, Elizabeth L/0000-0001-8929-7362; Fox, Nick C/0000-0002-6660-657X; Sommerlad, Andrew/0000-0002-8895-7055; Huntley, Jonathan/0000-0001-6304-6231; Howard, Robert/0000-0002-3071-2338; Orgeta, Vasiliki/0000-0001-8643-5061; Livingston, Gill/0000-0001-6741-5516; Ballard, Clive/0000-0003-0022-5632; Burns, Alistair/0000-0002-9837-0645; Costafreda Gonzalez, Sergi/0000-0001-6914-086X; Banerjee, Sube/0000-0002-8083-7649; Cooper, Claudia/0000-0002-2777-7616; Selbaek, Geir/0000-0001-6511-8219	University College London; Alzheimer's Society, UK; Economic and Social Research Council; Alzheimer's Research UK; ESRC [ES/L001780/1] Funding Source: UKRI; MRC [G0901982] Funding Source: UKRI	University College London(General Electric); Alzheimer's Society, UK; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are partnered by University College London, the Alzheimer's Society, UK, the Economic and Social Research Council, and Alzheimer's Research UK, and would like to thank them for financial help and attending our conferences. These organisations funded the fares, accommodation, and food for the Commission meetings but had no role in the writing of the manuscript or the decision to submit it for publication. We would like to thank Bernadette Courtney, Ephraim Robinson, Jacques Gianino, Nuj Monowari, and Alexandra Ferrell from University College London, London, UK, for their administrative help, including managing finances, booking rooms and food, and setting up a website. We would like to thank Sophie Naddell for proof reading. We would like to acknowledge the contribution of Kostas Lyketsos and John O'Brien who attended the second conference to comment on and improve the first draft of our Commission. We would also like to thank Frank Lin for his advice on hearing loss and its association with dementia.	Aalten P, 2007, DEMENT GERIATR COGN, V24, P457, DOI 10.1159/000110738; AAN, 2004, DET DIAGN MAN DEM GU; Aarsland D, 2009, LANCET NEUROL, V8, P613, DOI 10.1016/S1474-4422(09)70146-2; Adelman S, 2011, BRIT J PSYCHIAT, V199, P119, DOI 10.1192/bjp.bp.110.086405; Adelman S, 2009, INT J GERIATR PSYCH, V24, P657, DOI 10.1002/gps.2186; Ahronheim JC, 2001, J AM GERIATR SOC, V49, P148, DOI 10.1046/j.1532-5415.2001.49035.x; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alexopoulos GS, 2003, J AM GERIATR SOC, V51, P1178, DOI 10.1046/j.1532-5415.2003.51373.x; Almeida OP, 2014, BRIT J SPORT MED, V48, P220, DOI 10.1136/bjsports-2013-092814; Alva G, 2014, INT J GERIATR PSYCH, V29, P920, DOI 10.1002/gps.4080; Alzforum, ALZF NETW CUR; Alzheimer's Disease International, 2013, GLOB IMP DEM 2013 20; Ames D, 2016, DEMENTIA, V5th ed.; Amieva H, 2016, INT PSYCHOGERIATR, V28, P707, DOI 10.1017/S1041610215001830; Amieva H, 2015, J AM GERIATR SOC, V63, P2099, DOI 10.1111/jgs.13649; Amieva H, 2014, BRAIN, V137, P1167, DOI 10.1093/brain/awu035; Amjad H, 2016, JAMA INTERN MED, V176, P1371, DOI 10.1001/jamainternmed.2016.3553; Ancoli-Israel S, 2003, AM J GERIAT PSYCHIAT, V11, P194, DOI 10.1176/appi.ajgp.11.2.194; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Anderson RA, 2003, NURS RES, V52, P12, DOI 10.1097/00006199-200301000-00003; Andrieu S., 2017, LANCET NEUROL; Andrieu S, 2015, LANCET NEUROL, V14, P926, DOI 10.1016/S1474-4422(15)00153-2; Angevaren M, 2007, EUR J CARDIOV PREV R, V14, P825, DOI 10.1097/HJR.0b013e3282ef995b; ANNERSTEDT L, 1994, AGING-CLIN EXP RES, V6, P372, DOI 10.1007/BF03324268; [Anonymous], 2011, NICE SUBMISSION EVID; Apostolova LG, 2008, DEMENT GERIATR COGN, V25, P115, DOI 10.1159/000112509; Arai H, 2016, ALZHEIMERS DEMENT, V12, P823, DOI 10.1016/j.jalz.2016.03.006; Arcand M, 2009, J AM MED DIR ASSOC, V10, P50, DOI 10.1016/j.jamda.2008.07.008; Artero S, 2008, J NEUROL NEUROSUR PS, V79, P979, DOI 10.1136/jnnp.2007.136903; Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Ausserhofer D, 2016, J AM MED DIR ASSOC, V17, P685, DOI 10.1016/j.jamda.2016.03.009; Ayalon L, 2016, AGE AGEING, V45, P216, DOI 10.1093/ageing/afv193; Bahar-Fuchs A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003260.pub2; Bains J, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003944; BALDELLI MV, 1993, ARCH GERONTOL GERIAT, V17, P211, DOI 10.1016/0167-4943(93)90052-J; Baldelli MV, 2002, ARCH GERONTOL GERIAT, P15; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Ballard CG, 1996, INT J GERIATR PSYCH, V11, P507, DOI 10.1002/(SICI)1099-1166(199606)11:6<507::AID-GPS337>3.0.CO;2-U; Ballard C, 2008, PLOS MED, V5, P587, DOI 10.1371/journal.pmed.0050076; Ballard C, 2006, NAT REV NEUROSCI, V7, P492, DOI 10.1038/nrn1926; Ballard C, 2016, AM J PSYCHIAT, V173, P252, DOI 10.1176/appi.ajp.2015.15010130; Ballard C, 2015, J AM MED DIR ASSOC, V16, P316, DOI 10.1016/j.jamda.2014.11.002; Ballard C, 2014, BRIT J PSYCHIAT, V205, P4, DOI 10.1192/bjp.bp.113.128710; Ballard C, 2013, DRUG AGING, V30, P603, DOI 10.1007/s40266-013-0092-x; Ballard C, 2009, AM J GERIAT PSYCHIAT, V17, P726, DOI 10.1097/JGP.0b013e3181b0f8c0; Banerjee S., 2010, USE ANTIPSYCHOTIC ME; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Barclay S, 2014, BRIT J GEN PRACT, V64, pE576, DOI 10.3399/bjgp14X681397; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Beerens HC, 2014, J AM MED DIR ASSOC, V15, P54, DOI 10.1016/j.jamda.2013.09.010; Beerens HC, 2013, INT J NURS STUD, V50, P1259, DOI 10.1016/j.ijnurstu.2013.02.005; Ben Natan M, 2010, INT NURS REV, V57, P113, DOI 10.1111/j.1466-7657.2009.00771.x; Bentur N, 2015, AM J ALZHEIMERS DIS, V30, P165, DOI 10.1177/1533317514539726; Bergh S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1566; Bernabei R, 2014, AGING CLIN EXP RES, V26, P567, DOI 10.1007/s40520-014-0266-3; Bernstein AB, 2007, GERONTOLOGIST, V47, P350, DOI 10.1093/geront/47.3.350; Berry SD, 2016, J GERONTOL A-BIOL, V71, P273, DOI 10.1093/gerona/glv091; Berwald S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151878; Bharucha AJ, 2009, AM J GERIAT PSYCHIAT, V17, P88, DOI 10.1097/JGP.0b013e318187dde5; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Birks J, 2009, COCHRANE DB SYST REV, V2; Blake H, 2009, CLIN REHABIL, V23, P873, DOI 10.1177/0269215509337449; Blazer D, 2013, AM J PSYCHIAT, V170, P585, DOI 10.1176/appi.ajp.2013.13020179; Blennow K, 2005, INT J MOL MED, V16, P1147; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bohnen NI, 2005, J NEUROL NEUROSUR PS, V76, P315, DOI 10.1136/jnnp.2004.038729; Borenstein A, 2016, ALZHEIMERS DIS LIFE; Bossen AL, 2015, SMART HOMECARE TECHN, V3, P49, DOI 10.2147/SHTT.S59500; Bossen AL, 2009, J GERONTOL NURS, V35, P8, DOI 10.3928/00989134-20090301-01; Bottino CMC, 2005, CLIN REHABIL, V19, P861, DOI 10.1191/0269215505cr911oa; Bourgeois J, 2014, DRUG AGING, V31, P677, DOI 10.1007/s40266-014-0203-3; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; BREUIL V, 1994, INT J GERIATR PSYCH, V9, P211, DOI 10.1002/gps.930090306; Brodaty H, 2005, DEMENT GERIATR COGN, V20, P120, DOI 10.1159/000086613; Brodaty H, 2012, AM J GERIAT PSYCHIAT, V20, P549, DOI 10.1097/JGP.0b013e31822be242; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Brown AF, 2013, J AM GERIATR SOC, V61, P243, DOI 10.1111/jgs.12079; Brown BM, 2013, MOL PSYCHIATR, V18, P864, DOI 10.1038/mp.2012.162; Brown CA, 2013, DEMENTIA-LONDON, V12, P210, DOI 10.1177/1471301211426909; Bunn F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001331; Burgener SC, 2008, AM J ALZHEIMERS DIS, V23, P382, DOI 10.1177/1533317508317527; Burns A, 2005, BRIT J PSYCHIAT, V187, P143, DOI 10.1192/bjp.187.2.143; BURNS A, 1991, INT J GERIATR PSYCH, V6, P371, DOI 10.1002/gps.930060607; BURNS A, 2009, BRIT MED J, V338; Burns A, 2009, INT PSYCHOGERIATR, V21, P711, DOI 10.1017/S1041610209008886; Burstein A., 2014, ALZHEIMERS DEMENT S, V10, P571, DOI [10.1016/j.jalz.2014.05.936, DOI 10.1016/J.JALZ.2014.05.936]; Burton EJ, 2009, BRAIN, V132, P195, DOI 10.1093/brain/awn298; Butcher HK, 2001, RES NURS HEALTH, V24, P470, DOI 10.1002/nur.10005; Butterfield DA, 2003, CNS DRUGS, V17, P641, DOI 10.2165/00023210-200317090-00004; Cacciottolo M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.280; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Carlson MC, 2008, GERONTOLOGIST, V48, P793, DOI 10.1093/geront/48.6.793; Carone M, 2014, J AM STAT ASSOC, V109, P24, DOI 10.1080/01621459.2013.859076; Carrillo MC, 2009, ALZHEIMERS DEMENT, V5, P479, DOI 10.1016/j.jalz.2009.09.003; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Centers for Medicare and Medicaid Services, 2016, MED NAT COV DET MAN; Centers for Medicare and Medicaid Services, 2002, DEP HLTH HUM SERV PU; Chan D, 2013, INT J GERIATR PSYCH, V28, P1, DOI 10.1002/gps.3795; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chapman SB, 2004, J SPEECH LANG HEAR R, V47, P1149, DOI 10.1044/1092-4388(2004/085); Charlesworth G, 2008, BRIT MED J, V336, P1295, DOI 10.1136/bmj.39549.548831.AE; Charlesworth G, 2016, J NEUROL NEUROSUR PS, V87, P1218, DOI 10.1136/jnnp-2016-313736; Chen H, 2017, LANCET, V389, P718, DOI 10.1016/S0140-6736(16)32399-6; Chen Qi, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005008; Chen Y, 2010, ARCH INTERN MED, V170, P89, DOI 10.1001/archinternmed.2009.469; Chenoweth L, 2009, LANCET NEUROL, V8, P317, DOI 10.1016/S1474-4422(09)70045-6; Chetelat G, 2013, NEUROIMAGE-CLIN, V2, P356, DOI 10.1016/j.nicl.2013.02.006; Cheung SW, 2009, J NEUROSCI, V29, P7065, DOI 10.1523/JNEUROSCI.6072-08.2009; Cholerton B, 2016, AM J PATHOL, V186, P500, DOI 10.1016/j.ajpath.2015.12.001; Cholerton B, 2013, J ALZHEIMERS DIS, V36, P699, DOI 10.3233/JAD-130281; CHUI HC, 1994, ARCH NEUROL-CHICAGO, V51, P676, DOI 10.1001/archneur.1994.00540190056015; Chwiszczuk L, 2016, NEURODEGENER DIS, V16, P152, DOI 10.1159/000439252; Clare L, 2004, NEUROPSYCHOL REHABIL, V14, P385, DOI 10.1080/09602010443000074; Clare L, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-152; Coen Robert F., 2011, Irish Journal of Psychological Medicine, V28, P145, DOI 10.1017/S0790966700012131; Cohen-Mansfield J, 1999, ARCH INTERN MED, V159, P1733, DOI 10.1001/archinte.159.15.1733; Cohen-Mansfield J, 1996, Int Psychogeriatr, V8 Suppl 3, P309; Cohen-Mansfield J, 2006, GERONTOLOGIST, V46, P89, DOI 10.1093/geront/46.1.89; Cohen-Mansfield J, 2003, J GERIATR PSYCH NEUR, V16, P219, DOI 10.1177/0891988703258665; Cohen-Mansfield J., 2000, ALZHEIMERS CARE Q, V1, P22; Cohen-Mansfield J, 2016, AM J GERIAT PSYCHIAT, V24, P213, DOI 10.1016/j.jagp.2015.12.006; Cohen-Mansfield J, 2015, INT J GERIATR PSYCH, V30, P478, DOI 10.1002/gps.4164; Cohen-Mansfield J, 2013, JAMA INTERN MED, V173, P1378, DOI 10.1001/jamainternmed.2013.6483; Cohen-Mansfield J, 2011, J CLIN PSYCHIAT, V72, P480, DOI 10.4088/JCP.09m05694oli; Cohen-Mansfield J, 2010, J AM GERIATR SOC, V58, P1459, DOI 10.1111/j.1532-5415.2010.02951.x; Cohen-Mansfield J, 2010, AM J GERIAT PSYCHIAT, V18, P351, DOI 10.1097/JGP.0b013e3181c531fd; Cohen-Mansfield J, 2009, INT PSYCHOGERIATR, V21, P1160, DOI 10.1017/S1041610209990974; CohenMansfield J, 1997, J GERONTOL A-BIOL, V52, pM369, DOI 10.1093/gerona/52A.6.M369; Connelly K, 2014, GERONTOLOGY, V60, P282, DOI 10.1159/000355644; Coon JT, 2014, J AM MED DIR ASSOC, V15, P706, DOI 10.1016/j.jamda.2014.06.012; Cooper C, 2010, J NEUROL NEUROSUR PS, V81, P592, DOI 10.1136/jnnp.2009.190934; Cooper C, 2010, J AFFECT DISORDERS, V121, P136, DOI 10.1016/j.jad.2009.05.001; COOPER C, 2009, BMJ, V338; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Cooper C, 2007, INT J GERIATR PSYCH, V22, P181, DOI 10.1002/gps.1656; Cooper C, 2007, INT PSYCHOGERIATR, V19, P175, DOI 10.1017/S1041610206004297; Cooper C, 2006, AM J GERIAT PSYCHIAT, V14, P489, DOI 10.1097/01.JGP.0000192498.18316.b6; Cooper C, 2016, INT PSYCHOGERIATR, V28, P881, DOI 10.1017/S1041610215002033; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Cooper C, 2014, INT J GERIATR PSYCH, V29, P515, DOI 10.1002/gps.4034; Cooper C, 2013, BRIT J PSYCHIAT, V203, P255, DOI 10.1192/bjp.bp.113.127811; Cooper C, 2013, INT PSYCHOGERIATR, V25, P733, DOI 10.1017/S104161021200227X; Cooper C, 2013, AM J GERIAT PSYCHIAT, V21, P173, DOI 10.1016/j.jagp.2012.10.018; Cooper C, 2012, INT PSYCHOGERIATR, V24, P1447, DOI 10.1017/S1041610212000403; Cooper C, 2012, INT PSYCHOGERIATR, V24, P856, DOI 10.1017/S1041610211002614; Cooper C, 2010, BRIT J PSYCHIAT, V196, P480, DOI 10.1192/bjp.bp.109.071811; Cooper C, 2009, AM J GERIAT PSYCHIAT, V17, P826, DOI 10.1097/JGP.0b013e3181b0fa2e; Corbett A, 2015, J AM MED DIR ASSOC, V16, P990, DOI 10.1016/j.jamda.2015.06.014; Corbett A, 2012, INT J GERIATR PSYCH, V27, P628, DOI 10.1002/gps.2762; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coupland C, 2011, BMJ, V343; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cummings J, 2015, INT PSYCHOGERIATR, V27, P7, DOI 10.1017/S1041610214001963; Cummings J, 2012, DEMENT GERIATR COGN, V33, P341, DOI 10.1159/000340056; Cummings JL, 2015, JAMA-J AM MED ASSOC, V314, P1242, DOI 10.1001/jama.2015.10214; Cummings JL, 2013, CNS NEUROSCI THER, V19, P294, DOI 10.1111/cns.12076; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dauvilliers Y, 2007, SLEEP MED, V8, pS27, DOI 10.1016/S1389-9457(08)70006-6; Davies E, 2004, WHO REPORT; Daviglus Martha L, 2010, NIH Consens State Sci Statements, V27, P1; Davis A, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11420; De Beaumont L, 2016, J ALZHEIMERS DIS, V54, P913, DOI 10.3233/JAD-160373; de Jager CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI 10.1002/gps.2758; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; de Waal H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086558; Deal JA, 2015, AM J EPIDEMIOL, V181, P680, DOI 10.1093/aje/kwu333; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Department of Health, 2013, DEM STAT NAT REP DEM; Department of Health, 2009, LIVING WELL DEMENTIA; Department of Health, 2000, NO SECR GUID DEV IMP; Deudon A, 2009, INT J GERIATR PSYCH, V24, P1386, DOI 10.1002/gps.2275; Devanand DP, 2012, NEW ENGL J MED, V367, P1497, DOI 10.1056/NEJMoa1114058; Dickerson BC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00055; Dodge Hiroko H, 2012, Int J Alzheimers Dis, V2012, P956354, DOI 10.1155/2012/956354; Dotson VM, 2010, NEUROLOGY, V75, P27, DOI 10.1212/WNL.0b013e3181e62124; Douglas A, 2011, ARCH GERONTOL GERIAT, V52, pE1, DOI 10.1016/j.archger.2010.02.014; Dowling GA, 2005, INT J GERIATR PSYCH, V20, P738, DOI 10.1002/gps.1352; Dowling GA, 2008, J AM GERIATR SOC, V56, P239, DOI 10.1111/j.1532-5415.2007.01543.x; Dowling GA, 2007, WESTERN J NURS RES, V29, P961, DOI 10.1177/0193945907303083; Drye LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098426; Drye LT, 2011, INT J GERIATR PSYCH, V26, P573, DOI 10.1002/gps.2565; Duara R, 2008, NEUROLOGY, V71, P1986, DOI 10.1212/01.wnl.0000336925.79704.9f; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Duzel E, 2016, BRAIN, V139, P662, DOI 10.1093/brain/awv407; Emre M, 2010, LANCET NEUROL, V9, P969, DOI 10.1016/S1474-4422(10)70194-0; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; ESRC Growing Older Program, 2003, LONELINESS SOCIAL IS; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; Falahati F, 2015, DEMENT GERIATR COGN, V39, P81, DOI 10.1159/000366194; Farina N, 2017, INT J GERIATR PSYCH, V32, P32, DOI 10.1002/gps.4566; Farina N, 2014, INT PSYCHOGERIATR, V26, P9, DOI 10.1017/S1041610213001385; Farlow MR, 2010, CLIN THER, V32, P1234, DOI 10.1016/j.clinthera.2010.06.019; Feldman HH, 2007, J NEUROL NEUROSUR PS, V78, P1056, DOI 10.1136/jnnp.2006.099424; Feldman PH, 2003, MILBANK Q, V81, P179, DOI 10.1111/1468-0009.t01-1-00051; Finkel S, 2007, AM J GERIAT PSYCHIAT, V15, P443, DOI 10.1097/JGP.0b013e3180437d87; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub4; Forbes D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003946.pub4; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Fox C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035185; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Fritze T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156876; Gallacher J, 2012, NEUROLOGY, V79, P1583, DOI 10.1212/WNL.0b013e31826e263d; Gallagher D, 2011, AM J ALZHEIMERS DIS, V26, P205, DOI 10.1177/1533317511400307; Galvin JE, 2014, NEURODEGENER DIS MAN, V4, P455, DOI [10.2217/nmt.14.47, 10.2217/NMT.14.47]; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Gao SJ, 2016, ALZHEIMERS DEMENT, V12, P244, DOI 10.1016/j.jalz.2015.06.1894; Gates GA, 1996, ARCH OTOLARYNGOL, V122, P161; Gates GA, 2002, J AM GERIATR SOC, V50, P482, DOI 10.1046/j.1532-5415.2002.50114.x; Gates GA, 2012, OTOLARYNG HEAD NECK, V147, P1, DOI 10.1177/0194599812446282; Gates N, 2013, AM J GERIAT PSYCHIAT, V21, P1086, DOI 10.1016/j.jagp.2013.02.018; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Gauthier S, 2012, CAN GERIATR J, V15, P120, DOI 10.5770/cgj.15.49; GCBH, 2016, BRAIN BOD CONN GCBH; Gillon R, 2003, J MED ETHICS, V29, P307, DOI 10.1136/jme.29.5.307; Gitlin LN, 2010, JAMA-J AM MED ASSOC, V304, P983, DOI 10.1001/jama.2010.1253; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Godwin KM, 2013, AM J ALZHEIMERS DIS, V28, P216, DOI 10.1177/1533317513481091; Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845; Gomez-Isla T, 2008, ALZ DIS ASSOC DIS, V22, P21, DOI 10.1097/WAD.0b013e3181611024; Goodman C, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1493-4; Gopinath B, 2009, J AM GERIATR SOC, V57, P1306, DOI 10.1111/j.1532-5415.2009.02317.x; Goren A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0298-y; Gormley N, 2001, AGE AGEING, V30, P141, DOI 10.1093/ageing/30.2.141; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; GREENAMYRE JT, 1988, PROG NEURO-PSYCHOPH, V12, P421, DOI 10.1016/0278-5846(88)90102-9; GREENWALD BS, 1989, AM J PSYCHIAT, V146, P1472; Grossberg GT, 2015, CURR ALZHEIMER RES, V12, P53, DOI 10.2174/1567205011666141218122835; Grossberg GT, 2013, CNS DRUGS, V27, P469, DOI 10.1007/s40263-013-0077-7; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Haight Barbara K, 2006, Alzheimers Dement, V2, P56, DOI 10.1016/j.jalz.2005.12.003; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hansen EC, 2008, SOC SCI MED, V67, P1776, DOI 10.1016/j.socscimed.2008.09.020; Harper L, 2014, J NEUROL NEUROSUR PS, V85, P692, DOI 10.1136/jnnp-2013-306285; Hartley D, 2010, J AM ACAD AUDIOL, V21, P642, DOI 10.3766/jaaa.21.10.4; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Health and Social Care Information Centre, 2012, NAT DEM ANT PRESCR A; Hedenmalm K, 2006, J CLIN PSYCHOPHARM, V26, P192, DOI 10.1097/01.jcp.0000203200.96205.34; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Henn P., 2017, J PATIENT SAF, V10, DOI [10.1097/PTS.0000000000000298, DOI 10.1097/PTS.0000000000000298, DOI 10.1093/GERONA/GLW069]; Hepburn K, 2007, J GERONTOL NURS, V33, P30, DOI 10.3928/00989134-20070301-06; Hickam DH, 2013, COMP EFFECTIVENESS R; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hirschman KB, 2006, AM J GERIAT PSYCHIAT, V14, P659, DOI 10.1097/01.JGP.0000203179.94036.69; Ho T, 2016, BRIT J CLIN PHARMACO, V82, P784, DOI 10.1111/bcp.12997; Hoe J, 2007, INT J GERIATR PSYCH, V22, P1031, DOI 10.1002/gps.1786; Hoffmann K, 2016, J ALZHEIMERS DIS, V50, P443, DOI 10.3233/JAD-150817; Hoffmann K, 2013, NEUROEPIDEMIOLOGY, V41, P198, DOI 10.1159/000354632; Homma A, 2016, J ALZHEIMERS DIS, V52, P345, DOI 10.3233/JAD-151149; Hong T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147646; Hort J, 2010, EUR J NEUROL, V17, P1236, DOI 10.1111/j.1468-1331.2010.03040.x; Howard R, 2016, BRIT J PSYCHIAT, V209, P380, DOI 10.1192/bjp.bp.115.177683; Howard R, 2015, LANCET NEUROL, V14, P1171, DOI 10.1016/S1474-4422(15)00258-6; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Howard R, 2011, INT J GERIATR PSYCH, V26, P812, DOI 10.1002/gps.2607; Howard RJ, 2007, NEW ENGL J MED, V357, P1382, DOI 10.1056/NEJMoa066583; Howell MJ, 2015, JAMA NEUROL, V72, P707, DOI 10.1001/jamaneurol.2014.4563; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; Hsieh S, 2013, DEMENT GERIATR COGN, V36, P242, DOI 10.1159/000351671; Huang CQ, 2010, AGEING RES REV, V9, P131, DOI 10.1016/j.arr.2009.05.005; Hughes CM, 2007, DRUG AGING, V24, P81, DOI 10.2165/00002512-200724020-00001; Huntley JD, 2017, BRIT J PSYCHIAT, V210, P61, DOI 10.1192/bjp.bp.116.182048; Huntley JD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005247; Husebo BS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4065; Huybrechts KF, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e977; Hyare H, 2015, NEUROLOGY, V84, P1498, DOI 10.1212/WNL.0000000000000304; Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019; Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003; Institute of Medicine, 2009, LONG TERM CONS TRAUM; Intzandt B, 2015, CAN GERIATR J, V18, P65, DOI 10.5770/cgj.18.166; Ismail Z, 2016, ALZHEIMERS DEMENT, V12, P195, DOI 10.1016/j.jalz.2015.05.017; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jayes RL, 2012, J PAIN SYMPTOM MANAG, V44, P750, DOI 10.1016/j.jpainsymman.2012.08.004; Jensen CS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00187; Jiang HY, 2017, MOL NEUROBIOL, V54, P2997, DOI 10.1007/s12035-016-9831-4; Joling KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030936; Jones L, 2016, PALLIATIVE MED, V30, P279, DOI 10.1177/0269216315605447; Joranson N, 2015, J AM MED DIR ASSOC, V16, P867, DOI 10.1016/j.jamda.2015.05.002; Jordan A, 2012, PALLIATIVE MED, V26, P873, DOI 10.1177/0269216311412227; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; JPND, LONG COH STUD NEUR R; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Jutkowitz E, 2016, J AM GERIATR SOC, V64, P477, DOI 10.1111/jgs.13936; Jutkowitz E, 2010, VALUE HEALTH, V13, P720, DOI 10.1111/j.1524-4733.2010.00739.x; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kakigi A, 2000, AUDIOLOGY, V39, P153; Kales HC, 2007, AM J PSYCHIAT, V164, P1568, DOI 10.1176/appi.ajp.2007.06101710; Kales HC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h369; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Kales HC, 2012, AM J PSYCHIAT, V169, P71, DOI 10.1176/appi.ajp.2011.11030347; Kales HC, 2011, ARCH GEN PSYCHIAT, V68, P190, DOI 10.1001/archgenpsychiatry.2010.200; Kambugu A, 2016, JAIDS-J ACQ IMM DEF, V71, P506, DOI 10.1097/QAI.0000000000000898; Kaplan DB, 2013, J GERONTOL SOC WORK, V56, P164, DOI 10.1080/01634372.2012.753652; Kaplan DB, 2011, INT SOC WORK, V54, P361, DOI 10.1177/0020872810396255; Karantzas GC, 2016, ARCH GERONTOL GERIAT, V66, P89, DOI 10.1016/j.archger.2016.05.006; Karantzas GC, 2012, GERONTOLOGIST, V52, P506, DOI 10.1093/geront/gnr161; Karlawish Jason H T, 2002, LDI Issue Brief, V7, P1; Kavirajan H, 2007, LANCET NEUROL, V6, P782, DOI 10.1016/S1474-4422(07)70195-3; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kiely KM, 2012, J GERONTOL A-BIOL, V67, P997, DOI 10.1093/gerona/gls066; Kitchen Ginnette, 2002, Prof Nurse, V17, P647; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kivipelto M, 2013, ALZHEIMERS DEMENT, V9, P657, DOI 10.1016/j.jalz.2012.09.012; Knapp M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6342; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Kodner Dennis L, 2009, Healthc Q, V13 Spec No, P6; Koivisto AM, 2016, INT J GERIATR PSYCH, V31, P273, DOI 10.1002/gps.4321; Kolanowski A, 2011, J AM GERIATR SOC, V59, P1032, DOI 10.1111/j.1532-5415.2011.03449.x; Kopetz S, 2000, INT J GERIATR PSYCH, V15, P586, DOI 10.1002/1099-1166(200007)15:7<586::AID-GPS148>3.0.CO;2-D; KRAUSE T, 2011, BRIT MED J, V343; Kuhl DE, 2000, ANN NEUROL, V48, P391, DOI 10.1002/1531-8249(200009)48:3<391::AID-ANA17>3.0.CO;2-H; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Kupeli N, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0103-x; Laditka James N, 2008, J S C Med Assoc, V104, P219; Lai CKY, 2004, INT PSYCHOGERIATR, V16, P33, DOI 10.1017/S1041610204000055; Lai CKY, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006470.pub2; Laitinen ML, 2015, INT PSYCHOGERIATR, V27, P669, DOI 10.1017/S1041610214002427; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Langa KM, 2004, JAMA-J AM MED ASSOC, V292, P2901, DOI 10.1001/jama.292.23.2901; LARSON EB, 1993, NEW ENGL J MED, V328, P203, DOI 10.1056/NEJM199301213280308; Larson EB, RISING TIDE DEMENTIA; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Larson EB, 2010, INT PSYCHOGERIATR, V22, P1196, DOI 10.1017/S1041610210001080; Laver K, 2016, MED J AUSTRALIA, V204, P1, DOI 10.5694/mja15.01339; Lawrence V, 2011, BRIT J PSYCHIAT, V199, P417, DOI 10.1192/bjp.bp.111.093989; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; Leckie RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00985; Lee PE, 2004, BMJ-BRIT MED J, V329, P75, DOI 10.1136/bmj.38125.465579.55; Lester P, 2009, J AM MED DIR ASSOC, V10, P634, DOI 10.1016/j.jamda.2009.06.008; Li R, 2013, INT PSYCHOGERIATR, V25, P204, DOI 10.1017/S1041610212001755; Li R, 2012, J AFFECT DISORDERS, V139, P1, DOI 10.1016/j.jad.2011.05.055; Li Y, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009444.pub3; Lichtner V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-138; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Lim J, 2012, INT PSYCHOGERIATR, V24, P1571, DOI 10.1017/S1041610212000919; Lin FR, 2014, AGING MENT HEALTH, V18, P671, DOI 10.1080/13607863.2014.915924; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin FR, 2011, J GERONTOL A-BIOL, V66, P1131, DOI 10.1093/gerona/glr115; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Lin MY, 2004, J AM GERIATR SOC, V52, P1996, DOI 10.1111/j.1532-5415.2004.52554.x; Lin Y, 2011, INT J GERIATR PSYCH, V26, P670, DOI 10.1002/gps.2580; Livingston G, 2007, J NEUROL NEUROSUR PS, V78, P25, DOI 10.1136/jnnp.2006.094342; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; Livingston G., 2012, AGING HLTH, V8, P377, DOI [DOI 10.2217/AHE.12.42, 10.2217/ahe.12.42]; Livingston G, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002252; Livingston G, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18390; Livingston G, 2014, BRIT J PSYCHIAT, V205, P436, DOI 10.1192/bjp.bp.113.141119; Livingston G, 2014, LANCET PSYCHIAT, V1, P539, DOI 10.1016/S2215-0366(14)00073-X; Livingston G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6276; Livingston G, 2013, INT PSYCHOGERIATR, V25, P1849, DOI 10.1017/S1041610213001221; Livingston G, 2012, INT J GERIATR PSYCH, V27, P643, DOI 10.1002/gps.2772; Livingston G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4184; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Llorens F, 2016, PROG NEUROBIOL, V138, P36, DOI 10.1016/j.pneurobio.2016.03.003; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Logsdon RG, 2010, J GERONTOL B-PSYCHOL, V65, P691, DOI 10.1093/geronb/gbq054; Logsdon RG, 1997, GERONTOLOGIST, V37, P40, DOI 10.1093/geront/37.1.40; Lopez OL, 2007, ARCH NEUROL-CHICAGO, V64, P416, DOI 10.1001/archneur.64.3.416; Lord K, 2017, BJPSYCH OPEN, V3, P12, DOI 10.1192/bjpo.bp.116.003509; Lord K, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0242-1; Lord K, 2015, INT PSYCHOGERIATR, V27, P1301, DOI 10.1017/S1041610215000411; Luchsinger JA, 2009, CURR OPIN CLIN NUTR, V12, P15, DOI 10.1097/MCO.0b013e32831c8c71; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Lyketsos CG, 2001, INT J GERIATR PSYCH, V16, P1043, DOI 10.1002/gps.448; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Manthorpe J., 2010, NOTHING VENTURED NOT; Manton K C, 2005, Adv Gerontol, V16, P30; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Martin R, 2009, LANCET, V373, P2009, DOI 10.1016/S0140-6736(09)60349-4; Mate KE, 2017, INT J GERIATR PSYCH, V32, P316, DOI 10.1002/gps.4466; Matsunaga S, 2015, INT J NEUROPSYCHOPH, V19, pyv086; Matthews FE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11398; Matthews FE, 2002, LANCET, V360, P225, DOI 10.1016/S0140-6736(02)09461-8; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Maust DT, 2015, JAMA PSYCHIAT, V72, P438, DOI 10.1001/jamapsychiatry.2014.3018; McCallion P, 1999, J AM GERIATR SOC, V47, P203, DOI 10.1111/j.1532-5415.1999.tb04579.x; McCarrey AC, 2015, HORM BEHAV, V74, P167, DOI 10.1016/j.yhbeh.2015.04.018; McCarthy M, 1997, INT J GERIATR PSYCH, V12, P404; McCleery J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009178.pub3; McCleery J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010633.pub2; McConnell Eleanor S, 2016, Nurs Adm Q, V40, P244, DOI 10.1097/NAQ.0000000000000167; McCoy SL, 2005, Q J EXP PSYCHOL-A, V58, P22, DOI 10.1080/02724980443000151; McCrae CS, 2016, J GERONTOL B-PSYCHOL, V71, P458, DOI 10.1093/geronb/gbu162; McCurry SM, 2005, J AM GERIATR SOC, V53, P793, DOI 10.1111/j.1532-5415.2005.53252.x; McCurry SM, 2011, J AM GERIATR SOC, V59, P1393, DOI 10.1111/j.1532-5415.2011.03519.x; McGuinness B, 2016, COCHRANE DB SYST REV, V1; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub3; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MCSHANE R, 2006, COCHRANE DB SYST REV; Mendez MF, 2008, DEMENT GERIATR COGN, V25, P206, DOI 10.1159/000113418; MENENDEZGONZALEZ M, 2014, FRONT AGING NEUROSCI, V6; Mezey M, 1996, J AM GERIATR SOC, V44, P144, DOI 10.1111/j.1532-5415.1996.tb02430.x; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mitchell SL, 2004, ARCH INTERN MED, V164, P321, DOI 10.1001/archinte.164.3.321; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Mittelman MS, 2004, AM J PSYCHIAT, V161, P850, DOI 10.1176/appi.ajp.161.5.850; Moceri VM, 2001, EPIDEMIOLOGY, V12, P383, DOI 10.1097/00001648-200107000-00007; Moran M, 2005, SLEEP MED, V6, P347, DOI 10.1016/j.sleep.2004.12.005; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Morkem R, 2015, CAN J PSYCHIAT, V60, P564, DOI 10.1177/070674371506001207; Mormont E, 2014, J GERIATR PSYCH NEUR, V27, P231, DOI 10.1177/0891988714532021; Morris S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007382; Morrison RS, 2000, J PAIN SYMPTOM MANAG, V19, P240, DOI 10.1016/S0885-3924(00)00113-5; Moyle W, 2012, CURR OPIN PSYCHIATR, V25, P480, DOI 10.1097/YCO.0b013e32835a1ccf; Mukadam N, 2017, J ALZHEIMERS DIS, V58, P45, DOI [10.3233/jad-170131, 10.3233/JAD-170131]; Mukadam N, 2015, INT J GERIATR PSYCH, V30, P32, DOI 10.1002/gps.4184; Mukadam N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004119; Mukadam N, 2011, INT J GERIATR PSYCH, V26, P12, DOI 10.1002/gps.2484; MURRAY ME, 2014, ALZHEIMERS RES THER, V6; Murray PS, 2014, BIOL PSYCHIAT, V75, P542, DOI 10.1016/j.biopsych.2013.08.020; Nakanishi Miharu, 2012, Nihon Koshu Eisei Zasshi, V59, P3, DOI 10.11236/jph.59.1_3; Nasreddine Ziad S, 2012, Neurology, V78, P765, DOI 10.1212/01.wnl.0000413072.54070.a3; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson JC, 2011, J AM GERIATR SOC, V59, P577, DOI 10.1111/j.1532-5415.2011.03355.x; Nelson T, 2004, PSYCHOL MED, V34, P147, DOI 10.1017/S0033291703008808; Nelson T, 2002, AGE AGEING, V31, P445, DOI 10.1093/ageing/31.6.445; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; NICE, 2015, DEM DIS FRAILT LAT L; NICE, 2006, DEM SUPP PEOPL DEM T; Nichols LO, 2008, J AM GERIATR SOC, V56, P413, DOI 10.1111/j.1532-5415.2007.01569.x; Nieman CL, 2017, GERONTOLOGIST, V57, P1173, DOI 10.1093/geront/gnw153; Niu H, 2017, NEUROLOGIA, V32, P523, DOI 10.1016/j.nrl.2016.02.016; Norton MC, 2010, J AM GERIATR SOC, V58, P895, DOI 10.1111/j.1532-5415.2010.02806.x; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Nowak L., 2008, DISSERT ABSTR, V69, P1; O'Brien JT, 2017, J PSYCHOPHARMACOL, V31, P147, DOI 10.1177/0269881116680924; O'Brien JT, 2015, LANCET, V386, P1698, DOI 10.1016/S0140-6736(15)00463-8; O'Brien JT, 2014, J NUCL MED, V55, P1959, DOI 10.2967/jnumed.114.143347; O'Brien JT, 2001, NEUROLOGY, V56, P1386, DOI 10.1212/WNL.56.10.1386; Oeckl P, 2016, J NEUROCHEM, V138, P184, DOI 10.1111/jnc.13669; Ohman H, 2016, J AM GERIATR SOC, V64, P731, DOI 10.1111/jgs.14059; Okamura H, 2013, DEMENT GERIATR COGN, V36, P111, DOI 10.1159/000353444; Olafsdottir M, 2001, SCAND J PRIM HEALTH, V19, P194, DOI 10.1080/028134301316982469; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Onakpoya IJ, 2017, NUTR NEUROSCI, V20, P219, DOI [10.1080/1028415X.2015.1110899, 10.1080/1028415x.2015.1110899]; Onder G, 2005, BRIT J PSYCHIAT, V187, P450, DOI 10.1192/bjp.187.5.450; Onor Maria Luisa, 2007, Am J Alzheimers Dis Other Demen, V22, P261, DOI 10.1177/1533317507302071; Orgeta V, 2015, BRIT J PSYCHIAT, V207, P293, DOI 10.1192/bjp.bp.114.148130; Orgeta V, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19640; Orgeta V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009125.pub2; Palecek EJ, 2010, J AM GERIATR SOC, V58, P580, DOI 10.1111/j.1532-5415.2010.02740.x; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pimouguet C, 2010, J NUTR HEALTH AGING, V14, P669, DOI 10.1007/s12603-010-0314-4; Pinner G, 2003, INT PSYCHOGERIATR, V15, P279, DOI 10.1017/S1041610203009530; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Pitkala KH, 2013, JAMA INTERN MED, V173, P894, DOI 10.1001/jamainternmed.2013.359; Pollock BG, 2002, AM J PSYCHIAT, V159, P460, DOI 10.1176/appi.ajp.159.3.460; Pollock BG, 2007, AM J GERIAT PSYCHIAT, V15, P942, DOI 10.1097/JGP.0b013e3180cc1ff5; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Prince M, 2015, WORLD ALZHEIMERS REP; Prince M, 2011, WORLD ALZHEIMER REPO; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Rait G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3584; Rajkumar AP, 2016, J AM MED DIR ASSOC, V17, P741, DOI 10.1016/j.jamda.2016.04.006; Rapaport P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014177; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Regier NG, 2017, GERONTOLOGIST, V57, P987, DOI 10.1093/geront/gnw133; Reijnders J, 2013, AGEING RES REV, V12, P263, DOI 10.1016/j.arr.2012.07.003; Reilly S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008345.pub2; Reiman EM, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.177; Requena C, 2006, DEMENT GERIATR COGN, V22, P339, DOI 10.1159/000095600; Richard E, 2009, ALZ DIS ASSOC DIS, V23, P198, DOI 10.1097/WAD.0b013e31819783a4; Richardson B, 2002, AGE AGEING, V31, P335, DOI 10.1093/ageing/31.5.335; Riemersma-van Der Lek RF, 2008, JAMA-J AM MED ASSOC, V299, P2642, DOI 10.1001/jama.299.22.2642; Rijpma A, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0134-1; RITCHIE K, 2010, BRIT MED J, V341; Ritchie K, 2016, J CLIN PSYCHIAT, V77, pE305, DOI 10.4088/JCP.15m09989; Ritchie K, 2010, AM J GERIAT PSYCHIAT, V18, P692, DOI 10.1097/JGP.0b013e3181df4897; The Health and Social Care Information Centre, 2015, HLTH SURV ENGL 2014; Who Cares Wins, 2005, IMPR OUTC OLD PEOPL; World Health Organization, 2015, WHO GLOBAL REPORT ON; World Health Organization, INT STAT CLASS DIS R, V10th; Boekhorst ST, 2008, AGING MENT HEALTH, V12, P761, DOI 10.1080/13607860802380615; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Ritchie CW, 2016, LANCET PSYCHIAT, V3, P179, DOI 10.1016/S2215-0366(15)00454-X; Ritchie CW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001893; Ritchie Karen, 2015, Alzheimers Dement (N Y), V1, P122, DOI 10.1016/j.trci.2015.06.004; Robinson H, 2013, J AM MED DIR ASSOC, V14, P661, DOI 10.1016/j.jamda.2013.02.007; Robinson L, 2013, PALLIATIVE MED, V27, P401, DOI 10.1177/0269216312465651; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Roett Michelle A, 2013, FP Essent, V414, P11; Rokstad AMM, 2017, INT J OLDER PEOPLE N, V12, DOI 10.1111/opn.12139; Rolinski M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006504.pub2; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rosenberg PB, 2015, MOL ASPECTS MED, V43-44, P25, DOI 10.1016/j.mam.2015.05.005; Rosenberg PB, 2013, J CLIN PSYCHIAT, V74, P810, DOI 10.4088/JCP.12m08099; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Rosenblatt A, 2004, J AM GERIATR SOC, V52, P1618, DOI 10.1111/j.1532-5415.2004.52452.x; Roth M., 1996, British Journal of Psychiatry, V168, P149, DOI 10.1192/bjp.168.2.149; Rowe CC, 2013, MED CLIN N AM, V97, P377, DOI 10.1016/j.mcna.2012.12.017; Ryu SH, 2005, AM J GERIAT PSYCHIAT, V13, P976, DOI 10.1176/appi.ajgp.13.11.976; Sachdev PS, 2014, NAT REV NEUROL, V10, P634, DOI 10.1038/nrneurol.2014.181; Sampson EL, 2006, AGE AGEING, V35, P187, DOI 10.1093/ageing/afj025; Sampson EL, 2005, INT PSYCHOGERIATR, V17, P31, DOI 10.1017/S1041610205001018; Sampson Elizabeth L, 2008, BMC Palliat Care, V7, P8, DOI 10.1186/1472-684X-7-8; Sampson EL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007209.pub2; Samsi K, 2013, INT PSYCHOGERIATR, V25, P949, DOI 10.1017/S1041610213000306; Samus QM, 2014, AM J GERIAT PSYCHIAT, V22, P398, DOI 10.1016/j.jagp.2013.12.175; SantaCruz KS, 2011, J NEUROPATH EXP NEUR, V70, P832, DOI 10.1097/NEN.0b013e31822e8ae9; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Savva GM, 2009, BRIT J PSYCHIAT, V194, P212, DOI 10.1192/bjp.bp.108.049619; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P216, DOI 10.1001/archneurol.2008.536; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Schmidt R, 2015, EUR J NEUROL, V22, P889, DOI 10.1111/ene.12707; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schneider LS, 2016, LANCET, V388, P738, DOI 10.1016/S0140-6736(16)31129-1; Schneider LS, 2016, AM J PSYCHIAT, V173, P465, DOI 10.1176/appi.ajp.2015.15050648; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Scholes S, 2014, HEARING; SCHOTT JM, 2011, BMJ, V343; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; SCHWABER MK, 1993, AM J OTOL, V14, P252; Seitz D, 2010, INT PSYCHOGERIATR, V22, P1025, DOI 10.1017/S1041610210000608; Selwood A, 2007, J AFFECT DISORDERS, V101, P75, DOI 10.1016/j.jad.2006.10.025; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shah F, 2010, J AM MED DIR ASSOC, V11, P239, DOI 10.1016/j.jamda.2009.08.006; Shah RC, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt224; Sharkey N, 2012, GERONTOLOGY, V58, P282, DOI 10.1159/000329483; Shega JW, 2006, J AM GERIATR SOC, V54, P1892, DOI 10.1111/j.1532-5415.2006.00986.x; Sheline YI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008169; Shenkin SD, 2014, AGE AGEING, V43, P166, DOI 10.1093/ageing/aft184; Singh MAF, 2014, J AM MED DIR ASSOC, V15, P873, DOI 10.1016/j.jamda.2014.09.010; Singh-Manoux A, 2017, JAMA PSYCHIAT, V74, P712, DOI 10.1001/jamapsychiatry.2017.0660; SINHA UK, 1993, NEUROLOGY, V43, P779, DOI 10.1212/WNL.43.4.779; Skoog I, 1995, NEURODEGENERATION, V4, P433, DOI 10.1006/neur.1995.0052; Smith Marianne, 2008, Issues Ment Health Nurs, V29, P817, DOI 10.1080/01612840802182839; Smith Marianne, 2008, J Am Psychiatr Nurses Assoc, V14, P39, DOI 10.1177/1078390307310692; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Snitz BE, 2009, JAMA-J AM MED ASSOC, V302, P2663, DOI 10.1001/jama.2009.1913; Snowden JS, 2015, AMYOTROPH LAT SCL FR, V16, P497, DOI 10.3109/21678421.2015.1074700; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Somme D, 2012, ALZHEIMERS DEMENT, V8, P426, DOI 10.1016/j.jalz.2011.06.004; Sommerlad A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005273; Song XW, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0054-5; Sonnen JA, 2010, BRAIN PATHOL, V20, P654, DOI 10.1111/j.1750-3639.2009.00371.x; Sorbi S, 2012, EUR J NEUROL, V19, P1159, DOI 10.1111/j.1468-1331.2012.03784.x; Sorensen S, 2006, LANCET NEUROL, V5, P961, DOI 10.1016/S1474-4422(06)70599-3; Spector A, 2001, NEUROPSYCHOL REHABIL, V11, P377, DOI 10.1080/09602010143000068; Spector A, 2003, BRIT J PSYCHIAT, V183, P248, DOI 10.1192/bjp.183.3.248; SPECTOR A, 2012, TRIALS, V13; Spijker A, 2008, J AM GERIATR SOC, V56, P1116, DOI 10.1111/j.1532-5415.2008.01705.x; Stanley MA, 2013, AM J GERIAT PSYCHIAT, V21, P696, DOI 10.1016/j.jagp.2013.01.007; Starkstein SE, 2007, EUR J NEUROL, V14, P455, DOI 10.1111/j.1468-1331.2007.01745.x; Steenland K, 2013, J AM GERIATR SOC, V61, P1449, DOI 10.1111/jgs.12414; Steinberg M, 2004, INT J GERIATR PSYCH, V19, P19, DOI 10.1002/gps.1025; Steinert T, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00141; STERN Y, 1987, NEUROLOGY, V37, P1649, DOI 10.1212/WNL.37.10.1649; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Stewart R, 2014, AGE AGEING, V43, P562, DOI 10.1093/ageing/afu062; Stinton C, 2015, AM J PSYCHIAT, V172, P731, DOI 10.1176/appi.ajp.2015.14121582; Storey JE, 2004, INT PSYCHOGERIATR, V16, P13, DOI 10.1017/S1041610204000043; Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Strydom A, 2007, BRIT J PSYCHIAT, V191, P150, DOI 10.1192/bjp.bp.106.028845; Sultzer DL, 2008, AM J PSYCHIAT, V165, P844, DOI 10.1176/appi.ajp.2008.07111779; Sundstrom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008565; Sung HC, 2012, INT J GERIATR PSYCH, V27, P621, DOI 10.1002/gps.2761; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Tadaka E, 2007, GERIATR GERONTOL INT, V7, P167, DOI 10.1111/j.1447-0594.2007.00381.x; Tam-Tham H, 2013, INT J GERIATR PSYCH, V28, P889, DOI 10.1002/gps.3906; Tanner JA, 2015, AM J GERIAT PSYCHIAT, V23, P391, DOI 10.1016/j.jagp.2014.08.002; Tappen RM, 2009, RES GERONTOL NURS, V2, P267, DOI 10.3928/19404921-20090428-02; Tarraga L, 2006, J NEUROL NEUROSUR PS, V77, P1116, DOI 10.1136/jnnp.2005.086074; Teri L, 2008, J NUTR HEALTH AGING, V12, P391, DOI 10.1007/BF02982672; Teri L, 2005, GERONTOLOGIST, V45, P802, DOI 10.1093/geront/45.6.802; Teri L, 2005, GERONTOLOGIST, V45, P686, DOI 10.1093/geront/45.5.686; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Teri L, 2016, HDB PSYCHOL AGING, P447; Teri L, 2012, GERONTOLOGIST, V52, P452, DOI 10.1093/geront/gnr132; Teri L, 2010, AM J GERIAT PSYCHIAT, V18, P502, DOI 10.1097/JGP.0b013e3181c37b0e; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Tolson D, 2011, J AM MED DIR ASSOC, V12, P184, DOI 10.1016/j.jamda.2010.12.013; Tom SE, 2015, AM J PUBLIC HEALTH, V105, P408, DOI 10.2105/AJPH.2014.301935; Tomlinson E, 2015, PALLIATIVE MED, V29, P720, DOI 10.1177/0269216315582143; Tschanz JT, 2006, NEUROLOGY, V67, P229, DOI 10.1212/01.wnl.0000224748.48011.84; Tschanz JT, 2011, AM J GERIAT PSYCHIAT, V19, P532, DOI 10.1097/JGP.0b013e3181faec23; Valcarcel-Nazco C, 2014, J ALZHEIMERS DIS, V42, P777, DOI 10.3233/JAD-132216; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; Valenzuela MJ, 2008, CURR OPIN PSYCHIATR, V21, P296, DOI 10.1097/YCO.0b013e3282f97b1f; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Valls-Pedret C, 2015, JAMA INTERN MED, V175, P1094, DOI 10.1001/jamainternmed.2015.1668; van Charante EPM, 2016, LANCET, V388, P797, DOI 10.1016/S0140-6736(16)30950-3; van der Linde RM, 2016, BRIT J PSYCHIAT, V209, P368, DOI 10.1192/bjp.bp.114.148403; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; van der Steen JT, 2011, INT PSYCHOGERIATR, V23, P31, DOI 10.1017/S1041610210001079; van der Steen JT, 2009, J PALLIAT MED, V12, P789, DOI 10.1089/jpm.2009.0049; van Uffelen JGZ, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.044735; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; Vaughan S, 2014, AGE AGEING, V43, P623, DOI 10.1093/ageing/afu010; Velayudhan L, 2014, INT PSYCHOGERIATR, V26, P1247, DOI 10.1017/S1041610214000416; Vellas B, 2012, LANCET NEUROL, V11, P851, DOI 10.1016/S1474-4422(12)70206-5; Verbeek H, 2009, INT PSYCHOGERIATR, V21, P252, DOI 10.1017/S104161020800820X; Vigen CLP, 2011, AM J PSYCHIAT, V168, P831, DOI 10.1176/appi.ajp.2011.08121844; Vijverberg EGB, 2016, J ALZHEIMERS DIS, V53, P1287, DOI 10.3233/JAD-160285; Villemagne VL, 2016, AGEING RES REV, V30, P95, DOI 10.1016/j.arr.2016.01.005; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Villemagne VL, 2013, J ALZHEIMERS DIS, V33, pS349, DOI 10.3233/JAD-2012-129034; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Volicer L, 2012, INT J GERIATR PSYCH, V27, P749, DOI 10.1002/gps.2800; Wada T, 2014, J AM GERIATR SOC, V62, P1810, DOI 10.1111/jgs.13009; Waldorff FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4693; Walker AE, 2006, AGING MENT HEALTH, V10, P532, DOI 10.1080/13607860600637828; Wang HX, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002251; Wang JJ, 2007, INT J GERIATR PSYCH, V22, P1235, DOI 10.1002/gps.1821; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Warshaw GA, 2014, HEALTH AFFAIR, V33, P633, DOI 10.1377/hlthaff.2013.1232; Weich S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1996; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Weintraub D, 2015, AM J GERIAT PSYCHIAT, V23, P1127, DOI 10.1016/j.jagp.2015.05.006; Weintraub D, 2010, AM J GERIAT PSYCHIAT, V18, P332, DOI 10.1097/JGP.0b013e3181cc0333; Weuve Jennifer, 2014, Alzheimers Dement, V10, pe40, DOI 10.1016/j.jalz.2014.01.004; White L, 2002, ANN NY ACAD SCI, V977, P9, DOI 10.1111/j.1749-6632.2002.tb04794.x; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Winblad B, 2007, INT J GERIATR PSYCH, V22, P456, DOI 10.1002/gps.1788; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Woods B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005562.pub2; Woods DL, 2009, FORSCH KOMPLEMENTMED, V16, P181, DOI 10.1159/000220479; Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Yaffe K, 2007, ALZ DIS ASSOC DIS, V21, P167, DOI 10.1097/WAD.0b013e318065bfd6; Yang YC, 2016, P NATL ACAD SCI USA, V113, P578, DOI 10.1073/pnas.1511085112; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4; Yu F, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-394; Zahodne LB, 2015, AM J GERIAT PSYCHIAT, V23, P130, DOI 10.1016/j.jagp.2013.03.014; Zimmerman S, 2013, J AM GERIATR SOC, V61, P1399, DOI 10.1111/jgs.12372; ZUBENKO GS, 1988, ARCH NEUROL-CHICAGO, V45, P1182, DOI 10.1001/archneur.1988.00520350020008; Zubenko GS, 2003, AM J PSYCHIAT, V160, P857, DOI 10.1176/appi.ajp.160.5.857	663	3427	3546	71	745	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					2673	2734		10.1016/S0140-6736(17)31363-6	http://dx.doi.org/10.1016/S0140-6736(17)31363-6			62	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ1FF	28735855	Green Submitted			2022-12-28	WOS:000418101000028
J	Maretty, L; Jensen, JM; Petersen, B; Sibbesen, JAN; Liu, SY; Villesen, P; Kov, LS; Belling, K; Have, CTH; Izarzugaza, JMG; Rosjean, MG; Bork-Jensen, J; Rove, JG; Ls, TDA; Huang, SJ; Chang, YQ; Xu, RQ; Ye, WJ; Rao, JH; Guo, XS; Sun, JH; Cao, HZ; Ye, C; van Beusekom, J; Espeseth, T; Flindt, E; Friborg, RM; Halager, AE; Le Hellard, S; Hultman, CM; Lescai, F; Li, ST; Lund, O; Longren, P; Mailund, T; Matey-Hernandez, ML; Mors, O; Pedersen, CNS; Icheritz-Ponten, TS; Sullivan, P; Syed, A; Westergaard, D; Yadav, R; Li, N; Xu, X; Hansen, T; Krogh, A; Bolund, L; Sorensen, TIA; Pedersen, O; Upta, RG; Rasmussen, S; Besenbacher, S; Borglum, AD; Wang, J; Eiberg, H; Kristiansen, K; Brunak, S; Schierup, MH				Maretty, Lasse; Jensen, Jacob Malte; Petersen, Bent; Sibbesen, Jonas A. Ndreas; Liu, Siyang; Villesen, Palle; Kov, Laurits S.; Belling, Kirstine; Have, Christian T. Heil; Izarzugaza, Jose M. G.; Rosjean, Marie G.; Bork-Jensen, Jette; Rove, Jakob G.; Ls, Thomas D. A.; Huang, Shujia; Chang, Yuqi; Xu, Ruiqi; Ye, Weijian; Rao, Junhua; Guo, Xiaosen; Sun, Jihua; Cao, Hongzhi; Ye, Chen; van Beusekom, Johan; Espeseth, Thomas; Flindt, Esben; Friborg, Rune M.; Halager, Anders E.; Le Hellard, Stephanie; Hultman, Christina M.; Lescai, Francesco; Li, Shengting; Lund, Ole; Longren, Peter; Mailund, Thomas; Matey-Hernandez, Maria Luisa; Mors, Ole; Pedersen, Christian N. S.; Icheritz-Ponten, Thomas S.; Sullivan, Patrick; Syed, Ali; Westergaard, David; Yadav, Rachita; Li, Ning; Xu, Xun; Hansen, Torben; Krogh, Anders; Bolund, Lars; Sorensen, Thorkild I. A.; Pedersen, Oluf; Upta, Ramneek G.; Rasmussen, Simon; Besenbacher, Soren; Borglum, Anders D.; Wang, Jun; Eiberg, Hans; Kristiansen, Karsten; Brunak, Soren; Schierup, Mikkel Heide			Sequencing and de novo assembly of 150 genomes from Denmark as a population reference	NATURE			English	Article							STRUCTURAL VARIATION; MUTATIONS; DISCOVERY; ALIGNMENT; PATTERNS; QUALITY; LOCI; GENE; AGE; MAP	Hundreds of thousands of human genomes are now being sequenced to characterize genetic variation and use this information to augment association mapping studies of complex disorders and other phenotypic traits(1-4). Genetic variation is identified mainly by mapping short reads to the reference genome or by performing local assembly(2,5-7). However, these approaches are biased against discovery of structural variants and variation in the more complex parts of the genome. Hence, large-scale de novo assembly is needed. Here we show that it is possible to construct excellent de novo assemblies from high-coverage sequencing with mate-pair libraries extending up to 20 kilobases. We report de novo assemblies of 150 individuals (50 trios) from the GenomeDenmark project. The quality of these assemblies is similar to those obtained using the more expensive long-read technology(4,8-13). We use the assemblies to identify a rich set of structural variants including many novel insertions and demonstrate how this variant catalogue enables further deciphering of known association mapping signals. We leverage the assemblies to provide 100 completely resolved major histocompatibility complex haplotypes and to resolve major parts of the Y chromosome. Our study provides a regional reference genome that we expect will improve the power of future association mapping studies and hence pave the way for precision medicine initiatives, which now are being launched in many countries including Denmark.	[Maretty, Lasse; Sibbesen, Jonas A. Ndreas; Liu, Siyang; Krogh, Anders] Univ Copenhagen, Bioinformat Ctr, Dept Biol, DK-2200 Copenhagen, Denmark; [Jensen, Jacob Malte; Villesen, Palle; Kov, Laurits S.; Friborg, Rune M.; Halager, Anders E.; Mailund, Thomas; Pedersen, Christian N. S.; Besenbacher, Soren; Schierup, Mikkel Heide] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark; [Jensen, Jacob Malte; Villesen, Palle; Kov, Laurits S.; Rove, Jakob G.; Ls, Thomas D. A.; Lescai, Francesco; Li, Shengting; Mailund, Thomas; Mors, Ole; Pedersen, Christian N. S.; Borglum, Anders D.; Wang, Jun; Schierup, Mikkel Heide] Aarhus Univ, Ctr Integrat Sequencing, iSEQ, DK-8000 Aarhus, Denmark; [Petersen, Bent; Belling, Kirstine; Izarzugaza, Jose M. G.; Rosjean, Marie G.; van Beusekom, Johan; Lund, Ole; Longren, Peter; Matey-Hernandez, Maria Luisa; Icheritz-Ponten, Thomas S.; Syed, Ali; Westergaard, David; Yadav, Rachita; Upta, Ramneek G.; Rasmussen, Simon; Brunak, Soren] Tech Univ Denmark, Dept Bio & Hlth Informat, DTU Bioinformat, DK-2800 Kongens Lyngby, Denmark; [Liu, Siyang; Xu, Ruiqi; Ye, Weijian; Rao, Junhua; Sun, Jihua; Li, Ning] BGI Europe, Ole Maaloes Vej 3, DK-2200 Copenhagen, Denmark; [Villesen, Palle; Mors, Ole; Besenbacher, Soren] Aarhus Univ, Dept Clin Med, DK-8000 Aarhus, Denmark; [Have, Christian T. Heil; Bork-Jensen, Jette; Sun, Jihua; Hansen, Torben; Sorensen, Thorkild I. A.; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark; [Rove, Jakob G.; Ls, Thomas D. A.; Lescai, Francesco; Li, Shengting; Borglum, Anders D.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Rove, Jakob G.; Ls, Thomas D. A.; Lescai, Francesco; Li, Shengting; Mors, Ole; Borglum, Anders D.] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, DK-8000 Aarhus, Denmark; [Huang, Shujia; Chang, Yuqi; Guo, Xiaosen; Cao, Hongzhi; Ye, Chen; Xu, Xun; Bolund, Lars; Wang, Jun; Kristiansen, Karsten] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Huang, Shujia] South China Univ Technol, Sch Biosci & Biotechnol, Guangzhou 510006, Guangdong, Peoples R China; [Guo, Xiaosen; Flindt, Esben; Wang, Jun; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, DK-2100 Copenhagen, Denmark; [Espeseth, Thomas] Univ Oslo, Dept Psychol, N-0317 Oslo, Norway; [Espeseth, Thomas; Le Hellard, Stephanie] Univ Bergen, KG Jebsen Ctr Psychosis Res, Dept Clin Sci, NORMENT, N-5021 Bergen, Norway; [Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, Dr E Martens Res Grp Biol Psychiat, N-5021 Bergen, Norway; [Hultman, Christina M.; Sullivan, Patrick] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Sullivan, Patrick] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Dept Clin Epidemiol, DK-2000 Frederiksberg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, DK-2200 Copenhagen, Denmark; [Eiberg, Hans] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Brunak, Soren] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Schierup, Mikkel Heide] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark	University of Copenhagen; Aarhus University; Aarhus University; Technical University of Denmark; Aarhus University; Novo Nordisk Foundation; University of Copenhagen; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Beijing Genomics Institute (BGI); South China University of Technology; University of Copenhagen; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University	Schierup, MH (corresponding author), Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark.; Schierup, MH (corresponding author), Aarhus Univ, Ctr Integrat Sequencing, iSEQ, DK-8000 Aarhus, Denmark.; Brunak, S (corresponding author), Tech Univ Denmark, Dept Bio & Hlth Informat, DTU Bioinformat, DK-2800 Kongens Lyngby, Denmark.; Kristiansen, K (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.; Kristiansen, K (corresponding author), Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, DK-2100 Copenhagen, Denmark.; Brunak, S (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark.; Schierup, MH (corresponding author), Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark.	kk@bio.ku.dk; brunak@cbs.dtu.dk; mheide@birc.au.dk	Pedersen, Oluf/AAG-8015-2020; Rasmussen, Simon/G-6258-2016; Yadav, Rachita/AAU-6389-2021; Kristiansen, Karsten/J-5148-2014; Belling, Kirstine/AAJ-6569-2021; Schierup, Mikkel Heide/AAM-4997-2020; Westergaard, David/AAA-8248-2019; Pedersen, Oluf/Z-1731-2019; Rasmussen, Simon/AAA-2308-2020; Huang, Shujia/GXG-8583-2022; Xu, Xun/AAI-6763-2020; Schierup, Mikkel H/F-1675-2010; Lund, Ole/F-4437-2014; Chang, Yuqi/E-9891-2017; Sicheritz-Ponten, Thomas/A-4325-2017; Krogh, Anders/M-1541-2014; Liu, Siyang/M-6127-2014; Gonzalez-Izarzugaza, Jose Maria/N-4503-2014; Grove, Jakob/K-8112-2015; Brunak, Soren/O-6621-2016	Rasmussen, Simon/0000-0001-6323-9041; Yadav, Rachita/0000-0003-2123-5223; Kristiansen, Karsten/0000-0002-6024-0917; Belling, Kirstine/0000-0001-5664-1948; Schierup, Mikkel Heide/0000-0002-5028-1790; Westergaard, David/0000-0003-0128-8432; Pedersen, Oluf/0000-0002-3321-3972; Rasmussen, Simon/0000-0001-6323-9041; Huang, Shujia/0000-0003-2100-2534; Xu, Xun/0000-0002-5338-5173; Schierup, Mikkel H/0000-0002-5028-1790; Lund, Ole/0000-0003-1108-0491; Matey-Hernandez, Maria Luisa/0000-0002-6794-9419; Grosjean, Marie/0000-0002-2685-8078; Chang, Yuqi/0000-0001-7487-370X; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Sibbesen, Jonas Andreas/0000-0002-5528-0236; Borglum, Anders/0000-0001-8627-7219; Krogh, Anders/0000-0002-5147-6282; Liu, Siyang/0000-0001-6780-9419; Besenbacher, Soren/0000-0003-1455-1738; Gonzalez-Izarzugaza, Jose Maria/0000-0003-1754-5122; Mors, Ole/0000-0002-5660-0393; Villesen, Palle/0000-0001-7589-8781; Hansen, Torben/0000-0001-8748-3831; Lescai, Francesco/0000-0002-6399-9101; Grove, Jakob/0000-0003-2284-5744; Brunak, Soren/0000-0003-0316-5866; Petersen, Bent/0000-0002-2472-8317; Maretty, Lasse/0000-0003-4381-8948	Innovation Fund Denmark; Novo Nordisk Foundation [NNF14CC0001]; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Villum Fonden [00007278] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI S�ren Brunak] Funding Source: researchfish	Innovation Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Villum Fonden(Villum Fonden); Novo Nordisk Foundation Center for Protein Research	We thank the anonymous donors. The study was funded by Innovation Fund Denmark and the Novo Nordisk Foundation (grant NNF14CC0001).	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Besenbacher S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6969; Borglum AD, 2014, MOL PSYCHIATR, V19, P325, DOI 10.1038/mp.2013.2; Cao HZ, 2015, NAT BIOTECHNOL, V33, P617, DOI 10.1038/nbt.3200; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Deorowicz S, 2015, BIOINFORMATICS, V31, P1569, DOI 10.1093/bioinformatics/btv022; Eberle MA, 2017, GENOME RES, V27, P157, DOI 10.1101/gr.210500.116; EIBERG H, 1989, CLIN GENET, V35, P313; Espeseth T, 2012, TWIN RES HUM GENET, V15, P442, DOI 10.1017/thg.2012.8; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Helgason A, 2015, NAT GENET, V47, P453, DOI 10.1038/ng.3171; Hoehe MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6569; Hubley R., 2013, REPEATMASKER OPEN 40; Hubley R, 2016, NUCLEIC ACIDS RES, V44, pD81, DOI 10.1093/nar/gkv1272; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kloosterman WP, 2015, GENOME RES, V25, P792, DOI 10.1101/gr.185041.114; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; KUPFERMANN H, 1992, HUM IMMUNOL, V34, P267, DOI 10.1016/0198-8859(92)90026-J; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu SY, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0103-4; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Novak A. M., 2017, GENOME GRAPHS; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Poznik GD, 2016, NAT GENET, V48, P593, DOI 10.1038/ng.3559; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116; Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Sosic M., 2017, BIOINFORMATICS, V753; Steinberg KM, 2014, GENOME RES, V24, P2066, DOI 10.1101/gr.180893.114; Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; Wong WSW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10486	53	73	74	1	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					87	+		10.1038/nature23264	http://dx.doi.org/10.1038/nature23264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28746312	Green Published, hybrid			2022-12-28	WOS:000406831700042
J	Sinha, E; Michalak, AM; Balaji, V				Sinha, E.; Michalak, A. M.; Balaji, V.			Eutrophication will increase during the 21st century as a result of precipitation changes	SCIENCE			English	Article							GULF-OF-MEXICO; CLIMATE-CHANGE; NUTRIENT; VARIABILITY; NITROGEN; WATER; COASTAL; IMPACTS; BLOOMS; EXPORT	Eutrophication, or excessive nutrient enrichment, threatens water resources across the globe. We show that climate change-induced precipitation changes alone will substantially increase (19 +/- 14%) riverine total nitrogen loading within the continental United States by the end of the century for the "business-as-usual" scenario. The impacts, driven by projected increases in both total and extreme precipitation, will be especially strong for the Northeast and the corn belt of the United States. Offsetting this increase would require a 33 +/- 24% reduction in nitrogen inputs, representing a massive management challenge. Globally, changes in precipitation are especially likely to also exacerbate eutrophication in India, China, and Southeast Asia. It is therefore imperative that water quality management strategies account for the impact of projected future changes in precipitation on nitrogen loading.	[Sinha, E.; Michalak, A. M.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Sinha, E.; Michalak, A. M.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Balaji, V.] Princeton Univ, Cooperat Inst Climate Sci, Princeton, NJ 08544 USA	Carnegie Institution for Science; Stanford University; Princeton University	Sinha, E; Michalak, AM (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.; Sinha, E; Michalak, AM (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.	esinha@stanford.edu; michalak@stanford.edu			NSF [1313897]; Cooperative Institute for Climate Science, Princeton University, under NOAA [NA08OAR4320752]; NERC [NE/L013371/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); Cooperative Institute for Climate Science, Princeton University, under NOAA; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by NSF grant 1313897 (E.S. and A.M.M.) and by the Cooperative Institute for Climate Science, Princeton University, under NOAA grant NA08OAR4320752 (V.B.). We thank K. Findell, J. Ho, M. Lee, Y. Shiga, and three anonymous reviewers for incisive comments on the manuscript and analysis. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups (listed in table S2) for producing and making available their model output. For CMIP, the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. For the global analysis, global climate scenarios used were from the NEX-GDDP data set, prepared by the Climate Analytics Group and NASA Ames Research Center using the NASA Earth Exchange, and distributed by the NASA Center for Climate Simulation. Data used in this study are freely available online, as listed in table S3.	Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Bollasina MA, 2011, SCIENCE, V334, P502, DOI 10.1126/science.1204994; Bosch NS, 2014, J GREAT LAKES RES, V40, P581, DOI 10.1016/j.jglr.2014.04.011; Brekke L, 2013, DOWNSCALED CMIP3 CMI, P116; Bricker SB, 2008, HARMFUL ALGAE, V8, P21, DOI 10.1016/j.hal.2008.08.028; Carmichael W, 2008, ADV EXP MED BIOL, V619, P105, DOI 10.1007/978-0-387-75865-7_4; Chaplot V, 2007, J HYDROL, V337, P159, DOI 10.1016/j.jhydrol.2007.01.026; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Fezzi C, 2015, NAT CLIM CHANGE, V5, P255, DOI [10.1038/NCLIMATE2525, 10.1038/nclimate2525]; Ficklin DL, 2010, ENVIRON POLLUT, V158, P223, DOI 10.1016/j.envpol.2009.07.016; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Howarth RW, 2006, BIOGEOCHEMISTRY, V79, P163, DOI 10.1007/s10533-006-9010-1; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Jayakody P, 2014, HYDROL PROCESS, V28, P5776, DOI 10.1002/hyp.10088; Laepple T, 2014, P NATL ACAD SCI USA, V111, P16682, DOI 10.1073/pnas.1412077111; Lee MJ, 2016, GEOPHYS RES LETT, V43, P7520, DOI 10.1002/2016GL069254; McCrackin ML, 2015, J ENVIRON QUAL, V44, P345, DOI 10.2134/jeq2014.02.0081; Michalak AM, 2016, NATURE, V535, P349, DOI 10.1038/535349a; O'Neill BC, 2016, GEOSCI MODEL DEV, V9, P3461, DOI 10.5194/gmd-9-3461-2016; Obenour DR, 2013, ENVIRON SCI TECHNOL, V47, P9808, DOI 10.1021/es400983g; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Rabalais NN, 2007, ESTUAR COAST, V30, P753, DOI 10.1007/BF02841332; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Reed DC, 2016, GLOBAL BIOGEOCHEM CY, V30, P447, DOI 10.1002/2015GB005303; Royer TV, 2006, ENVIRON SCI TECHNOL, V40, P4126, DOI 10.1021/es052573n; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Sebestyen SD, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000778; Seitzinger SP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI [10.1029/2010GB003851, 10.1029/2009GB003587]; Sinha E, 2016, ENVIRON SCI TECHNOL, V50, P12874, DOI 10.1021/acs.est.6b04455; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; Tebaldi C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049863; U.S. Environmental Protection Agency, 2010, CHES BAY TOT MAX DAI; United Nations Department of Economic and Social Affairs Population Division, 2015, ESAPWP241 UN POP DIV; US Environmental Protection Agency, 2015, MISS RIV GULF MEX WA; Van Liew M. W., 2012, International Journal of Agricultural and Biological Engineering, V5, P13; Woznicki SA, 2011, T ASABE, V54, P171	36	455	480	50	516	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					405	408		10.1126/science.aan2409	http://dx.doi.org/10.1126/science.aan2409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751610				2022-12-28	WOS:000406362300046
J	Qiu, J				Qiu, Jane			RISING STAR	NATURE			English	News Item																		Ursin R, 2007, NAT PHYS, V3, P481, DOI 10.1038/nphys629; Xiao L, 2015, SCIENCE, V347, P1226, DOI 10.1126/science.1259866; Yin J, 2017, SCIENCE, V356, P1140, DOI 10.1126/science.aan3211	3	3	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					394	396		10.1038/547394a	http://dx.doi.org/10.1038/547394a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28748945	Bronze			2022-12-28	WOS:000406358300012
J	Shapiro, JM; Balza, R; Hundal, NKV; Hesterberg, PE; Zukerberg, LR				Shapiro, Jason M.; Balza, Rene; Hundal, Navneet K. Virk; Hesterberg, Paul E.; Zukerberg, Lawrence R.			Case 23-2017: A 9-Day-Old Girl with Vomiting, Acidosis, and Azotemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCED ENTEROCOLITIS SYNDROME; FOOD ALLERGY		[Shapiro, Jason M.] Brown Univ, Rhode Isl Hosp, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02903 USA; [Shapiro, Jason M.] Brown Univ, Hasbro Childrens Hosp, Warren Alpert Med Sch, Providence, RI 02912 USA; [Shapiro, Jason M.] Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA; [Balza, Rene] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Hundal, Navneet K. Virk; Hesterberg, Paul E.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Hesterberg, Paul E.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Balza, Rene] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Hundal, Navneet K. Virk] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Hesterberg, Paul E.] Harvard Med Sch, Dept Med, Boston, MA USA; [Zukerberg, Lawrence R.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Hasbro Children's Hospital; Brown University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shapiro, JM (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02903 USA.; Shapiro, JM (corresponding author), Brown Univ, Hasbro Childrens Hosp, Warren Alpert Med Sch, Providence, RI 02912 USA.; Shapiro, JM (corresponding author), Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02912 USA.			Balza, Rene/0000-0002-6517-2490	Mead Johnson Nutrition	Mead Johnson Nutrition	Dr. Virk Hundal reports receiving grant support from Mead Johnson Nutrition. No other potential conflict of interest relevant to this article was reported.	Berin MC, 2015, J ALLERGY CLIN IMMUN, V135, P1108, DOI 10.1016/j.jaci.2014.12.1948; Caubet JC, 2014, J ALLERGY CLIN IMMUN, V134, P382, DOI 10.1016/j.jaci.2014.04.008; Chu A, 2015, PEDIATR ANN, V44, pE237, DOI 10.3928/00904481-20151012-07; DeBrosse CW, 2006, PEDIATR DEVEL PATHOL, V9, P210, DOI 10.2350/11-05-0130.1; Katz Y, 2011, J ALLERGY CLIN IMMUN, V127, P647, DOI 10.1016/j.jaci.2010.12.1105; Moran CJ, 2015, INFLAMM BOWEL DIS, V21, P1166, DOI 10.1097/MIB.0000000000000329; Nowak-Wegrzyn A, 2017, J ALLERGY CLIN IMMUN, V139, P1111, DOI 10.1016/j.jaci.2016.12.966; Nowak-Wegrzyn A, 2015, ALLERGY ASTHMA PROC, V36, P172, DOI 10.2500/aap.2015.36.3811; Nowak-Wegrzyn A, 2015, J ALLERGY CLIN IMMUN, V135, P1114, DOI 10.1016/j.jaci.2015.03.025; Rice GM, 2016, PEDIATR REV, V37, P3, DOI 10.1542/pir.2014-0122; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Snapper Scott B, 2015, Gastroenterol Hepatol (N Y), V11, P554; Zuo L, 2007, IMMUNOL ALLERGY CLIN, V27, P443, DOI 10.1016/j.iac.2007.06.002	14	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					372	383		10.1056/NEJMcpc1703512	http://dx.doi.org/10.1056/NEJMcpc1703512			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28745994				2022-12-28	WOS:000406295000011
J	Wacker, D; Stevens, RC; Roth, BL				Wacker, Daniel; Stevens, Raymond C.; Roth, Bryan L.			How Ligands Illuminate GPCR Molecular Pharmacology	CELL			English	Review							PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTOR; STRUCTURE-BASED DISCOVERY; TERNARY COMPLEX MODEL; KAPPA-OPIOID RECEPTOR; CRYO-EM STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; FUNCTIONAL SELECTIVITY; STRUCTURAL BASIS	G protein-coupled receptors (GPCRs), which are modulated by a variety of endogenous and synthetic ligands, represent the largest family of druggable targets in the human genome. Recent structural and molecular studies have both transformed and expanded classical concepts of receptor pharmacology and have begun to illuminate the distinct mechanisms by which structurally, chemically, and functionally diverse ligands modulate GPCR function. These molecular insights into ligand engagement and action have enabled new computational methods and accelerated the discovery of novel ligands and tool compounds, especially for understudied and orphan GPCRs. These advances promise to streamline the development of GPCR-targeted medications.	[Wacker, Daniel; Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Wacker, Daniel; Roth, Bryan L.] Univ North Carolina Chapel Hill, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27514 USA; [Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Southern California; University of Southern California	Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA.; Roth, BL (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27514 USA.	bryan_roth@med.unc.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020; Stevens, Raymond/K-7272-2015	Roth, Bryan/0000-0002-0561-6520; Stevens, Raymond/0000-0002-4522-8725	National Institute of Health [RO1MH112205, UO1MH104974, U19MH82441, PO1DA035764]; Michael Hooker Distinguished Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK116195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH104974, R01MH112205, U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA035764] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Hooker Distinguished Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This review was supported by grants from the National Institute of Health (RO1MH112205; UO1MH104974; U19MH82441; and PO1DA035764) and the Michael Hooker Distinguished Professorship to BLR.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Aitken M, 2009, HEALTH AFFAIR, V28, pW151, DOI 10.1377/hlthaff.28.1.w151; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bortolato A., 2016, NATURE, V533, P277; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; CERIONE RA, 1984, BIOCHEMISTRY-US, V23, P4519, DOI 10.1021/bi00315a003; Changeux JP, 2016, CELL, V166, P1084, DOI 10.1016/j.cell.2016.08.015; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Christopher JA, 2015, J MED CHEM, V58, P6653, DOI 10.1021/acs.jmedchem.5b00892; Christopoulos A, 2014, PHARMACOL REV, V66, P918, DOI 10.1124/pr.114.008862; Clark AJ, 1926, J PHYSIOL-LONDON, V61, P547, DOI 10.1113/jphysiol.1926.sp002315; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Dillon GM, 2011, BEHAV PHARMACOL, V22, P91, DOI 10.1097/FBP.0b013e3283423d7e; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fedele J.M., 2016, SET NAT BIOTECHNOL; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Foord D.E., 2009, J MED CHEM, V52; Gimpl G, 2016, CHEM PHYS LIPIDS, V199, P61, DOI 10.1016/j.chemphyslip.2016.04.006; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; KENAKIN T, 1989, J PHARMACOL EXP THER, V250, P944; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Krupnick Jr O.B., 1996, NATURE; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lafferty-Whyte K, 2017, NAT REV DRUG DISCOV, V16, P10, DOI 10.1038/nrd.2016.263; Lagerstrom R., 2003, MOL PHARM; Lansu K, 2017, NAT CHEM BIOL, V13, P529, DOI [10.1038/NCHEMBIO.2334, 10.1038/nchembio.2334]; Lanzafame A, 1997, J PHARMACOL EXP THER, V282, P278; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; McAlear SD, 2010, ADV EXP MED BIOL, V664, P263, DOI 10.1007/978-1-4419-1399-9_30; Moore AR, 2016, NAT GENET, V48, P675, DOI 10.1038/ng.3549; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Ngo T, 2017, NAT CHEM BIOL, V13, P235, DOI [10.1038/NCHEMBIO.2266, 10.1038/nchembio.2266]; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; O'Connor C, 2015, P NATL ACAD SCI USA, V112, P11852, DOI 10.1073/pnas.1510117112; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Paek J, 2017, CELL, V169, P338, DOI 10.1016/j.cell.2017.03.028; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rasmussen S. G., NATURE, V477, P549; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2000, CIRCULATION, V102, P2836; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Shihoya W, 2016, NATURE, V537, P363, DOI 10.1038/nature19319; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Tesmer JJG, 2016, NAT REV MOL CELL BIO, V17, P439, DOI 10.1038/nrm.2016.36; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urs NM, 2016, P NATL ACAD SCI USA, V113, pE8178, DOI 10.1073/pnas.1614347113; van der Westhuizen ET, 2015, J PHARMACOL EXP THER, V353, P246, DOI 10.1124/jpet.114.221606; Vass M, 2016, CURR OPIN PHARMACOL, V30, P59, DOI 10.1016/j.coph.2016.07.007; Vemuri T., 2016, CRYSTAL STRUCTURE HU, V167, p[750, e714]; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wardman JH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac8035; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; White KL, 2015, J PHARMACOL EXP THER, V352, P98, DOI 10.1124/jpet.114.216820; Yamashita S.M., 2013, PHARM EXP THER, V344, P708; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	105	293	296	19	145	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					414	427		10.1016/j.cell.2017.07.009	http://dx.doi.org/10.1016/j.cell.2017.07.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753422	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000406462400003
J	Wu, JJ; Lorenzo, P; Zhong, SY; Ali, M; Butts, CP; Myers, EL; Aggarwal, VK				Wu, Jingjing; Lorenzo, Paula; Zhong, Siying; Ali, Muhammad; Butts, Craig P.; Myers, Eddie L.; Aggarwal, Varinder K.			Synergy of synthesis, computation and NMR reveals correct baulamycin structures	NATURE			English	Article							NATURAL-PRODUCTS; CHEMICAL-SHIFTS; BORONIC ESTERS; ALDEHYDES; ALLYLBORATION; HYDROBORATION; ANTIBIOTICS; MOLECULES; ALKENES; H-1	Small-molecule, biologically active natural products continue to be our most rewarding source of, and inspiration for, new medicines(1). Sometimes we happen upon such molecules in minute quantities in unique, difficult-to-reach, and often fleeting environments, perhaps never to be discovered again. In these cases, determining the structure of a molecule-including assigning its relative and absolute configurations-is paramount, enabling one to understand its biological activity. Molecules that comprise stereochemically complex acyclic and conformationally flexible carbon chains make such a task extremely challenging(2). The baulamycins (A and B) serve as a contemporary example. Isolated in small quantities and shown to have promising antimicrobial activity, the structure of the conformationally flexible molecules was determined largely through J-based configurational analysis(3,4), but has been found to be incorrect. Our subsequent campaign to identify the true structures of the baulamycins has revealed a powerful method for the rapid structural elucidation of such molecules. Specifically, the prediction of nuclear magnetic resonance (NMR) parameters through density functional theory-combined with an efficient sequence of boron-based synthetic transformations, which allowed an encoded (labelled) mixture of natural-product diastereomers to be prepared-enabled us rapidly to pinpoint and synthesize the correct structures.	[Wu, Jingjing; Lorenzo, Paula; Zhong, Siying; Ali, Muhammad; Butts, Craig P.; Myers, Eddie L.; Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England; [Ali, Muhammad] COMSATS Inst Informat Technol, Dept Chem, Abbottabad 22060, Pakistan	University of Bristol; COMSATS University Islamabad (CUI)	Butts, CP; Myers, EL; Aggarwal, VK (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	Craig.Butts@bristol.ac.uk; eddie.myers@bristol.ac.uk; v.aggarwal@bristol.ac.uk	Fernández, Paula Lorenzo/Z-6335-2019; Butts, Craig/B-7576-2008; Aggarwal, Varinder/AAG-8504-2019	Butts, Craig/0000-0001-6678-8839; Wu, Jingjing/0000-0001-8401-065X; Myers, Eddie/0000-0001-7742-4934; Aggarwal, Varinder/0000-0003-0344-6430; Zhong, Siying/0000-0003-1142-7889	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/I038071/1]; European Research Council (ERC) [670668]; UK Biotechnology and Biological Sciences Research Council (BBSRC)/EPSRC [L01386X]; Shanghai Institute of Organic Chemistry; EPSRC Bristol Chemical Synthesis Doctoral Training Centre [EP/L015366/1]; BBSRC [BB/L01386X/1] Funding Source: UKRI; EPSRC [EP/L011999/1, EP/I038071/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L01386X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L011999/1, EP/I038071/1, 1652562] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); UK Biotechnology and Biological Sciences Research Council (BBSRC)/EPSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); Shanghai Institute of Organic Chemistry; EPSRC Bristol Chemical Synthesis Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the UK Engineering and Physical Sciences Research Council (EPSRC; grant EP/I038071/1) and the European Research Council (ERC; funding programme FP7; grant 670668) for financial support; and the UK Biotechnology and Biological Sciences Research Council (BBSRC)/EPSRC-funded BrisSynBio Research Centre (L01386X) for providing the 700 MHz NMR spectrometer used. Parts of this work were carried out using the computational facilities of the Advanced Computing Research Centre at the University of Bristol (http://www.bris.ac.uk/acrc/). P.L. thanks Xunta de Galicia, M.A. thanks HEC Pakistan, and J.W. thanks the Shanghai Institute of Organic Chemistry for postdoctoral fellowships. S.Z. thanks the EPSRC Bristol Chemical Synthesis Doctoral Training Centre for a studentship (EP/L015366/1). We thank D. Sherman for providing the raw NMR (free induction decay) data for baulamycin A.	Blaisdell TP, 2014, J AM CHEM SOC, V136, P9264, DOI 10.1021/ja504228p; Burns M, 2014, NATURE, V513, P183, DOI 10.1038/nature13711; Curran DP, 2012, NAT CHEM, V4, P124, DOI [10.1038/NCHEM.1233, 10.1038/nchem.1233]; Dutheuil G, 2008, SYNTHESIS-STUTTGART, P2293, DOI 10.1055/s-2008-1067144; Fawcett A, 2016, ANGEW CHEM INT EDIT, V55, P14663, DOI 10.1002/anie.201608406; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Grayson MN, 2012, J AM CHEM SOC, V134, P2716, DOI 10.1021/ja210200d; Guchhait S, 2017, J ORG CHEM, V82, P2414, DOI 10.1021/acs.joc.6b02838; Jain P, 2010, J AM CHEM SOC, V132, P11884, DOI 10.1021/ja104956s; Jones CR, 2016, CHEM COMMUN, V52, P2920, DOI 10.1039/c5cc10509a; Lodewyk MW, 2012, CHEM REV, V112, P1839, DOI 10.1021/cr200106v; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; Molander GA, 2003, J ORG CHEM, V68, P5534, DOI 10.1021/jo0343331; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P1012, DOI 10.1002/anie.200460864; O'Neill J., 2014, REV ANTIMICROBIAL RE; Ohmura T, 2000, J AM CHEM SOC, V122, P4990, DOI 10.1021/ja0002823; Pereira S, 1996, J AM CHEM SOC, V118, P909, DOI 10.1021/ja952653z; Quadri Luis E. N., 2007, Infectious Disorders - Drug Targets, V7, P230, DOI 10.2174/187152607782110040; Rohr K, 2009, J ORG CHEM, V74, P3744, DOI 10.1021/jo9003635; Ruiz J, 2016, EUR J ORG CHEM, V2016, P773, DOI 10.1002/ejoc.201501344; SADHU KM, 1985, ORGANOMETALLICS, V4, P1687, DOI 10.1021/om00128a038; Sellars JD, 2009, TETRAHEDRON, V65, P5588, DOI 10.1016/j.tet.2009.01.116; Smith SG, 2010, J AM CHEM SOC, V132, P12946, DOI 10.1021/ja105035r; Tamao K, 1996, ORG SYNTH, V73, P94; Tripathi A, 2014, J AM CHEM SOC, V136, P1579, DOI 10.1021/ja4115924; Willoughby PH, 2014, NAT PROTOC, V9, P643, DOI 10.1038/nprot.2014.042; World Health Organization, 2016, ANTIMICROBIAL RESIST; Zweifel, 1967, J AM CHEM SOC, V89, DOI DOI 10.1021/JA00990A061	29	77	77	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					436	440		10.1038/nature23265	http://dx.doi.org/10.1038/nature23265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28748934	Green Submitted			2022-12-28	WOS:000406358300032
J	Basov, DN; Fogler, MM				Basov, D. N.; Fogler, M. M.			Plasmonic imaging is gaining momentum	SCIENCE			English	Editorial Material									[Basov, D. N.] Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA; [Fogler, M. M.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Columbia University; University of California System; University of California San Diego	Basov, DN (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	db3056@columbia.edu; mfogler@ucsd.edu	Fogler, Michael M/O-4610-2017	Fogler, Michael M/0000-0001-8239-7221				Alonso-Gonzalez P, 2017, NAT NANOTECHNOL, V12, P31, DOI [10.1038/nnano.2016.185, 10.1038/NNANO.2016.185]; Basov DN, 2016, SCIENCE, V354, DOI 10.1126/science.aag1992; Basov DN, 2014, REV MOD PHYS, V86, P959, DOI 10.1103/RevModPhys.86.959; Basov DN, 2011, REV MOD PHYS, V83, P471, DOI 10.1103/RevModPhys.83.471; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Elias DC, 2011, NAT PHYS, V7, P701, DOI [10.1038/nphys2049, 10.1038/NPHYS2049]; Gonzalez J, 1996, PHYS REV LETT, V77, P3589, DOI 10.1103/PhysRevLett.77.3589; Hirjibehedin CF, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161309; Kumar R. Krishna, 2017, ARXIV170306672V1; Lundeberg MB, 2017, SCIENCE, V357, P187, DOI 10.1126/science.aan2735; McLeod AS, 2017, NAT PHYS, V13, P80, DOI [10.1038/NPHYS3882, 10.1038/nphys3882]; Sun ZY, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.076805	12	4	4	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		132	133		10.1126/science.aan5361	http://dx.doi.org/10.1126/science.aan5361			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706027	Green Submitted			2022-12-28	WOS:000405391700023
J	Cohen, J				Cohen, Jon			SURVIVING THE CURE	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		122	125		10.1126/science.357.6347.122	http://dx.doi.org/10.1126/science.357.6347.122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706022				2022-12-28	WOS:000405391700018
J	Hemming, K; Eldridge, S; Forbes, G; Weijer, C; Taljaard, M				Hemming, K.; Eldridge, S.; Forbes, G.; Weijer, C.; Taljaard, M.			How to design efficient cluster randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIG	Cluster randomised trials have diminishing returns in power and precision as cluster size increases. Making the cluster a lot larger while keeping the number of clusters fixed might yield only a very small increase in power and precision, owing to the intracluster correlation. Identifying the point at which observations start making a negligible contribution to the power or precision of the study-which we call the point of diminishing returns-is important for designing efficient trials. Current methods for identifying this point are potentially useful as rules of thumb but don't generally work well. We introduce several practical aids to help researchers design cluster randomised trials in which all observations make a material contribution to the study. Power curves enable identification of the point at which observations begin to make a negligible contribution to a study for a given target difference. Under this paradigm, the number needed per arm under individual randomisation gives an upper bound on the cluster size, which should not be exceeded. Corresponding precision curves can be useful for accommodating flexibility in the choice of target difference and show the point at which confidence intervals around the estimated effect size no longer decrease. To design efficient trials, the number of clusters and cluster size should be determined concurrently, not independently. Funders and researchers should be aware of diminishing returns in cluster trials. Researchers should routinely plot power or precision curves when performing sample size calculations so that the implications of cluster sizes can be transparent. Even when data appear to be "free," in the sense that few resources are needed to obtain the data, excessive cluster sizes can have important ramifications	[Hemming, K.] Univ Birmingham, Inst Appl Hlth, Birmingham B15 2TT, W Midlands, England; [Eldridge, S.; Forbes, G.] Queen Marys Univ, Ctr Primary Care & Publ Hlth, Pragmat Clin Trials Unit, London, England; [Weijer, C.] Western Univ, Rotman Inst Philosophy, London, ON N6A 5B8, Canada; [Weijer, C.] Ottawa Hosp Res Inst, Clin Epidemiol Program, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada; [Taljaard, M.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada	University of Birmingham; University of London; Queen Mary University London; Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Hemming, K (corresponding author), Univ Birmingham, Inst Appl Hlth, Birmingham B15 2TT, W Midlands, England.	k.hemming@bham.ac.uk	Hemming, karla/AAB-3391-2021; Weijer, Charles/ABC-5433-2020	Hemming, karla/0000-0002-2226-6550; Weijer, Charles/0000-0002-5510-1074; Eldridge, Sandra/0000-0001-5638-2317; Forbes, Gordon/0000-0001-8662-3636; Taljaard, Monica/0000-0002-3978-8961				Angus DC, 2015, JAMA-J AM MED ASSOC, V314, P767, DOI 10.1001/jama.2015.7762; Bland JM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3985; Campbell MJ, 2007, STAT MED, V26, P2, DOI 10.1002/sim.2731; Campbell MJ, 2014, STAT PRACT, P1, DOI 10.1002/9781118763452; Campbell MK, 2001, STAT MED, V20, P391, DOI 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z; Carter B, 2010, STAT MED, V29, P2984, DOI 10.1002/sim.4050; Donner A, 1998, J R STAT SOC C-APPL, V47, P95, DOI 10.1111/1467-9876.00100; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Eldridge S, 2012, PRACTICAL GUIDE CLUS, DOI [10.1002/9781119966241.ch1, DOI 10.1002/9781119966241.CH1]; Eldridge SM, 2016, STAT METHODS MED RES, V25, P1039, DOI 10.1177/0962280215588242; Guittet Lydia, 2005, BMC Med Res Methodol, V5, P25, DOI 10.1186/1471-2288-5-25; Hemming K, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-102; Hooper R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2925; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Taljaard M, 2016, CLIN TRIALS, V13, P459, DOI 10.1177/1740774516634316	16	90	90	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2017	358								j3064	10.1136/bmj.j3064	http://dx.doi.org/10.1136/bmj.j3064			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MW	28710062	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000405770700002
J	Lipsitch, M; Eyal, N				Lipsitch, Marc; Eyal, Nir			Improving vaccine trials in infectious disease emergencies	SCIENCE			English	Review							EBOLA-VIRUS DISEASE; RING VACCINATION; SIERRA-LEONE; DESIGN; ZIKA; EFFICACY; GUINEA; PREVENTION; EPIDEMIC; RISK	Unprecedented global effort is under way to facilitate the testing of countermeasures in infectious disease emergencies. Better understanding of the various options for trial design is needed in advance of outbreaks, as is preliminary global agreement on the most suitable designs for the various scenarios. What would enhance the speed, validity, and ethics of clinical studies of such countermeasures? Focusing on studies of vaccine efficacy and effectiveness in emergencies, we highlight three needs: for formal randomized trialseven in most emergencies; for individually randomized trials-even in many emergencies; and for six areas of innovation in trial methodology. These needs should inform current updates of protocols and roadmaps.	[Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Eyal, Nir] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Lipsitch, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.; Lipsitch, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	mlipsitc@hsph.harvard.edu		Eyal, Nir/0000-0003-1056-6609; Lipsitch, Marc/0000-0003-1504-9213	National Institute of General Medical Sciences [U54GM088558]; Merck; Pfizer; Antigen Discovery; Affinivax; PATH Vaccine Solutions; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Merck(Merck & Company); Pfizer(Pfizer); Antigen Discovery; Affinivax; PATH Vaccine Solutions; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institute of General Medical Sciences grant U54GM088558 (M.L.). We thank R. Kahn, S. Bellan, and A. Rid for helpful conversations as we were writing this article, R. Kahn for research assistance, and anonymous reviewers for written comments. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. M.L. served on the Scientific Advisory Group for the Ebola ca Suffit vaccine efficacy trial (unpaid position) and has received consulting fees or honoraria from Merck, Pfizer, Antigen Discovery, and Affinivax. His research has received funding (through his employer) from Pfizer and PATH Vaccine Solutions. Discussions leading to the Oxford University Ethox workshop on Ethical Design of Vaccine Trials in Emerging Infections helped stimulate this paper.	Ajelli M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0678-3; [Anonymous], 1987, CANCER RES, V47, P5782; Bellan SE, 2015, LANCET INFECT DIS, V15, P703, DOI 10.1016/S1473-3099(15)70139-8; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bhatt DL, 2016, NEW ENGL J MED, V375, P65, DOI 10.1056/NEJMra1510061; Brende B, 2017, LANCET, V389, P233, DOI 10.1016/S0140-6736(17)30131-9; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Butler D, 2017, NATURE, V545, P396, DOI 10.1038/545396a; Camacho A, 2017, VACCINE, V35, P544, DOI 10.1016/j.vaccine.2016.12.019; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Chan KP, 2002, EPIDEMIOL INFECT, V128, P93, DOI 10.1017/S0950268801006422; Cohen J., SCIENCE; Cooper B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001815; Eyal N., 2016, DISASTER MED, P67; Eyal N., 2017, J MED ETHICS; Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590; Fowler VG, 2013, JAMA-J AM MED ASSOC, V309, P1368, DOI 10.1001/jama.2013.3010; Gertler PJ, 2011, IMPACT EVALUATION IN PRACTICE, P1, DOI 10.1596/978-0-8213-8541-8; Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Harling G, 2017, CLIN TRIALS, V14, P37, DOI 10.1177/1740774516673355; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740; Hersey S, 2015, MMWR-MORBID MORTAL W, V64, P981, DOI 10.15585/mmwr.mm6435a6; Hitchings MDT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005470; Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4; Joffe S, 2014, JAMA-J AM MED ASSOC, V312, P1299, DOI 10.1001/jama.2014.12867; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Keusch G., 2017, INTEGRATING CLIN RES; Kieny MP, 2016, LANCET, V387, P1509, DOI [10.1016/S0140-6736(16)00686-3, 10.1016/S0140-6736(16)32621-6]; Koff WC, 2016, EXPERT REV VACCINES, V15, P1235, DOI 10.1586/14760584.2016.1170600; Kupferschmidt K., 2016, SCIENCE, DOI [10.1126/science.aag0746, DOI 10.1126/SCIENCE.AAG0746]; Kupferschmidt K, 2015, SCIENCE, V348, P20, DOI 10.1126/science.348.6230.20; Lang T, 2011, AM J TROP MED HYG, V85, P967, DOI 10.4269/ajtmh.2011.11-0151; Lipsitch M, 2016, INT J EPIDEMIOL, V45, P2060, DOI 10.1093/ije/dyw124; Lipsitch M, 2015, SCIENCE, V348, P46, DOI 10.1126/science.aaa3178; Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146; Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]; Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990; Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755; Rid A, 2016, AM J PUBLIC HEALTH, V106, P432, DOI 10.2105/AJPH.2015.302996; Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5; Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218; World Health Organization, 2017, R D BLUEPR UPD; World Medical Association, 1994, Bull Med Ethics, VNo. 102, P9	45	16	17	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		153	+		10.1126/science.aam8334	http://dx.doi.org/10.1126/science.aam8334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706038	Green Accepted			2022-12-28	WOS:000405391700035
J	Du, ZH; Zheng, H; Huang, B; Ma, R; Wu, JY; Zhang, XL; He, J; Xiang, YL; Wang, QJ; Li, YY; Ma, J; Zhang, X; Zhang, K; Wang, Y; Zhang, MQ; Gao, JT; Dixon, JR; Wang, XW; Zeng, JY; Xie, W				Du, Zhenhai; Zheng, Hui; Huang, Bo; Ma, Rui; Wu, Jingyi; Zhang, Xianglin; He, Jing; Xiang, Yunlong; Wang, Qiujun; Li, Yuanyuan; Ma, Jing; Zhang, Xu; Zhang, Ke; Wang, Yang; Zhang, Michael Q.; Gao, Juntao; Dixon, Jesse R.; Wang, Xiaowo; Zeng, Jianyang; Xie, Wei			Allelic reprogramming of 3D chromatin architecture during early mammalian development	NATURE			English	Article							RNA-SEQ; PREIMPLANTATION EMBRYOS; ZYGOTIC TRANSITION; HUMAN GENOME; REVEALS; ORGANIZATION; CHROMOSOME; REORGANIZATION; TRANSCRIPTION; EXPRESSION	In mammals, chromatin organization undergoes drastic reprogramming after fertilization(1). However, the three-dimensional structure of chromatin and its reprogramming in preimplantation development remain poorly understood. Here, by developing a low-input Hi-C (genome-wide chromosome conformation capture) approach, we examined the reprogramming of chromatin organization during early development in mice. We found that oocytes in metaphase II show homogeneous chromatin folding that lacks detectable topologically associating domains (TADs) and chromatin compartments. Strikingly, chromatin shows greatly diminished higher-order structure after fertilization. Unexpectedly, the subsequent establishment of chromatin organization is a prolonged process that extends through preimplantation development, as characterized by slow consolidation of TADs and segregation of chromatin compartments. The two sets of parental chromosomes are spatially separated from each other and display distinct compartmentalization in zygotes. Such allele separation and allelic compartmentalization can be found as late as the 8-cell stage. Finally, we show that chromatin compaction in preimplantation embryos can partially proceed in the absence of zygotic transcription and is a multi-level hierarchical process. Taken together, our data suggest that chromatin may exist in a markedly relaxed state after fertilization, followed by progressive maturation of higher-order chromatin architecture during early development.	[Du, Zhenhai; Zheng, Hui; Wu, Jingyi; He, Jing; Xiang, Yunlong; Wang, Qiujun; Li, Yuanyuan; Ma, Jing; Zhang, Ke; Xie, Wei] Tsinghua Univ, Ctr Stem Cell Biol & Regenerat Med, MOE Key Lab Bioinformat, THU PKU Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Bo] Peking Univ, Acad Adv Interdisciplinary Studies, PKU THU Ctr Life Sci, Beijing 100871, Peoples R China; [Ma, Rui; Zeng, Jianyang] Tsinghua Univ, Inst Interdisciplinary Informat Sci, Beijing 100084, Peoples R China; [Wu, Jingyi; Xie, Wei] Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100084, Peoples R China; [Zhang, Xianglin; Zhang, Xu; Wang, Yang; Zhang, Michael Q.; Gao, Juntao; Wang, Xiaowo] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhang, Xianglin; Zhang, Xu; Wang, Yang; Zhang, Michael Q.; Gao, Juntao; Wang, Xiaowo] Tsinghua Univ, Bioinformat Div, TNLIST, Beijing 100084, Peoples R China; [Zhang, Xianglin; Zhang, Xu; Wang, Yang; Zhang, Michael Q.; Gao, Juntao; Wang, Xiaowo] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China; [Gao, Juntao] Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, 800 West Campbell Rd,RL11, Richardson, TX 75080 USA; [Dixon, Jesse R.] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Tsinghua University; Peking University; Tsinghua University; National Institute of Biological Sciences, Beijing; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; University of Texas System; University of Texas Dallas; Salk Institute	Xie, W (corresponding author), Tsinghua Univ, Ctr Stem Cell Biol & Regenerat Med, MOE Key Lab Bioinformat, THU PKU Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China.; Xie, W (corresponding author), Tsinghua Univ, Sch Life Sci, Joint Grad Program Peking Tsinghua NIBS, Beijing 100084, Peoples R China.	xiewei121@tsinghua.edu.cn	Dixon, Jesse/AAT-2914-2020; huang, bo/A-2690-2017; Wang, Xiaowo/K-4886-2012; Wu, Jingyi/S-9658-2019; zhang, xu/N-9161-2013	Dixon, Jesse/0000-0002-6273-2181; Wang, Xiaowo/0000-0003-2965-8036; zhang, xu/0000-0002-8098-8893; Zhang, Xianglin/0000-0002-8585-1917	National Key R&D Program of China [2016YFC0900301]; National Basic Research Program of China [2015CB856201, 2012CB316503]; National Natural Science Foundation of China [31422031, 61472205, 31371341, 31361163004, 31671383, 91519326, 31671384, 91329000]; THU-PKU Center for Life Sciences; Youth Thousand Scholar Program of China; State Key Research Development Program of China [2016YFC1200303]; TNLIST Cross-discipline Foundation; NIH [MH102616]; Beijing Advanced Innovation Center for Structural Biology	National Key R&D Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); THU-PKU Center for Life Sciences; Youth Thousand Scholar Program of China; State Key Research Development Program of China(State Key Development Program for Basic Research of China); TNLIST Cross-discipline Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Advanced Innovation Center for Structural Biology	We thank B. Ren, C. Li, Y. Chen, F. Yue and L. An for discussions, and members of the Xie laboratory for comments. This work was supported by the National Key R&D Program of China (2016YFC0900301 to W.X.), the National Basic Research Program of China (2015CB856201 to W.X.; 2012CB316503 to M.Q.Z.), the National Natural Science Foundation of China (31422031 to W.X.; 61472205 to J.Z.; 31371341 to X.W.; 31361163004 and 31671383 to J.G.; 91519326, 31671384, 31361163004 and 91329000 to M.Q.Z.), the THU-PKU Center for Life Sciences (W.X.), the Youth Thousand Scholar Program of China (W.X., J.Z.), State Key Research Development Program of China (2016YFC1200303 to J.G.), TNLIST Cross-discipline Foundation (M.Q.Z.), the NIH (MH102616 to M.Q.Z.) and Beijing Advanced Innovation Center for Structural Biology (W.X. and J.Z.).	Abe K, 2015, EMBO J, V34, P1523, DOI 10.15252/embj.201490648; Akdemir KC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0767-1; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Battulin N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0642-0; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fan XY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0706-1; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Gavrilov AA, 2013, NUCLEIC ACIDS RES, V41, P3563, DOI 10.1093/nar/gkt067; Hug CB, 2017, CELL, V169, P216, DOI 10.1016/j.cell.2017.03.024; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Nagano T., 2016, PREPRINT; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Qiu JJ, 2003, CELL RES, V13, P179, DOI 10.1038/sj.cr.7290162; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	30	254	268	7	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					232	+		10.1038/nature23263	http://dx.doi.org/10.1038/nature23263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703188				2022-12-28	WOS:000405314500042
J	Othman, F; Crooks, CJ; Card, TR				Othman, Fatmah; Crooks, Colin J.; Card, Timothy R.			Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; INFECTIONS; DATABASE	OBJECTIVE To examine the risk of community acquired pneumonia before and after prescription of proton pump inhibitor (PPI) and assess whether unmeasured confounding explains this association. DESIGN Cohort study and self controlled case series. SETTING Clinical Practice Research Datalink (1990 to 2013) in UK. PARTICIPANTS Adult patients with a new prescription for a PPI individually matched with controls. MAIN OUTCOME MEASURES Association of community acquired pneumonia with PPI prescription estimated by three methods: a multivariable Cox model comparing risk in PPI exposed patients with controls, corrected for potential confounders; a self controlled case series; and a prior event rate ratio (PERR) analysis over the 12 month periods before and after the first PPI prescription. RESULTS 160 000 new PPI users were examined. The adjusted Cox regression showed a risk of community acquired pneumonia 1.67 (95% confidence interval 1.55 to 1.79) times higher for patients exposed to PPI than for controls. In the self controlled case series, among 48 451 PPI exposed patients with a record of community acquired pneumonia, the incidence rate ratio was 1.19 (95% confidence interval 1.14 to 1.25) in the 30 days after PPI prescription but was higher in the 30 days before a PPI prescription (1.92, 1.84 to 2.00). The Cox regressions for prior event rate ratio similarly showed a greater increase in community acquired pneumonia in the year before than the year after PPI prescription, such that the analysis showed a reduced relative risk of pneumonia associated with PPI use (prior event rate ratio 0.91, 95% confidence interval 0.83 to 0.99). CONCLUSION The association between the use of PPIs and risk of community acquired pneumonia is likely to be due entirely to confounding factors.	[Othman, Fatmah; Crooks, Colin J.; Card, Timothy R.] Univ Nottingham, Dept Epidemiol & Publ Hlth, Nottingham NG5 1PB, England; [Othman, Fatmah] King Saud bin Abdulaziz Univ Hlth Sci, Dept Basic Med Sci, Riyadh, Saudi Arabia; [Card, Timothy R.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham, England; [Card, Timothy R.] Univ Nottingham, Nottingham, England	University of Nottingham; King Saud Bin Abdulaziz University for Health Sciences; Nottingham University Hospital NHS Trust; University of Nottingham	Othman, F (corresponding author), Univ Nottingham, Dept Epidemiol & Publ Hlth, Nottingham NG5 1PB, England.; Othman, F (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Dept Basic Med Sci, Riyadh, Saudi Arabia.	msxfo1@nottingham.ac.uk	Crooks, Colin John/I-1130-2016; Card, Timothy/J-8651-2013	Crooks, Colin John/0000-0002-6794-6621; Othman, Fatmah/0000-0002-6846-4632; Card, Timothy/0000-0003-2555-2250	KSAU-HS	KSAU-HS	FO carried out this study as part of her PhD programme at the University of Nottingham. She is a staff member at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Saudi Arabia. She has received a scholarship award from KSAU-HS, which sponsors her studies at University of Nottingham. The KSAU-HS had no role in the design, analysis, data interpretation, or preparation of this manuscript. TRC and CJC were independent of the funder.	Ahrens D, 2012, INT J CLIN PRACT, V66, P767, DOI 10.1111/j.1742-1241.2012.02973.x; Allison PD, 2002, SOCIOL METHODOL, V32, P247, DOI 10.1111/1467-9531.00117; Armstrong BG, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-122; Barkun AN, 2012, AM J GASTROENTEROL, V107, P507, DOI 10.1038/ajg.2011.474; Cahir C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-408; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen J, 2012, J CLIN GASTROENTEROL, V46, P93, DOI 10.1097/MCG.0b013e3182333820; Christine Bond, 2008, EUROHEALTH LOND, V14; Digital NHS, 2015, HOSPITAL EPISODE STA; Dublin S, 2010, PHARMACOEPIDEM DR S, V19, P792, DOI 10.1002/pds.1978; Eom CS, 2011, CAN MED ASSOC J, V183, P310, DOI 10.1503/cmaj.092129; Estborn L, 2015, ALIMENT PHARM THER, V42, P607, DOI 10.1111/apt.13304; Estborn L, 2008, DRUG SAFETY, V31, P627, DOI 10.2165/00002018-200831070-00008; Filion KB, 2014, GUT, V63, P552, DOI 10.1136/gutjnl-2013-304738; Fohl Alexander L, 2011, World J Gastrointest Pharmacol Ther, V2, P17, DOI 10.4292/wjgpt.v2.i3.17; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Heidelbaugh JJ, 2009, GASTROENTEROL HEPATO, V5, P725; Hermos JA, 2012, CLIN INFECT DIS, V54, P33, DOI 10.1093/cid/cir767; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Jena AB, 2013, J GEN INTERN MED, V28, P223, DOI 10.1007/s11606-012-2211-5; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lambert AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128004; Mazer-Amirshahi M, 2014, AM J EMERG MED, V32, P618, DOI 10.1016/j.ajem.2014.03.019; Millett ERC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075131; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P269, DOI 10.1002/pds.1715; National Institute for Health and Care Excellence, 2014, PNEUM AD DIAGN MAN; Niederman MS, 2004, CLIN INFECT DIS, V39, P1791, DOI 10.1086/426031; Quint JK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005540; Salisbury D, 2013, THE GREEN BOOK, P41; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Sultan N, 2008, CAN J GASTROENTEROL, V22, P761, DOI 10.1155/2008/821385; Tannen RL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b81; Uddin MJ, 2015, PHARMACOEPIDEM DR S, V24, P468, DOI 10.1002/pds.3724; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911; Yu MG, 2012, PHARMACOEPIDEM DR S, V21, P60, DOI 10.1002/pds.3235	38	47	48	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 15	2016	355								i5813	10.1136/bmj.i5813	http://dx.doi.org/10.1136/bmj.i5813			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED5VI	28715344	Green Published, hybrid			2022-12-28	WOS:000388920000001
J	Cabitza, F; Rasoini, R; Gensini, GF				Cabitza, Federico; Rasoini, Raffaele; Gensini, Gian Franco			Unintended Consequences of Machine Learning in Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Cabitza, Federico] Univ Milano Bicocca, Dept Informat, Milan, Italy; [Cabitza, Federico] IRCCS, Ist Ortoped Galeazzi, Milan, Italy; [Rasoini, Raffaele; Gensini, Gian Franco] Ctr Studi Med Avanzata, Florence, Italy	University of Milano-Bicocca; IRCCS Istituto Ortopedico Galeazzi	Cabitza, F (corresponding author), Univ Milano Bicocca, 1 Piazza Ateneo Nuovo, I-20126 Milan, Italy.	fcabitza@gmail.com	Cabitza, Federico/L-2263-2013	Cabitza, Federico/0000-0002-4065-3415				Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Dharmarajan K, 2016, J AM GERIATR SOC, V64, P1574, DOI 10.1111/jgs.14303; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hoff T, 2011, HEALTH CARE MANAGE R, V36, P338, DOI 10.1097/HMR.0b013e31821826a1; Povyakalo AA, 2013, MED DECIS MAKING, V33, P98, DOI 10.1177/0272989X12465490; Svensson CM, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/573165; Tsai TL, 2003, J AM MED INFORM ASSN, V10, P478, DOI 10.1197/jamia.M1279	8	363	370	3	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					517	518		10.1001/jama.2017.7797	http://dx.doi.org/10.1001/jama.2017.7797			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC9KM	28727867				2022-12-28	WOS:000407160100011
J	Hassenkam, T; Andersson, MP; Dalby, KN; Mackenzie, DMA; Rosing, MT				Hassenkam, T.; Andersson, M. P.; Dalby, K. N.; Mackenzie, D. M. A.; Rosing, M. T.			Elements of Eoarchean life trapped in mineral inclusions	NATURE			English	Article							SOUTHERN WEST GREENLAND; CARBONACEOUS MATERIAL; RAMAN-SPECTRA; SPECTROSCOPY; GRAPHITE; ROCKS; GRAPHITIZATION; APPROXIMATION; METASEDIMENTS; TEMPERATURE	Metasedimentary rocks from Isua, West Greenland (over 3,700 million years old) contain C-13-depleted carbonaceous compounds, with isotopic ratios that are compatible with a biogenic origin(1-3). Metamorphic garnet crystals in these rocks contain trails of carbonaceous inclusions that are contiguous with carbon-rich sedimentary beds in the host rock, where carbon is fully graphitized. Previous studies(4,5) have not been able to document other elements of life (mainly hydrogen, oxygen, nitrogen and phosphorus) structurally bound to this carbonaceous material. Here we study carbonaceous inclusions armoured within garnet porphyroblasts, by in situ infrared absorption on approximately 10(-21) m(3) domains within these inclusions. We show that the absorption spectra are consistent with carbon bonded to nitrogen and oxygen, and probably also to phosphate. The levels of C-H or O-H bonds were found to be low. These results are consistent with biogenic organic material isolated for billions of years and thermally matured at temperatures of around 500 degrees C. They therefore provide spatial characterization for potentially the oldest biogenic carbon relics in Earth's geological record. The preservation of Eoarchean organic residues within sedimentary material corroborates earlier claims(2,6) for the biogenic origins of carbon in Isua metasediments.	[Hassenkam, T.; Andersson, M. P.; Dalby, K. N.] Univ Copenhagen, Dept Chem, Nanosci Ctr, DK-2100 Copenhagen, Denmark; [Mackenzie, D. M. A.] Tech Univ Denmark, Dept Micro & Nanotechnol, CNG, DK-2800 Lyngby, Denmark; [Rosing, M. T.] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	Hassenkam, T (corresponding author), Univ Copenhagen, Dept Chem, Nanosci Ctr, DK-2100 Copenhagen, Denmark.	tue@nano.ku.dk	Hassenkam, Tue/B-8391-2015; Dalby, Kim N/J-8407-2012; Andersson, Martin/F-9598-2010; Mackenzie, David Michael Angus/H-6922-2012; Dalby, Kim/AAG-9709-2021; Rosing, Minik/A-9977-2013	Dalby, Kim N/0000-0001-6048-3583; Andersson, Martin/0000-0002-4921-1461; Mackenzie, David Michael Angus/0000-0003-1114-2955; Dalby, Kim/0000-0001-6048-3583; Rosing, Minik/0000-0001-7559-661X	Danish National Research Foundation (DNRF) [DNRF53]; NanoGeoScience group	Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond); NanoGeoScience group	The research was supported by the Danish National Research Foundation (DNRF; fund number DNRF53) to Nordic Center for Earth Evolution. The research was supported by the NanoGeoScience group. We are grateful to E. Mathez, S. L. S. Stipp, J. Generosi and K. Bechgaard for inspiring discussions and J. Andersen for establishing contact. We also wish to thank D. Buti for assistance with the Raman spectroscopy.	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Bauschlicher CW, 2010, ASTROPHYS J SUPPL S, V189, P341, DOI 10.1088/0067-0049/189/2/341; Bauschlicher CW, 2008, ASTROPHYS J, V678, P316, DOI 10.1086/533424; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Beyssac O, 2002, CONTRIB MINERAL PETR, V143, P19, DOI 10.1007/s00410-001-0324-7; Beyssac O, 2002, J METAMORPH GEOL, V20, P859, DOI 10.1046/j.1525-1314.2002.00408.x; BOAK JL, 1982, EARTH PLANET SC LETT, V59, P155, DOI 10.1016/0012-821X(82)90123-6; Coates J., 2006, ENCY ANAL CHEM, P1, DOI 10.1002/9780470027318.a5606; Dazzi A, 2012, APPL SPECTROSC, V66, P1365, DOI 10.1366/12-06804; De Gregorio BT, 2009, GEOLOGY, V37, P631, DOI 10.1130/G25683A.1; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; FERRY JM, 1978, CONTRIB MINERAL PETR, V66, P113, DOI 10.1007/BF00372150; HOFMEISTER AM, 1991, PHYS CHEM MINER, V17, P503; Hofmeister AM, 1996, AM MINERAL, V81, P418; KAGI H, 1994, GEOCHIM COSMOCHIM AC, V58, P3527, DOI 10.1016/0016-7037(94)90104-X; KITSON RE, 1952, ANAL CHEM, V24, P334, DOI 10.1021/ac60062a019; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Klamt A, 2010, ANNU REV CHEM BIOMOL, V1, P101, DOI 10.1146/annurev-chembioeng-073009-100903; LANDIS CA, 1971, CONTRIB MINERAL PETR, V30, P34, DOI 10.1007/BF00373366; Nutman AP, 2004, J GEOL SOC LONDON, V161, P421, DOI 10.1144/0016-764903-043; Ohtomo Y, 2014, NAT GEOSCI, V7, P25, DOI [10.1038/NGEO2025, 10.1038/ngeo2025]; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Pinti DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2301, DOI 10.1016/S0016-7037(01)00590-7; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Ruhela R, 2015, GREEN CHEM, V17, P827, DOI 10.1039/c4gc02020k; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Slawin AMZ, 2001, J CHEM SOC DALTON, P621, DOI 10.1039/b009074n; SPEAR FS, 1991, J METAMORPH GEOL, V9, P379, DOI 10.1111/j.1525-1314.1991.tb00533.x; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Khai TV, 2012, CARBON, V50, P3799, DOI 10.1016/j.carbon.2012.04.005; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; van Zuilen MA, 2005, GEOCHIM COSMOCHIM AC, V69, P1241, DOI 10.1016/j.gca.2004.08.033; Wang LP, 1996, AM MINERAL, V81, P706	37	55	55	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					78	+		10.1038/nature23261	http://dx.doi.org/10.1038/nature23261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28738409				2022-12-28	WOS:000406831700040
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Alarm overload makes a difficult job harder	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Kingston Hospital NHS Foundation Trust, 2013, WHAT IS SEPS; The Phoenix Partnership, 2016, SYSTM SEPS PROT SEES	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2017	358								j3593	10.1136/bmj.j3593	http://dx.doi.org/10.1136/bmj.j3593			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CB	28760749	Bronze, Green Published			2022-12-28	WOS:000407206300002
J	Betts, MG; Wolf, C; Ripple, WJ; Phalan, B; Millers, KA; Duarte, A; Butchart, SHM; Levi, T				Betts, Matthew G.; Wolf, Christopher; Ripple, William J.; Phalan, Ben; Millers, Kimberley A.; Duarte, Adam; Butchart, Stuart H. M.; Levi, Taal			Global forest loss disproportionately erodes biodiversity in intact landscapes	NATURE			English	Article							TROPICAL FORESTS; EXTINCTION RISK; HUMAN FOOTPRINT; HABITAT LOSS; WORLDS; FRAGMENTATION; RICHNESS; HOTSPOTS; IMPACT; MAPS	Global biodiversity loss is a critical environmental crisis, yet the lack of spatial data on biodiversity threats has hindered conservation strategies(1). Theory predicts that abrupt biodiversity declines are most likely to occur when habitat availability is reduced to very low levels in the landscape (10-30%)(2-4). Alternatively, recent evidence indicates that biodiversity is best conserved by minimizing human intrusion into intact and relatively unfragmented landscapes(5). Here we use recently available forest loss data(6) to test deforestation effects on International Union for Conservation of Nature Red List categories of extinction risk for 19,432 vertebrate species worldwide. As expected, deforestation substantially increased the odds of a species being listed as threatened, undergoing recent upgrading to a higher threat category and exhibiting declining populations. More importantly, we show that these risks were disproportionately high in relatively intact landscapes; even minimal deforestation has had severe consequences for vertebrate biodiversity. We found little support for the alternative hypothesis that forest loss is most detrimental in already fragmented landscapes. Spatial analysis revealed high-risk hot spots in Borneo, the central Amazon and the Congo Basin. In these regions, our model predicts that 121-219 species will become threatened under current rates of forest loss over the next 30 years. Given that only 17.9% of these high-risk areas are formally protected and only 8.9% have strict protection, new large-scale conservation efforts to protect intact forests(7,8) are necessary to slow deforestation rates and to avert a new wave of global extinctions.	[Betts, Matthew G.; Wolf, Christopher; Ripple, William J.; Phalan, Ben; Levi, Taal] Oregon State Univ, Dept Forest Ecosyst & Soc, Forest Biodivers Res Network, Corvallis, OR 97331 USA; [Betts, Matthew G.; Wolf, Christopher; Ripple, William J.] Oregon State Univ, Dept Forest Ecosyst & Soc, Global Troph Cascades Program, Corvallis, OR 97331 USA; [Phalan, Ben; Butchart, Stuart H. M.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Millers, Kimberley A.; Levi, Taal] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Duarte, Adam] Oregon State Univ, Dept Fisheries & Wildlife, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Butchart, Stuart H. M.] BirdLife Int, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England	Oregon State University; Oregon State University; University of Cambridge; Oregon State University; Oregon State University; BirdLife International	Betts, MG; Wolf, C (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Forest Biodivers Res Network, Corvallis, OR 97331 USA.; Betts, MG; Wolf, C (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Global Troph Cascades Program, Corvallis, OR 97331 USA.	matt.betts@oregonstate.edu; wolfch@science.oregonstate.edu	Butchart, Stuart/AAJ-1852-2021; Betts, Matthew G/Q-2978-2019; Phalan, Ben/A-5783-2009; Butchart, Stuart HM/Y-2711-2018; Ripple, William/ABE-9353-2020	Butchart, Stuart/0000-0002-1140-4049; Betts, Matthew G/0000-0002-7100-2551; Phalan, Ben/0000-0001-7876-7226; Levi, Taal/0000-0003-1853-8311	National Science Foundation [NSF-DEB-1457837]; College of Forestry IWFL Professorship in Forest Biodiversity Research	National Science Foundation(National Science Foundation (NSF)); College of Forestry IWFL Professorship in Forest Biodiversity Research	Funding from the National Science Foundation (NSF-DEB-1457837) and the College of Forestry IWFL Professorship in Forest Biodiversity Research to M.G.B. supported this research. We are grateful for comments from A. Hadley, U. Kormann, J. Bowman, C. Epps and C. Mendenhall on earlier versions of this manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Bates D.M., 2010, LME4 MIXED EFFECTS M; Bellard C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2454; Benitez-Lopez A, 2017, SCIENCE, V356, P180, DOI 10.1126/science.aaj1891; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Betts MG, 2014, ECOGRAPHY, V37, P517, DOI 10.1111/ecog.00740; BirdLife International, 2017, IUCN RED LIST BIRDS; BirdLife International and NatureServe, 2015, BIRD SPEC DISTR MAPS; Bivand R, 2017, SPDEP SPATIAL DEPEND; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Dormann CF, 2007, ECOL MODEL, V207, P234, DOI 10.1016/j.ecolmodel.2007.05.002; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; ESRI, 2012, ARCGIS REL 10 1; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gilleland M. E., 2015, VERIFICATION WEATHER; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann M, 2011, PHILOS T R SOC B, V366, P2598, DOI 10.1098/rstb.2011.0116; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; International Union for Conservation of Nature World Congress, 2016, MOT 48 PROT PRIM FOR; IUCN. IUCN, 2020, IUCN RED LIST THREAT; IUCN UNEP-WCMC, 2015, WORLD DAT PROT AR WD; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Joppa LN, 2016, SCIENCE, V352, P416, DOI 10.1126/science.aaf3565; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kim DH, 2014, REMOTE SENS ENVIRON, V155, P178, DOI 10.1016/j.rse.2014.08.017; Klier T., 2012, J BUS ECON STAT, V26, P460; Lee D, 2013, J STAT SOFTW, V55, P1; MacDicken KG, 2015, FOREST ECOL MANAG, V352, P3, DOI 10.1016/j.foreco.2015.02.006; McMillen, 2013, MCSPATIAL NONPARAMET; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Newbold T, 2016, SCIENCE, V353, P288, DOI 10.1126/science.aaf2201; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Petersen R., 2016, MAPPING TREE PLANTAT; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Potapov P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600821; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; R Development Core Team, 2009, R LANG ENV STAT COMP; Ripple WJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160498; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Seligman M, 2015, RBORIST EXTENSIBLE P; Swets JohnA., 2014, SIGNAL DETECTION THE, DOI [10.4324/9781315806167, DOI 10.4324/9781315806167]; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tracewski L, 2016, CONSERV BIOL, V30, P1070, DOI 10.1111/cobi.12715; United Nations, 2013, STAND COUNTR AR COD; Venter O., 2016, DATA GLOBAL TERRESTR; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Wilson E.O., 2016, HALF EARTH OUR PLANE	64	242	248	33	347	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					441	+		10.1038/nature23285	http://dx.doi.org/10.1038/nature23285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28723892				2022-12-28	WOS:000406358300033
J	Gulland, A				Gulland, Anne			Five minutes with ... Paula Bolton-Maggs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Serious Hazards of Transfusion (SHOT), 2017, ANN SHOT REP 2016	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j3555	10.1136/bmj.j3555	http://dx.doi.org/10.1136/bmj.j3555			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UW	28747309				2022-12-28	WOS:000406765900011
J	Zhu, SH; Zhuang, YL; Wong, SS; Cummins, SE; Tedeschi, GJ				Zhu, Shu-Hong; Zhuang, Yue-Lin; Wong, Shiushing; Cummins, Sharon E.; Tedeschi, Gary J.			E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUITTING SMOKING; ABSTINENCE; SAMPLE; IMPACT; 1ST	OBJECTIVE To examine whether the increase in use of electronic cigarettes in the USA, which became noticeable around 2010 and increased dramatically by 2014, was associated with a change in overall smoking cessation rate at the population level. DESIGN Population surveys with nationally representative samples. SETTING Five of the US Current Population Survey-Tobacco Use Supplement (CPS-TUS) in 2001-02, 2003, 2006-07, 2010-11, and 2014-15. PARTICIPANTS Data on e-cigarette use were obtained from the total sample of the 2014-15 CPS-TUS (n=161 054). Smoking cessation rates were obtained from those who reported smoking cigarettes 12 months before the survey (n=23 270). Rates from 2014-15 CPS-TUS were then compared with those from 2010-11 CPS-TUS (n=27 280) and those from three other previous surveys. MAIN OUTCOME MEASURES Rate of attempt to quit cigarette smoking and the rate of successfully quitting smoking, defined as having quit smoking for at least three months. RESULTS Of 161 054 respondents to the 2014-15 survey, 22 548 were current smokers and 2136 recent quitters. Among them, 38.2% of current smokers and 49.3% of recent quitters had tried e-cigarettes, and 11.5% and 19.0% used them currently (every day or some days). E-cigarette users were more likely than non-users to attempt to quit smoking, 65.1% v 40.1% (change=25.0%, 95% confidence interval 23.2% to 26.9%), and more likely to succeed in quitting, 8.2% v 4.8% (3.5%, 2.5% to 4.5%). The overall population cessation rate for 2014-15 was significantly higher than that for 2010-11, 5.6% v 4.5% (1.1%, 0.6% to 1.5%), and higher than those for all other survey years (range 4.3-4.5%). CONCLUSION The substantial increase in e-cigarette use among US adult smokers was associated with a statistically significant increase in the smoking cessation rate at the population level. These findings need to be weighed carefully in regulatory policy making regarding e-cigarettes and in planning tobacco control interventions.	[Zhu, Shu-Hong; Cummins, Sharon E.] Univ Calif San Diego, Dept Family Med & Publ Hlth, 9500 Gilman Dr MC 0905, La Jolla, CA 92093 USA; [Zhu, Shu-Hong; Zhuang, Yue-Lin; Wong, Shiushing; Cummins, Sharon E.; Tedeschi, Gary J.] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Zhu, SH (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, 9500 Gilman Dr MC 0905, La Jolla, CA 92093 USA.; Zhu, SH (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.	szhu@ucsd.edu	Zhu, Shu-Hong/AAF-5164-2019		National Cancer Institute of the National Institutes of Health under the State and Community Tobacco Control (SCTC) Initiative [U01CA154280]; NATIONAL CANCER INSTITUTE [U01CA154280] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health under the State and Community Tobacco Control (SCTC) Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute of the National Institutes of Health under the State and Community Tobacco Control (SCTC) Initiative (award No U01CA154280). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funders of this study had no role in the study design; collection, analysis, and interpretation of the data; writing of the manuscript; or decision to submit the manuscript for publication.	Al-Delaimy WK, 2015, AM J PUBLIC HEALTH, V105, P1213, DOI 10.2105/AJPH.2014.302482; [Anonymous], 2012, REL 11; [Anonymous], 2012, REL 11; Beard E, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4645; Biener L, 2015, NICOTINE TOB RES, V17, P127, DOI 10.1093/ntr/ntu200; Brown J, 2014, ADDICTION, V109, P1531, DOI 10.1111/add.12623; Chapman S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5512; Chen C, 2016, AM J PREV MED, V51, P356, DOI 10.1016/j.amepre.2016.02.002; Christensen T, 2014, PREV MED, V69, P90, DOI 10.1016/j.ypmed.2014.09.005; Davis WW, TRENDS SMOKING PREVA; Delnevo CD, 2016, NICOTINE TOB RES, V18, P715, DOI 10.1093/ntr/ntv237; Douglas H, 2015, AUST FAM PHYSICIAN, V44, P415; Etter JF, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0264-5; Farsalinos KE, 2016, ADDICTION, V111, P2032, DOI 10.1111/add.13506; Farsalinos KE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04133; Gilpin EA, 1997, J NATL CANCER I, V89, P572, DOI 10.1093/jnci/89.8.572; Glasser AM, 2017, AM J PREV MED, V52, pE33, DOI 10.1016/j.amepre.2016.10.036; Hartmann-Boyce Jamie, 2016, Cochrane Database Syst Rev, V9, pCD010216, DOI 10.1002/14651858.CD010216.pub3; Hitchman SC, 2015, NICOTINE TOB RES, V17, P1187, DOI 10.1093/ntr/ntv078; Huang J, 2012, 18026 NBER; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Levy DT, 2017, ADDICTION, V112, P8, DOI 10.1111/add.13394; Malas M, 2016, NICOTINE TOB RES, V18, P1926, DOI 10.1093/ntr/ntw119; McAfee T, 2013, LANCET, V382, P2003, DOI 10.1016/S0140-6736(13)61686-4; McMillen RC, 2015, NICOTINE TOB RES, V17, P1195, DOI 10.1093/ntr/ntu213; Medicines and Healthcare Products Regulatory Agency, LIC PROC EL CIG OTH; Neff LJ, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150556; Pearson JL, 2015, NICOTINE TOB RES, V17, P1219, DOI 10.1093/ntr/ntu269; Pierce JP, 2002, JAMA-J AM MED ASSOC, V288, P1260, DOI 10.1001/jama.288.10.1260; Ramamurthi D, 2016, AM J PUBLIC HEALTH, V106, P2057, DOI 10.2105/AJPH.2016.303437; Schoenborn Charlotte A, 2015, NCHS Data Brief, P1; Shi YY, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3770-x; Shiffman S, 1997, Tob Control, V6, P306; United States Census Bureau National Cancer Institute Food and Drug Administration, 2016, TOB US SUPPL CURR PO; United States Government Department of Health and Human Services, 2016, FED REGISTER, V81, P28973; US Department of Commerce. Census Bureau, 2006, NAT CANC I CTR DIS C; US Department of Commerce. Census Bureau, 2010, NAT CANC I SPONS TOB; US Department of Commerce. Census Bureau, 2004, NAT CANC I CTR DIS C; US Department of Commerce. Census Bureau, 2014, NAT CANC I FOOD DRUG; US Department of Commerce. Census Bureau, 2003, NAT CANC I CTR DIS C; West R, 2005, TOB CONTROL, V14, P166, DOI 10.1136/tc.2004.008649; Yong H-H, 2017, NICOTINE TOB RES, DOI 10.1093/ntr/ntx056; Zhu SH, 2016, TOB CONTROL, V25, P464, DOI 10.1136/tobaccocontrol-2015-052332; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670; Zhu SH, 2012, TOB CONTROL, V21, P110, DOI 10.1136/tobaccocontrol-2011-050371; Zhuang YL, 2016, TOB CONTROL, V25, pi90, DOI 10.1136/tobaccocontrol-2016-053096	46	227	229	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j3262	10.1136/bmj.j3262	http://dx.doi.org/10.1136/bmj.j3262			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3UW	28747333	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000406765900002
J	Dacso, CC				Dacso, Clifford C.			In older men, 5 alpha-reductase inhibitors were linked to increased risk for self-harm and depression but not suicide	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dacso, Clifford C.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Dacso, CC (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.		Dacso, Clifford/AAM-7746-2021	Dacso, Clifford/0000-0002-0710-1678				Center for Drug Evaluation and Research, 2011, 20788S017 NDA CTR DR	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC9	JC9		10.7326/ACPJC-2017-167-2-009	http://dx.doi.org/10.7326/ACPJC-2017-167-2-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715831				2022-12-28	WOS:000405573400010
J	Liljencrantz, J; Pitcher, MH; Low, LA; Bauer, L; Bushnell, MC				Liljencrantz, Jaquette; Pitcher, Mark H.; Low, Lucie A.; Bauer, Lucy; Bushnell, M. Catherine			Comment on "Molecular and neural basis of contagious itch behavior in mice"	SCIENCE			English	Editorial Material								Yu et al. (Reports, 10 March 2017, p. 1072) state that contagious itch occurs in mice based on imitative scratching in normal mice observing excessive scratching in genetically modified demonstrator mice. However, despite employing multiple behavioral analysis approaches, we were unable to extend these findings to normal mice observing the well-established histamine model of acute itch in demonstrator mice.	[Liljencrantz, Jaquette; Pitcher, Mark H.; Low, Lucie A.; Bauer, Lucy; Bushnell, M. Catherine] NIH, Pain & Integrat Neurosci Lab, Natl Ctr Complementary & Integrat Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Pitcher, MH (corresponding author), NIH, Pain & Integrat Neurosci Lab, Natl Ctr Complementary & Integrat Hlth, Bethesda, MD 20892 USA.	mark.pitcher@nih.gov		Bushnell, Mary/0000-0001-5207-9767; Low, Lucie/0000-0001-6082-8625	Division of Intramural Research of the National Center for Complementary and Integrative Health, National Institutes of Health; National Center for Complementary & Integrative Health [ZIAAT000027] Funding Source: NIH RePORTER	Division of Intramural Research of the National Center for Complementary and Integrative Health, National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Y. Q. Yu and coauthors for their willingness to engage in constructive discussion. We are also grateful to A. Chesler for his helpful comments on this manuscript. This research was supported by the Division of Intramural Research of the National Center for Complementary and Integrative Health, National Institutes of Health. The authors have no conflicts of interest to declare. All data are stored in NIH servers and will be made available upon request. J.L. and M.H.P. designed the study, performed experiments, analyzed data, and wrote the manuscript. L.A.L. designed the study, performed experiments, and edited the manuscript. L.B. performed experiments. M.C.B. designed the study and edited the manuscript.	Feneran AN, 2013, ACTA DERM-VENEREOL, V93, P27, DOI 10.2340/00015555-1406; Han N, 2012, CLIN EXP DERMATOL, V37, P290, DOI 10.1111/j.1365-2230.2011.04314.x; Holle H, 2012, P NATL ACAD SCI USA, V109, P19816, DOI 10.1073/pnas.1216160109; Lloyd DM, 2013, BRIT J DERMATOL, V168, P106, DOI 10.1111/bjd.12132; Nakayama K, 2004, J COMP PSYCHOL, V118, P20, DOI 10.1037/0735-7036.118.1.20; Ogden J, 2009, PSYCHOL HEALTH MED, V14, P695, DOI 10.1080/13548500903311547; Papoiu A D P, 2011, Br J Dermatol, V164, P1299, DOI 10.1111/j.1365-2133.2011.10318.x; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Yu YQ, 2017, SCIENCE, V355, DOI 10.1126/science.aak9748; Zhao ZQ, 2013, J CLIN INVEST, V123, P4769, DOI 10.1172/JCI70528	10	8	8	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI				eaan4749	10.1126/science.aan4749	http://dx.doi.org/10.1126/science.aan4749			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706013	Green Accepted			2022-12-28	WOS:000405391700001
J	Hudson, M; Sheron, N; Rowe, IA; Hirschfield, GM				Hudson, Mark; Sheron, Nick; Rowe, Ian A.; Hirschfield, Gideon M.			Should we screen for cirrhosis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALCOHOL; ABSTINENCE; EXCELLENCE; ACCURACY; HEALTH; CARE		[Hudson, Mark] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Sheron, Nick] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Rowe, Ian A.] Univ Leeds, Leeds Inst Data Analyt, Leeds, W Yorkshire, England; [Hirschfield, Gideon M.] Univ Birmingham, NIHR Biomed Res Ctr, Ctr Liver Res, Birmingham, W Midlands, England	Newcastle Freeman Hospital; Newcastle University - UK; University of Southampton; University of Leeds; University of Birmingham	Hudson, M (corresponding author), Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England.; Rowe, IA (corresponding author), Univ Leeds, Leeds Inst Data Analyt, Leeds, W Yorkshire, England.	Mark.Hudson@nuth.nhs.uk; i.a.c.rowe@leeds.ac.uk	Hirschfield, Gideon/M-2143-2015	Hirschfield, Gideon/0000-0002-6736-2255; Sheron, Nick/0000-0001-5232-8292; Sheron, Nick/0000-0002-6156-8367	NIHR; MRC; Wellcome Trust; British Liver Trust; Alcohol Education Research Council; Norgine; Kyowa Kirin; Public Health England	NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Liver Trust; Alcohol Education Research Council; Norgine; Kyowa Kirin; Public Health England	All authors have read and understood BMJ policy on declaration of interests and declare the following interests: MH has received personal fees from Abbvie, Norgine, Janssen, Astellas and Novartis outside the submitted work. NS has received research grants from NIHR, MRC, Wellcome Trust, British Liver Trust, Alcohol Education Research Council, and various other funding bodies. NNS has done paid consultancy work and received travelling expenses from pharmaceutical companies Norgine (2014) and Kyowa Kirin (2014) and done medicolegal work in hepatitis C and alcohol related liver disease. NS is a member of, or has done advisory work for, EU Alcohol Forum, Royal College of Physicians Alcohol Committee, Alcohol Health Alliance UK, UK Department of Health, Home Office, Department of Transport, Southampton City Council, British Liver Trust, clinical/scientific adviser to Public Health England (paid), EASL, BASL and BSG. IAR declares personal fees from Abbvie, from Bayer, and from Norgine outside the submitted work; GMH declares personal fees from Falk Pharma, and from Intercept outside the submitted work. GMH is also an investigator for many agents for immune mediated liver disease from Falk Pharma, Intercept, Gilead, GSK, FF Pharma, Novartis, Cymabay, NGM Bio, and BioTie.	Bertholet N, 2005, ARCH INTERN MED, V165, P986, DOI 10.1001/archinte.165.9.986; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Bouttell J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162980; Burton R, 2017, LANCET, V389, P1558, DOI 10.1016/S0140-6736(16)32420-5; Claxton K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19140; Farvardin S, 2017, HEPATOLOGY, V65, P875, DOI 10.1002/hep.28770; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Harris R, 2017, LANCET GASTROENTEROL, V2, P288, DOI 10.1016/S2468-1253(16)30205-9; Harrison P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i2850; Ilyas JA, 2014, GASTROENTEROL CLIN N, V43, P783, DOI 10.1016/j.gtc.2014.08.008; Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501; Lederle FA, 2012, ANN INTERN MED, V156, P387, DOI 10.7326/0003-4819-156-5-201203060-00012; NICE, 2016, CLIN GUID 50 CIRRH 1; Pavlov CS, 2016, ALIMENT PHARM THER, V43, P575, DOI 10.1111/apt.13524; Robinson S, 2008, GEN LIFESTYLE SURVEY; Sheron N, 2013, BRIT J GEN PRACT, V63, pE698, DOI 10.3399/bjgp13X673711; Taylor EJ, 2017, HEPATOLOGY, V66, P1546, DOI 10.1002/hep.29315; Thiele M, 2016, ALIMENT PHARM THER, V43, P1014, DOI 10.1111/apt.13561; Trabut JB, 2008, ALCOHOL ALCOHOLISM, V43, P559, DOI 10.1093/alcalc/agn046; Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9	21	3	3	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2017	358								j3233	10.1136/bmj.j3233	http://dx.doi.org/10.1136/bmj.j3233			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MU	28701337	Green Published			2022-12-28	WOS:000405770500005
J	Schorge, JO; Russo, AL; Greene, MF; Woythaler, MA; Oliva, E				Schorge, John O.; Russo, Andrea L.; Greene, Michael F.; Woythaler, Melissa A.; Oliva, Esther			Case 21-2017: A 28-Year-Old Pregnant Woman with Endocervical Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC RADIATION-THERAPY; CERVICAL-CANCER; HEMOLYTIC-DISEASE; RADICAL SURGERY; INTRAVENOUS IMMUNOGLOBULIN; ADENOCARCINOMA; MANAGEMENT; STAGE; CHEMOTHERAPY; MORPHOLOGY		[Schorge, John O.; Greene, Michael F.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Russo, Andrea L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Woythaler, Melissa A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Oliva, Esther] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Schorge, John O.; Greene, Michael F.] Harvard Med Sch, Dept Obstet Gynecol & Reprod Biol, Boston, MA USA; [Russo, Andrea L.] Harvard Med Sch, Dept Radiat Oncol, Boston, MA USA; [Woythaler, Melissa A.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Oliva, Esther] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Schorge, JO (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA.							Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Bishop JA, 2015, SEMIN DIAGN PATHOL, V32, P344, DOI 10.1053/j.semdp.2015.02.013; Bogani G, 2014, J MINIM INVAS GYN, V21, P857, DOI 10.1016/j.jmig.2014.03.018; Chen J, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.04.023; Corvaglia L, 2012, J MATERN-FETAL NEO M, V25, P2782, DOI 10.3109/14767058.2012.718387; Figueras-Aloy J, 2010, PEDIATRICS, V125, P139, DOI 10.1542/peds.2009-0676; FISCHER GW, 1988, PEDIATR CLIN N AM, V35, P517; Galic V, 2012, GYNECOL ONCOL, V125, P287, DOI 10.1016/j.ygyno.2012.01.012; Keir A, 2015, ARCH DIS CHILDHOOD-E, V100, P198, DOI 10.1136/archdischild-2013-305553; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Koh WJ, 2015, J NATL COMPR CANC NE, V13, P395, DOI 10.6004/jnccn.2015.0055; Kusanagi Y, 2010, AM J PATHOL, V177, P2169, DOI 10.2353/ajpath.2010.100323; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; LILEY AW, 1961, AM J OBSTET GYNECOL, V82, P1359; Maisels MJ, 2004, PEDIATRICS, V114, P297; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; Meserve Emily E K, 2016, Surg Pathol Clin, V9, P243, DOI 10.1016/j.path.2016.01.006; Mikami Y, 2013, ADV ANAT PATHOL, V20, P227, DOI 10.1097/PAP.0b013e31829c2d66; National Comprehensive Cancer Network, 2016, CLIN PRACT GUID ONC; Patra K, 2004, J PEDIATR-US, V144, P626, DOI 10.1016/j.jpeds.2004.01.054; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Ronnett BM, 2016, MODERN PATHOL, V29, pS12, DOI 10.1038/modpathol.2015.131; Ruba S, 2004, CANCER CYTOPATHOL, V102, P280, DOI 10.1002/cncr.20600; Schorge JO, 1999, OBSTET GYNECOL, V94, P386, DOI 10.1016/S0029-7844(99)00312-9; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Smits-Wintjens VEHJ, 2008, SEMIN FETAL NEONAT M, V13, P265, DOI 10.1016/j.siny.2008.02.005; Sood AK, 2000, OBSTET GYNECOL, V95, P832, DOI 10.1016/S0029-7844(00)00789-4; Tewari K, 1998, CANCER, V82, P1529, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1529::AID-CNCR15>3.0.CO;2-6; URSIN G, 1994, LANCET, V344, P1390, DOI 10.1016/S0140-6736(94)90567-3; Vaughan JI, 1998, NEW ENGL J MED, V338, P798, DOI 10.1056/NEJM199803193381204; Walker JL, 2015, CANCER-AM CANCER SOC, V121, P2108, DOI 10.1002/cncr.29321; Wilbur DC, 2014, WHO CLASSIFICATION T, P183; Young RH, 2002, HISTOPATHOLOGY, V41, P185, DOI 10.1046/j.1365-2559.2002.01462.x	34	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					174	182		10.1056/NEJMcpc1703511	http://dx.doi.org/10.1056/NEJMcpc1703511			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA2PC	28700849				2022-12-28	WOS:000405282300013
J	Lebwohl, B; Sanders, DS; Green, PHR				Lebwohl, Benjamin; Sanders, David S.; Green, Peter H. R.			Coeliac disease	LANCET			English	Review							GLUTEN-FREE DIET; SMALL-INTESTINAL HISTOPATHOLOGY; VILLOUS ATROPHY; TISSUE TRANSGLUTAMINASE; LYMPHOPROLIFERATIVE MALIGNANCY; PEDIATRIC GASTROENTEROLOGY; GASTROINTESTINAL SYMPTOMS; BACTERIA POPULATIONS; GLIADIN PEPTIDES; EUROPEAN-SOCIETY	Coeliac disease occurs in about 1% of people in most populations. Diagnosis rates are increasing, and this seems to be due to a true rise in incidence rather than increased awareness and detection. Coeliac disease develops in genetically susceptible individuals who, in response to unknown environmental factors, develop an immune response that is subsequently triggered by the ingestion of gluten. The disease has many clinical manifestations, ranging from severe malabsorption to minimally symptomatic or non-symptomatic presentations. Diagnosis requires the presence of duodenal villous atrophy, and most patients have circulating antibodies against tissue transglutaminase; in children, European guidelines allow a diagnosis without a duodenal biopsy provided that strict symptomatic and serological criteria are met. Although a gluten-free diet is an effective treatment in most individuals, a substantial minority develop persistent or recurrent symptoms. Difficulties adhering to a gluten-free diet have led to the development of non-dietary therapies, several of which are undergoing trials in human beings.	[Lebwohl, Benjamin; Green, Peter H. R.] Columbia Univ, Coll Phys & Surg, Med Ctr, Celiac Dis Ctr, New York, NY 10032 USA; [Lebwohl, Benjamin] Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Sanders, David S.] Royal Hallamshire Hosp, Acad Unit Gastroenterol, Sheffield, S Yorkshire, England; [Sanders, David S.] Univ Sheffield, Sheffield, S Yorkshire, England	Columbia University; Columbia University; University of Sheffield; University of Sheffield	Green, PHR (corresponding author), Columbia Univ, Celiac Dis Ctr, New York, NY 10032 USA.	pg11@columbia.edu			Dr Schar, a gluten-free company	Dr Schar, a gluten-free company	DSS receives an educational grant from Dr Schar, a gluten-free company, for an investigator-led study, but reports that this company have no control over outcomes. PHRG is on the scientific advisory board for ImmusanT, Celimmune, and ImmunogenX. BL declares no competing interests.	Abadie V, 2014, IMMUNOL REV, V260, P221, DOI 10.1111/imr.12191; Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Almeida RC, 2012, AM J HUM BIOL, V24, P710, DOI 10.1002/ajhb.22271; Aronsson CA, 2016, CLIN GASTROENTEROL H, V14, P403, DOI 10.1016/j.cgh.2015.09.030; Aronsson CA, 2015, PEDIATRICS, V135, P239, DOI 10.1542/peds.2014-1787; Aziz I, 2017, GUT, V66, P1563, DOI 10.1136/gutjnl-2016-312271; Aziz I, 2011, J GASTROINTEST LIVER, V20, P27; Bakker SF, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0166-0; Barratt SM, 2011, J GASTROINTEST LIVER, V20, P241; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Brocchi E, 2002, DIGEST LIVER DIS, V34, P177, DOI 10.1016/S1590-8658(02)80190-6; BROCCHI E, 1988, NEW ENGL J MED, V319, P741, DOI 10.1056/NEJM198809223191202; Canova C, 2014, AM J EPIDEMIOL, V180, P76, DOI 10.1093/aje/kwu101; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Chang MS, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-90; Choung RS, 2017, MAYO CLIN PROC, V92, P30, DOI 10.1016/j.mayocp.2016.10.012; Choung RS, 2017, GASTROENTEROLOGY, V152, P830, DOI 10.1053/j.gastro.2016.11.043; Choung RS, 2015, AM J GASTROENTEROL, V110, P455, DOI 10.1038/ajg.2015.8; Collin P, 2005, EUR J GASTROEN HEPAT, V17, P85, DOI 10.1097/00042737-200501000-00017; Collin P, 2007, J CLIN GASTROENTEROL, V41, P152, DOI 10.1097/01.mcg.0000212618.12455.a8; Comino I, 2016, AM J GASTROENTEROL, V111, P1456, DOI 10.1038/ajg.2016.439; Crespo-Escobar P, 2017, AM J CLIN NUTR, V105, P890, DOI 10.3945/ajcn.116.144352; Moreno MD, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010046; De Palma G, 2009, BRIT J NUTR, V102, P1154, DOI 10.1017/S0007114509371767; DeGaetani M, 2013, AM J GASTROENTEROL, V108, P647, DOI 10.1038/ajg.2013.45; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Downey L, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4513; Elfstrom P, 2012, CLIN GASTROENTEROL H, V10, P30, DOI 10.1016/j.cgh.2011.06.029; Elfstrom P, 2011, JNCI-J NATL CANCER I, V103, P436, DOI 10.1093/jnci/djq564; England CY, 2004, J HUM NUTR DIET, V17, P547, DOI 10.1111/j.1365-277X.2004.00561.x; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Galipeau HJ, 2015, AM J PATHOL, V185, P2969, DOI 10.1016/j.ajpath.2015.07.018; Gasbarrini G, 2009, INT J IMMUNOPATH PH, V22, P1; Gasbarrini GB, 2014, UNITED EUR GASTROENT, V2, P254, DOI 10.1177/2050640614535929; Giersiepen K, 2012, J PEDIATR GASTR NUTR, V54, P229, DOI 10.1097/MPG.0b013e318216f2e5; Godfrey JD, 2010, GASTROENTEROLOGY, V139, P763, DOI 10.1053/j.gastro.2010.05.041; Goel G, 2017, LANCET GASTROENTEROL, V2, P479, DOI 10.1016/S2468-1253(17)30110-3; Gray AM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-105; Green PHR, 2003, AM J MED, V115, P191, DOI 10.1016/S0002-9343(03)00302-4; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Gutierrez-Achury J, 2015, NAT GENET, V47, P577, DOI 10.1038/ng.3268; Hadjivassiliou M, 2013, NEUROLOGY, V80, P1740, DOI 10.1212/WNL.0b013e3182919070; Hoerter NA, 2017, DIGEST DIS SCI, V62, P1272, DOI 10.1007/s10620-017-4474-5; Hollon JR, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-40; Hopper AD, 2008, CLIN GASTROENTEROL H, V6, P314, DOI 10.1016/j.cgh.2007.12.008; Huebener S, 2015, J PROTEOME RES, V14, P503, DOI 10.1021/pr500809b; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ilus T, 2014, AM J GASTROENTEROL, V109, P1471, DOI 10.1038/ajg.2014.194; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Johnston SD, 1998, QJM-MON J ASSOC PHYS, V91, P853, DOI 10.1093/qjmed/91.12.853; Junker Y, 2012, J EXP MED, V209, P2395, DOI 10.1084/jem.20102660; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kemppainen KM, 2017, CLIN GASTROENTEROL H, V15, P694, DOI 10.1016/j.cgh.2016.10.033; Krigel A, 2016, CLIN GASTROENTEROL H, V14, P1105, DOI 10.1016/j.cgh.2016.04.032; Kuja-Halkola R, 2016, GUT, V65, P1793, DOI 10.1136/gutjnl-2016-311713; Latorre M, 2015, GASTROINTEST ENDOSC, V81, P1228, DOI 10.1016/j.gie.2014.10.024; Lebwohl B, 2014, ALIMENT PHARM THER, V39, P488, DOI 10.1111/apt.12621; Lebwohl B, 2010, ALIMENT PHARM THER, V32, P1037, DOI 10.1111/j.1365-2036.2010.04440.x; Lebwohl B, 2014, J CLIN ENDOCR METAB, V99, P609, DOI 10.1210/jc.2013-3164; Lebwohl B, 2014, DIGEST LIVER DIS, V46, P36, DOI 10.1016/j.dld.2013.08.128; Lebwohl B, 2013, AM J EPIDEMIOL, V178, P1721, DOI 10.1093/aje/kwt234; Lebwohl B, 2013, ANN INTERN MED, V159, P169, DOI 10.7326/0003-4819-159-3-201308060-00006; Lebwohl B, 2013, DIGEST DIS SCI, V58, P1293, DOI 10.1007/s10620-012-2551-3; Lebwohl B, 2013, ARCH DIS CHILD, V98, P48, DOI 10.1136/archdischild-2012-302360; Lebwohl B, 2011, GASTROINTEST ENDOSC, V74, P103, DOI 10.1016/j.gie.2011.03.1236; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Leffler D, 2013, GUT, V62, P996, DOI 10.1136/gutjnl-2012-302196; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; Leffler DA, 2015, GASTROENTEROLOGY, V148, P1311, DOI 10.1053/j.gastro.2015.02.008; Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276; Leonard MM, 2017, J PEDIATR GASTR NUTR, V64, P286, DOI 10.1097/MPG.0000000000001460; Lewis NR, 2009, ALIMENT PHARM THER, V31, P73, DOI 10.1111/j.1365-2036.2009.04110.x; Lionetti E, 2017, J PEDIATR-US, V184, P81, DOI 10.1016/j.jpeds.2017.01.023; Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697; Liu E, 2017, GASTROENTEROLOGY, V152, P1329, DOI 10.1053/j.gastro.2017.02.002; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; Lohi S, 2009, ANN MED, V41, P508, DOI 10.1080/07853890903036199; Ludvigsson JF, 2016, GUT, V65, P1242, DOI 10.1136/gutjnl-2016-311574; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Mahmud FH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008097; Mangione RA, 2011, J AM PHARM ASSOC, V51, P734, DOI 10.1331/JAPhA.2011.10137; Marild K, 2015, AM J GASTROENTEROL, V110, P1475, DOI 10.1038/ajg.2015.287; Marild K, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-109; Marild K, 2012, GASTROENTEROLOGY, V142, P39, DOI 10.1053/j.gastro.2011.09.047; Marlid K, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-75; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; McCarville JL, 2015, CURR OPIN PHARMACOL, V25, P7, DOI 10.1016/j.coph.2015.09.002; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Mooney PD, 2016, GASTROENTEROLOGY, V150, P1125, DOI 10.1053/j.gastro.2016.01.029; Murray JA, 2004, AM J CLIN NUTR, V79, P669; Murray JA, 2008, CLIN GASTROENTEROL H, V6, P186, DOI 10.1016/j.cgh.2007.10.012; Murray JA, 2017, GASTROENTEROLOGY, V152, P787, DOI 10.1053/j.gastro.2016.11.004; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Myleus A, 2009, J PEDIATR GASTR NUTR, V49, P170, DOI 10.1097/MPG.0b013e31818c52cc; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Nistal E, 2016, J APPL MICROBIOL, V120, P1691, DOI 10.1111/jam.13111; Nistal E, 2012, BIOCHIMIE, V94, P1724, DOI 10.1016/j.biochi.2012.03.025; Nistal E, 2012, INFLAMM BOWEL DIS, V18, P649, DOI 10.1002/ibd.21830; Olivares M, 2015, GUT, V64, P406, DOI 10.1136/gutjnl-2014-306931; Olmos M, 2008, DIGEST LIVER DIS, V40, P46, DOI 10.1016/j.dld.2007.09.006; Pallav K, 2014, DIGEST DIS SCI, V59, P2199, DOI 10.1007/s10620-014-3143-1; Pinto-Sanchez MI, 2016, J PEDIATR-US, V168, P132, DOI 10.1016/j.jpeds.2015.09.032; Raju SA, 2016, ALIMENT PHARM THER, V43, P656, DOI 10.1111/apt.13503; Ramakrishna BS, 2016, AM J GASTROENTEROL, V111, P115, DOI 10.1038/ajg.2015.398; Riddle MS, 2013, DIGEST DIS SCI, V58, P3242, DOI 10.1007/s10620-013-2733-7; Rostami K, 1999, AM J GASTROENTEROL, V94, P888; Rubio-Tapia A, 2016, ALIMENT PHARM THER, V44, P704, DOI 10.1111/apt.13755; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rubio-Tapia A, 2011, CLIN GASTROENTEROL H, V9, P13, DOI 10.1016/j.cgh.2010.07.014; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V136, P99, DOI 10.1053/j.gastro.2008.10.013; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Sanders DS, 2002, POSTGRAD MED J, V78, P31, DOI 10.1136/pmj.78.915.31; Schumann M, 2017, CELL MOL GASTROENTER, V3, P150, DOI 10.1016/j.jcmgh.2016.12.006; Shah S, 2012, GASTROENTEROLOGY, V142, pS87; Shah VH, 2000, GASTROINTEST ENDOSC, V51, P717, DOI 10.1067/mge.2000.104977; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sharkey LM, 2013, ALIMENT PHARM THER, V38, P1278, DOI 10.1111/apt.12510; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Stordal K, 2014, CLIN GASTROENTEROL H, V12, P624, DOI 10.1016/j.cgh.2013.09.061; Stoven SA, 2016, CLIN GASTROENTEROL H, V14, P1582, DOI 10.1016/j.cgh.2016.02.026; Sugai E, 2015, AM J GASTROENTEROL, V110, P1504, DOI 10.1038/ajg.2015.242; Szajewska H, 2016, J PEDIATR GASTR NUTR, V62, P507, DOI 10.1097/MPG.0000000000001105; Taavela J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076163; Tanpowpong P, 2013, J PEDIATR-US, V162, P501, DOI 10.1016/j.jpeds.2012.08.056; Taylor AK, 2015, GENEREVIEWS; Taylor TB, 2015, J INVEST DERMATOL, V135, P623, DOI 10.1038/jid.2014.368; Tio M, 2012, ALIMENT PHARM THER, V35, P540, DOI 10.1111/j.1365-2036.2011.04972.x; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; Volta U, 2016, DIGEST LIVER DIS, V48, P1018, DOI 10.1016/j.dld.2016.05.024; Vriezinga SL, 2014, NEW ENGL J MED, V371, P1304, DOI 10.1056/NEJMoa1404172; Welander A, 2010, PEDIATRICS, V125, pE530, DOI 10.1542/peds.2009-1200; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; Zingone F, 2016, ALIMENT PHARM THER, V44, P57, DOI 10.1111/apt.13652	144	473	485	9	104	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					70	81		10.1016/S0140-6736(17)31796-8	http://dx.doi.org/10.1016/S0140-6736(17)31796-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR9ZB	28760445				2022-12-28	WOS:000419432300031
J	Tewari, KS; Sill, MW; Penson, RT; Huang, H; Ramondetta, LM; Landrum, LM; Oaknin, A; Reid, TJ; Leitao, MM; Michael, HE; DiSaia, PJ; Copeland, LJ; Creasman, WT; Stehman, FB; Brady, MF; Burger, RA; Thigpen, JT; Birrer, MJ; Waggoner, SE; Moore, DH; Look, KY; Koh, WJ; Monk, BJ				Tewari, Krishnansu S.; Sill, Michael W.; Penson, Richard T.; Huang, Helen; Ramondetta, Lois M.; Landrum, Lisa M.; Oaknin, Ana; Reid, Thomas J.; Leitao, Mario M.; Michael, Helen E.; DiSaia, Philip J.; Copeland, Larry J.; Creasman, William T.; Stehman, Frederick B.; Brady, Mark F.; Burger, Robert A.; Thigpen, J. Tate; Birrer, Michael J.; Waggoner, Steven E.; Moore, David H.; Look, Katherine Y.; Koh, Wui-Jin; Monk, Bradley J.			Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)	LANCET			English	Article							TUMOR ANGIOGENESIS; THERAPY; STATE; CHEMOTHERAPY; PACLITAXEL; CARCINOMA; ART	Background On Aug 14, 2014, the US Food and Drug Administration approved the antiangiogenesis drug bevacizumab for women with advanced cervical cancer on the basis of improved overall survival (OS) after the second interim analysis (in 2012) of 271 deaths in the Gynecologic Oncology Group (GOG) 240 trial. In this study, we report the prespecified final analysis of the primary objectives, OS and adverse events. Methods In this randomised, controlled, open-label, phase 3 trial, we recruited patients with metastatic, persistent, or recurrent cervical carcinoma from 81 centres in the USA, Canada, and Spain. Inclusion criteria included a GOG performance status score of 0 or 1; adequate renal, hepatic, and bone marrow function; adequately anticoagulated thromboembolism; a urine protein to creatinine ratio of less than 1; and measurable disease. Patients who had received chemotherapy for recurrence and those with non-healing wounds or active bleeding conditions were ineligible. We randomly allocated patients 1:1:1:1 (blocking used; block size of four) to intravenous chemotherapy of either cisplatin (50 mg/m(2) on day 1 or 2) plus paclitaxel (135 mg/m(2) or 175 mg/m(2) on day 1) or topotecan (0.75 mg/m(2) on days 1-3) plus paclitaxel (175 mg/m(2) on day 1) with or without intravenous bevacizumab (15 mg/kg on day 1) in 21 day cycles until disease progression, unacceptable toxic effects, voluntary withdrawal by the patient, or complete response. We stratified randomisation by GOG performance status (0 vs 1), previous radiosensitising platinum-based chemotherapy, and disease status (recurrent or persistent vs metastatic). We gave treatment open label. Primary outcomes were OS (analysed in the intention-to-treat population) and adverse events (analysed in all patients who received treatment and submitted adverse event information), assessed at the second interim and final analysis by the masked data and safety monitoring board. The cutoff for final analysis was 450 patients with 346 deaths. This trial is registered with ClinicalTrials.gov, number NCT00803062. Findings Between April 6, 2009, and Jan 3, 2012, we enrolled 452 patients (225 [50%] in the two chemotherapy-alone groups and 227 [50%] in the two chemotherapy plus bevacizumab groups). By March 7, 2014, 348 deaths had occurred, meeting the prespecified cutoff for final analysis. The chemotherapy plus bevacizumab groups continued to show significant improvement in OS compared with the chemotherapy-alone groups: 16.8 months in the chemotherapy plus bevacizumab groups versus 13.3 months in the chemotherapy-alone groups (hazard ratio 0.77 [95% CI 0.62-0.95]; p=0.007). Final OS among patients not receiving previous pelvic radiotherapy was 24.5 months versus 16.8 months (0.64 [0.37-1.10]; p=0.11). Postprogression OS was not significantly different between the chemotherapy plus bevacizumab groups (8.4 months) and chemotherapy-alone groups (7.1 months; 0.83 [0.66-1.05]; p=0.06). Fistula (any grade) occurred in 32 (15%) of 220 patients in the chemotherapy plus bevacizumab groups (all previously irradiated) versus three (1%) of 220 in the chemotherapy-alone groups (all previously irradiated). Grade 3 fistula developed in 13 (6%) versus one (<1%). No fistulas resulted in surgical emergencies, sepsis, or death. Interpretation The benefit conferred by incorporation of bevacizumab is sustained with extended follow-up as evidenced by the overall survival curves remaining separated. After progression while receiving bevacizumab, we did not observe a negative rebound effect (ie, shorter survival after bevacizumab is stopped than after chemotherapy alone is stopped). These findings represent proof-of-concept of the efficacy and tolerability of antiangiogenesis therapy in advanced cervical cancer. Funding National Cancer Institute.	[Tewari, Krishnansu S.; DiSaia, Philip J.] Univ Calif Irvine, Irvine Med Ctr, Div Gynecol Oncol, Orange, CA 92868 USA; [Sill, Michael W.; Huang, Helen; Brady, Mark F.] SUNY Buffalo, Roswell Pk Canc Inst, Buffalo, NY USA; [Penson, Richard T.; Birrer, Michael J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ramondetta, Lois M.] Anderson Canc Ctr, Houston, TX USA; [Landrum, Lisa M.] Univ Oklahoma, Div Gynecol Oncol, Oklahoma City, OK USA; [Oaknin, Ana] Vall dHebron Univ Hosp, Barcelona, Spain; [Reid, Thomas J.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Reid, Thomas J.] Womens Canc Ctr, Kettering, OH USA; [Leitao, Mario M.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Michael, Helen E.; Stehman, Frederick B.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Copeland, Larry J.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Creasman, William T.] Med Univ South Carolina, Dept Obstet & Gynecol, Charleston, SC USA; [Burger, Robert A.] Univ Penn, Div Gynecol Oncol, Philadelphia, PA 19104 USA; [Thigpen, J. Tate] Univ Mississippi, Ed Ctr, Jackson, MS 39216 USA; [Waggoner, Steven E.] Case Western Reserve Univ, Dept Obstet & Gynecol, Cleveland, OH 44106 USA; [Moore, David H.] Franciscan St Francis Hlth, Indianapolis, IN USA; Genentech Inc, San Francisco, CA USA; [Koh, Wui-Jin] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA; [Monk, Bradley J.] Univ Arizona, Coll Med, Arizona Oncol, US Oncol Network,Creighton Univ,Sch Med,St Josep, Phoenix, AZ USA	University of California System; University of California Irvine; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Hospital Universitari Vall d'Hebron; University System of Ohio; University of Cincinnati; Memorial Sloan Kettering Cancer Center; Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio State University; Medical University of South Carolina; University of Pennsylvania; University of Mississippi; Case Western Reserve University; Roche Holding; Genentech; University of Washington; University of Washington Seattle; Creighton University; University of Arizona	Tewari, KS (corresponding author), Univ Calif Irvine, Irvine Med Ctr, Div Gynecol Oncol, Orange, CA 92868 USA.	ktewari@uci.edu		OAKNIN, ANA/0000-0002-3592-7194	National Cancer Institute; NATIONAL CANCER INSTITUTE [U10CA180822, UG1CA189867, U10CA101165, U10CA027469, U10CA180858, U10CA180868, R21CA156032, U10CA180867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Cancer Institute.	Bodily JM, 2011, CANCER RES, V71, P1187, DOI 10.1158/0008-5472.CAN-10-2626; Crafton SM, 2016, CLIN THER, V38, P449, DOI 10.1016/j.clinthera.2016.02.007; Dizon DS, 2014, CANCER-AM CANCER SOC, V120, P2282, DOI 10.1002/cncr.28722; Gadducci A, 2015, CRIT REV ONCOL HEMAT, V96, P113, DOI 10.1016/j.critrevonc.2015.05.009; Gourley C, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.5502; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Koh WJ, 2015, J NATL COMPR CANC NE, V13, P395, DOI 10.6004/jnccn.2015.0055; Kudelka AP, 1998, NEW ENGL J MED, V338, P991, DOI 10.1056/NEJM199804023381412; Liu FW, 2015, ONCOLOGY-NY, V29, P350; Lopez-Ocejo O, 2000, ONCOGENE, V19, P4611, DOI 10.1038/sj.onc.1203817; LUVERO D, 2017, MED ONCOL, V34; McLachlan J, 2017, CLIN ONCOL-UK, V29, P153, DOI 10.1016/j.clon.2016.10.002; Minion LE, 2015, GYNECOL ONCOL, V137, P490, DOI 10.1016/j.ygyno.2015.02.027; Monk BJ, 2007, J CLIN ONCOL, V25, P2952, DOI 10.1200/JCO.2007.10.8324; Monk BJ, 2010, J CLIN ONCOL, V28, P3562, DOI 10.1200/JCO.2009.26.9571; Monk BJ, 2009, J CLIN ONCOL, V27, P1069, DOI 10.1200/JCO.2008.18.9043; Moore DH, 2010, GYNECOL ONCOL, V116, P44, DOI 10.1016/j.ygyno.2009.09.006; National Cancer Institute, BEV SIGN IMPR SURV P; Nishida T, 2015, J CLIN ONCOL, V33; Obermair A, 1998, AM J OBSTET GYNECOL, V178, P314, DOI 10.1016/S0002-9378(98)80018-5; Penson RT, 2015, LANCET ONCOL, V16, P301, DOI 10.1016/S1470-2045(15)70004-5; Rosen VM, 2017, INT J GYNECOL CANCER, V27, P1237, DOI 10.1097/IGC.0000000000001000; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Small W, 2017, CANCER-AM CANCER SOC, V123, P2404, DOI 10.1002/cncr.30667; STAFL A, 1975, AM J OBSTET GYNECOL, V121, P845; Sugiyama T, 2017, JPN J CLIN ONCOL, V47, P39, DOI 10.1093/jjco/hyw143; Symonds RP, 2015, LANCET ONCOL, V16, P1515, DOI 10.1016/S1470-2045(15)00220-X; Tewari KS, 2015, CLIN CANCER RES, V21, P5480, DOI 10.1158/1078-0432.CCR-15-1346; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Tewari KS, 2014, EUR SOC MED ONC 2014; Wei XW, 2013, EXPERT OPIN INV DRUG, V22, P1181, DOI 10.1517/13543784.2013.812071	31	263	285	4	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1654	1663		10.1016/S0140-6736(17)31607-0	http://dx.doi.org/10.1016/S0140-6736(17)31607-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI9TS	28756902	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000412352800025
J	Schuetz, P; Mueller, B				Schuetz, Philipp; Mueller, Beat			Procalcitonin-guided antibiotic stewardship from newborns to centennials	LANCET			English	Editorial Material							RESPIRATORY-TRACT INFECTIONS; GENE-RELATED PEPTIDE; SEPSIS; EXPRESSION; IMMUNONEUTRALIZATION; ADRENOMEDULLIN; INFLAMMATION; FAMILY		[Mueller, Beat] Univ Basel, Kantonsspital Aarau, Med Univ Clin, CH-5001 Aarau, Switzerland; Univ Basel, Med Fac, CH-5001 Aarau, Switzerland	Kantonsspital Aarau AG (KSA); University of Basel; University of Basel	Mueller, B (corresponding author), Univ Basel, Kantonsspital Aarau, Med Univ Clin, CH-5001 Aarau, Switzerland.	happy.mueller@unibas.ch	Mueller, Beat/G-2662-2012; schuetz, philipp/C-8475-2013	schuetz, philipp/0000-0001-6400-4949	B.R.A.H.M.S/Thermofisher; bioMerieux	B.R.A.H.M.S/Thermofisher; bioMerieux	PS received support from B.R.A.H.M.S/Thermofisher and bioMerieux to attend meetings, fulfill speaking engagements and for unrestricted research grants related to PCT. BM has received research support, as well as consulting fees and speaker's honoraria from B.R.A.H.M.S/Thermofisher, and bioMerieux, related to PCT.	Albrich WC, 2012, ARCH INTERN MED, V172, P715, DOI 10.1001/archinternmed.2012.770; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Assumma M, 2000, CLIN CHEM, V46, P1583; Baer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068419; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Briel M, 2008, ARCH INTERN MED, V168, P2000, DOI 10.1001/archinte.168.18.2000; Brunkhorst FM, 1999, INT J CARDIOL, V72, P3, DOI 10.1016/S0167-5273(99)00118-7; Brunkhorst FM, 1998, INTENS CARE MED, V24, P888, DOI 10.1007/s001340050683; Chiesa C, 2003, CLIN CHEM, V49, P60, DOI 10.1373/49.1.60; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2008, CRIT CARE MED, V36, P1684, DOI 10.1097/CCM.0b013e3181726819; de Jong E, 2016, LANCET INFECT DIS, V16, P819, DOI 10.1016/S1473-3099(16)00053-0; Linscheid P, 2005, ENDOCRINOLOGY, V146, P2699, DOI 10.1210/en.2004-1424; Linscheid P, 2004, CRIT CARE MED, V32, P1715, DOI 10.1097/01.CCM.0000134404.63292.71; Martinez J M, 2001, Surg Infect (Larchmt), V2, P193, DOI 10.1089/109629601317202678; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; Nylen ES, 1998, CRIT CARE MED, V26, P1001, DOI 10.1097/00003246-199806000-00015; Schuetz P, 2007, ENDOTHELIUM-J ENDOTH, V14, P345, DOI 10.1080/10623320701678326; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Sexton PM, 2008, CRIT CARE MED, V36, P1637, DOI 10.1097/CCM.0b013e318170a554; Stocker M, 2017, LANCET; Tavares E, 2010, CLIN SCI, V119, P519, DOI 10.1042/CS20100007; Wagner KE, 2002, CRIT CARE MED, V30, P2313, DOI 10.1097/00003246-200210000-00021	25	9	9	2	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					826	829		10.1016/S0140-6736(17)31628-8	http://dx.doi.org/10.1016/S0140-6736(17)31628-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28711319				2022-12-28	WOS:000408330700006
J	Ali, ZA; Serruys, PW; Kimura, T; Gao, RL; Ellis, SG; Kereiakes, DJ; Onuma, Y; Simonton, C; Zhang, Z; Stone, GW				Ali, Ziad A.; Serruys, Patrick W.; Kimura, Takeshi; Gao, Runlin; Ellis, Stephen G.; Kereiakes, Dean J.; Onuma, Yoshinobu; Simonton, Charles; Zhang, Zhen; Stone, Gregg W.			2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy	LANCET			English	Review							OPTICAL COHERENCE TOMOGRAPHY; PACLITAXEL-ELUTING STENTS; VASCULAR SCAFFOLDS; CLINICAL-OUTCOMES; METALLIC STENTS; THROMBOSIS; IMPLANTATION	Background Bioresorbable vascular scaffolds (BVS) offer the potential to improve long-term outcomes of percutaneous coronary intervention after their complete bioresorption. Randomised trials have shown non-inferiority between BVS and metallic drug-eluting stents at 1 year in composite safety and effectiveness outcomes, although some increases in rates of target vessel-related myocardial infarction and device thrombosis were identified. Outcomes of BVS following the first year after implantation are unknown. We sought to ascertain whether BVS are as safe and effective as drugeluting stents within 2 years after implantation and between 1 and 2 years. Methods We did a systematic review and meta-analysis of randomised trials in which patients were randomly assigned to everolimus-eluting Absorb BVS or metallic everolimus-eluting stents (EES) and followed up for at least 2 years. We searched MEDLINE, the Cochrane database, TCTMD, ClinicalTrials. gov, Clinical Trial Results, CardioSource, and abstracts and presentations from major cardiovascular meetings up to April 1, 2017, to identify relevant studies. The primary efficacy outcome measure was the device-oriented composite endpoint (cardiac mortality, target vessel-related myocardial infarction, or ischaemia-driven target lesion revascularisation) and the primary safety outcome measure was definite or probable device thrombosis. Individual patient data from the four ABSORB trials were used for landmark and subgroup analysis and multivariable modelling. Findings We identified seven randomised trials in which 5583 patients were randomly assigned to Absorb BVS (n=3261) or metallic EES (n=2322) and followed up for 2 years. BVS had higher 2-year relative risks of the deviceoriented composite endpoint than did EES (9.4% [304 of 3217] vs 7.4% [169 of 2299]; relative risk [RR] 1.29 [95% CI 1.08-1.56], p=0.0059). These differences were driven by increased rates of target vessel-related myocardial infarction (5.8% [187 of 3218] vs 3.2% [74 of 2299]; RR 1.68 [95% CI 1.29-2.19], p=0.0003) and ischaemia-driven target lesion revascularisation (5.3% [169 of 3217] vs 3.9% [90 of 2300]; 1 . 40 [1.09-1.80], p=0.0090) with BVS, with non-significant differences in cardiac mortality. The cumulative 2-year incidence of device thrombosis was higher with BVS than with EES (2.3% [73 of 3187] vs 0.7% [16 of 2281]; RR 3.35 [95% CI 1.96-5.72], p<0.0001). Landmark analysis between 1 and 2 years also showed higher rates of the device-oriented composite endpoint (3.3% [69 of 2100] vs 1.9% [23 of 1193]; RR 1.64 [95% CI 1.03-2.61], p=0.0376) and device thrombosis (0.5% [11 of 2085] vs none [0 of 1183], p<0.0001) in BVS-treated patients than in EES-treated patients. Interpretation BVS was associated with increased rates of composite device-oriented adverse events and device thrombosis cumulatively at 2 years and between 1 and 2 years of follow-up compared with EES.	[Ali, Ziad A.; Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Ali, Ziad A.; Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Serruys, Patrick W.] Imperial Coll, Int Ctr Cardiovasc Hlth, London, England; [Kimura, Takeshi] Kyoto Univ Hosp, Kyoto, Japan; [Gao, Runlin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fu Wai Hosp, Beijing, Peoples R China; [Ellis, Stephen G.] Cleveland Clin, Cleveland, OH 44106 USA; [Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA; [Onuma, Yoshinobu] Erasmus MC, Thoraxctr, Rotterdam, Netherlands; [Simonton, Charles; Zhang, Zhen] Abbott Vasc, Santa Clara, CA USA	Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Imperial College London; Kyoto University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Cleveland Clinic Foundation; Christ Hospital - Ohio; Erasmus University Rotterdam; Erasmus MC	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10019 USA.	gs2184@columbia.edu	Onuma, Yoshinobu/AHB-6273-2022	Onuma, Yoshinobu/0000-0001-7702-0649; Zhang, Zhen/0000-0002-0804-8741	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	Abbott Vascular.	Ali ZA, 2016, LANCET, V388, P2618, DOI 10.1016/S0140-6736(16)31922-5; Arroyo D, 2017, INT J CARDIOL; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11; Ellis SG, 2017, AM COLL CARD ACC ANN; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; Gada H, 2013, JACC-CARDIOVASC INTE, V6, P1263, DOI 10.1016/j.jcin.2013.07.009; Gao RL, 2015, J AM COLL CARDIOL, V66, P2298, DOI 10.1016/j.jacc.2015.09.054; Hermiller JB, 2016, JACC-CARDIOVASC INTE, V9, P138, DOI 10.1016/j.jcin.2015.10.001; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kimura T, 2015, EUR HEART J, V36, P3332, DOI 10.1093/eurheartj/ehv435; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Navarese EP, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000064; Onuma Y, 2010, CIRCULATION, V122, P2288, DOI 10.1161/CIRCULATIONAHA.109.921528; Otsuka F, 2014, CIRC-CARDIOVASC INTE, V7, P330, DOI 10.1161/CIRCINTERVENTIONS.113.000990; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Puricel S, 2015, J AM COLL CARDIOL; Puricel S, 2016, J AM COLL CARDIOL, V67, P921, DOI 10.1016/j.jacc.2015.12.019; Raber L, 2015, J AM COLL CARDIOL, V66, P1901, DOI 10.1016/j.jacc.2015.08.853; Sabate M., 2016, BIODEGRADABLE SCAFFO; Sabate M, 2016, EUR HEART J, V37, P229, DOI 10.1093/eurheartj/ehv500; Serruys PW, 2016, LANCET, V388, P2479, DOI 10.1016/S0140-6736(16)32050-5; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Sotomi Y, 2017, EUROINTERVENTION, V12, P1747, DOI 10.4244/EIJ-D-16-00471; Stone GW, 2016, LANCET, V388, P127, DOI 10.1016/S0140-6736(16)30772-3; Stone GW, 2016, LANCET, V387, P1277, DOI 10.1016/S0140-6736(15)01039-9; Stone GW, 2015, J AM COLL CARDIOL, V66, P1915, DOI 10.1016/j.jacc.2015.08.863; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tanaka A, 2017, EUROINTERVENTION, V12, P1730, DOI 10.4244/EIJ-D-16-00247; Toyota T, 2017, JACC-CARDIOVASC INTE, V10, P27, DOI 10.1016/j.jcin.2016.10.027; Vorpahl M, 2014, EUROINTERVENTION, V10, P833, DOI 10.4244/EIJV10I7A143; Wykrzykowska JJ, 2017, NEW ENGL J MED, V376, P2319, DOI 10.1056/NEJMoa1614954; Yamaji K, 2016, EUR HEART J, V37, P3386, DOI 10.1093/eurheartj/ehw343; Yamaji K, 2010, CIRC-CARDIOVASC INTE, V3, P468, DOI 10.1161/CIRCINTERVENTIONS.110.958249	34	144	152	2	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					760	772		10.1016/S0140-6736(17)31470-8	http://dx.doi.org/10.1016/S0140-6736(17)31470-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD9RD	28732815				2022-12-28	WOS:000407858900020
J	Zenner, D; Beer, N; Harris, RJ; Lipman, MC; Stagg, HR; van der Werf, MJ				Zenner, Dominik; Beer, Netta; Harris, Ross J.; Lipman, Marc C.; Stagg, Helen R.; van der Werf, Marieke J.			Treatment of Latent Tuberculosis Infection An Updated Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ISONIAZID PREVENTIVE THERAPY; ANTIRETROVIRAL THERAPY; DOUBLE-BLIND; RIFAPENTINE; CHILDREN; TRIAL; REGIMENS; EFFICACY; ADULTS; RATES	Background: Treatment of latent tuberculosis infection (LTBI) is an important component of tuberculosis (TB) control, and this study updates a previous network meta-analysis of the best LTBI treatment options to inform public health action and programmatic management of LTBI. Purpose: To evaluate the comparative efficacy and harms of LTBI treatment regimens aimed at preventing active TB among adults and children. Data Sources: PubMed, Embase, and Web of Science from indexing to 8 May 2017; clinical trial registries; and conference abstracts. No language restrictions were applied. Study Selection: Randomized controlled trials that evaluated human LTBI treatments and recorded at least 1 of 2 prespecified end points (hepatotoxicity and prevention of active TB). Data Extraction: 2 investigators independently extracted data from eligible studies and assessed study quality according to a standard protocol. Data Synthesis: The network meta-analysis of 8 new and 53 previously included studies showed that isoniazid regimens of 6 months (odds ratio [OR], 0.65 [95% credible interval {CrI}, 0.50 to 0.83]) or 12 to 72 months (OR, 0.50 [CrI, 0.41 to 0.62]), rifampicin-only regimens (OR, 0.41 [CrI, 0.19 to 0.85]), rifampicinisoniazid regimens of 3 to 4 months (OR, 0.53 [CrI, 0.36 to 0.78]), rifampicin-isoniazid-pyrazinamide regimens (OR, 0.35 [CrI, 0.19 to 0.61]), and rifampicin-pyrazinamide regimens (OR, 0.53 [CrI, 0.33 to 0.84]) were efficacious compared with placebo. Evidence existed for efficacy of weekly rifapentine-isoniazid regimens compared with no treatment (OR, 0.36 [CrI, 0.18 to 0.73]). No conclusive evidence showed that HIV status altered treatment efficacy. Limitation: Evidence was sparse for many comparisons and hepatotoxicity outcomes, and risk of bias was high or unknown for many studies. Conclusion: Evidence exists for the efficacy and safety of 6-month isoniazid monotherapy, rifampicin monotherapy, and combination therapies with 3 to 4 months of isoniazid and rifampicin.	[Stagg, Helen R.] UCL, Inst Global Hlth, 3rd Floor,30 Guilford St, London WC1N 1EH, England; [Lipman, Marc C.] Royal Free London Natl Hlth Serv Fdn Trust, Ctr Resp Med, London NW3 2QG, England; [Lipman, Marc C.] Royal Free London Natl Hlth Serv Fdn Trust, Dept Med, London NW3 2QG, England; [Beer, Netta; van der Werf, Marieke J.] European Ctr Dis Prevent & Control, Granitsvag 8, S-17165 Stockholm, Sweden; [Zenner, Dominik] Publ Hlth England, Resp Dis Dept, TB Sect, 61 Colindale Ave, London NW9 5EQ, England; [Harris, Ross J.] Publ Hlth England, Stat Modelling & Bioinformat Dept, 61 Colindale Ave, London NW9 5EQ, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; European Centre for Disease Prevention & Control; Public Health England; Public Health England	Zenner, D (corresponding author), Publ Hlth England, Resp Dis Dept, TB Sect, 61 Colindale Ave, London NW9 5EQ, England.	dominik.zenner@ucl.ac.uk	Zenner, Dominik/AAF-5134-2019	Stagg, Helen/0000-0003-4022-3447; Lipman, Marc/0000-0001-7501-4448; Zenner, Dominik/0000-0002-9200-6180	U.K. National Institute for Health Research [PROSPERO: CRD42016037871]	U.K. National Institute for Health Research(National Institute for Health Research (NIHR))	U.K. National Institute for Health Research. (PROSPERO: CRD42016037871)	Ayele HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142290; Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91; Centers for Disease Control and Prevention, 2017, TREATM LAT TB INF; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Fox GJ, 2017, INT J INFECT DIS, V56, P68, DOI 10.1016/j.ijid.2016.11.006; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Gray DM, 2014, INT J TUBERC LUNG D, V18, P322, DOI 10.5588/ijtld.13.0354; Gupta RK, 2015, LANCET HIV, V2, pE243, DOI 10.1016/S2352-3018(15)00063-6; Gwee A, 2013, ARCH DIS CHILD, V98, P468, DOI 10.1136/archdischild-2013-303876; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hosseinipour MC, 2016, LANCET, V387, P1198, DOI 10.1016/S0140-6736(16)00546-8; Kahwati LC, 2016, JAMA-J AM MED ASSOC, V316, P970, DOI 10.1001/jama.2016.10357; Kim SH, 2015, J ANTIMICROB CHEMOTH, V70, P1567, DOI 10.1093/jac/dku562; Ma Li, 2014, Zhonghua Yi Xue Za Zhi, V94, P3579; Pease C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2377-x; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rivero A, 2003, ENFERM INFEC MICR CL, V21, P287, DOI 10.1157/13048575; Samandari T, 2015, AIDS, V29, P351, DOI 10.1097/QAD.0000000000000535; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Sandgren A, 2016, EUROSURVEILLANCE, V21, P20, DOI 10.2807/1560-7917.ES.2016.21.34.30325; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Stagg HR, 2014, ANN INTERN MED, V161, P419, DOI 10.7326/M14-1019; Sterling TR, 2016, AIDS, V30, P1607, DOI 10.1097/QAD.0000000000001098; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Stuurman AL, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1549-4; Torre-Cisneros J, 2015, CLIN INFECT DIS, V60, P1642, DOI 10.1093/cid/civ156; United Nations, SUST DEV GOALS 17 GO; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, GLOB STRAT TARG TUB; World Health Organization (WHO), 2015, GUIDELINES MANAGEMEN	32	103	111	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					248	+		10.7326/M17-0609	http://dx.doi.org/10.7326/M17-0609			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28761946	Green Submitted, Green Accepted			2022-12-28	WOS:000407797500013
J	Sok, D; Le, KM; Vadnais, ML; Saye-Francisco, KL; Jardine, JG; Torres, JL; Berndsen, ZT; Kong, L; Tanfield, RS; Ruiz, J; Ramos, A; Liang, CH; Chen, PL; Criscitiello, MF; Mwangi, W; Wilson, IA; Ward, AB; Smider, VV; Burton, DR				Sok, Devin; Le, Khoa M.; Vadnais, Melissa L.; Saye-Francisco, Karen L.; Jardine, Joseph G.; Torres, Jonathan L.; Berndsen, Zachary T.; Kong, Leopold; Tanfield, Robyn S.; Ruiz, Jennifer; Ramos, Alejandra; Liang, Chi-Hui; Chen, Patricia L.; Criscitiello, Michael F.; Mwangi, Waithaka; Wilson, Ian A.; Ward, Andrew B.; Smider, Vaughn V.; Burton, Dennis R.			Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows	NATURE			English	Article							V-H FAMILY; LONG CDR3S; ENVELOPE; POTENT; GENERATION; TARGET; REGION	No immunogen to date has reliably elicited broadly neutralizing antibodies to HIV in humans or animal models. Advances in the design of immunogens that antigenically mimic the HIV envelope glycoprotein (Env), such as the soluble cleaved trimer BG505 SOSIP1, have improved the elicitation of potent isolate-specific antibody responses in rabbits(2) and macaques(3), but so far failed to induce broadly neutralizing antibodies. One possible reason for this failure is that the relevant antibody repertoires are poorly suited to target the conserved epitope regions on Env, which are somewhat occluded relative to the exposed variable epitopes. Here, to test this hypothesis, we immunized four cows with BG505 SOSIP. The antibody repertoire of cows contains long third heavy chain complementary determining regions (HCDR3) with an ultralong subset that can reach more than 70 amino acids in length(4-9). Remarkably, BG505 SOSIP immunization resulted in rapid elicitation of broad and potent serum antibody responses in all four cows. Longitudinal serum analysis for one cow showed the development of neutralization breadth (20%, n = 117 crossclade isolates) in 42 days and 96% breadth (n = 117) at 381 days. A monoclonal antibody isolated from this cow harboured an ultralong HCDR3 of 60 amino acids and neutralized 72% of crossclade isolates (n = 117) with a potent median IC50 of 0.028 mu g ml(-1). Breadth was elicited with a single trimer immunogen and did not require additional envelope diversity. Immunization of cows may provide an avenue to rapidly generate antibody prophylactics and therapeutics to address disease agents that have evolved to avoid human antibody responses.	[Sok, Devin; Le, Khoa M.; Saye-Francisco, Karen L.; Jardine, Joseph G.; Ruiz, Jennifer; Ramos, Alejandra; Liang, Chi-Hui; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Sok, Devin; Le, Khoa M.; Saye-Francisco, Karen L.; Jardine, Joseph G.; Ruiz, Jennifer; Ramos, Alejandra; Liang, Chi-Hui; Wilson, Ian A.; Ward, Andrew B.; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Sok, Devin; Le, Khoa M.; Saye-Francisco, Karen L.; Jardine, Joseph G.; Ruiz, Jennifer; Ramos, Alejandra; Liang, Chi-Hui; Wilson, Ian A.; Ward, Andrew B.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Disc, La Jolla, CA 92037 USA; [Sok, Devin; Le, Khoa M.; Ruiz, Jennifer; Ramos, Alejandra] Int AIDS Vaccine Initiat, Beijing 100044, Peoples R China; [Vadnais, Melissa L.; Smider, Vaughn V.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Torres, Jonathan L.; Berndsen, Zachary T.; Kong, Leopold; Tanfield, Robyn S.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Chen, Patricia L.; Criscitiello, Michael F.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Mwangi, Waithaka] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Texas A&M University System; Texas A&M University College Station; Kansas State University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Disc, La Jolla, CA 92037 USA.; Smider, VV (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.; Burton, DR (corresponding author), Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA.	vvsmider@scripps.edu; burton@scripps.edu	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Torres, Jonathan/0000-0003-0137-8497; Kong, Leopold/0000-0001-7456-1773; Smider, Vaughn/0000-0003-3488-6383	International AIDS Vaccine Initiative Neutralizing Antibody Consortium through Collaboration for AIDS Vaccine Discovery grant [OPP1084519]; NIH [R21 AI120791, R01 GM105826]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant [UM1AI100663]; IOS [1257829]; USDA-NIFA grant [CSREES 2008-35204]; James and Jessie Minor Chair in Immunology; IAVI; Bill AMP; Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; World Bank; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); NATIONAL CANCER INSTITUTE [R21CA198595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120791, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105826] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Consortium through Collaboration for AIDS Vaccine Discovery grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant; IOS; USDA-NIFA grant; James and Jessie Minor Chair in Immunology; IAVI; Bill AMP; Melinda Gates Foundation(CGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; World Bank(The World Bank India); Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Consortium through the Collaboration for AIDS Vaccine Discovery grant OPP1084519 (D.R.B., I.A.W., A.B.W.), NIH grants R21 AI120791 (V.V.S.), R01 GM105826 (V.V.S.), Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1AI100663 (D.R.B., I.A.W., A.B.W.), IOS 1257829 (M.F.C.), and USDA-NIFA grant number CSREES 2008-35204 (W.M.). D.R.B. acknowledges the support of the James and Jessie Minor Chair in Immunology. We thank B. Schief and S. Menis for providing MD39 for competition experiments. This work was funded in part by IAVI and made possible by the support of many donors, including: the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan in partnership with The World Bank, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. The contents of this manuscript do not necessarily reflect the views of USAID or the US Government.	Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; de Los Rios M, 2015, CURR OPIN STRUC BIOL, V33, P27, DOI 10.1016/j.sbi.2015.06.002; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Heydarchi B., 2016, MABS, V9, P550; Heydarchi B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157353; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kodangattil S, 2014, MABS-AUSTIN, V6, P628, DOI 10.4161/mabs.28059; Kramski M, 2012, ANTIMICROB AGENTS CH, V56, P4310, DOI 10.1128/AAC.00453-12; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Lopez O, 1998, IMMUNOL REV, V162, P55, DOI 10.1111/j.1600-065X.1998.tb01429.x; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; McCoy LE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004552; McCoy LE, 2012, J EXP MED, V209, P1091, DOI 10.1084/jem.20112655; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saini SS, 2002, SCAND J IMMUNOL, V55, P140, DOI 10.1046/j.1365-3083.2002.01028.x; Saini SS, 2003, INT IMMUNOL, V15, P845, DOI 10.1093/intimm/dxg083; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Veselinovic M, 2012, VIROLOGY, V432, P505, DOI 10.1016/j.virol.2012.06.025; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	36	96	103	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					108	+		10.1038/nature23301	http://dx.doi.org/10.1038/nature23301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28726771	Green Accepted			2022-12-28	WOS:000406831700046
J	Ensrud, KE; Crandall, CJ				Ensrud, Kristine E.; Crandall, Carolyn J.			Osteoporosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BONE-MINERAL DENSITY; VERTEBRAL FRACTURE RISK; TASK-FORCE STRATEGY; OLDER MEN; POSTMENOPAUSAL WOMEN; DIAGNOSTIC-CRITERIA; PREVENT FRACTURES; CLINICAL UTILITY; ALENDRONATE; DISCONTINUATION		[Ensrud, Kristine E.] Univ Minnesota, Minneapolis, MN 55455 USA; Vet Affairs Hlth Care Syst, Minneapolis, MN USA; Univ Calif Los Angeles, Los Angeles, CA USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Los Angeles	Ensrud, KE (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.			Ensrud, Kristine/0000-0002-9069-3036	American College of Physicians	American College of Physicians	American College of Physicians.	Adler RA, 2003, MAYO CLIN PROC, V78, P723, DOI 10.4065/78.6.723; Adler RA, 2016, J BONE MINER RES, V31, P16, DOI 10.1002/jbmr.2708; Anastasilakis AD, 2017, EUR J ENDOCRINOL, V176, P677, DOI 10.1530/EJE-16-1027; Aubry-Rozier B, 2016, OSTEOPOROSIS INT, V27, P1923, DOI 10.1007/s00198-015-3380-y; Bauer DC, 2014, JAMA INTERN MED, V174, P1126, DOI 10.1001/jamainternmed.2014.1232; Bauer DC, 2013, NEW ENGL J MED, V369, P1537, DOI 10.1056/NEJMcp1210380; Bell KJL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2266; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Boudreau DM, 2017, J AM GERIATR SOC; Cadarette SM, 2004, OSTEOPOROSIS INT, V15, P361, DOI 10.1007/s00198-003-1552-7; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Camacho PM, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161435.GL; Centre for Metabolic Bone Diseases, 2017, FRAX WHO FRACT RISK; Chapurlat RD, 2005, OSTEOPOROSIS INT, V16, P842, DOI 10.1007/s00198-004-1770-7; Chen PQ, 2006, J BONE MINER RES, V21, P1785, DOI 10.1359/JBMR.060802; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Crandall CJ, 2014, J CLIN ENDOCR METAB, V99, P4514, DOI 10.1210/jc.2014-2332; Crandall CJ, 2014, J BONE MINER RES, V29, P1661, DOI 10.1002/jbmr.2174; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Dell RM, 2012, J BONE MINER RES, V27, P2544, DOI 10.1002/jbmr.1719; Diem SJ, J GEN INTER IN PRESS; Doherty DA, 2001, OSTEOPOROSIS INT, V12, P16, DOI 10.1007/s001980170152; Ensrud KE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4120; Ensrud KE, 2013, J GERONTOL A-BIOL, V68, P1236, DOI 10.1093/gerona/glt092; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Ettinger B, 2013, OSTEOPOROSIS INT, V24, P1185, DOI 10.1007/s00198-012-2215-3; Fink HA, 2016, OSTEOPOROSIS INT, V27, P331, DOI 10.1007/s00198-015-3356-y; Garvan Institute of Medical Research, 2016, BON FRACT RISK CALC; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Gourlay ML, 2016, AM J PREV MED, V50, P727, DOI 10.1016/j.amepre.2015.11.015; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Hill KD, 2015, MATURITAS, V82, P72, DOI 10.1016/j.maturitas.2015.04.005; Institute of Medicine, 2011, DIETARY REFERENCE IN; International Society for Clinical Densitometry, 2015, 2015 ISCD OFF POST A; Jamal SA, 2005, OSTEOPOROSIS INT, V16, P534, DOI 10.1007/s00198-004-1718-y; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P2395, DOI 10.1007/s00198-011-1713-z; Khan AA, 2017, J CLIN DENSITOM, V20, P8, DOI 10.1016/j.jocd.2016.09.005; Lee DR, 2017, J AM GERIATR SOC, V65, P656, DOI 10.1111/jgs.14723; Leslie WD, 2013, J CLIN DENSITOM, V16, P570, DOI 10.1016/j.jocd.2013.01.004; Looker AC, 2005, PERCENTAGE ADULTS AG; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; McClung MR, 2012, J BONE MINER RES, V27, P211, DOI 10.1002/jbmr.536; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Montori VM, 2011, AM J MED, V124, P549, DOI 10.1016/j.amjmed.2011.01.013; Moyer VA, 2013, ANN INTERN MED, V158, P47, DOI 10.7326/0003-4819-158-1-201301010-00553; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; National Committee for Quality Assurance, 2017, OST TEST MAN OLD WOM; National Osteoporosis Foundation, 2014, 2014 CLIN GUID PREV; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Ott SM, 2016, MENOPAUSE, V23, P1159, DOI 10.1097/GME.0000000000000757; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Romagnoli E, 2011, J RHEUMATOL, V38, P1671, DOI 10.3899/jrheum.110030; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Ryan CS, 2011, OSTEOPOROSIS INT, V22, P1845, DOI 10.1007/s00198-010-1421-0; Sarkar S, 2002, J BONE MINER RES, V17, P1, DOI 10.1359/jbmr.2002.17.1.1; Schousboe JT, 2015, LANCET DIABETES ENDO, V3, P236, DOI 10.1016/S2213-8587(15)00050-9; Schousboe JT, 2012, CURR OSTEOPOROS REP, V10, P56, DOI 10.1007/s11914-011-0091-y; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Siris E, 2014, OSTEOPOROSIS INT, V25, P1439, DOI 10.1007/s00198-014-2655-z; van den Bergh Joop P W, 2010, Curr Osteoporos Rep, V8, P131, DOI 10.1007/s11914-010-0022-3; Watts NB, 2005, J BONE MINER RES, V20, P2097, DOI 10.1359/JBMR.050814; Watts NB, 2012, J CLIN ENDOCR METAB, V97, P1802, DOI 10.1210/jc.2011-3045; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Wright NC, 2017, OSTEOPOROSIS INT, V28, P1225, DOI 10.1007/s00198-016-3865-3; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269	70	272	297	10	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					ITC17	ITC31		10.7326/AITC201708010	http://dx.doi.org/10.7326/AITC201708010			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28761958				2022-12-28	WOS:000406631400002
J	Schroeder, AR; Ralston, SL				Schroeder, Alan R.; Ralston, Shawn L.			Viral Testing for Pediatric Respiratory Infections Why Precise Diagnoses Do Not Always Translate to Patient Benefit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BRONCHIOLITIS	IMPORTANCE While most viral respiratory infections can be diagnosed clinically, clinicians frequently order tests to identify the specific offending virus. While there has been tremendous growth in the variety, availability, and sophistication of the types of respiratory viral tests, there may have been less critical thought and discussion among frontline clinicians about the clinical utility and specific indications for testing. We summarize the rationale historically used to support respiratory virus testing in children, with a review of the supporting evidence. We outline potential considerations and limitations of the various types of respiratory viral tests and suggest some clinical indications where viral testing may play an important role in clinical management. OBSERVATIONS The main value of testing for viruses in children who present with a respiratory infection is to differentiate between viral and bacterial infections, hopefully facilitating clinical decision making regarding further investigations and the need for antibiotics. We have highlighted commonly cited rationale used to support testing and the generally poor evidence on which to base this rationale. In addition, difficulties with interpretation of respiratory viral testing results include somewhat poor diagnostic test characteristics for some tests, uncertainty regarding true positives and causation of illness, delay in receiving the test result, and the incidence of concurrent bacterial infections or the presence of multiple viruses. We have given some examples of clinical scenarios where respiratory viral testing results could be expected to contribute to more appropriate clinical management decisions. CONCLUSIONS AND RELEVANCE It is not good enough to "do" just because we "can." We suggest that for many healthy immune-competent children presenting with typical viral respiratory tract symptoms, the diagnosis can be made clinically, and frontline clinicians should think critically before automatically requesting a somewhat uncomfortable, expensive respiratory viral test, the result of which may not contribute to the child's treatment.	[Schroeder, Alan R.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Ralston, Shawn L.] Dartmouth Coll, Geisel Sch Med, Dept Pediat, Hanover, NH 03755 USA	Stanford University; Dartmouth College	Schroeder, AR (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr,MC 5776, Stanford, CA 94305 USA.	aschroe@stanford.edu						Gill PJ, 2017, JAMA PEDIAT, V170, P429; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Mangione-Smith R, 2006, ARCH PEDIAT ADOL MED, V160, P945, DOI 10.1001/archpedi.160.9.945; Quinonez RA, 2013, J HOSP MED, V8, P479, DOI 10.1002/jhm.2064; Ralston S, 2011, ARCH PEDIAT ADOL MED, V165, P951, DOI 10.1001/archpediatrics.2011.155; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Schroeder AR, 2013, PEDIATRICS, V132, pE1194, DOI 10.1542/peds.2013-1501; Welch H, 2011, OVERDIAGNOSED MAKING	8	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					472	473		10.1001/jama.2017.3985	http://dx.doi.org/10.1001/jama.2017.3985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763534				2022-12-28	WOS:000406659800018
J	Knowles, JW; Rader, DJ; Khoury, MJ				Knowles, Joshua W.; Rader, Daniel J.; Khoury, Muin J.			Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IDENTIFICATION		[Knowles, Joshua W.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Knowles, Joshua W.] Stanford Univ, Cardiovasc Inst, Stanford, CA 94305 USA; [Knowles, Joshua W.; Rader, Daniel J.] FH Fdn, Pasadena, CA USA; [Rader, Daniel J.] Univ Penn, Philadelphia, PA 19104 USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA USA	Stanford University; Stanford University; University of Pennsylvania; Centers for Disease Control & Prevention - USA	Knowles, JW (corresponding author), Stanford Univ, Falk Cardiovasc Res Ctr, Div Cardiovasc Med, 870 Quarry Rd, Stanford, CA 94304 USA.; Knowles, JW (corresponding author), Stanford Univ, Falk Cardiovasc Res Ctr, Cardiovasc Inst, 870 Quarry Rd, Stanford, CA 94304 USA.	knowlej@stanford.edu			American Heart Association; Amgen	American Heart Association(American Heart Association); Amgen(Amgen)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Knowles reports grants paid to the institution from the American Heart Association and Amgen. No other disclosures were reported.	Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Lozano P, 2016, JAMA-J AM MED ASSOC, V316, P645, DOI 10.1001/jama.2016.6176; Nherera L, 2011, HEART, V97, P1175, DOI 10.1136/hrt.2010.213975; de Isla LP, 2016, J AM COLL CARDIOL, V67, P1278, DOI 10.1016/j.jacc.2016.01.008; Safarova MS, 2016, J CLIN LIPIDOL, V10, P1230, DOI 10.1016/j.jacl.2016.08.001; Shaw E., 2008, CLIN GUIDELINES EVID; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; Wald DS, 2016, NEW ENGL J MED, V375, P1628, DOI 10.1056/NEJMoa1602777; Wonderling David, 2004, Semin Vasc Med, V4, P97	10	98	98	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					381	382		10.1001/jama.2017.8543	http://dx.doi.org/10.1001/jama.2017.8543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742895	Green Accepted			2022-12-28	WOS:000406296700018
J	Kickbusch, I; Hanefeld, J				Kickbusch, Ilona; Hanefeld, Johanna			Role for academic institutions and think tanks in speeding progress on sustainable development goals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POLICY		[Kickbusch, Ilona] Global Hlth Ctr, Grad Inst, Geneva, Switzerland; [Hanefeld, Johanna] London Sch Hyg & Trop Med, Hlth Policy & Syst, London, England	University of London; London School of Hygiene & Tropical Medicine	Hanefeld, J (corresponding author), London Sch Hyg & Trop Med, Hlth Policy & Syst, London, England.	Johanna.Hanefeld@lshtm.ac.uk			IDRC	IDRC	IK is the chair and convenor of the Global Health Policy Think Tank Network and received a grant from IDRC to build and enable this network. JH is representing LSHTM on the steering committee of the GHPTT	[Anonymous], 2016, WORLD DEV IND; Bennett S, 2012, HEALTH POLICY PLANN, V27, P194, DOI 10.1093/heapol/czr035; Hawkins B, 2014, AM J PUBLIC HEALTH, V104, P1363, DOI 10.2105/AJPH.2013.301858; Jha A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i409; Kickbusch I., 2010, IMPLEMENTING HLTH AL; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Shaw SE, 2014, SOCIOL HEALTH ILL, V36, P447, DOI 10.1111/1467-9566.12071; World Health Organization, 2017, AD STAT II OUTC STAT; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]	9	16	16	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2017	358								j3519	10.1136/bmj.j3519	http://dx.doi.org/10.1136/bmj.j3519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3US	28739591	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000406765500002
J	Reuveni, S; Ehrenberg, M; Paulsson, J				Reuveni, Shlomi; Ehrenberg, Mans; Paulsson, Johan			Ribosomes are optimized for autocatalytic production	NATURE			English	Article							MITOCHONDRIAL RIBOSOME; PROTEIN-SYNTHESIS; CELL-GROWTH; BACTERIAL; TRANSLATION; REVEALS; ORIGIN; LIMITS; LAWS; S1	Many fine-scale features of ribosomes have been explained in terms of function, revealing a molecular machine that is optimized for error-correction, speed and control. Here we demonstrate mathematically that many less well understood, larger-scale features of ribosomes-such as why a few ribosomal RNA molecules dominate the mass and why the ribosomal protein content is divided into 55-80 small, similarly sized segments-speed up their autocatalytic production.	[Reuveni, Shlomi; Paulsson, Johan] Harvard Univ, Dept Syst Biol, HMS, 200 Longwood Ave, Boston, MA 02115 USA; [Ehrenberg, Mans] Uppsala Univ, Dept Cell & Mol Biol, Uppsala Biomed Ctr BMC, Husargatan 3, Uppsala, Sweden	Harvard University; Harvard Medical School; Uppsala University	Paulsson, J (corresponding author), Harvard Univ, Dept Syst Biol, HMS, 200 Longwood Ave, Boston, MA 02115 USA.	johan_paulsson@hms.harvard.edu	Reuveni, Shlomi/M-3296-2016	Reuveni, Shlomi/0000-0003-2292-8005	James S. McDonnell Foundation; NSF-DMS grant [PD127334]; NIH [R01GM095784]; HFSP grant [RGP0042]; Swedish Research Council; Wallenberg Foundation (RiboCORE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095784] Funding Source: NIH RePORTER	James S. McDonnell Foundation; NSF-DMS grant(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Foundation (RiboCORE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.R. was supported by a James S. McDonnell Foundation fellowship. S.R. and J.P. were supported by NSF-DMS grant PD127334 and NIH grant R01GM095784. J.P. and M.E. were supported by HFSP grant RGP0042 and M.E. was further supported by the Swedish Research Council and the Wallenberg Foundation (RiboCORE). We are grateful to R. Ward, A. Hilfinger, R. Milo, R. Jajoo and M. Landon for discussions.	Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Bremer H, 2008, ECOSAL PLUS, V3; Cech TR, 2009, COLD SH Q B, V74, P11, DOI 10.1101/sqb.2009.74.024; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Klumpp S, 2013, P NATL ACAD SCI USA, V110, P16754, DOI 10.1073/pnas.1310377110; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Liebermeister W, 2014, P NATL ACAD SCI USA, V111, P8488, DOI 10.1073/pnas.1314810111; Maaloe O, 1969, DEVELOP BIOL       S, V3, P33; Maitra A, 2016, BIOPHYS J, V110, P743, DOI 10.1016/j.bpj.2015.12.016; Maitra A, 2015, P NATL ACAD SCI USA, V112, P406, DOI 10.1073/pnas.1421138111; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Myasnikov AG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6294; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; O'Brien TW, 2002, GENE, V286, P73, DOI 10.1016/S0378-1119(01)00808-3; Qu XH, 2012, P NATL ACAD SCI USA, V109, P14458, DOI 10.1073/pnas.1208950109; Rodnina MV, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P199; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sauert M, 2015, BIOCHIMIE, V114, P39, DOI 10.1016/j.biochi.2014.12.011; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Yamamoto H, 2016, P NATL ACAD SCI USA, V113, pE1180, DOI 10.1073/pnas.1524554113; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1	34	32	32	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					293	+		10.1038/nature22998	http://dx.doi.org/10.1038/nature22998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28726822	Green Accepted			2022-12-28	WOS:000405844900023
J	Trevatt, AEJ				Trevatt, Alexander E. J.			A patient with a painful and swollen hand	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Trevatt, Alexander E. J.] St Georges Univ Hosp NHS Fdn Trust, Plast & Reconstruct Surg Dept, London, England		Trevatt, AEJ (corresponding author), St Georges Univ Hosp NHS Fdn Trust, Plast & Reconstruct Surg Dept, London, England.	alextrevatt@gmail.com						Ben-Amotz O, 2015, PLAST RECONSTR SURG, V136, p370E, DOI 10.1097/PRS.0000000000001527; Fusetti C, 2002, J TRAUMA, V52, P535, DOI 10.1097/00005373-200203000-00019; HOVE LM, 1993, SCAND J PLAST RECONS, V27, P317, DOI 10.1080/02844311.1993.12005647; Kollitz Kathleen M, 2014, Hand (N Y), V9, P16, DOI 10.1007/s11552-013-9562-1; Ozer K, 2008, J HAND SURG-AM, V33A, P1724, DOI 10.1016/j.jhsa.2008.07.011	5	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2017	358								j3127	10.1136/bmj.j3127	http://dx.doi.org/10.1136/bmj.j3127			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7KC	28729374				2022-12-28	WOS:000406318500002
J	Zheng, Y; Manson, JE; Yuan, CZ; Liang, MH; Grodstein, F; Stampfer, MJ; Willett, WC; Hu, FB				Zheng, Yan; Manson, JoAnn E.; Yuan, Changzheng; Liang, Matthew H.; Grodstein, Francine; Stampfer, Meir J.; Willett, Walter C.; Hu, Frank B.			Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CORONARY-DISEASE; RISK; CANCER; OSTEOARTHRITIS; ADIPOSITY; MORTALITY; OBESITY; MIDLIFE; WOMEN	IMPORTANCE Data describing the effects of weight gain across adulthood on overall health are important for weight control. OBJECTIVE To examine the association of weight gain from early to middle adulthood with health outcomes later in life. DESIGN, SETTING, AND PARTICIPANTS Cohort analysis of US women from the Nurses' Health Study (1976-June 30, 2012) and US men from the Health Professionals Follow-Up Study (1986-January 31, 2012) who recalled weight during early adulthood (at age of 18 years in women; 21 years in men), and reported current weight during middle adulthood (at age of 55 years). EXPOSURES Weight change from early to middle adulthood (age of 18 or 21 years to age of 55 years). MAIN OUTCOMES AND MEASURES Beginning at the age of 55 years, participants were followed up to the incident disease outcomes. Cardiovascular disease, cancer, and death were confirmed by medical records or the National Death Index. A composite healthy aging outcome was defined as being free of 11 chronic diseases and major cognitive or physical impairment. RESULTS A total of 92 837 women (97% white; mean [SD] weight gain: 12.6 kg [12.3 kg] over 37 years) and 25 303 men (97% white; mean [SD] weight gain: 9.7 kg [9.7 kg] over 34 years) were included in the analysis. For type 2 diabetes, the adjusted incidence per 100 000 person-years was 207 among women who gained a moderate amount of weight (>= 2.5 kg to <10 kg) vs 110 among women who maintained a stable weight (weight loss <= 2.5 kg or gain <2.5 kg) (absolute rate difference [ARD] per 100 000 person-years, 98; 95% CI, 72 to 127) and 258 vs 147, respectively, among men (ARD, 111; 95% CI, 58 to 179); hypertension: 3415 vs 2754 among women (ARD, 662; 95% CI, 545 to 782) and 2861 vs 2366 among men (ARD, 495; 95% CI, 281 to 726); cardiovascular disease: 309 vs 248 among women (ARD, 61; 95% CI, 38 to 87) and 383 vs 340 among men (ARD, 43; 95% CI, -14 to 109); obesity-related cancer: 452 vs 415 among women (ARD, 37; 95% CI, 4 to 73) and 208 vs 165 among men (ARD, 42; 95% CI, 0.5 to 94). Among those who gained a moderate amount of weight, 3651 women (24%) and 2405 men (37%) achieved the composite healthy aging outcome. Among those who maintained a stable weight, 1528 women (27%) and 989 men (39%) achieved the composite healthy aging outcome. The multivariable-adjusted odds ratio for the composite healthy aging outcome associated with moderate weight gain was 0.78 (95% CI, 0.72 to 0.84) in women and 0.88 (95% CI, 0.79 to 0.97) in men. Higher amounts of weight gain were associated with greater risks of major chronic diseases and lower likelihood of healthy aging. CONCLUSIONS AND RELEVANCE In these cohorts of health professionals, weight gain during adulthood was associated with significantly increased risk of major chronic diseases and decreased odds of healthy aging. These findings may help counsel patients regarding the risks of weight gain.	[Zheng, Yan; Yuan, Changzheng; Stampfer, Meir J.; Willett, Walter C.; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA; [Zheng, Yan] Fudan Univ, Key Lab Contemporary Anthropol, Minist Educ, Collaborat Innovat Ctr Genet & Dev,Sch Life Sci, Shanghai, Peoples R China; [Zheng, Yan] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China; [Manson, JoAnn E.; Grodstein, Francine; Stampfer, Meir J.; Willett, Walter C.; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA; [Manson, JoAnn E.; Grodstein, Francine; Stampfer, Meir J.; Willett, Walter C.; Hu, Frank B.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA; [Manson, JoAnn E.] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA USA; [Liang, Matthew H.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Liang, Matthew H.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA; [Liang, Matthew H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Liang, Matthew H.] VA Boston Healthcare Syst, Rheumatol Sect, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Fudan University; Fudan University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Hu, FB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.; Hu, FB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	nhbfh@channing.harvard.edu	Zheng, Yan/E-7388-2018		National Institutes of Health [UM1 CA186107, P01 CA87969, UM1 CA167552]; National Heart, Lung, and Blood Institute [HL034595]; National Institute of Diabetes and Digestive and Kidney Diseases [DK46200]; American Diabetes Association [7-12-MN-34]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association)	The cohorts were supported by grants UM1 CA186107, P01 CA87969, and UM1 CA167552 from the National Institutes of Health. The current study was supported by grant HL034595 from the National Heart, Lung, and Blood Institute and grant DK46200 from the National Institute of Diabetes and Digestive and Kidney Diseases. Dr Zheng was supported by fellowship 7-12-MN-34 from the American Diabetes Association.	Ahn J, 2007, ARCH INTERN MED, V167, P2091, DOI 10.1001/archinte.167.19.2091; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Allman-Farinelli M, 2014, AM J EPIDEMIOL, V179, P145, DOI 10.1093/aje/kwt252; Bao Y, 2016, AM J PUBLIC HEALTH, V106, P1573, DOI 10.2105/AJPH.2016.303338; Canale MP, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/865965; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Hutfless S, 2013, STRATEGIES PREVENTWE; Karlson EW, 2003, AM J MED, V114, P93, DOI 10.1016/S0002-9343(02)01447-X; Keum N, 2015, JNCI-J NATL CANCER I, V107, DOI [10.1093/jnci/dju428, 10.1093/jnci/djv088]; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; MACLURE KM, 1989, NEW ENGL J MED, V321, P563, DOI 10.1056/NEJM198908313210902; McDowell Margaret A, 2008, Natl Health Stat Report, P1; Pan A, 2014, AM J EPIDEMIOL, V180, P254, DOI 10.1093/aje/kwu136; Prickett C, 2015, OBES RES CLIN PRACT, V9, P93, DOI 10.1016/j.orcp.2014.05.001; RHOADS GG, 1983, LANCET, V1, P492; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Song MY, 2016, INT J CANCER, V138, P2383, DOI 10.1002/ijc.29981; Song MY, 2015, CANCER PREV RES, V8, P620, DOI 10.1158/1940-6207.CAPR-15-0061; Strand BH, 2017, J GERONTOL A-BIOL, V72, P855, DOI 10.1093/gerona/glw157; Sun Q, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3796; TROY LM, 1995, INT J OBESITY, V19, P570; Weintraub JM, 2002, INT J OBESITY, V26, P1588, DOI 10.1038/sj.ijo.0802158; Willett W., 1998, NUTR EPIDEMIOL, V122, P101	34	277	285	2	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					255	269		10.1001/jama.2017.7092	http://dx.doi.org/10.1001/jama.2017.7092			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA9OJ	28719691	Green Published			2022-12-28	WOS:000405775000012
J	Prince, M				Prince, Martin			Progress on dementia-leaving no one behind	LANCET			English	Editorial Material									[Prince, Martin] Kings Coll London, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England	University of London; King's College London	Prince, M (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England.	martin.prince@kcl.ac.uk	Prince, Martin J/A-9170-2010	Prince, Martin J/0000-0003-1379-7146	Alzheimer's Disease International; WHO; European Research Council	Alzheimer's Disease International; WHO(World Health Organization); European Research Council(European Research Council (ERC)European Commission)	I have received grants to my institution from Alzheimer's Disease International, WHO, and the European Research Council. I declare no other competing interests.	Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Livingston GSA, 2017, LANCET, DOI http://dx.doi; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Prince M., 2014, DEMENTIA RISK REDUCT; Prince M., WORLD ALZHEIMER REPO; Prince M., 2016, WORLD ALZHEIMER REPO; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Prince MJ, 2012, J HYPERTENS, V30, P177, DOI 10.1097/HJH.0b013e32834d9eda; van Charante EPM, 2016, LANCET, V388, P797, DOI 10.1016/S0140-6736(16)30950-3; WHO, 2017, GLOB ACT PL IN PRESS; WHO, 2008, MHGAP MENTAL HLTH GA; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	14	22	22	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					E51	E53		10.1016/S0140-6736(17)31757-9	http://dx.doi.org/10.1016/S0140-6736(17)31757-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ1FF	28735856				2022-12-28	WOS:000418101000001
J	Liu, L; Li, XY; Ma, J; Li, ZQ; You, LL; Wang, JY; Wang, M; Zhang, XZ; Wang, YL				Liu, Liang; Li, Xueyan; Ma, Jun; Li, Zongqiang; You, Lilan; Wang, Jiuyu; Wang, Min; Zhang, Xinzheng; Wang, Yanli			The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a	CELL			English	Article							TARGET DNA RECOGNITION; STRUCTURAL BASIS; CRYO-EM; CRISPR; SYSTEMS; COMPLEX; REVEALS; ENDONUCLEASE; PROKARYOTES; IMMUNITY	Cas13a, a type VI-A CRISPR-Cas RNA-guided RNA ribonuclease, degrades invasive RNAs targeted by CRISPR RNA (crRNA) and has potential applications in RNA technology. To understand how Cas13a is activated to cleave RNA, we have determined the crystal structure of Leptotrichia buccalis (Lbu) Cas13a bound to crRNA and its target RNA, as well as the cryo-EM structure of the LbuCas13a-crRNA complex. The crRNA-target RNA duplex binds in a positively charged central channel of the nuclease (NUC) lobe, and Cas13a protein and crRNA undergo a significant conformational change upon target RNA binding. The guide-target RNA duplex formation triggers HEPN1 domain to move toward HEPN2 domain, activating the HEPN catalytic site of Cas13a protein, which subsequently cleaves both single-stranded target and collateral RNAs in a non-specific manner. These findings reveal how Cas13a of type VI CRISPR-Cas systems defend against RNA phages and set the stage for its development as a tool for RNA manipulation.	[Liu, Liang; Li, Xueyan; Li, Zongqiang; You, Lilan; Wang, Jiuyu; Wang, Min; Wang, Yanli] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Li, Xueyan; You, Lilan; Zhang, Xinzheng; Wang, Yanli] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ma, Jun; Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, Ctr Biol Imaging, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China; [Wang, Yanli] Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, YL (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China.; Zhang, XZ; Wang, YL (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Zhang, XZ (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Zhang, XZ (corresponding author), Chinese Acad Sci, Inst Biophys, Ctr Biol Imaging, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China.; Wang, YL (corresponding author), Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China.	xzzhang@ibp.ac.cn; ylwang@ibp.ac.cn	zhang, xinzheng/L-6254-2019	Wang, Yanli/0000-0002-5969-1745; liu, liang/0000-0002-5379-0638; Li, Xueyan/0000-0003-2251-710X; Ma, Jun/0000-0002-3823-8714	Chinese Ministry of Science and Technology [2014CB910102]; Natural Science Foundation of China [91440201, 31571335, 31400640, 31570874]; Chinese Academy of Sciences [XDB08010203]; "National Thousand (Young) Talents Program" from the Office of Global Experts Recruitment in China	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); "National Thousand (Young) Talents Program" from the Office of Global Experts Recruitment in China	We thank the staff of the BL-17U1, BL-18U, and BL-19U1 beamlines at the National Center for Protein Sciences Shanghai (NCPSS) at SSRF. We thank X. Huang, G. Ji, Z. Guo, B. Zhu, D. Fan, F. Sun, and other staff members at the Center for Biological Imaging (IBP, CAS) for their support in cryo-EM data collection. This work was supported by grants from the Chinese Ministry of Science and Technology (2014CB910102), the Natural Science Foundation of China (91440201, 31571335, 31400640, 31570874), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08010203). X.Z. received scholarships from the "National Thousand (Young) Talents Program" from the Office of Global Experts Recruitment in China. We thank Joy Fleming for critical reading of the manuscript and linguistic assistance.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; [Anonymous], ACTA CRYSTALLOGR D, V71, P136; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brown A., 2015, CELL, V170, p[714, 725]; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han YC, 2014, SCIENCE, V343, P1244, DOI 10.1126/science.1249845; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lewis KM, 2017, MOL CELL, V65, P377, DOI 10.1016/j.molcel.2017.01.024; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Makarova KS, 2017, CELL, V168, P946, DOI [10.1016/j.cell.2017.02.018, 10.1016/j.cell.2016.12.038]; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B., 2015, CPF1 IS SINGLE RNA G	42	201	227	33	189	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					714	+		10.1016/j.cell.2017.06.050	http://dx.doi.org/10.1016/j.cell.2017.06.050			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28757251	Bronze			2022-12-28	WOS:000407445700012
J	Staniszewska, S; Brett, J; Simera, I; Seers, K; Mockford, C; Goodlad, S; Altman, DG; Moher, D; Barber, R; Denegri, S; Entwistle, A; Littlejohns, P; Morris, C; Suleman, R; Thomas, V; Tysall, C				Staniszewska, S.; Brett, J.; Simera, I.; Seers, K.; Mockford, C.; Goodlad, S.; Altman, D. G.; Moher, D.; Barber, R.; Denegri, S.; Entwistle, A.; Littlejohns, P.; Morris, C.; Suleman, R.; Thomas, V.; Tysall, C.			GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE RESEARCH; HEALTH-CARE; IMPACT	BACKGROUND While the patient and public involvement (PPI) evidence base has expanded over the past decade, the quality of reporting within papers is often inconsistent, limiting our understanding of how it works, in what context, for whom, and why. OBJECTIVE To develop international consensus on the key items to report to enhance the quality, transparency, and consistency of the PPI evidence base. To collaboratively involve patients as research partners at all stages in the development of GRIPP2. METHODS The EQUATOR method for developing reporting guidelines was used. The original GRIPP (Guidance for Reporting Involvement of Patients and the Public) checklist was revised, based on updated systematic review evidence. A three round Delphi survey was used to develop consensus on items to be included in the guideline. A subsequent face-to-face meeting produced agreement on items not reaching consensus during the Delphi process. RESULTS 143 participants agreed to participate in round one, with an 86% (123/143) response for round two and a 78% (112/143) response for round three. The Delphi survey identified the need for long form (LF) and short form (SF) versions. GRIPP2-LF includes 34 items on aims, definitions, concepts and theory, methods, stages and nature of involvement, context, capture or measurement of impact, outcomes, economic assessment, and reflections and is suitable for studies where the main focus is PPI. GRIPP2SF includes five items on aims, methods, results, outcomes, and critical perspective and is suitable for studies where PPI is a secondary focus. CONCLUSIONS GRIPP2-LF and GRIPP2-SF represent the first international evidence based, consensus informed guidance for reporting patient and public involvement in research. Both versions of GRIPP2 aim to improve the quality, transparency, and consistency of the international PPI evidence base, to ensure PPI practice is based on the best evidence. In order to encourage its wide dissemination this article is freely accessible on The BMJ and Research Involvement and Engagement journal websites.	[Staniszewska, S.; Seers, K.] Univ Warwick, Warwick Res Nursing, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Brett, J.] Oxford Brookes Univ, Fac Hlth & Life Sci, Oxford, England; [Simera, I.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Simera, I.] Univ Oxford, UK EQUATOR Ctr, Oxford, England; [Mockford, C.; Entwistle, A.; Suleman, R.; Tysall, C.] Warwick Med Sch, Coventry, W Midlands, England; [Goodlad, S.] Coventry Univ, Coventry, W Midlands, England; [Altman, D. G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Moher, D.] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada; [Barber, R.] Univ Sheffield, Sch Hlth & Related Res, Sect Publ Hlth, Sheffield, S Yorkshire, England; [Denegri, S.] UCL Sch Life & Med Sci, Natl Inst Hlth Res, London, England; [Littlejohns, P.] Kings Coll London, London, England; [Morris, C.] Univ Exeter, Sch Med, Exeter, Devon, England; [Thomas, V.] Natl Inst Hlth & Care Excellence, Publ Involvement Programme, London, England	University of Warwick; Oxford Brookes University; University of Oxford; University of Oxford; University of Warwick; Coventry University; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute; University of Sheffield; University of London; University College London; University of London; King's College London; University of Exeter; National Institute for Health & Care Excellence	Staniszewska, S (corresponding author), Univ Warwick, Warwick Res Nursing, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	sophie.staniszewska@warwick.ac.uk	Moher, David/I-3408-2019; Simera, Iveta/AFN-5638-2022	Moher, David/0000-0003-2434-4206; Simera, Iveta/0000-0001-5785-6756; Brett, Jo/0000-0002-5116-4238	Royal College of Nursing Research Institute, Warwick Medical School, University of Warwick; Cancer Research UK [16895] Funding Source: researchfish	Royal College of Nursing Research Institute, Warwick Medical School, University of Warwick; Cancer Research UK(Cancer Research UK)	The development of GRIPP2 was recognised as strategically important and funded by Royal College of Nursing Research Institute, Warwick Medical School, University of Warwick.	Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Brett J, BMJ OPEN IN PRESS; Brett J, 2014, PATIENT, V7, P387, DOI 10.1007/s40271-014-0065-0; Brett J, 2014, HEALTH EXPECT, V17, P637, DOI 10.1111/j.1369-7625.2012.00795.x; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Gagnon MP, 2011, INT J TECHNOL ASSESS, V27, P31, DOI 10.1017/S0266462310001315; Kuhn TS., 2012, STRUCTURE SCI REVOLU, DOI [10.7208/chicago/9780226458144.001.0001, DOI 10.7208/CHICAGO/9780226458144.001.0001]; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mockford C, 2012, INT J QUAL HEALTH C, V24, P28, DOI 10.1093/intqhc/mzr066; Moher D, 2007, CAN J ANAESTH, V54, P331, DOI 10.1007/BF03022653; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Moher D, 2009, CAN J ANAESTH, V56, P96, DOI 10.1007/s12630-008-9027-0; National Institute for Health, 2015, GOING EXTR MIL IMPR; Shippee ND, 2015, HEALTH EXPECT, V18, P1151, DOI 10.1111/hex.12090; Staley K., 2009, EXPLORING IMPACT PUB; Stephens Richard, 2015, Res Involv Engagem, V1, P1, DOI 10.1186/s40900-015-0005-8; Tarrow S., 1994, POWER MOVEMENT SOCIA; Wilson P., 2015, HLTH SERVICES DELIVE, V3, P1	21	321	313	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2017	358								j3453	10.1136/bmj.j3453	http://dx.doi.org/10.1136/bmj.j3453			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CG	28768629	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000407206800003
J	Hurley, R				Hurley, Richard			MEDICINE AND THE MEDIA How a fight for Charlie Gard became a fight against the state	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hurley, Richard] BMJ, London, England		Hurley, R (corresponding author), BMJ, London, England.	rhurley@bmj.com						[Anonymous], 2017, PRIVATE EYE, V358, P6; [Anonymous], 2017, MEDIA ADVISORY CG FO; Das R., 2017, SOCIAL MEDIA C GARD; Editorial Board, 2017, FAR C GARD; Krauthammer C, 2017, WHAT LITTLE C GARD E; Moschella M., 2017, C GARD CASE THREATEN; Phillips M, 2017, CRUEL IGNORANT CAMPA; Samuelson K, 2017, US CONSERVATIVES HAV; Tuttle I, 2017, COURT ORDERED KILLIN	9	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2017	358								j3675	10.1136/bmj.j3675	http://dx.doi.org/10.1136/bmj.j3675			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CE	28765108				2022-12-28	WOS:000407206600004
J	Frederick, AR				Frederick, Alyssa R.			From abalone to advocacy	SCIENCE			English	Editorial Material								Three months ago, as I stood on the edge of the National Mall in Washington, D.C., I allowed myself a few moments to appreciate what I was about to do. With a few deep breaths, I reminded myself that I was probably facing an uphill battle; took one last look at the Capitol; and, with three other graduate students, began a whirlwind tour of 12 congressional offices to push for policies to address climate change.	[Frederick, Alyssa R.] Univ Calif Irvine, Irvine, CA 92697 USA	University of California System; University of California Irvine	Frederick, AR (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.								0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					422	422		10.1126/science.357.6349.422	http://dx.doi.org/10.1126/science.357.6349.422			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751612	Bronze			2022-12-28	WOS:000406362300049
J	Kostova, KK; Hickey, KL; Osuna, BA; Hussmann, JA; Frost, A; Weinberg, DE; Weissman, JS				Kostova, Kamena K.; Hickey, Kelsey L.; Osuna, Beatriz A.; Hussmann, Jeffrey A.; Frost, Adam; Weinberg, David E.; Weissman, Jonathan S.			CAT-tailing as a fail-safe mechanism for efficient degradation of stalled nascent polypeptides	SCIENCE			English	Article							PROTEIN-QUALITY CONTROL; LARGE RIBOSOMAL-SUBUNIT; MESSENGER-RNA; STRUCTURAL BASIS; CONTROL COMPLEX; TRANSLATION; UBIQUITINATION; SURVEILLANCE; AGGREGATION; PROTEASOME	Ribosome stalling leads to recruitment of the ribosome quality control complex (RQC), which targets the partially synthesized polypeptide for proteasomal degradation through the action of the ubiquitin ligase Ltn1p. A second core RQC component, Rqc2p, modifies the nascent polypeptide by adding a carboxyl-terminal alanine and threonine (CAT) tail through a noncanonical elongation reaction. Here we examined the role of CAT-tailing in nascent-chain degradation in budding yeast. We found that Ltn1p efficiently accessed only nascent-chain lysines immediately proximal to the ribosome exit tunnel. For substrates without Ltn1p-accessible lysines, CAT-tailing enabled degradation by exposing lysines sequestered in the ribosome exit tunnel. Thus, CAT-tails do not serve as a degron, but rather provide a fail-safe mechanism that expands the range of RQC-degradable substrates.	[Kostova, Kamena K.; Hickey, Kelsey L.; Osuna, Beatriz A.; Weinberg, David E.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Kostova, Kamena K.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Osuna, Beatriz A.; Frost, Adam] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Hussmann, Jeffrey A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Frost, Adam; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Frost, Adam] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Frost, Adam] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Weissman, Jonathan S.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Weinberg, DE; Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA.; Weissman, JS (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.	david.weinberg@ucsf.edu; jonathan.weissman@ucsf.edu	Kostova, Kamena/AAK-9431-2020	Kostova, Kamena/0000-0001-9973-401X; Frost, Adam/0000-0003-2231-2577; Hickey, Kelsey/0000-0001-9904-0966; Hussmann, Jeffrey/0000-0002-7778-9893; Weinberg, David/0000-0002-9348-1709; Weissman, Jonathan/0000-0003-2445-670X	Howard Hughes Medical Institute (HHMI); University of California San Francisco (UCSF); NIH Center for RNA Systems Biology; HHMI; UCSF; Searle Scholars Program; NIH [1DP2GM110772-01, DP5OD017895, 5R01AG041826-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM110772, P50GM102706, T32GM007810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041826] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017895] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); University of California San Francisco (UCSF)(University of California System); NIH Center for RNA Systems Biology; HHMI(Howard Hughes Medical Institute); UCSF; Searle Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Shen for providing the Ltn1 Delta RING strain and E. Costa for advice on protein purification. We thank O. Brandman, M. Jost, E. Costa, C. Gross, S. Torres, M. Chan, D. Santos, N. Schirle Oakdale, P. Shen, and P. Walter for scientific input. This work was supported by Howard Hughes Medical Institute (HHMI) (J.S.W.), University of California San Francisco (UCSF) Discovery Fellowship (K.K. and B.A.O.), NIH Center for RNA Systems Biology (J.S.W.), HHMI Faculty Scholar award (A.F.), UCSF Program for Breakthrough Biomedical Research (A.F. and D.E.W.), the Searle Scholars Program (A.F.), and NIH grants 1DP2GM110772-01 (A.F.), DP5OD017895 (D.E.W.), and NIH 5R01AG041826-05 (J.S.W.). B.A.O. is a National Science Foundation Graduate Research Fellow. J.A.H. is the Rebecca Ridley Kry Fellow of the Damon Runyon Cancer Research Foundation (DRG-2262-16). K.K. is a Howard Hughes Medical Institute International Student Research fellow. A.F. is a Chan Zuckerberg Biohub investigator. K.K., B.A.O., D.E.W., A.F., and J.S.W. conceived the study. All authors evaluated the results and edited the manuscript. K.K. and J.S.W. wrote the manuscript. K.K. and K.L.H. performed all experiments. J.A.H. performed the computational analysis.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973; Defenouillere Q, 2016, J BIOL CHEM, V291, P12245, DOI 10.1074/jbc.M116.722264; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Guydosh NR, 2017, RNA, V23, P749, DOI 10.1261/rna.060418.116; Higgins R, 2015, MOL CELL, V59, P35, DOI 10.1016/j.molcel.2015.04.026; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Shao SC, 2014, MOL CELL, V55, P880, DOI 10.1016/j.molcel.2014.07.006; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Simms CL, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1366; Simms CL, 2014, CELL REP, V9, P1256, DOI 10.1016/j.celrep.2014.10.042; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; von der Malsburg K, 2015, MOL BIOL CELL, V26, P2168, DOI 10.1091/mbc.E15-01-0040; Yonashiro R, 2016, ELIFE, V5, DOI 10.7554/eLife.11794	27	67	69	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					414	417		10.1126/science.aam7787	http://dx.doi.org/10.1126/science.aam7787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751611	Green Accepted			2022-12-28	WOS:000406362300048
J	Gupta, RM; Hadaya, J; Trehan, A; Zekavat, SM; Roselli, C; Klarin, D; Emdin, CA; Hilvering, CRE; Bianchi, V; Mueller, C; Khera, AV; Ryan, RJH; Engreitz, JM; Issner, R; Shoresh, N; Epstein, CB; De Laat, W; Brown, JD; Schnabel, RB; Bernstein, BE; Kathiresan, S				Gupta, Rajat M.; Hadaya, Joseph; Trehan, Aditi; Zekavat, Seyedeh M.; Roselli, Carolina; Klarin, Derek; Emdin, Connor A.; Hilvering, Catharina R. E.; Bianchi, Valerio; Mueller, Christian; Khera, Amit V.; Ryan, Russell J. H.; Engreitz, Jesse M.; Issner, Robbyn; Shoresh, Noam; Epstein, Charles B.; De laat, Wouter; Brown, Jonathan D.; Schnabel, Renate B.; Bernstein, Bradley E.; Kathiresan, Sekar			A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression	CELL			English	Article							CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; IDENTITY GENES; RISK-FACTORS; ATHEROSCLEROSIS; MICE; MIGRAINE	Genome-wide association studies (GWASs) implicate the PHACTR1 locus (6p24) in risk for five vascular diseases, including coronary artery disease, migraine headache, cervical artery dissection, fibromuscular dysplasia, and hypertension. Through genetic fine mapping, we prioritized rs9349379, a common SNP in the third intron of the PHACTR1 gene, as the putative causal variant. Epigenomic data from human tissue revealed an enhancer signature at rs9349379 exclusively in aorta, suggesting a regulatory function for this SNP in the vasculature. CRISPR-edited stem cell-derived endothelial cells demonstrate rs9349379 regulates expression of endothelin 1 (EDN1), a gene located 600 kb upstream of PHACTR1. The known physiologic effects of EDN1 on the vasculature may explain the pattern of risk for the five associated diseases. Overall, these data illustrate the integration of genetic, phenotypic, and epigenetic analysis to identify the biologic mechanism by which a common, non-coding variant can distally regulate a gene and contribute to the pathogenesis of multiple vascular diseases.	[Gupta, Rajat M.; Hadaya, Joseph; Trehan, Aditi; Zekavat, Seyedeh M.; Roselli, Carolina; Klarin, Derek; Emdin, Connor A.; Khera, Amit V.; Ryan, Russell J. H.; Engreitz, Jesse M.; Issner, Robbyn; Shoresh, Noam; Epstein, Charles B.; Bernstein, Bradley E.; Kathiresan, Sekar] Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA; [Gupta, Rajat M.; Khera, Amit V.; Kathiresan, Sekar] Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02114 USA; [Gupta, Rajat M.; Khera, Amit V.; Ryan, Russell J. H.; Bernstein, Bradley E.; Kathiresan, Sekar] Harvard Med Sch, Boston, MA 02115 USA; [Gupta, Rajat M.; Khera, Amit V.; Kathiresan, Sekar] Massachusetts Gen Hosp, Dept Med, Ctr Genom Med, Boston, MA 02114 USA; [Hilvering, Catharina R. E.; Bianchi, Valerio; De laat, Wouter] Univ Med Ctr Utrecht, Hubrecht Inst, Utrecht, Netherlands; [Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mueller, Christian; Schnabel, Renate B.] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Brown, Jonathan D.] Vanderbilt Univ, Ctr Med, Div Cardiovasc Med, Nashville, TN 37232 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Harvard University; Massachusetts General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Vanderbilt University	Gupta, RM; Kathiresan, S (corresponding author), Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA.; Gupta, RM; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA 02114 USA.; Gupta, RM; Kathiresan, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Gupta, RM; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Genom Med, Boston, MA 02114 USA.	rgupta@broadinstitute.org; skathiresan1@mgh.harvard.edu	Hilvering, Carien/AGN-4641-2022; Zekavat, Seyedeh M/N-7570-2018; Schnabel, Renate B/ABE-6668-2021	Zekavat, Seyedeh M/0000-0003-4026-8944; Schnabel, Renate B/0000-0001-7170-9509; Issner, Robbyn/0000-0003-4132-9219; Epstein, Charles B./0000-0001-8358-8345; Hilvering, Carien/0000-0002-2005-2479; Klarin, Derek/0000-0002-4636-5780; Bianchi, Valerio/0000-0001-9025-7923; Muller, Christian/0000-0002-9449-6865; Roselli, Carolina/0000-0001-5267-6756; de Laat, Wouter/0000-0002-6393-595X; Ryan, Russell/0000-0001-8174-3962	Sarnoff Scholar Award; Harvard Catalyst CMERIT Award; NIH NHLBI [K08-HL128810]; NIH [T32 HL007734, R01HL127564]; NIH NHGRI [U54HG006991]; NIH NIDDK [R01 DK097768]; Fondation Leducq CVGeneF(x) Transatlantic Network of Excellence; Ofer and Shelly Nemirovsky MGH Research Scholar Award; Bayer Healthcare; Amarin; Regeneron; Novartis; Sanofi; AstraZeneca; Alnylam; Eli Lilly; Lerink Partners; Noble Insights; Merck; Quest Diagnostics; Amgen; Genentech; Corvidia; Ionis Pharmaceuticals; NATIONAL CANCER INSTITUTE [K08CA208013] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127564, K08HL128810, T32HL007734] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991, UM1HG009390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER	Sarnoff Scholar Award; Harvard Catalyst CMERIT Award; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fondation Leducq CVGeneF(x) Transatlantic Network of Excellence(Leducq Foundation); Ofer and Shelly Nemirovsky MGH Research Scholar Award; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Amarin; Regeneron(Regeneron); Novartis(Novartis); Sanofi; AstraZeneca(AstraZeneca); Alnylam; Eli Lilly(Eli Lilly); Lerink Partners; Noble Insights; Merck(Merck & Company); Quest Diagnostics; Amgen(Amgen); Genentech(Roche HoldingGenentech); Corvidia; Ionis Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Sarnoff Scholar Award, a Harvard Catalyst CMERIT Award, and NIH NHLBI K08-HL128810 (to R.M.G.); NIH T32 HL007734 (to D.K.); NIH NHGRI U54HG006991 to B.E.B.; and NIH NIDDK R01 DK097768, Fondation Leducq CVGeneF(x) Transatlantic Network of Excellence, NIH R01HL127564, and the Ofer and Shelly Nemirovsky MGH Research Scholar Award (to S.K.). The CHARGE endothelial function working group provided data for FMD analysis. S.K. reports receiving grants from Bayer Healthcare, Amarin, and Regeneron; serving on scientific advisory boards for Catabasis, Regeneron Genetics Center, Merck, Celera, and Genomics PLC; receiving consulting fees from Novartis, Sanofi, AstraZeneca, Alnylam, Eli Lilly, Lerink Partners, Noble Insights, Merck, Quest Diagnostics, Amgen, Genentech, Corvidia, Ionis Pharmaceuticals, and Eli Lilly; and holding equity in Catabasis and San Therapeutics.	Aguet F., 2016, BIORXIV; Amiri F, 2004, CIRCULATION, V110, P2233, DOI 10.1161/01.CIR.0000144462.08345.B9; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Bacon CR, 1996, CIRC RES, V79, P794, DOI 10.1161/01.RES.79.4.794; Barton M, 1998, P NATL ACAD SCI USA, V95, P14367, DOI 10.1073/pnas.95.24.14367; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bauer RC, 2015, CIRCULATION, V131, P1202, DOI 10.1161/CIRCULATIONAHA.114.012669; Beaudoin M, 2015, ARTERIOSCL THROM VAS, V35, P1472, DOI 10.1161/ATVBAHA.115.305534; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fukaya T., 2016, AM J PHYSIOL-RENAL, V288, pF912; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; HIRATA Y, 1989, ATHEROSCLEROSIS, V78, P225, DOI 10.1016/0021-9150(89)90227-X; Jarray R, 2015, BIOCHIMIE, V118, P151, DOI 10.1016/j.biochi.2015.09.008; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kiando SR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006367; Klein FA, 2015, BIOINFORMATICS, V31, P3085, DOI 10.1093/bioinformatics/btv335; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; KOWALA MC, 1995, AM J PATHOL, V146, P819; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LI JS, 1994, HYPERTENSION, V24, P183, DOI 10.1161/01.HYP.24.2.183; Li MW, 2013, ARTERIOSCL THROM VAS, V33, P2306, DOI 10.1161/ATVBAHA.113.302028; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nurnberg ST, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005155; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Olin JW, 2014, CIRCULATION, V129, P1048, DOI 10.1161/01.cir.0000442577.96802.8c; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Peters D. T., 2013, GENOME EDITING HUMAN; Pezzini A, 2005, CEPHALALGIA, V25, P575, DOI 10.1111/j.1468-2982.2005.00919.x; Ren B, 2015, COLD SH Q B, V80, P17, DOI 10.1101/sqb.2015.80.027219; Reschen ME, 2016, ATHEROSCLEROSIS, V250, P95, DOI 10.1016/j.atherosclerosis.2016.04.025; Rubinstein SM, 2005, STROKE, V36, P1575, DOI 10.1161/01.STR.0000169919.73219.30; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schiffrin EL, 2005, VASC PHARMACOL, V43, P19, DOI 10.1016/j.vph.2005.03.004; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; SORENSEN KE, 1995, BRIT HEART J, V74, P247; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Webb TR, 2017, J AM COLL CARDIOL, V69, P823, DOI 10.1016/j.jacc.2016.11.056; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Woods M, 1999, MOL PHARMACOL, V55, P902; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200; Xu SW, 2001, J INVEST DERMATOL, V116, P417, DOI 10.1046/j.1523-1747.2001.01256.x; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; YOSHIZUMI M, 1990, BIOCHEM BIOPH RES CO, V166, P324, DOI 10.1016/0006-291X(90)91948-R; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	71	231	240	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					522	+		10.1016/j.cell.2017.06.049	http://dx.doi.org/10.1016/j.cell.2017.06.049			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753427	Green Accepted, Bronze			2022-12-28	WOS:000406462400011
J	McDonald, ER; de Weck, A; Schlabach, MR; Billy, E; Mavrakis, KJ; Hoffman, GR; Belur, D; Castelletti, D; Frias, E; Gampa, K; Golji, J; Kao, I; Li, L; Megel, P; Perkins, TA; Ramadan, N; Ruddy, DA; Silver, SJ; Sovath, S; Stump, M; Weber, O; Widmer, R; Yu, JJ; Yu, K; Yue, YZ; Abramowski, D; Ackley, E; Barrett, R; Berger, J; Bernard, JL; Billig, R; Brachmann, SM; Buxton, F; Caothien, R; Caushi, JX; Chung, FS; Cortes-Cros, M; Debeaumont, RS; Delaunay, C; Desplat, A; Duong, W; Dwoske, DA; Eldridge, RS; Farsidjani, A; Feng, F; Feng, JJ; Flemming, D; Forrester, W; Galli, GG; Gao, ZH; Gauter, FO; Gibaja, V; Haas, K; Hattenberger, M; Hood, T; Hurov, KE; Jagani, Z; Jenal, M; Johnson, JA; Jones, MD; Kapoor, A; Korn, J; Liu, JL; Liu, QM; Liu, SM; Liu, Y; Loo, AT; Macchi, KJ; Martin, T; McAllister, G; Meyer, A; Molle, S; Pagliarini, RA; Phadke, T; Repko, B; Schouwey, T; Shanahan, F; Shen, Q; Stamm, C; Stephan, C; Stucke, VM; Tiedt, R; Varadarajan, M; Venkatesan, K; Vitari, AC; Wallroth, M; Weiler, J; Zhang, J; Mickanin, C; Myer, VE; Porter, JA; Lai, A; Bitter, H; Lees, E; Keen, N; Kauffmann, A; Stegmeier, F; Hofmann, F; Schmelzle, T; Sellers, WR				McDonald, E. Robert, III; de Weck, Antoine; Schlabach, Michael R.; Billy, Eric; Mavrakis, Konstantinos J.; Hoffman, Gregory R.; Belur, Dhiren; Castelletti, Deborah; Frias, Elizabeth; Gampa, Kalyani; Golji, Javad; Kao, Iris; Li, Li; Megel, Philippe; Perkins, Thomas A.; Ramadan, Nadire; Ruddy, David A.; Silver, Serena J.; Sovath, Sosathya; Stump, Mark; Weber, Odile; Widmer, Roland; Yu, Jianjun; Yu, Kristine; Yue, Yingzi; Abramowski, Dorothee; Ackley, Elizabeth; Barrett, Rosemary; Berger, Joel; Bernard, Julie L.; Billig, Rebecca; Brachmann, Saskia M.; Buxton, Frank; Caothien, Roger; Caushi, Justina X.; Chung, Franklin S.; Cortes-Cros, Marta; debeaumont, Rosalie S.; Delaunay, Clara; Desplat, Aurore; Duong, William; Dwoske, Donald A.; Eldridge, Richard S.; Farsidjani, Ali; Feng, Fei; Feng, JiaJia; Flemming, Daisy; Forrester, William; Galli, Giorgio G.; Gao, Zhenhai; Gauter, Franc Ois; Gibaja, Veronica; Haas, Kristy; Hattenberger, Marc; Hood, Tami; Hurov, Kristen E.; Jagani, Zainab; Jenal, Mathias; Johnson, Jennifer A.; Jones, Michael D.; Kapoor, Avnish; Korn, Joshua; Liu, Jilin; Liu, Qiumei; Liu, Shumei; Liu, Yue; Loo, Alice T.; Macchi, Kaitlin J.; Martin, Typhaine; McAllister, Gregory; Meyer, Amandine; Molle, Sandra; Pagliarini, Raymond A.; Phadke, Tanushree; Repko, Brian; Schouwey, Tanja; Shanahan, Frances; Shen, Qiong; Stamm, Christelle; Stephan, Christine; Stucke, Volker M.; Tiedt, Ralph; Varadarajan, Malini; Venkatesan, Kavitha; Vitari, Alberto C.; Wallroth, Marco; Weiler, Jan; Zhang, Jing; Mickanin, Craig; Myer, Vic E.; Porter, Jeffery A.; Lai, Albert; Bitter, Hans; Lees, Emma; Keen, Nicholas; Kauffmann, Audrey; Stegmeier, Frank; Hofmann, Francesco; Schmelzle, Tobias; Sellers, William R.			Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening	CELL			English	Article							OVARIAN-CANCER; BREAST-CANCER; LUNG-CANCER; C-RAF; GENE; CELLS; VULNERABILITIES; MUTATIONS; PHENOTYPE; CARCINOMA	Elucidation of the mutational landscape of human cancer has progressed rapidly and been accompanied by the development of therapeutics targeting mutant oncogenes. However, a comprehensive mapping of cancer dependencies has lagged behind and the discovery of therapeutic targets for counteracting tumor suppressor gene loss is needed. To identify vulnerabilities relevant to specific cancer subtypes, we conducted a large-scale RNAi screen in which viability effects of mRNA knockdown were assessed for 7,837 genes using an average of 20 shRNAs per gene in 398 cancer cell lines. We describe findings of this screen, outlining the classes of cancer dependency genes and their relationships to genetic, expression, and lineage features. In addition, we describe robust gene-interaction networks recapitulating both protein complexes and functional cooperation among complexes and pathways. This dataset along with a web portal is provided to the community to assist in the discovery and translation of new therapeutic approaches for cancer.	[McDonald, E. Robert, III; de Weck, Antoine; Schlabach, Michael R.; Billy, Eric; Mavrakis, Konstantinos J.; Hoffman, Gregory R.; Belur, Dhiren; Castelletti, Deborah; Frias, Elizabeth; Gampa, Kalyani; Golji, Javad; Kao, Iris; Li, Li; Megel, Philippe; Perkins, Thomas A.; Ramadan, Nadire; Ruddy, David A.; Silver, Serena J.; Sovath, Sosathya; Stump, Mark; Weber, Odile; Widmer, Roland; Yu, Jianjun; Yu, Kristine; Yue, Yingzi; Abramowski, Dorothee; Ackley, Elizabeth; Barrett, Rosemary; Berger, Joel; Bernard, Julie L.; Billig, Rebecca; Brachmann, Saskia M.; Buxton, Frank; Caothien, Roger; Caushi, Justina X.; Chung, Franklin S.; Cortes-Cros, Marta; debeaumont, Rosalie S.; Delaunay, Clara; Desplat, Aurore; Duong, William; Dwoske, Donald A.; Eldridge, Richard S.; Farsidjani, Ali; Feng, Fei; Feng, JiaJia; Flemming, Daisy; Forrester, William; Galli, Giorgio G.; Gao, Zhenhai; Gauter, Franc Ois; Gibaja, Veronica; Haas, Kristy; Hattenberger, Marc; Hood, Tami; Hurov, Kristen E.; Jagani, Zainab; Jenal, Mathias; Johnson, Jennifer A.; Jones, Michael D.; Kapoor, Avnish; Korn, Joshua; Liu, Jilin; Liu, Qiumei; Liu, Shumei; Liu, Yue; Loo, Alice T.; Macchi, Kaitlin J.; Martin, Typhaine; McAllister, Gregory; Meyer, Amandine; Molle, Sandra; Pagliarini, Raymond A.; Phadke, Tanushree; Repko, Brian; Schouwey, Tanja; Shanahan, Frances; Shen, Qiong; Stamm, Christelle; Stephan, Christine; Stucke, Volker M.; Tiedt, Ralph; Varadarajan, Malini; Venkatesan, Kavitha; Vitari, Alberto C.; Wallroth, Marco; Weiler, Jan; Zhang, Jing; Mickanin, Craig; Myer, Vic E.; Porter, Jeffery A.; Lai, Albert; Bitter, Hans; Lees, Emma; Keen, Nicholas; Kauffmann, Audrey; Stegmeier, Frank; Hofmann, Francesco; Schmelzle, Tobias; Sellers, William R.] Novartis Inst Biomed Res, Oncol Dis Area, CH-4002 Basel, Switzerland; [McDonald, E. Robert, III; de Weck, Antoine; Schlabach, Michael R.; Billy, Eric; Mavrakis, Konstantinos J.; Hoffman, Gregory R.; Belur, Dhiren; Castelletti, Deborah; Frias, Elizabeth; Gampa, Kalyani; Golji, Javad; Kao, Iris; Li, Li; Megel, Philippe; Perkins, Thomas A.; Ramadan, Nadire; Ruddy, David A.; Silver, Serena J.; Sovath, Sosathya; Stump, Mark; Weber, Odile; Widmer, Roland; Yu, Jianjun; Yu, Kristine; Yue, Yingzi; Abramowski, Dorothee; Ackley, Elizabeth; Barrett, Rosemary; Berger, Joel; Bernard, Julie L.; Billig, Rebecca; Brachmann, Saskia M.; Buxton, Frank; Caothien, Roger; Caushi, Justina X.; Chung, Franklin S.; Cortes-Cros, Marta; debeaumont, Rosalie S.; Delaunay, Clara; Desplat, Aurore; Duong, William; Dwoske, Donald A.; Eldridge, Richard S.; Farsidjani, Ali; Feng, Fei; Feng, JiaJia; Flemming, Daisy; Forrester, William; Galli, Giorgio G.; Gao, Zhenhai; Gauter, Franc Ois; Gibaja, Veronica; Haas, Kristy; Hattenberger, Marc; Hood, Tami; Hurov, Kristen E.; Jagani, Zainab; Jenal, Mathias; Johnson, Jennifer A.; Jones, Michael D.; Kapoor, Avnish; Korn, Joshua; Liu, Jilin; Liu, Qiumei; Liu, Shumei; Liu, Yue; Loo, Alice T.; Macchi, Kaitlin J.; Martin, Typhaine; McAllister, Gregory; Meyer, Amandine; Molle, Sandra; Pagliarini, Raymond A.; Phadke, Tanushree; Repko, Brian; Schouwey, Tanja; Shanahan, Frances; Shen, Qiong; Stamm, Christelle; Stephan, Christine; Stucke, Volker M.; Tiedt, Ralph; Varadarajan, Malini; Venkatesan, Kavitha; Vitari, Alberto C.; Wallroth, Marco; Weiler, Jan; Zhang, Jing; Mickanin, Craig; Myer, Vic E.; Porter, Jeffery A.; Lai, Albert; Bitter, Hans; Lees, Emma; Keen, Nicholas; Kauffmann, Audrey; Stegmeier, Frank; Hofmann, Francesco; Schmelzle, Tobias; Sellers, William R.] Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA; [McDonald, E. Robert, III; de Weck, Antoine; Schlabach, Michael R.; Billy, Eric; Mavrakis, Konstantinos J.; Hoffman, Gregory R.; Belur, Dhiren; Castelletti, Deborah; Frias, Elizabeth; Gampa, Kalyani; Golji, Javad; Kao, Iris; Li, Li; Megel, Philippe; Perkins, Thomas A.; Ramadan, Nadire; Ruddy, David A.; Silver, Serena J.; Sovath, Sosathya; Stump, Mark; Weber, Odile; Widmer, Roland; Yu, Jianjun; Yu, Kristine; Yue, Yingzi; Abramowski, Dorothee; Ackley, Elizabeth; Barrett, Rosemary; Berger, Joel; Bernard, Julie L.; Billig, Rebecca; Brachmann, Saskia M.; Buxton, Frank; Caothien, Roger; Caushi, Justina X.; Chung, Franklin S.; Cortes-Cros, Marta; debeaumont, Rosalie S.; Delaunay, Clara; Desplat, Aurore; Duong, William; Dwoske, Donald A.; Eldridge, Richard S.; Farsidjani, Ali; Feng, Fei; Feng, JiaJia; Flemming, Daisy; Forrester, William; Galli, Giorgio G.; Gao, Zhenhai; Gauter, Franc Ois; Gibaja, Veronica; Haas, Kristy; Hattenberger, Marc; Hood, Tami; Hurov, Kristen E.; Jagani, Zainab; Jenal, Mathias; Johnson, Jennifer A.; Jones, Michael D.; Kapoor, Avnish; Korn, Joshua; Liu, Jilin; Liu, Qiumei; Liu, Shumei; Liu, Yue; Loo, Alice T.; Macchi, Kaitlin J.; Martin, Typhaine; McAllister, Gregory; Meyer, Amandine; Molle, Sandra; Pagliarini, Raymond A.; Phadke, Tanushree; Repko, Brian; Schouwey, Tanja; Shanahan, Frances; Shen, Qiong; Stamm, Christelle; Stephan, Christine; Stucke, Volker M.; Tiedt, Ralph; Varadarajan, Malini; Venkatesan, Kavitha; Vitari, Alberto C.; Wallroth, Marco; Weiler, Jan; Zhang, Jing; Mickanin, Craig; Myer, Vic E.; Porter, Jeffery A.; Lai, Albert; Bitter, Hans; Lees, Emma; Keen, Nicholas; Kauffmann, Audrey; Stegmeier, Frank; Hofmann, Francesco; Schmelzle, Tobias; Sellers, William R.] Novartis Inst Biomed Res, Oncol Dis Area, Emeryville, CA 94608 USA	Novartis; Novartis; Novartis	McDonald, ER; Schmelzle, T (corresponding author), Novartis Inst Biomed Res, Oncol Dis Area, CH-4002 Basel, Switzerland.; McDonald, ER; Schmelzle, T (corresponding author), Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA.; McDonald, ER; Schmelzle, T (corresponding author), Novartis Inst Biomed Res, Oncol Dis Area, Emeryville, CA 94608 USA.	rob.mcdonald@novartis.com; tobias.schmelzle@novartis.com		Billy, Eric/0000-0002-8859-0089; Meyer, Amandine/0000-0001-6875-3285; de Weck, Antoine/0000-0003-0887-6771; Galli, Giorgio/0000-0002-9401-060X; Jones, Michael/0000-0001-7541-7634				Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; [Anonymous], CELL DEATH DIFFER, V10, P185; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Bondurand N, 2013, DEV BIOL, V382, P330, DOI 10.1016/j.ydbio.2013.04.024; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cyr AR, 2015, ONCOGENE, V34, P436, DOI 10.1038/onc.2013.569; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ishihara T, 2008, CANCER SCI, V99, P1940, DOI 10.1111/j.1349-7006.2008.00900.x; Jackson CL, 2014, J CELL SCI, V127, P4103, DOI 10.1242/jcs.144899; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Kim J, 2016, NATURE, V538, P114, DOI 10.1038/nature19771; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Marjon K, 2016, CELL REP, V15, P574, DOI 10.1016/j.celrep.2016.03.043; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; Mayer IA, 2017, CLIN CANCER RES, V23, P26, DOI 10.1158/1078-0432.CCR-16-0134; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Novetsky AP, 2013, GYNECOL ONCOL, V128, P470, DOI 10.1016/j.ygyno.2012.10.026; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pasqualucci L, 2015, SEMIN HEMATOL, V52, P67, DOI 10.1053/j.seminhematol.2015.01.005; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Theurillat JP, 2011, CANCER CELL, V19, P317, DOI 10.1016/j.ccr.2011.01.019; Tracey WD, 2000, SEMIN CELL DEV BIOL, V11, P337, DOI 10.1006/scdb.2000.0186; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Weinstein J.N., 2013, NATURE, V497, P638; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	55	332	335	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					577	+		10.1016/j.cell.2017.07.005	http://dx.doi.org/10.1016/j.cell.2017.07.005			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753431	Bronze			2022-12-28	WOS:000406462400015
J	Perkel, JM				Perkel, Jeffrey M.			HOW TO HACK THE GENOME	NATURE			English	Editorial Material							DESIGN							Perkel, Jeffrey/0000-0001-5699-1008				Fernandez-Rodriguez J, 2017, NAT CHEM BIOL, V13, P706, DOI 10.1038/nchembio.2390; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Lau YH, 2017, NUCLEIC ACIDS RES, V45, P6971, DOI 10.1093/nar/gkx415; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Ostrov N, 2016, SCIENCE, V353, P819, DOI 10.1126/science.aaf3639; Richardson SM, 2017, SCIENCE, V355, P1040, DOI 10.1126/science.aaf4557; Weinberg BH, 2017, NAT BIOTECHNOL, V35, P453, DOI 10.1038/nbt.3805; Zakeri B, 2015, TRENDS BIOTECHNOL, V33, P57, DOI 10.1016/j.tibtech.2014.10.008	9	2	2	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					477	479		10.1038/547477a	http://dx.doi.org/10.1038/547477a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB7ZK	28748939				2022-12-28	WOS:000406358300044
J	Wilhelm, M; Hahne, H; Savitski, M; Marx, H; Lemeer, S; Bantscheff, M; Kuster, B				Wilhelm, Mathias; Hahne, Hannes; Savitski, Mikhail; Marx, Harald; Lemeer, Simone; Bantscheff, Marcus; Kuster, Bernhard			Wilhelm et al. reply	NATURE			English	Letter									[Wilhelm, Mathias; Hahne, Hannes; Marx, Harald; Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany; [Savitski, Mikhail] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Bantscheff, Marcus] Cellzome GmbH, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Hahne, Hannes] OmicScouts GmbH, Lise Meitner Str 30, D-85354 Freising Weihenstephan, Germany; [Marx, Harald] Univ Wisconsin, Dept Chem, 4426 Biotech,425 Henry Mall, Madison, WI 53706 USA; [Lemeer, Simone] Univ Utrecht, Padualaan 8, NL-3584 CH Utrecht, Netherlands	Technical University of Munich; European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Cellzome GmbH; University of Wisconsin System; University of Wisconsin Madison; Utrecht University	Wilhelm, M (corresponding author), Tech Univ Munich, Chair Prote & Bioanalyt, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany.		Bantscheff, Marcus/AAQ-2903-2021	Bantscheff, Marcus/0000-0002-8343-8977; Wilhelm, Mathias/0000-0002-9224-3258				Fortelny N, 2017, NATURE, V547, pE19, DOI 10.1038/nature22293; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319	3	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					E23	E23		10.1038/nature22294	http://dx.doi.org/10.1038/nature22294			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28748931				2022-12-28	WOS:000406358300002
J	Watkins, K				Watkins, Kevin			Saving lives with equity-the efficient route to the SDGs	LANCET			English	Editorial Material									[Watkins, Kevin] Save Children, London SE14 5NX, England	Save the Children	Watkins, K (corresponding author), Save Children, London SE14 5NX, England.	k.watkins@savethechildren.org.uk						Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Gavi the Vaccine Alliance, 2017, PNEUM VACC SUPPL PRO; Mathieson K., 2016, FURTHER FASTER FAIRE; Mulholland K, 2016, PNEUMONIA CHILDREN E, P18; UNICEF, 2016, STATE WORLDS CHILDRE; UNICEF, 2016, ON IS TOO MAN END CH, P34; UNICEF, 2017, EST CHILD CAUS DEATH; Unicef, 2017, NARR GAPS POW INV PO; Wagstaff A, 2014, 6894 WORLD BANK GROU; WHO, 2017, DIR GEN TEDR TAK HEL; WHO UNICEF., 2013, END PREV DEATHS GLOB	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					339	340						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28745590				2022-12-28	WOS:000405911300006
J	Kaiser, J				Kaiser, Jocelyn			US BIOMEDICAL RESEARCH NIH redefines clinical trials, attracting critics	SCIENCE			English	News Item																			0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					236	237		10.1126/science.357.6348.236	http://dx.doi.org/10.1126/science.357.6348.236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729489				2022-12-28	WOS:000405901600013
J	Triantafyllou, MS				Triantafyllou, Michael S.			Tuna fin hydraulics inspire aquatic robotics	SCIENCE			English	Editorial Material							PROPULSION		[Triantafyllou, Michael S.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Triantafyllou, MS (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	mistetri@mit.edu						Aleyev Y.G, 1977, NEKTON; Anderson JM, 2002, INTEGR COMP BIOL, V42, P118, DOI 10.1093/icb/42.1.118; Borst, 1985, FLUID DYNAMIC LIFT P; Burrows M, 2013, SCIENCE, V341, P1254, DOI 10.1126/science.1240284; Lauder GV, 2012, INTEGR COMP BIOL, V52, P576, DOI 10.1093/icb/ics096; Pavlov V, 2017, SCIENCE, V357, P310, DOI 10.1126/science.aak9607; Read DA, 2003, J FLUID STRUCT, V17, P163, DOI 10.1016/S0889-9746(02)00115-9	7	7	7	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					251	252		10.1126/science.aan8354	http://dx.doi.org/10.1126/science.aan8354			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729498				2022-12-28	WOS:000405901600022
J	Turner, J; Comiso, J				Turner, John; Comiso, Josefino			Solve Antarctica's sea-ice puzzle	NATURE			English	Editorial Material							CLIMATE; TRENDS		[Turner, John] British Antarct Survey, Polar Climate & Predict Grp, Cambridge, England; [Turner, John] Int Assoc Meteorol & Atmospher Sci, Reading, Berks, England; [Comiso, Josefino] NASAs Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Comiso, J (corresponding author), NASAs Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	jtu@bas.ac.uk			Directorate For Geosciences [1440435] Funding Source: National Science Foundation; Natural Environment Research Council [bas0100032] Funding Source: researchfish	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2017, ANTARCTIC SEA ICE VA; Comiso JC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004257; Hobbs WR, 2016, GLOBAL PLANET CHANGE, V143, P228, DOI 10.1016/j.gloplacha.2016.06.008; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Jones JM, 2016, NAT CLIM CHANGE, V6, P917, DOI [10.1038/nclimate3103, 10.1038/NCLIMATE3103]; Reid P. A., 2015, B AM METEOROL SOC, V96, pS163, DOI [10.1175/2015BAMSStateoftheClimate.1, DOI 10.1175/2015BAMSSTATEOFTHECLIMATE.1, DOI 10.1175/2015BAMSSTATE0FTHECLIMATE.1]; Serreze MC, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0159; Turner J, 2013, J CLIMATE, V26, P1473, DOI 10.1175/JCLI-D-12-00068.1; Turner J, 2009, POLAR RES, V28, P146, DOI 10.1111/j.1751-8369.2009.00128.x	9	55	57	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					275	277		10.1038/547275a	http://dx.doi.org/10.1038/547275a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB0OR	28726837	Green Accepted			2022-12-28	WOS:000405844900012
J	Appleby, J				Appleby, John			DATA BRIEFING Health spending: is there another way to plan?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Nuffield Trust, London, England		Appleby, J (corresponding author), Nuffield Trust, London, England.	john.appleby@nuffieldtrust.org.uk						Charlsworth A, 2017, GEN ELECTION 2017 3; NHS Confederation, 2017, NIALL DICKS NHS SPEN; Office for Budget Responsibility, 2017, FISC SUST REP; Office for Budget Responsibility, 2017, WHAT WE DO; Wanless, 2002, SECURING OUR FUTURE; Wanless D, 2007, OUR FUTURE HLTH SECU	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2017	358								j3299	10.1136/bmj.j3299	http://dx.doi.org/10.1136/bmj.j3299			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MW	28710058				2022-12-28	WOS:000405770700003
J	Billerbeck, E; Wolfisberg, R; Fahnoe, U; Xiao, JW; Quirk, C; Luna, JM; Cullen, JM; Hartlage, AS; Chiriboga, L; Ghoshal, K; Lipkin, WI; Bukh, J; Scheel, TKH; Kapoor, A; Rice, CM				Billerbeck, Eva; Wolfisberg, Raphael; Fahnoe, Ulrik; Xiao, Jing W.; Quirk, Corrine; Luna, Joseph M.; Cullen, John M.; Hartlage, Alex S.; Chiriboga, Luis; Ghoshal, Kalpana; Lipkin, W. Ian; Bukh, Jens; Scheel, Troels K. H.; Kapoor, Amit; Rice, Charles M.			Mouse models of acute and chronic hepacivirus infection	SCIENCE			English	Article							HEPATITIS-C VIRUS; T-CELL EXHAUSTION; MEMORY; VACCINE	An estimated 71 million people worldwide are infected with hepatitis C virus (HCV). The lack of small-animal models has impeded studies of antiviral immune mechanisms. Here we show that an HCV-related hepacivirus discovered in Norway rats can establish high-titer hepatotropic infections in laboratory mice with immunological features resembling those seen in human viral hepatitis. Whereas immune-compromised mice developed persistent infection, immune-competent mice cleared the virus within 3 to 5 weeks. Acute clearance was T cell dependent and associated with liver injury. Transient depletion of CD4(+) T cells before infection resulted in chronic infection, characterized by high levels of intrahepatic regulatory T cells and expression of inhibitory molecules on intrahepatic CD8(+) T cells. Natural killer cells controlled early infection but were not essential for viral clearance. This model may provide mechanistic insights into hepatic antiviral immunity, a prerequisite for the development of HCV vaccines.	[Billerbeck, Eva; Xiao, Jing W.; Quirk, Corrine; Luna, Joseph M.; Scheel, Troels K. H.; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Wolfisberg, Raphael; Fahnoe, Ulrik; Bukh, Jens; Scheel, Troels K. H.] Hvidovre Univ Hosp, Dept Infect Dis, Copenhagen Hepatitis Program CO HEP C, Copenhagen, Denmark; [Wolfisberg, Raphael; Fahnoe, Ulrik; Bukh, Jens; Scheel, Troels K. H.] Hvidovre Univ Hosp, Clin Res Ctr, Copenhagen, Denmark; [Wolfisberg, Raphael; Fahnoe, Ulrik; Bukh, Jens; Scheel, Troels K. H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Copenhagen, Denmark; [Cullen, John M.] North Carolina State Univ, Coll Vet Med, Raleigh, NC USA; [Hartlage, Alex S.; Kapoor, Amit] Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, Columbus, OH USA; [Hartlage, Alex S.; Kapoor, Amit] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Chiriboga, Luis] NYU, Dept Pathol, Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Ghoshal, Kalpana] Ohio State Univ, Dept Pathol, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA	Rockefeller University; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of North Carolina; North Carolina State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; New York University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Columbia University	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	ricec@rockefeller.edu	Cullen, John M/I-2051-2019; Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Wolfisberg, Raphael/0000-0002-6191-2084; Bukh, Jens/0000-0002-7815-4806; Scheel, Troels/0000-0003-1545-4067; Chiriboga, Luis/0000-0002-2028-6873; Luna, Joseph/0000-0003-2415-9203; Fahnoe, Ulrik/0000-0002-2527-5751	NIH [R01AI072613, R01CA057973, R01AI131688-01, AI107631, R01A193244]; Starr Foundation; Greenberg Medical Research Institute; Nationwide Children's Hospital Research Institute; Danish Council for Independent Research [6110-00595, 6111-00314, 4004-00598]; Novo Nordisk Foundation [NNF15OC0017404, NNF14OC0012533]; Lundbeck Foundation [R192-2015-1154, R221-2016-1455]; NATIONAL CANCER INSTITUTE [R01CA193244, R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI131688, R21AI107631, R01AI072613] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC0002037, NNF15OC0017404, NNF14OC0012533] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; Greenberg Medical Research Institute; Nationwide Children's Hospital Research Institute; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank M. MacDonald, M. Saeed, and W. Schneider for manuscript editing. This work was supported by the NIH (grants R01AI072613, R01CA057973, and R01AI131688-01), The Starr Foundation, the Greenberg Medical Research Institute, and several generous donors (C.M.R.); NIH grant AI107631 and the Nationwide Children's Hospital Research Institute (A.K); the Danish Council for Independent Research [grants 6110-00595 and 6111-00314 (T.K.H.S); grant 4004-00598 (J.B.)]; The Novo Nordisk Foundation [grants NNF15OC0017404 (T.K.H.S.) and NNF14OC0012533 (J.B.)]; The Lundbeck Foundation [grants R192-2015-1154 (T.K.H.S), R221-2016-1455 (J.B.)]; and NIH grant R01A193244 (K.G). The HCV-related hepacivirus NrHV is available from the authors under a material transfer agreement. The ORF consensus sequence of the NrHV rat inoculum was deposited at GenBank (accession no. MF113386). The authors declare no conflict of interest.	Billerbeck E, 2013, CURR TOP MICROBIOL, V369, P49, DOI 10.1007/978-3-642-27340-7_3; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bukh J, 2008, J VIROL, V82, P8183, DOI 10.1128/JVI.00142-08; Cashman SB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00550; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Gardiner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063818; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Scheel TKH, 2015, ANTIVIR RES, V115, P83, DOI 10.1016/j.antiviral.2014.12.014; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Walker CM, 2015, CURR OPIN IMMUNOL, V35, P137, DOI 10.1016/j.coi.2015.06.010; Zehn D, 2015, ADV EXP MED BIOL, V850, P137, DOI 10.1007/978-3-319-15774-0_10; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	20	75	79	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		204	+		10.1126/science.aal1962	http://dx.doi.org/10.1126/science.aal1962			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706073	Green Accepted			2022-12-28	WOS:000405391700047
J	Warrell, M				Warrell, Mary			Is there a future for mRNAs as viral vaccines?	LANCET			English	Editorial Material							RABIES		[Warrell, Mary] Univ Oxford, Oxford Vaccine Grp, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LE, England	University of Oxford	Warrell, M (corresponding author), Univ Oxford, Oxford Vaccine Grp, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LE, England.	mary.warrell@ndm.ox.ac.uk						Alberer M, 2017, LANCET; Ertl HCJ, 2003, EXPERT OPIN BIOL TH, V3, P639, DOI 10.1517/14712598.3.4.639; Ertl HCJ, 2016, CURR OPIN VIROL, V21, P1, DOI 10.1016/j.coviro.2016.06.001; Kubler H, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0068-y; Schnee M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004746; Warrell MJ, 2015, CLIN MED, V15, P78, DOI 10.7861/clinmedicine.14-6-78; Weide B, 2009, J IMMUNOTHER, V32, P498, DOI 10.1097/CJI.0b013e3181a00068	7	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1470	1471		10.1016/S0140-6736(17)31964-5	http://dx.doi.org/10.1016/S0140-6736(17)31964-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FH7BS	28754493				2022-12-28	WOS:000411337100006
J	Han, B; Compton, WM; Blanco, C; Crane, E; Lee, JH; Jones, CM				Han, Beth; Compton, Wilson M.; Blanco, Carlos; Crane, Elizabeth; Lee, Jinhee; Jones, Christopher M.			Prescription Opioid Use, Misuse, and Use Disorders in US Adults: 2015 National Survey on Drug Use and Health	ANNALS OF INTERNAL MEDICINE			English	Article							SUBSTANCE USE DISORDERS; UNITED-STATES; NONMEDICAL USE; TREATMENT-SEEKING; PAIN RELIEVERS; YOUNG-ADULTS; HEROIN USE; OVERDOSE; ASSOCIATION; PREDICTORS	Background: Despite the continuing epidemic of opioid misuse, data on the prevalence of prescription opioid use, misuse, and use disorders are limited. Objective: To estimate the prevalence of prescription opioid use, misuse, and use disorders and motivations for misuse among U.S. adults. Design: Survey. Setting: The 2015 National Survey on Drug Use and Health (NSDUH). Participants: 72 600 eligible civilian, noninstitutionalized adults were selected for NSDUH, and 51 200 completed the survey interview. Measurements: Prescription opioid use, misuse, and use disorders. Results: Weighted NSDUH estimates suggested that, in 2015, 91.8 million (37.8%) U.S. civilian, noninstitutionalized adults used prescription opioids; 11.5 million (4.7%) misused them; and 1.9 million (0.8%) had a use disorder. Among adults with prescription opioid use, 12.5% reported misuse; of these, 16.7% reported a prescription opioid use disorder. The most commonly reported motivation for misuse was to relieve physical pain (63.4%). Misuse and use disorders were most commonly reported in adults who were uninsured, were unemployed, had low income, or had behavioral health problems. Among adults with misuse, 59.9% reported using opioids without a prescription, and 40.8% obtained prescription opioids for free from friends or relatives for their most recent episode of misuse. Limitation: Cross-sectional, self-reported data. Conclusion: More than one third of U.S. civilian, noninstitutionalized adults reported prescription opioid use in 2015, with substantial numbers reporting misuse and use disorders. Relief from physical pain was the most commonly reported motivation for misuse. Economic disadvantage and behavioral health problems may be associated with prescription opioid misuse. The results suggest a need to improve access to evidence-based pain management and to decrease excessive prescribing that may leave unused opioids available for potential misuse.	[Han, Beth] Subst Abuse & Mental Hlth Serv Adm, 5600 Fishers Lane,15E85C, Rockville, MD 20857 USA; [Crane, Elizabeth] Subst Abuse & Mental Hlth Serv Adm, 5600 Fishers Lane,15E89D, Rockville, MD 20857 USA; [Compton, Wilson M.; Blanco, Carlos] NIDA, NIH, 6001 Execut Blvd,MSC 9589, Bethesda, MD 20892 USA; [Lee, Jinhee] NIDA, NIH, 6001 Execut Blvd,Room 5219, Bethesda, MD 20892 USA; [Jones, Christopher M.] US Dept HHS, Off Sci & Data Policy, Assistant Secretary Planning & Evaluat, 200 Independence Ave SW,434E-2, Washington, DC 20201 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Compton, WM (corresponding author), NIDA, NIH, 6001 Execut Blvd,MSC 9589, Bethesda, MD 20892 USA.	Beth.Han@samhsa.hhs.gov; wcompton@nida.nih.gov	Blanco, Carlos/I-4906-2013	Blanco, Carlos/0000-0001-6187-3057	U.S. Department of Health and Human Services	U.S. Department of Health and Human Services	U.S. Department of Health and Human Services.	American Association for Public Opinion Research, 2015, STAND DEF FIN DISP C, V8th ed, P52; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; American Society of Addiction Medicine, 2016, C PASS CARAI ASAM AP; [Anonymous], 2017, CCENDU B CALL; Barth KS, 2013, AM J ADDICTION, V22, P486, DOI 10.1111/j.1521-0391.2013.12038.x; Bates C, 2011, J UROLOGY, V185, P551, DOI 10.1016/j.juro.2010.09.088; Baumblatt JAG, 2014, JAMA INTERN MED, V174, P796, DOI 10.1001/jamainternmed.2013.12711; Blanco C, 2016, AM J PSYCHIAT, V173, P1189, DOI 10.1176/appi.ajp.2016.15091179; Blanco C, 2013, DRUG ALCOHOL DEPEN, V133, P473, DOI 10.1016/j.drugalcdep.2013.07.011; Blanco C, 2013, DRUG ALCOHOL DEPEN, V131, P143, DOI 10.1016/j.drugalcdep.2012.12.013; Center for Behavioral Health Statistics and Quality, 2017, 2015 NAT SURV DRUG U; Chou R, 2014, 14E005EF AG HEALTHCA; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Compton WM, 2015, PREV MED, V80, P5, DOI 10.1016/j.ypmed.2015.04.003; Compton WM, 2010, AM J PSYCHIAT, V167, P473, DOI 10.1176/appi.ajp.2009.09081087; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Evans TI, 2017, J ADDICT MED; Ferguson KM, 2015, SOC SCI MED, V135, P47, DOI 10.1016/j.socscimed.2015.04.028; Grucza RA, 2007, ADDICTION, V102, P623, DOI 10.1111/j.1360-0443.2007.01745.x; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Harris K, 2013, JAMA DERMATOL, V149, P317, DOI 10.1001/jamadermatol.2013.1871; Hwang CS, 2016, AM J PREV MED, V51, P151, DOI 10.1016/j.amepre.2016.02.014; Inciardi James A, 2007, Law Enforc Exec Forum, V7, P127; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Jones CM, 2014, JAMA-J AM MED ASSOC, V312, P1733, DOI 10.1001/jama.2014.13480; Jones CM, 2014, JAMA INTERN MED, V174, P802, DOI 10.1001/jamainternmed.2013.12809; Jones CM, 2013, DRUG ALCOHOL DEPEN, V132, P95, DOI 10.1016/j.drugalcdep.2013.01.007; Jordan BK, 2008, ADDICT BEHAV, V33, P782, DOI 10.1016/j.addbeh.2007.12.007; Kelly BC, 2015, J SUBST ABUSE TREAT, V48, P49, DOI 10.1016/j.jsat.2014.07.005; Larochelle MR, 2016, ANN INTERN MED, V164, P1, DOI 10.7326/M15-0038; LeClair A, 2015, DRUG-EDUC PREV POLIC, V22, P208, DOI 10.3109/09687637.2015.1030355; Lipari R.N., 2016, PRESCRIPTION DRUG US; Martins SS, 2012, PSYCHOL MED, V42, P1261, DOI 10.1017/S0033291711002145; McCabe SE, 2012, J ADOLESCENT HEALTH, V51, P445, DOI 10.1016/j.jadohealth.2012.02.004; McCabe SE, 2009, ARCH PEDIAT ADOL MED, V163, P739, DOI 10.1001/archpediatrics.2009.120; McCabe SE, 2009, DRUG ALCOHOL DEPEN, V102, P63, DOI 10.1016/j.drugalcdep.2009.01.007; Patrick SW, 2016, HEALTH AFFAIR, V35, P1324, DOI 10.1377/hlthaff.2015.1496; Research Triangle Institute, 2015, SUDAAN COMP PROGR RE; Rigg KK, 2010, J SUBST ABUSE TREAT, V39, P236, DOI 10.1016/j.jsat.2010.06.004; RUBIN DB, 1986, J BUS ECON STAT, V4, P87, DOI 10.2307/1391390; Saloner B, 2016, HEALTH AFFAIR, V35, P1058, DOI 10.1377/hlthaff.2016.0005; Shiffman S, 2004, NICOTINE TOB RES, V6, P327, DOI 10.1080/1462220042000202481; Substance Abuse and Mental Health Services Administration, 2010, HHS PUBL, VSMA 09- 4425; Substance Abuse and Mental Health Services Administration, 2010, REL KEY MEAS NAT SUR, VM-8	46	582	583	0	82	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					293	+		10.7326/M17-0865	http://dx.doi.org/10.7326/M17-0865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF6LC	28761945				2022-12-28	WOS:000409120400003
J	Ullman, TA; Atreja, A				Ullman, Thomas A.; Atreja, Ashish			Building evidence for care beyond the medical centre	LANCET			English	Editorial Material									[Ullman, Thomas A.; Atreja, Ashish] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ullman, TA (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	thomas.ullman@mssm.edu		Atreja, Ashish/0000-0002-0628-4417	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097451] Funding Source: NIH RePORTER; NIDDK NIH HHS [K23 DK097451] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		de Jong MJ, 2017, LANCET; Hanlon Peter, 2017, J Med Internet Res, V19, pe172, DOI 10.2196/jmir.6688; Nakamura N, 2014, J TELEMED TELECARE, V20, P11, DOI 10.1177/1357633X13517352; Sonnier P., STORY DIGITAL HLTH D; Tildesley HD, 2015, MED CLIN N AM, V99, P17, DOI 10.1016/j.mcna.2014.08.019; van Beugen S, 2014, J MED INTERNET RES, V16, P251, DOI 10.2196/jmir.2777	6	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					919	920		10.1016/S0140-6736(17)31857-3	http://dx.doi.org/10.1016/S0140-6736(17)31857-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28716311				2022-12-28	WOS:000408746300006
J	Sommers, BD; Grabowski, DC				Sommers, Benjamin D.; Grabowski, David C.			What Is Medicaid? More Than Meets the Eye	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sommers, Benjamin D.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave,Kresge Room 406, Boston, MA 02115 USA; [Sommers, Benjamin D.] Brigham & Womens Hosp, 677 Huntington Ave,Kresge Room 406, Boston, MA 02115 USA; [Grabowski, David C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sommers, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave,Kresge Room 406, Boston, MA 02115 USA.; Sommers, BD (corresponding author), Brigham & Womens Hosp, 677 Huntington Ave,Kresge Room 406, Boston, MA 02115 USA.	bsommers@hsph.harvard.edu		Grabowski, David/0000-0003-2915-5770				Eiken Steve, 2011, MEDICAID EXPENDITURE; Grabowski DC, 2017, HEALTH AFFAIR, V36, P846, DOI 10.1377/hlthaff.2016.1082; Iglehart JK, 2015, NEW ENGL J MED, V372, P2152, DOI 10.1056/NEJMhpr1500791; Sommers BD, N ENGL J MED	4	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					695	696		10.1001/jama.2017.10304	http://dx.doi.org/10.1001/jama.2017.10304			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28715569				2022-12-28	WOS:000408095800013
J	Morgan, DJ; Malani, P; Diekema, DJ				Morgan, Daniel J.; Malani, Preeti; Diekema, Daniel J.			Diagnostic Stewardship-Leveraging the Laboratory to Improve Antimicrobial Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Morgan, Daniel J.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Morgan, Daniel J.] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA; [Malani, Preeti] Univ Michigan Hlth Syst, Div Infect Dis, Dept Internal Med, Ann Arbor, MI USA; [Diekema, Daniel J.] Univ Iowa, Dept Pathol, Carver Coll Med, Div Med Microbiol, Iowa City, IA 52242 USA; [Diekema, Daniel J.] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Infect Dis, Iowa City, IA 52242 USA	University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan; University of Iowa; University of Iowa	Morgan, DJ (corresponding author), 334,10 S Pine St, Baltimore, MD 21201 USA.	dmorgan@som.umaryland.edu		Diekema, Daniel/0000-0003-1273-0724	Centers for Disease Control and Prevention; National Institutes of Health; Agency for Healthcare Research and Quality; VA Health Services Research and Development Service; bioMerieux	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); VA Health Services Research and Development Service(US Department of Veterans Affairs); bioMerieux	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Morgan reported serving as coinvestigator on grants from the Centers for Disease Control and Prevention, National Institutes of Health, and Agency for Healthcare Research and Quality; a merit award from the VA Health Services Research and Development Service; travel expenses from the Infectious Diseases Society of America, American Society for Microbiology, Lown, and Society for Healthcare Epidemiology of America; and honoraria from Springer. Dr Diekema reported receiving research funding from bioMerieux. Dr Malani reported no disclosures.	McGlynn EA, 2015, JAMA-J AM MED ASSOC, V314, P2501, DOI 10.1001/jama.2015.13453; Messacar K, 2017, J CLIN MICROBIOL, V55, P715, DOI 10.1128/JCM.02264-16; Polage CR, 2015, JAMA INTERN MED, V175, P1792, DOI 10.1001/jamainternmed.2015.4114; Woods-Hill CZ, 2017, JAMA PEDIATR, V171, P157, DOI 10.1001/jamapediatrics.2016.3153	4	106	107	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					607	608		10.1001/jama.2017.8531	http://dx.doi.org/10.1001/jama.2017.8531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28759678				2022-12-28	WOS:000407616000010
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Is the NHS trying to help or bully social care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Davidoliver372@googlemail.com						Bunn J., 2017, HLTH SERV J, P23; Calkin S, 2017, HLTH SERV J, P6; Care Quality Commission, 2017, CQC COND 12 LOC SYST; Carter R., 2017, COMMUNITY CARE, P358; Department for Communities and Local Government, 2017, POL PAP ALL ADD FUND; Humphries R., 2016, SOCIAL CARE OLDER PE; Humphries R, 2017, ALLOCATING SOCIAL CA; King's Fund, 2017, SHORT HIST SOC CAR F; Local Government Association, 2017, COUNC RESP GOV RUL S; National Audit Office, 2016, HC18 SESS 2016 17; National Audit Office. Department of Health Department for Communities and Local Government and NHS England, 2017, HLTH SOC CAR INT; Oliver D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5195; Weatherley M., 2016, GUARDIAN; Wheeler C., 2017, TIMES	14	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2017	358								j3623	10.1136/bmj.j3623	http://dx.doi.org/10.1136/bmj.j3623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CE	28765107	Bronze, Green Published			2022-12-28	WOS:000407206600001
J	Moon, RY; Hauck, FR; Colson, ER; Kellams, AL; Geller, NL; Heeren, T; Kerr, SM; Drake, EE; Tanabe, K; McClain, M; Corwin, MJ				Moon, Rachel Y.; Hauck, Fern R.; Colson, Eve R.; Kellams, Ann L.; Geller, Nicole L.; Heeren, Timothy; Kerr, Stephen M.; Drake, Emily E.; Tanabe, Kawai; McClain, Mary; Corwin, Michael J.			The Effect of Nursing Quality Improvement and Mobile Health Interventions on Infant Sleep Practices A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEATH-SYNDROME; EDUCATIONAL INTERVENTION; CHILDREN PROGRAM; POSITION; SUDDEN; TRENDS; WOMEN; RISK; CARE; DECISIONS	IMPORTANCE Inadequate adherence to recommendations known to reduce the risk of sudden unexpected infant death has contributed to a slowing in the decline of these deaths. OBJECTIVE To assess the effectiveness of 2 interventions separately and combined to promote infant safe sleep practices compared with control interventions. DESIGN, SETTING, AND PARTICIPANTS Four-group cluster randomized clinical trial of mothers of healthy term newborns who were recruited between March 2015 and May 2016 at 16 US hospitals with more than 100 births annually. Data collection ended in October 2016. INTERVENTIONS All participants were beneficiaries of a nursing quality improvement campaign in infant safe sleep practices (intervention) or breastfeeding (control), and then received a 60-day mobile health program, in which mothers received frequent emails or text messages containing short videos with educational content about infant safe sleep practices (intervention) or breastfeeding (control) and queries about infant care practices. MAIN OUTCOMES AND MEASURES The primary outcome was maternal self-reported adherence to 4 infant safe sleep practices of sleep position (supine), sleep location (room sharing without bed sharing), soft bedding use (none), and pacifier use (any); data were collected by maternal survey when the infant was aged 60 to 240 days. RESULTS Of the 1600 mothers who were randomized to 1 of 4 groups (400 per group), 1263 completed the survey (78.9%). The mean (SD) maternal age was 28.1 years (5.8 years) and 32.8% of respondents were non-Hispanic white, 32.3% Hispanic, 27.2% non-Hispanic black, and 7.7% other race/ethnicity. The mean (SD) infant age was 11.2 weeks (4.4 weeks) and 51.2% were female. In the adjusted analyses, mothers receiving the safe sleep mobile health intervention had higher prevalence of placing their infants supine compared with mothers receiving the control mobile health intervention (89.1% vs 80.2%, respectively; adjusted risk difference, 8.9%[95% CI, 5.3%-11.7%]), room sharing without bed sharing (82.8% vs 70.4%; adjusted risk difference, 12.4%[95% CI, 9.3%-15.1%]), no soft bedding use (79.4% vs 67.6%; adjusted risk difference, 11.8%[95% CI, 8.1%-15.2%]), and any pacifier use (68.5% vs 59.8%; adjusted risk difference, 8.7%[95% CI, 3.9%-13.1%]). The independent effect of the nursing quality improvement intervention was not significant for all outcomes. Interactions between the 2 interventions were only significant for the supine sleep position. CONCLUSIONS AND RELEVANCE Among mothers of healthy term newborns, a mobile health intervention, but not a nursing quality improvement intervention, improved adherence to infant safe sleep practices compared with control interventions. Whether widespread implementation is feasible or if it reduces sudden and unexpected infant death rates remains to be studied.	[Moon, Rachel Y.; Kellams, Ann L.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Hauck, Fern R.; Tanabe, Kawai] Univ Virginia, Sch Med, Dept Family Med, Charlottesville, VA 22908 USA; [Colson, Eve R.] Yale Univ, Dept Pediat, New Haven, CT 06520 USA; [Geller, Nicole L.; Kerr, Stephen M.; McClain, Mary; Corwin, Michael J.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Heeren, Timothy] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Drake, Emily E.] Univ Virginia, Sch Nursing, Dept Family Community & Mental Hlth Syst, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; Yale University; Boston University; Boston University; University of Virginia	Moon, RY (corresponding author), Univ Virginia, Div Gen Pediat, Dept Pediat, POB 800386, Charlottesville, VA 22908 USA.	rym4z@virginia.edu	Drake, Emily/AAT-7282-2021	Drake, Emily/0000-0002-1395-2911; Corwin, Michael/0000-0002-6591-209X	National Institute of Child Health and Human Development [1R01HD072815-01]; CJ Foundation for SIDS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072815] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CJ Foundation for SIDS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by grant 1R01HD072815-01 from the National Institute of Child Health and Human Development and funding from the CJ Foundation for SIDS.	Bartick M, 2010, J HUM LACT, V26, P405, DOI 10.1177/0890334410379797; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; Colson ER, 2005, AMBUL PEDIATR, V5, P349, DOI 10.1367/A04-220R1.1; Colson ER, 2002, ARCH PEDIAT ADOL MED, V156, P717, DOI 10.1001/archpedi.156.7.717; Colson ER, 2006, PEDIATRICS, V118, pE243, DOI 10.1542/peds.2005-2517; Colson ER, 2013, JAMA PEDIATR, V167, P1032, DOI 10.1001/jamapediatrics.2013.2560; Colson ER, 2009, ARCH PEDIAT ADOL MED, V163, P1122, DOI 10.1001/archpediatrics.2009.234; Corwin MJ, 2003, PEDIATRICS, V111, P52, DOI 10.1542/peds.111.1.52; Degan Viviane V, 2004, J Dent Child (Chic), V71, P148; Eisenberg SR, 2015, PEDIATRICS, V136, pE315, DOI 10.1542/peds.2015-0551; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Hauck FR, 2008, PEDIATRICS, V122, pS113, DOI 10.1542/peds.2008-1315o; Hauck FR, 2015, J COMMUN HEALTH, V40, P457, DOI 10.1007/s10900-014-9957-0; Hauck FR, 2005, PEDIATRICS, V116, pE716, DOI 10.1542/peds.2004-2631; Hauck FR, 2002, PEDIATRICS, V110, P772, DOI 10.1542/peds.110.4.772; Haughton J, 2010, J HUM LACT, V26, P266, DOI 10.1177/0890334410365067; Hwang SS, 2016, MATERN CHILD HLTH J, V20, P1956, DOI 10.1007/s10995-016-2011-3; Joyner BL, 2016, J IMMIGR MINOR HEALT, V18, P402, DOI 10.1007/s10903-015-0206-0; Joyner BL, 2010, J NATL MED ASSOC, V102, P881, DOI 10.1016/S0027-9684(15)30706-9; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; MacGregor Elizabeth, 2010, Community Pract, V83, P30; Mathews A, 2016, J PEDIAT, V175, P79; Moon RY, 2008, PEDIATRICS, V122, P788, DOI 10.1542/peds.2007-3010; Moon RY, 2004, PEDIATRICS, V113, P542, DOI 10.1542/peds.113.3.542; Oden RP, 2010, J NATL MED ASSOC, V102, P870, DOI 10.1016/S0027-9684(15)30705-7; Perrine CG, 2012, PEDIATRICS, V130, P54, DOI 10.1542/peds.2011-3633; Philipp BL, 2001, PEDIATRICS, V108, P677, DOI 10.1542/peds.108.3.677; Rojjanasrirat W, 2010, J CLIN NURS, V19, P2014, DOI 10.1111/j.1365-2702.2009.03152.x; Shapiro-Mendoza CK, 2015, PEDIATRICS, V135, P10, DOI 10.1542/peds.2014-1793; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Issler RMS, 2009, BIRTH-ISS PERINAT C, V36, P115, DOI 10.1111/j.1523-536X.2009.00308.x; Smith LA, 2016, ACAD PEDIATR, V16, P540, DOI 10.1016/j.acap.2016.01.021; Viswanath K., 2008, HLTH BEHAV HLTH ED T; Whalen B, 2010, CURR OPIN PEDIATR, V22, P655, DOI 10.1097/MOP.0b013e32833c8996	34	36	38	3	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					351	359		10.1001/jama.2017.8982	http://dx.doi.org/10.1001/jama.2017.8982			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742913	Green Accepted			2022-12-28	WOS:000406296700015
J	Gibbons, A				Gibbons, Ann			ARCHAEOLOGY The first Australians arrived early	SCIENCE			English	News Item																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					238	239		10.1126/science.357.6348.238	http://dx.doi.org/10.1126/science.357.6348.238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729491				2022-12-28	WOS:000405901600015
J	Schwarze, ML; Taylor, LJ				Schwarze, Margaret L.; Taylor, Lauren J.			Managing Uncertainty - Harnessing the Power of Scenario Planning	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROGNOSIS		[Schwarze, Margaret L.; Taylor, Lauren J.] Univ Wisconsin, Dept Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Schwarze, ML (corresponding author), Univ Wisconsin, Dept Surg, Madison, WI 53706 USA.				NCI NIH HHS [T32 CA090217] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], HARVARD BUSINESS SEP; [Anonymous], HARVARD BUSINESS NOV; Levin TT, 2015, ONCOLOGY-NY, V29, P142; Russ AJ, 2005, CULT MED PSYCHIAT, V29, P103, DOI 10.1007/s11013-005-4625-6; Schwartz P., 1991, ART LONG VIEW	5	38	39	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					206	208		10.1056/NEJMp1704149	http://dx.doi.org/10.1056/NEJMp1704149			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA9PI	28723329	Green Accepted			2022-12-28	WOS:000405777600003
J	Lenzer, J				Lenzer, Jeanne			Big data's big bias: bringing noise and conflicts to US drug regulation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lenzer, Jeanne] BMJ, Hoboken, NJ 07030 USA		Lenzer, J (corresponding author), BMJ, Hoboken, NJ 07030 USA.	jlenzer@bmj.com						[Anonymous], 2007, NBC NEWS; [Anonymous], 2009, KAISER HLTH NEWS; [Anonymous], 2010, GUARDIAN; Austin PC, 2006, J CLIN EPIDEMIOL, V59, P964, DOI 10.1016/j.jclinepi.2006.01.012; Califf RM, 2017, FDA VOICE; FDA, 2015, PUBL M PRESCR DRUG U; FDA, 2016, UCM437973 FDA; FDA, 2014, FDA STUD MED PAT FIN; FDA Subcommittee on Science and Technology, 2007, FDA SCI MISS RISK; Finkelstein JB, 2008, J NATL CANCER I, V100, P296, DOI 10.1093/jnci/djn051; Golomb BA, 2007, DRUG SAFETY, V30, P669, DOI 10.2165/00002018-200730080-00003; Hanskamp-Sebregts M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011078; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Hemkens LG, 2016, CAN MED ASSOC J, V188, pE158, DOI 10.1503/cmaj.150653; Hemkens LG, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i493; Jefferson T., 2015, TRANSPARENCY OPAQUEN; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Keefe-Feldman M., 2012, NONPROFIT Q; Layton L., 2009, WASHINGTON POST; Lenzer J, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1339; Lenzer J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h658; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5535; Mailankody S, 2017, JAMA ONCOL, V3, P889, DOI 10.1001/jamaoncol.2016.5296; Moore T, 2015, DRUG SAFETY, V38, P601, DOI 10.1007/s40264-015-0305-9; Murff HJ, 2003, J BIOMED INFORM, V36, P131, DOI 10.1016/j.jbi.2003.08.003; Norris S., 2016, NONPROFITPRO; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Piller C, 2007, L A TIMES; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Sigal EV, 2017, STAT; Steering Committee, 2017, INN MED EV DEV SURV; Stergiopoulos S, 2016, DRUG SAFETY, V39, P1117, DOI 10.1007/s40264-016-0455-4; Union of Concerned Scientists, 2009, FDA MED DEV APPR BAS; Wennberg JE, 2014, HEALTH POLICY, V114, P1, DOI 10.1016/j.healthpol.2013.11.010; Yu KH, 2016, PAC S BIOCOMPUT, V358, P635; Zito JM, 2016, MED CARE, V55, P1045, DOI 10.1097/MLR.0000000000000647	36	0	1	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2017	358								j3275	10.1136/bmj.j3275	http://dx.doi.org/10.1136/bmj.j3275			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7JY	28720567				2022-12-28	WOS:000406318100002
J	Shah, SD; Cifu, AS				Shah, Sachin D.; Cifu, Adam S.			Management of Acute Diverticulitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shah, Sachin D.; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	acifu@medicine.bsd.uchicago.edu						Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Daniels L, 2017, BRIT J SURG, V104, P52, DOI 10.1002/bjs.10309; Daniels L, 2014, UNITED EUR GASTRO S1, V2, pA2; Feuerstein JD, 2016, MAYO CLIN PROC, V91, P1094, DOI 10.1016/j.mayocp.2016.03.012; Morris AM, 2014, JAMA-J AM MED ASSOC, V311, P287, DOI 10.1001/jama.2013.282025; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Stollman N, 2015, GASTROENTEROLOGY, V149, P1944, DOI 10.1053/j.gastro.2015.10.003; Strate LL, 2015, GASTROENTEROLOGY, V149, P1950, DOI 10.1053/j.gastro.2015.10.001; Sultan S, 2013, CLIN GASTROENTEROL H, V11, P329, DOI 10.1016/j.cgh.2013.02.001	9	12	12	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					291	292		10.1001/jama.2017.6373	http://dx.doi.org/10.1001/jama.2017.6373			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719679				2022-12-28	WOS:000405775000015
J	Giberson, M; Brassard, A				Giberson, Mariah; Brassard, Alain			Salt-and-Pepper Skin Changes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Giberson, Mariah; Brassard, Alain] Univ Alberta, Edmonton, AB, Canada	University of Alberta	Giberson, M (corresponding author), Univ Alberta, Edmonton, AB, Canada.	mgiberso@ualberta.ca							0	2	2	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					173	173		10.1056/NEJMicm1610737	http://dx.doi.org/10.1056/NEJMicm1610737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA2PC	28700851				2022-12-28	WOS:000405282300011
J	Piccolo, R; Juni, P; Windecker, S				Piccolo, Raffaele; Juni, Peter; Windecker, Stephan			Bioresorbable scaffolds: in search of event-free dissolution	LANCET			English	Editorial Material							CORONARY-ARTERY-DISEASE; VASCULAR SCAFFOLDS; NEW-GENERATION; PATIENT-LEVEL; STENTS; OUTCOMES; REVASCULARIZATION; METAANALYSIS		[Piccolo, Raffaele; Windecker, Stephan] Univ Bern, Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Juni, Peter] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Bern; University Hospital of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Windecker, S (corresponding author), Univ Bern, Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	Piccolo, Raffaele/U-4297-2017; Juni, Peter/Q-8700-2016; Piccolo, Raffaele/AAA-7871-2019	Juni, Peter/0000-0002-5985-0670; Piccolo, Raffaele/0000-0002-3124-9912	AstraZeneca; Biosensors International; Medicines Company for GLOBAL LEADERS [NCT01813435]; Biotronik for BIOSCIENCE [NCT01443104]; Eli Lilly; Medicines Company (GLOBAL LEADERS); Biotronik (BIOSCIENCE); St Jude Medical [NCT01132495]; Abbott; Absorb BVS; Biotronik; Boston Scientific; Bracco Pharmaceutical; Edwards Lifesciences; Medtronic; Terumo Inc; Daiichi Sankyo	AstraZeneca(AstraZeneca); Biosensors International; Medicines Company for GLOBAL LEADERS; Biotronik for BIOSCIENCE; Eli Lilly(Eli Lilly); Medicines Company (GLOBAL LEADERS); Biotronik (BIOSCIENCE); St Jude Medical(St. Jude Medical); Abbott(Abbott Laboratories); Absorb BVS; Biotronik; Boston Scientific(Boston Scientific); Bracco Pharmaceutical; Edwards Lifesciences; Medtronic(Medtronic); Terumo Inc; Daiichi Sankyo(Daiichi Sankyo Company Limited)	RP declares no competing interests. PJ has received grants, all related to percutaneous coronary intervention, to his institution from AstraZeneca, Biosensors International, and The Medicines Company for GLOBAL LEADERS (NCT01813435), from Biotronik for BIOSCIENCE (NCT01443104), from AstraZeneca and Eli Lilly for a prospective cohort study in acute coronary syndrome, and was an unpaid member of the steering group of trials funded by AstraZeneca, Biosensors International, and The Medicines Company (GLOBAL LEADERS), Biotronik (BIOSCIENCE), and St Jude Medical (Fame 2, NCT01132495). SW has received unrestricted grants to his institution from Abbott for research support (Xience [stents] and Absorb BVS [scaffolds]), Biotronik for research support (Orsiro [ stents]), Boston Scientific for research support (Lotus and Synergy [stents]), Bracco Pharmaceutical for research support (contrast material), Edwards Lifesciences for research support (Sapien), Medtronic for research support (Resolute [stents] and CoreValve), Terumo Inc for research support (Ultimaster [stents]), and St Jude Medical for research support (OCT catheters [percutaneous coronary intervention]), and has received personal fees from Boston Scientific and Daiichi Sankyo for lectures.	Ali ZA, 2017, LANCET; Byrne RA, 2015, EUR HEART J, V36, P2608, DOI 10.1093/eurheartj/ehv203; Cassese S, 2016, LANCET, V387, P537, DOI 10.1016/S0140-6736(15)00979-4; Foin N, 2015, EUROINTERVENTION, V10, P1139, DOI 10.4244/EIJY14M11_09; Head SJ, 2013, EUR HEART J, V34, P2510, DOI 10.1093/eurheartj/eht059; Kereiakes DJ, 2016, CIRCULATION, V134, P168, DOI 10.1161/CIRCULATIONAHA.116.021539; Piccolo R, 2015, JACC-CARDIOVASC INTE, V8, P1657, DOI 10.1016/j.jcin.2015.08.013; Piccolo R, 2015, LANCET, V386, P702, DOI 10.1016/S0140-6736(15)61220-X; Puricel S, 2016, J AM COLL CARDIOL, V67, P921, DOI 10.1016/j.jacc.2015.12.019; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Stone GW, 2016, LANCET, V387, P1277, DOI 10.1016/S0140-6736(15)01039-9; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Yamaji K, 2017, EUROINTERVENTION, V12, P1684, DOI 10.4244/EIJV12I14A277	14	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					720	722		10.1016/S0140-6736(17)31871-8	http://dx.doi.org/10.1016/S0140-6736(17)31871-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD9RD	28732814				2022-12-28	WOS:000407858900006
J	VanderWeele, TJ; Balboni, TA; Koh, HK				VanderWeele, Tyler J.; Balboni, Tracy A.; Koh, Howard K.			Health and Spirituality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RELIGIOUS SERVICE ATTENDANCE; ASSOCIATION; PHYSICIANS; MORTALITY; WOMEN; LIFE		[VanderWeele, Tyler J.; Koh, Howard K.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Balboni, Tracy A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Balboni, Tracy A.] Harvard Med Sch, Boston, MA USA; [Koh, Howard K.] Harvard Kennedy Sch, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University	Koh, HK (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	hkoh@hsph.harvard.edu	Balboni, Tracy/AAH-4490-2020		Templeton Foundation	Templeton Foundation	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr VanderWeele reported receiving grants from the Templeton Foundation. No other disclosures were reported.	Balboni MJ, 2013, J CLIN ONCOL, V31, P461, DOI 10.1200/JCO.2012.44.6443; Cohen R, 2016, PSYCHOSOM MED, V78, P122, DOI 10.1097/PSY.0000000000000274; Koenig HG, 2012, HDB RELIG HLTH; Li SS, 2016, JAMA INTERN MED, V176, P777, DOI 10.1001/jamainternmed.2016.1615; Puchalski CM, 2014, J PALLIAT MED, V17, P105, DOI [10.1089/jpm.2014.9427, 10.1089/jpm.2013.9458]; Swinton J., 2017, SPIRITUALITY RELIG C; VanderWeele TJ, 2016, JAMA PSYCHIAT, V73, P845, DOI 10.1001/jamapsychiatry.2016.1243; WHO, CONST WHO PRINC; Yoon JD, 2017, ACAD PSYCHIATR, V41, P167, DOI 10.1007/s40596-016-0487-1	9	77	81	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					519	520		10.1001/jama.2017.8136	http://dx.doi.org/10.1001/jama.2017.8136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28750127				2022-12-28	WOS:000407160100012
J	Goodman, CW; Brett, AS				Goodman, Christopher W.; Brett, Allan S.			Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goodman, Christopher W.; Brett, Allan S.] Univ South Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Goodman, CW (corresponding author), Univ South Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA.		Goodman, Christopher/AAJ-3784-2021	Goodman, Christopher/0000-0003-4863-6342				[Anonymous], 2017, MED US SPEND US REV; Dowell D, 2016, JAMA-J AM MED ASSOC, V2016, P1624, DOI DOI 10.1001/JAMA.2016.1464; Evoy KE, 2017, DRUGS, V77, P403, DOI 10.1007/s40265-017-0700-x; Mathieson S, 2017, NEW ENGL J MED, V376, P1111, DOI 10.1056/NEJMoa1614292; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008	5	183	184	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					411	414		10.1056/NEJMp1704633	http://dx.doi.org/10.1056/NEJMp1704633			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3NW	28767350	Bronze			2022-12-28	WOS:000406747100002
J	Frank, JW; Lovejoy, TI; Becker, WC; Morasco, BJ; Koenig, CJ; Hoffecker, L; Dischinger, HR; Dobscha, SK; Krebs, EE				Frank, Joseph W.; Lovejoy, Travis I.; Becker, William C.; Morasco, Benjamin J.; Koenig, Christopher J.; Hoffecker, Lilian; Dischinger, Hannah R.; Dobscha, Steven K.; Krebs, Erin E.			Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC NONCANCER PAIN; COGNITIVE-BEHAVIORAL THERAPY; PRIMARY-CARE; REHABILITATION PROGRAM; MINDFULNESS MEDITATION; ANALGESIC MEDICATION; COMPREHENSIVE PAIN; OPIATE REDUCTION; UNITED-STATES; WITHDRAWAL	Background: Expert guidelines recommend reducing or discontinuing long-term opioid therapy (LTOT) when risks outweigh benefits, but evidence on the effect of dose reduction on patient outcomes has not been systematically reviewed. Purpose: To synthesize studies of the effectiveness of strategies to reduce or discontinue LTOT and patient outcomes after dose reduction among adults prescribed LTOT for chronic pain. Data Sources: MEDLINE, EMBASE, PsycINFO, CINAHL, and the Cochrane Library from inception through April 2017; reference lists; and expert contacts. Study Selection: Original research published in English that addressed dose reduction or discontinuation of LTOT for chronic pain. Data Extraction: Two independent reviewers extracted data and assessed study quality using the U.S. Preventive Services Task Force quality rating criteria. All authors assessed evidence quality using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Prespecified patient outcomes were pain severity, function, quality of life, opioid withdrawal symptoms, substance use, and adverse events. Data Synthesis: Sixty-seven studies (11 randomized trials and 56 observational studies) examining 8 intervention categories, including interdisciplinary pain programs, buprenorphine-assisted dose reduction, and behavioral interventions, were found. Study quality was good for 3 studies, fair for 13 studies, and poor for 51 studies. Many studies reported dose reduction, but rates of opioid discontinuation ranged widely across interventions and the overall quality of evidence was very low. Among 40 studies examining patient outcomes after dose reduction (very low overall quality of evidence), improvement was reported in pain severity (8 of 8 fair-quality studies), function (5 of 5 fair-quality studies), and quality of life (3 of 3 fair-quality studies). Limitation: Heterogeneous interventions and outcome measures; poor-quality studies with uncontrolled designs. Conclusion: Very low quality evidence suggests that several types of interventions may be effective to reduce or discontinue LTOT and that pain, function, and quality of life may improve with opioid dose reduction.	[Frank, Joseph W.] VA Eastern Colorado Hlth Care Syst, 1055 Clermont St, Denver, CO 80220 USA; Univ Colorado, Sch Med, Aurora, CO USA; VA Portland Hlth Care Syst, Portland, OR USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Becker, William C.] VA Connecticut Healthcare Syst, 950 Campbell Ave,Mail Stop 151B, West Haven, CT 06516 USA; Yale Univ, Sch Med, New Haven, CT USA; San Francisco State Univ, San Francisco, CA 94132 USA; Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Lovejoy, Travis I.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, 3710 SW US Vet Hosp Rd,Mail Code R&D 66, Portland, OR 97239 USA; [Morasco, Benjamin J.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, 3710 SW US Vet Hosp Rd,Mail Code R&D 99, Portland, OR 97239 USA; [Koenig, Christopher J.] San Francisco State Univ, Dept Commun Studies, 1600 Holloway Ave,Humanities Bldg,Room 282, San Francisco, CA 94132 USA; [Hoffecker, Lilian] Univ Colorado, Hlth Sci Lib, 12950 East Montview Blvd,MS-A003, Aurora, CO 80045 USA; [Dischinger, Hannah R.] Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Dobscha, Steven K.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Krebs, Erin E.] Minneapolis Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, One Vet Dr, Minneapolis, MN 55417 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; California State University System; San Francisco State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; California State University System; San Francisco State University; University of Colorado System; University of Colorado Anschutz Medical Campus; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Frank, JW (corresponding author), VA Eastern Colorado Hlth Care Syst, 1055 Clermont St, Denver, CO 80220 USA.	joseph.frank@ucdenver.edu	Koenig, Christopher J./AAA-2831-2020	Hoffecker, Lilian/0000-0001-8277-2300; Koenig, Christopher J./0000-0003-0884-4120; Krebs, Erin/0000-0003-0843-7410	Veterans Health Administration [PROSPERO: CRD42015020347]; Veterans Affairs [IK2HX001516] Funding Source: NIH RePORTER	Veterans Health Administration(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Veterans Health Administration. (PROSPERO: CRD42015020347)	Bair MJ, 2015, JAMA INTERN MED, V175, P682, DOI 10.1001/jamainternmed.2015.97; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Baron Michael J, 2006, J Opioid Manag, V2, P277; Beaudoin Francesca L, 2016, J Opioid Manag, V12, P109, DOI 10.5055/jom.2016.0322; Berland DW, 2013, AM J THER, V20, P316, DOI 10.1097/MJT.0b013e31827ab599; Berna C, 2015, MAYO CLIN PROC, V90, P828, DOI 10.1016/j.mayocp.2015.04.003; Blondell RD, 2010, J ADDICT MED, V4, P140, DOI 10.1097/ADM.0b013e3181ba895d; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; BUCKLEY FP, 1986, PAIN, V26, P153, DOI 10.1016/0304-3959(86)90071-0; Caraway D, 2015, NEUROMODULATION, V18, P508, DOI 10.1111/ner.12318; Centers for Medicare & Medicaid Services, 2017, OP MIS STRAT 2016; Chen JH, 2016, JAMA INTERN MED, V176, P259, DOI 10.1001/jamainternmed.2015.6662; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Coffin PO, 2016, ANN INTERN MED, V165, P245, DOI 10.7326/M15-2771; Cowan DT, 2005, PAIN MED, V6, P113, DOI 10.1111/j.1526-4637.2005.05020.x; Cowan DT, 2003, PAIN MED, V4, P340, DOI 10.1111/j.1526-4637.2003.03038.x; Crisostomo RA, 2008, AM J PHYS MED REHAB, V87, P527, DOI 10.1097/PHM.0b013e31817c124f; Cunningham JL, 2016, PAIN MED, V17, P1676, DOI 10.1093/pm/pnv079; Daitch D, 2014, PAIN MED, V15, P2087, DOI 10.1111/pme.12520; Daitch J, 2012, PAIN PHYSICIAN, V15, pES59; Darchuk KM, 2010, PAIN MED, V11, P1352, DOI 10.1111/j.1526-4637.2010.00937.x; Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Dersh J, 2008, SPINE, V33, P2219, DOI 10.1097/BRS.0b013e31818096d1; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Drossman DA, 2012, AM J GASTROENTEROL, V107, P1426, DOI 10.1038/ajg.2012.142; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Frank JW, 2016, PAIN MED, V17, P1838, DOI 10.1093/pm/pnw078; Gomes T, 2013, JAMA INTERN MED, V173, P196, DOI 10.1001/2013.jamainternmed.733; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Hanson KA, 2009, INFLAMM BOWEL DIS, V15, P772, DOI 10.1002/ibd.20847; Harden P, 2015, PAIN MED, V16, P1975, DOI 10.1111/pme.12812; Haroutounian S, 2016, CLIN J PAIN, V32, P1036, DOI 10.1097/AJP.0000000000000364; Hassamal S, 2016, SCAND J PAIN, V13, P27, DOI 10.1016/j.sjpain.2016.06.007; Heapy AA, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0924-z; Heiwe S, 2011, EUR J PAIN, V15, P966, DOI 10.1016/j.ejpain.2011.03.006; Hooten WM, 2007, PAIN MED, V8, P624, DOI 10.1111/j.1526-4637.2006.00202.x; Hooten WM, 2007, PAIN MED, V8, P8, DOI 10.1111/j.1526-4637.2007.00253.x; Hooten WM, 2015, ADDICT BEHAV, V42, P69, DOI 10.1016/j.addbeh.2014.11.007; Hooten WM, 2010, PAIN MED, V11, P1587, DOI 10.1111/j.1526-4637.2010.00962.x; Hooten WM, 2009, ANESTH ANALG, V108, P308, DOI 10.1213/ane.0b013e31818c7b99; Huffman KL, 2017, PAIN, V158, P1380, DOI 10.1097/j.pain.0000000000000907; Huffman KL, 2013, PAIN MED, V14, P1908, DOI 10.1111/pme.12201; Ilgen MA, 2016, PAIN, V157, P1079, DOI 10.1097/j.pain.0000000000000484; Kapural L, 2010, PAIN PHYSICIAN, V13, P389; Kidner CL, 2009, J BONE JOINT SURG AM, V91A, P919, DOI 10.2106/JBJS.H.00286; KROENING RJ, 1985, INT J ADDICT, V20, P1347, DOI 10.3109/10826088509047771; Kroenke K, 2014, JAMA-J AM MED ASSOC, V312, P240, DOI 10.1001/jama.2014.7689; Krumova EK, 2013, CLIN J PAIN, V29, P760, DOI 10.1097/AJP.0b013e31827c7cf6; Lake AE, 2009, HEADACHE, V49, P555, DOI 10.1111/j.1526-4610.2009.01364.x; Larochelle MR, 2016, ANN INTERN MED, V164, P1, DOI 10.7326/M15-0038; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Levine AB, 2017, PAIN PHYSICIAN, V20, P95; Maani CV, 2011, J TRAUMA, V71, pS114, DOI 10.1097/TA.0b013e3182219209; MacLaren JE, 2006, CLIN J PAIN, V22, P392, DOI 10.1097/01.ajp.0000208250.15572.01; Malinoff Herbert L, 2005, Am J Ther, V12, P379, DOI 10.1097/01.mjt.0000160935.62883.ff; Marchetti F, 2015, EUR J PAIN, V19, P984, DOI 10.1002/ejp.624; Martin BC, 2011, J GEN INTERN MED, V26, P1450, DOI 10.1007/s11606-011-1771-0; Mehl-Madrona L, 2016, J ALTERN COMPLEM MED, V22, P621, DOI 10.1089/acm.2015.0212; Miller Norman S, 2006, Am J Ther, V13, P527, DOI 10.1097/01.mjt.0000212702.94495.25; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murphy JL, 2016, J REHABIL RES DEV, V53, P83, DOI 10.1682/JRRD.2014.10.0250; Murphy JL, 2013, CLIN J PAIN, V29, P109, DOI 10.1097/AJP.0b013e3182579935; Naylor MR, 2010, J PAIN, V11, P1410, DOI 10.1016/j.jpain.2010.03.019; Nilsen HK, 2010, ACTA ANAESTH SCAND, V54, P571, DOI 10.1111/j.1399-6576.2009.02164.x; Nissen LM, 2001, BRIT J CLIN PHARMACO, V52, P693, DOI 10.1046/j.0306-5251.2001.01502.x; Peterson K, 2016, 09199 VA ESP US DEP; Qaseem Amir, 2017, Ann Intern Med, V166, P514, DOI 10.7326/M16-2367; Quinlan J, 2012, PAIN MED, V13, P1524, DOI 10.1111/j.1526-4637.2012.01486.x; RALPHS JA, 1994, PAIN, V56, P279, DOI 10.1016/0304-3959(94)90166-X; Rome JD, 2004, MAYO CLIN PROC, V79, P759; Rosenblum Andrew, 2012, J Opioid Manag, V8, P369, DOI 10.5055/jom.2012.0137; Roux P, 2013, PAIN, V154, P1442, DOI 10.1016/j.pain.2013.05.004; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Scherrer JF, 2014, J GEN INTERN MED, V29, P491, DOI 10.1007/s11606-013-2648-1; Schneider Jennifer P, 2010, J Opioid Manag, V6, P385; Schwarzer A, 2015, PAIN, V156, P2167, DOI 10.1097/j.pain.0000000000000279; Smith VK, 2016, IMPLEMENTING COVERAG; Streltzer J, 2015, AM J ADDICTION, V24, P357, DOI 10.1111/ajad.12198; Sullivan MD, 2017, J PAIN, V18, P308, DOI 10.1016/j.jpain.2016.11.003; TAYLOR CB, 1980, PAIN, V8, P319, DOI 10.1016/0304-3959(80)90077-9; TENNANT FS, 1982, ARCH INTERN MED, V142, P1845, DOI 10.1001/archinte.142.10.1845; Thielke SM, 2014, CLIN J PAIN, V30, P93, DOI 10.1097/AJP.0b013e31828e361b; Thieme K, 2003, ARTHRIT RHEUM-ARTHR, V49, P314, DOI 10.1002/art.11124; Townsend CO, 2008, PAIN, V140, P177, DOI 10.1016/j.pain.2008.08.005; Vanderlip ER, 2014, PAIN, V155, P2673, DOI 10.1016/j.pain.2014.09.034; Vines S W, 1996, Rehabil Nurs, V21, P25; Wang HL, 2011, PAIN MED, V12, P1720, DOI 10.1111/j.1526-4637.2011.01276.x; Washington State Agency Medical Directors' Group, 2015, OP DOS CALC VERS 2 0; Webster L, 2016, PAIN MED; Weimer MB, 2016, SUBST ABUS, V37, P141, DOI 10.1080/08897077.2015.1129526; Whitten SK, 2013, J AM ASSOC NURSE PRA, V25, P368, DOI 10.1111/j.1745-7599.2012.00800.x; Williams ACD, 1996, PAIN, V66, P13, DOI 10.1016/0304-3959(96)02996-X; Williams DR, 2003, CEPHALALGIA, V23, P963, DOI 10.1046/j.1468-2982.2003.00623.x; Windmill J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010323.pub2; Younger J, 2008, PAIN MED, V9, P1158, DOI 10.1111/j.1526-4637.2008.00475.x; Zekry O, 2016, J PAIN PALLIAT CARE, V30, P91, DOI 10.3109/15360288.2016.1161690; Zgierska AE, 2016, PAIN MED, V17, P1865, DOI 10.1093/pm/pnw006; Zgierska AE, 2016, J ALTERN COMPLEM MED, V22, P610, DOI 10.1089/acm.2015.0314; Zheng Z, 2008, EUR J PAIN, V12, P671, DOI 10.1016/j.ejpain.2007.10.003	102	197	198	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					181	+		10.7326/M17-0598	http://dx.doi.org/10.7326/M17-0598			29	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC1XN	28715848				2022-12-28	WOS:000406631400008
J	Kazazian, HH; Moran, JV				Kazazian, Haig H., Jr.; Moran, John V.			Mobile DNA in Health and Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INDEPENDENT LINE-1 RETROTRANSPOSITION; SOMATIC L1 RETROTRANSPOSITION; PRIMED REVERSE TRANSCRIPTION; EMBRYONIC STEM-CELLS; ENDOGENOUS RETROVIRUSES; HUMAN GENOME; TRANSPOSABLE ELEMENTS; SVA RETROTRANSPOSON; COLORECTAL-CANCER; HUMAN BRAIN		[Kazazian, Haig H., Jr.] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Johns Hopkins University; Johns Hopkins Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kazazian, HH (corresponding author), Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA.; Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA.; Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA.	hkazazi1@jhmi.edu; moranj@umich.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107632, R01GM099875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106892] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM107632, R01 GM099875] Funding Source: Medline; NIMH NIH HHS [U01 MH106892] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Bundo M, 2014, NEURON, V81, P306, DOI 10.1016/j.neuron.2013.10.053; Buzdin A, 2002, GENOMICS, V80, P402, DOI 10.1006/geno.2002.6843; Christensen SM, 2005, MOL CELL BIOL, V25, P6617, DOI 10.1128/MCB.25.15.6617-6628.2005; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Craig NL, 2015, MOBILE DNA 3, V3rd; de Boer M, 2014, HUM MUTAT, V35, P486, DOI 10.1002/humu.22519; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; Doucet-O'Hare TT, 2016, HUM MUTAT, V37, P942, DOI 10.1002/humu.23027; Doucet-O'Hare TT, 2015, P NATL ACAD SCI USA, V112, pE4894, DOI 10.1073/pnas.1502474112; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2015, GENOME RES, V25, P1536, DOI 10.1101/gr.196238.115; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Garcia-Perez JL, 2007, GENOME RES, V17, P602, DOI 10.1101/gr.5870107; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Goodier JL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005252; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Hancks DC, 2011, HUM MOL GENET, V20, P3386, DOI 10.1093/hmg/ddr245; Helman E, 2014, GENOME RES, V24, P1053, DOI 10.1101/gr.163659.113; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Hu SQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005367; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Huang SF, 2016, CELL, V166, P102, DOI 10.1016/j.cell.2016.05.032; Hulme AE, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P35, DOI 10.1007/978-1-59745-039-3_3; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Konkel MK, 2010, SEMIN CANCER BIOL, V20, P211, DOI 10.1016/j.semcancer.2010.03.001; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Mager DL, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0009-2014; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MIKI Y, 1992, CANCER RES, V52, P643; Mine M, 2007, HUM MUTAT, V28, P137, DOI 10.1002/humu.20449; Moldovan JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005121; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morisada N, 2010, PEDIATR NEPHROL, V25, P1343, DOI 10.1007/s00467-010-1445-x; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; National Human Genome Research Institute, 2015, CATALOG PUBLISHED GE; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Pitkanen E, 2014, ONCOTARGET, V5, P853, DOI 10.18632/oncotarget.1781; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Richardson SR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0061-2014; Richardson SR, 2014, ANNU REV GENET, V48, P1, DOI 10.1146/annurev-genet-120213-092412; Rodic N, 2015, NAT MED, V21, P1060, DOI 10.1038/nm.3919; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Scott EC, 2016, GENOME RES, V26, P745, DOI 10.1101/gr.201814.115; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Trono D, 2015, COLD SH Q B, V80, P281, DOI 10.1101/sqb.2015.80.027573; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Vogt J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r80; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weiss RA, 2016, APMIS, V124, P4, DOI 10.1111/apm.12476; Wimmer K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002371; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wolf G, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0050-8; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114	100	182	182	3	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					361	370		10.1056/NEJMra1510092	http://dx.doi.org/10.1056/NEJMra1510092			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28745987	Green Accepted			2022-12-28	WOS:000406295000008
J	Manguso, RT; Pope, HW; Zimmer, MD; Brown, FD; Yates, KB; Miller, BC; Collins, NB; Bi, K; Lafleur, MW; Juneja, VR; Weiss, SA; Lo, J; Fisher, DE; Miao, D; Van Allen, E; Root, DE; Sharpe, AH; Doench, JG; Haining, WN				Manguso, Robert T.; Pope, Hans W.; Zimmer, Margaret D.; Brown, Flavian D.; Yates, Kathleen B.; Miller, Brian C.; Collins, Natalie B.; Bi, Kevin; Lafleur, Martin W.; Juneja, Vikram R.; Weiss, Sarah A.; Lo, Jennifer; Fisher, David E.; Miao, Diana; Van Allen, Eliezer; Root, David E.; Sharpe, Arlene H.; Doench, John G.; Haining, W. Nicholas			In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target	NATURE			English	Article							HLA-E; GENE; EXPRESSION; BLOCKADE; CELLS; CD94/NKG2A; PD-1	Immunotherapy with PD-1 checkpoint blockade is effective in only a minority of patients with cancer, suggesting that additional treatment strategies are needed. Here we use a pooled in vivo genetic screening approach using CRISPR-Cas9 genome editing in transplantable tumours in mice treated with immunotherapy to discover previously undescribed immunotherapy targets. We tested 2,368 genes expressed by melanoma cells to identify those that synergize with or cause resistance to checkpoint blockade. We recovered the known immune evasion molecules PD-L1 and CD47, and confirmed that defects in interferon-gamma signalling caused resistance to immunotherapy. Tumours were sensitized to immunotherapy by deletion of genes involved in several diverse pathways, including NF-kappa B signalling, antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by enhancing interferon-gamma-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways.	[Manguso, Robert T.; Pope, Hans W.; Zimmer, Margaret D.; Brown, Flavian D.; Yates, Kathleen B.; Miller, Brian C.; Collins, Natalie B.; Bi, Kevin; Lafleur, Martin W.; Weiss, Sarah A.; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Manguso, Robert T.; Brown, Flavian D.; Lafleur, Martin W.; Miao, Diana; Van Allen, Eliezer] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Manguso, Robert T.; Pope, Hans W.; Zimmer, Margaret D.; Yates, Kathleen B.; Miller, Brian C.; Collins, Natalie B.; Bi, Kevin; Miao, Diana; Van Allen, Eliezer; Root, David E.; Doench, John G.; Haining, W. Nicholas] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Miller, Brian C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Collins, Natalie B.; Sharpe, Arlene H.; Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Juneja, Vikram R.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Lo, Jennifer; Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA; [Lo, Jennifer; Fisher, David E.] Harvard Med Sch, Bldg 149,13th St, Charlestown, MA 02129 USA; [Sharpe, Arlene H.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Haining, WN (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Haining, WN (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.; Haining, WN (corresponding author), Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	Nicholas_Haining@dfci.harvard.edu	Doench, John G/HCI-9570-2022; Fisher, David/AAH-2878-2019; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; /0000-0002-9520-6874; Zimmer, Margaret/0000-0002-3317-6569; Miller, Brian/0000-0001-5931-4184	Broad Institute of Harvard; MIT; NIGMS [T32GM007753]; NATIONAL CANCER INSTITUTE [T32CA207021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Broad Institute of Harvard; MIT; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by BroadIgnite and BroadNext10 awards from the Broad Institute of Harvard and MIT. S.A.W. was supported by award number T32GM007753 from the NIGMS. We thank members of the Haining laboratory for their spirited discussions.	Benevolo M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-184; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dranoff G, 2003, ONCOGENE, V22, P3188, DOI 10.1038/sj.onc.1206459; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Howard TP, 2016, COLD SH Q B, V81, P237, DOI 10.1101/sqb.2016.81.031070; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Morandi F, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00394; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pike KA, 2016, CYTOKINE, V82, P52, DOI 10.1016/j.cyto.2015.12.025; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Saez-Borderias A, 2009, J IMMUNOL, V182, P829, DOI 10.4049/jimmunol.182.2.829; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Wada H, 2004, EUR J IMMUNOL, V34, P81, DOI 10.1002/eji.200324432; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yazdi MT, 2016, ONCOTARGET, V7, P3467; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	35	529	558	18	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					413	+		10.1038/nature23270	http://dx.doi.org/10.1038/nature23270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28723893	Green Accepted			2022-12-28	WOS:000406358300027
J	Zhou, XE; He, YZ; de Waal, PW; Gao, X; Kang, YY; Van Eps, N; Yin, YT; Pal, K; Goswami, D; White, TA; Barty, A; Latorraca, NR; Chapman, HN; Hubbell, WL; Dror, RO; Stevens, RC; Cherezov, V; Gurevich, VV; Griffin, PR; Ernst, OP; Melcher, K; Xu, HE				Zhou, X. Edward; He, Yuanzheng; de Waal, Parker W.; Gao, Xiang; Kang, Yanyong; Van Eps, Ned; Yin, Yanting; Pal, Kuntal; Goswami, Devrishi; White, Thomas A.; Barty, Anton; Latorraca, Naomi R.; Chapman, Henry N.; Hubbell, Wayne L.; Dror, Ron O.; Stevens, Raymond C.; Cherezov, Vadim; Gurevich, Vsevolod V.; Griffin, Patrick R.; Ernst, Oliver P.; Melcher, Karsten; Xu, H. Eric			Identification of Phosphorylation Codes for Arrestin Recruitment by G Protein-Coupled Receptors	CELL			English	Article							BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; 7-TRANSMEMBRANE RECEPTORS; VISUAL ARRESTIN; DOWN-REGULATION; C-TERMINUS; MECHANISM; BINDING	G protein-coupled receptors (GPCRs) mediate diverse signaling in part through interaction with arrestins, whose binding promotes receptor internalization and signaling through G protein-independent pathways. High-affinity arrestin binding requires receptor phosphorylation, often at the receptor's C-terminal tail. Here, we report an X-ray free electron laser (XFEL) crystal structure of the rhodopsin-arrestin complex, in which the phosphorylated C terminus of rhodopsin forms an extended intermolecular b sheet with the N-terminal b strands of arrestin. Phosphorylation was detected at rhodopsin C-terminal tail residues T336 and S338. These two phosphoresidues, together with E341, form an extensive network of electrostatic interactions with three positively charged pockets in arrestin in a mode that resembles binding of the phosphorylated vasopressin-2 receptor tail to beta-arrestin-1. Based on these observations, we derived and validated a set of phosphorylation codes that serve as a common mechanism for phosphorylation-dependent recruitment of arrestins by GPCRs.	[Zhou, X. Edward; Yin, Yanting; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Zhou, X. Edward; He, Yuanzheng; de Waal, Parker W.; Gao, Xiang; Kang, Yanyong; Yin, Yanting; Pal, Kuntal; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Van Eps, Ned; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Florida, Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [White, Thomas A.; Barty, Anton; Chapman, Henry N.] Deutsch Elekt Synchrotron DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Latorraca, Naomi R.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Latorraca, Naomi R.; Dror, Ron O.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Latorraca, Naomi R.; Dror, Ron O.] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Latorraca, Naomi R.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Latorraca, Naomi R.; Dror, Ron O.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Chapman, Henry N.] Ctr Ultrafast Imaging, D-22761 Hamburg, Germany; [Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Stevens, Raymond C.; Cherezov, Vadim] Univ Southern Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, 2F Bldg 6,99 Haike Rd, Shanghai 201210, Peoples R China; [Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; University of Toronto; Scripps Research Institute; State University System of Florida; University of Florida; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California; ShanghaiTech University; Vanderbilt University; University of Toronto	Xu, HE (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China.; Xu, HE (corresponding author), Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA.	eric.xu@vai.org	Barty, Anton/K-5137-2014; Gurevich, Vsevolod/A-3236-2008; Cherezov, Vadim/L-9812-2013; sarkar, sabyasachi/A-9896-2010; Xu, H. Eric/ABD-7487-2021; Pal, Kuntal/W-6348-2019; Melcher, Karsten/AAZ-3861-2020; Cote, Rick H/G-3363-2013; Stevens, Raymond/K-7272-2015; FRS, Henry N Chapman/G-2153-2010; de Waal, Parker/M-1138-2017	Barty, Anton/0000-0003-4751-2727; Gurevich, Vsevolod/0000-0002-3950-5351; Cherezov, Vadim/0000-0002-5265-3914; sarkar, sabyasachi/0000-0002-8954-4375; Melcher, Karsten/0000-0002-9125-4027; Cote, Rick H/0000-0002-1573-6526; Stevens, Raymond/0000-0002-4522-8725; FRS, Henry N Chapman/0000-0002-4655-1743; Xu, H. Eric/0000-0002-6829-8144; He, Yuanzheng/0000-0001-9131-140X; PAL, KUNTAL/0000-0001-7094-2456; Van Eps, Ned/0000-0001-9178-1436; Yin, Yanting/0000-0001-9310-1094; de Waal, Parker/0000-0001-6922-9768; Dror, Ron/0000-0002-6418-2793	NIH [DK071662, R01 GM108635, RO1 EY011500, R35 GM122491, RO1 EY005216]; American Asthma Foundation; Jay and Betty Van Andel Foundation; Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Canada Excellence Research Chairs program; Canadian Institute for Advanced Research; Anne and Max Tanenbaum Chair in Neuroscience; Jules Stein Professorship Endowment; David Van Andel Advanced Electron Microscopy Core Facility; NSF Science and Technology Center [1231306]; NATIONAL EYE INSTITUTE [R01EY005216, R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662, R01DK066202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109955, R01GM087413, R01GM108635, T32GM008294, R35GM122491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Jay and Betty Van Andel Foundation; Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Canada Excellence Research Chairs program(Canada Research Chairs); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Anne and Max Tanenbaum Chair in Neuroscience; Jules Stein Professorship Endowment; David Van Andel Advanced Electron Microscopy Core Facility; NSF Science and Technology Center(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH (DK071662), the American Asthma Foundation, the Jay and Betty Van Andel Foundation, and the Ministry of Science and Technology (China) (2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001) to H.E.X., the Canada Excellence Research Chairs program, the Canadian Institute for Advanced Research, and the Anne and Max Tanenbaum Chair in Neuroscience to O.P.E., NIH (R01 GM108635) to V.C., NIH (RO1 EY011500 and R35 GM122491) to V.V.G., NIH (RO1 EY005216) and the Jules Stein Professorship Endowment to W.L.H., and the David Van Andel Advanced Electron Microscopy Core Facility. The original XFEL data were collected at the Linac Coherent Light Source at SLAC National Laboratory and was assisted by Sebastien Boutet, Garth Williams, and members of the Petra Fromme, Uwe Weierstall, and John Spence groups from Arizona State University, which are funded in part by the NSF Science and Technology Center (award 1231306 to John Spence, Petra Fromme, and Uwe Weierstall). All computation was performed on the Van Andel Research Institute compute cluster. We thank Dr. Qingping Xu for assistance with structure validation.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Fernandez-Arenas E, 2014, EMBO J, V33, P559, DOI 10.1002/embj.201386022; Fleissner MR, 2009, PROTEIN SCI, V18, P893, DOI 10.1002/pro.96; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; Hebda JK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-37; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ostermaier MK, 2014, CURR OPIN STRUC BIOL, V29, P143, DOI 10.1016/j.sbi.2014.07.006; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Por ED, 2013, BIOCHEM J, V451, P101, DOI 10.1042/BJ20121637; Por ED, 2012, J BIOL CHEM, V287, P37552, DOI 10.1074/jbc.M112.391847; R Core Team, 2000, R LANG DEF R FDN STA; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; West GM, 2013, STRUCTURE, V21, P229, DOI 10.1016/j.str.2012.12.001; White TA, 2016, J APPL CRYSTALLOGR, V49, P680, DOI 10.1107/S1600576716004751; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xiao K., 2007, P NATL ACAD; Yang F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9202; Yang Z., 2017, MOL PHARM; Yu MC, 2008, NAT IMMUNOL, V9, P898, DOI 10.1038/ni.1635; Zhou XE, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.21; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	61	234	239	4	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					457	+		10.1016/j.cell.2017.07.002	http://dx.doi.org/10.1016/j.cell.2017.07.002			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753425	Green Accepted, Bronze			2022-12-28	WOS:000406462400006
J	Moberly, T				Moberly, Tom			"Going the extra mile" endangers doctors, patients, and NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moberly, Tom] BMJ, London, England		Moberly, T (corresponding author), BMJ, London, England.	tmoberly@bmj.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j3547	10.1136/bmj.j3547	http://dx.doi.org/10.1136/bmj.j3547			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UW	28747312				2022-12-28	WOS:000406765900009
J	Hise, JH				Hise, Joseph Henry			And Then Came the PACS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hise, Joseph Henry] Baylor Univ, Med Ctr, Amer Radiol Associates, Dallas, TX USA	Baylor University; Baylor University Medical Center	Hise, JH (corresponding author), Baylor Univ, Med Ctr, Radiol, 3500 Gaston Ave, Dallas, TX 75246 USA.	jhise@americanrad.com							0	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					331	331		10.1001/jama.2017.5991	http://dx.doi.org/10.1001/jama.2017.5991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742916				2022-12-28	WOS:000406296700009
J	Hanefeld, J; Khan, M; Tomson, G; Smith, R				Hanefeld, Johanna; Khan, Mishal; Tomson, Goran; Smith, Richard			ACCELERATING ACTION ON SUSTAINABLE DEVELOPMENT GOALS Trade is central to achieving the sustainable development goals: a case study of antimicrobial resistance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLIC-HEALTH; POLITICAL ORIGINS; POLICY; GLOBALIZATION; GENERATION; THAILAND; OBESITY; IMPACT		[Hanefeld, Johanna] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Hlth Policy & Syst, London, England; [Khan, Mishal] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Hlth Policy & Syst Res, London, England; [Smith, Richard] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Hlth Econ & Syst, London, England; [Tomson, Goran] Karolinska Inst, Publ Hlth Global Hlth IHCAR, Global Hlth, Stockholm, Sweden; [Tomson, Goran] SIGHT, Global Hlth, Stockholm, Sweden	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Karolinska Institutet; Royal Swedish Academy of Sciences	Hanefeld, J (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Hlth Policy & Syst, London, England.	Johanna.Hanefeld@lshtm.ac.uk			ESRC [ES/P003842/1] Funding Source: UKRI; Economic and Social Research Council [ES/P003842/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Aginam O., 2010, GLOBAL HLTH GOVERNAN; Alexander TW, 2010, INT J FOOD MICROBIOL, V137, P40, DOI 10.1016/j.ijfoodmicro.2009.11.008; Arroyo P, 2012, INT J OCCUP ENV HEAL, V18, P348, DOI 10.1179/2049396712Y.0000000003; Bureau JC, 1998, EUR REV AGRIC ECON, V25, P437, DOI 10.1093/erae/25.4.437; Clark SE, 2012, INT J OCCUP ENV HEAL, V18, P53, DOI 10.1179/1077352512Z.0000000007; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; Founou LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01881; Friel S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-46; Gleeson D, 2013, LANCET, V381, P1507, DOI 10.1016/S0140-6736(13)60312-8; Gleeson DH, 2012, MED J AUSTRALIA, V196, P354, DOI 10.5694/mja11.11635; Gray A, 2013, NEW POLITICAL EC PHA, DOI [10.1057/9781137315854_10, DOI 10.1057/9781137315854_10]; Hanefeld J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000099; Hanefeld J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070406; Hanefeld Johanna, 2015, GLOBALISATION HLTH; Hawkes Corinna, 2009, GLOBALIZATION HLTH P, P235; Holmes Alison H, 2016, Lancet, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Jarman H, 2014, EUR J PUBLIC HEALTH, V24, P181, DOI 10.1093/eurpub/ckt201; Jha A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i409; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-7; Labonte R, 2011, ANNU REV PUBL HEALTH, V32, P263, DOI 10.1146/annurev-publhealth-031210-101225; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Mackey TK, 2011, J PHARM SCI-US, V100, P4571, DOI 10.1002/jps.22679; MCCARTHY M, 2017, BMJ-BRIT MED J, V358, P87536, DOI DOI 10.1136/BMJ.J3044; McGrady B, 2007, TOB CONTROL, V16, P280, DOI 10.1136/tc.2006.019141; McNeill D, 2017, LANCET, V389, P760, DOI 10.1016/S0140-6736(16)31013-3; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; Noree T, 2016, B WORLD HEALTH ORGAN, V94, P30, DOI 10.2471/BLT.14.152165; O'Neill A., 2016, REV ANTIMICROBIAL RE; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Saliba V, 2012, INT J MED INFORM, V81, P793, DOI 10.1016/j.ijmedinf.2012.08.003; Smith RD, 2009, LANCET, V373, P768, DOI 10.1016/S0140-6736(08)61780-8; Smith RD, 2009, LANCET, V373, P593, DOI 10.1016/S0140-6736(08)61778-X; Stiglitz JE, 2009, LANCET, V373, P363, DOI 10.1016/S0140-6736(08)61772-9; Sugden R, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.187, 10.1038/nmicrobiol.2016.187]; Swedish Government, 2017, SWED 2030 AG REP UN; 't Hoen E, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-15; Thaiprayoon S, 2015, HEALTH POLICY PLANN, V30, P1118, DOI 10.1093/heapol/czu117; Thow AM, 2017, HEALTH PROMOT INT, DOI [10.1093/heapro/daw109pmid:28082373, DOI 10.1093/HEAPRO/DAW109PMID:28082373]; Thow AM, 2015, HEALTH POLICY, V119, P88, DOI 10.1016/j.healthpol.2014.08.002; Thow AM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-249; US Department of Agriculture, 2017, LIV POULTR WORLD MAR; Walls HL, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0099-7; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; WTO, 2017, WTO SUST DEV GOALS	47	8	8	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2017	358								j3505	10.1136/bmj.j3505	http://dx.doi.org/10.1136/bmj.j3505			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3US	28739673	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000406765500001
J	Alba, AC; Guyatt, G				Alba, Ana Carolina; Guyatt, Gordon			In patients receiving DAPT after coronary stents, the PRECISE-DAPT score predicted bleeding moderately well	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Alba, Ana Carolina] Univ Hlth Network, Toronto, ON, Canada; [Guyatt, Gordon] McMaster Univ, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University	Alba, AC (corresponding author), Univ Hlth Network, Toronto, ON, Canada.			Alba, Ana/0000-0003-2744-2696				Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117	1	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC11	JC11		10.7326/ACPJC-2017-167-2-011	http://dx.doi.org/10.7326/ACPJC-2017-167-2-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715833				2022-12-28	WOS:000405573400012
J	Friedrich, MJ				Friedrich, M. J.			Health Care Attacks Continue in 23 Countries Around the World	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					231	231		10.1001/jama.2017.8323	http://dx.doi.org/10.1001/jama.2017.8323			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719699				2022-12-28	WOS:000405775000003
J	Levine, M				Levine, Mitchell			Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Levine, Mitchell] McMaster Univ, Hamilton, ON, Canada	McMaster University	Levine, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.	michael2@clalit.org.il						Serebruany VL, 2015, THROMB HAEMOSTASIS, V114, P1104, DOI 10.1160/TH15-01-0077	1	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC10	JC10		10.7326/ACPJC-2017-167-2-010	http://dx.doi.org/10.7326/ACPJC-2017-167-2-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715832				2022-12-28	WOS:000405573400011
J	Barry, DM; Yu, YQ; Hao, Y; Liu, XT; Chen, ZF				Barry, Devin M.; Yu, Yao-Qing; Hao, Yan; Liu, Xue-Ting; Chen, Zhou-Feng			Response to Comment on "Molecular and neural basis of contagious itch behavior in mice"	SCIENCE			English	Editorial Material							SENSATION	Liljencrantz et al. report the failure of observing contagious itch behavior using mice injected with histamine as the demonstrators. Analysis of their results shows that the histamine model is limited by inadequate frequency and duration of scratching bouts required for contagious itch test. To streamline the contagious itch test, the screen paradigm is highly recommended.	[Barry, Devin M.; Yu, Yao-Qing; Hao, Yan; Liu, Xue-Ting; Chen, Zhou-Feng] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA; [Barry, Devin M.; Yu, Yao-Qing; Hao, Yan; Liu, Xue-Ting; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Yu, Yao-Qing] Fourth Mil Med Univ, Tangdu Hosp, Inst Biomed Sci Pain, Xian 710038, Shaanxi, Peoples R China; [Hao, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat, Wuhan 430030, Hubei, Peoples R China; [Liu, Xue-Ting] Guangzhou Med Univ, Affiliated Hosp 2, State Key Lab Resp Dis, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou 510260, Guangdong, Peoples R China	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Air Force Military Medical University; Huazhong University of Science & Technology; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chen, ZF (corresponding author), Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA.; Chen, ZF (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Chen, ZF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.; Chen, ZF (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	chenz@wustl.edu	Liu, Xueting/GPP-2573-2022; Yu, Yao-Qing/D-6163-2017	Liu, Xueting/0000-0001-5419-198X; Barry, Devin/0000-0002-3140-6121; Yu, Yao-Qing/0000-0002-8047-9714	NIH-NIDA T32 training grant [5T32DA007261-23]; NIH [1R01AR056318-06]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261] Funding Source: NIH RePORTER	NIH-NIDA T32 training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Munanairi for the histamine scratching behavior data and J. Yin for technical support. This work was supported by NIH-NIDA T32 training grant 5T32DA007261-23 and by NIH grant 1R01AR056318-06.	Liljencrantz J, 2017, SCIENCE, V357, DOI 10.1126/science.aan4749; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Yu YQ, 2017, SCIENCE, V355, DOI 10.1126/science.aak9748; Zhao ZQ, 2013, J CLIN INVEST, V123, P4769, DOI 10.1172/JCI70528	5	6	6	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI				eaan5000	10.1126/science.aan5000	http://dx.doi.org/10.1126/science.aan5000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706014				2022-12-28	WOS:000405391700002
J	Chen, BB; Xu, HR; Ma, C; Mattauch, S; Lan, D; Jin, F; Guo, Z; Wan, SY; Chen, PF; Gao, GY; Chen, F; Su, YX; Wu, WB				Chen, Binbin; Xu, Haoran; Ma, Chao; Mattauch, Stefan; Lan, Da; Jin, Feng; Guo, Zhuang; Wan, Siyuan; Chen, Pingfan; Gao, Guanyin; Chen, Feng; Su, Yixi; Wu, Wenbin			All-oxide-based synthetic antiferromagnets exhibiting layer-resolved magnetization reversal	SCIENCE			English	Article							POSITIVE MAGNETORESISTANCE; SUPERLATTICES; SPINTRONICS; FILMS	Synthesizing antiferromagnets with correlated oxides has been challenging, owing partly to the markedly degraded ferromagnetism of the magnetic layer at nanoscale thicknesses. Here we report on the engineering of an antiferromagnetic interlayer exchange coupling (AF-IEC) between ultrathin but ferromagnetic La2/3Ca1/3MnO3 layers across an insulating CaRu1/2Ti1/2O3 spacer. The layer-resolved magnetic switching leads to sharp steplike hysteresis loops with magnetization plateaus depending on the repetition number of the stacking bilayers. The magnetization configurations can be switched at moderate fields of hundreds of oersted. Moreover, the AF-IEC can also be realized with an alternative magnetic layer of La2/3Sr1/3MnO3 that possesses a Curie temperature near room temperature. The findings will add functionalities to devices with correlated-oxide interfaces.	[Chen, Binbin; Xu, Haoran; Ma, Chao; Lan, Da; Jin, Feng; Guo, Zhuang; Wan, Siyuan; Chen, Pingfan; Gao, Guanyin; Wu, Wenbin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Chen, Binbin; Jin, Feng; Chen, Feng; Wu, Wenbin] Chinese Acad Sci, Anhui Key Lab Condensed Matter Phys Extreme Condi, High Magnet Field Lab, Hefei 230031, Peoples R China; [Mattauch, Stefan; Su, Yixi] Forschungszentrum Julich, JCNS, Heinz Maier Leibnitz Zentrum MLZ, D-85747 Garching, Germany; [Wu, Wenbin] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Helmholtz Association; Research Center Julich; Nanjing University	Wu, WB (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.; Wu, WB (corresponding author), Chinese Acad Sci, Anhui Key Lab Condensed Matter Phys Extreme Condi, High Magnet Field Lab, Hefei 230031, Peoples R China.; Wu, WB (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China.	wuwb@ustc.edu.cn	Jin, Feng/R-5745-2017; Su, Yixi/K-9119-2013; Gao, Guan-Yin/O-3265-2019; CHEN, Pingfan/HHZ-0079-2022; Chen, Feng/AAC-5116-2021; Ma, Chao/J-4569-2015; Gao, Guan-Yin/A-5686-2010	Jin, Feng/0000-0002-4610-5073; Su, Yixi/0000-0001-8434-1758; CHEN, Pingfan/0000-0002-7557-0206; Chen, Feng/0000-0002-8183-5856; Gao, Guan-Yin/0000-0001-8340-5107	National Natural Science Foundation of China [11474263, 11574281, U1432251]; National Basic Research Program of China [2015CB921201, 2016YFA0401003]; Hefei Science Center of the Chinese Academy of Sciences [2016HSC-IU006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Hefei Science Center of the Chinese Academy of Sciences	We thank D. C. Meng, L. J. Zhang, W. S. Yan, and G. B. Zhang for experimental assistance and K. Yang, G. Cao, and Y. H. Zhang for helpful discussions. This work has been supported by the National Natural Science Foundation of China (grants 11474263, 11574281, and U1432251), the National Basic Research Program of China (grants 2015CB921201 and 2016YFA0401003), and the Hefei Science Center of the Chinese Academy of Sciences (grant 2016HSC-IU006).	Boschker H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.214425; Bowen M, 2003, APPL PHYS LETT, V82, P233, DOI 10.1063/1.1534619; BRUNO P, 1995, PHYS REV B, V52, P411, DOI 10.1103/PhysRevB.52.411; Charilaou M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880821; Chen BB, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4885080; Chen PF, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4857715; Dobrich KM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.227203; Faure-Vincent J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107206; Freeland JW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.094414; Gibert M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11227; He T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.172403; Hellwig O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.197203; Hellwig O, 2003, NAT MATER, V2, P112, DOI 10.1038/nmat806; Hoffman JD, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041038; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; Jungwirth T, 2016, NAT NANOTECHNOL, V11, P231, DOI [10.1038/NNANO.2016.18, 10.1038/nnano.2016.18]; Lavrijsen R, 2013, NATURE, V493, P647, DOI 10.1038/nature11733; Li BZ, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4964407; Loth S, 2012, SCIENCE, V335, P196, DOI 10.1126/science.1214131; Lu WM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11015; Moon EJ, 2014, NANO LETT, V14, P2509, DOI 10.1021/nl500235f; Nanda BRK, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.216804; Nikolaev KR, 2000, PHYS REV LETT, V85, P3728, DOI 10.1103/PhysRevLett.85.3728; Orozco A, 1999, PHYS REV LETT, V83, P1680, DOI 10.1103/PhysRevLett.83.1680; Park JH, 1998, NATURE, V392, P794, DOI 10.1038/33883; PARKIN SSP, 1991, PHYS REV LETT, V67, P3598, DOI 10.1103/PhysRevLett.67.3598; PARKIN SSP, 1991, APPL PHYS LETT, V58, P1473, DOI 10.1063/1.105201; Poulopoulos P, 1998, PHYS REV B, V57, P14036, DOI 10.1103/PhysRevB.57.R14036; QIU ZQ, 1992, PHYS REV B, V46, P8659, DOI 10.1103/PhysRevB.46.8659; Song JH, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.060405; Stiles MD, 1999, J MAGN MAGN MATER, V200, P322, DOI 10.1016/S0304-8853(99)00334-0; te Velthuis SGE, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.127203; Terai K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115128; Vemulkar T, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4926336; Wadley P, 2016, SCIENCE, V351, P587, DOI 10.1126/science.aab1031; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yamada H, 2004, SCIENCE, V305, P646, DOI 10.1126/science.1098867; Yang SH, 2015, NAT NANOTECHNOL, V10, P221, DOI [10.1038/NNANO.2014.324, 10.1038/nnano.2014.324]; Zhuravlev MY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026806; Ziese M, 2012, NANO LETT, V12, P4276, DOI 10.1021/nl301963a	40	59	62	12	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		191	194		10.1126/science.aak9717	http://dx.doi.org/10.1126/science.aak9717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706069				2022-12-28	WOS:000405391700043
J	Houlihan, C; Behrens, R				Houlihan, Catherine; Behrens, Ron			CLINICAL UPDATES Lassa fever	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Houlihan, Catherine] UCL, Infect Dis Virol, London, England; [Behrens, Ron] Hosp Trop Dis, Trop & Travel Med, London, England; [Behrens, Ron] Hosp Trop Dis, London, England; [Behrens, Ron] London Sch Hyg & Trop Med, Trop & Travel Med, London, England; [Behrens, Ron] London Sch Hyg & Trop Med, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Houlihan, C (corresponding author), UCL, Infect Dis Virol, London, England.	catherine.houlihan@lshtm.ac.uk		Behrens, Ron/0000-0002-8166-2633	National Institute for Health Research [CL-2014-18-012] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bausch DG, 2010, CLIN INFECT DIS, V51, P1435, DOI 10.1086/657315; Bausch DG, 2000, J CLIN MICROBIOL, V38, P2670, DOI 10.1128/JCM.38.7.2670-2677.2000; Centers for Disease Control and Prevention, 2013, VIR HEM FEV AR; Centers for Disease Control and Prevention, 2014, VIR HEM FEV VHFS; Centers for Disease Control and Prevention, 2015, FACT SHEET LASS FEV; CUMMINS D, 1990, JAMA-J AM MED ASSOC, V264, P2093; Department of Health, 2015, MAN HAZ GROUP 4 VIR; Dongo AE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-123; Eze Kenneth C, 2014, Niger Med J, V55, P195, DOI 10.4103/0300-1652.132037; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Gunther S, 2001, J INFECT DIS, V184, P345, DOI 10.1086/322033; Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853; Hartnett JN, 2015, FUTURE VIROL, V10, P559, DOI 10.2217/FVL.15.41; MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445; MONSON MH, 1987, AM J TROP MED HYG, V36, P408, DOI 10.4269/ajtmh.1987.36.408; PRICE ME, 1988, BRIT MED J, V297, P584, DOI 10.1136/bmj.297.6648.584; Public Health England, 2017, LASS FEV OR RES TRAN; Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271; Shaffer JG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002748; Solbrig M. V., 1991, Journal of Tropical and Geographical Neurology, V1, P23; STEPHENSON EH, 1984, J MED VIROL, V14, P295, DOI 10.1002/jmv.1890140402; terMeulen J, 1996, AM J TROP MED HYG, V55, P661; World Health Organization, 2014, PERS PROT EQ CONT FI; World Health Organization, 2017, LASS FEV BEN TOG BUR; World Health Organization, 2016, CLIN MAN PAT VIR HAE; World Health Organization, 2016, LASS FEV FACT SHEET	26	16	17	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2017	358								j2986	10.1136/bmj.j2986	http://dx.doi.org/10.1136/bmj.j2986			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MT	28701331				2022-12-28	WOS:000405770400001
J	Divakaran, S; Dellaripa, P; Kobzik, L; Levy, B; Loscalzo, J				Divakaran, Sanjay; Dellaripa, Paul; Kobzik, Lester; Levy, Bruce; Loscalzo, Joseph			All That Wheezes ...	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHURG-STRAUSS-SYNDROME; TERM-FOLLOW-UP; EOSINOPHILIC GRANULOMATOSIS; POLYANGIITIS; COHORT; CLASSIFICATION; MEPOLIZUMAB; CRITERIA; ASTHMA		[Levy, Bruce] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, B (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	blevy@partners.org	Divakaran, Sanjay/AAG-3330-2020; Loscalzo, Joseph/ABD-8980-2021	Divakaran, Sanjay/0000-0003-0598-6502; 				Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Detoraki A, 2016, J ASTHMA, V53, P201, DOI 10.3109/02770903.2015.1081700; Durel CA, 2016, ARTHRIT CARE RES, V68, P374, DOI 10.1002/acr.22686; Guillevin L, 1996, MEDICINE, V75, P17, DOI 10.1097/00005792-199601000-00003; Guillevin L, 2011, MEDICINE, V90, P19, DOI 10.1097/MD.0b013e318205a4c6; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Noth I, 2003, LANCET, V361, P587, DOI 10.1016/S0140-6736(03)12518-4; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Sinico RA, 2005, ARTHRITIS RHEUM, V52, P2926, DOI 10.1002/art.21250; Wechsler ME, 2017, NEW ENGL J MED, V376, P1921, DOI 10.1056/NEJMoa1702079; Wechsler ME, 1998, JAMA-J AM MED ASSOC, V279, P455, DOI 10.1001/jama.279.6.455	12	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					477	484		10.1056/NEJMcps1607526	http://dx.doi.org/10.1056/NEJMcps1607526			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3NW	28767340				2022-12-28	WOS:000406747100011
J	Frieden, TR				Frieden, Thomas R.			Evidence for Health Decision Making - Beyond Randomized, Controlled Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INFLUENZA VACCINE EFFECTIVENESS; CARDIOVASCULAR-DISEASE; SODIUM-INTAKE; RESISTANT TUBERCULOSIS; CARDIAC OUTCOMES; HORMONE-THERAPY; CLINICAL-TRIALS; URINARY SODIUM; RARE DISEASES; UNITED-STATES		[Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	tfrieden@gmail.com		Frieden, Thomas/0000-0002-4759-2256				Akkslip S, 1999, INT J TUBERC LUNG D, V3, P1061; Angus DC, 2015, JAMA-J AM MED ASSOC, V314, P767, DOI 10.1001/jama.2015.7762; [Anonymous], 1976, JAMA, V235, P825; [Anonymous], 1948, Br Med J, V2, P769; [Anonymous], 2007, NAS INFL VACC APPR Y; [Anonymous], 2016, ACIP VOT DOWN US LAI; [Anonymous], 1997, TREATM TUB GUID NAT; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Bhatt DL, 2016, NEW ENGL J MED, V375, P65, DOI 10.1056/NEJMra1510061; Bothwell LE, 2016, NEW ENGL J MED, V374, P2175, DOI 10.1056/NEJMms1604593; Centers for Disease Control, 1981, MMWR-MORBID MORTAL W, V30, P250; Chavez-MacGregor M, 2016, J CLIN ONCOL, V34, P772, DOI 10.1200/JCO.2015.64.7487; Chung JR, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3279; Cobb LK, 2014, CIRCULATION, V129, P1173, DOI 10.1161/CIR.0000000000000015; Cogswell ME, 2016, NEW ENGL J MED, V375, P580, DOI 10.1056/NEJMsb1607161; Cogswell ME, 2015, ANNU REV NUTR, V35, P349, DOI 10.1146/annurev-nutr-071714-034322; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook NR, 2016, J AM COLL CARDIOL, V68, P1609, DOI 10.1016/j.jacc.2016.07.745; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; DAWSON JJY, 1966, B WORLD HEALTH ORGAN, V34, P533; Deaton A, 2010, J ECON LIT, V48, P424, DOI 10.1257/jel.48.2.424; Dorsch MP, 2011, HYPERTENSION, V57, P689, DOI 10.1161/HYPERTENSIONAHA.110.161505; Ernst ME, 2010, J CLIN HYPERTENS, V12, P927, DOI 10.1111/j.1751-7176.2010.00373.x; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Flannery B., 2014, M ADV COMM IMM PRACT; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; FOX W, 1962, Bull Int Union Tuberc, V32, P307; Frakt AB, 2015, JAMA-J AM MED ASSOC, V313, P1091, DOI 10.1001/jama.2015.0544; Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P579, DOI 10.1001/jama.2016.7992; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Gaglani M, 2016, J INFECT DIS, V213, P1546, DOI 10.1093/infdis/jiv577; Golfam M, 2015, EUR J CLIN INVEST, V45, P87, DOI 10.1111/eci.12371; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Graudal N, 2014, AM J HYPERTENS, V27, P1129, DOI 10.1093/ajh/hpu028; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grohskopf LA, 2014, MMWR-MORBID MORTAL W, V63, P691; Groopman J, 2007, DOCTORS THINK; Hayes JH, 2010, JAMA-J AM MED ASSOC, V304, P2373, DOI 10.1001/jama.2010.1720; He FJ, 2016, NAT REV NEPHROL, V12, P514, DOI 10.1038/nrneph.2016.97; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; Institute of Medicine [IOM], 2010, STRATEGIES REDUCE SO; Irving M, 2016, EVAL HLTH PROF  0510; ISEMAN MD, 1991, AM REV RESPIR DIS, V143, P697, DOI 10.1164/ajrccm/143.4_Pt_1.697; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jones DS, 2015, LANCET, V385, P1502, DOI 10.1016/S0140-6736(15)60742-5; Khan Muhib, 2014, J Vasc Interv Neurol, V7, P11; Kones R, 2014, CURR MED RES OPIN, V30, P2009, DOI 10.1185/03007995.2014.925438; Lederle FA, 2016, ANN INTERN MED, V165, P663, DOI 10.7326/M16-1208; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; Mendelsohn ME, 2007, NEW ENGL J MED, V356, P2639, DOI 10.1056/NEJMe078072; Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6; MITCHELL EA, 1991, NEW ZEAL MED J, V104, P71; Mitchison DA, 2005, AM J RESP CRIT CARE, V171, P699, DOI 10.1164/rccm.200411-1603OE; Moonan PK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-19; Moss AJ, 2011, NEW ENGL J MED, V364, P789, DOI 10.1056/NEJMp1013194; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Prentice RL, 2006, AM J EPIDEMIOL, V163, P589, DOI 10.1093/aje/kwj079; Prentice RL, 2005, AM J EPIDEMIOL, V162, P404, DOI 10.1093/aje/kwi223; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Roush GC, 2012, HYPERTENSION, V59, P1110, DOI 10.1161/HYPERTENSIONAHA.112.191106; Rubinstein YR, 2010, CONTEMP CLIN TRIALS, V31, P394, DOI 10.1016/j.cct.2010.06.007; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Schrag D, 1997, NEW ENGL J MED, V336, P1465, DOI 10.1056/NEJM199705153362022; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shroff GR, 2012, AM HEART J, V163, P399, DOI 10.1016/j.ahj.2011.12.002; Sterling TR, 2003, BMJ-BRIT MED J, V326, P574, DOI 10.1136/bmj.326.7389.574; Tai V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110403; Thall PF, 2007, EUR J CANCER, V43, P859, DOI 10.1016/j.ejca.2007.01.006; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Vandenbroucke JP, 2009, LANCET, V373, P1233, DOI 10.1016/S0140-6736(09)60708-X; Willett W., 2013, NUTR EPIDEMIOLOGY MO; Wisotzky M, 2004, PUBLIC HEALTH REP, V119, P303, DOI 10.1016/j.phr.2004.04.009; Woodcock J, 2016, NEW ENGL J MED, V374, P2167, DOI 10.1056/NEJMe1601510; Woolever Donald R, 2008, Fam Pract Manag, V15, P31; Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; Zou BW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003507; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7	97	397	405	1	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					465	475		10.1056/NEJMra1614394	http://dx.doi.org/10.1056/NEJMra1614394			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3NW	28767357	Bronze			2022-12-28	WOS:000406747100008
J	Brouwers, MC; Qaseem, A; Spithoff, K; Florez, ID				Brouwers, Melissa C.; Qaseem, Amir; Spithoff, Karen; Florez, Ivan D.			Guidelines to Limit Added Sugar Intake	ANNALS OF INTERNAL MEDICINE			English	Letter							AGREE II		[Brouwers, Melissa C.; Spithoff, Karen] McMaster Univ, Hamilton, ON, Canada; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA USA; [Florez, Ivan D.] Univ Antioquia, Medellin, Colombia	McMaster University; American College of Physicians; Universidad de Antioquia	Brouwers, MC (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Florez, Ivan D./K-3536-2015	Florez, Ivan D./0000-0002-0751-8932				[Anonymous], 2013, APPR GUID RES EV 2 I; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Erickson J, 2017, ANN INTERN MED, V166, P257, DOI 10.7326/M16-2020; Schillinger D, 2017, ANN INTERN MED, V166, P305, DOI 10.7326/M16-2754	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					219	220		10.7326/L17-0256	http://dx.doi.org/10.7326/L17-0256			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28761954				2022-12-28	WOS:000406631400022
J	Ioannidis, JPA				Ioannidis, John P. A.			Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE; MANAGEMENT		[Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Prevent Res Ctr, 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859				Anderson TJ, 2016, CAN J CARDIOL, V32, P1263, DOI 10.1016/j.cjca.2016.07.510; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Chou R, 2016, JAMA-J AM MED ASSOC, V316, P2008, DOI 10.1001/jama.2015.15629; Lipinski MJ, 2016, EUR HEART J, V37, P536, DOI 10.1093/eurheartj/ehv563; Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951; Pagidipati NJ, 2017, JAMA-J AM MED ASSOC, V317, P1563, DOI 10.1001/jama.2017.3416; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	9	7	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					419	420		10.1001/jama.2017.6765	http://dx.doi.org/10.1001/jama.2017.6765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28738115				2022-12-28	WOS:000406659800008
J	Yeung, CA				Yeung, C. Albert			The Scientific Basis of Guideline Recommendations on Sugar Intake	ANNALS OF INTERNAL MEDICINE			English	Letter									[Yeung, C. Albert] Natl Hlth Serv Lanarkshire, Bothwell, Scotland		Yeung, CA (corresponding author), Natl Hlth Serv Lanarkshire, Bothwell, Scotland.							Dietary Guidelines Advisory Committee, 2015, SCI REP 2015 DIET GU; Erickson J, 2017, ANN INTERN MED, V166, P257, DOI 10.7326/M16-2020; United States Department of Agriculture, 2014, SER SYST REV REL DIE; US Department of Agriculture U. D. o. H. a. H. S, 2015, DIET GUID AM	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					218	219		10.7326/L17-0253	http://dx.doi.org/10.7326/L17-0253			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28761951				2022-12-28	WOS:000406631400020
J	Pain, E				Pain, Elisabeth			FUNDING Head of France's main funding body resigns amid acrimony	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					341	341		10.1126/science.357.6349.341	http://dx.doi.org/10.1126/science.357.6349.341			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751587				2022-12-28	WOS:000406362300015
J	Hannah-Shmouni, F; Pacak, K; Stratakis, CA				Hannah-Shmouni, Fady; Pacak, Karel; Stratakis, Constantine A.			Metanephrines for Evaluating Palpitations and Flushing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIOCHEMICAL-DIAGNOSIS; PLASMA METANEPHRINES; PHEOCHROMOCYTOMA		[Hannah-Shmouni, Fady; Stratakis, Constantine A.] NIH, Sect Genet & Endocrinol, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bldg 10, Bethesda, MD 20892 USA; [Pacak, Karel] NIH, Sect Med Neuroendocrinol, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Stratakis, CA (corresponding author), NICHD, Sect Genet & Endocrinol, NIH, CRC, 9000 Rockville Pike,Bldg 10,Room 1-3330,MSC1103, Bethesda, MD 20892 USA.	stratakc@mail.nih.gov	Stratakis, Constantine/AAP-4745-2020; Fady Hannah-Shmouni, FRCPC/AAF-5159-2019	Fady Hannah-Shmouni, FRCPC/0000-0001-6829-6205	Intramural NIH HHS [Z99 HD999999, ZIA HD008735] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735, ZIAHD008920] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON GH, 1994, J HYPERTENS, V12, P609, DOI 10.1097/00004872-199405000-00015; Darr R, 2014, CLIN ENDOCRINOL, V80, P478, DOI 10.1111/cen.12327; Eisenhofer G, 2003, J CLIN ENDOCR METAB, V88, P2656, DOI 10.1210/jc.2002-030005; Eisenhofer G, 1998, J CLIN ENDOCR METAB, V83, P2175, DOI 10.1210/jc.83.6.2175; Lenders JWM, 2007, CLIN CHEM, V53, P352, DOI 10.1373/clinchem.2006.076489; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427	7	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					385	386		10.1001/jama.2017.5926	http://dx.doi.org/10.1001/jama.2017.5926			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742886	Green Accepted			2022-12-28	WOS:000406296700020
J	Larsson, SC; Burgess, S; Michaelsson, K				Larsson, Susanna C.; Burgess, Stephen; Michaelsson, Karl			Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR-DISEASE; MENDELIAN RANDOMIZATION; RISK-FACTORS; DIETARY; SUPPLEMENTS; MORTALITY; METAANALYSIS; NUTRITION; CARBONATE	IMPORTANCE Serum calcium has been associated with cardiovascular disease in observational studies and evidence from randomized clinical trials indicates that calcium supplementation, which raises serum calcium levels, may increase the risk of cardiovascular events, particularly myocardial infarction. OBJECTIVE To evaluate the potential causal association between genetic variants related to elevated serum calcium levels and risk of coronary artery disease (CAD) and myocardial infarction using mendelian randomization. DESIGN, SETTING, AND PARTICIPANTS The analyses were performed using summary statistics obtained for single-nucleotide polymorphisms (SNPs) identified from a genome-wide association meta-analysis of serum calcium levels (N = up to 61 079 individuals) and from the Coronary Artery Disease Genome-wide Replication and Meta-analysis Plus the Coronary Artery Disease Genetics (CardiogramplusC4D) consortium's 1000 genomes-based genome-wide association meta-analysis (N = up to 184 305 individuals) that included cases (individuals with CAD andmyocardial infarction) and noncases, with baseline data collected from 1948 and populations derived from across the globe. The association of each SNP with CAD andmyocardial infarction was weighted by its association with serum calcium, and estimates were combined using an inverse-variance weighted meta-analysis. EXPOSURES Genetic risk score based on genetic variants related to elevated serum calcium levels. MAIN OUTCOMES AND MEASURES Co-primary outcomes were the odds of CAD and myocardial infarction. RESULTS Among the mendelian randomized analytic sample of 184 305 individuals (60 801 CAD cases [approximately 70% with myocardial infarction] and 123 504 noncases), the 6 SNPs related to serum calcium levels and without pleiotropic associations with potential confounders were estimated to explain about 0.8% of the variation in serum calcium levels. In the inverse-variance weighted meta-analysis (combining the estimates of the 6 SNPs), the odds ratios per 0.5-mg/dL increase (about 1 SD) in genetically predicted serum calcium levels were 1.25 (95% CI, 1.08-1.45; P = .003) for CAD and 1.24 (95% CI, 1.05-1.46; P = .009) for myocardial infarction. CONCLUSIONS AND RELEVANCE A genetic predisposition to higher serum calcium levels was associated with increased risk of CAD andmyocardial infarction. Whether the risk of CAD associated with lifelong genetic exposure to increased serum calcium levels can be translated to a risk associated with short-term to medium-term calcium supplementation is unknown.	[Larsson, Susanna C.] Karolinska Inst, Inst Environm Med, Unit Nutr Epidemiol, SE-17177 Stockholm, Sweden; [Burgess, Stephen] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Burgess, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden	Karolinska Institutet; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; Uppsala University	Larsson, SC (corresponding author), Karolinska Inst, Inst Environm Med, Unit Nutr Epidemiol, SE-17177 Stockholm, Sweden.	susanna.larsson@ki.se	Michaelsson, Karl/AAM-9094-2021; Larsson, Susanna C./F-6065-2015	Larsson, Susanna C./0000-0003-0118-0341; Michaelsson, Karl/0000-0003-2815-1217; Burgess, Stephen/0000-0001-5365-8760	Junior Researcher Award grant from the Strategic Research Area in Epidemiology at Karolinska Institutet; MRC [MR/L003120/1, MC_UU_00002/7] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1, MC_UU_00002/7] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish	Junior Researcher Award grant from the Strategic Research Area in Epidemiology at Karolinska Institutet; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Junior Researcher Award grant from the Strategic Research Area in Epidemiology at Karolinska Institutet (Dr Larsson).	An RP, 2015, DISABIL HEALTH J, V8, P240, DOI 10.1016/j.dhjo.2014.09.001; Anderson JJB, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003815; Barry EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108094; Bauer DC, 2014, J BONE MINER RES, V29, P531, DOI 10.1002/jbmr.2184; Bolland MJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2040; Bristow SM, 2016, OSTEOPOROSIS INT, V27, P1209, DOI 10.1007/s00198-015-3372-y; Bristow SM, 2015, BRIT J NUTR, V113, P1585, DOI 10.1017/S000711451500080X; Bristow SM, 2014, BRIT J NUTR, V112, P1611, DOI 10.1017/S0007114514002785; Burgess S., 2015, MENDELIAN RANDOMIZAT, DOI [10.1201/b18084, DOI 10.1201/B18084]; Burgess S, 2017, EPIDEMIOLOGY, V28, P30, DOI 10.1097/EDE.0000000000000559; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Burgess S, 2015, EUR J EPIDEMIOL, V30, P543, DOI 10.1007/s10654-015-0011-z; Dickinson A, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-14; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Hagg S, 2015, INT J EPIDEMIOL, V44, P578, DOI 10.1093/ije/dyv094; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Li KR, 2012, HEART, V98, P920, DOI 10.1136/heartjnl-2011-301345; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mangano KM, 2011, J AM DIET ASSOC, V111, P687, DOI 10.1016/j.jada.2011.02.014; Margolis KL, 2016, ANN INTERN MED, V165, P884, DOI 10.7326/M16-2193; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; Reid IR, 2016, J INTERN MED, V279, P524, DOI 10.1111/joim.12464; Reid IR, 2015, J CELL BIOCHEM, V116, P494, DOI 10.1002/jcb.25028; Rohrmann S, 2016, ATHEROSCLEROSIS, V251, P85, DOI 10.1016/j.atherosclerosis.2016.06.004; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Van Hemelrijck M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061037; van Iperen EPA, 2016, ATHEROSCLEROSIS, V254, P35, DOI 10.1016/j.atherosclerosis.2016.09.008; White J, 2016, JAMA CARDIOL, V1, P692, DOI 10.1001/jamacardio.2016.1884; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283	34	96	97	3	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					371	380		10.1001/jama.2017.8981	http://dx.doi.org/10.1001/jama.2017.8981			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742912	Green Published, Green Submitted			2022-12-28	WOS:000406296700017
J	Mez, J; Daneshvar, DH; Kiernan, PT; Abdolmohammadi, B; Alvarez, VE; Huber, BR; Alosco, ML; Solomon, TM; Nowinski, CJ; McHale, L; Cormier, KA; Kubilus, CA; Martin, BM; Murphy, L; Baugh, CM; Montenigro, PH; Chaisson, CE; Tripodis, Y; Kowall, N; Weuve, J; McClean, MD; Cantu, RC; Goldstein, LE; Katz, DI; Stern, RA; Stein, TD; McKee, AC				Mez, Jesse; Daneshvar, Daniel H.; Kiernan, Patrick T.; Abdolmohammadi, Bobak; Alvarez, Victor E.; Huber, Bertrand R.; Alosco, Michael L.; Solomon, Todd M.; Nowinski, Christopher J.; McHale, Lisa; Cormier, Kerry A.; Kubilus, Caroline A.; Martin, Brett M.; Murphy, Lauren; Baugh, Christine M.; Montenigro, Phillip H.; Chaisson, Christine E.; Tripodis, Yorghos; Kowall, Neilw.; Weuve, Jennifer; McClean, Michael D.; Cantu, Robert C.; Goldstein, Lee E.; Katz, Douglas I.; Stern, Robert A.; Stein, Thor D.; McKee, Ann C.			Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; REPETITIVE HEAD-INJURY; MOTOR-NEURON DISEASE; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; LEAGUE PLAYER; 1ST EXPOSURE; CRITERIA; ASSOCIATION; RELIABILITY	IMPORTANCE Players of American football may be at increased risk of long-term neurological conditions, particularly chronic traumatic encephalopathy (CTE). OBJECTIVE To determine the neuropathological and clinical features of deceased football players with CTE. DESIGN, SETTING, AND PARTICIPANTS Case series of 202 football players whose brains were donated for research. Neuropathological evaluations and retrospective telephone clinical assessments (including head trauma history) with informants were performed blinded. Online questionnaires ascertained athletic and military history. EXPOSURES Participation in American football at any level of play. MAIN OUTCOMES AND MEASURES Neuropathological diagnoses of neurodegenerative diseases, including CTE, based on defined diagnostic criteria; CTE neuropathological severity (stages I to IV or dichotomized into mild [stages I and II] and severe [stages III and IV]); informant-reported athletic history and, for players who died in 2014 or later, clinical presentation, including behavior, mood, and cognitive symptoms and dementia. RESULTS Among 202 deceased former football players (median age at death, 66 years [interquartile range, 47-76 years]), CTE was neuropathologically diagnosed in 177 players (87%; median age at death, 67 years [interquartile range, 52-77 years]; mean years of football participation, 15.1 [SD, 5.2]), including 0 of 2 pre-high school, 3 of 14 high school (21%), 48 of 53 college (91%), 9 of 14 semiprofessional (64%), 7 of 8 Canadian Football League (88%), and 110 of 111 National Football League (99%) players. Neuropathological severity of CTE was distributed across the highest level of play, with all 3 former high school players having mild pathology and the majority of former college (27 [56%]), semiprofessional (5 [56%]), and professional (101 [86%]) players having severe pathology. Among 27 participants with mild CTE pathology, 26 (96%) had behavioral or mood symptoms or both, 23 (85%) had cognitive symptoms, and 9 (33%) had signs of dementia. Among 84 participants with severe CTE pathology, 75 (89%) had behavioral or mood symptoms or both, 80 (95%) had cognitive symptoms, and 71 (85%) had signs of dementia. CONCLUSIONS AND RELEVANCE In a convenience sample of deceased football players who donated their brains for research, a high proportion had neuropathological evidence of CTE, suggesting that CTE may be related to prior participation in football.	[Mez, Jesse; Daneshvar, Daniel H.; Kiernan, Patrick T.; Abdolmohammadi, Bobak; Alvarez, Victor E.; Huber, Bertrand R.; Alosco, Michael L.; Solomon, Todd M.; Nowinski, Christopher J.; Cormier, Kerry A.; Kubilus, Caroline A.; Chaisson, Christine E.; Tripodis, Yorghos; Kowall, Neilw.; Cantu, Robert C.; Goldstein, Lee E.; Stern, Robert A.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Mez, Jesse; Kiernan, Patrick T.; Abdolmohammadi, Bobak; Huber, Bertrand R.; Alosco, Michael L.; Cormier, Kerry A.; Kubilus, Caroline A.; Murphy, Lauren; Montenigro, Phillip H.; Kowall, Neilw.; Cantu, Robert C.; Goldstein, Lee E.; Katz, Douglas I.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Daneshvar, Daniel H.] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Alvarez, Victor E.; Huber, Bertrand R.; Kowall, Neilw.; Stein, Thor D.; McKee, Ann C.] US Dept Vet Affairs, VA Boston Healthcare Syst, Boston, MA USA; [Alvarez, Victor E.; Huber, Bertrand R.; Stein, Thor D.; McKee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Nowinski, Christopher J.; McHale, Lisa; Cantu, Robert C.] Concuss Legacy Fdn, Waltham, MA USA; [Martin, Brett M.; Chaisson, Christine E.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Boston, MA 02115 USA; [Baugh, Christine M.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Tripodis, Yorghos] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Tripodis, Yorghos; Weuve, Jennifer; McClean, Michael D.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Kowall, Neilw.; Goldstein, Lee E.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Weuve, Jennifer] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [McClean, Michael D.] Boston Univ, Dept Environm Hlth, Boston, MA 02215 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Dept Biomed Engn, Coll Engn, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University; Boston University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Harvard University; Boston Children's Hospital; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University	McKee, AC (corresponding author), Boston Univ, Sch Med, Alzheimers Dis Ctr, VA Boston Healthcare Syst,Neuropathol Serv,CTE Ct, 150 S Huntington Ave, Boston, MA 02118 USA.	amckee@bu.edu	Baugh, Christine/AAG-2324-2020; Tripodis, Yorghos/GRY-0583-2022; , Bob/ABA-8507-2020; Lang, Steven/AAE-8102-2021	Baugh, Christine/0000-0002-9340-6338; Lang, Steven/0000-0003-1669-9146; Stein, Thor/0000-0001-6954-4477; Tripodis, Yorghos/0000-0003-2190-7608; Daneshvar, Daniel/0000-0003-3691-9513	NINDS [U01 NS086659, R01 NS078337, R56 NS078337, U01 NS093334, F32 NS096803]; National Institute on Aging [K23 AG046377, P30AG13846, 0572063345-5, R01 AG1649]; US Department of Defense [W81XWH-13-2-0064]; US Department of Veterans Affairs [I01 CX001038]; Veterans Affairs Biorepository [CSP 501]; Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; Department of Defense Peer Reviewed Alzheimer's Research Program [13267017]; National Operating Committee on Standards for Athletic Equipment; Alzheimer's Association [NIRG-15-362697, NIRG-305779]; Concussion Legacy Foundation; Andlinger Family Foundation; WWE; NFL; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, K23AG046377, RF1AG057902] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US Department of Defense(United States Department of Defense); US Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs Biorepository; Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence; Department of Defense Peer Reviewed Alzheimer's Research Program; National Operating Committee on Standards for Athletic Equipment; Alzheimer's Association(Alzheimer's Association); Concussion Legacy Foundation; Andlinger Family Foundation; WWE; NFL; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study received support from NINDS (grants U01 NS086659, R01 NS078337, R56 NS078337, U01 NS093334, and F32 NS096803), the National Institute on Aging (grants K23 AG046377, P30AG13846 and supplement 0572063345-5, R01 AG1649), the US Department of Defense (grant W81XWH-13-2-0064), the US Department of Veterans Affairs (I01 CX001038), the Veterans Affairs Biorepository (CSP 501), the Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (grant B6796-C), the Department of Defense Peer Reviewed Alzheimer's Research Program (grant 13267017), the National Operating Committee on Standards for Athletic Equipment, the Alzheimer's Association (grants NIRG-15-362697 and NIRG-305779), the Concussion Legacy Foundation, the Andlinger Family Foundation, the WWE, and the NFL.	Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Haneuse S, 2009, NEUROEPIDEMIOLOGY, V32, P229, DOI 10.1159/000197389; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Love S, 2008, GREENFIELDS NEUROPAT, DOI 10.1201/b22602; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; SU JH, 1994, NEUROREPORT, V5, P2358, DOI 10.1097/00001756-199411000-00037; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42	36	529	532	8	227	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					360	370		10.1001/jama.2017.8334	http://dx.doi.org/10.1001/jama.2017.8334			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742910	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000406296700016
J	Slomski, A				Slomski, Anita			Fewer Seizures With Cannabidiol in Catastrophic Epilepsy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					323	323		10.1001/jama.2017.8846	http://dx.doi.org/10.1001/jama.2017.8846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MY	28742905				2022-12-28	WOS:000426800100005
J	Green, A				Green, Andrew			The HIV response in Ukraine: at a crossroads	LANCET			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					347	348						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28745594				2022-12-28	WOS:000405911300010
J	Zarocostas, J				Zarocostas, John			The UN adopts treaty to ban the use of nuclear weapons	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					349	349		10.1016/S0140-6736(17)31870-6	http://dx.doi.org/10.1016/S0140-6736(17)31870-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28712535				2022-12-28	WOS:000405911300011
J	Jayachandran, S; De Laat, J; Lambin, EF; Stanton, CY; Audy, R; Thomas, NE				Jayachandran, Seema; De laat, Joost; Lambin, Eric F.; Stanton, Charlotte Y.; Audy, Robin; Thomas, Nancy E.			Cash for carbon: A randomized trial of payments for ecosystem services to reduce deforestation	SCIENCE			English	Article							ENVIRONMENTAL SERVICES; FOREST COVER; CONSERVATION; MONEY	We evaluated a program of payments for ecosystem services in Uganda that offered forest-owning households annual payments of 70,000 Ugandan shillings per hectare if they conserved their forest. The program was implemented as a randomized controlled trial in 121 villages, 60 of which received the program for 2 years. The primary outcome was the change in land area covered by trees, measured by classifying high-resolution satellite imagery. We found that tree cover declined by 4.2% during the study period in treatment villages, compared to 9.1% in control villages. We found no evidence that enrollees shifted their deforestation to nearby land. We valued the delayed carbon dioxide emissions and found that this program benefit is 2.4 times as large as the program costs.	[Jayachandran, Seema] Northwestern Univ, Dept Econ, 2211 Campus Dr, Evanston, IL 60208 USA; [De laat, Joost] Porticus, POB 7867, NL-1008 AB Amsterdam, Netherlands; [Lambin, Eric F.] Stanford Univ, Sch Earth Energy & Environm Sci, 473 Via Ortega, Stanford, CA 94305 USA; [Lambin, Eric F.] Stanford Univ, Woods Inst Environm, 473 Via Ortega, Stanford, CA 94305 USA; [Lambin, Eric F.] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, Pl Louis Pasteur 3, B-1348 Louvain La Neuve, Belgium; [Stanton, Charlotte Y.] Carnegie Inst Sci, 260 Panama St, Stanford, CA 94305 USA; [Audy, Robin] 9 Harrison St, Somerville, MA 02143 USA; [Thomas, Nancy E.] Univ Calif Berkeley, Geospatial Innovat Facil, 111 Mulford Hall, Berkeley, CA 94720 USA	Northwestern University; Stanford University; Stanford University; Universite Catholique Louvain; Carnegie Institution for Science; University of California System; University of California Berkeley	Jayachandran, S (corresponding author), Northwestern Univ, Dept Econ, 2211 Campus Dr, Evanston, IL 60208 USA.	seema@northwestern.edu		Lambin, Eric/0000-0002-0673-5257; Jayachandran, Seema/0000-0002-6015-2300	Global Environment Facility, through the United Nations Environment Programme; International Initiative for Impact Evaluation; National Science Foundation [SES-1156941]	Global Environment Facility, through the United Nations Environment Programme; International Initiative for Impact Evaluation; National Science Foundation(National Science Foundation (NSF))	We thank R. Chang, A. Favela, S. Kagera, M. Kearns, L. Kim, P. Marimo, E. Moscoe, S. Oh, A. Persaud, C. Rowe, J. Stapleton, and Z. Zeng for outstanding research assistance; Chimpanzee Sanctuary Wildlife Conservation Trust (including L. Ajarova and P. Hatanga), Government of Uganda National Environment Management Authority (including F. Ogwal), Innovations for Poverty Action (IPA) (including D. Parkerson and P. Raffler), International Institute for Environment and Development (including M. Grieg-Gran), and Nature Harness Initiatives (including B. Biryahwaho) for collaborating on the project; R. Dizon-Ross, K. Jack, C. Kinnan, M. Lipscomb, L. Lockwood, D. Marvin, S. Pagiola, K. Sims, and several seminar participants for helpful comments; and the Global Environment Facility, through the United Nations Environment Programme, and the International Initiative for Impact Evaluation for funding. S. J. also thanks the National Science Foundation for funding (SES-1156941). S. J. is an affiliate and board member of the Abdul Latif Jameel Poverty Action Lab, whose activities include disseminating research findings based on randomized controlled trials conducted by its affiliates, such as this study. The study received institutional review board (IRB) approval from Northwestern University IRB (IRB 00000418, 00000419, 00000736, 00000420, 00002600, and 00005003, with IRB Protocol STU00055401); Stanford IRB (IRB 00000348, 00000349, 00000350, 00000351, 00004593, 00004947, 00005136, and 00006208, with IRB Protocol 19468); IPA IRB-USA (IRB 00006083, with IRB Protocol 258.10July-002); and Uganda National Council for Science and Technology (IRB Protocol SS2234). Informed consent was obtained from study subjects, and the nature and possible consequences of the study were explained to them. The data used in the study are available through Harvard Dataverse (doi:10.7910/DVN/MGMDYN). The views expressed in this article are not necessarily those of the partner organizations, funders, or their members. All errors are our own.	Alix-Garcia J, 2014, ANNU REV RESOUR ECON, V6, P361, DOI 10.1146/annurev-resource-100913-012524; Alix-Garcia JM, 2015, AM ECON J-ECON POLIC, V7, P1, DOI 10.1257/pol.20130139; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; [Anonymous], 2008, STAT ENV REP UG 2008; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Assuncao J., 2014, WORKING PAPER; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Bruhn M, 2009, AM ECON J-APPL ECON, V1, P200, DOI 10.1257/app.1.4.200; Burgess R, 2012, Q J ECON, V127, P1707, DOI 10.1093/qje/qjs034; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; FAO, 2010, GLOBAL FOREST RESOUR; Ferraro PJ, 2015, P NATL ACAD SCI USA, V112, P7420, DOI 10.1073/pnas.1406487112; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Fisher B, 2010, NAT GEOSCI, V3, P375, DOI 10.1038/ngeo873; Foster AD, 2003, Q J ECON, V118, P601, DOI 10.1162/003355303321675464; Gayer T., 2013, CAR ALLOWANCE REBATE; Greenstone M., 2011, 16913 NAT BUR EC RES; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Interagency Working Group, 2013, 12866 INT WORK GROUP; Jack B. K., 2015, 21414 NAT BUR EC RES; Jack BK, 2013, AM ECON J-APPL ECON, V5, P113, DOI 10.1257/app.5.3.113; Knittel CR, 2012, J ECON PERSPECT, V26, P93, DOI 10.1257/jep.26.1.93; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P349, DOI 10.5194/essd-7-349-2015; Lee DS, 2009, REV ECON STUD, V76, P1071, DOI 10.1111/j.1467-937X.2009.00536.x; Nabuurs G. J., 2007, CLIMATE CHANGE 2007, P542; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Solon G, 2015, J HUM RESOUR, V50, P301, DOI 10.3368/jhr.50.2.301; Somanathan E, 2009, P NATL ACAD SCI USA, V106, P4143, DOI 10.1073/pnas.0810049106; Stern Nicholas, 2006, STERN REV EC CLIMATE; United Nations FCCC, 2001, C PART ITS 7 SESS HE; United Nations Framework Convention on Climate Change (FCCC), 2015, 21 C PART 1992 UNFCC; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	37	192	195	24	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					267	273		10.1126/science.aan0568	http://dx.doi.org/10.1126/science.aan0568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729505				2022-12-28	WOS:000405901600033
J	Lohmann, U; Gasparini, B				Lohmann, Ulrike; Gasparini, Blaz			A cirrus cloud climate dial?	SCIENCE			English	Editorial Material							COOL		[Lohmann, Ulrike; Gasparini, Blaz] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Lohmann, U (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland.	ulrike.lohmann@env.ethz.ch	Gasparini, Blaž/AAV-5206-2020; Lohmann, Ulrike/B-6153-2009	Gasparini, Blaž/0000-0002-7177-0155; Lohmann, Ulrike/0000-0001-8885-3785				Boucher O, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P571, DOI 10.1017/cbo9781107415324.016; Cziczo DJ, 2013, SCIENCE, V340, P1320, DOI 10.1126/science.1234145; Gasparini B, 2017, ATMOS CHEM PHYS, V17, P4871, DOI 10.5194/acp-17-4871-2017; Gasparini B, 2016, J GEOPHYS RES-ATMOS, V121, P4877, DOI 10.1002/2015JD024666; Hong YL, 2016, J CLIMATE, V29, P7651, DOI 10.1175/JCLI-D-15-0799.1; Kristjansson JE, 2015, GEOPHYS RES LETT, V42, P10807, DOI 10.1002/2015GL066795; Lohmann U, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045022; Mitchell DL, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045102; Niemeier U, 2017, SCIENCE, V357, P246, DOI 10.1126/science.aan3317; Penner JE, 2015, GEOPHYS RES LETT, V42, P8775, DOI 10.1002/2015GL065992; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Storelvmo T, 2014, J GEOPHYS RES-ATMOS, V119, P2375, DOI 10.1002/2013JD020816; Storelvmo T, 2013, GEOPHYS RES LETT, V40, P178, DOI 10.1029/2012GL054201	13	32	37	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					248	249		10.1126/science.aan3325	http://dx.doi.org/10.1126/science.aan3325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729496				2022-12-28	WOS:000405901600020
J	Kohrt, WM; Wierman, ME				Kohrt, Wendy M.; Wierman, Margaret E.			Preventing Fat Gain by Blocking Follicle-Stimulating Hormone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESTRADIOL; SUBUNIT; WOMEN		[Kohrt, Wendy M.; Wierman, Margaret E.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Kohrt, WM (corresponding author), Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.				NICHD NIH HHS [P50 HD073063] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD073063] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Glidewell-Kenney C, 2008, ENDOCRINOLOGY, V149, P4168, DOI 10.1210/en.2007-1807; Liu P, 2017, NATURE, V546, P107, DOI 10.1038/nature22342; Melanson EL, 2015, J APPL PHYSIOL, V119, P975, DOI 10.1152/japplphysiol.00473.2015; Salpeter SR, 2006, DIABETES OBES METAB, V8, P538, DOI 10.1111/j.1463-1326.2005.00545.x; Van Pelt RE, 2015, ENDOCRIN METAB CLIN, V44, P663, DOI 10.1016/j.ecl.2015.05.011; Zhu LL, 2012, P NATL ACAD SCI USA, V109, P14574, DOI 10.1073/pnas.1212806109	7	10	10	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					293	295		10.1056/NEJMcibr1704542	http://dx.doi.org/10.1056/NEJMcibr1704542			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9PI	28723332				2022-12-28	WOS:000405777600016
J	Schattner, A				Schattner, Ami			Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY		[Schattner, Ami] Hebrew Univ Jerusalem, Hadassah Med Sch, Jerusalem, Israel	Hebrew University of Jerusalem	Schattner, A (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Jerusalem, Israel.		Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Avouac J, 2017, SEMIN ARTHRITIS RHEU, V46, P537, DOI 10.1016/j.semarthrit.2016.10.007; del Rincon I, 2014, ARTHRITIS RHEUMATOL, V66, P264, DOI 10.1002/art.38210; Giles JT, 2005, ARTHRITIS RES THER, V7, P195, DOI 10.1186/ar1814	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC8	JC8		10.7326/ACPJC-2017-167-2-008	http://dx.doi.org/10.7326/ACPJC-2017-167-2-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715830				2022-12-28	WOS:000405573400009
J	Barabasi, AL				Barabasi, Albert-Laszlo			Scale	SCIENCE			English	Book Review									[Barabasi, Albert-Laszlo] Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA	Northeastern University	Barabasi, AL (corresponding author), Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA.	a.barabasi@northeastern.edu	Gallant, John C/A-9035-2010; Barabasi, Albert-Laszlo/S-6474-2017; McKenzie, Neil J/A-9921-2011	Gallant, John C/0000-0002-5967-5809; McKenzie, Neil J/0000-0003-3803-3492; Barabasi, Albert/0000-0002-4028-3522				West G., 2017, SCALE	1	4	4	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		138	138		10.1126/science.aan4040	http://dx.doi.org/10.1126/science.aan4040			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706031				2022-12-28	WOS:000405391700027
J	Spengler, JR; Bente, DA				Spengler, Jessica R.; Bente, Dennis A.			Focus on Research Crimean-Congo Hemorrhagic Fever in Spain - New Arrival or Silent Resident?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Spengler, Jessica R.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Bente, Dennis A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Bente, Dennis A.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA	Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Spengler, JR (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.		Spengler, Jessica R./AAN-9099-2020	Spengler, Jessica R./0000-0002-5383-0513	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Gargili A, 2017, ANTIVIR RES, V144, P93, DOI 10.1016/j.antiviral.2017.05.010	3	11	11	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					106	108		10.1056/NEJMp1707436	http://dx.doi.org/10.1056/NEJMp1707436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA2PC	28700846	Green Accepted			2022-12-28	WOS:000405282300003
J	Carli, P; Pons, F; Levraut, J; Millet, B; Tourtier, JP; Ludes, B; Lafont, A; Riou, B				Carli, Pierre; Pons, Francois; Levraut, Jacques; Millet, Bruno; Tourtier, Jean-Pierre; Ludes, Bertrand; Lafont, Antoine; Riou, Bruno			The French emergency medical services after the Paris and Nice terrorist attacks: what have we learnt?	LANCET			English	Editorial Material							DAMAGE CONTROL; ORGANIZATION; EVENTS		[Carli, Pierre; Ludes, Bertrand; Lafont, Antoine] Univ Paris 05, Paris, France; [Carli, Pierre] Hop Necker Enfants Malad, AP HP, SAMU Paris, Paris, France; [Pons, Francois] French Mil Hlth Serv Acad, Ecole Val de Grace, Paris, France; [Levraut, Jacques] Univ Nice Sophia Antipolis, Nice, France; [Levraut, Jacques] Ctr Hosp Univ Nice, Dept Emergency Med, Nice, France; [Millet, Bruno; Riou, Bruno] Univ Pierre & Marie & Curie, Sorbonne Univ, Paris, France; [Millet, Bruno] Hop La Pitie Salpetriere, AP HP, Dept Psychiat, Paris, France; [Riou, Bruno] Hop La Pitie Salpetriere, AP HP, Dept Emergency Med & Surg, Paris, France; [Tourtier, Jean-Pierre] Brigade Sapeurs Pompiers Paris, Paris, France; [Ludes, Bertrand] Inst Legal Med, Paris, France; [Lafont, Antoine] Hop Europeen Georges Pompidou, APHP, Dept Cardiol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Riou, B (corresponding author), CHU Pitie Salpetriere, Serv Accueil Urgences, F-75651 Paris 13, France.	bruno.riou@aphp.fr	LUDES, Bertrand/AAB-6309-2022					[Anonymous], 2015, THE GUARDIAN    1201; Braun F, 2016, ANN FR MED URGENCE, V6, P373, DOI 10.1007/s13341-016-0687-z; Braun F, 2016, ANN FR MED URGENCE, V6, P62, DOI 10.1007/s13341-016-0612-5; Carles M, 2016, LANCET, V388, P2349, DOI 10.1016/S0140-6736(16)32128-6; Cerriteli A., 2014, INTERPOL DISASTER VI; Fenech G, RAPPORT FAIT NOM COM; French Republic, ARR 21 AVR 2017 REL; Gregory TM, 2016, INJURY, V47, P2122, DOI 10.1016/j.injury.2016.08.014; Hirsch M, 2015, LANCET, V386, P2535, DOI 10.1016/S0140-6736(15)01063-6; Jacobs LM, 2013, J TRAUMA ACUTE CARE, V74, P1399, DOI 10.1097/TA.0b013e318296b237; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Lagadec P., 1993, PREVENTING CHAOS CRI; Ludes B, 2016, REV MED LEG, V7, P2; Philippe JM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1259-8; Prieto JL, 2007, INT J LEGAL MED, V121, P517, DOI 10.1007/s00414-007-0196-0; Serv Med RAID Rech Assistance, 2015, ANN FR MED URGENCE, V5, P166, DOI 10.1007/s13341-015-0545-4; Sockeel P, 2008, J CHIR-PARIS, V145, P459, DOI 10.1016/S0021-7697(08)74656-8; Tourtier JP, 2013, ANN FR ANESTH, V32, P520, DOI 10.1016/j.annfar.2013.07.012	18	50	50	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					2735	2738		10.1016/S0140-6736(17)31590-8	http://dx.doi.org/10.1016/S0140-6736(17)31590-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ1FF	28754492				2022-12-28	WOS:000418101000029
J	Streed, CG; Harfouch, O; Marvel, F; Blumenthal, RS; Martin, SS; Mukherjee, M				Streed, Carl G., Jr.; Harfouch, Omar; Marvel, Francoise; Blumenthal, Roger S.; Martin, Seth S.; Mukherjee, Monica			Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							CONJUGATED EQUINE ESTROGENS; CORONARY-HEART-DISEASE; POSTMENOPAUSAL WOMEN; SEX-HORMONES; REPLACEMENT THERAPY; TESTOSTERONE LEVELS; MINORITY STRESS; PLUS PROGESTIN; OLDER MEN; HEALTH	Recent reports estimate that 0.6% of adults in the United States, or approximately 1.4 million persons, identify as transgender. Despite gains in rights and media attention, the reality is that transgender persons experience health disparities, and a dearth of research and evidence-based guidelines remains regarding their specific health needs. The lack of research to characterize cardiovascular disease (CVD) and CVD risk factors in transgender populations receiving cross-sex hormone therapy (CSHT) limits appropriate primary and specialty care. As with hormone therapy in cisgender persons (that is, those whose sex assigned at birth aligns with their gender identity), existing research in transgender populations suggests that CVD risk factors are altered by CSHT. Currently, systemic hormone replacement for cisgender adults requires a nuanced discussion based on baseline risk factors and age of administration of exogenous hormones because of concern regarding an increased risk for myocardial infarction and stroke. For transgender adults, CSHT has been associated with the potential for worsening CVD risk factors (such as blood pressure elevation, insulin resistance, and lipid derangements), although these changes have not been associated with increases in morbidity or mortality in transgender men receiving CSHT. For transgender women, CSHT has known thromboembolic risk, and lower-dose transdermal estrogen formulations are preferred over high-dose oral formulations. In addition, many studies of transgender adults focus predominantly on younger persons, limiting the generalizability of CSHT in older transgender adults. The lack of randomized controlled trials comparing various routes and formulations of CSHT, as well as the paucity of prospective cohort studies, limits knowledge of any associations between CSHT and CVD.	[Streed, Carl G., Jr.] Brigham & Womens Hosp, Div Gen Internal Med, 1620 Tremont St, Boston, MA 02120 USA; [Harfouch, Omar] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 North Wolfe St, Baltimore, MD 21205 USA; [Marvel, Francoise] Johns Hopkins Bayview Med Ctr, Dept Med, 1200 South Conkling St,208, Baltimore, MD 21224 USA; [Blumenthal, Roger S.] Johns Hopkins Univ Hosp, Div Cardiol, Ciccarone Ctr, 600 North Wolfe St,Halsted 560, Baltimore, MD 21287 USA; [Martin, Seth S.] Johns Hopkins Univ Hosp, Div Cardiol, 600 North Wolfe St,Carnegie 591, Baltimore, MD 21287 USA; [Mukherjee, Monica] Johns Hopkins Bayview Med Ctr, Div Cardiol, 301 Mason Lord Dr,Suite 2400, Baltimore, MD 21224 USA	Harvard University; Brigham & Women's Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Streed, CG (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med, 1620 Tremont St, Boston, MA 02120 USA.	cstreed@bwh.harvard.edu	Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168; Streed Jr, Carl/0000-0003-3075-253X; Harfouch, Omar/0000-0002-0327-7772; Martin, Seth/0000-0002-7021-7622; Mukherjee, Monica/0000-0001-6088-0773	National Research Service Award [T32HP10251]; Ryoichi Sasakawa Fellowship Fund; Brigham and Women's Hospital Division of General Internal Medicine and Primary Care; David and June Trone Family Foundation; PJ Schafer Cardiovascular Research Fund; American Heart Association; Aetna Foundation; CASCADE FH; Google; Apple	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ryoichi Sasakawa Fellowship Fund; Brigham and Women's Hospital Division of General Internal Medicine and Primary Care; David and June Trone Family Foundation; PJ Schafer Cardiovascular Research Fund; American Heart Association(American Heart Association); Aetna Foundation; CASCADE FH; Google(Google Incorporated); Apple	Dr. Streed has received funding support from an institutional National Research Service Award (T32HP10251), the Ryoichi Sasakawa Fellowship Fund, and the Brigham and Women's Hospital Division of General Internal Medicine and Primary Care. Dr. Martin has received research support from the David and June Trone Family Foundation, PJ Schafer Cardiovascular Research Fund, American Heart Association, Aetna Foundation, CASCADE FH, Google, and Apple; is a co-inventor on a pending patent filed by Johns Hopkins University for the novel method of low-density lipoprotein cholesterol estimation; and has served as a consultant to Quest Diagnostics, Sanofi/Regeneron, Amgen, and the Pew Research Center. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-0577.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; ASSCHEMAN H, 1989, METABOLISM, V38, P869, DOI 10.1016/0026-0495(89)90233-3; Asscheman H, 2011, EUR J ENDOCRINOL, V164, P635, DOI 10.1530/EJE-10-1038; Baker K, 2016, SEXUAL ORIENTATION G; Balsam KF, 2011, CULT DIVERS ETHN MIN, V17, P163, DOI 10.1037/a0023244; Bertone-Johnson ER, 2015, MENOPAUSE, V22, P1, DOI [10.1097/gme.0000000000000385, 10.1097/GME.0000000000000385]; Budoff MJ, 2017, JAMA-J AM MED ASSOC, V317, P708, DOI 10.1001/jama.2016.21043; Bunck MCM, 2006, EUR J ENDOCRINOL, V154, P569, DOI 10.1530/eje.1.02126; Canonico M, 2008, BMJ-BRIT MED J, V336, P1227, DOI 10.1136/bmj.39555.441944.BE; Chandra P, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/945053; Culic V, 2015, INT J CARDIOL, V179, P190, DOI 10.1016/j.ijcard.2014.11.079; Cunningham GR, 2015, J CLIN ENDOCR METAB, V100, P1146, DOI 10.1210/jc.2014-3818; De Cuypere G, 2005, ARCH SEX BEHAV, V34, P679, DOI 10.1007/s10508-005-7926-5; Deutsch MB., 2016, GUIDELINES PRIMARY G; Dhejne C, 2014, ARCH SEX BEHAV, V43, P1535, DOI 10.1007/s10508-014-0300-8; Dhejne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016885; Elamin MB, 2010, CLIN ENDOCRINOL, V72, P1, DOI 10.1111/j.1365-2265.2009.03632.x; Emi Y, 2008, J OBSTET GYNAECOL RE, V34, P890, DOI 10.1111/j.1447-0756.2008.00857.x; Flores AR, 2016, RACE ETHNICITY ADULT; Gava G, 2016, CLIN ENDOCRINOL, V85, P239, DOI 10.1111/cen.13050; Giltay EJ, 2004, J ENDOCRINOL, V180, P107, DOI 10.1677/joe.0.1800107; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gooren L, 2014, J SEX MED, V11, P2012, DOI 10.1111/jsm.12563; Gooren LJ, 2014, EUR J ENDOCRINOL, V170, P809, DOI 10.1530/EJE-14-0011; Gooren LJ, 2013, J SEX MED, V10, P3129, DOI 10.1111/jsm.12319; Grant JM, 2011, INJUSTICE EVERY TRUN; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hatzenbuehler ML, 2013, AM J PREV MED, V44, P612, DOI 10.1016/j.amepre.2013.01.027; Hemnes Anna R, 2012, Pulm Circ, V2, P352, DOI 10.4103/2045-8932.101647; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Institute of Medicine, 2011, HLTH LESB GAY BISEX; Institute of Medicine Board on the Health of Select Populations, 2013, COLL SEX OR GEND ID; Kemmeren JM, 2002, STROKE, V33, P1202, DOI 10.1161/01.STR.0000015345.61324.3F; Kloner RA, 2016, J AM COLL CARDIOL, V67, P545, DOI 10.1016/j.jacc.2015.12.005; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Laliberte F, 2011, MENOPAUSE, V18, P1052, DOI 10.1097/gme.0b013e3182175e5c; LUSCHER TF, 1994, J CARDIOVASC PHARM, V24, pS16; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Marsche G, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002371; McCrohon JA, 1997, J AM COLL CARDIOL, V29, P1432, DOI 10.1016/S0735-1097(97)00063-6; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Meyer IH, 2017, AM J PUBLIC HEALTH, V107, P582, DOI 10.2105/AJPH.2016.303648; Meyer Ilan H, 2016, Psychol Sex Rev, V7, P81; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; Oskui PM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000272; Ott J, 2010, FERTIL STERIL, V93, P1267, DOI 10.1016/j.fertnstert.2008.12.017; POLDERMAN KH, 1993, ANN INTERN MED, V118, P429, DOI 10.7326/0003-4819-118-6-199303150-00006; Reisner SL, 2016, LANCET, V388, P412, DOI 10.1016/S0140-6736(16)00684-X; Rood Brian A, 2016, Transgend Health, V1, P151, DOI 10.1089/trgh.2016.0012; Rosano GMC, 1999, DRUG AGING, V15, P219, DOI 10.2165/00002512-199915030-00005; Sare GM, 2008, EUR HEART J, V29, P2031, DOI 10.1093/eurheartj/ehn299; Schuster MA, 2016, NEW ENGL J MED, V375, P101, DOI 10.1056/NEJMp1605912; Shatzel JJ, 2017, AM J HEMATOL, V92, P204, DOI 10.1002/ajh.24593; Shores MM, 2012, J CLIN ENDOCR METAB, V97, P2050, DOI 10.1210/jc.2011-2591; Spieker L E, 2001, Am J Cardiovasc Drugs, V1, P293, DOI 10.2165/00129784-200101040-00007; Sumii K, 2016, ANDROLOGIA, V48, P198, DOI 10.1111/and.12433; Toorians AWFT, 2003, J CLIN ENDOCR METAB, V88, P5723, DOI 10.1210/jc.2003-030520; vanKesteren PJM, 1997, CLIN ENDOCRINOL, V47, P337, DOI 10.1046/j.1365-2265.1997.2601068.x; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; White Hughto Jaclyn M, 2016, Transgend Health, V1, P21; Wierckx K, 2013, EUR J ENDOCRINOL, V169, P471, DOI 10.1530/EJE-13-0493; Wierckx K, 2012, J SEX MED, V9, P2641, DOI 10.1111/j.1743-6109.2012.02876.x; Wilson R, 2009, MATURITAS, V62, P281, DOI 10.1016/j.maturitas.2009.01.009; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108	67	102	102	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					256	+		10.7326/M17-0577	http://dx.doi.org/10.7326/M17-0577			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD8TR	28738421				2022-12-28	WOS:000407797500014
J	Bonnie, RJ; Kesselheim, AS; Clark, DJ				Bonnie, Richard J.; Kesselheim, Aaron S.; Clark, David J.			Both Urgency and Balance Needed in Addressing Opioid Epidemic A Report From the National Academies of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC PAIN		[Bonnie, Richard J.] Univ Virginia, Sch Law, 580 Massie Rd, Charlottesville, VA 22903 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Clark, David J.] Palo Alto VA Hosp, Palo Alto, CA USA	University of Virginia; Harvard University; Brigham & Women's Hospital	Bonnie, RJ (corresponding author), Univ Virginia, Sch Law, 580 Massie Rd, Charlottesville, VA 22903 USA.	rjb6f@eservices.virginia.edu	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Bonnie, Richard/0000-0003-2945-7699	FDA	FDA(United States Department of Health & Human Services)	The National Academies of Sciences, Engineering, and Medicine report described in this Viewpoint was sponsored by the FDA.	[Anonymous], 2013, CBHSQ DATA REV; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Kroenke K, 2017, JAMA-J AM MED ASSOC, V317, P2365, DOI 10.1001/jama.2017.4884; National Academies of Sciences Engineering and Medicine, 2017, PAIN MAN OP EP BAL S; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Schneiderhan J, 2017, JAMA-J AM MED ASSOC, V317, P2367, DOI 10.1001/jama.2017.5787	6	41	41	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					423	424		10.1001/jama.2017.10046	http://dx.doi.org/10.1001/jama.2017.10046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28715551				2022-12-28	WOS:000406659800010
J	Park, J; Yan, ZZ; Loh, HQ; Will, SA; Zwierlein, M				Park, JeeWoo; Yan, Zoe Z.; Loh, Huanqian; Will, Sebastian A.; Zwierlein, MartinW.			Second-scale nuclear spin coherence time of ultracold (NaK)-Na-23-K-40 molecules	SCIENCE			English	Article							POLAR-MOLECULES; QUANTUM GAS; LATTICE; SPECTROSCOPY; FERMIONS	Coherence, the stability of the relative phase between quantum states, is central to quantum mechanics and its applications. For ultracold dipolar molecules at sub-microkelvin temperatures, internal states with robust coherence are predicted to offer rich prospects for quantum many-body physics and quantum information processing. We report the observation of stable coherence between nuclear spin states of ultracold fermionic sodium-potassium (NaK) molecules in the singlet rovibrational ground state. Ramsey spectroscopy reveals coherence times on the scale of 1 second; this enables high-resolution spectroscopy of the molecular gas. Collisional shifts are shown to be absent down to the 100-millihertz level. This work opens the door to the use of molecules as a versatile quantum memory and for precision measurements on dipolar quantum matter.	[Park, JeeWoo; Yan, Zoe Z.; Loh, Huanqian; Will, Sebastian A.; Zwierlein, MartinW.] MIT, Massachusetts Inst Technol Harvard Ctr Ultracold, Res Lab Elect, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Loh, Huanqian] Natl Univ Singapore, Ctr Quantum Technol, 3 Sci Dr 2, Singapore 117543, Singapore; [Park, JeeWoo] Seoul Natl Univ, Dept Phys & Astron, 1 Gwanak Ro, Seoul 08826, South Korea; [Will, Sebastian A.] Columbia Univ, Dept Phys, 538 West 120th St, New York, NY 10027 USA	Massachusetts Institute of Technology (MIT); National University of Singapore; Seoul National University (SNU); Columbia University	Zwierlein, M (corresponding author), MIT, Massachusetts Inst Technol Harvard Ctr Ultracold, Res Lab Elect, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zwierlein@mit.edu	Park, Jee Woo/K-1655-2017; Loh, Huanqian/K-6811-2015; Will, Sebastian/B-8933-2011	Park, Jee Woo/0000-0003-4329-5163; Loh, Huanqian/0000-0002-7325-0815; Yan, Zoe/0000-0003-3784-6440; /0000-0001-8120-8548; Will, Sebastian/0000-0003-2672-5264	NSF; Air Force Office of Scientific Research (AFOSR) Presidential Early Career Award for Scientists and Engineers; U.S. Army Research Office (ARO); ARO Multidisciplinary University Research Inititative (MURI) on "High-Resolution Quantum Control of Chemical Reactions"; AFOSR MURI on " Exotic Phases of Matter"; David and Lucile Packard Foundation; NSF Graduate Research Fellowship Program	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research (AFOSR) Presidential Early Career Award for Scientists and Engineers; U.S. Army Research Office (ARO); ARO Multidisciplinary University Research Inititative (MURI) on "High-Resolution Quantum Control of Chemical Reactions"; AFOSR MURI on " Exotic Phases of Matter"; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	We thank R. Field and collaborators, K.-K. Ni, and T. Nicholson for fruitful discussions. This work was supported by the NSF, the Air Force Office of Scientific Research (AFOSR) Presidential Early Career Award for Scientists and Engineers, the U.S. Army Research Office (ARO), an ARO Multidisciplinary University Research Inititative (MURI) on "High-Resolution Quantum Control of Chemical Reactions," an AFOSR MURI on " Exotic Phases of Matter," and the David and Lucile Packard Foundation. Z.Z.Y. acknowledges additional support from the NSF Graduate Research Fellowship Program. The data supporting this manuscript are available from the corresponding author on request.	Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Buchler HP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060404; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Cheng C, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.253201; Cooper NR, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.155302; Danzl JG, 2008, SCIENCE, V321, P1062, DOI 10.1126/science.1159909; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; DeMille D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043202; Gaunt AL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.200406; Gregory PD, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.041403; Guo MY, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.205303; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Haroche S., 2006, RAIMOND EXPLORING QU; Hazzard KRA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.033608; Karr JP, 2014, J MOL SPECTROSC, V300, P37, DOI 10.1016/j.jms.2014.03.016; Kaufman AM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041014; Krems R V, 2009, COLD MOL THEORY EXPT; Loh H, 2013, SCIENCE, V342, P1220, DOI 10.1126/science.1243683; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Mayle M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.012709; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Molony PK, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.255301; Neyenhuis B, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.230403; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ospelkaus S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.030402; Park JW, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/7/075016; Park JW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.205302; Quemener G, 2012, CHEM REV, V112, P4949, DOI 10.1021/cr300092g; Schiller S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.023004; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Takekoshi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.205301; Will SA, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.225306; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; Yelin SF, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.050301; Zelevinsky T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043201; Zwierlein MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250404	38	65	65	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					372	375		10.1126/science.aal5066	http://dx.doi.org/10.1126/science.aal5066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751602	Green Submitted			2022-12-28	WOS:000406362300037
J	Ledingham, J; Snowden, N; Ide, Z				Ledingham, Joanna; Snowden, Neil; Ide, Zoe			CLINICAL UPDATE Diagnosis and early management of inflammatory arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TREATING RHEUMATOID-ARTHRITIS; MODIFYING ANTIRHEUMATIC DRUGS; WORK DISABILITY; BHPR GUIDELINE; DISEASE; METHOTREXATE; EFFICACY; FATIGUE; BSR; GLUCOCORTICOIDS		[Ledingham, Joanna] Queen Alexandra Hosp, Portsmouth, Hants, England; [Snowden, Neil] Integrated Care Ctr, Pennine MSK Partnership, Oldham, England; [Ide, Zoe] Natl Rheumatoid Arthrit Soc, Maidenhead, Berks, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Ledingham, J (corresponding author), Queen Alexandra Hosp, Portsmouth, Hants, England.	jo.ledingham@porthosp.nhs.uk						Aletaha D, 2010, ARTHRITIS RHEUM, V69, P315; Ali A, 2007, CURR OPIN OPHTHALMOL, V18, P476, DOI 10.1097/ICU.0b013e3282f0fda2; Bakker MF, 2007, ANN RHEUM DIS, V66, P56, DOI 10.1136/ard.2007.078360; Bykerk VP, 2014, J RHEUMATOL, V41, P227, DOI 10.3899/jrheum.121521; Coakley G, 2006, RHEUMATOLOGY, V45, P1039, DOI 10.1093/rheumatology/kel163a; Conway R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1269; Cooney Jennifer K, 2011, J Aging Res, V2011, P681640, DOI 10.4061/2011/681640; Cramp F, 2013, COCHRANE DATABASE SY, V8; Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008; Dickens C, 2001, RHEUMATOLOGY, V40, P1327, DOI 10.1093/rheumatology/40.12.1327; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Eberhardt K, 2007, J RHEUMATOL, V34, P481; Flint J, 2016, RHEUMATOLOGY, V55, P1693, DOI 10.1093/rheumatology/kev404; Franklin J, 2007, ANN RHEUM DIS, V66, P308, DOI 10.1136/ard.2006.057265; Gaujoux-Viala C, 2014, ANN RHEUM DIS, V73, P510, DOI 10.1136/annrheumdis-2013-204588; Hannu T, 2011, BEST PRACT RES CL RH, V25, P347, DOI 10.1016/j.berh.2011.01.018; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Hewlett S, 2011, ANN RHEUM DIS, V70, P1060, DOI 10.1136/ard.2010.144691; Hua C, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000406; Humphreys JH, 2014, ARTHRIT CARE RES, V66, P1296, DOI 10.1002/acr.22296; Humphreys JH, 2013, ANN RHEUM DIS, V72, P1315, DOI 10.1136/annrheumdis-2012-201960; Keat A., 2010, MEDICINE, V38, P185, DOI [10.1016/j.mpmed.2009.12.007, DOI 10.1016/J.MPMED.2009.12.007]; Klarenbeek NB, 2009, CURR OPIN RHEUMATOL, V21, P291, DOI 10.1097/BOR.0b013e32832a2f1c; Lacaille D, 2017, ANN RHEUM DIS, V76, P1057, DOI 10.1136/annrheumdis-2016-209562; Lard LR, 2001, AM J MED, V111, P446, DOI 10.1016/S0002-9343(01)00872-5; Ledingham J, 2017, RHEUMATOLOGY, V56, P865, DOI 10.1093/rheumatology/kew479; Low ASL, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209784; Malaiya R, 2015, RHEUMATOLOGY, V54, P567, DOI 10.1093/rheumatology/keu164; Marks JL, 2012, THER ADV MUSCULOSKEL, V4, P149, DOI 10.1177/1759720X11436239; Markusse IM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0730-2; McHugh NJ, 2015, RHEUM DIS CLIN N AM, V41, P615, DOI 10.1016/j.rdc.2015.07.005; Mohan C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5079; MORAND EF, 1992, J RHEUMATOL, V19, P704; National Audit Office, 2009, SERV PEOPL REHUM ART; National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis National, 2016, 2 ANN REP; National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis National, 2015, 1 ANN REP; National Institue for Health and Clinical Excellence, 2009, RHEUM ARTH AD MAN CL, V79; National Institute for Health and Clinical Excellence, 2013, RHEUM ARTH 16S QUAL; Nikolaus S, 2013, ARTHRIT CARE RES, V65, P1128, DOI 10.1002/acr.21949; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Nystad TW, 2016, SCAND J RHEUMATOL, V45, P1, DOI 10.3109/03009742.2015.1050451; Ogdie A, 2015, RHEUM DIS CLIN N AM, V41, P545, DOI 10.1016/j.rdc.2015.07.001; Olofsson T, 2014, ANN RHEUM DIS, V73, P845, DOI 10.1136/annrheumdis-2012-202911; Pincus T, 2015, NEUROIMMUNOMODULAT, V22, P46, DOI 10.1159/000362734; Roubille C, 2014, SEMIN ARTHRITIS RHEU, V43, P613, DOI 10.1016/j.semarthrit.2013.09.005; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Sparks JA, 2014, RHEUM DIS CLIN N AM, V40, P637, DOI 10.1016/j.rdc.2014.07.005; Stoffer MA, 2016, ANN RHEUM DIS, V75, P16, DOI 10.1136/annrheumdis-2015-207526; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793; van Zanten JJCSV, 2015, SPORTS MED, V45, P1401, DOI 10.1007/s40279-015-0363-2; Waddell G., 2006, IS WORK GOOD YOUR HL; Wasko MCM, 2013, ARTHRITIS RHEUM-US, V65, P334, DOI 10.1002/art.37723; Wevers-de Boer KVC, 2013, ANN RHEUM DIS, V72, P1436, DOI 10.1136/annrheumdis-2012-203165; Woodworth T., 2013, AGING HLTH, V9, P167, DOI DOI 10.2217/AHE.13.15; Zagora SL, 2014, CURR OPIN OPHTHALMOL, V25, P495, DOI 10.1097/ICU.0000000000000098	56	29	31	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2017	358								j3248	10.1136/bmj.j3248	http://dx.doi.org/10.1136/bmj.j3248			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UX	28751303				2022-12-28	WOS:000406766000003
J	Voelker, R				Voelker, Rebecca			Decline in Student Tobacco Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					324	324		10.1001/jama.2017.8899	http://dx.doi.org/10.1001/jama.2017.8899			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NA	28742919				2022-12-28	WOS:000426800300001
J	Coster, G; Diffley, JFX				Coster, Gideon; Diffley, John F. X.			Bidirectional eukaryotic DNA replication is established by quasi-symmetrical helicase loading (vol 357, pg 314, 2017)	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MCM2-7 HELICASE; ORIGINS; COMPLEX; ARCHITECTURE; CHROMOSOME; ACTIVATION; INITIATION; BINDING; SITES	Bidirectional replication from eukaryotic DNA replication origins requires the loading of two ring-shaped minichromosome maintenance (MCM) helicases around DNA in opposite orientations. MCM loading is orchestrated by binding of the origin recognition complex (ORC) to DNA, but how ORC coordinates symmetrical MCM loading is unclear. We used natural budding yeast DNA replication origins and synthetic DNA sequences to show that efficient MCM loading requires binding of two ORC molecules to two ORC binding sites. The relative orientation of these sites, but not the distance between them, was found to be critical for MCM loading in vitro and origin function in vivo. We propose that quasi-symmetrical loading of individual MCM hexamers by ORC and directed MCM translocation into double hexamers acts as a unifying mechanism for the establishment of bidirectional replication in archaea and eukaryotes.	[Coster, Gideon; Diffley, John F. X.] Francis Crick Inst, London NW1 1AT, England	Francis Crick Institute	Diffley, JFX (corresponding author), Francis Crick Inst, London NW1 1AT, England.	john.diffley@crick.ac.uk	Coster, Gideon/L-6319-2019	Coster, Gideon/0000-0002-1449-6655; Diffley, John/0000-0001-5184-7680	Francis Crick Institute, from Cancer Research UK [FC001066]; UK Medical Research Council [FC001066]; Wellcome Trust [FC001066, 106252/Z/14/Z]; European Research Council [669424-CHROMOREP]; Cancer Research UK [15669] Funding Source: researchfish; The Francis Crick Institute [10066, 10397, 10349] Funding Source: researchfish	Francis Crick Institute, from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	We thank H. Yardimci for advice and reagents, H. Patel and G. Kelly for bioinformatic analyses, and A. McClure for critical reading of the manuscript. Supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001066), the UK Medical Research Council (FC001066), and the Wellcome Trust (FC001066). This work was also funded by a Wellcome Trust Senior Investigator Award (106252/Z/14/Z) and a European Research Council Advanced Grant (669424-CHROMOREP) to J.F.X.D. The authors declare no conflict of interest. All data are contained within the paper and the accompanying supplementary materials. J.F.X.D. and G.C. designed the experiments, analyzed data, and wrote the manuscript; G.C. performed all experiments.	BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bell SP, 2016, GENETICS, V203, P1027, DOI 10.1534/genetics.115.186452; Belsky JA, 2015, GENE DEV, V29, P212, DOI 10.1101/gad.247924.114; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Breier AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r22; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2017, SCIENCE, V357, P314, DOI 10.1126/science.aan0063; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Cvetic C, 2005, SEMIN CELL DEV BIOL, V16, P343, DOI 10.1016/j.semcdb.2005.02.009; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Georgescu R, 2017, P NATL ACAD SCI USA, V114, pE697, DOI 10.1073/pnas.1620500114; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Kolodner RD, 2007, P NATL ACAD SCI USA, V104, P12953, DOI 10.1073/pnas.0705698104; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; PALZKILL TG, 1988, CELL, V53, P441, DOI 10.1016/0092-8674(88)90164-X; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Szczelkun MD, 2010, BIOCHEM SOC T, V38, P404, DOI 10.1042/BST0380404; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012; Yardimci H, 2012, NATURE, V492, P205, DOI 10.1038/nature11730	27	69	71	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					314	318		10.1126/science.aan0063	http://dx.doi.org/10.1126/science.aan0063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729513	Green Accepted, Green Submitted			2022-12-28	WOS:000405901600044
J	Lee, CJ; Moher, D				Lee, Carole J.; Moher, David			Promote scientific integrity via journal peer review data	SCIENCE			English	Editorial Material							QUALITY; TRIAL; IMPROVE; SCIENCE		[Lee, Carole J.] Univ Washington, Dept Philosophy, Seattle, WA 98195 USA; [Moher, David] Ottawa Hosp, Ctr Journalol, Clin Epidemiol Program, Res Inst, Gen Campus, Ottawa, ON K1H 8L6, Canada; [Moher, David] Stanford Univ, METR, Palo Alto, CA 94304 USA	University of Washington; University of Washington Seattle; University of Ottawa; Ottawa Hospital Research Institute; Stanford University	Lee, CJ (corresponding author), Univ Washington, Dept Philosophy, Seattle, WA 98195 USA.	c3@uw.edu	Moher, David/I-3408-2019	Moher, David/0000-0003-2434-4206				BAILAR JC, 1985, NEW ENGL J MED, V312, P654, DOI 10.1056/NEJM198503073121023; Bruce R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0631-5; Committee on Publication Ethics (COPE), COD COND BEST PRACT; Fang FC, 2011, INFECT IMMUN, V79, P3855, DOI 10.1128/IAI.05661-11; Fraley RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109019; Goldacre B, 2016, COMPARE TRIALS PROJE; Hoke I., 2016, WHO OWNS PEER REV CO; Ioannidis JPA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002264; Jannot AS, 2013, J CLIN EPIDEMIOL, V66, P296, DOI 10.1016/j.jclinepi.2012.09.015; Justice AC, 1998, JAMA-J AM MED ASSOC, V280, P240, DOI 10.1001/jama.280.3.240; Kleinert S, 2014, LANCET, V383, P197, DOI 10.1016/S0140-6736(13)62678-1; Lariviere V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127502; Nuijten MB, 2016, BEHAV RES METHODS, V48, P1205, DOI 10.3758/s13428-015-0664-2; Rowhani-Farid A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011784; Schimmack U., REPLICABILITY RANKIN; Shanahan D., PEERLESS REV AUTOMAT; van Rooyen S, 1999, BRIT MED J, V318, P23; Vasilevsky N., PEERJ PREPRINTS; Wager E., 2012, ACAD PROFESSIONAL PU; Wager E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5248	20	35	36	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					256	257		10.1126/science.aan4141	http://dx.doi.org/10.1126/science.aan4141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729501				2022-12-28	WOS:000405901600025
J	Mason, E; Edmonds, M; Turchyn, AV				Mason, Emily; Edmonds, Marie; Turchyn, Alexandra V.			Remobilization of crustal carbon may dominate volcanic arc emissions	SCIENCE			English	Article							SUBDUCTION ZONES; MIDOCEAN RIDGE; EARTHS MANTLE; NOBLE-GASES; VOLATILES; FLUXES; CYCLE; CO2; ISOTOPES; BASALTS	The flux of carbon into and out of Earth's surface environment has implications for Earth's climate and habitability. We compiled a global data set for carbon and helium isotopes from volcanic arcs and demonstrated that the carbon isotope composition of mean global volcanic gas is considerably heavier, at -3.8 to -4.6 per mil (parts per thousand), than the canonical mid-ocean ridge basalt value of -6.0 parts per thousand. The largest volcanic emitters outgas carbon with higher delta C-13 and are located in mature continental arcs that have accreted carbonate platforms, indicating that reworking of crustal limestone is an important source of volcanic carbon. The fractional burial of organic carbon is lower than traditionally determined from a global carbon isotope mass balance and may have varied over geological time, modulated by supercontinent formation and breakup.	[Mason, Emily; Edmonds, Marie; Turchyn, Alexandra V.] Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England	University of Cambridge	Edmonds, M (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	marie.edmonds@esc.cam.ac.uk		Turchyn, Alexandra/0000-0002-9298-2173; Edmonds, Marie/0000-0003-1243-137X	Alfred P. Sloan Foundation; Deep Carbon Observatory; European Research Council Starting Investigator Grant [307582]; Natural Environment Research Council [NE/J017930/1] Funding Source: researchfish; NERC [NE/J017930/1] Funding Source: UKRI	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Deep Carbon Observatory; European Research Council Starting Investigator Grant(European Research Council (ERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The data reported in this paper are available in the supplementary materials. This study was supported by the Alfred P. Sloan Foundation and the Deep Carbon Observatory. This work was supported by a European Research Council Starting Investigator Grant (307582) to A.V.T.	Ague JJ, 2014, NAT GEOSCI, V7, P355, DOI [10.1038/NGEO2143, 10.1038/ngeo2143]; Aiuppa A, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004307; Aiuppa A, 2017, EARTH-SCI REV, V168, P24, DOI 10.1016/j.earscirev.2017.03.005; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; Bickle MJ, 1996, TERRA NOVA, V8, P270, DOI 10.1111/j.1365-3121.1996.tb00756.x; Blair NE, 2012, ANNU REV MAR SCI, V4, P401, DOI 10.1146/annurev-marine-120709-142717; Burton MR, 2013, REV MINERAL GEOCHEM, V75, P323, DOI 10.2138/rmg.2013.75.11; Cartigny P, 2005, ELEMENTS, V1, P79, DOI 10.2113/gselements.1.2.79; Chiodini G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019480; CHIODINI G, 1995, GEOTHERMICS, V24, P81, DOI 10.1016/0375-6505(94)00023-6; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Derry L. A., 2014, TREATISE GEOCHEMISTR, V12, P239, DOI DOI 10.1016/B978-0-08-095975-7.01014-7; DESMARAIS DJ, 1984, EARTH PLANET SC LETT, V69, P43, DOI 10.1016/0012-821X(84)90073-6; Etiope G, 2011, PLANET SPACE SCI, V59, P182, DOI 10.1016/j.pss.2010.06.003; Facq S, 2014, GEOCHIM COSMOCHIM AC, V132, P375, DOI 10.1016/j.gca.2014.01.030; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Farley KA, 1998, ANNU REV EARTH PL SC, V26, P189, DOI 10.1146/annurev.earth.26.1.189; Fischer TP, 2008, GEOCHEM J, V42, P21, DOI 10.2343/geochemj.42.21; GARRELS RM, 1984, AM J SCI, V284, P989, DOI 10.2475/ajs.284.9.989; Gorman PJ, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001125; Graham DW, 2002, REV MINERAL GEOCHEM, V47, P247, DOI 10.2138/rmg.2002.47.8; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Hilton DR, 2002, REV MINERAL GEOCHEM, V47, P319, DOI 10.2138/rmg.2002.47.9; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Iacono-Marziano G, 2008, CONTRIB MINERAL PETR, V155, P719, DOI 10.1007/s00410-007-0267-8; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; Johnston FKB, 2011, EARTH PLANET SC LETT, V303, P143, DOI 10.1016/j.epsl.2010.12.049; Kelemen PB, 2015, P NATL ACAD SCI USA, V112, pE3997, DOI 10.1073/pnas.1507889112; Kerrick DM, 2001, NATURE, V411, P293, DOI 10.1038/35077056; Kerrick DM, 1998, GEOLOGY, V26, P375, DOI 10.1130/0091-7613(1998)026<0375:SOOARO>2.3.CO;2; KUMP LR, 1991, GEOLOGY, V19, P299, DOI 10.1130/0091-7613(1991)019<0299:ICIESO>2.3.CO;2; Lee CTA, 2013, GEOSPHERE, V9, P21, DOI 10.1130/GES00822.1; Lee H, 2016, NAT GEOSCI, V9, P145, DOI 10.1038/NGEO2622; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Marty B, 1999, GEOCHIM COSMOCHIM AC, V63, P3619, DOI 10.1016/S0016-7037(99)00169-6; Marty B, 1998, CHEM GEOL, V145, P233, DOI 10.1016/S0009-2541(97)00145-9; MATTEY DP, 1984, EARTH PLANET SC LETT, V70, P196, DOI 10.1016/0012-821X(84)90005-0; McKenzie NR, 2016, SCIENCE, V352, P444, DOI 10.1126/science.aad5787; Morner NA, 2002, GLOBAL PLANET CHANGE, V33, P185, DOI 10.1016/S0921-8181(02)00070-X; Sano Y, 1996, GEOPHYS RES LETT, V23, P2749, DOI 10.1029/96GL02260; SANO Y, 1995, CHEM GEOL, V119, P265, DOI 10.1016/0009-2541(94)00097-R; Sano Y., 1994, JAPAN APPL GEOCHEM, V9, P371; Schrag DP, 2013, SCIENCE, V339, P540, DOI 10.1126/science.1229578; Shinohara H, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005185; Shirey SB, 2013, REV MINERAL GEOCHEM, V75, P355, DOI 10.2138/rmg.2013.75.12; Tatsumi Y., 1995, SUBDUCTION ZONE MAGM, VI; Tedesco D, 1997, EARTH PLANET SC LETT, V151, P255, DOI 10.1016/S0012-821X(97)81852-3; Werner C, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000473	48	118	121	8	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					290	294		10.1126/science.aan5049	http://dx.doi.org/10.1126/science.aan5049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729507				2022-12-28	WOS:000405901600038
J	O'Brien, E; Holt, ME; Thompson, MK; Salay, LE; Ehlinger, AC; Chazin, WJ; Barton, JK				O'Brien, Elizabeth; Holt, Marilyn E.; Thompson, Matthew K.; Salay, Lauren E.; Ehlinger, Aaron C.; Chazin, Walter J.; Barton, Jacqueline K.			Response to Comments on "The [4Fe4S] cluster of human DNA primase functions as a redox switch using DNA charge transport"	SCIENCE			English	Editorial Material							C-TERMINAL DOMAIN; SUBUNIT	Baranovskiy et al. and Pellegrini argue that, based on structural data, the path for charge transfer through the [4Fe4S] domain of primase is not feasible. Our manuscript presents electrochemical data directly showing charge transport through DNA to the [4Fe4S] cluster of a primase p58C construct and a reversible switch in the DNA-bound signal with oxidation/reduction, which is inhibited by mutation of three tyrosine residues. Although the dispositions of tyrosines differ in different constructs, all are within range for microsecond electron transfer.	[O'Brien, Elizabeth; Barton, Jacqueline K.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Holt, Marilyn E.; Thompson, Matthew K.; Salay, Lauren E.; Ehlinger, Aaron C.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37235 USA; [Holt, Marilyn E.; Thompson, Matthew K.; Salay, Lauren E.; Ehlinger, Aaron C.; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Struct Biol Ctr, Box 1583, Nashville, TN 37235 USA	California Institute of Technology; Vanderbilt University; Vanderbilt University	Barton, JK (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.; Chazin, WJ (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37235 USA.; Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Chem, Struct Biol Ctr, Box 1583, Nashville, TN 37235 USA.	walter.j.chazin@vanderbilt.edu; jkbarton@caltech.edu		Chazin, Walter/0000-0002-2180-0790	NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065484, R35GM118089, T32GM008320] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009582] Funding Source: Medline; NIGMS NIH HHS [R01 GM065484, R35 GM118089, T32 GM008320] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Baranovskiy AG, 2017, SCIENCE, V357, DOI 10.1126/science.aan2396; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2016, J BIOL CHEM, V291, P4793, DOI 10.1074/jbc.M115.704064; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; O'Brien E, 2017, SCIENCE, V355, DOI 10.1126/science.aag1789; Pellegrini L, 2017, SCIENCE, V357, DOI 10.1126/science.aan2954; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Winkler JR, 2014, J AM CHEM SOC, V136, P2930, DOI 10.1021/ja500215j	11	23	23	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348							eaan2762	10.1126/science.aan2762	http://dx.doi.org/10.1126/science.aan2762			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729485	Green Accepted			2022-12-28	WOS:000405901600002
J	Clarkson, C; Jacobs, Z; Marwick, B; Fullagar, R; Wallis, L; Smith, M; Roberts, RG; Hayes, E; Lowe, K; Carah, X; Florin, SA; McNeil, J; Cox, D; Arnold, LJ; Hua, Q; Huntley, J; Brand, HEA; Manne, T; Fairbairn, A; Shulmeister, J; Lyle, L; Salinas, M; Page, M; Connell, K; Park, G; Norman, K; Murphy, T; Pardoe, C				Clarkson, Chris; Jacobs, Zenobia; Marwick, Ben; Fullagar, Richard; Wallis, Lynley; Smith, Mike; Roberts, Richard G.; Hayes, Elspeth; Lowe, Kelsey; Carah, Xavier; Florin, S. Anna; McNeil, Jessica; Cox, Delyth; Arnold, Lee J.; Hua, Quan; Huntley, Jillian; Brand, Helen E. A.; Manne, Tiina; Fairbairn, Andrew; Shulmeister, James; Lyle, Lindsey; Salinas, Makiah; Page, Mara; Connell, Kate; Park, Gayoung; Norman, Kasih; Murphy, Tessa; Pardoe, Colin			Human occupation of northern Australia by 65,000 years ago	NATURE			English	Article							HUMAN COLONIZATION; LAKE MUNGO; NEW-GUINEA; LUMINESCENCE; STRATIGRAPHY; ARCHAEOLOGY; CHRONOLOGY; SETTLEMENT; MIGRATION; SHELTER	The time of arrival of people in Australia is an unresolved question. It is relevant to debates about when modern humans first dispersed out of Africa and when their descendants incorporated genetic material from Neanderthals, Denisovans and possibly other hominins. Humans have also been implicated in the extinction of Australia's megafauna. Here we report the results of new excavations conducted at Madjedbebe, a rock shelter in northern Australia. Artefacts in primary depositional context are concentrated in three dense bands, with the stratigraphic integrity of the deposit demonstrated by artefact refits and by optical dating and other analyses of the sediments. Human occupation began around 65,000 years ago, with a distinctive stone tool assemblage including grinding stones, ground ochres, reflective additives and ground-edge hatchet heads. This evidence sets a new minimum age for the arrival of humans in Australia, the dispersal of modern humans out of Africa, and the subsequent interactions of modern humans with Neanderthals and Denisovans.	[Clarkson, Chris; Lowe, Kelsey; Carah, Xavier; Florin, S. Anna; McNeil, Jessica; Cox, Delyth; Manne, Tiina; Fairbairn, Andrew; Norman, Kasih] Univ Queensland, Sch Social Sci, Brisbane, Qld 4072, Australia; [Jacobs, Zenobia; Roberts, Richard G.] Univ Wollongong, Australian Res Council, Ctr Excellence Australian Biodivers & Heritage, Wollongong, NSW 2522, Australia; [Jacobs, Zenobia; Marwick, Ben; Fullagar, Richard; Roberts, Richard G.; Hayes, Elspeth] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Marwick, Ben; Lyle, Lindsey; Salinas, Makiah; Page, Mara; Park, Gayoung; Murphy, Tessa] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Wallis, Lynley] Univ Notre Dame, Nulungu Res Inst, Broome, WA 6725, Australia; [Smith, Mike] Natl Museum Australia, Ctr Hist Res, Canberra, ACT 2601, Australia; [McNeil, Jessica] Harvard Univ, Dept Anthropol, Cambridge, MA 02143 USA; [Arnold, Lee J.] Univ Adelaide, Environm Inst, Sch Phys Sci, Adelaide, SA 5005, Australia; [Arnold, Lee J.] Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA 5005, Australia; [Hua, Quan] Australian Nucl Sci & Technol Org, Lucas Heights, NSW 2234, Australia; [Huntley, Jillian] Griffith Univ, Sch Humanities, Pl Evolut Rock Art Heritage Unit, Nathan, Qld 4222, Australia; [Brand, Helen E. A.] Australian Synchrotron, 800 Blackburn Rd, Clayton, Vic 3168, Australia; [Shulmeister, James] Univ Queensland, Sch Earth & Environm Sci, Brisbane, Qld 4072, Australia; [Pardoe, Colin] Australian Natl Univ, Sch Culture Hist & Language, Archaeol & Nat Hist, Canberra, ACT 2601, Australia	University of Queensland; University of Wollongong; University of Wollongong; University of Washington; University of Washington Seattle; University of Notre Dame Australia; Harvard University; University of Adelaide; University of Adelaide; Australian Nuclear Science & Technology Organisation; Griffith University; University of Queensland; Australian National University	Clarkson, C (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld 4072, Australia.; Jacobs, Z (corresponding author), Univ Wollongong, Australian Res Council, Ctr Excellence Australian Biodivers & Heritage, Wollongong, NSW 2522, Australia.; Jacobs, Z (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	c.clarkson@uq.edu.au; zenobia@uow.edu.au	Fullagar, Richard/AAT-1155-2020; CABAH, ARC/T-6419-2019; Jacobs, Zenobia/B-2721-2012; Hua, Quan/F-9593-2014; Florin, S. Anna/AAE-6767-2019; Lowe, Kelsey/H-1826-2014; Wallis, Lynley/U-9161-2019; Manne, Tiina/B-3791-2019; Wallis, Lynley/AAD-2481-2021; Roberts, Richard Graham/B-8245-2013; Marwick, Ben/H-1747-2013; Arnold, Lee J/J-4356-2018; Shulmeister, James/J-2859-2015; Huntley, Jillian/AAW-7798-2020	Jacobs, Zenobia/0000-0001-5424-5837; Hua, Quan/0000-0003-0179-8539; Florin, S. Anna/0000-0001-6229-900X; Lowe, Kelsey/0000-0002-0857-2877; Wallis, Lynley/0000-0002-9324-8069; Manne, Tiina/0000-0003-2202-791X; Roberts, Richard Graham/0000-0002-0128-4119; Marwick, Ben/0000-0001-7879-4531; Arnold, Lee J/0000-0001-9603-3824; Shulmeister, James/0000-0001-5863-9462; Huntley, Jillian/0000-0002-9701-9925; Fairbairn, Andrew/0000-0002-4004-6957; Norman, Kasih/0000-0002-4975-2516; Smith, Mike/0000-0002-6177-8217; Fullagar, Richard/0000-0003-1047-1466	Australian Research Council [DP110102864, FT140100101, DP1092843, FT150100138, FL130100116, DE150101597, FT130100195]; DAAD [A/14/01370]; UW-UQ Trans-Pacific Fellowship; UW Royalty Research Fellowship [65-4630]; AINSE [11877]; Wenner Gren Dissertation Fieldwork Grant [Gr. 9260]; Australian Institute of Nuclear Science and Engineering [13/003, 15/001]; Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)	Australian Research Council(Australian Research Council); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); UW-UQ Trans-Pacific Fellowship; UW Royalty Research Fellowship; AINSE; Wenner Gren Dissertation Fieldwork Grant; Australian Institute of Nuclear Science and Engineering; Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	The authors are grateful to the custodians of Madjedbebe, the Mirarr Senior Traditional Owners (Y. Margarula and M. Nango) and our research partners (Gundjeihmi Aboriginal Corporation) for permission to carry out this research and publish this paper. We are also grateful to J. O'Brien and D. Vadiveloo for assistance in the field. This research was funded through Australian Research Council grants and fellowships to C.C., B.M., L.W., R.F., M. Sm. (DP110102864), B.M. (FT140100101), Z.J. (DP1092843, FT150100138), R.G.R. (FL130100116), T.Ma. (DE150101597) and L.J.A. (FT130100195), and through Australian Postgraduate Awards to X.C., E.H., S.A.F. and K.L. B.M. was also supported by a DAAD Fellowship (A/14/01370), a UW-UQ Trans-Pacific Fellowship, and UW Royalty Research Fellowship (65-4630). S.A.F. was also supported by an AINSE Postgraduate Research Award (11877) and a Wenner Gren Dissertation Fieldwork Grant (Gr. 9260). Radiocarbon analyses were partly funded by Australian Institute of Nuclear Science and Engineering grants 13/003 and 15/001 to C.C., X.C., S.A.F. and K.N. We acknowledge financial support from the Australian Government's National Collaborative Research Infrastructure Strategy (NCRIS) for the Centre for Accelerator Science at the Australian Nuclear Science and Technology Organisation. A L'Oreal Australia For Women in Science Fellowship to Z.J. supported the re-dating of the original sediment samples. Part of this work was undertaken on the powder diffraction beamline at the Australian Synchrotron. We thank E. Grey, R. MacPhail, S. Mentzer, C. Miller, M. Svob, and X. Villagran for assistance with geoarchaeological analysis, T. Lachlan and Y. Jafari for help with OSL dating and related illustrations, and C. Matheson and J. Field for assistance with residue analysis.	Allen J, 2014, AUST ARCHAEOL, P86; Asouti E, 2005, ENVIRON ARCHAEOL, V10, P1, DOI 10.1179/env.2005.10.1.1; Baas P, 2004, IAWA J, V25, P1, DOI 10.1163/22941932-90000349; Bird MI, 1999, RADIOCARBON, V41, P127, DOI 10.1017/S0033822200019482; Bird MI, 2014, QUAT GEOCHRONOL, V22, P25, DOI 10.1016/j.quageo.2014.02.003; Bird MI, 2013, J QUATERNARY SCI, V28, P439, DOI 10.1002/jqs.2639; BOTTERJENSEN L, 1988, NUCL TRACKS RAD MEAS, V14, P187; Bowdler S., 1990, AUST ARCHAEOL, V31, P93; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Clarkson C, 2015, J HUM EVOL, V83, P46, DOI 10.1016/j.jhevol.2015.03.014; Fink D, 2004, NUCL INSTRUM METH B, V223, P109, DOI 10.1016/j.nimb.2004.04.025; French D. H., 1971, ANATOL STUD, V21, P59, DOI DOI 10.2307/3642629; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fullagar R, 2015, ARCHAEOL OCEAN, V50, P3, DOI 10.1002/arco.5053; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Geneste JM, 2010, AUST ARCHAEOL, P66; Hamm G, 2016, NATURE, V539, P280, DOI 10.1038/nature20125; Hather J. G., 2000, ARCHAEOLOGICAL PAREN; Hather J. G., 1994, TROPICAL ARCHAEOBOTA, P51; Hiscock P., 1990, ARCHAEOL OCEAN, V25, P122; Hiscock P, 2016, AUST ARCHAEOL, V82, P2, DOI 10.1080/03122417.2016.1164379; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Hua Q, 2001, RADIOCARBON, V43, P275; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; Huntley J, 2012, AUST ARCHAEOL, V75, P78, DOI 10.1080/03122417.2012.11681952; IAWA Committee, 1989, IAWA B N S, V10, P219, DOI DOI 10.1163/22941932-90000496; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Johnson CN, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2399; Jones Rhys, 1999, P BRIT ACAD, V99, P37; Kamminga J., 1973, ALLIGATOR RIVERS ENV; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Lowe K. M., 2016, ARCHAEOL ANTHR SCI; Lowe KM, 2016, GEOARCHAEOLOGY, V31, P211, DOI 10.1002/gea.21544; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Marwick B, 2017, J ARCHAEOL SCI, V79, P73, DOI 10.1016/j.jas.2017.01.008; McNeil J.-L., 2015, 80 ANN M SOC AM ARCH; Mondal M, 2016, NAT GENET, V48, P1066, DOI 10.1038/ng.3621; NESBITT M, 1995, BIBLIC ARCHAEOL, V58, P68, DOI 10.2307/3210477; O'Connell JF, 2015, J ARCHAEOL SCI, V56, P73, DOI 10.1016/j.jas.2015.02.020; O'Connell JF, 1998, EVOL ANTHROPOL, V6, P132, DOI 10.1002/(SICI)1520-6505(1998)6:4<132::AID-EVAN3>3.0.CO;2-F; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rhodes EJ, 2003, QUATERNARY SCI REV, V22, P1231, DOI 10.1016/S0277-3791(03)00046-5; Roberts R. G., 2001, HUMANITY AFRICAN NAI, P239; Roberts R.G., 1998, ANCIENT TL, V16, P19; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Roberts RG, 1994, AUSTR ABORIGINAL STU, V2, P2; Roberts RG, 2015, J ARCHAEOL SCI, V56, P41, DOI 10.1016/j.jas.2015.02.028; Roberts Richard G., 1990, ARCHAEOL OCEAN, V25, P125; Saltre F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10511; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Smith MA, 1997, QUATERNARY SCI REV, V16, P299, DOI 10.1016/S0277-3791(96)00085-6; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Sutikna T, 2016, NATURE, V532, P366, DOI 10.1038/nature17179; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195; van der Kaars S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14142; Veth P, 2017, QUATERNARY SCI REV, V168, P19, DOI 10.1016/j.quascirev.2017.05.002; Wilkins J. R., 2008, THESIS; Wood R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160123	67	421	430	7	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					306	+		10.1038/nature22968	http://dx.doi.org/10.1038/nature22968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FB0OR	28726833	Green Submitted, Green Published			2022-12-28	WOS:000405844900025
J	Dalal, F; Dalal, HM; Voukalis, C; Gandhi, MM				Dalal, Fatima; Dalal, Hasnain M.; Voukalis, Christos; Gandhi, Manish M.			Management of patients after primary percutaneous coronary intervention for myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; DUAL ANTIPLATELET THERAPY; 2013 ACCF/AHA GUIDELINE; COLLEGE-OF-CARDIOLOGY; CARDIAC REHABILITATION; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; SEXUAL-ACTIVITY; ANTITHROMBOTIC THERAPY; EUROPEAN ASSOCIATION		[Dalal, Fatima] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham B15 2GW, W Midlands, England; [Dalal, Hasnain M.] Univ Exeter, Med Sch Primary Care, Truro Campus, Truro TR1 3HD, England; [Voukalis, Christos] Univ Birmingham, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Gandhi, Manish M.] Royal Devon & Exeter NHS Fdn Trust, Cardiac Dept, Exeter EX2 5DW, Devon, England	University of Birmingham; University of Exeter; University of Birmingham; University of Exeter	Dalal, HM (corresponding author), Univ Exeter, Med Sch Primary Care, Truro Campus, Truro TR1 3HD, England.	hmdalal@doctors.net.uk			NHS [NIHR PGfAR RP-PG-0611-12004]; NIHR	NHS; NIHR(National Institute for Health Research (NIHR))	We have read and understood the BMJ Group's policy on declaration of interests and declare the following interests. HMD has co-authored Cochrane reviews on cardiac rehabilitation, is co-chief investigator on a National Institute for Health Research (NIHR) and NHS-funded programme grant for applied research (NIHR PGfAR RP-PG-0611-12004), and is an ordinary member of the council of the British Association of Cardiovascular Prevention and Rehabilitation (BACPR). MMG is a co-investigator on the NIHR funded CADENCE study of enhanced psychological interventions in cardiac rehabilitation. Provenance and peer review: Encouraged; externally peer reviewed.	Ades PA, 2017, MAYO CLIN PROC, V92, P234, DOI 10.1016/j.mayocp.2016.10.014; American Association of Cardiovascular & Pulmonary Rehabilitation, 2004, GUID CARD REH SEC PR; American College of Sports Medicine, 2021, ACSMS GUIDELINES EXE; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], 2017, PROJ NHS CAR PAT HEA; Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003; Balady GJ, 2007, J CARDIOPULM REHABIL, V27, P121; Bang CN, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000382; Bethell HJN, 1996, BMJ-BRIT MED J, V312, P1372, DOI 10.1136/bmj.312.7043.1372; Bhindi R, 2017, CIRCULATION, V135, P1574, DOI 10.1161/CIRCULATIONAHA.116.025266; Blumenthal JA, 2016, CIRCULATION, V133, P1341, DOI 10.1161/CIRCULATIONAHA.115.018926; British Heart Foundation, 2016, NAT AUD CARD REH ANN; Colantonio LD, 2017, JAMA CARDIOL, V2, P890, DOI 10.1001/jamacardio.2017.0911; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Cummings KM, 2017, LANCET, V389, P768, DOI 10.1016/S0140-6736(17)30125-3; Cupples Margaret, 2016, Monaldi Arch Chest Dis, V86, P755, DOI 10.4081/monaldi.2016.755; Dalal HM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5000; Dalen JE, 2014, AM J MED, V127, P364, DOI 10.1016/j.amjmed.2013.12.014; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Driver Vehicle Licensing Agency, 2017, ASS FITN DRIV A GUID; Gale CP, 2012, EUR HEART J, V33, P630, DOI 10.1093/eurheartj/ehr381; Hansen D, 2017, EUR J PREV CARDIOL, V24, P1017, DOI 10.1177/2047487317702042; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Kloner RA, 2003, J AM COLL CARDIOL, V42, P1855, DOI 10.1016/j.jacc.2003.09.023; Kostis JB, 2005, AM J CARDIOL, V96, P313, DOI 10.1016/j.amjcard.2005.03.065; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Levine GN, 2012, CIRCULATION, V125, P1058, DOI 10.1161/CIR.0b013e3182447787; Lindau ST, 2014, CIRCULATION, V130, P2302, DOI 10.1161/CIRCULATIONAHA.114.012709; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Luo C, 2014, AM J CLIN NUTR, V100, P256, DOI 10.3945/ajcn.113.076109; Mukamal KJ, 2005, CIRCULATION, V112, P3839, DOI 10.1161/CIRCULATIONAHA.105.574749; National Institute for Health and Care Excellence, 2013, MYOC INF CARD REH PR; National Institute for Health and Care Excellence, 2016, CARD DIS RISK ASS RE; NAUGHTON J, 2000, J REHABILITATION OUT, V4, P64; NHS Lothian, 2015, HEART MAN; NICE, 2015, MED OPT SAF EFF MED; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Ohman EM, 2017, LANCET, V389, P1799, DOI 10.1016/S0140-6736(17)30751-1; Oldroyd KG, 2017, CIRCULATION, V135, P1571, DOI 10.1161/CIRCULATIONAHA.117.025265; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rea TD, 2002, ANN INTERN MED, V137, P494, DOI 10.7326/0003-4819-137-6-200209170-00009; Richards SH, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002902.pub4; Richards SH, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1184-9; Rigotti NA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub3; Rosendorff C, 2015, CIRCULATION, V131, pE435, DOI [10.1161/CIR.0000000000000207, 10.1016/j.jacc.2015.02.038]; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Smith D, 2010, HEART, V96, pII1, DOI 10.1136/hrt.2010.203091; Smith JG, 2012, EUROINTERVENTION, V8, P672, DOI 10.4244/EIJV8I6A105; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Smolderen KG, 2017, CIRCULATION, V135, P1681, DOI 10.1161/CIRCULATIONAHA.116.025140; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steinke EE, 2013, CIRCULATION, V128, P2075, DOI 10.1161/CIR.0b013e31829c2e53; Steptoe A, 2016, HEART, V102, P1095, DOI 10.1136/heartjnl-2015-308993; Anderson Lindsey, 2017, Cochrane Database Syst Rev, V6, pCD007130, DOI [10.1002/14651858.CD007130.pub3, 10.1002/14651858.CD007130.pub4]; Van Horn L, 2016, CIRCULATION, V134, pE505, DOI 10.1161/CIR.0000000000000462; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Wei MY, 2013, J CLIN LIPIDOL, V7, P472, DOI 10.1016/j.jacl.2013.03.001; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Yusuf S, 2016, LANCET, V388, P943, DOI 10.1016/S0140-6736(16)31532-X; Zaman MJ, 2014, EUR HEART J, V35, P1551, DOI 10.1093/eurheartj/ehu039; Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	8	9	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2017	358								j3237	10.1136/bmj.j3237	http://dx.doi.org/10.1136/bmj.j3237			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7KC	28729460				2022-12-28	WOS:000406318500004
J	Zenk, F; Loeser, E; Schiavo, R; Kilpert, F; Bogdanovic, O; Iovino, N				Zenk, Fides; Loeser, Eva; Schiavo, Rosaria; Kilpert, Fabian; Bogdanovic, Ozren; Iovino, Nicola			Germ line-inherited H3K27me3 restricts enhancer function during maternal-to-zygotic transition	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; CHROMATIN STATE; GENE-EXPRESSION; IN-VIVO; POLYCOMB; MECHANISMS; REPRESSION; MAMMALS; MEMORY; DNA	Gametes carry parental genetic material to the next generation. Stress-induced epigenetic changes in the germ line can be inherited and can have a profound impact on offspring development. However, the molecular mechanisms and consequences of transgenerational epigenetic inheritance are poorly understood. We found that Drosophila oocytes transmit the repressive histone mark H3K27me3 to their offspring. Maternal contribution of the histone methyltransferase Enhancer of zeste, the enzymatic component of Polycomb repressive complex 2, is required for active propagation of H3K27me3 during early embryogenesis. H3K27me3 in the early embryo prevents aberrant accumulation of the active histone mark H3K27ac at regulatory regions and precocious activation of lineage-specific genes at zygotic genome activation. Disruption of the germ line-inherited Polycomb epigenetic memory causes embryonic lethality that cannot be rescued by late zygotic reestablishment of H3K27me3. Thus, maternally inherited H3K27me3, propagated in the early embryo, regulates the activation of enhancers and lineage-specific genes during development.	[Zenk, Fides; Loeser, Eva; Schiavo, Rosaria; Iovino, Nicola] Max Planck Inst Immunobiol & Epigenet, Dept Chromatin Regulat, D-79108 Freiburg, Germany; [Zenk, Fides] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Kilpert, Fabian] Max Planck Inst Immunobiol & Epigenet, Bioinformat Facil, D-79108 Freiburg, Germany; [Bogdanovic, Ozren] Garvan Inst Med Res, Genom & Epigenet Div, Sydney, NSW, Australia; [Bogdanovic, Ozren] Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Bogdanovic, Ozren] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia	Max Planck Society; University of Freiburg; Max Planck Society; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Western Australia	Iovino, N (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Chromatin Regulat, D-79108 Freiburg, Germany.	iovino@ie-freiburg.mpg.de	Bogdanovic, Ozren/ABG-9527-2020	Bogdanovic, Ozren/0000-0001-5680-0056; Iovino, Nicola/0000-0002-3335-7618	Max Planck Society; IMPRS; German Research Foundation (DFG) [CRC992]; Australian Research Council [DE140101962]; DFG [CRC992]	Max Planck Society(Max Planck SocietyFoundation CELLEX); IMPRS; German Research Foundation (DFG)(German Research Foundation (DFG)); Australian Research Council(Australian Research Council); DFG(German Research Foundation (DFG))	We thank the Iovino lab, in particular D. Latreille, D. Ibarra-Morales, and V. Asimi; our colleagues A. Akhtar, T. Jenuwein, P. Becker, R. Sawarkar, E. Trompouki, and especially T. Boehm for critical reading of the manuscript; the Bioinformatics and Sequencing facilities at the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE) (T. Manke, U. Boenisch, L. Arrigoni, and in particular D. Ryan); C. Hug and J. M. Vaquerizas (MPI for Molecular Biomedicine, Muenster, Germany) for initial help in RNA-seq data analysis; S. De Renzis (EMBL) for initial help in staging of the embryos; the Imaging facility, Proteomics facility, and Fly facility at MPI-IE; L. Ringrose and V. Pirrotta for sharing fly stocks; and J. Mueller [E(z)], T. Jenuwein (H3K27me3 and H3K27me2), and the Developmental Studies Hybridoma Bank (Abd-B) for antibodies. The Bloomington Drosophila Stock Center (NIH P40OD018537) and the Transgenic RNAi Project at Harvard Medical School (NIH/NIGMS R01-GM084947) provided fly stocks used in this study. Supported by the Max Planck Society and IMPRS program (F. Z. and E. L.); German Research Foundation (DFG) CRC992, Project B06 and Z01 (R. S. and F. K.); Australian Research Council Discovery Early Career Researcher Award DE140101962 (O. B.); and the Max Planck Society and DFG CRC992, Project B06 (N. I.). All the data are deposited at ENA (www.ebi.ac.uk/ena) PRJEB18481 (primary accession), ERP020413 (secondary accession).	Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Bowman SK, 2014, ELIFE, V3, DOI 10.7554/eLife.02833; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cheutin T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002465; Copur O, 2013, DEVELOPMENT, V140, P3478, DOI 10.1242/dev.097204; Elnfati AH, 2016, GENOM DATA, V7, P175, DOI 10.1016/j.gdata.2015.12.021; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Grossniklaus U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019331; Haigh AJ, 2005, GENETICS, V169, P1165, DOI 10.1534/genetics.104.035113; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; HAYNIE JL, 1983, DEV BIOL, V100, P399, DOI 10.1016/0012-1606(83)90234-8; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Hontelez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10148; Iovino N, 2013, DEV CELL, V26, P431, DOI 10.1016/j.devcel.2013.06.021; JONES RS, 1990, GENETICS, V126, P185; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Li XY, 2014, ELIFE, V3, DOI 10.7554/eLife.03737; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Miska EA, 2016, SCIENCE, V354, P59, DOI 10.1126/science.aaf4945; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Mu WP, 2014, GENE DEV, V28, P2056, DOI 10.1101/gad.246124.114; PELEGRI F, 1994, GENETICS, V136, P1341; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Samson M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004588; Schroeder MD, 2011, DEVELOPMENT, V138, P3067, DOI 10.1242/dev.062141; Sharma U, 2017, CELL METAB, V25, P544, DOI 10.1016/j.cmet.2017.02.003; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; STRUHL G, 1982, CELL, V31, P285, DOI 10.1016/0092-8674(82)90428-7; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Zheng H, 2016, MOL CELL, V63, P1066, DOI 10.1016/j.molcel.2016.08.032	35	94	99	4	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		212	216		10.1126/science.aam5339	http://dx.doi.org/10.1126/science.aam5339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706074				2022-12-28	WOS:000405391700049
J	Reardon, S				Reardon, Sara			White House science office adrift as staff dwindles	NATURE			English	News Item																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					145	146		10.1038/547145a	http://dx.doi.org/10.1038/547145a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703212				2022-12-28	WOS:000405314500009
J	Kanchanachitra, C; Tangcharoensathien, V				Kanchanachitra, Churnrurtai; Tangcharoensathien, Viroj			Health inequality across prefectures in Japan	LANCET			English	Editorial Material							SOCIOECONOMIC-STATUS		[Kanchanachitra, Churnrurtai] Mahidol Univ, Inst Populat & Social Res, Phutthamonthon, Nakhon Pathom, Thailand; [Tangcharoensathien, Viroj] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand	Mahidol University; Ministry of Public Health - Thailand	Kanchanachitra, C (corresponding author), Mahidol Univ, Inst Populat & Social Res, Phutthamonthon, Nakhon Pathom, Thailand.	churnrurtai.kan@mahidol.edu						Crombie I.K., 2005, CLOSING HLTH INEQUAL; Fone DL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002337; Fukuda Y, 2007, BIOSCI TRENDS, V1, P38; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hiyoshi A, 2014, SOC SCI MED, V104, P201, DOI 10.1016/j.socscimed.2013.12.028; IKEDA N, 2011, LANCET, V378, P1094, DOI DOI 10.1016/S0140-6736(11)61055-6; Japan Statistics Bureau, JAP STAT YB 2017 POP; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Marmot M, 2014, AM J PUBLIC HEALTH, V104, pS517, DOI 10.2105/AJPH.2014.302200; Nagassar RP, 2010, W INDIAN MED J, V59, P20; Nomura S, 2017, LANCET; Sugisawa H, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0095-z; UN Development Programme , 2016, HUMAN DEV REPORT 201; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x	14	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1471	1473		10.1016/S0140-6736(17)31792-0	http://dx.doi.org/10.1016/S0140-6736(17)31792-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FH7BS	28734671	hybrid			2022-12-28	WOS:000411337100007
J	Niewoehner, O; Garcia-Doval, C; Rostol, JT; Berk, C; Schwede, F; Bigler, L; Hall, J; Marraffini, LA; Jinek, M				Niewoehner, Ole; Garcia-Doval, Carmela; Rostol, Jakob T.; Berk, Christian; Schwede, Frank; Bigler, Laurent; Hall, Jonathan; Marraffini, Luciano A.; Jinek, Martin			Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers	NATURE			English	Article							EFFECTOR COMPLEX; THERMUS-THERMOPHILUS; DNA CLEAVAGE; PROTEIN; IMMUNITY; RECOGNITION; ENDORIBONUCLEASE; CLASSIFICATION; DEGRADATION; BACTERIA	In many prokaryotes, type III clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated (Cas) systems detect and degrade invasive genetic elements by an RNA-guided, RNA-targeting multisubunit interference complex. The CRISPR-associated protein Csm6 additionally contributes to interference by functioning as a standalone RNase that degrades invader RNA transcripts, but the mechanism linking invader sensing to Csm6 activity is not understood. Here we show that Csm6 proteins are activated through a second messenger generated by the type III interference complex. Upon target RNA binding by the interference complex, its Cas10 subunit converts ATP into a cyclic oligoadenylate product, which allosterically activates Csm6 by binding to its CRISPR-associated Rossmann fold (CARF) domain. CARF domain mutations that abolish allosteric activation inhibit Csm6 activity in vivo, and mutations in the Cas10 Palm domain phenocopy loss of Csm6. Together, these results point to an unprecedented mechanism for regulation of CRISPR interference that bears striking conceptual similarity to oligoadenylate signalling in mammalian innate immunity.	[Niewoehner, Ole; Garcia-Doval, Carmela; Jinek, Martin] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Rostol, Jakob T.; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA; [Berk, Christian; Hall, Jonathan] Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland; [Schwede, Frank] BIOLOG Life Sci Inst GmbH, Flughafendamm 9a, D-28199 Bremen, Germany; [Bigler, Laurent] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Zurich; Rockefeller University; University of Zurich	Jinek, M (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jinek@bioc.uzh.ch	Bigler, Laurent/AAP-3799-2020; Jinek, Martin/E-6621-2011	Bigler, Laurent/0000-0003-3548-3594; Berk, Christian/0000-0003-3858-5764; Jinek, Martin/0000-0002-7601-210X; Rostol, Jakob/0000-0001-9485-9972; Hall, Jonathan/0000-0003-4160-7135; Garcia Doval, Carmela/0000-0002-3422-9490	Swiss National Science Foundation [SNSF 31003A_149393]; Swiss National Competence Center for Research (NCCR) 'RNA Disease'; European Molecular Biology Organization; Boehringer Ingelheim Fonds PhD fellowship; Rita Allen Scholars Program; Burroughs Wellcome Fund PATH award; National Institutes of Health Director's New Innovator Award [1DP2AI104556-01]; Howard Hughes Medical Institute-Simons Faculty Scholar Award	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Competence Center for Research (NCCR) 'RNA Disease'; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim Fonds PhD fellowship(Boehringer Ingelheim); Rita Allen Scholars Program; Burroughs Wellcome Fund PATH award(Burroughs Wellcome Fund); National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute-Simons Faculty Scholar Award	We thank members of the Jinek and Marraffini laboratories for discussions and comments on the manuscript. We thank D. Swarts and P. Sledz for technical assistance and sharing reagents. We thank U. Manzau for technical assistance during A4>P synthesis and purification. We thank the Service for Mass Spectrometry of ETH Zurich for support with MS analysis. This study was supported by a Swiss National Science Foundation project grant to M.J. (SNSF 31003A_149393) and by funding from the Swiss National Competence Center for Research (NCCR) 'RNA & Disease' (to M.J. and J.H.). M.J. is an International Research Scholar of the Howard Hughes Medical Institute and Vallee Scholar of the Bert L & N Kuggie Vallee Foundation. C.G.-D. was supported by a Long-Term Fellowship from the European Molecular Biology Organization. J.T.R. was supported by a Boehringer Ingelheim Fonds PhD fellowship. L.A.M. is supported by the Rita Allen Scholars Program, a Burroughs Wellcome Fund PATH award, a National Institutes of Health Director's New Innovator Award (1DP2AI104556-01), and a Howard Hughes Medical Institute-Simons Faculty Scholar Award.	Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Burroughs AM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1267; Carroll SS, 1997, J BIOL CHEM, V272, P19193, DOI 10.1074/jbc.272.31.19193; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Geertsma ER, 2014, METHODS MOL BIOL, V1116, P153, DOI 10.1007/978-1-62703-764-8_11; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; He F, 2017, NUCLEIC ACIDS RES, V45, P1902, DOI 10.1093/nar/gkw1265; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Osawa T, 2013, J MOL BIOL, V425, P3811, DOI 10.1016/j.jmb.2013.03.042; Prischi F., 2014, NAT COMMUN, V5, P3554; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sheppard NF, 2016, RNA, V22, P216, DOI 10.1261/rna.039842.113; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Topuzlu E, 2016, RNA BIOL, V13, P254, DOI 10.1080/15476286.2015.1130209; Yan XF, 2015, RNA BIOL, V12, P749, DOI 10.1080/15476286.2015.1051300	41	207	225	6	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					543	+		10.1038/nature23467	http://dx.doi.org/10.1038/nature23467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28722012	Green Submitted			2022-12-28	WOS:000408703100029
J	Russell, S; Bennett, J; Wellman, JA; Chung, DC; Yu, ZF; Tillman, A; Wittes, J; Pappas, J; Elci, O; McCague, S; Cross, D; Marshall, KA; Walshire, J; Kehoe, TL; Reichert, H; Davis, M; Raffini, L; George, LA; Hudson, FP; Dingfield, L; Zhu, XS; Haller, JA; Sohn, EH; Mahajan, VB; Pfeifer, W; Weckmann, M; Johnson, C; Gewaily, D; Drack, A; Stone, E; Wachtel, K; Simonelli, F; Leroy, BP; Wright, JF; High, KA; Maguire, AM				Russell, Stephen; Bennett, Jean; Wellman, Jennifer A.; Chung, Daniel C.; Yu, Zi-Fan; Tillman, Amy; Wittes, Janet; Pappas, Julie; Elci, Okan; McCague, Sarah; Cross, Dominique; Marshall, Kathleen A.; Walshire, Jean; Kehoe, Taylor L.; Reichert, Hannah; Davis, Maria; Raffini, Leslie; George, Lindsey A.; Hudson, F. Parker; Dingfield, Laura; Zhu, Xiaosong; Haller, Julia A.; Sohn, Elliott H.; Mahajan, Vinit B.; Pfeifer, Wanda; Weckmann, Michelle; Johnson, Chris; Gewaily, Dina; Drack, Arlene; Stone, Edwin; Wachtel, Katie; Simonelli, Francesca; Leroy, Bart P.; Wright, J. Fraser; High, Katherine A.; Maguire, Albert M.			Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial	LANCET			English	Article							LEBER CONGENITAL AMAUROSIS; GENE-THERAPY; RPE65 MUTATIONS; ADENOASSOCIATED VIRUS; RETINITIS-PIGMENTOSA; VISUAL FUNCTION; CANINE MODEL; VISION; IDENTIFICATION; BLINDNESS	Background Phase 1 studies have shown potential benefit of gene replacement in RPE65-mediated inherited retinal dystrophy. This phase 3 study assessed the efficacy and safety of voretigene neparvovec in participants whose inherited retinal dystrophy would otherwise progress to complete blindness. Methods In this open-label, randomised, controlled phase 3 trial done at two sites in the USA, individuals aged 3 years or older with, in each eye, best corrected visual acuity of 20/60 or worse, or visual field less than 20 degrees in any meridian, or both, with confirmed genetic diagnosis of biallelic RPE65 mutations, sufficient viable retina, and ability to perform standardised multi-luminance mobility testing (MLMT) within the luminance range evaluated, were eligible. Participants were randomly assigned (2: 1) to intervention or control using a permuted block design, stratified by age (<10 years and >= 10 years) and baseline mobility testing passing level (pass at >= 125 lux vs <125 lux). Graders assessing primary outcome were masked to treatment group. Intervention was bilateral, subretinal injection of 1.5 x 10(11) vector genomes of voretigene neparvovec in 0.3 mL total volume. The primary efficacy endpoint was 1-year change in MLMT performance, measuring functional vision at specified light levels. The intention-to-treat (ITT) and modified ITT populations were included in primary and safety analyses. This trial is registered with ClinicalTrials. gov, number NCT00999609, and enrolment is complete. Findings Between Nov 15, 2012, and Nov 21, 2013, 31 individuals were enrolled and randomly assigned to intervention (n=21) or control (n=10). One participant from each group withdrew after consent, before intervention, leaving an mITT population of 20 intervention and nine control participants. At 1 year, mean bilateral MLMT change score was 1.8 (SD 1.1) light levels in the intervention group versus 0.2 (1.0) in the control group (difference of 1.6, 95% CI 0.72-2.41, p=0.0013). 13 (65%) of 20 intervention participants, but no control participants, passed MLMT at the lowest luminance level tested (1 lux), demonstrating maximum possible improvement. No product-related serious adverse events or deleterious immune responses occurred. Two intervention participants, one with a pre-existing complex seizure disorder and another who experienced oral surgery complications, had serious adverse events unrelated to study participation. Most ocular events were mild in severity. Interpretation Voretigene neparvovec gene replacement improved functional vision in RPE65-mediated inherited retinal dystrophy previously medically untreatable.	[Russell, Stephen; Stone, Edwin] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Bennett, Jean; Maguire, Albert M.] Univ Penn, Perelman Sch Med, Dept Ophthalmol, Philadelphia, PA USA; [Dingfield, Laura] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA USA; [Hudson, F. Parker] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA USA; [Hudson, F. Parker] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA; [Wellman, Jennifer A.; Chung, Daniel C.; Wachtel, Katie; Wright, J. Fraser; High, Katherine A.] Spark Therapeut, Philadelphia, PA USA; [Yu, Zi-Fan; Tillman, Amy; Wittes, Janet] Stat Collaborat, Washington, DC USA; [Pappas, Julie; Elci, Okan] Childrens Hosp Philadelphia, Westat Biostatist & Data Management Core, Philadelphia, PA USA; [McCague, Sarah; Cross, Dominique; Marshall, Kathleen A.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA USA; [Walshire, Jean; Kehoe, Taylor L.; Reichert, Hannah; Davis, Maria; Pfeifer, Wanda] Univ Iowa Hlth Care, Iowa City, IA USA; [Raffini, Leslie; George, Lindsey A.; Zhu, Xiaosong] Childrens Hosp Philadelphia, Dept Hematol, Philadelphia, PA USA; [Leroy, Bart P.] Childrens Hosp Philadelphia, Div Ophthalmol, Philadelphia, PA USA; [Leroy, Bart P.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA USA; [Haller, Julia A.] Thomas Jefferson Univ, Jefferson Med Coll, Wills Eye Hosp, Philadelphia, PA USA; [Haller, Julia A.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Ophthalmol, Philadelphia, PA USA; [Haller, Julia A.] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Sohn, Elliott H.; Mahajan, Vinit B.; Johnson, Chris; Drack, Arlene] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Weckmann, Michelle] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Gewaily, Dina] Philadelphia Retina Associates, Philadelphia, PA USA; [Simonelli, Francesca] Univ Campania Luigi Vanvitelli, Eye Clin, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy; [Leroy, Bart P.] Ghent Univ Hosp, Dept Ophthalmol, Ghent, Belgium	University of Iowa; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jefferson University; Jefferson University; Jefferson University; University of Iowa; University of Iowa; Universita della Campania Vanvitelli; Ghent University; Ghent University Hospital	Russell, S (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.	steve-russell@uiowa.edu	Simonelli, Francesca/AHE-7571-2022; High, Katherine A./AAB-9322-2020; Pfeifer, Wanda/T-6868-2019	Simonelli, Francesca/0000-0001-8520-6769; George, Lindsey/0000-0002-9763-1559; Mahajan, Vinit/0000-0003-1886-1741; Johnson, Chris/0000-0002-0090-630X; Weckmann, Michelle/0000-0002-3172-3733; Sohn, Elliott/0000-0002-3778-9362; Drack, Arlene/0000-0002-8195-8426; Stone, Edwin M./0000-0003-3343-4414; High, Katherine/0000-0002-0805-6223; Russell, Stephen/0000-0003-3776-1367	Spark Therapeutics; NATIONAL EYE INSTITUTE [DP1EY023177] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007150] Funding Source: NIH RePORTER	Spark Therapeutics; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Spark Therapeutics.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Ashtari M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8791; Ashtari M, 2011, J CLIN INVEST, V121, P2160, DOI 10.1172/JCI57377; Astuti GDN, 2016, EUR J HUM GENET, V24, P1071, DOI 10.1038/ejhg.2015.241; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bemelmans AP, 2006, ADV EXP MED BIOL, V572, P247; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Bittner AK, 2014, CLIN EXP OPTOM, V97, P240, DOI 10.1111/cxo.12117; Chung DC, CLIN EXP OP IN PRESS; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; den Hollander AI, 2016, INVEST OPHTH VIS SCI, V57, P1378, DOI 10.1167/iovs.15-18167; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Klein M, 2009, DOC OPHTHALMOL, V119, P217, DOI 10.1007/s10633-009-9204-7; Koenekoop RK, 2014, LANCET, V384, P1513, DOI 10.1016/S0140-6736(14)60153-7; Kono M, 2015, PROG MOL BIOL TRANSL, V134, P465, DOI 10.1016/bs.pmbts.2015.06.002; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; RetNet, 2016, SUMM GEN LOC CAUS RE; Scholl HPN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143846; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Tang PH, 2011, J NEUROSCI, V31, P18618, DOI 10.1523/JNEUROSCI.4265-11.2011; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Trapani I, 2014, PROG RETIN EYE RES, V43, P108, DOI 10.1016/j.preteyeres.2014.08.001; Vandenberghe LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002103; Weleber RG, 2016, OPHTHALMOLOGY, V123, P1606, DOI 10.1016/j.ophtha.2016.03.003; Wright JF, 2010, CURR GENE THER, V10, P341; Wright JF, 2009, HUM GENE THER, V20, P698, DOI 10.1089/hum.2009.064; Wright JF, 2005, MOL THER, V12, P171, DOI 10.1016/j.ymthe.2005.02.021; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Znoiko SL, 2002, INVEST OPHTH VIS SCI, V43, P1604	43	794	822	3	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					849	860		10.1016/S0140-6736(17)31868-8	http://dx.doi.org/10.1016/S0140-6736(17)31868-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE6PF	28712537	Green Accepted			2022-12-28	WOS:000408330700023
J	Macias-Romero, C; Nahalka, I; Okur, HI; Roke, S				Macias-Romero, Carlos; Nahalka, Igor; Okur, Halil I.; Roke, Sylvie			Optical imaging of surface chemistry and dynamics in confinement	SCIENCE			English	Article							2ND-HARMONIC GENERATION MICROSCOPY; CHARGED INTERFACE; FLOW; POLARIZATION; ILLUMINATION; DOMAINS; ACIDITY	We imaged the interfacial structure and dynamics of water in a microscopically confined geometry, in three dimensions and on millisecond time scales, with a structurally illuminated wide-field second harmonic microscope. The second harmonic images reported on the orientational order of interfacial water, induced by charge-dipole interactions between water molecules and surface charges. The images were converted into surface potential maps. Spatially resolved surface acid dissociation constant (pK(a,s)) values were determined for the silica deprotonation reaction by following pH-induced chemical changes on the curved and confined surfaces of a glass microcapillary immersed in aqueous solutions. These values ranged from 2.3 to 10.7 along the wall of a single capillary because of surface heterogeneities. Water molecules that rotate along an oscillating external electric field were also imaged.	[Roke, Sylvie] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Fundamental BioPhoton, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Sch Engn, Inst Mat Sci, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Lausanne Ctr Ultrafast Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Roke, S (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Fundamental BioPhoton, CH-1015 Lausanne, Switzerland.	sylvie.roke@epfl.ch	Okur, Halil I./AAM-6125-2020; Macias-Romero, Carlos/D-2127-2012	Macias-Romero, Carlos/0000-0002-6533-5835; Okur, Halil I./0000-0002-2492-1168	Julia Jacobi Foundation; Swiss National Science Foundation [200021-146884]; European Research Council [616305]; European Union [721766]	Julia Jacobi Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission)	We thank S. Caneva for supplying samples and K. F. Domke for discussions. Supported by the Julia Jacobi Foundation, Swiss National Science Foundation grant 200021-146884, European Research Council grant 616305, and the European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement 721766 (FBI). All data are reported in the main text and supplement. S.R. and C.M.-R. are inventors on patent application US 20150233820 A1 that covers the device and method for measuring and imaging second harmonic and multiphoton-generation scattered radiation.	Amstad E, 2015, SCIENCE, V349, P956, DOI 10.1126/science.aac9582; [Anonymous], SECTIONING MICROSCOP; Baret JC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016106; Bockris J.O., 2013, SURFACE ELECTROCHEMI; Boyd R. W., 2003, NONLINEAR OPTICS; Brown MA, 2016, ANGEW CHEM INT EDIT, V55, P3790, DOI 10.1002/anie.201512025; Brown MA, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.011007; Bulushev RD, 2015, NANO LETT, V15, P7118, DOI 10.1021/acs.nanolett.5b03264; Cimatu K, 2008, J AM CHEM SOC, V130, P8030, DOI 10.1021/ja8011676; Darlington AM, 2015, J PHYS CHEM C, V119, P16560, DOI 10.1021/acs.jpcc.5b02480; DeWalt EL, 2013, ACTA CRYSTALLOGR D, V69, P74, DOI 10.1107/S0907444912042503; Dong CY, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031101; Finlayson-Pitts B.J., 1999, CHEM UPPER LOWER ATM; Gibbs-Davis JM, 2008, J AM CHEM SOC, V130, P15444, DOI 10.1021/ja804302s; Gonella G, 2016, J PHYS CHEM C, V120, P9165, DOI 10.1021/acs.jpcc.5b12453; Grzybowski BA, 2016, NAT NANOTECHNOL, V11, P584, DOI [10.1038/NNANO.2016.116, 10.1038/nnano.2016.116]; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Gustafsson MGL, 2000, PROC SPIE, V3919, P141, DOI 10.1117/12.384189; Hoover EE, 2013, NAT PHOTONICS, V7, P93, DOI [10.1038/nphoton.2013.361, 10.1038/nphoton.2012.361]; Jena KC, 2011, J PHYS CHEM LETT, V2, P1056, DOI 10.1021/jz200251h; Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Konek CT, 2004, J AM CHEM SOC, V126, P11754, DOI 10.1021/ja0474300; Kriech MA, 2005, J AM CHEM SOC, V127, P2834, DOI 10.1021/ja0430649; Laohakunakorn N, 2013, NANO LETT, V13, P5141, DOI 10.1021/nl402350a; Leung K, 2009, J AM CHEM SOC, V131, P18358, DOI 10.1021/ja906190t; Lim D, 2008, OPT LETT, V33, P1819, DOI 10.1364/OL.33.001819; Lim D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528656; Lis D, 2014, SCIENCE, V344, P1138, DOI 10.1126/science.1253793; Macias-Romero C, 2014, OPT EXPRESS, V22, P31102, DOI 10.1364/OE.22.031102; Macias-Romero C, 2014, NANO LETT, V14, P2552, DOI 10.1021/nl500356u; Mertz J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3324890; Michaelson J, 2012, BIOMED OPT EXPRESS, V3, P1241, DOI 10.1364/BOE.3.001241; Mrksich M, 2002, CURR OPIN CHEM BIOL, V6, P794, DOI 10.1016/S1367-5931(02)00362-9; ONG SW, 1992, CHEM PHYS LETT, V191, P327, DOI 10.1016/0009-2614(92)85309-X; Pearce TM, 2007, LAB CHIP, V7, P30, DOI 10.1039/b612856b; Peterson MD, 2011, OPT MATER EXPRESS, V1, P57, DOI 10.1364/OME.1.000057; Pfeiffer-Laplaud M, 2015, J PHYS CHEM C, V119, P27354, DOI 10.1021/acs.jpcc.5b02854; Santos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130266; Schasfoort RBM, 1999, SCIENCE, V286, P942, DOI 10.1126/science.286.5441.942; SONNEFELD J, 1995, COLLOID POLYM SCI, V273, P926, DOI 10.1007/BF00660369; Steinbock LJ, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454113; Traa, 2008, HDB HETEROGENEOUS CA, DOI DOI 10.1002/9783527610044.HETCAT0130; van der Heyden FHJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.116104; VONSCHINDLER P, 1968, HELV CHIM ACTA, V51, P1781; Yew E. Y. S., 2011, SPIE BIOS; Yew EYS, 2013, OPT EXPRESS, V21, P12951, DOI 10.1364/OE.21.012951; Zachara J, 2016, ENVIRON SCI TECHNOL, V50, P2811, DOI 10.1021/acs.est.5b05015	47	64	63	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					784	787		10.1126/science.aal4346	http://dx.doi.org/10.1126/science.aal4346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28729352	Green Submitted			2022-12-28	WOS:000408327900039
J	Rao, H; Chmidt, LCS; Bonin, J; Robert, M				Rao, Heng; Chmidt, Luciana C. S.; Bonin, Julien; Robert, Marc			Visible-light-driven methane formation from CO2 with a molecular iron catalyst	NATURE			English	Article							CARBON-DIOXIDE; ELECTROCHEMICAL CONVERSION; PHOTOCHEMICAL REDUCTION; EFFICIENT; ELECTROREDUCTION; COMPLEXES; CHEMICALS; CH4; FE	Converting CO2 into fuel or chemical feedstock compounds could in principle reduce fossil fuel consumption and climate-changing CO2 emissions(1,2). One strategy aims for electrochemical conversions powered by electricity from renewable sources(3-5), but photochemical approaches driven by sunlight are also conceivable(6). A considerable challenge in both approaches is the development of efficient and selective catalysts, ideally based on cheap and Earth-abundant elements rather than expensive precious metals(7). Of the molecular photo-and electrocatalysts reported, only a few catalysts are stable and selective for CO2 reduction; moreover, these catalysts produce primarily CO or HCOOH, and catalysts capable of generating even low to moderate yields of highly reduced hydrocarbons remain rare(8-17). Here we show that an iron tetraphenylporphyrin complex functionalized with trimethylammonio groups, which is the most efficient and selective molecular electro-catalyst for converting CO2 to CO known(18-20), can also catalyse the eight-electron reduction of CO2 to methane upon visible light irradiation at ambient temperature and pressure. We find that the catalytic system, operated in an acetonitrile solution containing a photosensitizer and sacrificial electron donor, operates stably over several days. CO is the main product of the direct CO2 photoreduction reaction, but a two-pot procedure that first reduces CO2 and then reduces CO generates methane with a selectivity of up to 82 per cent and a quantum yield (light-to-product efficiency) of 0.18 per cent. However, we anticipate that the operating principles of our system may aid the development of other molecular catalysts for the production of solar fuels from CO2 under mild conditions.	[Rao, Heng; Chmidt, Luciana C. S.; Bonin, Julien; Robert, Marc] Univ Paris Diderot, Sorbonne Paris Cite, Lab Electrochim Mol, UMR CNRS 7591, 15 Rue Jean Antoine de Baif, F-75205 Paris 13, France; [Chmidt, Luciana C. S.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Organ, INFIQC CONICET, RA-5000 Cordoba, Argentina	UDICE-French Research Universities; Universite Paris Cite; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Bonin, J; Robert, M (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Lab Electrochim Mol, UMR CNRS 7591, 15 Rue Jean Antoine de Baif, F-75205 Paris 13, France.	julien.bonin@univ-paris-diderot.fr; robert@univ-paris-diderot.fr	Schmidt, Luciana Carina/C-4416-2017; BONIN, Julien/B-4404-2013; Rao, Heng/AAN-9067-2020; RAO, HENG/AAD-5334-2019	Schmidt, Luciana Carina/0000-0001-7059-3938; BONIN, Julien/0000-0001-9943-0219; Rao, Heng/0000-0001-7270-3301; 	CNRS; Defi Transition energetique "Emergence CO2" (the PERIODIC project); China Scholarship Council [201507040033]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Defi Transition energetique "Emergence CO2" (the PERIODIC project); China Scholarship Council(China Scholarship Council)	This work was partially supported by the CNRS, Defi Transition energetique "Emergence CO<INF>2</INF>" (the PERIODIC project). H.R. thanks the China Scholarship Council for a PhD fellowship (CSC student number 201507040033). We thank D. Clainquart (Universite Paris Diderot) for assistance in gas chromatography/mass spectrometry analysis and I. Azcarate for porphyrin synthesis.	AlOtaibi B, 2015, ACS CATAL, V5, P5342, DOI 10.1021/acscatal.5b00776; Alsabeh PG, 2016, CATAL SCI TECHNOL, V6, P3623, DOI 10.1039/c5cy01129a; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Aresta M, 2014, CHEM REV, V114, P1709, DOI 10.1021/cr4002758; Azcarate I, 2016, J AM CHEM SOC, V138, P16639, DOI 10.1021/jacs.6b07014; Bhugun I, 1996, J AM CHEM SOC, V118, P3982, DOI 10.1021/ja954326x; Bonin J, 2017, COORDIN CHEM REV, V334, P184, DOI 10.1016/j.ccr.2016.09.005; Bonin J, 2014, J AM CHEM SOC, V136, P16768, DOI 10.1021/ja510290t; Bonin J, 2014, CHEMCATCHEM, V6, P3200, DOI 10.1002/cctc.201402515; Costentin C, 2015, P NATL ACAD SCI USA, V112, P6882, DOI 10.1073/pnas.1507063112; Costentin C, 2014, J AM CHEM SOC, V136, P11821, DOI 10.1021/ja506193v; Costentin C, 2012, SCIENCE, V338, P90, DOI 10.1126/science.1224581; DAVIES SG, 1982, J CHEM SOC CHEM COMM, P1404, DOI 10.1039/c39820001404; DEDEIAN K, 1991, INORG CHEM, V30, P1685, DOI 10.1021/ic00008a003; Jhong HR, 2013, CURR OPIN CHEM ENG, V2, P191, DOI 10.1016/j.coche.2013.03.005; Liu X, 2016, ANGEW CHEM INT EDIT, V55, P14924, DOI 10.1002/anie.201600395; Manthiram K, 2014, J AM CHEM SOC, V136, P13319, DOI 10.1021/ja5065284; Montalti M., 2006, HDB PHOTOCHEMISTRY; Parajuli R, 2015, TOP CATAL, V58, P57, DOI 10.1007/s11244-014-0345-x; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qiao JL, 2014, CHEM SOC REV, V43, P631, DOI 10.1039/c3cs60323g; Rao H, 2017, CHEM COMMUN, V53, P2830, DOI 10.1039/c6cc09967j; Sahara G, 2015, INORG CHEM, V54, P5096, DOI 10.1021/ic502675a; Shen J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9177; Takeda H, 2017, ACS CATAL, V7, P70, DOI 10.1021/acscatal.6b02181; Tatin A, 2016, P NATL ACAD SCI USA, V113, P5526, DOI 10.1073/pnas.1604628113; Wang HX, 2016, GREEN CHEM, V18, P3250, DOI 10.1039/c6gc00410e; Wang YG, 2016, ACS APPL MATER INTER, V8, P17212, DOI 10.1021/acsami.6b03472; Weng Z, 2016, J AM CHEM SOC, V138, P8076, DOI 10.1021/jacs.6b04746; Wu TS, 2014, GREEN CHEM, V16, P2142, DOI 10.1039/c3gc42454e; Xie MS, 2016, ENERG ENVIRON SCI, V9, P1687, DOI 10.1039/c5ee03694a; Yu L, 2016, ACS CATAL, V6, P6444, DOI 10.1021/acscatal.6b01455; Zhu S., GREEN CHEM, V18	33	512	513	58	1178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					74	+		10.1038/nature23016	http://dx.doi.org/10.1038/nature23016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28723895				2022-12-28	WOS:000406831700039
J	Goswami, S; Sharma, P				Goswami, Sangeeta; Sharma, Padmanee			Genetic biomarker for cancer immunotherapy	SCIENCE			English	Editorial Material							CTLA-4 BLOCKADE; COLORECTAL-CANCER; PD-1 BLOCKADE; LANDSCAPE; MELANOMA		[Goswami, Sangeeta; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sharma, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	padsharma@mdanderson.org		Goswami, Sangeeta/0000-0001-9201-4503				ESHLEMAN JR, 1995, ONCOGENE, V10, P33; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X	14	6	8	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					358	358		10.1126/science.aao1894	http://dx.doi.org/10.1126/science.aao1894			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751597				2022-12-28	WOS:000406362300026
J	Bradley, S				Bradley, Stephen			PERSONAL VIEW Junior doctors can use the new contract to take back some control	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bradley_stephen@hotmail.com	Bradley, Stephen/AAX-3023-2020						0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2017	358								j3413	10.1136/bmj.j3413	http://dx.doi.org/10.1136/bmj.j3413			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UX	28751506				2022-12-28	WOS:000406766000006
J	Nectow, AR; Schneeberger, M; Zhang, HX; Field, BC; Renier, N; Azevedo, E; Patel, B; Liang, YP; Mitra, S; Tessier-Lavigne, M; Han, MH; Friedman, JM				Nectow, Alexander R.; Schneeberger, Marc; Zhang, Hongxing; Field, Bianca C.; Renier, Nicolas; Azevedo, Estefania; Patel, Bindiben; Liang, Yupu; Mitra, Siddhartha; Tessier-Lavigne, Marc; Han, Ming-Hu; Friedman, Jeffrey M.			Identification of a Brainstem Circuit Controlling Feeding	CELL			English	Article							MIDBRAIN RAPHE NUCLEI; PHA-L ANALYSIS; CELL-TYPES; MOLECULAR CHARACTERIZATION; PARAVENTRICULAR NUCLEUS; GABAERGIC NEURONS; REWARD CIRCUITRY; RAT; PROJECTIONS; GLUTAMATE	Hunger, driven by negative energy balance, elicits the search for and consumption of food. While this response is in part mediated by neurons in the hypothalamus, the role of specific cell types in other brain regions is less well defined. Here, we show that neurons in the dorsal raphe nucleus, expressing vesicular transporters for GABA or glutamate (hereafter, DRN Vgat and DRN VGLUT3 neurons), are reciprocally activated by changes in energy balance and that modulating their activity has opposite effects on feeding-DRN Vgat neurons increase, whereas DRN VGLUT3 neurons suppress, food intake. Furthermore, modulation of these neurons in obese (ob/ob) mice suppresses food intake and body weight and normalizes locomotor activity. Finally, using molecular profiling, we identify druggable targets in these neurons and show that local infusion of agonists for specific receptors on these neurons has potent effects on feeding. These data establish the DRN as an important node controlling energy balance.	[Nectow, Alexander R.; Schneeberger, Marc; Field, Bianca C.; Azevedo, Estefania; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Genet, New York, NY 10065 USA; [Zhang, Hongxing; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Pharmacol Sci, New York, NY 10029 USA; [Renier, Nicolas; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA; [Renier, Nicolas] Hop La Pitie Salpetriere, Brain & Spine Inst, ICM, F-75013 Paris, France; [Liang, Yupu; Mitra, Siddhartha] Rockefeller Univ, Hosp Informat, New York, NY 10065 USA; [Nectow, Alexander R.; Patel, Bindiben] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Rockefeller University; Icahn School of Medicine at Mount Sinai; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Rockefeller University; Princeton University	Nectow, AR; Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Genet, New York, NY 10065 USA.; Nectow, AR (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	anectow@princeton.edu; friedj@rockefeller.edu	Han, Ming-Hu/G-8836-2012; Schneeberger Pane, Marc/ABC-2627-2021; Core, Vector/CAF-4832-2022; Renier, Nicolas/E-1855-2018; Pane, Marc Schneeberger/ABG-7816-2020	Schneeberger Pane, Marc/0000-0001-7369-104X; Renier, Nicolas/0000-0003-2642-4402; 	JPB foundation [CEN 5402133]; David Rockefeller Fellowship; Brain and Behavior Research Foundation NARSAD; Princeton Neuroscience Institute; Rockefeller University's Shapiro-Silverberg Fund [CEN5301493]; National Natural Science Foundation of China [81200862]; NIMH [R01MH092306]; NIAA; Brain and Behavior Research Foundation NARSAD [21464]	JPB foundation; David Rockefeller Fellowship; Brain and Behavior Research Foundation NARSAD(NARSAD); Princeton Neuroscience Institute; Rockefeller University's Shapiro-Silverberg Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAA; Brain and Behavior Research Foundation NARSAD(NARSAD)	We thank Mats Ekstrand for help designing pAAV-IV-GFPL10, Brad Lowell, Linh Vong, and Dong Kong for contributing VGLUT3-IRES-Cre and Vgat-IRES-Cre mice, Chitra Kumar and Varun Bhave for help with chemogenetic studies, Karl Deisseroth for contributing pAAV-EF1a-DIO-ChR2-mCherry, used in the creation of pAAV-IV-GFPL10, Todd Anthony and David Anderson for contributing the virus AAV5-EF1a-'Cre-out'-ChR2-EYFP, Masago Ishikawa and Paul Kenny for help with electrophysiology, Ilana Witten and Eric Nestler for helpful discussions, and The Rockefeller University Genomics and Bio-Imaging Resource Centers. This work is supported by funding from The JPB foundation (CEN 5402133; J.M.F.). A.R.N. acknowledges support from the David Rockefeller Fellowship, the Brain and Behavior Research Foundation NARSAD Young Investigator Award, the Princeton Neuroscience Institute's CV Starr Fellowship and Innovation Award, and The Rockefeller University's Shapiro-Silverberg Fund (CEN5301493). H.Z is supported by the National Natural Science Foundation of China (81200862). M.H.H. acknowledges support from the NIMH (R01MH092306), NIAA, and the Brain and Behavior Research Foundation NARSAD Independent Investigator Award (21464).	[Anonymous], NEUROPSYCHOPHARMACOL, V41, P2122; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; BENDOTTI C, 1986, PHARMACOL BIOCHEM BE, V24, P1189, DOI 10.1016/0091-3057(86)90169-3; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Challis C, 2013, J NEUROSCI, V33, P13978, DOI 10.1523/JNEUROSCI.2383-13.2013; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; CURRIE PJ, 1994, AM J PHYSIOL, V266, pR1645, DOI 10.1152/ajpregu.1994.266.5.R1645; Domingos AI, 2014, MOL METAB, V3, P73, DOI 10.1016/j.molmet.2013.10.007; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; FLETCHER PJ, 1990, EUR J PHARMACOL, V184, P265, DOI 10.1016/0014-2999(90)90618-G; Fornal CA, 1996, BRAIN RES, V716, P123, DOI 10.1016/0006-8993(96)00006-6; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garfield AS, 2015, NAT NEUROSCI, V18, P863, DOI 10.1038/nn.4011; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Han MH, 2006, J NEUROSCI, V26, P4624, DOI 10.1523/JNEUROSCI.4701-05.2006; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hioki H, 2010, J COMP NEUROL, V518, P668, DOI 10.1002/cne.22237; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Larsen PJ, 1996, NEUROSCIENCE, V70, P963, DOI 10.1016/0306-4522(95)00415-7; Li C., 2016, CELL, V170, P429; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040; McDevitt RA, 2014, CELL REP, V8, P1857, DOI 10.1016/j.celrep.2014.08.037; Nectow AR, 2017, CELL REP, V19, P655, DOI 10.1016/j.celrep.2017.03.048; Nectow AR, 2015, NAT PROTOC, V10, P1319, DOI 10.1038/nprot.2015.087; Okaty BW, 2015, NEURON, V88, P774, DOI 10.1016/j.neuron.2015.10.007; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; PETROVICKY P, 1981, BRAIN RES BULL, V7, P131, DOI 10.1016/0361-9230(81)90077-0; Pomeranz LE, 2017, J NEUROSCI, V37, P4128, DOI 10.1523/JNEUROSCI.3193-16.2017; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; SCHAERENWIEMERS N, 1995, J NEUROCHEM, V65, P10; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Veasey SC, 1997, NEUROSCIENCE, V79, P161, DOI 10.1016/S0306-4522(96)00673-2; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; VERTES RP, 1994, J COMP NEUROL, V340, P11, DOI 10.1002/cne.903400103; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Weissbourd B, 2014, NEURON, V83, P645, DOI 10.1016/j.neuron.2014.06.024; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	50	78	80	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					429	+		10.1016/j.cell.2017.06.045	http://dx.doi.org/10.1016/j.cell.2017.06.045			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753423	Bronze			2022-12-28	WOS:000406462400004
J	Zhang, Z; Liu, FY; Chen, J				Zhang, Zhe; Liu, Fangyu; Chen, Jue			Conformational Changes of CFTR upon Phosphorylation and ATP Binding	CELL			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; STRUCTURE VALIDATION; CHLORIDE CHANNEL; R-DOMAIN; NUCLEOTIDE; ARCHITECTURE; HYDROLYSIS; REFINEMENT; MOLPROBITY; MUTATIONS	The cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel evolved from an ATP-binding cassette transporter. CFTR channel gating is strictly coupled to phosphorylation and ATP hydrolysis. Previously, we reported essentially identical structures of zebrafish and human CFTR in the dephosphorylated, ATP-free form. Here, we present the structure of zebrafish CFTR in the phosphorylated, ATP-bound conformation, determined by cryoelectron microscopy to 3.4 angstrom resolution. Comparison of the two conformations shows major structural rearrangements leading to channel opening. The phosphorylated regulatory domain is disengaged from its inhibitory position; the nucleotide-binding domains (NBDs) form a "head-to-tail" dimer upon binding ATP; and the cytoplasmic pathway, found closed off in other ATP-binding cassette transporters, is cracked open, consistent with CFTR's unique channel function. Unexpectedly, the extracellular mouth of the ion pore remains closed, indicating that local movements of the transmembrane helices can control ion access to the pore even in the NBD-dimerized conformation.	[Zhang, Zhe; Liu, Fangyu; Chen, Jue] Rockefeller Univ, Lab Membrane Biophys & Biol, 1230 York Ave, New York, NY 10021 USA; [Zhang, Zhe; Chen, Jue] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Liu, Fangyu] Rockefeller Univ, Tri Inst Training Program Chem Biol, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Chen, J (corresponding author), Rockefeller Univ, Lab Membrane Biophys & Biol, 1230 York Ave, New York, NY 10021 USA.; Chen, J (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	juechen@rockefeller.edu			Rockefeller University; Howard Hughes Medical Institute	Rockefeller University; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank David C. Gadsby, Laszlo Csanady, and Roderick MacKinnon for critical comments, Mark Ebrahim and Johanna Sotiris at the Rockefeller Evelyn Gruss Lipper Cryo-Electron Microscopy Resource Center for assistance in data collection, and Sarah McCarry for editing this manuscript. This work is supported by the Rockefeller University and the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Brubaker M. A., 2015, J STRUCT BIOL; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chaves LAP, 2015, J GEN PHYSIOL, V145, P261, DOI 10.1085/jgp.201411347; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CLIFF WH, 1992, AM J PHYSIOL, V262, pC1154, DOI 10.1152/ajpcell.1992.262.5.C1154; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; De la Rosa MB, 2011, J BIOL CHEM, V286, P26258, DOI 10.1074/jbc.M111.256305; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Drumm M. L., 1995, J BIOL CHEM; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; HAWS C, 1992, AM J PHYSIOL, V263, pL692, DOI 10.1152/ajplung.1992.263.6.L692; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hryc Z., 2014, NAT, V5, P4808; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Iannuzzi J. M., 1989, IDENTIFICA CYSTIC FI, P1059; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Lin WY, 2014, J GEN PHYSIOL, V144, P311, DOI 10.1085/jgp.201411247; Linsdell P, 2017, CELL MOL LIFE SCI, V74, P67, DOI 10.1007/s00018-016-2389-5; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sorum B, 2015, CELL, V163, P724, DOI 10.1016/j.cell.2015.09.052; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; TILLY BC, 1992, J BIOL CHEM, V267, P9470; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; WINTER MC, 1994, BIOPHYS J, V66, P1398, DOI 10.1016/S0006-3495(94)80930-0; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014	61	156	158	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					483	+		10.1016/j.cell.2017.06.041	http://dx.doi.org/10.1016/j.cell.2017.06.041			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28735752	Bronze			2022-12-28	WOS:000406462400008
J	Slomski, A				Slomski, Anita			Parent-Based Therapy Helps Children LoseWeight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					323	323		10.1001/jama.2017.9523	http://dx.doi.org/10.1001/jama.2017.9523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MY	28742906				2022-12-28	WOS:000426800100001
J	Slomski, A				Slomski, Anita			Blended CBT Controls Anxiety in Cancer Survivors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					323	323		10.1001/jama.2017.9529	http://dx.doi.org/10.1001/jama.2017.9529			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MY	28742909				2022-12-28	WOS:000426800100004
J	Stokstad, E				Stokstad, Erik			SAVING EUROPE'S SALAMANDERS	SCIENCE			English	Editorial Material																			0	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					242	245		10.1126/science.357.6348.242	http://dx.doi.org/10.1126/science.357.6348.242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729494				2022-12-28	WOS:000405901600018
J	Castelvecchi, D				Castelvecchi, Davide			THE SHAPE OF THINGS TO COME	NATURE			English	News Item																		Bradlyn B, 2017, NATURE, V547, P298, DOI 10.1038/nature23268; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Gooth J, 2017, NATURE, V547, P324, DOI 10.1038/nature23005; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Lu L, 2015, SCIENCE, V349, P622, DOI 10.1126/science.aaa9273; Lv BQ, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031013; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297	10	20	20	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					272	274		10.1038/547272a	http://dx.doi.org/10.1038/547272a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28726840	Bronze			2022-12-28	WOS:000405844900011
J	Yacoub, M; Mayosi, B; ElGuindy, A; Carpentier, A; Yusuf, S				Yacoub, Magdi; Mayosi, Bongani; ElGuindy, Ahmed; Carpentier, Alain; Yusuf, Salim			Eliminating acute rheumatic fever and rheumatic heart disease	LANCET			English	Editorial Material							OUTCOMES; SURGERY		[Yacoub, Magdi; ElGuindy, Ahmed] Aswan Heart Ctr, Aswan, Egypt; [Yacoub, Magdi; ElGuindy, Ahmed] Heart Sci Ctr, London UB9 6JH, England; [Mayosi, Bongani] Univ Cape Town, Fac Hlth Sci, The Deanery, Cape Town, South Africa; [Carpentier, Alain] Hopital Europeen Georges Pompidou, Dept Chirurg Cardiovasc & Transplantat Organes, Paris, France; [Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	Egyptian Knowledge Bank (EKB); Aswan University; University of Cape Town; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; McMaster University; Population Health Research Institute	Yacoub, M (corresponding author), Aswan Heart Ctr, Aswan, Egypt.; Yacoub, M (corresponding author), Heart Sci Ctr, London UB9 6JH, England.	m.yacoub@imperial.ac.uk		Yusuf, Salim/0000-0003-4776-5601	Bayer	Bayer(Bayer AG)	SY declares that the Population Health Research Institute, of which he is Director, has received funding from Bayer for the INVICTUS study programme on rheumatic heart disease. The other authors declare no competing interests.	Carapetis JR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.84; Gandhi GD, 2017, GLOB CARDIOL SCI PRA, V1, P4; Grimaldi A, 2016, J CARDIOVASC MED, V17, P105, DOI 10.2459/JCM.0000000000000228; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960; Remenyi B, 2016, LANCET, V387, P1335, DOI 10.1016/S0140-6736(16)00547-X; van Dam J, 2015, CARDIOVASC J AFR, V26, P227, DOI 10.5830/CVJA-2015-058; Watkins D, 2016, CARDIOVASC J AFR, V27, P184, DOI 10.5830/CVJA-2015-090; Watkins DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121363; Yacoub M, 2014, J CARDIOVASC TRANSL, V7, P797, DOI 10.1007/s12265-014-9598-9; Yacoub MH, 2015, J AM COLL CARDIOL, V66, P889, DOI 10.1016/j.jacc.2015.07.007; Yacoub S, 2011, PHILOS T R SOC A, V369, P1719, DOI 10.1098/rsta.2011.0013; Zuhlke L, 2016, CIRCULATION, V134, P1456, DOI 10.1161/CIRCULATIONAHA.116.024769	13	33	37	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					212	213		10.1016/S0140-6736(17)31608-2	http://dx.doi.org/10.1016/S0140-6736(17)31608-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA5IZ	28721865				2022-12-28	WOS:000405477900008
J	Kumar, RK; Chen, X; Auton, GH; Mishchenko, A; Bandurin, DA; Morozov, SV; Cao, Y; Khestanova, E; Ben Shalom, M; Kretinin, AV; Novoselov, KS; Eaves, L; Grigorieva, IV; Ponomarenko, LA; Fal'ko, VI; Geim, AK				Kumar, R. Krishna; Chen, X.; Auton, G. H.; Mishchenko, A.; Bandurin, D. A.; Morozov, S. V.; Cao, Y.; Khestanova, E.; Ben Shalom, M.; Kretinin, A. V.; Novoselov, K. S.; Eaves, L.; Grigorieva, I. V.; Ponomarenko, L. A.; Fal'ko, V. I.; Geim, A. K.			High-temperature quantum oscillations caused by recurring Bloch states in graphene superlattices	SCIENCE			English	Article							DIRAC FERMIONS; ELECTRONS	Cyclotron motion of charge carriers in metals and semiconductors leads to Landau quantization and magneto-oscillatory behavior in their properties. Cryogenic temperatures are usually required to observe these oscillations. We show that graphene superlattices support a different type of quantum oscillation that does not rely on Landau quantization. The oscillations are extremely robust and persist well above room temperature in magnetic fields of only a few tesla. We attribute this phenomenon to repetitive changes in the electronic structure of superlattices such that charge carriers experience effectively no magnetic field at simple fractions of the flux quantum per superlattice unit cell. Our work hints at unexplored physics in Hofstadter butterfly systems at high temperatures.	[Kumar, R. Krishna; Mishchenko, A.; Bandurin, D. A.; Khestanova, E.; Ben Shalom, M.; Grigorieva, I. V.; Fal'ko, V. I.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Kumar, R. Krishna; Chen, X.; Auton, G. H.; Cao, Y.; Kretinin, A. V.; Novoselov, K. S.; Eaves, L.; Fal'ko, V. I.; Geim, A. K.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Kumar, R. Krishna; Ponomarenko, L. A.] Univ Lancaster, Dept Phys, Lancaster LA1 4YW, England; [Morozov, S. V.] Russian Acad Sci, Inst Microelect Technol & High Pur Mat, Chernogolovka 142432, Russia; [Morozov, S. V.] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia; [Kretinin, A. V.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [Eaves, L.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Manchester; University of Manchester; Lancaster University; Russian Academy of Sciences; Institute of Microelectronics Technology & High-Purity Materials, RAS; National University of Science & Technology (MISIS); University of Manchester; University of Nottingham	Fal'ko, VI; Geim, AK (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.; Fal'ko, VI; Geim, AK (corresponding author), Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England.	vladimir.falko@manchester.ac.uk; geim@manchester.ac.uk	Geim, Andre K/J-7888-2012; Novoselov, Kostya S/G-9581-2014; Khestanova, Ekaterina/G-2115-2018; Kretinin, Andrey V/L-5122-2013; Kretinin, Andrey/L-1105-2019; Bandurin, Denis/T-3401-2019; Ponomarenko, Leonid/AAF-1731-2021; Morozov, Sergey V/H-3171-2014; Ben Shalom, Moshe/ABC-3999-2021; Mishchenko, Artem/C-7561-2011	Geim, Andre K/0000-0003-2861-8331; Novoselov, Kostya S/0000-0003-4972-5371; Khestanova, Ekaterina/0000-0002-0270-8550; Kretinin, Andrey V/0000-0003-4110-4837; Kretinin, Andrey/0000-0003-4110-4837; Morozov, Sergey V/0000-0003-3075-7787; Mishchenko, Artem/0000-0002-0427-5664; Bandurin, Denis/0000-0001-9257-4105; Ben Shalom, Moshe/0000-0001-5781-0037; Fal'ko, Vladimir/0000-0003-0828-0310; hai yan, he/0000-0003-0366-6185	European Research Council; Lloyd's Register Foundation; Graphene Flagship; Royal Society; Engineering and Physical Sciences Research Council; Marie Curie program SPINOGRAPH; Russian Science Foundation; National University of Science and Technology (MISiS); Engineering and Physical Sciences Research Council [EP/N010345/1] Funding Source: researchfish; Russian Science Foundation [17-12-01393] Funding Source: Russian Science Foundation; EPSRC [EP/N010345/1, EP/K005014/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Lloyd's Register Foundation; Graphene Flagship; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Curie program SPINOGRAPH; Russian Science Foundation(Russian Science Foundation (RSF)); National University of Science and Technology (MISiS); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Russian Science Foundation(Russian Science Foundation (RSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Research Council, Lloyd's Register Foundation, the Graphene Flagship, and the Royal Society. R.K.K. and E.K. acknowledge support from the Engineering and Physical Sciences Research Council, D.A.B. and I.V.G. from the Marie Curie program SPINOGRAPH, and S.V.M. from the Russian Science Foundation and National University of Science and Technology (MISiS).	Albrecht C, 2001, PHYS REV LETT, V86, P147, DOI 10.1103/PhysRevLett.86.147; Ashcroft N.W., 1976, SOLID STATE PHYS; BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; BROWN E, 1964, PHYS REV, V133, P1038; Chen X, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075401; Chen ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5461; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Freitag NM, 2016, NANO LETT, V16, P5798, DOI 10.1021/acs.nanolett.6b02548; Geisler MC, 2004, PHYSICA E, V25, P227, DOI 10.1016/j.physe.2004.06.021; HARPER PG, 1955, P PHYS SOC LOND A, V68, P879, DOI 10.1088/0370-1298/68/10/305; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Melinte S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.036802; Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Springford M., 1980, ELECT FERMI SURFACE; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Wang L, 2015, SCIENCE, V350, P1231, DOI 10.1126/science.aad2102; WANNIER GH, 1978, PHYS STATUS SOLIDI B, V88, P757, DOI 10.1002/pssb.2220880243; WEBB RA, 1985, PHYS REV LETT, V54, P2696, DOI 10.1103/PhysRevLett.54.2696; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/NPHYS2954, 10.1038/nphys2954]; Yang W, 2016, NANO LETT, V16, P2387, DOI 10.1021/acs.nanolett.5b05161; Yu GL, 2014, NAT PHYS, V10, P525, DOI [10.1038/NPHYS2979, 10.1038/nphys2979]; ZAK J, 1964, PHYS REV, V134, P1602, DOI 10.1103/PhysRev.134.A1602; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	29	72	74	5	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		181	184		10.1126/science.aal3357	http://dx.doi.org/10.1126/science.aal3357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706067	Green Submitted, Green Accepted			2022-12-28	WOS:000405391700040
J	Troshin, K; Hartwig, JF				Troshin, Konstantin; Hartwig, John F.			Snap deconvolution: An informatics approach to high-throughput discovery of catalytic reactions	SCIENCE			English	Article							COUPLING REACTIONS; MASS-SPECTROMETRY; PALLADIUM; EFFICIENT; HYDROALLYLATION; OPTIMIZATION; EXPERIMENTATION; CHEMOSENSOR; BORYLATION; LIBRARIES	We present an approach to multidimensional high-throughput discovery of catalytic coupling reactions that integrates molecular design with automated analysis and interpretation of mass spectral data. We simultaneously assessed the reactivity of three pools of compounds that shared the same functional groups (halides, boronic acids, alkenes, and alkynes, among other groups) but carried inactive substituents having specifically designed differences in masses. The substituents were chosen such that the products from any class of reaction in multiple reaction sets would have unique differences in masses, thus allowing simultaneous identification of the products of all transformations in a set of reactants. In this way, we easily distinguished the products of new reactions from noise and known couplings. Using this method, we discovered an alkyne hydroallylation and a nickel-catalyzed variant of alkyne diarylation.	[Troshin, Konstantin; Hartwig, John F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Troshin, Konstantin; Hartwig, John F.] Lawrence Berkeley Natl Lab, Chem Sci Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Hartwig, JF (corresponding author), Lawrence Berkeley Natl Lab, Chem Sci Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	jhartwig@berkeley.edu		Troshin, Konstantin/0000-0001-8713-1932	Office of Science, U.S. Department of Energy [DE-AC02-05CH11231]; Deutsche Forschungsgemeinschaft (Forschungsstipendium) [TR 1239/1-1]	Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft (Forschungsstipendium)	This work was supported by the Director, Office of Science, U.S. Department of Energy, under contract no. DE-AC02-05CH11231 and the Deutsche Forschungsgemeinschaft (Forschungsstipendium TR 1239/1-1 to K.T.). We are grateful to S.D. Dreher at Merck Research Laboratories for advice on conducting experiments in multiwell formats and to S. Herzon for initial discussions on the use of MS to identify products in mixtures. All data are provided in the supplementary materials.	Arcadi A, 2013, J ORG CHEM, V78, P4490, DOI 10.1021/jo400503f; Bellomo A, 2012, ANGEW CHEM INT EDIT, V51, P6912, DOI 10.1002/anie.201201720; Buitrago Santanilla Alexander, 2015, Science, V347, P49, DOI 10.1126/science.1259203; Cabrera-Pardo JR, 2013, NAT CHEM, V5, P423, DOI 10.1038/nchem.1612; Collins KD, 2014, NAT CHEM, V6, P859, DOI [10.1038/NCHEM.2062, 10.1038/nchem.2062]; Copeland GT, 1999, J AM CHEM SOC, V121, P4306, DOI 10.1021/ja984139+; Creminon C, 2015, CHEM COMMUN, V51, P7996, DOI 10.1039/c5cc00599j; Cui XZ, 2013, ORG BIOMOL CHEM, V11, P3094, DOI 10.1039/c3ob40232k; Diagne AB, 2015, ACS COMB SCI, V17, P658, DOI 10.1021/acscombsci.5b00131; DiRocco DA, 2014, ANGEW CHEM INT EDIT, V53, P4802, DOI 10.1002/anie.201402023; Doyle SK, 2016, CURR OPIN CHEM BIOL, V30, P28, DOI 10.1016/j.cbpa.2015.10.032; Dreher SD, 2008, J AM CHEM SOC, V130, P9257, DOI 10.1021/ja8031423; Eom MS, 2016, ORG LETT, V18, P1720, DOI 10.1021/acs.orglett.6b00300; Friest JA, 2011, ANGEW CHEM INT EDIT, V50, P8895, DOI 10.1002/anie.201103365; Gogsig TM, 2012, J AM CHEM SOC, V134, P443, DOI 10.1021/ja2084509; Han FS, 2013, CHEM SOC REV, V42, P5270, DOI 10.1039/c3cs35521g; Hansen EC, 2016, NAT CHEM, V8, P1126, DOI [10.1038/nchem.2587, 10.1038/NCHEM.2587]; Jo HH, 2014, ACCOUNTS CHEM RES, V47, P2212, DOI 10.1021/ar500147x; Kanan MW, 2004, NATURE, V431, P545, DOI 10.1038/nature02920; Krattiger P, 2003, ANGEW CHEM INT EDIT, V42, P1722, DOI 10.1002/anie.200250422; Lewis CA, 2009, J NAT PROD, V72, P1864, DOI 10.1021/np9004932; Mailig M, 2017, J AM CHEM SOC, V139, P6969, DOI 10.1021/jacs.7b02104; Martin VI, 2014, J ORG CHEM, V79, P3838, DOI 10.1021/jo500190b; McNally A, 2011, SCIENCE, V334, P1114, DOI 10.1126/science.1213920; Metz AE, 2012, ORG LETT, V14, P760, DOI 10.1021/ol203303b; Molander GA, 2013, J ORG CHEM, V78, P6427, DOI 10.1021/jo401104y; Molander GA, 2012, J AM CHEM SOC, V134, P16856, DOI 10.1021/ja307861n; Preshlock SM, 2013, J AM CHEM SOC, V135, P7572, DOI 10.1021/ja400295v; Robbins DW, 2011, SCIENCE, V333, P1423, DOI 10.1126/science.1207922; Schmink JR, 2013, ALDRICHIM ACTA, V46, P71; Shaughnessy KH, 1999, J AM CHEM SOC, V121, P2123, DOI 10.1021/ja983419m; Shields JD, 2015, ORG LETT, V17, P2166, DOI 10.1021/acs.orglett.5b00766; Srinivas HD, 2014, ORG LETT, V16, P3596, DOI 10.1021/ol5016724; Todd DP, 2015, J AM CHEM SOC, V137, P12788, DOI 10.1021/jacs.5b08448; Wang YM, 2016, J AM CHEM SOC, V138, P5024, DOI 10.1021/jacs.6b02527; Yamamoto Y, 2016, GREEN CHEM, V18, P4628, DOI 10.1039/c6gc01782g; Zhou CX, 2003, ORG LETT, V5, P1579, DOI 10.1021/ol034435d	37	57	57	4	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		175	180		10.1126/science.aan1568	http://dx.doi.org/10.1126/science.aan1568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706066				2022-12-28	WOS:000405391700039
J	Seib, KL				Seib, Kate L.			Gonorrhoea vaccines: a step in the right direction	LANCET			English	Editorial Material							VACCINATION		[Seib, Kate L.] Griffith Univ, Inst Glyc, Parklands Dr, Gold Coast, Qld 4215, Australia	Griffith University	Seib, KL (corresponding author), Griffith Univ, Inst Glyc, Parklands Dr, Gold Coast, Qld 4215, Australia.	k.seib@griffith.edu.au	Seib, Kate L/B-4670-2015	Seib, Kate L/0000-0002-7094-3528	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	I am supported by a career development fellowship from the Australian National Health and Medical Research Council. I declare no other competing interests.	Arnold R, 2011, VACCINE, V29, P7100, DOI 10.1016/j.vaccine.2011.06.120; Craig AP, 2015, VACCINE, V33, P4520, DOI 10.1016/j.vaccine.2015.07.015; Edwards JL, 2016, CRIT REV MICROBIOL, V42, P928, DOI 10.3109/1040841X.2015.1105782; Hook EW., 2008, SEX TRANSM DIS, V4th ed., P627; Petousis-Harris H, 2017, LANCET; Toneatto D, 2017, EXPERT REV VACCINES, V16, P433, DOI 10.1080/14760584.2017.1308828; Unemo M, 2017, NAT REV UROL, V14, P139, DOI 10.1038/nrurol.2016.268; US Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; World Health Organization, GLOB ACT PLAN CONTR; World Health Organization (WHO), GLOB PRIOR LIST ANT	11	9	9	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2017	390	10102					1567	1569		10.1016/S0140-6736(17)31605-7	http://dx.doi.org/10.1016/S0140-6736(17)31605-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI3RA	28705461	Green Submitted			2022-12-28	WOS:000411883300007
J	Nomura, S; Sakamoto, H; Glenn, S; Tsugawa, Y; Abe, SK; Rahman, MM; Brown, JC; Ezoe, S; Fitzmaurice, C; Inokuchi, T; Kassebaum, NJ; Kawakami, N; Kita, Y; Kondo, N; Lim, SS; Maruyama, S; Miyata, H; Mooney, MD; Naghavi, M; Onoda, T; Ota, E; Otake, Y; Roth, GA; Saito, E; Tabuchi, T; Takasaki, Y; Tanimura, T; Uechi, M; Vos, T; Wang, HD; Inoue, M; Murray, CJL; Shibuya, K				Nomura, Shuhei; Sakamoto, Haruka; Glenn, Scott; Tsugawa, Yusuke; Abe, Sarah K.; Rahman, Md M.; Brown, Jonathan C.; Ezoe, Satoshi; Fitzmaurice, Christina; Inokuchi, Tsuyoshi; Kassebaum, Nicholas J.; Kawakami, Norito; Kita, Yosuke; Kondo, Naoki; Lim, Stephen S.; Maruyama, Satoshi; Miyata, Hiroaki; Mooney, Meghan D.; Naghavi, Mohsen; Onoda, Tomoko; Ota, Erika; Otake, Yuji; Roth, Gregory A.; Saito, Eiko; Tabuchi, Takahiro; Takasaki, Yohsuke; Tanimura, Tadayuki; Uechi, Manami; Vos, Theo; Wang, Haidong; Inoue, Manami; Murray, Christopher J. L.; Shibuya, Kenji			Population health and regional variations of disease burden in Japan, 1990-2015: a systematic subnational analysis for the Global Burden of Disease Study 2015	LANCET			English	Article							MORTALITY; CARE; SMOKING; STATES; DEATH	Background Japan has entered the era of super-ageing and advanced health transition, which is increasingly putting pressure on the sustainability of its health system. The level and pace of this health transition might vary across regions within Japan and concern is growing about increasing regional variations in disease burden. The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) provides a comprehensive, comparable framework. We used data from GBD 2015 with the aim to quantify the burden of disease and injuries, and to attribute risk factors in Japan at a subnational, prefecture-level. Methods We used data from GBD 2015 for 315 causes and 79 risk factors of death, disease, and injury incidence and prevalence to measure the burden of diseases and injuries in Japan and in the 47 Japanese prefectures from 1990 to 2015. We extracted data from GBD 2015 to assess mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), life expectancy, and healthy life expectancy (HALE) in Japan and its 47 prefectures. We split extracted data by prefecture and applied GBD methods to generate estimates of burden, and attributable burden due to known risk factors. We examined the prefecture-level relationships of common health system inputs (eg, health expenditure and workforces) to the GBD outputs in 2015 to address underlying determinants of regional health variations. Findings Life expectancy at birth in Japan increased by 4.2 years from 79.0 years (95% uncertainty interval [UI] 79.0 to 79.0) to 83.2 years (83.1 to 83.2) between 1990 and 2015. However, the gaps between prefectures with the lowest and highest life expectancies and HALE have widened, from 2.5 to 3.1 years and from 2.3 to 2.7 years, respectively, from 1990 to 2015. Although overall age-standardised death rates decreased by 29.0% (28.7 to 29.3) from 1990 to 2015, the rates of mortality decline in this period substantially varied across the prefectures, ranging from -32.4% (-34.8 to -30.0) to -22.0% (-20.4 to -20.1). During the same time period, the rate of age-standardised DALYs was reduced overall by 19.8% (17.9 to 22.0). The reduction in rates of age-standardised YLDs was very small by 3.5% (2.6 to 4.3). The pace of reduction in mortality and DALYs in many leading causes has largely levelled off since 2005. Known risk factors accounted for 34.5% (32.4 to 36.9) of DALYs; the two leading behavioural risk factors were unhealthy diets and tobacco smoking in 2015. The common health system inputs were not associated with age-standardised death and DALY rates in 2015. Interpretation Japan has been successful overall in reducing mortality and disability from most major diseases. However, progress has slowed down and health variations between prefectures is growing. In view of the limited association between the prefecture-level health system inputs and health outcomes, the potential sources of regional variations, including subnational health system performance, urgently need assessment. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Nomura, Shuhei; Sakamoto, Haruka; Abe, Sarah K.; Rahman, Md M.; Ezoe, Satoshi; Saito, Eiko; Inoue, Manami; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo 1130033, Japan; [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Dept Mental Hlth, Tokyo, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Tokyo, Japan; [Glenn, Scott; Brown, Jonathan C.; Fitzmaurice, Christina; Kassebaum, Nicholas J.; Lim, Stephen S.; Mooney, Meghan D.; Naghavi, Mohsen; Roth, Gregory A.; Vos, Theo; Wang, Haidong; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Tsugawa, Yusuke] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Takasaki, Yohsuke] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Inokuchi, Tsuyoshi; Onoda, Tomoko] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo, Japan; [Kassebaum, Nicholas J.] Univ Washington, Seattle Childrens Hosp, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Kita, Yosuke] Yamaguchi Prefectural Govt, Hlth Promot Div, Yamaguchi, Japan; [Fitzmaurice, Christina] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Maruyama, Satoshi] Stanford Univ, Dept Hlth Serv Res & Policy, Stanford, CA 94305 USA; [Miyata, Hiroaki] Bur Int Hlth Cooperat, Natl Ctr Global Hlth & Med, Inst Global Hlth Policy Res, Dept Global Hlth Syst & Innovat, Tokyo, Japan; [Ota, Erika] St Lukes Int Univ, Grad Sch Nursing Sci, Global Hlth Nursing, Tokyo, Japan; [Otake, Yuji] Hokkaido Prefectural Govt, Hlth & Welf Bur, Sapporo, Hokkaido, Japan; [Tabuchi, Takahiro] Osaka Int Canc Inst, Canc Control Ctr, Osaka, Japan; [Saito, Eiko] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Div Canc Stat Integrat, Tokyo, Japan; [Inoue, Manami] Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan; [Tanimura, Tadayuki] Osaka Univ, Grad Sch Med, Dept Publ Hlth, Osaka, Japan; [Uechi, Manami; Shibuya, Kenji] Bur Int Hlth Cooperat, Natl Ctr Global Hlth & Med, Inst Global Hlth Policy Res, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard T.H. Chan School of Public Health; Keio University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; National Center for Global Health & Medicine - Japan; St. Luke's International Hospital; National Cancer Center - Japan; National Cancer Center - Japan; Osaka University; National Center for Global Health & Medicine - Japan	Shibuya, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp	Kondo, Naoki/K-3898-2012; Abe, Sarah/ABF-2941-2020; Nomura, Shuhei/HCH-5356-2022	Kondo, Naoki/0000-0002-6425-6844; Abe, Sarah/0000-0003-3991-2739; Nomura, Shuhei/0000-0002-2963-7297; Tabuchi, Takahiro/0000-0002-1050-3125; Tsugawa, Yusuke/0000-0002-1937-4833; Ota, Erika/0000-0002-3945-7441; Shibuya, Kenji/0000-0003-2528-7530	Bill & Melinda Gates Foundation; Japan Ministry of Education, Science, Sports and Culture; Japan Ministry of Health, Labour and Welfare; AXA CR Fixed Income Fund; AXA Research Fund	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Japan Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); AXA CR Fixed Income Fund; AXA Research Fund(AXA Research Fund)	Bill & Melinda Gates Foundation, Japan Ministry of Education, Science, Sports and Culture, Japan Ministry of Health, Labour and Welfare, AXA CR Fixed Income Fund and AXA Research Fund.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; [Anonymous], 2016, ANN HLTH LAB WELF RE; [Anonymous], 2017, JAPAN TIMES; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; Bongaarts J, 2014, POPUL DEV REV, V40, P189, DOI 10.1111/j.1728-4457.2014.00670.x; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Fukuda Y, 2005, ANN EPIDEMIOL, V15, P365, DOI 10.1016/j.annepidem.2004.09.003; Fukuda Y, 2005, INT J EPIDEMIOL, V34, P100, DOI 10.1093/ije/dyh283; Gilmour Stuart, 2014, J Prev Med Public Health, V47, P136, DOI 10.3961/jpmph.2014.47.3.136; Gomez-Dantes H, 2016, LANCET, V388, P2386, DOI 10.1016/S0140-6736(16)31773-1; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Ministry of Health, 2016, OV VIT STAT 2015; Ministry of Health, 2015, OV REP PUBL HLTH ADM; Ministry of Health, 2015, REP NAT HLTH NUTR SU; Ministry of Health Labour and Welfare, 2012, PREF SPEC RES NAT HL; Ministry of Health Labour and Welfare, HLTH JAP 21, V2, P21; Miyata H, 2015, LANCET, V385, P2549, DOI 10.1016/S0140-6736(15)61135-7; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National Police Agency, 2016, DAM SIT POL COUNT AS; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; OECD, 2016, OECD FACTB EC ENV SO; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Reich MR, 2015, NEW ENGL J MED, V373, P1793, DOI 10.1056/NEJMp1410676; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Solar O, 2010, CONCEPTUAL FRAMEWORK, V2; Statistics Bureau, 2016, POP EST AG 5 YEAR AG; Statistics Bureau, 2017, CHAPT 2 POP HOUS; Tsugawa Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008374; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Vital Health and Social Statistics Office, VIT STAT; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	38	105	106	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1521	1538		10.1016/S0140-6736(17)31544-1	http://dx.doi.org/10.1016/S0140-6736(17)31544-1			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7BS	28734670	Green Published, hybrid			2022-12-28	WOS:000411337100027
J	de Jong, MJ; van der Meulen-de Jong, AE; Romberg-Camps, MJ; Becx, MC; Maljaars, JP; Cilissen, M; van Bodegraven, AA; Mahmmod, N; Markus, T; Hameeteman, WM; Dijkstra, G; Masclee, AA; Boonen, A; Winkens, B; van Tubergen, A; Jonkers, DM; Pierik, MJ				de Jong, Marin J.; van der Meulen-de Jong, Andrea E.; Romberg-Camps, Marielle J.; Becx, Marco C.; Maljaars, Jeroen P.; Cilissen, Mia; van Bodegraven, Ad A.; Mahmmod, Nofel; Markus, Tineke; Hameeteman, Wim M.; Dijkstra, Gerard; Masclee, Ad A.; Boonen, Annelies; Winkens, Bjorn; van Tubergen, Astrid; Jonkers, Daisy M.; Pierik, Marie J.			Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; ULCERATIVE-COLITIS; HEALTH-CARE; IMPROVE; METAANALYSIS; PREDICTORS; STRATEGIES; ADHERENCE; COMMUNITY; COHORT	Background Tight and personalised control of inflammatory bowel disease in a traditional setting is challenging because of the disease complexity, high pressure on outpatient clinics, and rising incidence. We compared the effects of self-management with a telemedicine system, which was developed for all subtypes of inflammatory bowel disease, on health-care utilisation and patient-reported quality of care versus standard care. Methods We did this pragmatic, randomised trial in two academic and two non-academic hospitals in the Netherlands. Outpatients aged 18-75 years with inflammatory bowel disease and without an ileoanal or ileorectal pouch anastomosis, who had internet access and Dutch proficiency, were randomly assigned (1: 1) to care via a telemedicine system (myIBDcoach) that monitors and registers disease activity or standard care and followed up for 12 months. Randomisation was done with a computer-generated sequence and used the minimisation method. Participants, health-care providers, and staff who assessed outcome measures were not masked to treatment allocation. Primary outcomes were the number of outpatient visits and patient-reported quality of care (assessed by visual analogue scale score 0-10). Safety endpoints were the numbers of flares, corticosteroid courses, hospital admissions, emergency visits, and surgeries. Analyses were by intention to treat. This trial is registered with ClinicalTrials. gov, number NCT02173002. Findings Between Sept 9, 2014, and May 18, 2015, 909 patients were randomly assigned to telemedicine (n=465) or standard care (n=444). At 12 months, the mean number of outpatient visits to the gastroenterologist or nurse was significantly lower in the telemedicine group (1.55 [SD1.50]) than in the standard care group (2.34 [1.64]; difference -0.79 [95%CI -0.98 to -0.59]; p < 0.0001), as was the mean number of hospital admissions (0.05 [0.28] vs 0.10 [0.43]; difference -0.05 [-0.10 to 0.00]; p=0.046). At 12 months, both groups reported high mean patient-reported quality of care scores (8.16 [1.37] in the telemedicine group vs 8.27 [1.28] in the standard care group; difference 0.10 [-0.13 to 0.32]; p=0.411). The mean numbers of flares, corticosteroid courses, emergency visits, and surgeries did not differ between groups. Interpretation Telemedicine was safe and reduced outpatient visits and hospital admissions compared with standard care. This self-management tool might be useful for reorganising care of inflammatory bowel disease towards personalised and value-based health care.	[de Jong, Marin J.; Cilissen, Mia; Hameeteman, Wim M.; Masclee, Ad A.; Jonkers, Daisy M.; Pierik, Marie J.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Maastricht, Netherlands; [de Jong, Marin J.; Masclee, Ad A.; Jonkers, Daisy M.; Pierik, Marie J.] Maastricht Univ, Med Ctr, NUTRIM, Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Boonen, Annelies; van Tubergen, Astrid] Maastricht Univ, Med Ctr, Dept Internal Med, Div Rheumatol, Maastricht, Netherlands; [Boonen, Annelies; van Tubergen, Astrid] Maastricht Univ, Med Ctr, Care & Publ Hlth Res Inst, Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [van der Meulen-de Jong, Andrea E.; Maljaars, Jeroen P.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Romberg-Camps, Marielle J.; van Bodegraven, Ad A.] Zuyderland Med Ctr, Dept Gastroenterol Geriatr Internal & Intens Care, Sittard Geleen, Netherlands; [Becx, Marco C.; Mahmmod, Nofel] St Antonius Hosp, Dept Gastroenterol & Hepatol, Nieuwegein, Netherlands; [Markus, Tineke] CCUVN, Woerden, Netherlands; [Dijkstra, Gerard] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Winkens, Bjorn] Maastricht Univ, Dept Methodol & Stat, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St. Antonius Hospital Utrecht; University of Groningen; Maastricht University	Pierik, MJ (corresponding author), Maastricht Univ, Dept Gastroenterol & Hepatol, Med Ctr, NL-6202 AZ Maastricht, Netherlands.	m.pierik@mumc.nl	van Bodegraven, Ad/ABG-4367-2020; van der Meulen, Andrea/AAU-9430-2020; van Tubergen, Astrid/AAY-7065-2020; van Bodegraven, Ad A/L-3180-2013	van der Meulen, Andrea/0000-0001-9353-5431; van Tubergen, Astrid/0000-0001-8477-0683; Maljaars, Jeroen/0000-0003-0477-9499; Winkens, Bjorn/0000-0002-6747-6228; /0000-0003-4563-7462	Maastricht University Medical Centre; Ferring	Maastricht University Medical Centre; Ferring(Ferring Pharmaceuticals)	Maastricht University Medical Centre and Ferring.	Aguas M, 2016, INFLAMM BOWEL DIS, V22, pE4, DOI 10.1097/MIB.0000000000000676; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Bradley SM, 2016, JAMA-J AM MED ASSOC, V316, P487, DOI 10.1001/jama.2016.6495; Burisch J, 2015, SCAND J GASTROENTERO, V50, P942, DOI 10.3109/00365521.2015.1014407; Colombel JF, 2017, GASTROENTEROLOGY, V152, P351, DOI 10.1053/j.gastro.2016.09.046; Cross RK, 2012, INFLAMM BOWEL DIS, V18, P1018, DOI 10.1002/ibd.21795; de Jong M, 2015, J CROHNS COLITIS, V9, pS192; de Jong M, 2017, INFLAMM BOWEL DIS, V23, P485, DOI 10.1097/MIB.0000000000001034; Diez ID, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0537-y; Elkjaer M, 2010, GUT, V59, P1652, DOI 10.1136/gut.2010.220160; Feuerstein JD, 2016, CLIN GASTROENTEROL H, V14, P421, DOI 10.1016/j.cgh.2015.09.042; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Huang VW, 2014, WORLD J GASTROENTERO, V20, P829, DOI 10.3748/wjg.v20.i3.829; Irvine EJ, 1996, AM J GASTROENTEROL, V91, P1571; Jackson BD, 2016, J CROHNS COLITIS, V10, P1103, DOI 10.1093/ecco-jcc/jjw059; Jeuring SFG, 2017, AM J GASTROENTEROL, V112, P325, DOI 10.1038/ajg.2016.524; Jeuring SFG, 2015, J CROHNS COLITIS, V9, P837, DOI 10.1093/ecco-jcc/jjv129; Jonkman NH, 2016, INT J CHRONIC OBSTR, V11, P2063, DOI 10.2147/COPD.S107884; Keefer L, 2011, INFLAMM BOWEL DIS, V17, P614, DOI 10.1002/ibd.21314; Lakatos PL, 2009, WORLD J GASTROENTERO, V15, P4234, DOI 10.3748/wjg.15.4234; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Magro F, 2017, J CROHNS COLITIS, V11, P649, DOI 10.1093/ecco-jcc/jjx008; Melmed GY, 2013, INFLAMM BOWEL DIS, V19, P662, DOI 10.1097/mib.0b013e31828278a2; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Pedersen N, 2012, ALIMENT PHARM THER, V36, P840, DOI 10.1111/apt.12043; Pedersen N, 2014, INFLAMM BOWEL DIS, V20, P2276, DOI 10.1097/MIB.0000000000000199; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Reigada LC, 2016, INFLAMM BOWEL DIS, V22, P2127, DOI 10.1097/MIB.0000000000000864; Rudin RS, 2016, NEW ENGL J MED, V375, P815, DOI 10.1056/NEJMp1606884; Siegel CA, 2013, CLIN GASTROENTEROL H, V11, P908, DOI 10.1016/j.cgh.2013.05.027; Sulz MC, 2013, EUR J GASTROEN HEPAT, V25, P790, DOI 10.1097/MEG.0b013e32836019b9; van den Heuvel TR, 2015, INT J EPIDEMIOL	32	166	166	2	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					959	968		10.1016/S0140-6736(17)31327-2	http://dx.doi.org/10.1016/S0140-6736(17)31327-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF2SE	28716313	Green Published			2022-12-28	WOS:000408746300025
J	Yagi, M; Kishigami, S; Tanaka, A; Semi, K; Mizutani, E; Wakayama, S; Wakayama, T; Yamamoto, T; Yamada, Y				Yagi, Masaki; Kishigami, Satoshi; Tanaka, Akito; Semi, Katsunori; Mizutani, Eiji; Wakayama, Sayaka; Wakayama, Teruhiko; Yamamoto, Takuya; Yamada, Yasuhiro			Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation	NATURE			English	Article							EMBRYONIC STEM-CELLS; REGULATORY PRINCIPLES; PLURIPOTENT STATE; SELF-RENEWAL; GENOME; NAIVE; MICE; DIFFERENTIATION; HYPOMETHYLATION; DEMETHYLATION	Inhibitors of Mek1/2 and Gsk3 beta, known as 2i, enhance the derivation of embryonic stem (ES) cells and promote ground-state pluripotency in rodents(1,2). Here we show that the derivation of female mouse ES cells in the presence of 2i and leukaemia inhibitory factor (2i/L ES cells) results in a widespread loss of DNA methylation, including a massive erasure of genomic imprints. Despite this global loss of DNA methylation, early-passage 2i/L ES cells efficiently differentiate into somatic cells, and this process requires genome-wide de novo DNA methylation. However, the majority of imprinting control regions (ICRs) remain unmethylated in 2i/L-ES-cell-derived differentiated cells. Consistently, 2i/L ES cells exhibit impaired autonomous embryonic and placental development by tetraploid embryo complementation or nuclear transplantation. We identified the derivation conditions of female ES cells that display 2i/L-ES-cell-like transcriptional signatures while preserving gamete-derived DNA methylation and autonomous developmental potential. Upon prolonged culture, however, female ES cells exhibited ICR demethylation regardless of culture conditions. Our results provide insights into the derivation of female ES cells reminiscent of the inner cell mass of preimplantation embryos.	[Yagi, Masaki; Tanaka, Akito; Semi, Katsunori; Yamamoto, Takuya; Yamada, Yasuhiro] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Life Sci Frontiers, Kyoto 6068507, Japan; [Kishigami, Satoshi; Mizutani, Eiji; Wakayama, Sayaka; Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi 4008510, Japan; [Mizutani, Eiji; Wakayama, Sayaka; Wakayama, Teruhiko] Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi 4008510, Japan; [Yamamoto, Takuya] CREST, AMED, 1-7-1 Otemachi, Tokyo 1000004, Japan	Kyoto University; University of Yamanashi; University of Yamanashi; Japan Science & Technology Agency (JST)	Yamamoto, T (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Life Sci Frontiers, Kyoto 6068507, Japan.; Yamamoto, T (corresponding author), CREST, AMED, 1-7-1 Otemachi, Tokyo 1000004, Japan.	takuya@cira.kyoto-u.ac.jp; y-yamada@cira.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947; Kishigami, Satoshi/0000-0001-9447-5100	P-CREATE, Japan Agency for Medical Research and Development (AMED); SICORP, Japan Agency for Medical Research and Development (AMED); JSPS KAKENHI [15H04721, 15H01352, 15J05792]; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; Naito Foundation; Core Center for iPS Cell Research; Research Center Network for Realization of Regenerative Medicine, AMED; AMED-CREST; iPS Cell Research Fund; Grants-in-Aid for Scientific Research [15J05792, 16H02593] Funding Source: KAKEN	P-CREATE, Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); SICORP, Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Core Center for iPS Cell Research; Research Center Network for Realization of Regenerative Medicine, AMED; AMED-CREST; iPS Cell Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. Shiroishi, M. Saitou and S. Yokobayashi for helpful suggestions, K. Woltjen for providing piggyBac vectors, P. Karagiannis for critical reading of this manuscript, and T. Ukai, M. Kabata, S. Sakurai, D. Seki and T. Sato for technical assistance. Y.Y. was supported in part by P-CREATE, SICORP, Japan Agency for Medical Research and Development (AMED); JSPS KAKENHI 15H04721; the Princess Takamatsu Cancer Research Fund; the Takeda Science Foundation; and the Naito Foundation. Y.Y. and T.Y. were supported by Core Center for iPS Cell Research, Research Center Network for Realization of Regenerative Medicine, AMED. T.Y. was supported by AMED-CREST; JSPS KAKENHI 15H01352; and iPS Cell Research Fund. M.Y. was supported by JSPS KAKENHI 15J05792.	Branco MR, 2016, DEV CELL, V36, P152, DOI 10.1016/j.devcel.2015.12.027; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Choi J, 2017, CELL STEM CELL, V20, P706, DOI 10.1016/j.stem.2017.03.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hackett JA, 2013, STEM CELL REP, V1, P518, DOI 10.1016/j.stemcr.2013.11.010; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Kato Y, 1999, DEVELOPMENT, V126, P1823; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SI, 2016, METHODS MOL BIOL, V1357, P111, DOI 10.1007/7651_2015_251; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Pastor WA, 2016, CELL STEM CELL, V18, P323, DOI 10.1016/j.stem.2016.01.019; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schulz EG, 2014, CELL STEM CELL, V14, P203, DOI 10.1016/j.stem.2013.11.022; Shimizu T, 2012, STEM CELLS, V30, P1394, DOI 10.1002/stem.1119; Shirane K, 2016, DEV CELL, V39, P87, DOI 10.1016/j.devcel.2016.08.008; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takada T, 2015, MAMM GENOME, V26, P331, DOI 10.1007/s00335-015-9569-8; Takada T, 2013, GENOME RES, V23, P1329, DOI 10.1101/gr.156497.113; Terashita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078380; Terashita Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098764; Theunissen TW, 2016, CELL STEM CELL, V19, P502, DOI 10.1016/j.stem.2016.06.011; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	47	107	108	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					224	+		10.1038/nature23286	http://dx.doi.org/10.1038/nature23286			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28746308	Green Submitted			2022-12-28	WOS:000407284300046
J	Green, AA; Kim, JM; Ma, D; Ilver, PAS; Collins, JJ; Yin, P				Green, Alexander A.; Kim, Jongmin; Ma, Duo; Ilver, Pamela A. S.; Collins, James J.; Yin, Peng			Complex cellular logic computation using ribocomputing devices	NATURE			English	Article							DNA STRAND DISPLACEMENT; MAMMALIAN-CELLS; GENE-EXPRESSION; LIVING CELLS; CIRCUITS; GATES; REGULATORS; NETWORK	Synthetic biology aims to develop engineering-driven approaches to the programming of cellular functions that could yield transformative technologies(1). Synthetic gene circuits that combine DNA, protein, and RNA components have demonstrated a range of functions such as bistability(2), oscillation(3,4), feedback(5,6), and logic capabilities(7-15). However, it remains challenging to scale up these circuits owing to the limited number of designable, orthogonal, high-performance parts, the empirical and often tedious composition rules, and the requirements for substantial resources for encoding and operation. Here, we report a strategy for constructing RNA-only nanodevices to evaluate complex logic in living cells. Our 'ribocomputing' systems are composed of de-novo-designed parts and operate through predictable and designable base-pairing rules, allowing the effective in silico design of computing devices with prescribed configurations and functions in complex cellular environments. These devices operate at the post-transcriptional level and use an extended RNA transcript to co-localize all circuit sensing, computation, signal transduction, and output elements in the same self-assembled molecular complex, which reduces diffusion-mediated signal losses, lowers metabolic cost, and improves circuit reliability. We demonstrate that ribocomputing devices in Escherichia coli can evaluate two-input logic with a dynamic range up to 900-fold and scale them to four-input AND, six-input OR, and a complex 12-input expression (A1 AND A2 AND NOT A1*) OR (B1 AND B2 AND NOT B2*) OR (C1 AND C2) OR (D1 AND D2) OR (E1 AND E2). Successful operation of ribocomputing devices based on programmable RNA interactions suggests that systems employing the same design principles could be implemented in other host organisms or in extracellular settings.	[Green, Alexander A.; Kim, Jongmin; Ilver, Pamela A. S.; Collins, James J.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Green, Alexander A.; Ma, Duo] Arizona State Univ, Biodesign Inst, Biodesign Ctr Mol Design & Biomimet, Tempe, AZ 85287 USA; [Green, Alexander A.; Ma, Duo] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Kim, Jongmin; Ilver, Pamela A. S.; Yin, Peng] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Collins, James J.] MIT, Dept Biol Engn, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] Broad Inst & Harvard, Cambridge, MA 02142 USA	Harvard University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Green, AA; Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Green, AA (corresponding author), Arizona State Univ, Biodesign Inst, Biodesign Ctr Mol Design & Biomimet, Tempe, AZ 85287 USA.; Green, AA (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; Yin, P (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	alexgreen@asu.edu; py@hms.harvard.edu	Kim, Jongmin/AAM-2795-2020; Green, Alexander A./X-7025-2019	Kim, Jongmin/0000-0002-2713-1006; Green, Alexander A./0000-0003-2058-1204	NIH Director's New Innovator and Transformative Research Awards [1DP2OD007292, 1R01EB018659]; ONR Young Investigator Program Award [N000141110914]; NSF [CCF1054898, CCF1317291]; Wyss Institute Molecular Robotics Initiative; DARPA Living Foundries grant [HR001112C0061]; ONR MURI Program grant; DTRA grant [HDTRA1-15-1-0040]; Paul G. Allen Frontiers Group funds; Arizona Biomedical Research Commission New Investigator Award; Alfred P. Sloan Research Fellowship [FG-2017-9108]; Arizona State University funds; Wyss Institute Director's Cross-Platform Fellowship;  [N000141010827];  [N000141310593];  [N000141410610];  [N000141612410];  [CCF1162459];  [ERASynBio 1540214]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [1317291] Funding Source: National Science Foundation	NIH Director's New Innovator and Transformative Research Awards; ONR Young Investigator Program Award; NSF(National Science Foundation (NSF)); Wyss Institute Molecular Robotics Initiative; DARPA Living Foundries grant; ONR MURI Program grant; DTRA grant; Paul G. Allen Frontiers Group funds; Arizona Biomedical Research Commission New Investigator Award; Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Arizona State University funds; Wyss Institute Director's Cross-Platform Fellowship; ; ; ; ; ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by NIH Director's New Innovator and Transformative Research Awards (1DP2OD007292, 1R01EB018659), an ONR Young Investigator Program Award (N000141110914) and grants (N000141010827, N000141310593, N000141410610, N000141612410), NSF CAREER and Expedition in Computing Awards (CCF1054898, CCF1317291) and grants (CCF1162459, ERASynBio 1540214), and Wyss Institute Molecular Robotics Initiative support to P.Y.; a DARPA Living Foundries grant (HR001112C0061) to P.A.S., P.Y., and J.J.C.; an ONR MURI Program grant, a DTRA grant (HDTRA1-15-1-0040), and Paul G. Allen Frontiers Group funds to J.J.C.; and an Arizona Biomedical Research Commission New Investigator Award, an Alfred P. Sloan Research Fellowship (FG-2017-9108), and Arizona State University funds to A.A.G. J.K. acknowledges a Wyss Institute Director's Cross-Platform Fellowship.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Braich RS, 2002, SCIENCE, V296, P499, DOI 10.1126/science.1069528; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Chappell J, 2015, NAT CHEM BIOL, V11, P214, DOI 10.1038/nchembio.1737; Chen X, 2012, J AM CHEM SOC, V134, P263, DOI 10.1021/ja206690a; Chen YJ, 2015, NAT NANOTECHNOL, V10, P748, DOI [10.1038/NNANO.2015.195, 10.1038/nnano.2015.195]; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elbaz J, 2010, NAT NANOTECHNOL, V5, P417, DOI [10.1038/NNANO.2010.88, 10.1038/nnano.2010.88]; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Genot AJ, 2013, ANGEW CHEM INT EDIT, V52, P1189, DOI 10.1002/anie.201206201; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/nmeth.2969, 10.1038/NMETH.2969]; Lake A, 2010, ANGEW CHEM INT EDIT, V49, P4459, DOI 10.1002/anie.200907135; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zhu JB, 2013, ACS NANO, V7, P10211, DOI 10.1021/nn4044854	31	196	208	14	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					117	+		10.1038/nature23271	http://dx.doi.org/10.1038/nature23271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28746304	Green Published, Green Accepted			2022-12-28	WOS:000406831700048
J	Poonia, A; Giridhara, P				Poonia, Amitabh; Giridhara, Priya			Xanthomas in Familial Hypercholesterolemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Poonia, Amitabh; Giridhara, Priya] Sree Chitra Tirunal Inst Med Sci & Technol, Thiruvananthapuram, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Poonia, A (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Thiruvananthapuram, Kerala, India.	amitabhpoonia@gmail.com							0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					E7	E7		10.1056/NEJMicm1616147	http://dx.doi.org/10.1056/NEJMicm1616147			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3NW	28767354				2022-12-28	WOS:000406747100010
J	Mega, ER				Mega, Emiliano Rodriguez			HIGHER EDUCATION Turmoil imperils research university in Andes	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					340	341		10.1126/science.357.6349.340	http://dx.doi.org/10.1126/science.357.6349.340			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751586				2022-12-28	WOS:000406362300014
J	Seitzinger, SP; Phillips, L				Seitzinger, Sybil P.; Phillips, Leigh			Nitrogen stewardship in the Anthropocene	SCIENCE			English	Editorial Material									[Seitzinger, Sybil P.; Phillips, Leigh] Univ Victoria, Pacific Inst Climate Solut, Victoria, BC, Canada	University of Victoria	Seitzinger, SP (corresponding author), Univ Victoria, Pacific Inst Climate Solut, Victoria, BC, Canada.	seitzing@uvic.ca			INI	INI	From 2008 until 2015, S.P.S. was the director of the International Geosphere-Biosphere Program (IGBP), which cosponsored the INI. As director of IGBP, she approved the appointment of the INI chairs.	[Anonymous], 2016, MEET THE NEW MEAT; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Dobermann A, 2002, FIELD CROP RES, V74, P37, DOI 10.1016/S0378-4290(01)00197-6; Edenhofer O., 2014, CLIMATE CHANGE 2014; FAO, 2006, LIV LONG SHAD; Hutchings NJ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/115012; Lassaletta L, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/095007; Matassa S, 2015, ENVIRON SCI TECHNOL, V49, P5247, DOI 10.1021/es505432w; Moritz MSM, 2015, J INTEGR AGR, V14, P208, DOI 10.1016/S2095-3119(14)60889-3; Seitzinger SP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI [10.1029/2010GB003851, 10.1029/2009GB003587]; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Stokstad E, 2016, SCIENCE, V353, P1225, DOI 10.1126/science.353.6305.1225	12	25	27	7	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					350	351		10.1126/science.aao0812	http://dx.doi.org/10.1126/science.aao0812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751593				2022-12-28	WOS:000406362300021
J	Goldschen-Ohm, MP; Chanda, B				Goldschen-Ohm, Marcel P.; Chanda, Baron			SnapShot: Channel Gating Mechanisms	CELL			English	Editorial Material							ACTIVATION		[Goldschen-Ohm, Marcel P.; Chanda, Baron] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA; [Chanda, Baron] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goldschen-Ohm, MP (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA.			Chanda, Baron/0000-0003-4954-7034	 [R01NS081293];  [R01NS101723]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS101723, R01NS081293] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Rick Aldrich, David Clapham, Cindy Czajkowski, Katie Henzler-Wildman, Andy Meredith, Chris Miller, Eduardo Perozo, Andrew Plested, Gail Robertson, and Kenton Swartz for their helpful comments and suggestions. B.C. is funded by R01NS081293 and R01NS101723.	Boscardin E, 2016, BRIT J PHARMACOL, V173, P2671, DOI 10.1111/bph.13533; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Cuello LG, 2010, FEBS LETT, V584, P1126, DOI 10.1016/j.febslet.2010.02.003; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Meredith A.L., 2015, HDB ION CHANNELS, P545; Palkar R, 2015, CURR OPIN NEUROBIOL, V34, P14, DOI 10.1016/j.conb.2015.01.010; Palovcak E, 2014, J GEN PHYSIOL, V143, P145, DOI 10.1085/jgp.201311103; Plested AJR, 2016, NAT STRUCT MOL BIOL, V23, P494, DOI 10.1038/nsmb.3214; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002	11	11	11	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					594	+		10.1016/j.cell.2017.07.019	http://dx.doi.org/10.1016/j.cell.2017.07.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW8TA	28753432	Bronze			2022-12-28	WOS:000425608100001
J	Pagano, M				Pagano, Michele			Don't run biomedical science as a business	NATURE			English	Editorial Material									[Pagano, Michele] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA; [Pagano, Michele] Howard Hughes Med Inst, Chevy Chase, MD USA	New York University; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA.; Pagano, M (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	michele.pagano@nyumc.org		pagano, michele/0000-0003-3210-2442	NCI NIH HHS [R01 CA076584] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Kaelin WG, 2017, NATURE, V545, P387, DOI 10.1038/545387a	1	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					381	381		10.1038/547381a	http://dx.doi.org/10.1038/547381a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB7ZK	28748949	Bronze			2022-12-28	WOS:000406358300006
J	Yang, H; Sternson, SM				Yang, Hui; Sternson, Scott M.			Raphe Circuits on the Menu	CELL			English	Editorial Material							FEEDING-BEHAVIOR; NEURONS; 5-HT		[Yang, Hui; Sternson, Scott M.] HHMI, Janelia Res Campus, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), HHMI, Janelia Res Campus, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org		Sternson, Scott/0000-0002-0835-444X				Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cohen JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06346; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; HUTSON PH, 1986, EUR J PHARMACOL, V129, P347, DOI 10.1016/0014-2999(86)90445-0; Li C, 2016, NEUROPSYCHOPHARMACOL, V41, P2122, DOI 10.1038/npp.2016.12; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008	9	0	0	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					409	410		10.1016/j.cell.2017.07.017	http://dx.doi.org/10.1016/j.cell.2017.07.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753420	Bronze			2022-12-28	WOS:000406462400001
J	Akbulatov, S; Tian, Y; Huang, Z; Kucharski, TJ; Yang, QZ; Boulatov, R				Akbulatov, Sergey; Tian, Yancong; Huang, Zhen; Kucharski, Timothy J.; Yang, Qing-Zheng; Boulatov, Roman			Experimentally realized mechanochemistry distinct from force-accelerated scission of loaded bonds	SCIENCE			English	Article							POLYMER MECHANOCHEMISTRY; ESTER HYDROLYSIS; CATCH BONDS; KINETICS; REACTIVITY; STRESS; MECHANOPHORES; STRAIN; CHEMOMECHANICS; BEHAVIOR	Stretching polymer chains accelerates dissociation of a variety of internal covalent bonds, to an extent that correlates well with the force experienced by the scissile bond. Recent theory has also predicted scenarios in which applied force accelerates dissociation of unloaded bonds and kinetically strengthens strained bonds. We report here unambiguous experimental validation of this hypothesis: Detailed kinetic measurements demonstrate that stretching phosphotriesters accelerates dissociation of the unloaded phosphorus-oxygen bond orthogonal to the pulling axis, whereas stretching organosiloxanes inhibits dissociation of the aligned loaded silicon-oxygen bonds. Qualitatively, the outcome is determined by phosphoester elongation and siloxane contraction along the pulling axis in the respective rate-determining transition states. Quantitatively, the results agree with a simple mechanochemical kinetics model.	[Akbulatov, Sergey; Tian, Yancong; Boulatov, Roman] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Huang, Zhen; Kucharski, Timothy J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Yang, Qing-Zheng] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China	University of Liverpool; University of Illinois System; University of Illinois Urbana-Champaign; Beijing Normal University	Boulatov, R (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.	boulatov@liv.ac.uk	Boulatov, Roman/AAO-7865-2020; Boulatov, Roman/B-7092-2018; Kucharski, Timothy/I-4417-2013; Yang, Qing-Zheng/S-5057-2016	Boulatov, Roman/0000-0002-7601-4279; Boulatov, Roman/0000-0002-7601-4279; Kucharski, Timothy/0000-0001-7235-974X; Yang, Qing-Zheng/0000-0002-9131-4907	U.K. Engineering and Physical Sciences Research Council (Early Career Fellowship); U.S. NSF (CAREER Award); NSF; U.K. Engineering and Physical Sciences Research Council (Early Career Fellowship); U.S. NSF (CAREER Award); NSF; EPSRC [EP/L000075/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L000075/1] Funding Source: researchfish	U.K. Engineering and Physical Sciences Research Council (Early Career Fellowship); U.S. NSF (CAREER Award)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); U.K. Engineering and Physical Sciences Research Council (Early Career Fellowship); U.S. NSF (CAREER Award)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was supported by the U.K. Engineering and Physical Sciences Research Council (Early Career Fellowship) and the U.S. NSF (CAREER Award); computational resources were provided by XSEDE (Extreme Science and Engineering Discovery Environment), supported by the NSF. S.A. synthesized the compounds and contributed to data analysis and writing of the manuscript; Y.T. performed the quantum-chemical computations and contributed to data analysis; Z.H. measured the kinetics of reactions 1a to 1c; T.J.K. measured the kinetics of reactions 2a and 2b and contributed to synthesis; Q.-Z.Y. developed stiff-stilbene syntheses; and R.B. conceived of and supervised the project, analyzed the data, and prepared the manuscript. Data supporting the results and conclusions in the manuscript are available as supplementary materials.	Akbulatov S, 2013, ANGEW CHEM INT EDIT, V52, P6992, DOI 10.1002/anie.201300746; Akbulatov S, 2012, J AM CHEM SOC, V134, P7620, DOI 10.1021/ja301928d; Bailey A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3678010; Baker J, 2006, J AM CHEM SOC, V128, P11324, DOI 10.1021/ja0618503; Boulatov R, 2013, NAT CHEM, V5, P84, DOI 10.1038/nchem.1541; Chakrabarti S, 2017, J STRUCT BIOL, V197, P50, DOI 10.1016/j.jsb.2016.03.022; Craig SL, 2012, NATURE, V487, P176, DOI 10.1038/487176a; Diesendruck CE, 2014, NAT CHEM, V6, P624, DOI [10.1038/nchem.1938, 10.1038/NCHEM.1938]; Dopieralski P, 2017, NAT CHEM, V9, P164, DOI [10.1038/NCHEM.2632, 10.1038/nchem.2632]; Ducrot E, 2014, SCIENCE, V344, P186, DOI 10.1126/science.1248494; Groote R, 2014, MACROMOLECULES, V47, P1187, DOI 10.1021/ma4022339; Hermes M, 2011, J AM CHEM SOC, V133, P20044, DOI 10.1021/ja207421v; Huang Z, 2011, CHEM SOC REV, V40, P2359, DOI 10.1039/c0cs00148a; Huang Z, 2010, PURE APPL CHEM, V82, P931, DOI 10.1351/PAC-CON-09-11-36; Kean ZS, 2013, J AM CHEM SOC, V135, P13598, DOI 10.1021/ja4075997; Kochhar GS, 2015, TOP CURR CHEM, V369, P37, DOI 10.1007/128_2015_648; Konda SSM, 2013, J AM CHEM SOC, V135, P12722, DOI 10.1021/ja4051108; Krupicka M, 2014, J PHYS CHEM LETT, V5, P905, DOI 10.1021/jz402644e; Kryger MJ, 2011, J AM CHEM SOC, V133, P18992, DOI 10.1021/ja2086728; Kucharski TJ, 2011, J MATER CHEM, V21, P8237, DOI 10.1039/c0jm04079g; Kucharski TJ, 2010, J PHYS CHEM LETT, V1, P2820, DOI 10.1021/jz100878z; Kucharski TJ, 2009, ANGEW CHEM INT EDIT, V48, P7040, DOI 10.1002/anie.200901511; Larsen MB, 2013, J AM CHEM SOC, V135, P8189, DOI 10.1021/ja403757p; Lee B, 2015, J AM CHEM SOC, V137, P10826, DOI 10.1021/jacs.5b06937; Ramirez ALB, 2013, NAT CHEM, V5, P757, DOI [10.1038/NCHEM.1720, 10.1038/nchem.1720]; Rapoport N, 1983, RUSS CHEM REV, V52, P897; Ribas-Arino J, 2012, CHEM REV, V112, P5412, DOI 10.1021/cr200399q; Schmidt SW, 2012, ACS NANO, V6, P1314, DOI 10.1021/nn204111w; Stauch T, 2016, CHEM REV, V116, P14137, DOI 10.1021/acs.chemrev.6b00458; Suzuki Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048101; Tian YC, 2016, PHYS CHEM CHEM PHYS, V18, P26990, DOI 10.1039/c6cp04696g; Tian YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3538; Tian YC, 2013, CHEM COMMUN, V49, P4187, DOI 10.1039/c2cc37095f; Tian YC, 2012, CHEMPHYSCHEM, V13, P2277, DOI 10.1002/cphc.201200207; Tobe M.L., 1999, INORG REACT MECH; Tyler DR, 2004, J MACROMOL SCI-POL R, VC44, P351, DOI 10.1081/MC-200033682; Wang JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13433; Wu D, 2010, J AM CHEM SOC, V132, P15936, DOI 10.1021/ja108429h; Yang QZ, 2009, NAT NANOTECHNOL, V4, P302, DOI [10.1038/NNANO.2009.55, 10.1038/nnano.2009.55]; Zhao CY, 1997, J PHYS CHEM A, V101, P5174, DOI 10.1021/jp9634262	40	55	55	7	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348								10.1126/science.aan1026	http://dx.doi.org/10.1126/science.aan1026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729509				2022-12-28	WOS:000405901600040
J	Dalu, MTB; Dalu, T; Wasserman, RJ				Dalu, Mwazvita T. B.; Dalu, Tatenda; Wasserman, Ryan J.			Restrict bush fires used in animal hunts	NATURE			English	Letter									[Dalu, Mwazvita T. B.; Dalu, Tatenda] Rhodes Univ, Grahamstown, South Africa; [Wasserman, Ryan J.] Monash Univ Malaysia, Bandar Sunway, Malaysia	Rhodes University; Monash University; Monash University Sunway	Wasserman, RJ (corresponding author), Monash Univ Malaysia, Bandar Sunway, Malaysia.	smazvita@gmail.com	Dalu, Tatenda/K-3089-2012; Dalu, Mwazvita TB/J-2112-2019	Dalu, Tatenda/0000-0002-9019-7702; Dalu, Mwazvita TB/0000-0001-6757-316X; Wasserman, Ryan/0000-0002-4162-1503				Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10	1	2	2	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					281	281		10.1038/547281c	http://dx.doi.org/10.1038/547281c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB0OR	28726820	Bronze			2022-12-28	WOS:000405844900016
J	Northcott, PA; Buchhalter, I; Morrissy, AS; Hovestadt, V; Weischenfeldt, J; Ehrenberger, T; Grobner, S; Segura-Wang, M; Zichner, T; Rudneva, VA; Warnatz, HJ; Sidiropoulos, N; Phillips, AH; Schumacher, S; Kleinheinz, K; Waszak, SM; Erkek, S; Jones, DTW; Worst, BC; Kool, M; Zapatka, M; Jager, N; Chavez, L; Hutter, B; Bieg, M; Paramasivam, N; Heinold, M; Gu, ZG; Ishaque, N; Jager-Schmidt, C; Imbusch, CD; Jugold, A; Hubschmann, D; Risch, T; Amstislavskiy, V; Gonzalez, FGR; Weber, UD; Wolf, S; Robinson, GW; Zhou, X; Wu, G; Finkelstein, D; Liu, YL; Cavalli, FMG; Luu, B; Ramaswamy, V; Wu, XC; Koster, J; Ryzhova, M; Cho, YJ; Pomeroy, SL; Herold-Mende, C; Schuhmann, M; Ebinger, M; Liau, LM; Mora, J; McLendon, E; Jabado, N; Kumabe, T; Chuah, E; Ma, Y; Moore, RA; Mungall, AJ; Mungall, KL; Thiessen, N; Tse, K; Wong, T; Jones, SJM; Witt, O; Milde, T; Von Deimling, A; Capper, D; Korshunov, A; Yaspo, ML; Kriwacki, R; Gajjar, A; Zhang, JH; Beroukhim, R; Fraenkel, E; Korbel, JO; Brors, B; Schlesner, M; Eils, R; Marra, MA; Pfister, SM; Taylor, MD; Lichter, P				Northcott, Paul A.; Buchhalter, Ivo; Morrissy, A. Sorana; Hovestadt, Volker; Weischenfeldt, Joachim; Ehrenberger, Tobias; Groebner, Susanne; Segura-Wang, Maia; Zichner, Thomas; Rudneva, Vasilisa A.; Warnatz, Hans-Joeg; Sidiropoulos, Nikos; Phillips, Aaron H.; Schumacher, Steven; Kleinheinz, Kortine; Waszak, Sebastian M.; Erkek, Serap; Jones, David T. W.; Worst, Barbara C. .; Kool, Marcel; Zapatka, Marc; Jaeger, Natalie; Chavez, Lukas; Hutter, Barbara; Bieg, Matthias; Paramasivam, Nagarajan; Heinold, Michael; Gu, Zuguang; Ishaque, Naveed; Jaeger-Schmidt, Christina; Imbusch, Charles D.; Jugold, Alke; Huebschmann, Daniel; Risch, Thomas; Amstislavskiy, Vyacheslav; Gonzalez, Francisco German Rodriguez; Weber, Ursula D.; Wolf, Stephan; Robinson, Giles W.; Zhou, Xin; Wu, Gang; Finkelstein, David; Liu, Yanling; Cavalli, Florence M. G.; Luu, Betty; Ramaswamy, Vijay; Wu, Xiaochong; Koster, Jan; Ryzhova, Marina; Cho, Yoon-Jae; Pomeroy, Scott L. .; Herold-Mende, Christel; Schuhmann, Martin; Ebinger, Martin; Liau, Linda M.; Mora, Jaume; McLendon, E.; Jabado, Nada; Kumabe, Toshihiro; Chuah, Eric; Ma, Yussanne; Moore, Richard A.; Mungall, Andrew J.; Mungall, Karen L.; Thiessen, Nina; Tse, Kane; Wong, Tina; Jones, Steven J. M.; Witt, Olaf; Milde, Till; Von Deimling, Andreas; Capper, David; Korshunov, Andrey; Yaspo, Marie-Laure; Kriwacki, Richard; Gajjar, Amar; Zhang, Jinghui; Beroukhim, Rameen; Fraenkel, Ernest; Korbel, Jan O.; Brors, Benedikt; Schlesner, Matthias; Eils, Roland; Marra, Marco A.; Pfister, Stefan M.; Taylor, Michael D.; Lichter, Peter			The whole-genome landscape of medulloblastoma subtypes	NATURE			English	Article							COPY-NUMBER; MUTATIONAL PROCESSES; CANCER; METHYLATION; SIGNATURES; SUBGROUPS; DATABASE; GENE; TUMORS; FAMILY	Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose debilitating effects on the developing child, and highlight the need for molecularly targeted treatments with reduced toxicity. Previous studies have been unable to identify the full spectrum of driver genes and molecular processes that operate in medulloblastoma subgroups. Here we analyse the somatic landscape across 491 sequenced medulloblastoma samples and the molecular heterogeneity among 1,256 epigenetically analysed cases, and identify subgroup-specific driver alterations that include previously undiscovered actionable targets. Driver mutations were confidently assigned to most patients belonging to Group 3 and Group 4 medulloblastoma subgroups, greatly enhancing previous knowledge. New molecular subtypes were differentially enriched for specific driver events, including hotspot in-frame insertions that target KBTBD4 and 'enhancer hijacking' events that activate PRDM6. Thus, the application of integrative genomics to an extensive cohort of clinical samples derived from a single childhood cancer entity revealed a series of cancer genes and biologically relevant subtype diversity that represent attractive therapeutic targets for the treatment of patients with medulloblastoma.	[Northcott, Paul A.; Groebner, Susanne; Erkek, Serap; Jones, David T. W.; Worst, Barbara C. .; Kool, Marcel; Chavez, Lukas; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Northcott, Paul A.; Rudneva, Vasilisa A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Buchhalter, Ivo; Kleinheinz, Kortine; Jaeger, Natalie; Bieg, Matthias; Paramasivam, Nagarajan; Heinold, Michael; Gu, Zuguang; Ishaque, Naveed; Jaeger-Schmidt, Christina; Jugold, Alke; Brors, Benedikt; Schlesner, Matthias; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Buchhalter, Ivo; Hutter, Barbara; Imbusch, Charles D.; Brors, Benedikt] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany; [Buchhalter, Ivo; Heinold, Michael; Huebschmann, Daniel; Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol IPMB & BioQuant, Dept Bioinformat & Funct Gen, Heidelberg, Germany; [Morrissy, A. Sorana; Cavalli, Florence M. G.; Luu, Betty; Ramaswamy, Vijay; Wu, Xiaochong; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Hovestadt, Volker; Zapatka, Marc; Weber, Ursula D.; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Weischenfeldt, Joachim; Sidiropoulos, Nikos] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Weischenfeldt, Joachim; Wolf, Stephan] Finsen Lab, Rigshosp, Copenhagen, Denmark; [Ehrenberger, Tobias; Fraenkel, Ernest] MIT, Dept Biochem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Groebner, Susanne; Jones, David T. W.; Worst, Barbara C. .; Kool, Marcel; Chavez, Lukas; Brors, Benedikt; Eils, Roland; Pfister, Stefan M.; Lichter, Peter] German Canc Consortium DKTK, Heidelberg, Germany; [Segura-Wang, Maia; Zichner, Thomas; Rudneva, Vasilisa A.; Waszak, Sebastian M.; Erkek, Serap; Korbel, Jan O.] EMBL, Genome Biol Unit, Heidelberg, Germany; [Warnatz, Hans-Joeg; Risch, Thomas; Amstislavskiy, Vyacheslav; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Gen, Berlin, Germany; [Phillips, Aaron H.; Kriwacki, Richard] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Schumacher, Steven; Beroukhim, Rameen] Broad Inst Harvard, Cambridge, MA USA; [Schumacher, Steven; Beroukhim, Rameen] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bieg, Matthias; Gu, Zuguang; Ishaque, Naveed] German Canc Res Ctr, Heidelberg Ctr Personalized Oncol DKFZ HIPO, Heidelberg, Germany; [Paramasivam, Nagarajan] Heidelberg Univ, Med Fac Heidelberg, Heidelberg, Germany; [Huebschmann, Daniel; Witt, Olaf; Milde, Till; Pfister, Stefan M.] Heidelberg Hosp Univ, Dept Pediat Hematol & Oncol, Heidelberg, Germany; [Wolf, Stephan] German Canc Res Ctr, Gen & Prote Core Facil, Heidelberg, Germany; [Robinson, Giles W.; Gajjar, Amar] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zhou, Xin; Wu, Gang; Finkelstein, David; Liu, Yanling; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Koster, Jan] Amsterdam Med Ctr, Dept Oncogen, Amsterdam, Netherlands; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow, Russia; [Cho, Yoon-Jae] Oregon Hlth & Sci Univ, Knight Canc Inst, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR 97201 USA; [Pomeroy, Scott L. .] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Pomeroy, Scott L. .] Harvard Med Sch, Boston, MA USA; [Herold-Mende, Christel] Heidelberg Univ, Univ Clin, Heidelberg Hosp, Dept Neurosurg, Heidelberg, Germany; [Schuhmann, Martin] Univ Tubingen Hosp, Dept Neurosurg, Tubingen, Germany; [Ebinger, Martin] Childrens Univ Hosp Tubingen, Dept Hematol & Oncol, Tubingen, Germany; [Liau, Linda M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Mora, Jaume] Hosp San Juan Dios, Dev Tumor Biol Lab, Barcelona, Spain; [McLendon, E.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Kumabe, Toshihiro] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa, Japan; [Chuah, Eric; Ma, Yussanne; Moore, Richard A.; Mungall, Andrew J.; Mungall, Karen L.; Thiessen, Nina; Tse, Kane; Wong, Tina; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Von Deimling, Andreas; Capper, David; Korshunov, Andrey] Univ Heidelberg Hosp, Dept Neuropathol, Heidelberg, Germany; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada	Helmholtz Association; German Cancer Research Center (DKFZ); St Jude Children's Research Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); University of Copenhagen; Rigshospitalet; University of Copenhagen; Massachusetts Institute of Technology (MIT); Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Max Planck Society; St Jude Children's Research Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Oregon Health & Science University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Barcelona; Duke University; McGill University; Kitasato University; British Columbia Cancer Agency; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Pfister, SM (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany.; Taylor, MD (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON, Canada.; Lichter, P (corresponding author), German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany.; Pfister, SM; Lichter, P (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Pfister, SM (corresponding author), Heidelberg Hosp Univ, Dept Pediat Hematol & Oncol, Heidelberg, Germany.; Taylor, MD (corresponding author), Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada.	s.pfister@dkfz-heidelberg.de; mdtaylor@sickkids.ca; peter.lichter@dkfz-heidelberg.de	Mungall, Andrew J./U-7067-2018; Waszak, Sebastian M./D-7828-2015; Rudneva, Vasilisa/Q-5495-2018; Weischenfeldt, Joachim/O-3681-2015; Zapatka, Marc/G-9896-2013; Gajjar, Amar/N-8059-2018; Marra, Marco A/B-5987-2008; Jones, David TW/G-9588-2013; Koster, Jan/C-5934-2008; Kriwacki, Richard/N-8154-2018; Eils, Roland/B-6121-2009; von Deimling, Andreas/F-7774-2013; Gu, Zuguang/C-5914-2009; Jones, Steven J/C-3621-2009; Jabado, Nada/AAN-4026-2020; Milde, Till/AAR-4528-2021; Erkek, Serap/AAV-5549-2020; Ryzhova, Marina/G-4178-2014; Ebinger, Martin/O-4936-2016; Brors, Benedikt/E-5620-2013; Ishaque, Naveed/AAF-3454-2020; Jones, David T. W./Z-1963-2019; Capper, David/I-8500-2014; Wu, Gang/M-8012-2014; Robinson, Giles W/N-8095-2018; Sidiropoulos, Nikos/AAE-8014-2019; Northcott, Paul A/N-4022-2018; Pfister, Stefan M/F-6860-2013; Zhang, Jing/GWZ-7332-2022; Schlesner, Matthias/I-4030-2013	Mungall, Andrew J./0000-0002-0905-2742; Waszak, Sebastian M./0000-0003-3042-9521; Weischenfeldt, Joachim/0000-0002-3917-5524; Zapatka, Marc/0000-0001-8287-5967; Marra, Marco A/0000-0001-7146-7175; Jones, David TW/0000-0002-2036-5141; Koster, Jan/0000-0002-0890-7585; Kriwacki, Richard/0000-0002-9798-6018; Eils, Roland/0000-0002-0034-4036; von Deimling, Andreas/0000-0002-5863-540X; Jones, Steven J/0000-0003-3394-2208; Milde, Till/0000-0002-7267-1052; Ryzhova, Marina/0000-0001-7206-6365; Ebinger, Martin/0000-0002-4229-8058; Brors, Benedikt/0000-0001-5940-3101; Ishaque, Naveed/0000-0002-8426-901X; Capper, David/0000-0003-1945-497X; Wu, Gang/0000-0002-1678-5864; Robinson, Giles W/0000-0001-7441-9486; Sidiropoulos, Nikos/0000-0002-1854-1193; Northcott, Paul A/0000-0002-1220-5252; Pfister, Stefan M/0000-0002-5447-5322; Chavez, Lukas/0000-0002-8718-8848; Huebschmann, Daniel/0000-0002-6041-7049; Gu, Zuguang/0000-0002-7395-8709; Fraenkel, Ernest/0000-0001-9249-8181; Rodriguez Gonzalez, Francisco G/0000-0002-8509-0804; Rudneva, Vasilisa/0000-0002-4340-9311; Cavalli, Florence M. G./0000-0002-4409-9642; Erkek, Serap/0000-0003-4439-5203; Kleinheinz, Kortine/0000-0002-1859-2281; Schlesner, Matthias/0000-0002-5896-4086; Korshunov, Andrey/0000-0002-5257-3623; Mora, Jaume/0000-0002-9386-5980; Zichner, Thomas/0000-0001-9848-7598; Segura-Wang, Maia/0000-0003-2424-618X; Buchhalter, Ivo/0000-0003-0764-5832; Liau, Linda/0000-0002-4053-0052; Ramaswamy, Vijay/0000-0002-6557-895X; Morrissy, Sorana/0000-0001-8526-562X; Taylor, Michael/0000-0001-7009-3466	ICGC PedBrain Tumour Project - German Cancer Aid [109252]; German Federal Ministry of Education and Research: BMBF [01KU1201A, 01KU1505A]; Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dutch Cancer Foundation KWF [2010-4713]; Dutch Cancer Foundation KIKA; Genome Canada; Genome BC; Terry Fox Research Institute; Ontario Institute for Cancer Research; Pediatric Oncology Group Ontario; The Family of Kathleen Lorette; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children: Sonia; Arthur Labatt Brain Tumour Research Centre; Chief of Research Fund; Cancer Genetics Program; Garron Family Cancer Centre; b.r.a.i.n.child; Garron Family Endowment; BC Childhood Cancer Parents Association; Garron Family Chair in Childhood Cancer Research; Cure Search Foundation; National Institutes of Health [R01CA148699, R01CA159859]; Ontario Institute for Cancer Research through Government of Ontario; BC Cancer Foundation; Canada Research Chairs program; Canadian Institutes for Health Research [FDN 143288]; Hertie Foundation; V Foundation V Scholar Award; Sontag Foundation Distinguished Scientist Award; Pew-Stewart Scholar for Cancer Research (Alexander and Margaret Stewart Trust); American Lebanese Syrian Associated Charities (ALSAC); St Jude Children's Research Hospital; ICGC-DE-MINING project [BMBF 01KU1505E]; NATIONAL CANCER INSTITUTE [R01CA148699, R01CA109467, R01CA159859] Funding Source: NIH RePORTER; The Brain Tumour Charity [GN-000356] Funding Source: researchfish	ICGC PedBrain Tumour Project - German Cancer Aid; German Federal Ministry of Education and Research: BMBF(Federal Ministry of Education & Research (BMBF)); Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Dutch Cancer Foundation KWF(KWF Kankerbestrijding); Dutch Cancer Foundation KIKA; Genome Canada(Genome Canada); Genome BC; Terry Fox Research Institute; Ontario Institute for Cancer Research; Pediatric Oncology Group Ontario; The Family of Kathleen Lorette; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children: Sonia; Arthur Labatt Brain Tumour Research Centre; Chief of Research Fund; Cancer Genetics Program; Garron Family Cancer Centre; b.r.a.i.n.child; Garron Family Endowment; BC Childhood Cancer Parents Association; Garron Family Chair in Childhood Cancer Research; Cure Search Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Institute for Cancer Research through Government of Ontario; BC Cancer Foundation; Canada Research Chairs program(Canada Research Chairs); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Hertie Foundation; V Foundation V Scholar Award; Sontag Foundation Distinguished Scientist Award; Pew-Stewart Scholar for Cancer Research (Alexander and Margaret Stewart Trust); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St Jude Children's Research Hospital; ICGC-DE-MINING project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Brain Tumour Charity	This work was supported by the ICGC PedBrain Tumour Project, funded by the German Cancer Aid (109252) and by the German Federal Ministry of Education and Research: BMBF grants 01KU1201A (PedBrain Tumor) and 01KU1505A (ICGC-DE-MINING). Additional support was provided by the Heidelberg Center for Personalized Oncology (DKFZ-HIPO) and the Dutch Cancer Foundations KWF (2010-4713) and KIKA (to M.K.). The MAGIC project is financially supported by: Genome Canada, Genome BC, Terry Fox Research Institute, Ontario Institute for Cancer Research, Pediatric Oncology Group Ontario, Funds from 'The Family of Kathleen Lorette' and the Clark H. Smith Brain Tumour Centre, Montreal Children's Hospital Foundation, Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre, Chief of Research Fund, Cancer Genetics Program, Garron Family Cancer Centre, b.r.a.i.n.child, Garron Family Endowment, and BC Childhood Cancer Parents Association. M.D.T. is supported by The Garron Family Chair in Childhood Cancer Research, and grants from the Cure Search Foundation, the National Institutes of Health (R01CA148699 and R01CA159859), The Pediatric Brain Tumor Foundation, The Terry Fox Research Institute, and b.r.a.i.n.child. This study was conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. This work was also supported by a Program Project Grant from the Terry Fox Research Institute. M.A.M. wishes to acknowledge the support of the BC Cancer Foundation, the Canada Research Chairs program and the Canadian Institutes for Health Research (FDN 143288). P.A.N. is the recipient of a Roman-Herzog Postdoctoral Fellowship (Hertie Foundation), V Foundation V Scholar Award, Sontag Foundation Distinguished Scientist Award, and is a Pew-Stewart Scholar for Cancer Research (Alexander and Margaret Stewart Trust). P.A.N. acknowledges additional funding support from American Lebanese Syrian Associated Charities (ALSAC) and St Jude Children's Research Hospital. I.B. was partially funded by the ICGC-DE-MINING project (BMBF 01KU1505E). We thank B. Stelter for assistance with artwork.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Decker B, 2016, AM J HUM GENET, V98, P818, DOI 10.1016/j.ajhg.2016.03.003; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Leiserson MDM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0700-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; MORI T, 1994, GENE CHROMOSOME CANC, V9, P168, DOI 10.1002/gcc.2870090304; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Olshen AB, 2011, BIOINFORMATICS, V27, P2038, DOI 10.1093/bioinformatics/btr329; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shih DJH, 2014, J CLIN ONCOL, V32, P886, DOI 10.1200/JCO.2013.50.9539; Snuderl M, 2015, J CLIN ONCOL, V33, pE27, DOI 10.1200/JCO.2013.49.4864; Stein LD, 2015, NATURE, V523, P149, DOI 10.1038/523149a; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Tuncbag N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004879; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weischenfeldt J, 2017, NAT GENET, V49, P65, DOI 10.1038/ng.3722; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065	65	504	509	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					311	+		10.1038/nature22973	http://dx.doi.org/10.1038/nature22973			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28726821	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000405844900026
J	Boeckle, M; Clayton, NS				Boeckle, Markus; Clayton, Nicola S.			A raven's memories are for the future	SCIENCE			English	Editorial Material							MENTAL TIME-TRAVEL; INTELLIGENCE; EVOLUTION		[Boeckle, Markus; Clayton, Nicola S.] Univ Cambridge, Dept Psychol, Cambridge, England	University of Cambridge	Boeckle, M (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	markus.boeckle@gmail.com; nsc22@cam.ac.uk	Boeckle, Markus/A-9968-2010	Boeckle, Markus/0000-0002-0738-2764; Clayton, Nicola/0000-0003-1835-423X				Bugnyar T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10506; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Clayton NS, 1999, ANIM BEHAV, V57, P435, DOI 10.1006/anbe.1998.0989; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Holekamp KE, 2007, TRENDS COGN SCI, V11, P65, DOI 10.1016/j.tics.2006.11.003; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kabadayi C, 2017, SCIENCE, V357, P202, DOI 10.1126/science.aam8138; Kwan D, 2012, HIPPOCAMPUS, V22, P1215, DOI 10.1002/hipo.20981; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Redshaw J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00404; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301	11	7	7	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		126	127		10.1126/science.aan8802	http://dx.doi.org/10.1126/science.aan8802			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706023				2022-12-28	WOS:000405391700019
J	Du, CH; van der Sar, T; Zhou, TX; Upadhyaya, P; Casola, F; Zhang, HL; Onbasli, MC; Ross, CA; Walsworth, RL; Tserkovnyak, Y; Yacoby, A				Du, Chunhui; van der Sar, Toeno; Zhou, Tony X.; Upadhyaya, Pramey; Casola, Francesco; Zhang, Huiliang; Onbasli, Mehmet C.; Ross, Caroline A.; Walsworth, Ronald L.; Tserkovnyak, Yaroslav; Yacoby, Amir			Control and local measurement of the spin chemical potential in a magnetic insulator	SCIENCE			English	Article							ROOM-TEMPERATURE; TRANSPORT; NANOSTRUCTURES; ACCUMULATION; SPINTRONICS; DIAMOND; TORQUE	The spin chemical potential characterizes the tendency of spins to diffuse. Probing this quantity could provide insight into materials such as magnetic insulators and spin liquids and aid optimization of spintronic devices. Here we introduce single-spin magnetometry as a generic platform for nonperturbative, nanoscale characterization of spin chemical potentials. We experimentally realize this platform using diamond nitrogen-vacancy centers and use it to investigate magnons in a magnetic insulator, finding that the magnon chemical potential can be controlled by driving the system's ferromagnetic resonance. We introduce a symmetry-based two-fluid theory describing the underlying magnon processes, measure the local thermomagnonic torque, and illustrate the detection sensitivity using electrically controlled spin injection. Our results pave the way for nanoscale control and imaging of spin transport in mesoscopic systems.	[Du, Chunhui; van der Sar, Toeno; Zhou, Tony X.; Casola, Francesco; Zhang, Huiliang; Walsworth, Ronald L.; Yacoby, Amir] Harvard Univ, Dept Phys, 17 Oxford St, Cambridge, MA 02138 USA; [Zhou, Tony X.; Yacoby, Amir] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Upadhyaya, Pramey; Tserkovnyak, Yaroslav] Univ Calif Los Angeles, Dept Phys & Astron, 475 Portola Plaza, Los Angeles, CA 90095 USA; [Casola, Francesco; Zhang, Huiliang; Walsworth, Ronald L.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Onbasli, Mehmet C.; Ross, Caroline A.] MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Onbasli, Mehmet C.] Koc Univ, Dept Elect & Elect Engn, TR-34450 Istanbul, Turkey	Harvard University; Harvard University; University of California System; University of California Los Angeles; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Massachusetts Institute of Technology (MIT); Koc University	Yacoby, A (corresponding author), Harvard Univ, Dept Phys, 17 Oxford St, Cambridge, MA 02138 USA.; Yacoby, A (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	yacoby@physics.harvard.edu	Onbasli, M. C./H-1773-2016; van der Sar, Toeno/Q-8751-2017	Onbasli, M. C./0000-0002-3554-7810; van der Sar, Toeno/0000-0002-6197-4808; Walsworth, Ronald/0000-0003-0311-4751; Zhou, Tony/0000-0002-8451-3385; /0000-0003-2262-1249	Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems (EPiQS) Initiative [GBMF4531]; Multidisciplinary University Research Initiative (MURI) Quibit Enabled Imaging, Sensing, and Metrology (QuISM) project; Army Research Office [W911NF-17-1-0023]; U. S. Department of Energy (DOE), Office of Basic Energy Sciences (BES) [DE-SC0012190]; Solid-State Solar-Thermal Energy Conversion Center (S3TEC), an Energy Frontier Research Center - DOE, Office of Science, BES [DE-SC0001299/DE-FG02-09ER46577]; Swiss National Science Foundation [P300P2-158417]; NSF [1541959]	Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems (EPiQS) Initiative; Multidisciplinary University Research Initiative (MURI) Quibit Enabled Imaging, Sensing, and Metrology (QuISM) project; Army Research Office; U. S. Department of Energy (DOE), Office of Basic Energy Sciences (BES)(United States Department of Energy (DOE)); Solid-State Solar-Thermal Energy Conversion Center (S3TEC), an Energy Frontier Research Center - DOE, Office of Science, BES(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSF(National Science Foundation (NSF))	We thank P. Kim for providing the setup for the nanobeam transfer and M. Warner and M. Burek for help with nanobeam fabrication. This work is supported by the Gordon and Betty Moore Foundation's Emergent Phenomena in Quantum Systems (EPiQS) Initiative through grant GBMF4531. A. Y. and R. L. W. are also partly supported by the Multidisciplinary University Research Initiative (MURI) Quibit Enabled Imaging, Sensing, and Metrology (QuISM) project. A. Y. was also partly supported by Army Research Office grant W911NF-17-1-0023. Work at the University of California, Los Angeles, is supported by the U. S. Department of Energy (DOE), Office of Basic Energy Sciences (BES) under award no. DE-SC0012190. R. L. W. and H. Z. thank the DARPA Quantum-assisted Sensing and Readout (QuASAR) program and the Smithsonian Institution. Work at the Massachusetts Institute of Technology was supported by the Solid-State Solar-Thermal Energy Conversion Center (S3TEC), an Energy Frontier Research Center funded by DOE, Office of Science, BES under award no. DE-SC0001299/DE-FG02-09ER46577. F. C. acknowledges support from the Swiss National Science Foundation grant no. P300P2-158417. Device fabrication was performed at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Coordinated Infrastructure Network, which is supported by the NSF under award no. 1541959. CNS is part of Harvard University. C. D. and A. Y. conceived the idea and designed the project. C. D. led the project. C. D., T. v. d. S., and A. Y. designed the measurement schemes and analyzed the data. C. D. fabricated the devices and performed the measurements. T. X. Z. built the confocal setup and contributed to the device fabrication. P. U. and Y. T. developed the theory of FMR-pumping of thermal magnons. F. C. and H. Z. proposed and fabricated the nanobeams. M. C. O. and C. A. R. provided the YIG sample. C. D., T. v. d. S., and A. Y. wrote the manuscript with the help from all coauthors. C. D., T. v. d. S., T. X. Z., P. U., Y. T., F. C., H. Z., R. L. W., and A. Y. contributed to the discussions. A. Y. supervised the project. The data that support the plots within this paper and other findings of this study are available from the corresponding author on request. The authors declare no competing financial interests.	Acosta VM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070801; Bauer GEW, 2012, NAT MATER, V11, P391, DOI [10.1038/nmat3301, 10.1038/NMAT3301]; Bender SA, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.064418; Bender SA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.246601; Burek MJ, 2012, NANO LETT, V12, P6084, DOI 10.1021/nl302541e; Chumak AV, 2015, NAT PHYS, V11, P453, DOI [10.1038/nphys3347, 10.1038/NPHYS3347]; Collet M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10377; Cornelissen LJ, 2015, NAT PHYS, V11, P1022, DOI [10.1038/NPHYS3465, 10.1038/nphys3465]; Demokritov SO, 2006, NATURE, V443, P430, DOI 10.1038/nature05117; Demokritov SO, 2008, IEEE T MAGN, V44, P6, DOI 10.1109/TMAG.2007.910227; Dlubak B, 2012, NAT PHYS, V8, P557, DOI [10.1038/nphys2331, 10.1038/NPHYS2331]; Flebus B, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.117201; Flebus B, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.214428; Fukuma Y, 2011, NAT MATER, V10, P527, DOI [10.1038/nmat3046, 10.1038/NMAT3046]; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Jaworski CM, 2010, NAT MATER, V9, P898, DOI [10.1038/nmat2860, 10.1038/NMAT2860]; Jedema FJ, 2001, NATURE, V410, P345, DOI 10.1038/35066533; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Onbasli MC, 2014, APL MATER, V2, DOI 10.1063/1.4896936; Page M. R., 2016, ARXIV160707485CONDMA; Sachdev S., 2011, QUANTUM PHASE TRANSI; Sinova J, 2015, REV MOD PHYS, V87, P1213, DOI 10.1103/RevModPhys.87.1213; Sommer A, 2011, NATURE, V472, P201, DOI 10.1038/nature09989; van der Sar T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8886; Wolfe CS, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.180406; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323; Zwierlein MW, 2006, SCIENCE, V311, P492, DOI 10.1126/science.1122318	31	150	152	10	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		195	198		10.1126/science.aak9611	http://dx.doi.org/10.1126/science.aak9611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706070	Green Submitted			2022-12-28	WOS:000405391700044
J	Robie, AA; Hirokawa, J; Edwards, AW; Umayam, LA; Lee, A; Phillips, ML; Card, GM; Korff, W; Rubin, GM; Simpson, JH; Reiser, MB; Branson, K				Robie, Alice A.; Hirokawa, Jonathan; Edwards, Austin W.; Umayam, Lowell A.; Lee, Allen; Phillips, Mary L.; Card, Gwyneth M.; Korff, Wyatt; Rubin, Gerald M.; Simpson, Julie H.; Reiser, Michael B.; Branson, Kristin			Mapping the Neural Substrates of Behavior	CELL			English	Article							DROSOPHILA CENTRAL COMPLEX; FALSE DISCOVERY RATE; ELLIPSOID BODY; LOCUST BRAIN; NEURONS; CIRCUITS; MELANOGASTER; ORGANIZATION; EXPRESSION; PATHWAYS	Assigning behavioral functions to neural structures has long been a central goal in neuroscience and is a necessary first step toward a circuit-level understanding of how the brain generates behavior. Here, we map the neural substrates of locomotion and social behaviors for Drosophila melanogaster using automated machine-vision and machine-learning techniques. From videos of 400,000 flies, we quantified the behavioral effects of activating 2,204 genetically targeted populations of neurons. We combined a novel quantification of anatomy with our behavioral analysis to create brain-behavior correlation maps, which are shared as browsable web pages and interactive software. Based on these maps, we generated hypotheses of regions of the brain causally related to sensory processing, locomotor control, courtship, aggression, and sleep. Our maps directly specify genetic tools to target these regions, which we used to identify a small population of neurons with a role in the control of walking.	[Robie, Alice A.; Hirokawa, Jonathan; Edwards, Austin W.; Umayam, Lowell A.; Lee, Allen; Phillips, Mary L.; Card, Gwyneth M.; Korff, Wyatt; Rubin, Gerald M.; Simpson, Julie H.; Reiser, Michael B.; Branson, Kristin] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Hirokawa, Jonathan] Rockefeller Univ, Lab Integrat Brain Funct, 1230 York Ave, New York, NY 10021 USA; [Simpson, Julie H.] UC Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA USA; [Phillips, Mary L.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA	Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Santa Barbara; University of Alabama System; University of Alabama Birmingham	Branson, K (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	bransonk@janelia.hhmi.org		Simpson, Julie/0000-0002-6793-7100; Phillips, Mary/0000-0003-4696-1555				Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Cavanaugh DJ, 2014, CELL, V157, P689, DOI 10.1016/j.cell.2014.02.024; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Costa M, 2016, NEURON, V91, P293, DOI 10.1016/j.neuron.2016.06.012; Dasgupta S, 2005, J COMPUT SYST SCI, V70, P555, DOI 10.1016/j.jcss.2004.10.006; Dus M, 2015, NEURON, V87, P139, DOI 10.1016/j.neuron.2015.05.032; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Fosque BF, 2015, SCIENCE, V347, P755, DOI 10.1126/science.1260922; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hale ME, 2016, J NEUROGENET, V30, P89, DOI 10.1080/01677063.2016.1182526; Hampel S, 2015, ELIFE, V4, DOI 10.7554/eLife.08758; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hoopfer ED, 2015, ELIFE, V4, DOI 10.7554/eLife.11346; Hsu CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20259; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/nmeth.2281, 10.1038/NMETH.2281]; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Mann K, 2013, NEURON, V79, P754, DOI 10.1016/j.neuron.2013.06.018; Martin-Pena A, 2014, EUR J NEUROSCI, V39, P1586, DOI 10.1111/ejn.12537; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Owald D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0211; Panser K, 2016, CURR BIOL, V26, P1943, DOI 10.1016/j.cub.2016.05.052; PENFIELD W, 1950, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V185, P670, DOI 10.1007/BF00935517; Peng HC, 2011, NAT METHODS, V8, P493, DOI [10.1038/NMETH.1602, 10.1038/nmeth.1602]; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Pfeiffer K, 2005, J NEUROPHYSIOL, V94, P3903, DOI 10.1152/jn.00276.2005; Randlett O, 2015, NAT METHODS, V12, P1039, DOI 10.1038/NMETH.3581; Renn SCP, 1999, J NEUROBIOL, V41, P189; Schoofs A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001893; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; Sivanantharajah L, 2015, J COMP PHYSIOL A, V201, P895, DOI 10.1007/s00359-015-1010-y; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Trager U, 2008, J COMP NEUROL, V506, P288, DOI 10.1002/cne.21512; Triphan T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27000; Vogelstein JT, 2014, SCIENCE, V344, P386, DOI 10.1126/science.1250298; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wolff T, 2015, J COMP NEUROL, V523, P997, DOI 10.1002/cne.23705; Wu M, 2016, ELIFE, V5, DOI 10.7554/eLife.21022; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	54	101	103	6	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					393	+		10.1016/j.cell.2017.06.032	http://dx.doi.org/10.1016/j.cell.2017.06.032			42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28709004	Bronze			2022-12-28	WOS:000405493900017
J	Jarow, JP; LaVange, L; Woodcock, J				Jarow, Jonathan P.; LaVange, Lisa; Woodcock, Janet			Multidimensional Evidence Generation and FDA Regulatory Decision Making Defining and Using "Real-World" Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jarow, Jonathan P.; LaVange, Lisa; Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, WO51 RM6364,10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Jarow, JP (corresponding author), US FDA, Ctr Drug Evaluat & Res, WO51 RM6364,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	jonathan.jarow@fda.hhs.gov						Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; FEINSTEIN AR, 1985, ARCHITECTURE CLIN RE; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Sasinowski FJ, 2015, THER INNOV REGUL SCI, V49, P680, DOI 10.1177/2168479015580383; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]	7	122	125	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					703	704		10.1001/jama.2017.9991	http://dx.doi.org/10.1001/jama.2017.9991			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28715550				2022-12-28	WOS:000408095800017
J	Mroz, P; Udalski, A; Skowron, J; Poleski, R; Kozlowski, S; Szymanski, MK; Soszynski, I; Wyrzykowski, L; Pietrukowicz, P; Ulaczyk, K; Skowron, D; Pawlak, M				Mroz, Przemek; Udalski, Andrzej; Skowron, Jan; Poleski, Radoslaw; Kozlowski, Szymon; Szymanski, Michal K.; Soszynski, Igor; Wyrzykowski, Lukasz; Pietrukowicz, Pawel; Ulaczyk, Krzysztof; Skowron, Dorota; Pawlak, Michal			No large population of unbound or wide-orbit Jupiter-mass planets	NATURE			English	Article							GRAVITATIONAL LENSING EXPERIMENT; FREE-FLOATING PLANETS; M-CIRCLE-DOT; GALACTIC BULGE; MICROLENSING CONSTRAINTS; MILKY-WAY; M-DWARFS; STELLAR; CLUSTER; OBJECTS	Planet formation theories predict that some planets may be ejected from their parent systems as result of dynamical interactions and other processes(1-3). Unbound planets can also be formed through gravitational collapse, in a way similar to that in which stars form(4). A handful of free-floating planetary-mass objects have been discovered by infrared surveys of young stellar clusters and star-forming regions(5,6) as well as wide-field surveys(7), but these studies are incomplete(8-10) for objects below five Jupiter masses. Gravitational microlensing is the only method capable of exploring the entire population of free-floating planets down to Mars-mass objects, because the microlensing signal does not depend on the brightness of the lensing object. A characteristic timescale of microlensing events depends on the mass of the lens: the less massive the lens, the shorter the microlensing event. A previous analysis(11) of 474 microlensing events found an excess of ten very short events (1-2 days)-more than known stellar populations would suggest-indicating the existence of a large population of unbound or wide-orbit Jupiter-mass planets (reported to be almost twice as common as main-sequence stars). These results, however, do not match predictions of planet-formation theories(3,12) and surveys of young clusters(8-10). Here we analyse a sample of microlensing events six times larger than that of ref. 11 discovered during the years 2010-15. Although our survey has very high sensitivity (detection efficiency) to short-timescale (1-2 days) microlensing events, we found no excess of events with timescales in this range, with a 95 per cent upper limit on the frequency of Jupiter-mass free-floating or wide-orbit planets of 0.25 planets per main-sequence star. We detected a few possible ultrashort-timescale events (with timescales of less than half a day), which may indicate the existence of Earth-mass and super-Earth-mass free-floating planets, as predicted by planet-formation theories(3,12).	[Mroz, Przemek; Udalski, Andrzej; Skowron, Jan; Poleski, Radoslaw; Kozlowski, Szymon; Szymanski, Michal K.; Soszynski, Igor; Wyrzykowski, Lukasz; Pietrukowicz, Pawel; Ulaczyk, Krzysztof; Skowron, Dorota; Pawlak, Michal] Univ Warsaw Observ, Aleje Ujazdowskie 4, PL-00478 Warsaw, Poland; [Poleski, Radoslaw] Ohio State Univ, Dept Astron, 140 West 18th Ave, Columbus, OH 43210 USA; [Ulaczyk, Krzysztof] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warsaw; Warsaw University Observatory; University System of Ohio; Ohio State University; University of Warwick	Mroz, P (corresponding author), Univ Warsaw Observ, Aleje Ujazdowskie 4, PL-00478 Warsaw, Poland.	pmroz@astrouw.edu.pl	Poleski, Radoslaw/AAM-7565-2021; Kozlowski, Szymon/G-4799-2013; Pawlak, Michał/AGD-5351-2022; Szymański, Michał Krzysztof/X-5627-2019; Mroz, Przemek/ABH-9105-2020; Szymański, Michał K/H-6951-2018; Skowron, Jan/M-5186-2014; Skowron, Dorota M/AAL-8373-2020	Poleski, Radoslaw/0000-0002-9245-6368; Kozlowski, Szymon/0000-0003-4084-880X; Pawlak, Michał/0000-0002-5632-9433; Szymański, Michał Krzysztof/0000-0002-0548-8995; Szymański, Michał K/0000-0002-0548-8995; Skowron, Jan/0000-0002-2335-1730; Skowron, Dorota M/0000-0001-9439-604X; Wyrzykowski, Lukasz/0000-0002-9658-6151; Soszynski, Igor/0000-0002-7777-0842; Ulaczyk, Krzysztof/0000-0001-6364-408X; Udalski, Andrzej/0000-0001-5207-5619; Pietrukowicz, Pawel/0000-0002-2339-5899; Mroz, Przemek/0000-0001-7016-1692	National Science Center, Poland [MAESTRO 2014/14/A/ST9/00121]	National Science Center, Poland(National Science Centre, Poland)	We thank M. Kubiak and G. Pietrzynski, former members of the OGLE team, for their contribution to the collection of the OGLE photometric data over the past years. The OGLE project has received funding from the National Science Center, Poland through grant MAESTRO 2014/14/A/ST9/00121 to A.U.	Alard C, 1998, ASTROPHYS J, V503, P325, DOI 10.1086/305984; Allen PR, 2005, ASTROPHYS J, V625, P385, DOI 10.1086/429548; Barclay T, 2017, ASTROPHYS J, V841, DOI 10.3847/1538-4357/aa705b; Belczynski K, 2008, ASTROPHYS J SUPPL S, V174, P223, DOI 10.1086/521026; Bennett DP, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/119; Bennett DP, 1996, ASTROPHYS J, V472, P660, DOI 10.1086/178096; Bissantz N, 2004, ASTROPHYS J, V601, pL155, DOI 10.1086/382043; Bowler BP, 2015, ASTROPHYS J SUPPL S, V216, DOI 10.1088/0067-0049/216/1/7; Clanton C, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/1/46; de Oliveira C. Alves, 2013, MEM SOC ASTRON ITAL, V84, P905; Dupuy TJ, 2013, SCIENCE, V341, P1492, DOI 10.1126/science.1241917; DWEK E, 1995, ASTROPHYS J, V445, P716, DOI 10.1086/175734; Gould A, 2000, ASTROPHYS J, V535, P928, DOI 10.1086/308865; GOULD A, 1992, ASTROPHYS J, V392, P442, DOI 10.1086/171443; Han CC, 2003, ASTROPHYS J, V592, P172, DOI 10.1086/375706; HAN CH, 1995, ASTROPHYS J, V447, P53, DOI 10.1086/175856; Han CH, 1996, ASTROPHYS J, V467, P540, DOI 10.1086/177631; Hawley SL, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/121; Holtzman JA, 1998, ASTRON J, V115, P1946, DOI 10.1086/300336; Ida S, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/42; Jiang GF, 2004, ASTROPHYS J, V617, P1307, DOI 10.1086/425678; KIRAGA M, 1994, ASTROPHYS J, V430, pL101, DOI 10.1086/187448; Kiziltan B, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/66; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Lafreniere D, 2007, ASTROPHYS J, V670, P1367, DOI 10.1086/522826; Liu MC, 2013, ASTROPHYS J LETT, V777, DOI 10.1088/2041-8205/777/2/L20; Luhman KL, 2012, ANNU REV ASTRON ASTR, V50, P65, DOI 10.1146/annurev-astro-081811-125528; Ma SZ, 2016, MON NOT R ASTRON SOC, V461, pL107, DOI 10.1093/mnrasl/slw110; Mao S, 1996, ASTROPHYS J, V473, P57, DOI 10.1086/178126; Muzic K, 2015, ASTROPHYS J, V810, DOI 10.1088/0004-637X/810/2/159; Novati SC, 2008, ASTRON ASTROPHYS, V480, P723, DOI 10.1051/0004-6361:20078439; Ozel F, 2010, ASTROPHYS J, V725, P1918, DOI 10.1088/0004-637X/725/2/1918; Osorio MRZ, 2000, SCIENCE, V290, P103, DOI 10.1126/science.290.5489.103; Park BG, 2004, ASTROPHYS J, V609, P166, DOI 10.1086/420926; Ramirez KP, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/30; Penny MT, 2013, MON NOT R ASTRON SOC, V434, P2, DOI 10.1093/mnras/stt927; Pfyffer S, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201424295; Quanz SP, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118320; Rasio FA, 1996, SCIENCE, V274, P954, DOI 10.1126/science.274.5289.954; Scholz A, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/24; Skowron J, 2016, ACTA ASTRONOM, V66, P1; Smith MC, 2007, MON NOT R ASTRON SOC, V380, P805, DOI 10.1111/j.1365-2966.2007.12130.x; Spergel D, 2015, PREPRINT; Sumi T, 2011, NATURE, V473, P349, DOI 10.1038/nature10092; Veras D, 2012, MON NOT R ASTRON SOC, V421, pL117, DOI 10.1111/j.1745-3933.2012.01218.x; Wegg C, 2016, MON NOT R ASTRON SOC, V463, P557, DOI 10.1093/mnras/stw1954; Weidenschilling SJ, 1996, NATURE, V384, P619, DOI 10.1038/384619a0; Williams KA, 2009, ASTROPHYS J, V693, P355, DOI 10.1088/0004-637X/693/1/355; Wood A, 2005, MON NOT R ASTRON SOC, V362, P945, DOI 10.1111/j.1365-2966.2005.09357.x; Wozniak P, 1997, ASTROPHYS J, V487, P55, DOI 10.1086/304607; Wozniak PR, 2000, ACTA ASTRONOM, V50, P421; Wray JJ, 2004, MON NOT R ASTRON SOC, V349, P1059, DOI 10.1111/j.1365-2966.2004.07587.x; Wyrzykowski L, 2015, ASTROPHYS J SUPPL S, V216, DOI 10.1088/0067-0049/216/1/12; Zheng Z, 2001, ASTROPHYS J, V555, P393, DOI 10.1086/321485; Zoccali M, 2000, ASTROPHYS J, V530, P418, DOI 10.1086/308359	57	154	154	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					183	+		10.1038/nature23276	http://dx.doi.org/10.1038/nature23276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28738410	Green Submitted			2022-12-28	WOS:000407284300037
J	Gu, ZR; Kalamboglas, J; Yoshioka, S; Han, WQ; Li, Z; Kawasawa, YI; Pochareddy, S; Li, Z; Liu, FC; Xu, XM; Wijeratne, S; Ueno, M; Blatz, E; Salomone, J; Kumanogoh, A; Rasin, MR; Gebelein, B; Weirauch, MT; Sestan, N; Martin, JH; Yoshida, Y				Gu, Zirong; Kalamboglas, John; Yoshioka, Shin; Han, Wenqi; Li, Zhuo; Kawasawa, Yuka Imamura; Pochareddy, Sirisha; Li, Zhen; Liu, Fuchen; Xu, Xuming; Wijeratne, Sagara; Ueno, Masaki; Blatz, Emily; Salomone, Joseph; Kumanogoh, Atsushi; Rasin, Mladen-Roko; Gebelein, Brian; Weirauch, Matthew T.; Sestan, Nenad; Martin, John H.; Yoshida, Yutaka			Control of species-dependent cortico-motoneuronal connections underlying manual dexterity	SCIENCE			English	Article							CORTICOMOTONEURONAL CONNECTIONS; MOTOR CONTROL; SPINAL-CORD; NEURONS; GENES; CELLS; RATS	Superior manual dexterity in higher primates emerged together with the appearance of cortico-motoneuronal (CM) connections during the evolution of the mammalian corticospinal (CS) system. Previously thought to be specific to higher primates, we identified transient CM connections in early postnatal mice, which are eventually eliminated by Sema6D-PlexA1 signaling. PlexA1 mutant mice maintain CM connections into adulthood and exhibit superior manual dexterity as compared with that of controls. Last, differing PlexA1 expression in layer 5 of the motor cortex, which is strong in wild-type mice but weak in humans, may be explained by FEZF2-mediated cis-regulatory elements that are found only in higher primates. Thus, species-dependent regulation of PlexA1 expression may have been crucial in the evolution of mammalian CS systems that improved fine motor control in higher primates.	[Gu, Zirong; Yoshioka, Shin; Ueno, Masaki; Blatz, Emily; Salomone, Joseph; Gebelein, Brian; Yoshida, Yutaka] CCHMC, Div Dev Biol, Cincinnati, OH 45229 USA; [Kalamboglas, John; Martin, John H.] CUNY, Sch Med, Dept Cellular Mol & Biomed Sci, New York, NY 10031 USA; [Kalamboglas, John; Martin, John H.] CUNY, Grad Ctr, New York, NY 10017 USA; [Han, Wenqi; Li, Zhuo; Kawasawa, Yuka Imamura; Pochareddy, Sirisha; Li, Zhen; Liu, Fuchen; Xu, Xuming; Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, Dept Neurosci, New Haven, CT 06510 USA; [Li, Zhuo] Zhengzhou Univ, Basic Med Sch, Zhengzhou, Henan, Peoples R China; [Kawasawa, Yuka Imamura] Penn State Coll Med, Dept Biochem, Inst Personalized Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Coll Med, Dept Mol Biol & Pharmacol, Inst Personalized Med, Hershey, PA 17033 USA; [Wijeratne, Sagara; Rasin, Mladen-Roko] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Ueno, Masaki; Martin, John H.] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Suita, Osaka 5650871, Japan; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Yale University; Zhengzhou University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; Japan Science & Technology Agency (JST); Osaka University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Yoshida, Y (corresponding author), CCHMC, Div Dev Biol, Cincinnati, OH 45229 USA.; Martin, JH (corresponding author), CUNY, Sch Med, Dept Cellular Mol & Biomed Sci, New York, NY 10031 USA.; Martin, JH (corresponding author), CUNY, Grad Ctr, New York, NY 10017 USA.	jmartin@ccny.cuny.edu; yutaka.yoshida@cchmc.org	Ueno, Masaki/J-1216-2019; Weirauch, Matthew/M-5459-2019; Li, Zhen/J-7456-2019	Li, Zhen/0000-0002-6418-9485; Salomone, Joseph/0000-0002-5972-3452; Imamura Kawasawa, Yuka/0000-0002-8638-6738; Gu, Zirong/0000-0002-8262-7573; Ueno, Masaki/0000-0003-1484-9921	Graduate Summer Undergraduate Mentoring Program at the University of Cincinnati; National Institutes of Health (NIH) [R01 NS099068, R21 HG008186]; Lupus Research Alliance; CCHMC CpG Pilot Study award; NIH [MH106934, MH103339, NS079569, NS093002];  [NEI 5P30EY012196-17]; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG008186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106934, U01MH103339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099068, R01NS079569, R01NS093002, K99NS064303, R01NS075367] Funding Source: NIH RePORTER	Graduate Summer Undergraduate Mentoring Program at the University of Cincinnati; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Alliance; CCHMC CpG Pilot Study award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. Baccei, J. N. Betley, K. Campbell, S. Crone, C. Gu, T. Isa, D. Ladle, M. Nakafuku, and R. Yu for critical comments on the manuscript. We thank Boston Children's Hospital Viral Core (supported by core grant NEI 5P30EY012196-17) for making the AAV6-G virus. We thank P. Arlotta for the Fezf2 construct. Z.G. and E.B. were supported by the Graduate Summer Undergraduate Mentoring Program at the University of Cincinnati. M.T.W. is supported by the National Institutes of Health (NIH) grants R01 NS099068 and R21 HG008186, Lupus Research Alliance "Novel Approaches" award, and a CCHMC CpG Pilot Study award. N. S. is supported by NIH grants MH106934 and MH103339. J.H.M. and Y.Y. are supported by NIH grants NS079569 and NS093002, respectively. All data are available in the main texts and supplementary materials. Z.G. and Y.Y. conceived of the project and contributed to experimental design and interpretation. Z.G. performed most of the experiments. Z.G., J.K., and J.H.M. designed the cortico-muscular electrophysiology assay, performed EMG recordings, and analyzed and interpreted the electrophysiological data. Y.I.K., W.H., Z.L., Z.L., F.L., S.P., X.X., and N.S. performed the in situ hybridizations using human tissues, chromatin immunoprecipitation-sequencing using human and mouse tissues, and culture experiments using Fezf2-floxed mice. S.Y. contributed to cloning of the human and mouse genomic regions and the luciferase assays. E.B. performed the grid-walking test and contributed to the immunochemistry studies. M.U. purified rabies viruses and assisted in the dorsal hemisection surgery. S.W. and M.-R.R. analyzed the cortical layers and cortico-cortical projections and also conducted the Golgi analyses. J.S. and B.G. performed the EMSA analyses. M.T.W. performed the cross-species cis-regulatory element comparisons. A.K. provided the Sema6D mutant mice. Y.Y. supervised all aspects of the work, and Z.G., J.H.M, and Y.Y. prepared the manuscript with contributions from other authors.	Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Alstermark B, 2004, J NEUROPHYSIOL, V92, P1958, DOI 10.1152/jn.00092.2004; Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; Chen LS, 2011, J BIOL CHEM, V286, P18641, DOI 10.1074/jbc.M111.236471; Ezer D, 2014, COMPUT STRUCT BIOTEC, V10, P63, DOI 10.1016/j.csbj.2014.07.005; FETZ EE, 1976, BRAIN RES, V114, P505, DOI 10.1016/0006-8993(76)90973-2; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; HEFFNER R, 1975, BRAIN BEHAV EVOLUT, V12, P161, DOI 10.1159/000124401; Jiang YQ, 2016, J NEUROSCI, V36, P193, DOI 10.1523/JNEUROSCI.3441-15.2016; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; LAWRENCE DG, 1976, BRAIN, V99, P235, DOI 10.1093/brain/99.2.235; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lodato S, 2014, NAT NEUROSCI, V17, P1046, DOI 10.1038/nn.3757; Park MC, 2004, J NEUROPHYSIOL, V92, P2968, DOI 10.1152/jn.00649.2003; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Shibata M, 2015, TRENDS GENET, V31, P77, DOI 10.1016/j.tig.2014.12.004; Shimizu T, 2010, DEVELOPMENT, V137, P1875, DOI 10.1242/dev.047167; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Yang HW, 2003, EXP BRAIN RES, V149, P458, DOI 10.1007/s00221-003-1393-9	19	55	55	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					400	404		10.1126/science.aan3721	http://dx.doi.org/10.1126/science.aan3721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751609	Green Accepted			2022-12-28	WOS:000406362300045
J	Ou, HD; Phan, S; Deerinck, TJ; Thor, A; Ellisman, MH; O'Shea, CC				Ou, Horng D.; Phan, Sebastien; Deerinck, Thomas J.; Thor, Andrea; Ellisman, Mark H.; O'Shea, Clodagh C.			ChromEMT: Visualizing 3D chromatin structure and compaction in interphase and mitotic cells	SCIENCE			English	Article							CRYOELECTRON MICROSCOPY; DOMAIN ORGANIZATION; ELECTRON MICROSCOPY; LINKER HISTONE; CRYO-EM; DNA; CHROMOSOMES; FIBERS; REVEALS; POLYMER	The chromatin structure of DNA determines genome compaction and activity in the nucleus. On the basis of in vitro structures and electron microscopy (EM) studies, the hierarchical model is that 11-nanometer DNA-nucleosome polymers fold into 30- and subsequently into 120- and 300- to 700-nanometer fibers and mitotic chromosomes. To visualize chromatin in situ, we identified a fluorescent dye that stains DNA with an osmiophilic polymer and selectively enhances its contrast in EM. Using ChromEMT (ChromEM tomography), we reveal the ultrastructure and three-dimensional (3D) organization of individual chromatin polymers, megabase domains, and mitotic chromosomes. We show that chromatin is a disordered 5- to 24-nanometer-diameter curvilinear chain that is packed together at different 3D concentration distributions in interphase and mitosis. Chromatin chains have many different particle arrangements and bend at various lengths to achieve structural compaction and high packing densities.	[Ou, Horng D.; O'Shea, Clodagh C.] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Phan, Sebastien; Deerinck, Thomas J.; Thor, Andrea; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	O'Shea, CC (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	oshea@salk.edu			W. M. Keck Foundation; NIH [5U01EB021247]; Howard Hughes Medical Institute; William Scandling Trust; Price Family Foundation; Leona M. and Harry B. Helmsley Charitable Trust; National Cancer Institute [P30CA014195]; University of California, San Diego (UCSD); National Institute of General Medical Sciences [GM103412]; NATIONAL CANCER INSTITUTE [DP1CA174420, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412, P50GM085764] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021784] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); William Scandling Trust; Price Family Foundation; Leona M. and Harry B. Helmsley Charitable Trust; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of California, San Diego (UCSD); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the O'Shea and Ellisman laboratories for their insights and comments. We are grateful to the Waitt Advanced Biophotonics Center for computational support and S. Navlakha for advice on image analysis. This work was supported by grants from the W. M. Keck Foundation and the NIH (grant 5U01EB021247). The research of C.C.O. is supported in part by a Faculty Scholar grant from the Howard Hughes Medical Institute. C.C.O. is also supported by the William Scandling Trust, the Price Family Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust grant. Salk core services were supported by grant P30CA014195 from the National Cancer Institute. University of California, San Diego (UCSD), National Center for Microscopy and Imaging Research (NCMIR) technologies and instrumentation are supported by grant GM103412 from the National Institute of General Medical Sciences. The EM tomograms are deposited in the Cell Image Library: www.cellimagelibrary.org/groups/49801.	Ahmed K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010531; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; BALERCIA G, 1992, J NEUROSCI METH, V45, P87, DOI 10.1016/0165-0270(92)90046-G; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; BELMONT AS, 1987, J CELL BIOL, V105, P77, DOI 10.1083/jcb.105.1.77; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; BENTIVOGLIO M, 1990, NEUROSCI LETT, V113, P127, DOI 10.1016/0304-3940(90)90291-G; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Bouchet-Marquis C, 2006, HISTOCHEM CELL BIOL, V125, P43, DOI 10.1007/s00418-005-0093-x; Bozzola J. J., 1992, ELECT MICROSCOPY PRI; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Clo E, 2007, CHEMBIOCHEM, V8, P475, DOI 10.1002/cbic.200600454; COGLIATI R, 1973, CR ACAD SCI D NAT, V276, P3041; Collepardo-Guevara R, 2014, P NATL ACAD SCI USA, V111, P8061, DOI 10.1073/pnas.1315872111; Davis L., 1991, HDB GENETIC ALGORITH, DOI DOI 10.1.1.87.3586; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Dehghani H, 2005, MICRON, V36, P95, DOI 10.1016/j.micron.2004.10.003; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Frank J., 2010, ELECT TOMOGRAPHY MET; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Gallego I, 2010, BIOPHYS J, V99, P3951, DOI 10.1016/j.bpj.2010.11.015; Gallego I, 2009, EUR BIOPHYS J BIOPHY, V38, P503, DOI 10.1007/s00249-008-0401-1; Garton HJL, 1996, ANAT RECORD, V244, P112, DOI 10.1002/(SICI)1097-0185(199601)244:1<112::AID-AR11>3.0.CO;2-S; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; HUXLEY HE, 1961, J BIOPHYS BIOCHEM CY, V11, P273, DOI 10.1083/jcb.11.2.273; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Konig P, 2007, CHROMOSOMA, V116, P349, DOI 10.1007/s00412-007-0101-0; LANGMORE JP, 1980, NATURE, V288, P620, DOI 10.1038/288620a0; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Lawrence A, 2006, J STRUCT BIOL, V154, P144, DOI 10.1016/j.jsb.2005.12.012; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; MANDELKOW EM, 1985, J MOL BIOL, V181, P123, DOI 10.1016/0022-2836(85)90330-4; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; MCDOWALL AW, 1986, EMBO J, V5, P1395, DOI 10.1002/j.1460-2075.1986.tb04373.x; Ngo JT, 2016, NAT CHEM BIOL, V12, P459, DOI [10.1038/nchembio.2076, 10.1038/NCHEMBIO.2076]; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Njoh KL, 2006, CYTOM PART A, V69A, P805, DOI 10.1002/cyto.a.20308; OLINS AL, 1989, J HISTOCHEM CYTOCHEM, V37, P395, DOI 10.1177/37.3.2465337; OLINS AL, 1975, J CELL BIOL, V64, P528, DOI 10.1083/jcb.64.3.528; OLINS AL, 1976, J CELL BIOL, V68, P787, DOI 10.1083/jcb.68.3.787; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ou HD, 2015, METHODS, V90, P39, DOI 10.1016/j.ymeth.2015.06.002; Ou HD, 2012, CELL, V151, P304, DOI 10.1016/j.cell.2012.08.035; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Phan S, 2012, J STRUCT BIOL, V180, P154, DOI 10.1016/j.jsb.2012.06.006; Raghavan SR, 2012, SOFT MATTER, V8, P8539, DOI 10.1039/c2sm25107h; RATTNER JB, 1985, CELL, V42, P291, DOI 10.1016/S0092-8674(85)80124-0; Reeves R, 2015, DNA REPAIR, V36, P122, DOI 10.1016/j.dnarep.2015.09.015; Richard E, 2011, PHOTOCHEM PHOTOBIOL, V87, P256, DOI 10.1111/j.1751-1097.2010.00852.x; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rusu M, 2010, J STRUCT BIOL, V170, P164, DOI 10.1016/j.jsb.2009.12.028; SALZMAN NP, 1966, P NATL ACAD SCI USA, V56, P1449, DOI 10.1073/pnas.56.5.1449; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Scheffer MP, 2011, P NATL ACAD SCI USA, V108, P16992, DOI 10.1073/pnas.1108268108; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schlick T, 2012, J BIOL CHEM, V287, P5183, DOI 10.1074/jbc.R111.305763; Phan S, 2016, ADV STRUCT CHEM IMAG, V2, DOI 10.1186/s40679-016-0021-2; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Smeets D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-8; Smith Paul J, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0725s28; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Stalling D., 2005, VISUAL HDB, V38, P749, DOI DOI 10.1016/B978-012387582-2/50040-X; STOCKERT JC, 1974, EXPERIENTIA, V30, P751, DOI 10.1007/BF01924164; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Tan S, 2011, CURR OPIN STRUC BIOL, V21, P128, DOI 10.1016/j.sbi.2010.11.006; Tark-Dame M, 2011, J CELL SCI, V124, P839, DOI 10.1242/jcs.077628; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P727, DOI 10.1083/jcb.4.6.727; Wojcik K, 2008, CYTOM PART A, V73A, P555, DOI 10.1002/cyto.a.20573; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zessin PJM, 2012, J STRUCT BIOL, V177, P344, DOI 10.1016/j.jsb.2011.12.015; Zhou BR, 2015, MOL CELL, V59, P628, DOI 10.1016/j.molcel.2015.06.025; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	88	429	436	5	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349							eaag0025	10.1126/science.aag0025	http://dx.doi.org/10.1126/science.aag0025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751582	Green Accepted			2022-12-28	WOS:000406362300035
J	Lee, C; Guo, JT; Zeng, WZ; Kim, S; She, J; Cang, CL; Ren, DJ; Jiang, YX				Lee, Changkeun; Guo, Jiangtao; Zeng, Weizhong; Kim, Sunghoon; She, Ji; Cang, Chunlei; Ren, Dejian; Jiang, Youxing			The lysosomal potassium channel TMEM175 adopts a novel tetrameric architecture	NATURE			English	Article							K+ CHANNEL; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; SELECTIVITY; TRANSPORT; PROTEINS; DISEASE; COMPLEX; SHAKER; NA+	TMEM175 is a lysosomal K+ channel that is important for maintaining the membrane potential and pH stability in lysosomes(1). It contains two homologous copies of a six-transmembrane-helix (6-TM) domain, which has no sequence homology to the canonical tetrameric K+ channels and lacks the TVGYG selectivity filter motif found in these channels2-4. The prokaryotic TMEM175 channel, which is present in a subset of bacteria and archaea, contains only a single 6-TM domain and functions as a tetramer. Here, we present the crystal structure of a prokaryotic TMEM175 channel from Chamaesiphon minutus, CmTMEM175, the architecture of which represents a completely different fold from that of canonical K+ channels. All six transmembrane helices of CmTMEM175 are tightly packed within each subunit without undergoing domain swapping. The highly conserved TM1 helix acts as the pore-lining inner helix, creating an hourglass-shaped ion permeation pathway in the channel tetramer. Three layers of hydrophobic residues on the carboxy-terminal half of the TM1 helices form a bottleneck along the ion conduction pathway and serve as the selectivity filter of the channel. Mutagenesis analysis suggests that the first layer of the highly conserved isoleucine residues in the filter is primarily responsible for channel selectivity. Thus, the structure of CmTMEM175 represents a novel architecture of a tetrameric cation channel whose ion selectivity mechanism appears to be distinct from that of the classical K+ channel family.	[Lee, Changkeun; Guo, Jiangtao; Zeng, Weizhong; Kim, Sunghoon; She, Ji; Jiang, Youxing] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Lee, Changkeun; Guo, Jiangtao; Zeng, Weizhong; Kim, Sunghoon; She, Ji; Jiang, Youxing] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Lee, Changkeun; Zeng, Weizhong; Kim, Sunghoon; Jiang, Youxing] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Cang, Chunlei; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Pennsylvania	Jiang, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Jiang, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Jiang, YX (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	youxing.jiang@utsouthwestern.edu	Cang, Chunlei/D-9185-2019; She, Ji/AAW-6150-2021	kim, sunghoon/0000-0002-1570-3230; Cang, Chunlei/0000-0002-3302-0927	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; National Institutes of Health [GM079179, NS055293, NS074257]; Welch Foundation [I-1578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074257, R01NS055293] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Nguyen for manuscript preparation. The experimental results reported in this article derive from work performed at Argonne National Laboratory, Structural Biology Center (19ID) and GM/CA (23ID) at the Advanced Photon Source, and from work performed at the Berkeley Center for Structural Biology at the Advanced Light Source (ALS). Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. This work was supported in part by the Howard Hughes Medical Institute and by grants from the National Institutes of Health (GM079179 to Y.J.; NS055293 and NS074257 to D.R.) and the Welch Foundation (Grant I-1578 to Y.J.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cang CL, 2015, CELL, V162, P1101, DOI 10.1016/j.cell.2015.08.002; Carrillo-Tripp M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.168104; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jinn S, 2017, P NATL ACAD SCI USA, V114, P2389, DOI 10.1073/pnas.1616332114; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2015, P NATL ACAD SCI USA, V112, P10851, DOI 10.1073/pnas.1513718112; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schulze H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004804; Shao Q, 2009, NANO LETT, V9, P989, DOI 10.1021/nl803044k; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Vaisey G, 2016, P NATL ACAD SCI USA, V113, pE7399, DOI 10.1073/pnas.1614688113; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Xiong J, 2016, SCI CHINA LIFE SCI, V59, P777, DOI 10.1007/s11427-016-5090-x; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yang TT, 2014, SCIENCE, V346, P355, DOI 10.1126/science.1259723; Zhou XB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1949; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	41	33	36	5	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					472	+		10.1038/nature23269	http://dx.doi.org/10.1038/nature23269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28723891	Green Accepted			2022-12-28	WOS:000406358300040
J	Niemeier, U; Tilmes, S				Niemeier, Ulrike; Tilmes, Simone			Sulfur injections for a cooler planet	SCIENCE			English	Editorial Material							ALBEDO ENHANCEMENT; EMISSIONS		[Niemeier, Ulrike] Max Planck Inst Meteorol, Hamburg, Germany; [Tilmes, Simone] Natl Ctr Atmospher Res, Atmospher Chem Observat & Modeling Lab, POB 3000, Boulder, CO 80307 USA	Max Planck Society; National Center Atmospheric Research (NCAR) - USA	Niemeier, U (corresponding author), Max Planck Inst Meteorol, Hamburg, Germany.	ulrike.niemeier@mpimet.mpg.de		Tilmes, Simone/0000-0002-6557-3569				Anderson K, 2016, SCIENCE, V354, P182, DOI 10.1126/science.aah4567; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; Dykema JA, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0059; Joeri R., 2016, NATURE, V534; Keith DW, 2016, P NATL ACAD SCI USA, V113, P14910, DOI 10.1073/pnas.1615572113; Lohmann U, 2017, SCIENCE, V357, P248, DOI 10.1126/science.aan3325; Mills MJ, 2016, J GEOPHYS RES-ATMOS, V121, P2332, DOI 10.1002/2015JD024290; Moriyama R., 2016, MITIG ADAPT STRAT GL, V21, P1; Niemeier U, 2015, ATMOS CHEM PHYS, V15, P9129, DOI 10.5194/acp-15-9129-2015; Niemeier U, 2013, J GEOPHYS RES-ATMOS, V118, P11905, DOI 10.1002/2013JD020445; Pasztor J, 2017, SCIENCE, V357, P231, DOI 10.1126/science.aan6794; Reynolds JL, 2016, EARTHS FUTURE, V4, P562, DOI 10.1002/2016EF000416; Robock A, 2016, EARTHS FUTURE, V4, P644, DOI 10.1002/2016EF000407; SAXLER B, 2015, LAW INNOVAT TECHNOL, V7, P112, DOI DOI 10.1080/17579961.2015.1052645; Tilmes S, 2016, GEOPHYS RES LETT, V43, P8222, DOI 10.1002/2016GL070122; Tilmes S, 2008, SCIENCE, V320, P1201, DOI 10.1126/science.1153966; Visioni D, 2017, ATMOS CHEM PHYS, V17, P3879, DOI 10.5194/acp-17-3879-2017	17	18	18	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					246	248		10.1126/science.aan3317	http://dx.doi.org/10.1126/science.aan3317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729495				2022-12-28	WOS:000405901600019
J	Pellegrini, L				Pellegrini, Luca			Comment on "The [4Fe4S] cluster of human DNA primase functions as a redox switch using DNA charge transport"	SCIENCE			English	Editorial Material							DOMAIN	O'Brien et al. (Research Article, 24 February 2017, eaag1789) report that the iron-sulfur cluster of primase has a redox role in enzyme activity. Their analysis is based on a partially misfolded structure of the iron-sulfur cluster domain of primase. In the correctly folded structure, two of the three tyrosines putatively involved in electron transfer, Y345 and Y347, contact the RNA/DNA helix, providing an alternative explanation for the data of O'Brien et al.	[Pellegrini, Luca] Univ Cambridge, Dept Biochem, Cambridge, England	University of Cambridge	Pellegrini, L (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	lp212@cam.ac.uk	Pellegrini, Luca/AAE-2312-2022	Pellegrini, Luca/0000-0002-9300-497X				Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Baranovskiy AG, 2016, J BIOL CHEM, V291, P4793, DOI 10.1074/jbc.M115.704064; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; O'Brien E, 2017, SCIENCE, V355, DOI 10.1126/science.aag1789; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107	6	9	9	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348							eaan2954	10.1126/science.aan2954	http://dx.doi.org/10.1126/science.aan2954			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729486				2022-12-28	WOS:000405901600003
J	Sivis, M; Taucer, M; Vampa, G; Johnston, K; Staudte, A; Naumov, AY; Villeneuve, DM; Ropers, C; Corkum, PB				Sivis, Murat; Taucer, Marco; Vampa, Giulio; Johnston, Kyle; Staudte, Andre; Naumov, Andrei Yu.; Villeneuve, D. M.; Ropers, Claus; Corkum, P. B.			Tailored semiconductors for high-harmonic optoelectronics	SCIENCE			English	Article							GENERATION; SOLIDS; GASES	The advent of high-harmonic generation in gases 30 years ago set the foundation for attosecond science and facilitated ultrafast spectroscopy in atoms, molecules, and solids. We explore high-harmonic generation in the solid state by means of nanostructured and ion-implanted semiconductors. We use wavelength-selective microscopic imaging to map enhanced harmonic emission and show that the generation medium and the driving field can be locally tailored in solids by modifying the chemical composition and morphology. This enables the control of high-harmonic technology within precisely engineered solid targets. We demonstrate customized high-harmonic wave fields with wavelengths down to 225 nanometers (ninth-harmonic order of 2-micrometer laser pulses) and present an integrated Fresnel zone plate target in silicon, which leads to diffraction-limited self-focusing of the generated harmonics down to 1-micrometer spot sizes.	[Sivis, Murat; Taucer, Marco; Vampa, Giulio; Johnston, Kyle; Staudte, Andre; Naumov, Andrei Yu.; Villeneuve, D. M.; Corkum, P. B.] Natl Res Council Canada, Joint Attosecond Sci Lab, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Sivis, Murat; Taucer, Marco; Vampa, Giulio; Johnston, Kyle; Staudte, Andre; Naumov, Andrei Yu.; Villeneuve, D. M.; Corkum, P. B.] Univ Ottawa, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Sivis, Murat; Ropers, Claus] Univ Gottingen, Phys Inst Solids & Nanostruct 4, Gottingen, Germany	National Research Council Canada; University of Ottawa; University of Gottingen	Sivis, M (corresponding author), Natl Res Council Canada, Joint Attosecond Sci Lab, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.; Sivis, M (corresponding author), Univ Ottawa, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.; Sivis, M (corresponding author), Univ Gottingen, Phys Inst Solids & Nanostruct 4, Gottingen, Germany.	msivis@uni-goettingen.de	Villeneuve, David M/I-4140-2012; Ropers, Claus/D-4843-2015	Villeneuve, David M/0000-0002-2810-3648; Ropers, Claus/0000-0002-9539-3817; Corkum, Paul/0000-0003-3394-5572; Staudte, Andre/0000-0002-8284-3831	Deutsche Forschungsgemeinschaft (DFG) [DFG-SFB755]; National Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation/Ontario Research Fund; U.S. Air Force Office of Scientific Research (AFOSR) [FA9550-16-1-0109]; AFOSR Multidisciplinary University Research Initiative [FA9550-15-1-0037]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Research Council of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation/Ontario Research Fund(Canada Foundation for Innovation); U.S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); AFOSR Multidisciplinary University Research Initiative(MURI)	We thank D. Crane and B. Avery for technical support and S. Zayko and N. Rubiano da Silva for valuable discussions. The work of the German authors was supported by the Deutsche Forschungsgemeinschaft (DFG) within DFG-SFB755, "Nanoscale Photonic Imaging" (project C08). The Canadian authors gratefully acknowledge financial support from the National Research Council of Canada, the Natural Sciences and Engineering Research Council of Canada, and the Canada Foundation for Innovation/Ontario Research Fund; the U.S. Air Force Office of Scientific Research (AFOSR) under award number FA9550-16-1-0109; and the AFOSR Multidisciplinary University Research Initiative under grant number FA9550-15-1-0037. M.S. and M.T. conducted the experiments with contributions from G.V. and K.J., analyzed the data, and wrote the manuscript with contributions from all authors. M.S. conceived and prepared the nanostructures and carried out the simulations. P.B.C. and C.R. directed the study. All authors discussed the results and interpretation.	Azzam RMA, 2004, J OPT SOC AM A, V21, P1559, DOI 10.1364/JOSAA.21.001559; Bastard G., 1990, WAVE MECH APPL SEMIC; Cai XL, 2012, SCIENCE, V338, P363, DOI 10.1126/science.1226528; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Han S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13105; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; KLINGSHIRN C, 1975, PHYS STATUS SOLIDI B, V71, P547, DOI 10.1002/pssb.2220710216; LHUILLIER A, 1993, PHYS REV LETT, V70, P774, DOI 10.1103/PhysRevLett.70.774; Liu CD, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.043806; Luu TT, 2015, NATURE, V521, P498, DOI 10.1038/nature14456; Rimini E., 1995, ION IMPLANTATION BAS, P131; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Sivis M, 2013, NAT PHYS, V9, P304, DOI [10.1038/nphys2590, 10.1038/NPHYS2590]; Vampa G, 2017, NAT PHYS, V13, P659, DOI [10.1038/NPHYS4087, 10.1038/nphys4087]; Vampa G, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.193603; Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517; Worner HJ, 2010, NATURE, V466, P604, DOI 10.1038/nature09185; You S. Y., 2016, NAT PHYS, V13, P345; Zayko S, 2015, OPT EXPRESS, V23, P19911, DOI 10.1364/OE.23.019911	22	137	141	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					303	306		10.1126/science.aan2395	http://dx.doi.org/10.1126/science.aan2395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729510	Green Submitted			2022-12-28	WOS:000405901600041
J	Aglipay, M; Birken, CS; Parkin, PC; Loeb, MB; Thorpe, K; Chen, Y; Laupacis, A; Mamdani, M; Macarthur, C; Hoch, JS; Mazzulli, T; Maguire, JL				Aglipay, Mary; Birken, Catherine S.; Parkin, Patricia C.; Loeb, Mark B.; Thorpe, Kevin; Chen, Yang; Laupacis, Andreas; Mamdani, Muhammad; Macarthur, Colin; Hoch, Jeffrey S.; Mazzulli, Tony; Maguire, Jonathon L.		TARGET Kids Collaboration	Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN METAPNEUMOVIRUS; RANDOMIZED-TRIAL; D DEFICIENCY; PREVENTION; VIRUSES; RISK; EPIDEMIOLOGY; PREGNANCY; INFANTS; ILLNESS	IMPORTANCE Epidemiological studies support a link between low 25-hydroxyvitamin D levels and a higher risk of viral upper respiratory tract infections. However, whether winter supplementation of vitamin D reduces the risk among children is unknown. OBJECTIVE To determine whether high-dose vs standard-dose vitamin D supplementation reduces the incidence of wintertime upper respiratory tract infections in young children. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial was conducted during the winter months between September 13, 2011, and June 30, 2015, among children aged 1 through 5 years enrolled in TARGet Kids!, a multisite primary care practice-based research network in Toronto, Ontario, Canada. INTERVENTIONS Three hundred forty-nine participants were randomized to receive 2000 IU/d of vitamin D oral supplementation (high-dose group) vs 354 participants who were randomized to receive 400 IU/d (standard-dose group) for a minimum of 4 months between September and May. MAIN OUTCOME MEASURES The primary outcome was the number of laboratory-confirmed viral upper respiratory tract infections based on parent-collected nasal swabs over the winter months. Secondary outcomes included the number of influenza infections, noninfluenza infections, parent-reported upper respiratory tract illnesses, time to first upper respiratory tract infection, and serum 25-hydroxyvitamin D levels at study termination. RESULTS Among 703 participants who were randomized (mean age, 2.7 years, 57.7% boys), 699 (99.4%) completed the trial. The mean number of laboratory-confirmed upper respiratory tract infections per child was 1.05 (95% CI, 0.91-1.19) for the high-dose group and 1.03 (95% CI, 0.90-1.16) for the standard-dose group, for a between-group difference of 0.02 (95% CI, -0.17 to 0.21) per child. There was no statistically significant difference in number of laboratory-confirmed infections between groups (incidence rate ratio [RR], 0.97; 95% CI, 0.80-1.16). There was also no significant difference in the median time to the first laboratory-confirmed infection: 3.95 months (95% CI, 3.02-5.95 months) for the high-dose group vs 3.29 months (95% CI, 2.66-4.14 months) for the standard-dose group, or number of parent-reported upper respiratory tract illnesses between groups (625 for high-dose vs 600 for standard-dose groups, incidence RR, 1.01; 95% CI, 0.88-1.16). At study termination, serum 25-hydroxyvitamin D levels were 48.7 ng/mL (95% CI, 46.9-50.5 ng/mL) in the high-dose group and 36.8 ng/mL (95% CI, 35.4-38.2 ng/mL) in the standard-dose group. CONCLUSIONS AND RELEVANCE Among healthy children aged 1 to 5 years, daily administration of 2000 IU compared with 400 IU of vitamin D supplementation did not reduce overall wintertime upper respiratory tract infections. These findings do not support the routine use of high-dose vitamin D supplementation in children for the prevention of viral upper respiratory tract infections.	[Aglipay, Mary; Maguire, Jonathon L.] St Michaels Hosp, Pediat Res, Dept Pediat, Toronto, ON, Canada; [Birken, Catherine S.; Parkin, Patricia C.; Macarthur, Colin; Maguire, Jonathon L.] Hosp Sick Children, Pediat Outcomes Res Team, Div Pediat Med, Dept Pediat, Toronto, ON, Canada; [Birken, Catherine S.; Parkin, Patricia C.; Macarthur, Colin; Maguire, Jonathon L.] Univ Toronto, Fac Med, Dept Pediat, Toronto, ON, Canada; [Birken, Catherine S.; Parkin, Patricia C.; Macarthur, Colin; Hoch, Jeffrey S.; Maguire, Jonathon L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Birken, Catherine S.; Parkin, Patricia C.; Macarthur, Colin] Sick Kids Res Inst, Child Hlth Evaluat Sci, Toronto, ON, Canada; [Loeb, Mark B.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Loeb, Mark B.] McMaster Univ, Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Thorpe, Kevin; Chen, Yang; Laupacis, Andreas; Mamdani, Muhammad; Hoch, Jeffrey S.; Maguire, Jonathon L.] Univ Toronto, St Michaels Hosp, La Ka Shing Knowledge Inst, Toronto, ON, Canada; [Thorpe, Kevin] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Laupacis, Andreas] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Laupacis, Andreas] Univ Toronto, Fac Med, Toronto, ON, Canada; [Hoch, Jeffrey S.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Mazzulli, Tony] Mt Sinai Hosp, Dept Microbiol, Toronto, ON, Canada; [Mazzulli, Tony] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Maguire, JL (corresponding author), St Michaels Hosp, Pediat Ambulatory Clin, 61 Queen St East,Second Floor, Toronto, ON M5C 2T2, Canada.	jonathon.maguire@utoronto.ca	Anderson, Laura/K-4707-2019; Hoch, Jeffrey/O-3406-2017	Anderson, Laura/0000-0002-6106-5073; Hoch, Jeffrey/0000-0002-4880-4281; Thorpe, Kevin/0000-0002-7586-3893	Canadian Institutes of Health Research Institutes of Human Development, Child and Youth Health and Nutrition, Metabolism and Diabetes [MOP-114945]; Thrasher Research Fund [9113]	Canadian Institutes of Health Research Institutes of Human Development, Child and Youth Health and Nutrition, Metabolism and Diabetes(Canadian Institutes of Health Research (CIHR)); Thrasher Research Fund	This study was funded by competitive grants from the Canadian Institutes of Health Research Institutes of Human Development, Child and Youth Health and Nutrition, Metabolism and Diabetes (MOP-114945) and the Thrasher Research Fund (award number 9113). The vitamin D formulations were provided in-kind by Ddrops.	Aloia JF, 2006, AM J CLIN NUTR, V84, P602, DOI 10.1093/ajcn/84.3.602; [Anonymous], 2016, KIDS DDROPS; Barger-Lux MJ, 1998, OSTEOPOROSIS INT, V8, P222, DOI 10.1007/s001980050058; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Barrett B, 2007, ANN FAM MED, V5, P216, DOI 10.1370/afm.698; Bergman P, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0065835; Bergman P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001663; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; CLEMENS TL, 1982, LANCET, V1, P74; de Nooijer J, 2012, NUTRIENTS, V4, P1454, DOI 10.3390/nu4101454; Esposito S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-85; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Grant CC, 2015, ACTA PAEDIATR, V104, P396, DOI 10.1111/apa.12819; Gysin DV, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0162996, 1]; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Hintzpeter B, 2008, J NUTR, V138, P1482, DOI 10.1093/jn/138.8.1482; Jacobs B, 2000, J CLIN EPIDEMIOL, V53, P793, DOI 10.1016/S0895-4356(99)00238-3; Lambert SB, 2007, PEDIATRICS, V120, pe929, DOI 10.1542/peds.2006-3703; Langlois Kellie, 2010, Health Rep, V21, P47; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Mansbach JM, 2009, PEDIATRICS, V124, P1404, DOI 10.1542/peds.2008-2041; Mao S, 2013, SCAND J INFECT DIS, V45, P696, DOI 10.3109/00365548.2013.803293; MisraM PD, 2008, PEDIATRICS, V122, P398; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Rawlinson WD, 2003, J INFECT DIS, V187, P1314, DOI 10.1086/368411; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; SCHWARTZ B, 1994, PEDIATRICS, V94, P1018; SIGNORINI DF, 1991, BIOMETRIKA, V78, P446; Taylor JA, 2010, PEDIATRICS, V125, P105, DOI 10.1542/peds.2009-1195; Taylor S, 2017, J INFECTION, V74, P29, DOI 10.1016/j.jinf.2016.09.003; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; van Belle G, 2011, STAT RULES THUMB; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Walker VP, 2009, PEDIATR RES, V65, p106R, DOI 10.1203/PDR.0b013e31819dba91; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; Xiao LM, 2015, BRIT J NUTR, V114, P1026, DOI 10.1017/S000711451500207X	41	79	85	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					245	254		10.1001/jama.2017.8708	http://dx.doi.org/10.1001/jama.2017.8708			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719693	Green Published, Bronze			2022-12-28	WOS:000405775000011
J	Nguyen, JT; Molony, DA				Nguyen, John T.; Molony, Donald A.			Review: Dapagliflozin increases, and empagliflozin reduces, adverse renal events in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Nguyen, John T.; Molony, Donald A.] Univ Texas Houston, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Nguyen, JT (corresponding author), Univ Texas Houston, McGovern Med Sch, Houston, TX 77030 USA.							Vallon V, 2017, DIABETOLOGIA, V60, P215, DOI 10.1007/s00125-016-4157-3; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC5	JC5		10.7326/ACPJC-2017-167-2-005	http://dx.doi.org/10.7326/ACPJC-2017-167-2-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715827				2022-12-28	WOS:000405573400006
J	Voelker, R				Voelker, Rebecca			Generic ADHD Drug	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					232	232		10.1001/jama.2017.8439	http://dx.doi.org/10.1001/jama.2017.8439			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719678				2022-12-28	WOS:000405775000029
J	Wilensky, G				Wilensky, Gail			Revisiting Medicaid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Wilensky, Gail] Project HOPE, Bethesda, MD 20814 USA		Wilensky, G (corresponding author), Project HOPE, Bethesda, MD 20814 USA.	gwilensky@projecthope.org							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					229	230		10.1001/jama.2017.7999	http://dx.doi.org/10.1001/jama.2017.7999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719681				2022-12-28	WOS:000405775000002
J	Metcalf, CJE; Lessler, J				Metcalf, C. Jessica E.; Lessler, Justin			Opportunities and challenges in modeling emerging infectious diseases	SCIENCE			English	Review							EBOLA-VIRUS DISEASE; PANDEMIC INFLUENZA; WEST-AFRICA; ZIKA VIRUS; TRANSMISSION; EPIDEMIC; SURVEILLANCE; PROJECTIONS; STRATEGIES; OUTBREAK	The term "pathogen emergence" encompasses everything from previously unidentified viruses entering the human population to established pathogens invading new populations and the evolution of drug resistance. Mathematical models of emergent pathogens allow forecasts of case numbers, investigation of transmission mechanisms, and evaluation of control options. Yet, there are numerous limitations and pitfalls to their use, often driven by data scarcity. Growing availability of data on pathogen genetics and human ecology, coupled with computational and methodological innovations, is amplifying the power of models to inform the public health response to emergence events. Tighter integration of infectious disease models with public health practice and development of resources at the ready has the potential to increase the timeliness and quality of responses.	[Metcalf, C. Jessica E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Metcalf, C. Jessica E.] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Lessler, Justin] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Princeton University; Princeton University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Metcalf, CJE (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.; Metcalf, CJE (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.	cmetcalf@princeton.edu		Lessler, Justin/0000-0002-9741-8109	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NICHD NIH HHS [P2C HD047879] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agua-Agum J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002170; [Anonymous], 2009, WASHINGTON POST; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Camacho A, 2017, VACCINE, V35, P544, DOI 10.1016/j.vaccine.2016.12.019; Camacho A, 2014, EPIDEMICS-NETH, V9, P70, DOI 10.1016/j.epidem.2014.09.003; Cauchemez S, 2016, P NATL ACAD SCI USA, V113, P9081, DOI 10.1073/pnas.1519235113; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Funk S, 2014, NATURE, V515, P493, DOI 10.1038/515492b; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Kucharski AJ, 2014, LANCET, V384, P1260, DOI 10.1016/S0140-6736(14)61706-2; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Lessler J, 2016, AM J EPIDEMIOL, V183, P657, DOI 10.1093/aje/kwv452; Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255; Mao L, 2015, J TRANSP GEOGR, V48, P52, DOI 10.1016/j.jtrangeo.2015.08.017; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272; Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Read JM, 2015, LANCET, V385, P23, DOI 10.1016/S0140-6736(14)61894-8; Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670; Stobbe M., 2015, SEATTLE TIMES; Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4; Wesolowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05678; Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	44	74	75	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		149	152		10.1126/science.aam8335	http://dx.doi.org/10.1126/science.aam8335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706037	Green Accepted			2022-12-28	WOS:000405391700034
J	Maison, SF; Rauch, SD				Maison, Stephane F.; Rauch, Steven D.			Ethical considerations in noise-induced hearing loss research	LANCET			English	Editorial Material							AUDITORY-NERVE FIBERS; DEGENERATION; INJURY; DAMAGE		[Maison, Stephane F.; Rauch, Steven D.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Rauch, SD (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA.	steven_rauch@meei.harvard.edu						Arenas JP, 2014, NOISE HEALTH, V16, P306, DOI 10.4103/1463-1741.140511; Bohne BA, 2000, AM J OTOL, V21, P505; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; JOHNSSON LG, 1974, ANN OTO RHINOL LARYN, V83, P294, DOI 10.1177/000348947408300303; JOHNSSON LG, 1976, ANN OTO RHINOL LARYN, V85, P725, DOI 10.1177/000348947608500603; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kul J., 2017, LANCET; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; SCHMIEDT RA, 1984, J ACOUST SOC AM, V76, P1293, DOI 10.1121/1.391446; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014	14	4	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					920	922		10.1016/S0140-6736(17)31875-5	http://dx.doi.org/10.1016/S0140-6736(17)31875-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28716312				2022-12-28	WOS:000408746300007
J	Harding, SM; Benci, JL; Irianto, J; Discher, DE; Minn, AJ; Reenberg, RAG				Harding, Shane M.; Benci, Joseph L.; Irianto, Jerome; Discher, Dennis E.; Minn, Andy J.; Reenberg, Roger A. G.			Mitotic progression following DNA damage enables pattern recognition within micronuclei	NATURE			English	Article							INTERFERON REGULATORY FACTOR-3; TARGET GENES; RADIATION; RADIOTHERAPY; SENSOR; CELLS; MECHANISMS; RESISTANCE	Inflammatory gene expression following genotoxic cancer therapy is well documented, yet the events underlying its induction remain poorly understood. Inflammatory cytokines modify the tumour microenvironment by recruiting immune cells and are critical for both local and systemic (abscopal) tumour responses to radiotherapy(1). A poorly understood feature of these responses is the delayed onset (days), in contrast to the acute DNA-damage responses that occur in minutes to hours. Such dichotomous kinetics implicate additional rate-limiting steps that are essential for DNA-damage-induced inflammation. Here we show that cell cycle progression through mitosis following double-stranded DNA breaks leads to the formation of micronuclei, which precede activation of inflammatory signalling and are a repository for the pattern-recognition receptor cyclic GMP-AMP synthase (cGAS). Inhibiting progression through mitosis or loss of pattern recognition by stimulator of interferon genes (STING)-cGAS impaired interferon signalling. Moreover, STING loss prevented the regression of abscopal tumours in the context of ionizing radiation and immune checkpoint blockade in vivo. These findings implicate temporal modulation of the cell cycle as an important consideration in the context of therapeutic strategies that combine genotoxic agents with immune checkpoint blockade.	[Harding, Shane M.; Reenberg, Roger A. G.] Univ Penn, Dept Canc Biol, Basser Ctr BRCA, Abramson Family Canc Res Inst,Perelman Sch Med, 421 Curie Blvd, Philadelphia, PA 19104 USA; [Benci, Joseph L.; Minn, Andy J.] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Benci, Joseph L.; Minn, Andy J.] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Benci, Joseph L.; Minn, Andy J.] Univ Penn, Parker Inst Canc Immunotherapy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Irianto, Jerome; Discher, Dennis E.] Univ Penn, Phys Sci Oncol Ctr Penn, 129 Towne Bldg, Philadelphia, PA 19104 USA; [Irianto, Jerome; Discher, Dennis E.] Univ Penn, Mol & Cell Biophys Lab, 129 Towne Bldg, Philadelphia, PA 19104 USA; [Irianto, Jerome; Discher, Dennis E.] Univ Penn, Grad Grp, Dept Phys & Astron, 129 Towne Bldg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Reenberg, RAG (corresponding author), Univ Penn, Dept Canc Biol, Basser Ctr BRCA, Abramson Family Canc Res Inst,Perelman Sch Med, 421 Curie Blvd, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu	Harding, Shane M/N-2377-2017	Harding, Shane M/0000-0002-5524-3566; Benci, Joseph/0000-0002-1759-4621; Minn, Andy/0000-0003-1418-0906; Irianto, Jerome/0000-0002-4804-7225	NIH [CA17494, GM101149, CA138835]; PSOC [U54-CA193417]; Basser Center; NATIONAL CANCER INSTITUTE [R01CA174904, R01CA138835, U54CA193417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124106, R21HL128187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101149] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSOC; Basser Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Greenberg laboratory for critical discussion and A. Jackson (University of Edinburgh, Scotland) for sharing unpublished results. We are also grateful to R. Vance (UC Berkeley) for providing the IFN beta-promoter-driven plasmid that we subsequently modified to drive eGFP expression. This work was supported by NIH grants CA17494, GM101149, and CA138835 (to R.A.G.), PSOC U54-CA193417 to (D.E.D. and R.A.G.), and by funds from the Basser Center for BRCA.	Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Di Maggio FM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0058-3; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Erdal E, 2017, GENE DEV, V31, P353, DOI 10.1101/gad.289769.116; Ferguson B. J., 2012, LIFE SCI, V1; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Harding SM, 2015, CELL REP, V13, P251, DOI 10.1016/j.celrep.2015.08.085; Harding SM, 2012, CELL CYCLE, V11, P1432, DOI 10.4161/cc.19824; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hu B, 2016, SCIENCE, V354, P765, DOI 10.1126/science.aaf7532; Irianto J, 2017, CURR BIOL, V27, P210, DOI 10.1016/j.cub.2016.11.049; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Karpova AY, 2002, P NATL ACAD SCI USA, V99, P2818, DOI 10.1073/pnas.052713899; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rodriguez-Ruiz ME, 2016, CANCER RES, V76, P5994, DOI 10.1158/0008-5472.CAN-16-0549; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaue D, 2015, NAT REV CLIN ONCOL, V12, P527, DOI 10.1038/nrclinonc.2015.120; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Terradas M, 2010, MUTAT RES-REV MUTAT, V705, P60, DOI 10.1016/j.mrrev.2010.03.004; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017	34	694	715	11	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					466	+		10.1038/nature23470	http://dx.doi.org/10.1038/nature23470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28759889	Green Accepted, Green Submitted			2022-12-28	WOS:000408279000041
J	de Vrieze, J				de Vrieze, Jop			Funders groan under growing review burden	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					343	343		10.1126/science.357.6349.343	http://dx.doi.org/10.1126/science.357.6349.343			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751589				2022-12-28	WOS:000406362300017
J	Gulland, A				Gulland, Anne			The war on US women's reproductive rights	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk						Berwick DM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2718	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2017	358								j3635	10.1136/bmj.j3635	http://dx.doi.org/10.1136/bmj.j3635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3VB	28754696				2022-12-28	WOS:000406766400003
J	Rimmer, A				Rimmer, Abi			60 seconds on ... Black Wednesday	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Academy of Medical Royal Colleges, 2013, REC SAF TRAIN CHANG; BMA, 2017, SHAD FIN YEAR MED ST; Innes E., 2013, DAILY MAIL; Jen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007103	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j3574	10.1136/bmj.j3574	http://dx.doi.org/10.1136/bmj.j3574			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UW	28747303				2022-12-28	WOS:000406765900012
J	Lyon, J				Lyon, Jeff			New Medical Officer at Indian Health Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					322	322		10.1001/jama.2017.9618	http://dx.doi.org/10.1001/jama.2017.9618			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NN	28742893				2022-12-28	WOS:000426801700002
J	Slomski, A				Slomski, Anita			Clinical Trials Update	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					323	323		10.1001/jama.2017.8846	http://dx.doi.org/10.1001/jama.2017.8846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742905				2022-12-28	WOS:000406296700004
J	Flavahan, WA; Gaskell, E; Bernstein, BE				Flavahan, William A.; Gaskell, Elizabeth; Bernstein, Bradley E.			Epigenetic plasticity and the hallmarks of cancer	SCIENCE			English	Review							CHROMATIN-STRUCTURE; DNA METHYLATION; GENE-EXPRESSION; STEM-CELLS; MUTATIONS; DYNAMICS; MECHANISMS; EZH2; HETEROGENEITY; TRANSCRIPTION	Chromatin and associated epigenetic mechanisms stabilize gene expression and cellular states while also facilitating appropriate responses to developmental or environmental cues. Genetic, environmental, or metabolic insults can induce overly restrictive or overly permissive epigenetic landscapes that contribute to pathogenesis of cancer and other diseases. Restrictive chromatin states may prevent appropriate induction of tumor suppressor programs or block differentiation. By contrast, permissive or "plastic" states may allow stochastic oncogene activation or nonphysiologic cell fate transitions. Whereas many stochastic events will be inconsequential "passengers," some will confer a fitness advantage to a cell and be selected as "drivers." We review the broad roles played by epigenetic aberrations in tumor initiation and evolution and their potential to give rise to all classic hallmarks of cancer.	[Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA 02114 USA; Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	bernstein.bradley@mgh.harvard.edu			National Cancer Institute; NIH Common Fund grant [DP1CA216873]; National Human Genome Research Institute; American Cancer Society; Leukemia and Lymphoma Society; Starr Cancer Consortium; F32 from the National Cancer Institute; NATIONAL CANCER INSTITUTE [DP1CA216873] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Common Fund grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Starr Cancer Consortium; F32 from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Bernstein lab for thoughtful discussion, and R. Macrae, Y. Drier, and P. van Galen for helpful comments on the manuscript. Research in the Bernstein laboratory is supported by National Cancer Institute and NIH Common Fund grant DP1CA216873, the National Human Genome Research Institute, the American Cancer Society, the Leukemia and Lymphoma Society, and the Starr Cancer Consortium. W.A.F. is supported by an F32 from the National Cancer Institute. B.E.B. owns equity in Fulcrum Therapeutics and 1CellBio Inc.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bayliss J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aah6904; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bell RE, 2016, GENOME RES, V26, P601, DOI 10.1101/gr.197194.115; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Black JC, 2015, GENE DEV, V29, P1018, DOI 10.1101/gad.259796.115; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Cowey CL, 2009, CURR ONCOL REP, V11, P94, DOI 10.1007/s11912-009-0015-5; Curtin Karen, 2011, Patholog Res Int, V2011, P902674, DOI 10.4061/2011/902674; Davis A, 2017, BBA-REV CANCER, V1867, P151, DOI 10.1016/j.bbcan.2017.01.003; Dekker J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019356; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Filippova GN, 2002, CANCER RES, V62, P48; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Guryanova OA, 2016, NAT MED, V22, P1488, DOI 10.1038/nm.4210; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Harikumar A, 2015, EMBO REP, V16, P1609, DOI 10.15252/embr.201541011; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hesson LB, 2010, CURR OPIN GENET DEV, V20, P290, DOI 10.1016/j.gde.2010.02.005; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Hore TA, 2016, P NATL ACAD SCI USA, V113, P12202, DOI 10.1073/pnas.1608679113; Hormanseder E, 2017, CELL STEM CELL, V21, P135, DOI 10.1016/j.stem.2017.03.003; Inoue S, 2016, CANCER CELL, V30, P337, DOI 10.1016/j.ccell.2016.05.018; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kemp CJ, 2014, CELL REP, V7, P1020, DOI 10.1016/j.celrep.2014.04.004; Killian JK, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009961; Kim J, 2011, GENOME MED, V3, DOI 10.1186/gm291; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Leibowitz ML, 2015, ANNU REV GENET, V49, P183, DOI 10.1146/annurev-genet-120213-092228; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Liau BB, 2017, CELL STEM CELL, V20, P233, DOI 10.1016/j.stem.2016.11.003; Lu R, 2016, CANCER CELL, V30, P92, DOI 10.1016/j.ccell.2016.05.008; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Madar S, 2013, TRENDS MOL MED, V19, P447, DOI 10.1016/j.molmed.2013.05.004; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Marshall AD, 2017, ONCOGENE, V36, P4100, DOI 10.1038/onc.2017.25; Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115; Mazor T, 2016, CANCER CELL, V29, P440, DOI 10.1016/j.ccell.2016.03.009; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perino M, 2016, DEV CELL, V38, P610, DOI 10.1016/j.devcel.2016.08.004; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Ryan RJH, 2015, CANCER DISCOV, V5, P1058, DOI 10.1158/2159-8290.CD-15-0370; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sharma U, 2017, CELL METAB, V25, P544, DOI 10.1016/j.cmet.2017.02.003; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Waddington C., 1957, STRATEGY GENES; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang LB, 2016, CANCER CELL, V29, P922, DOI 10.1016/j.ccell.2016.05.003; Yang QY, 2016, CELL METAB, V24, P542, DOI 10.1016/j.cmet.2016.08.010; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940	102	593	596	12	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348							eaal2380	10.1126/science.aal2380	http://dx.doi.org/10.1126/science.aal2380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729483	Green Accepted			2022-12-28	WOS:000405901600032
J	Donnelly, C; Guizar-Sicairos, M; Scagnoli, V; Gliga, S; Holler, M; Raabe, J; Heyderman, LJ				Donnelly, Claire; Guizar-Sicairos, Manuel; Scagnoli, Valerio; Gliga, Sebastian; Holler, Mirko; Raabe, Jorg; Heyderman, Laura J.			Three-dimensional magnetization structures revealed with X-ray vector nanotomography	NATURE			English	Article							COMPUTED-TOMOGRAPHY; PHASE TOMOGRAPHY; PILATUS	In soft ferromagnetic materials, the smoothly varying magnetization leads to the formation of fundamental patterns such as domains, vortices and domain walls(1). These have been studied extensively in thin films of thicknesses up to around 200 nanometres, in which the magnetization is accessible with current transmission imaging methods that make use of electrons or soft X-rays. In thicker samples, however, in which the magnetization structure varies throughout the thickness and is intrinsically three dimensional, determining the complex magnetic structure directly still represents a challenge(1,3). We have developed hard-X-ray vector nanotomography with which to determine the three-dimensional magnetic configuration at the nanoscale within micrometre-sized samples. We imaged the structure of the magnetization within a soft magnetic pillar of diameter 5 micrometres with a spatial resolution of 100 nanometres and, within the bulk, observed a complex magnetic configuration that consists of vortices and antivortices that form cross-tie walls and vortex walls along intersecting planes. At the intersections of these structures, magnetic singularities-Bloch points-occur. These were predicted more than fifty years ago(4) but have so far not been directly observed. Here we image the three-dimensional magnetic structure in the vicinity of the Bloch points, which until now has been accessible only through micromagnetic simulations, and identify two possible magnetization configurations: a circulating magnetization structure(5) and a twisted state that appears to correspond to an 'anti-Bloch point'. Our imaging method enables the nanoscale study of topological magnetic structures(6) in systems with sizes of the order of tens of micrometres. Knowledge of internal nanomagnetic textures is critical for understanding macroscopic magnetic properties and for designing bulk magnets for technological applications(7).	[Donnelly, Claire; Scagnoli, Valerio; Heyderman, Laura J.] ETH, Dept Mat, Lab Mesoscop Syst, CH-8093 Zurich, Switzerland; [Donnelly, Claire; Guizar-Sicairos, Manuel; Scagnoli, Valerio; Holler, Mirko; Raabe, Jorg; Heyderman, Laura J.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Gliga, Sebastian] Univ Glasgow, Sch Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Glasgow	Donnelly, C (corresponding author), ETH, Dept Mat, Lab Mesoscop Syst, CH-8093 Zurich, Switzerland.; Donnelly, C; Guizar-Sicairos, M (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.; Gliga, S (corresponding author), Univ Glasgow, Sch Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland.	claire.donnelly@psi.ch; manuel.guizar-sicairos@psi.ch; sebastian.gliga@glasgow.ac.uk	scagnoli, valerio/C-6833-2008; Guizar-Sicairos, Manuel/I-4899-2013; Gliga, Sebastian/O-2788-2017; Guizar-Sicairos, Manuel/AAB-3793-2019; Holler, Mirko/I-3962-2014; scagnoli, valerio/T-1355-2019; Heyderman, Laura/E-7959-2015; Raabe, Jörg/C-4818-2012	scagnoli, valerio/0000-0002-8116-8870; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Gliga, Sebastian/0000-0003-1729-1070; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Holler, Mirko/0000-0001-8141-0148; scagnoli, valerio/0000-0002-8116-8870; Heyderman, Laura/0000-0003-3843-6611; Raabe, Jörg/0000-0002-2071-6896; Donnelly, Claire/0000-0002-9942-2419	European Union [708674]	European Union(European Commission)	X-ray measurements were performed at the cSAXS beamline at the Swiss Light Source, Paul Scherrer Institut, Switzerland. We thank R. M. Galera for providing and performing magnetic characterizations of the GdCo<INF>2</INF> nugget, and S. Stutz and E. Muller for the sample fabrication, as well as K. Metlov, A. Arrott and G. Hrkac for discussions. S. G. was funded by the European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie grant agreement number 708674.	Andreas C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.134403; Arrott AS, 2016, IEEE MAGN LETT, V7, DOI 10.1109/LMAG.2016.2631127; ARROTT AS, 1979, IEEE T MAGN, V15, P1228, DOI 10.1109/TMAG.1979.1060342; Bouchenoire L, 2003, J SYNCHROTRON RADIAT, V10, P172, DOI 10.1107/S0909049502018654; Braun HB, 2012, ADV PHYS, V61, P1, DOI 10.1080/00018732.2012.663070; BURZO E, 1972, PHYS REV B-SOLID ST, V6, P2882, DOI 10.1103/PhysRevB.6.2882; Chen YT, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/39/395302; Chukazumi S., 2009, PHYS FERROMAGNETISM; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Donnelly C, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.064421; Elias RG, 2011, EUR PHYS J B, V82, P159, DOI 10.1140/epjb/e2011-20146-6; Eriksson M, 2014, J SYNCHROTRON RADIAT, V21, P837, DOI 10.1107/S1600577514019286; FELDTKELLER E, 1965, Z ANGEW PHYSIK, V19, P530; GILES C, 1994, J APPL CRYSTALLOGR, V27, P232, DOI 10.1107/S0021889893007976; Guizar-Sicairos M, 2008, OPT EXPRESS, V16, P7264, DOI 10.1364/OE.16.007264; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Guizar-Sicairos M, 2015, OPTICA, V2, P259, DOI 10.1364/OPTICA.2.000259; Guizar-Sicairos M, 2014, OPT EXPRESS, V22, P14859, DOI 10.1364/OE.22.014859; Guizar-Sicairos M, 2011, OPT EXPRESS, V19, P21345, DOI 10.1364/OE.19.021345; Gutfleisch O, 2011, ADV MATER, V23, P821, DOI 10.1002/adma.201002180; HANNON JP, 1988, PHYS REV LETT, V61, P1245, DOI 10.1103/PhysRevLett.61.1245; Henrich B, 2009, NUCL INSTRUM METH A, V607, P247, DOI 10.1016/j.nima.2009.03.200; Hertel R, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/48/483002; Hertel R., 2013, SPIN, V3; Hertel R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.177202; Holler M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03857; Holler M, 2017, NATURE, V543, P402, DOI 10.1038/nature21698; Howells MR, 2009, J ELECTRON SPECTROSC, V170, P4, DOI 10.1016/j.elspec.2008.10.008; Hubert A., 1998, MAGNETIC DOMAINS ANA; Kardjilov N, 2008, NAT PHYS, V4, P399, DOI 10.1038/nphys912; Kraft P, 2009, IEEE T NUCL SCI, V56, P758, DOI 10.1109/TNS.2008.2009448; Manke I, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1125; Phatak C, 2008, ULTRAMICROSCOPY, V108, P503, DOI 10.1016/j.ultramic.2007.08.002; Phatak C, 2014, NANO LETT, V14, P759, DOI 10.1021/nl404071u; Phatak C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.253901; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Scagnoli V, 2009, J SYNCHROTRON RADIAT, V16, P778, DOI 10.1107/S0909049509035006; Schafer R, 2000, J MAGN MAGN MATER, V215, P652, DOI 10.1016/S0304-8853(00)00252-3; Shin S, 2013, METALL MATER TRANS A, V44A, P4239, DOI 10.1007/s11661-013-1750-7; Stoehr J., 2006, MAGNETISM FUNDAMENTA; Streubel R, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/36/363001; Streubel R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8612; Tanigaki T, 2015, NANO LETT, V15, P1309, DOI 10.1021/nl504473a; Thiaville A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094410; Thibault P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063004; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Thibault P, 2014, J SYNCHROTRON RADIAT, V21, P1011, DOI 10.1107/S1600577514015343; Tripathi A, 2011, P NATL ACAD SCI USA, V108, P13393, DOI 10.1073/pnas.1104304108; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009	50	140	140	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					328	+		10.1038/nature23006	http://dx.doi.org/10.1038/nature23006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28726832	Green Accepted			2022-12-28	WOS:000405844900029
J	Drazen, JM; Yialamas, MA				Drazen, Jeffrey M.; Yialamas, Maria A.			Certain about Dying with Uncertainty	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Drazen, Jeffrey M.; Yialamas, Maria A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Drazen, JM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					208	209		10.1056/NEJMp1706795	http://dx.doi.org/10.1056/NEJMp1706795			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA9PI	28723331	Bronze			2022-12-28	WOS:000405777600004
J	Shah, H				Shah, Hetan			The DeepMind debacle demands dialogue on data	NATURE			English	Editorial Material									[Shah, Hetan] Royal Stat Soc, London, England		Shah, H (corresponding author), Royal Stat Soc, London, England.	h.shah@rss.org.uk							0	15	15	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					259	259		10.1038/547259a	http://dx.doi.org/10.1038/547259a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB0OR	28726841	Bronze			2022-12-28	WOS:000405844900004
J	Williams, K; Swanson, K				Williams, Kathryn; Swanson, Karen			Bronchoscopic Removal of an Obstructing Broncholith	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Williams, Kathryn] Mayo Clin, Scottsdale, AZ 85259 USA; [Swanson, Karen] Mayo Clin, Rochester, MN USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Williams, K (corresponding author), Mayo Clin, Scottsdale, AZ 85259 USA.	williams.kathryn@mayo.edu							0	0	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					E4	E4		10.1056/NEJMicm1612226	http://dx.doi.org/10.1056/NEJMicm1612226			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9PI	28723339				2022-12-28	WOS:000405777600011
J	Dharmarajan, K; Wang, YF; Lin, ZQ; Normand, SLT; Ross, JS; Horwitz, LI; Desai, NR; Suter, LG; Drye, EE; Bernheim, SM; Krumholz, HM				Dharmarajan, Kumar; Wang, Yongfei; Lin, Zhenqiu; Normand, Sharon-Lise T.; Ross, Joseph S.; Horwitz, Leora I.; Desai, Nihar R.; Suter, Lisa G.; Drye, Elizabeth E.; Bernheim, Susannah M.; Krumholz, Harlan M.			Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; REDUCTION PROGRAM; UNINTENDED CONSEQUENCES; MEDICARE BENEFICIARIES; 30-DAY READMISSION; NATIONAL TRENDS; PERFORMANCE; CARE; INTERVENTION	IMPORTANCE The Affordable Care Act has led to US national reductions in hospital 30-day readmission rates for heart failure (HF), acute myocardial infarction (AMI), and pneumonia. Whether readmission reductions have had the unintended consequence of increasing mortality after hospitalization is unknown. OBJECTIVE To examine the correlation of paired trends in hospital 30-day readmission rates and hospital 30-day mortality rates after discharge. DESIGN, SETTING, AND PARTICIPANTS Retrospective study of Medicare fee-for-service beneficiaries aged 65 years or older hospitalized with HF, AMI, or pneumonia from January 1, 2008, through December 31, 2014. EXPOSURE Thirty-day risk-adjusted readmission rate (RARR). MAIN OUTCOMES AND MEASURES Thirty-day RARRs and 30-day risk-adjusted mortality rates (RAMRs) after discharge were calculated for each condition in each month at each hospital in 2008 through 2014. Monthly trends in each hospital's 30-day RARRs and 30-day RAMRs after discharge were examined for each condition. The weighted Pearson correlation coefficient was calculated for hospitals' paired monthly trends in 30-day RARRs and 30-day RAMRs after discharge for each condition. RESULTS In 2008 through 2014, 2 962 554 hospitalizations for HF, 1 229 939 for AMI, and 2 544 530 for pneumonia were identified at 5016, 4772, and 5057 hospitals, respectively. In January 2008, mean hospital 30-day RARRs and 30-day RAMRs after discharge were 24.6% and 8.4% for HF, 19.3% and 7.6% for AMI, and 18.3% and 8.5% for pneumonia. Hospital 30-day RARRs declined in the aggregate across hospitals from 2008 through 2014; monthly changes in RARRs were -0.053%(95% CI, -0.055% to -0.051%) for HF, -0.044% (95% CI, -0.047% to -0.041%) for AMI, and -0.033%(95% CI, -0.035% to -0.031%) for pneumonia. In contrast, monthly aggregate changes across hospitals in hospital 30-day RAMRs after discharge varied by condition: HF, 0.008%(95% CI, 0.007% to 0.010%); AMI, -0.003%(95% CI, -0.005% to -0.001%); and pneumonia, 0.001%(95% CI, -0.001% to 0.003%). However, correlation coefficients in hospitals' paired monthly changes in 30-day RARRs and 30-day RAMRs after discharge were weakly positive: HF, 0.066 (95% CI, 0.036 to 0.096); AMI, 0.067 (95% CI, 0.027 to 0.106); and pneumonia, 0.108 (95% CI, 0.079 to 0.137). Findings were similar in secondary analyses, including with alternate definitions of hospital mortality. CONCLUSIONS AND RELEVANCE Among Medicare fee-for-service beneficiaries hospitalized for heart failure, acute myocardial infarction, or pneumonia, reductions in hospital 30-day readmission rates were weakly but significantly correlated with reductions in hospital 30-day mortality rates after discharge. These findings do not support increasing postdischarge mortality related to reducing hospital readmissions.	[Dharmarajan, Kumar; Wang, Yongfei; Lin, Zhenqiu; Ross, Joseph S.; Desai, Nihar R.; Suter, Lisa G.; Drye, Elizabeth E.; Bernheim, Susannah M.; Krumholz, Harlan M.] Yale New Haven Hlth, Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Dharmarajan, Kumar; Wang, Yongfei; Desai, Nihar R.; Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA; [Dharmarajan, Kumar] Clover Hlth, Jersey City, NJ 07302 USA; [Normand, Sharon-Lise T.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Normand, Sharon-Lise T.] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Ross, Joseph S.; Bernheim, Susannah M.] Yale Sch Med, Gen Internal Med Sect, Dept Internal Med, New Haven, CT USA; [Ross, Joseph S.; Bernheim, Susannah M.; Krumholz, Harlan M.] Yale Sch Med, Clin Scholars Program, Robert Wood Johnson Fdn, Dept Internal Med, New Haven, CT USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Horwitz, Leora I.] NYU Langone Med Ctr, Ctr Healthcare Innovat & Delivery Sci, New York, NY USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, New York, NY USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Med, Div Gen Internal Med & Clin Innovat, New York, NY USA; [Suter, Lisa G.] Yale Sch Med, Rheumatol Sect, Dept Internal Med, New Haven, CT USA; [Drye, Elizabeth E.] Yale Sch Med, Sect Gen Pediat, Dept Pediat, New Haven, CT USA	Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; NYU Langone Medical Center; New York University; New York University; Yale University; Yale University	Dharmarajan, K (corresponding author), Clover Hlth, Harborside Financial Ctr, 3 Second St,Plaza 10,Ste 803, Jersey City, NJ 07302 USA.	kumar.dharmarajan@cloverhealth.com	, Harlan/AAI-2875-2020; Horwitz, Leora/ABD-1292-2020	Ross, Joseph/0000-0002-9218-3320	National Institute on Aging [K23AG048331]; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; Yale Claude D. Pepper Older Americans Independence Center [P30AG021342]; Agency for Healthcare Research and Quality [R01HS022882, K12HS023000]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS022882] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, KL2TR001862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG048331, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; Yale Claude D. Pepper Older Americans Independence Center; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Dharmarajan is supported by grant K23AG048331 from the National Institute on Aging and the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program, and by grant P30AG021342 from the Yale Claude D. Pepper Older Americans Independence Center. Drs Ross and Horwitz are supported by grant R01HS022882 from the Agency for Healthcare Research and Quality. Dr Desai is supported by grant K12HS023000 from the Agency for Healthcare Research and Quality.	American Hospital Association, 2014, AV LENGTH STAY COMM; Bhalla R, 2010, ANN INTERN MED, V152, P114, DOI 10.7326/0003-4819-152-2-201001190-00185; Bradley EH, 2015, J GEN INTERN MED, V30, P605, DOI 10.1007/s11606-014-3105-5; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Brewster AL, 2016, MED CARE, V54, P600, DOI 10.1097/MLR.0000000000000530; Brotman DJ, 2016, J HOSP MED, V11, P650, DOI 10.1002/jhm.2604; Carey K, 2016, HEALTH AFFAIR, V35, P1918, DOI 10.1377/hlthaff.2016.0537; Carlson Joe, 2013, MODERN HEALTHCARE; Chen J, 2013, J AM COLL CARDIOL, V61, P1078, DOI 10.1016/j.jacc.2012.11.057; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Desai NR, 2016, JAMA-J AM MED ASSOC, V316, P2647, DOI 10.1001/jama.2016.18533; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Figueroa JF, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2214; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Gu Q, 2014, HEALTH SERV RES, V49, P818, DOI 10.1111/1475-6773.12150; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Himmelstein D., 2015, HLTH AFFAIRS BLOG; Horwitz LI, 2015, J HOSP MED, V10, P670, DOI 10.1002/jhm.2416; Joynt KE, 2016, AM J MANAG CARE, V22, pE287; Joynt KE, 2016, ANN INTERN MED, V165, P153, DOI 10.7326/M15-1462; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kociol RD, 2012, CIRC-HEART FAIL, V5, P680, DOI 10.1161/CIRCHEARTFAILURE.112.967406; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; Nallamothu BK, 2015, LANCET, V385, P1114, DOI 10.1016/S0140-6736(14)61932-2; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; Naylor MD, 2012, HEALTH AFFAIR, V31, P1623, DOI 10.1377/hlthaff.2012.0110; Ouslander JG, 2014, J AM MED DIR ASSOC, V15, P162, DOI 10.1016/j.jamda.2013.12.005; Sacks NC, 2015, EPIDEMIOLOGY, V26, pE46, DOI 10.1097/EDE.0000000000000298; Werner RM, 2010, HEALTH AFFAIR, V29, P1319, DOI 10.1377/hlthaff.2008.0770; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	40	138	140	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					270	278		10.1001/jama.2017.8444	http://dx.doi.org/10.1001/jama.2017.8444			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719692	Green Published			2022-12-28	WOS:000405775000013
J	Makri, A				Makri, Anita			Frontline: the vital need for information	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					218	218		10.1016/S0140-6736(17)31867-6	http://dx.doi.org/10.1016/S0140-6736(17)31867-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA5IZ	28721870				2022-12-28	WOS:000405477900013
J	Chang, HY; Nadeau, KC				Chang, Howard Y.; Nadeau, Kari C.			IL-4R alpha Inhibitor for Atopic Disease	CELL			English	Editorial Material									[Chang, Howard Y.; Nadeau, Kari C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Chang, HY; Nadeau, KC (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu; knadeau@stanford.edu							0	21	25	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					222	222		10.1016/j.cell.2017.06.046	http://dx.doi.org/10.1016/j.cell.2017.06.046			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708993	Bronze			2022-12-28	WOS:000405493900003
J	Doring, K; Ahmed, N; Riemer, T; Suresh, HG; Vainshtein, Y; Habich, M; Riemer, J; Mayer, MP; O'Brien, EP; Kramer, G; Bukau, B				Doering, Kristina; Ahmed, Nabeel; Riemer, Trine; Suresh, Harsha Garadi; Vainshtein, Yevhen; Habich, Markus; Riemer, Jan; Mayer, Matthias P.; O'Brien, Edward P.; Kramer, Guenter; Bukau, Bernd			Profiling Ssb-Nascent Chain Interactions Reveals Principles of Hsp70-Assisted Folding	CELL			English	Article							RIBOSOME-ASSOCIATED COMPLEX; MOLECULAR CHAPERONE SSB; HSP70 HOMOLOG SSB; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TRIGGER FACTOR; HEAT-SHOCK; COTRANSLATIONAL CHAPERONE; TRANSLATION TERMINATION; EUKARYOTIC RIBOSOME	The yeast Hsp70 chaperone Ssb interacts with ribosomes and nascent polypeptides to assist protein folding. To reveal its working principle, we determined the nascent chain-binding pattern of Ssb at near-residue resolution by in vivo selective ribosome profiling. Ssb associates broadly with cytosolic, nuclear, and hitherto unknown substrate classes of mitochondrial and endoplasmic reticulum (ER) nascent proteins, supporting its general chaperone function. Ssb engages most substrates by multiple binding-release cycles to a degenerate sequence enriched in positively charged and aromatic amino acids. Timely association with this motif upon emergence at the ribosomal tunnel exit requires ribosome-associated complex (RAC) but not nascent polypeptide-associated complex (NAC). Ribosome footprint densities along orfs reveal faster translation at times of Ssb binding, mainly imposed by biases in mRNA secondary structure, codon usage, and Ssb action. Ssb thus employs substrate-tailored dynamic nascent chain associations to coordinate co-translational protein folding, facilitate accelerated translation, and support membrane targeting of organellar proteins.	[Doering, Kristina; Riemer, Trine; Suresh, Harsha Garadi; Vainshtein, Yevhen; Mayer, Matthias P.; Kramer, Guenter; Bukau, Bernd] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, Heidelberg, Germany; [Doering, Kristina; Riemer, Trine; Suresh, Harsha Garadi; Kramer, Guenter; Bukau, Bernd] German Canc Res Ctr, Neuenheimer Feld 280, Heidelberg, Germany; [Ahmed, Nabeel; O'Brien, Edward P.] Penn State Univ, Bioinformat & Genom Grad Program, Huck Inst Life Sci, University Pk, PA 16802 USA; [Suresh, Harsha Garadi] Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON, Canada; [Habich, Markus; Riemer, Jan] Univ Cologne, Inst Biochem, Zuelpicher Str 47, Cologne, Germany; [O'Brien, Edward P.] Penn State Univ, Dept Chem, University Pk, PA USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto; University of Cologne; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kramer, G; Bukau, B (corresponding author), Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, Heidelberg, Germany.; Kramer, G; Bukau, B (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, Heidelberg, Germany.	g.kramer@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de	Ahmed, Nabeel/ABH-5305-2020; Riemer, Jan/AAC-1072-2021; Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Vainshtein, Yevhen/0000-0001-7944-8892; Ahmed, Nabeel/0000-0003-4839-2392; Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393; Riemer, Jan/0000-0002-7574-8457	HFSP [RGP0038/2015]; Deutsche Forschungsgemeinschaft [SFB1036]	HFSP(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank members of the Bukau laboratory and S. Anders (ZMBH) for insightful discussions; the DKFZ Genomics & Proteomics Core facility for sequencing; K. Richter and the DKFZ electron microscopy facility; the ZMBH mass spectrometry facility for experimental support; N. Altman for useful discussions on statistical analyses; U. Friedrich, C. Glasser, and D. Schibich for support with data analysis; and Elizabeth Craig for providing antibodies. This work was supported by research grants from the HFSP (RGP0038/2015) to E.P.O. and B.B. and the Deutsche Forschungsgemeinschaft to M.P.M. and B.B. (SFB1036).	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Altmann Katrin, 2007, Methods Mol Biol, V372, P81, DOI 10.1007/978-1-59745-365-3_6; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; BOEHLKE KW, 1975, J BACTERIOL, V121, P429, DOI 10.1128/JB.121.2.429-433.1975; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Chiabudini M, 2014, MOL CELL BIOL, V34, P4062, DOI 10.1128/MCB.00799-14; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; CRAIG EA, 1985, MOL CELL BIOL, V5, P3517, DOI 10.1128/MCB.5.12.3517; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Gloge F, 2014, CURR OPIN STRUC BIOL, V24, P24, DOI 10.1016/j.sbi.2013.11.004; GOOD P., 2005, PERMUTATION PARAMETR, V3rd, P766; Gumiero A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13563; Hanebuth MA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13695; Hatin I, 2007, GENETICS, V177, P1527, DOI 10.1534/genetics.107.070771; Herrmann JM, 2010, ANTIOXID REDOX SIGN, V13, P1341, DOI 10.1089/ars.2009.3063; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hubscher V, 2016, NUCLEIC ACIDS RES, V44, P5629, DOI 10.1093/nar/gkw168; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee K, 2016, NAT STRUCT MOL BIOL, V23, P1003, DOI 10.1038/nsmb.3299; Leidig C, 2013, NAT STRUCT MOL BIOL, V20, P23, DOI 10.1038/nsmb.2447; Li WC, 2008, BIOINFORMATICS, V24, P2254, DOI 10.1093/bioinformatics/btn407; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shieh YW, 2015, SCIENCE, V350, P678, DOI 10.1126/science.aac8171; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Tripathi A, 2017, J BIOL CHEM, V292, P8007, DOI 10.1074/jbc.M116.761122; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Vogtle FN, 2012, MOL CELL PROTEOMICS, V11, P1840, DOI 10.1074/mcp.M112.021105; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; von Plehwe U, 2009, GENE DEV, V23, P2102, DOI 10.1101/gad.529409; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809; Zahedi RP, 2006, MOL BIOL CELL, V17, P1436, DOI 10.1091/mbc.E05-08-0740; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008; Zhang YX, 2014, NAT STRUCT MOL BIOL, V21, P1042, DOI 10.1038/nsmb.2908	68	85	87	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					298	+		10.1016/j.cell.2017.06.038	http://dx.doi.org/10.1016/j.cell.2017.06.038			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708998	Green Accepted, Bronze			2022-12-28	WOS:000405493900010
J	Gonzalez, S; Klatt, P; Delgado, S; Conde, E; Lopez-Rios, F; Sanchez-Cespedes, M; Mendez, J; Antequera, F; Serrano, M				Gonzalez, Susana; Klatt, Peter; Delgado, Sonia; Conde, Esther; Lopez-Rios, Fernando; Sanchez-Cespedes, Montserrat; Mendez, Juan; Antequera, Francisco; Serrano, Manuel			RETRACTION: Oncogenic activity of Cdc6 through repression of the INK4/ARF locus (Retraction of Vol 440, Pg 702, 2006)	NATURE			English	Retraction													Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312				Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585	1	2	2	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					246	246		10.1038/nature23287	http://dx.doi.org/10.1038/nature23287			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4OC	28703201				2022-12-28	WOS:000426803400001
J	Marletto, C; Vedral, V				Marletto, Chiara; Vedral, Vlatko			Witness gravity's quantum side in the lab	NATURE			English	Editorial Material							REDUCTION		[Marletto, Chiara] Univ Oxford Wolfson Coll, Oxford, England; [Vedral, Vlatko] Univ Oxford, Dept Phys, Clarendon Lab, Quantum Informat Sci, Oxford OX1 3PU, England	University of Oxford; University of Oxford	Marletto, C (corresponding author), Univ Oxford Wolfson Coll, Oxford, England.	chiara.marletto@physics.ox.ac.uk; vlatko.vedral@qubit.org	Vedral, Vlatko/L-3270-2016	Vedral, Vlatko/0000-0002-8588-2940; vedral, vlatko/0000-0003-4561-5124				BRUNE M, 1992, PHYS REV A, V45, P5193, DOI 10.1103/PhysRevA.45.5193; DIOSI L, 1989, PHYS REV A, V40, P1165, DOI 10.1103/PhysRevA.40.1165; Dyson F, 2013, INT J MOD PHYS A, V28, DOI 10.1142/S0217751X1330041X; Feynman R., 2011, ROLE GRAVITATION PHY; Krauss LM, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.047501; Margalit Y, 2015, SCIENCE, V349, P1205, DOI 10.1126/science.aac6498; Penrose R, 1996, GEN RELAT GRAVIT, V28, P581, DOI 10.1007/BF02105068; Pikovski I, 2015, NAT PHYS, V11, P668, DOI [10.1038/nphys3366, 10.1038/NPHYS3366]; Rothman T, 2006, FOUND PHYS, V36, P1801, DOI 10.1007/s10701-006-9081-9	10	16	16	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					156	158		10.1038/547156a	http://dx.doi.org/10.1038/547156a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3AX	28703205	Bronze			2022-12-28	WOS:000405314500016
J	McDade, E; Bateman, RJ				McDade, Eric; Bateman, Randall J.			Stop Alzheimer's before it starts	NATURE			English	Editorial Material							DISEASE		[McDade, Eric; Bateman, Randall J.] Washington Univ, Sch Med, Neurol, St Louis, MO 63130 USA	Washington University (WUSTL)	McDade, E (corresponding author), Washington Univ, Sch Med, Neurol, St Louis, MO 63130 USA.	ericmcdade@wustl.edu; batemanr@wustl.edu		Bateman, Randall/0000-0002-7729-1702	NIA NIH HHS [K23 AG046363] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG046363] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Carrillo MC, 2013, ALZHEIMERS DEMENT, V9, P123, DOI 10.1016/j.jalz.2012.12.004; Das P, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-39; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Karran E, 2014, ANN NEUROL, V76, P185, DOI 10.1002/ana.24188; Kennedy ME, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9704; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; Wiegman A, 2015, EUR HEART J, V36, P2425, DOI 10.1093/eurheartj/ehv157	11	153	162	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					153	155		10.1038/547153a	http://dx.doi.org/10.1038/547153a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3AX	28703214	Bronze			2022-12-28	WOS:000405314500015
J	Stocker, M; van Herk, W; el Helou, S; Dutta, S; Fontana, MS; Schuerman, FABA; van den Tooren-de Groot, RK; Wieringa, JW; Janota, J; van der Meer-Kappelle, LH; Moonen, R; Sie, SD; de Vries, E; Donker, AE; Zimmerman, U; Schlapbach, LJ; de Mol, AC; Hoffman-Haringsma, A; Roy, M; Tomaske, M; Kornelisse, RF; van Gijsel, J; Visser, EG; Willemsen, SP; van Rossum, AMC				Stocker, Martin; van Herk, Wendy; el Helou, Salhab; Dutta, Sourabh; Fontana, Matteo S.; Schuerman, Frank A. B. A.; van den Tooren-de Groot, Rita K.; Wieringa, Jantien W.; Janota, Jan; van der Meer-Kappelle, Laura H.; Moonen, Rob; Sie, Sintha D.; de Vries, Esther; Donker, Albertine E.; Zimmerman, Urs; Schlapbach, Luregn J.; de Mol, Amerik C.; Hoffman-Haringsma, Angelique; Roy, Madan; Tomaske, Maren; Kornelisse, Rene F.; van Gijsel, Juliette; Visser, Eline G.; Willemsen, Sten P.; van Rossum, Annemarie M. C.		NeoPInS Study Grp	Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)	LANCET			English	Article							C-REACTIVE PROTEIN; LATE PRETERM INFANTS; INTENSIVE-CARE; ANTIMICROBIAL RESISTANCE; INFECTION; RISK; COLONIZATION; STEWARDSHIP; EXPOSURE; CHILDREN	Background Up to 7% of term and late-preterm neonates in high-income countries receive antibiotics during the first 3 days of life because of suspected early-onset sepsis. The prevalence of culture-proven early-onset sepsis is 0.1% or less in high-income countries, suggesting substantial overtreatment. We assess whether procalcitonin-guided decision making for suspected early-onset sepsis can safely reduce the duration of antibiotic treatment. Methods We did this randomised controlled intervention trial in Dutch (n=11), Swiss (n=4), Canadian (n=2), and Czech (n=1) hospitals. Neonates of gestational age 34 weeks or older, with suspected early-onset sepsis requiring antibiotic treatment were stratified into four risk categories by their treating physicians and randomly assigned [1:1] using a computer-generated list stratified per centre to procalcitonin-guided decision making or standard care-based antibiotic treatment. Neonates who underwent surgery within the first week of life or had major congenital malformations that would have required hospital admission were excluded. Only principal investigators were masked for group assignment. Co-primary outcomes were non-inferiority for re-infection or death in the first month of life (margin 2.0%) and superiority for duration of antibiotic therapy. Intention-to-treat and per-protocol analyses were done. This trial was registered with ClinicalTrials. gov, number NCT00854932. Findings Between May 21, 2009, and Feb 14, 2015, we screened 2440 neonates with suspected early-onset sepsis. 622 infants were excluded due to lack of parental consent, 93 were ineligible for reasons unknown (68), congenital malformation (22), or surgery in the first week of life (3). 14 neonates were excluded as 100% data monitoring or retrieval was not feasible, and one neonate was excluded because their procalcitonin measurements could not be taken. 1710 neonates were enrolled and randomly assigned to either procalcitonin-guided therapy (n=866) or standard therapy (n=844). 1408 neonates underwent per-protocol analysis (745 in the procalcitonin group and 663 standard group). For the procalcitonin group, the duration of antibiotic therapy was reduced (intention to treat: 55.1 vs 65.0 h, p<0.0001; per protocol: 51.8 vs 64.0 h; p<0.0001). No sepsis-related deaths occurred, and 9 (<1%) of 1710 neonates had possible re-infection. The risk difference for non-inferiority was 0.1% (95% CI -4.6 to 4.8) in the intention-totreat analysis (5 [0.6%] of 866 neonates in the procalcitonin group vs 4 [0.5%] of 844 neonates in the standard group) and 0.1% (-5.2 to 5.3) in the per-protocol analysis (5 [0.7%] of 745 neonates in the procalcitonin group vs 4 [0.6%] of 663 neonates in the standard group). Interpretation Procalcitonin-guided decision making was superior to standard care in reducing antibiotic therapy in neonates with suspected early-onset sepsis. Non-inferiority for re-infection or death could not be shown due to the low occurrence of re-infections and absence of study-related death.	[Stocker, Martin; Fontana, Matteo S.] Childrens Hosp Lucerne, Dept Paediat, Neonatal & Paediat Intens Care Unit, Luzern, Switzerland; [van Herk, Wendy; Visser, Eline G.; van Rossum, Annemarie M. C.] Erasmus MC Univ Med Ctr, Sophia Childrens Hosp, Dept Paediat, Div Paediat Infect Dis & Immunol, Rotterdam, Netherlands; [el Helou, Salhab; Dutta, Sourabh] McMaster Univ Childrens Hosp, Hamilton Hlth Sci, Div Neonatol, Hamilton, ON, Canada; [Schuerman, Frank A. B. A.] Flevo Hosp, Dept Paediat, Almere, Netherlands; [van den Tooren-de Groot, Rita K.] Bronovo Hosp, Dept Paediat, The Hague, Netherlands; [Wieringa, Jantien W.] MC Haaglanden, Dept Paediat, The Hague, Netherlands; [Janota, Jan] Thomayer Hosp, Dept Neonatol, Prague, Czech Republic; [Janota, Jan] Charles Univ Prague, Inst Pathol Physiol, Med Fac 1, Prague, Czech Republic; [van der Meer-Kappelle, Laura H.] Reinier Graaf Gasthuis, Dept Neonatol, Delft, Netherlands; [Moonen, Rob] Atrium Med Ctr, Dept Neonatol, Heerlen, Netherlands; [Sie, Sintha D.] Vrije Univ Amsterdam Med Ctr, Dept Neonatol, Amsterdam, Netherlands; [de Vries, Esther] Jeroen Bosch Hosp, Dept Paediat, sHertogenbosch, Netherlands; [Donker, Albertine E.] Maxima Med Ctr, Dept Paediat, Veldhoven, Netherlands; [Zimmerman, Urs] Kantonsspital Winterthur, Dept Paediat, Winterthur, Switzerland; [Schlapbach, Luregn J.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Paediat, Bern, Switzerland; [Schlapbach, Luregn J.] Univ Queensland, Mater Res Inst, Paediat Crit Care Res Grp, Brisbane, Qld, Australia; [Schlapbach, Luregn J.] Lady Cilento Childrens Hosp, Paediat Intens Care Unit, Brisbane, Qld, Australia; [de Mol, Amerik C.] Albert Schweitzer Hosp, Dept Neonatol, Dordrecht, Netherlands; [Hoffman-Haringsma, Angelique] St Franciscus Gasthuis, Dept Neonatol, Rotterdam, Netherlands; [Roy, Madan] St Josephs Healthcare, Hamilton Hlth Sci, Dept Neonatol, Hamilton, ON, Canada; [Tomaske, Maren] Stadtspital Triemli, Dept Paediat, Zurich, Switzerland; [Kornelisse, Rene F.] Erasmus MC Univ Med Ctr, Sophia Childrens Hosp, Div Neonatol, Rotterdam, Netherlands; [van Gijsel, Juliette] Univ Med Ctr Utrecht, Julius Training Gen Practitioner, Utrecht, Netherlands; [Willemsen, Sten P.] Erasmus MC Univ Med Ctr, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; McMaster University; Haaglanden Medical Center; Bronovo Hospital; Thomayer Hospital; Charles University Prague; Reinier de Graaf Hospital; Atrium Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Jeroen Bosch Ziekenhuis; Maxima Medical Center; University of Bern; University Hospital of Bern; Mater Research; University of Queensland; Albert Schweitzer Ziekenhuis; Franciscus Gasthuis; McMaster University; Triemli Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	van Herk, W (corresponding author), Erasmus MC Univ Med Centre, Sophia Childrens Hosp, Dept Paediat, Div Infect Dis & Immunol, NL-3015 CN Rotterdam, Netherlands.	w.vanherk@erasmusmc.nl	Martin, Stocker/AAV-7124-2021; van Rossum, Annemarie/AAC-7050-2019; Schlapbach, Luregn J/F-7465-2017; Janota, Jan/H-3200-2017; Helou, Salhab/ABB-8396-2021	Schlapbach, Luregn J/0000-0003-2281-2598; Janota, Jan/0000-0002-0684-375X; Helou, Salhab/0000-0002-1066-8763; van Weissenbruch, Mirjam M/0000-0002-8086-9552; Andriessen, Peter/0000-0002-5159-6874; Stocker, Martin/0000-0002-1461-333X; van Rossum, Annemarie/0000-0002-1259-477X; Siiskonen, Satu J/0000-0003-3095-9530; de Vries, Esther/0000-0003-4311-3550	Thrasher Foundation; NutsOhra Foundation; Sophia Foundation for Scientific research	Thrasher Foundation; NutsOhra Foundation; Sophia Foundation for Scientific research	The Thrasher Foundation, the NutsOhra Foundation, the Sophia Foundation for Scientific research.	Aly H, 2015, J MATERN-FETAL NEO M, V28, P598, DOI 10.3109/14767058.2014.927428; Armand-Lefevre L, 2013, ANTIMICROB AGENTS CH, V57, P1488, DOI 10.1128/AAC.01823-12; Assumma M, 2000, CLIN CHEM, V46, P1583; Baer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068419; Bhandari V, 2014, J PEDIAT INF DIS SOC, V3, P234, DOI 10.1093/jpids/piu063; Cantey JB, 2016, LANCET INFECT DIS, V16, P1178, DOI 10.1016/S1473-3099(16)30205-5; Cantey JB, 2014, INFECT DIS CLIN N AM, V28, P247, DOI 10.1016/j.idc.2014.01.005; Centres for Disease Control and Prevention (CDC), 2002, CDC 12 STEP PROGR PR; Chiesa C, 2003, CLIN CHEM, V49, P60, DOI 10.1373/49.1.60; Chiesa C, 1998, CLIN INFECT DIS, V26, P664, DOI 10.1086/514576; Chiesa C, 2015, MEDICINE, V94, P1, DOI 10.1097/MD.0000000000001230; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; de Jong E, 2016, LANCET INFECT DIS, V16, P819, DOI 10.1016/S1473-3099(16)00053-0; De Santis V, 2015, J ANTIMICROB CHEMOTH, V70, P273, DOI 10.1093/jac/dku338; Ehl S, 1997, PEDIATRICS, V99, P216, DOI 10.1542/peds.99.2.216; Escobar GJ, 2014, PEDIATRICS, V133, P30, DOI 10.1542/peds.2013-1689; Escobar Gabriel J, 2005, Pediatr Crit Care Med, V6, pS138, DOI 10.1097/01.PCC.0000161586.06575.78; Fjalstad JW, 2016, PEDIATR INFECT DIS J, V35, P1, DOI 10.1097/INF.0000000000000906; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Hersh AL, 2009, INFECT CONT HOSP EP, V30, P1211, DOI 10.1086/648088; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; National Institute for Health and Clinical Excellence, 2012, ANT EARL ONS NEON IN; Patel SJ, 2010, INFECT CONT HOSP EP, V31, P1298, DOI 10.1086/657334; Philip AGS, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e4; Poignant S, 2016, ANTIMICROB AGENTS CH, V60, P1883, DOI 10.1128/AAC.02101-15; Randolph AG, 2016, LANCET, V387, P1697, DOI 10.1016/S0140-6736(16)00566-3; Ruppe E, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0061-0; Ruppe E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00129; Schulfer A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004903; Schulman J, 2015, PEDIATRICS, V135, P826, DOI 10.1542/peds.2014-3409; Soll RF, 2015, PEDIATRICS, V135, P928, DOI 10.1542/peds.2015-0707; Stocker M, 2010, NEONATOLOGY, V97, P165, DOI 10.1159/000241296; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; van Rossum AMC, 2004, LANCET INFECT DIS, V4, P620, DOI 10.1016/S1473-3099(04)01146-6; Vergnano S, 2011, ARCH DIS CHILD-FETAL, V96, pF9, DOI 10.1136/adc.2009.178798; Vouloumanou EK, 2011, INTENS CARE MED, V37, P747, DOI 10.1007/s00134-011-2174-8; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Weiss SL, 2014, CRIT CARE MED, V42, P2409, DOI 10.1097/CCM.0000000000000509; WHO, 2001, WHO GLOB STRAT CONT	40	132	142	5	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					871	881		10.1016/S0140-6736(17)31444-7	http://dx.doi.org/10.1016/S0140-6736(17)31444-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE6PF	28711318				2022-12-28	WOS:000408330700025
J	Mackenzie, KJ; Carroll, P; Martin, CA; Murina, O; Fluteau, A; Impson, DJS; Olova, N; Sutcliffe, H; Rainger, JK; Leitch, A; Osborn, RT; Wheeler, AP; Nowotny, M; Gilbert, N; Chandra, T; Reijns, MAM; Jackson, AP				Mackenzie, Karen J.; Carroll, Paula; Martin, Carol-Anne; Murina, Olga; Fluteau, Adeline; Impson, Daniel J. S.; Olova, Nelly; Sutcliffe, Hannah; Rainger, Jacqueline K.; Leitch, Andrea; Osborn, Ruby T.; Wheeler, Ann P.; Nowotny, Marcin; Gilbert, Nick; Chandra, Tamir; Reijns, Martin A. M.; Jackson, Andrew P.			cGAS surveillance of micronuclei links genome instability to innate immunity	NATURE			English	Article							GMP-AMP SYNTHASE; CYTOSOLIC DNA SENSOR; RNA-SEQ; SENSING PATHWAY; CELL-MIGRATION; 30 NM; NUCLEAR; CHROMATIN; ENVELOPE; CANCER	DNA is strictly compartmentalized within the nucleus to prevent autoimmunity(1); despite this, cyclic GMP-AMP synthase (cGAS), a cytosolic sensor of double-stranded DNA, is activated in autoinflammatory disorders and by DNA damage(2-6). Precisely how cellular DNA gains access to the cytoplasm remains to be determined. Here, we report that cGAS localizes to micronuclei arising from genome instability in a mouse model of monogenic autoinflammation, after exogenous DNA damage and spontaneously in human cancer cells. Such micronuclei occur after mis-segregation of DNA during cell division and consist of chromatin surrounded by its own nuclear membrane. Breakdown of the micronuclear envelope, a process associated with chromothripsis(7), leads to rapid accumulation of cGAS, providing a mechanism by which self-DNA becomes exposed to the cytosol. cGAS is activated by chromatin, and consistent with a mitotic origin, micronuclei formation and the proinflammatory response following DNA damage are cell-cycle dependent. By combining live-cell laser microdissection with single cell transcriptomics, we establish that interferon-stimulated gene expression is induced in micronucleated cells. We therefore conclude that micronuclei represent an important source of immunostimulatory DNA. As micronuclei formed from lagging chromosomes also activate this pathway, recognition of micronuclei by cGAS may act as a cell-intrinsic immune surveillance mechanism that detects a range of neoplasia-inducing processes.	[Mackenzie, Karen J.; Carroll, Paula; Martin, Carol-Anne; Murina, Olga; Fluteau, Adeline; Impson, Daniel J. S.; Olova, Nelly; Sutcliffe, Hannah; Rainger, Jacqueline K.; Leitch, Andrea; Osborn, Ruby T.; Wheeler, Ann P.; Gilbert, Nick; Chandra, Tamir; Reijns, Martin A. M.; Jackson, Andrew P.] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Nowotny, Marcin] Int Inst Mol & Cell Biol, Lab Prot Struct, Warsaw, Poland	University of Edinburgh; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Reijns, MAM; Jackson, AP (corresponding author), Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	martin.reijns@igmm.ed.ac.uk; Andrew.jackson@igmm.ed.ac.uk	Chandra, Tamir/Y-3577-2019; Olova, Nelly/J-7118-2019; Reijns, Martin/L-4355-2013; Jackson, Andrew P/D-3442-2009	Olova, Nelly/0000-0002-8093-4932; Reijns, Martin/0000-0002-5048-2752; Jackson, Andrew P/0000-0002-8739-2646; Mackenzie, Karen/0000-0002-5441-1476; Chandra, Tamir/0000-0002-7935-317X; Martin, Carol-Anne/0000-0001-5914-2757; Simpson, Daniel J/0000-0002-8431-7384; Nowotny, Marcin/0000-0001-8632-0977; Wheeler, Ann/0000-0001-8617-827X; Murina, Olga/0000-0003-1650-2892; Gilbert, Nick/0000-0003-0505-6081	Medical Research Council HGU core grant (MRC) [U127580972]; Newlife the Charity for Disabled Children; Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund 2; MRC [MC_PC_15075]; Howard Hughes Medical Institute; EMBO Long-Term Fellowship [ALTF 7-2015]; European Commission [GA-2013-609409]; Swiss National Science Foundation [P2ZHP3_158709]; MRC [MC_PC_U127580972, 1805075, MR/K01563X/1, MC_UU_12018/24] Funding Source: UKRI; Medical Research Council [MC_UU_12018/24, MC_PC_15075, MC_PC_U127580972, 1805075] Funding Source: researchfish	Medical Research Council HGU core grant (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newlife the Charity for Disabled Children; Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund 2; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Rehwinkel, N. Hastie, I. Adams, D. Papadopoulos, C. Ponting and W. Bickmore for discussions and comments on the manuscript; A. Wood, G. Taylor, D. Jamieson, H. Kato, P. Gao and B. Ramsahoye for technical advice and assistance; K. S. Mackenzie, P. Vagnarelli, H. Kato and T. Fujita for sharing reagents; R. Greenberg for discussion of unpublished data; the IGMM Transgenic, Sequencing, Imaging and Flow Cytometry facilities; and C. Nicol and A. Colley for graphics assistance. This work was funded by the Medical Research Council HGU core grant (MRC, U127580972) (A. P. J., N. G.), Newlife the Charity for Disabled Children (K.J.M.), the Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund 2 (K.J.M.), MRC Discovery Award (MC_PC_15075, T. C.), an International Early Career Scientist grant from the Howard Hughes Medical Institute (M. N.), an EMBO Long-Term Fellowship (ALTF 7-2015), the European Commission FP7 (Marie Curie Actions, LTFCOFUND2013, GA-2013-609409) and the Swiss National Science Foundation (P2ZHP3_158709) (O.M.).	Ablasser A, 2016, J MOL MED, V94, P1085, DOI 10.1007/s00109-016-1423-2; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6166; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Balmus G, 2015, NAT PROTOC, V10, P205, DOI 10.1038/nprot.2015.010; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kirschner K, 2017, CELL REP, V19, P1503, DOI 10.1016/j.celrep.2017.04.074; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mackenzie KJ, 2016, EMBO J, V35, P831, DOI 10.15252/embj.201593339; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Micutkova L, 2012, INT J CANCER, V130, P1544, DOI 10.1002/ijc.26149; Naughton C, 2010, MOL CELL, V40, P397, DOI 10.1016/j.molcel.2010.10.013; Ohkuri T, 2014, CANCER IMMUNOL RES, V2, P1199, DOI 10.1158/2326-6066.CIR-14-0099; Paludan SR, 2015, MICROBIOL MOL BIOL R, V79, P225, DOI 10.1128/MMBR.00061-14; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Rogge RA, 2013, JOVE-J VIS EXP, V79, P50354; Saleiro D, 2015, CELL REP, V11, P605, DOI 10.1016/j.celrep.2015.03.056; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Shen YJ, 2015, CELL REP, V11, P460, DOI 10.1016/j.celrep.2015.03.041; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003	55	727	753	12	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					461	+		10.1038/nature23449	http://dx.doi.org/10.1038/nature23449			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28738408	Green Submitted, Green Accepted			2022-12-28	WOS:000408279000040
J	Roe, JS; Hwang, CI; Somerville, TDD; Milazzo, JP; Lee, EJ; Da Silva, B; Maiorino, L; Tiriac, H; Young, CM; Miyabayashi, K; Filippini, D; Creighton, B; Burkhart, RA; Buscaglia, JM; Kim, EJ; Grem, JL; Lazenby, AJ; Grunkemeyer, JA; Hollingsworth, MA; Grandgenett, PM; Egeblad, M; Park, Y; Tuveson, DA; Vakoc, CR				Roe, Jae-Seok; Hwang, Chang-Il; Somerville, Tim D. D.; Milazzo, Joseph P.; Lee, Eun Jung; Da Silva, Brandon; Maiorino, Laura; Tiriac, Herve; Young, C. Megan; Miyabayashi, Koji; Filippini, Dea; Creighton, Brianna; Burkhart, Richard A.; Buscaglia, Jonathan M.; Kim, Edward J.; Grem, Jean L.; Lazenby, Audrey J.; Grunkemeyer, James A.; Hollingsworth, Michael A.; Grandgenett, Paul M.; Egeblad, Mikala; Park, Youngkyu; Tuveson, David A.; Vakoc, Christopher R.			Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis	CELL			English	Article							DUCTAL ADENOCARCINOMA; TRANSCRIPTION FACTORS; DISTANT METASTASIS; GENE-MUTATIONS; MOUSE MODELS; STEM-CELLS; RNA-SEQ; CHROMATIN; PROGRESSION; BINDING	Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal human malignancies, owing in part to its propensity for metastasis. Here, we used an organoid culture system to investigate how transcription and the enhancer landscape become altered during discrete stages of disease progression in a PDA mouse model. This approach revealed that the metastatic transition is accompanied by massive and recurrent alterations in enhancer activity. We implicate the pioneer factor FOXA1 as a driver of enhancer activation in this system, a mechanism that renders PDA cells more invasive and less anchorage-dependent for growth in vitro, as well as more metastatic in vivo. In this context, FOXA1-dependent enhancer reprogramming activates a transcriptional program of embryonic foregut endoderm. Collectively, our study implicates enhancer reprogramming, FOXA1 upregulation, and a retrograde developmental transition in PDA metastasis.	[Roe, Jae-Seok; Hwang, Chang-Il; Somerville, Tim D. D.; Milazzo, Joseph P.; Lee, Eun Jung; Da Silva, Brandon; Maiorino, Laura; Tiriac, Herve; Young, C. Megan; Miyabayashi, Koji; Filippini, Dea; Creighton, Brianna; Egeblad, Mikala; Park, Youngkyu; Tuveson, David A.; Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hwang, Chang-Il; Lee, Eun Jung; Da Silva, Brandon; Tiriac, Herve; Young, C. Megan; Miyabayashi, Koji; Filippini, Dea; Creighton, Brianna; Park, Youngkyu; Tuveson, David A.] Lustgarten Fdn, Pancreat Canc Res Lab, Cold Spring Harbor, NY 11724 USA; [Burkhart, Richard A.] Johns Hopkins Univ Hosp, Dept Surg, Div Hepatobiliary & Pancreat Surg, Baltimore, MD 21287 USA; [Buscaglia, Jonathan M.] SUNY Stony Brook, Sch Med, Div Gastroenterol & Hepatol, Stony Brook, NY 11790 USA; [Kim, Edward J.] UC Davis Med Ctr, Div Hematol Oncol, Sacramento, CA 95817 USA; [Grem, Jean L.] Univ Nebraska Med Ctr, Dept Med, Omaha, NE 68198 USA; [Lazenby, Audrey J.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Grunkemeyer, James A.; Hollingsworth, Michael A.; Grandgenett, Paul M.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	Cold Spring Harbor Laboratory; Johns Hopkins University; Johns Hopkins Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Davis; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tuveson, DA; Vakoc, CR (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.; Tuveson, DA (corresponding author), Lustgarten Fdn, Pancreat Canc Res Lab, Cold Spring Harbor, NY 11724 USA.	dtuveson@cshl.edu; vakoc@cshl.edu	Egeblad, Mikala/GNP-0620-2022; Kim, Edward/W-2366-2019; Maiorino, Laura/AAM-9495-2021	Egeblad, Mikala/0000-0002-3371-1445; Roe, Jae-Seok/0000-0002-9994-3062; Tiriac, Herve/0000-0001-5039-6750; Maiorino, Laura/0000-0001-8217-1337; Filippini, Dea/0000-0002-4792-613X	Cold Spring Harbor Cancer Center Support Grant (CCSG) [P30CA045508-29]; NCI [5P01CA013106, 1F32CA180717-01A1, P50CA127297]; Pancreatic Cancer Action Network-AACR [16-20-25-VAKO]; Lustgarten Foundation; Cold Spring Harbor Laboratory Association; National Institutes of Health (NIH) [5P30CA45508-29, 5P50CA101955-07, 1U10CA180944-04, 5U01CA168409-5, 1R01CA188134-01, 1R01CA190092-04]; V Foundation; Stand Up to Cancer/AACR [PS09]; Daiichi Sankyo Foundation of Life Science fellowship; Uehara Memorial Foundation research fellowship; Stony Brook pilot project grant; ASGE; SWOG ITSC [5U10CA180944-04]; NIH [R50CA211506-01, P20CA19299402, 5T32CA126607-08]; NATIONAL CANCER INSTITUTE [P50CA101955, R01CA190092, U10CA180944, R50CA211462, P30CA045508, P30CA093373, R50CA211506, P01CA013106, T32CA126607, U01CA168409, F32CA180717, P50CA127297, R01CA188134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020122] Funding Source: NIH RePORTER	Cold Spring Harbor Cancer Center Support Grant (CCSG); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pancreatic Cancer Action Network-AACR; Lustgarten Foundation; Cold Spring Harbor Laboratory Association; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation; Stand Up to Cancer/AACR; Daiichi Sankyo Foundation of Life Science fellowship; Uehara Memorial Foundation research fellowship; Stony Brook pilot project grant; ASGE; SWOG ITSC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank all members of the C.R.V. and D.A.T. laboratories for helpful discussions and suggestions throughout the course of this study. The authors would like to thank the Cold Spring Harbor Cancer Center Support Grant (CCSG, P30CA045508-29) shared resources: Bioinformatics Shared Resource, Microscope, DNA Sequencing, Animal & Tissue Imaging, and the Animal Facility. We are grateful to Junichi Takagi at Osaka University for sharing the Afamin/Wnt3A cell line. This project was also funded by NCI 5P01CA013106-Project 4 (C.R.V.), a Career Development Award from the Pancreatic Cancer Action Network-AACR 16-20-25-VAKO (C.R.V.), and the Lustgarten Foundation, where D.A.T. is a distinguished scholar and Director of the Lustgarten Foundation-designated Laboratory of Pancreatic Cancer Research. D.A.T. is also supported by the Cold Spring Harbor Laboratory Association, the National Institutes of Health (NIH; 5P30CA45508-29, 5P50CA101955-07, 1U10CA180944-04, 5U01CA168409-5, 1R01CA188134-01, and 1R01CA190092-04), and the V Foundation. In addition, we are grateful for support from the following: Stand Up to Cancer/AACR PS09 (D.A.T.), NCI (1F32CA180717-01A1 for C.-I.H. and P50CA127297 for P.M.G, M.A.H., J.L.G., A.J.L., and J.A.G), Daiichi Sankyo Foundation of Life Science fellowship and Uehara Memorial Foundation research fellowship (K.M.), Stony Brook pilot project grant (J.M.B.), ASGE (J.M.B.), SWOG ITSC 5U10CA180944-04 (E.J.K, D.A.T., H.T.), and NIH (R50CA211506-01 for Y.P., P20CA19299402 for J.M.B. and D.A.T., and 5T32CA126607-08 for R.A.B.).	ABRAHAM BJ, 2017, NAT COMMUN, V8; Arda HE, 2016, CELL METAB, V23, P909, DOI 10.1016/j.cmet.2016.04.002; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hessmann E, 2017, GUT, V66, P168, DOI 10.1136/gutjnl-2016-312539; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Kugel S, 2016, CELL, V165, P1401, DOI 10.1016/j.cell.2016.04.033; Larsen HL, 2017, SEMIN CELL DEV BIOL, V66, P51, DOI 10.1016/j.semcdb.2017.01.005; Levine AJ, 2012, ONCOTARGET, V3, P1503; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mihara E, 2016, ELIFE, V5, DOI 10.7554/eLife.11621; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Muzumdar MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12685; Neureiter D, 2014, WORLD J GASTROENTERO, V20, P7830, DOI 10.3748/wjg.v20.i24.7830; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sakai Y, 2000, HUM PATHOL, V31, P795, DOI 10.1053/hupa.2000.8442; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Soares Kevin C, 2014, J Vis Exp, P51677, DOI 10.3791/51677; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stelnicki EJ, 1998, J INVEST DERMATOL, V111, P57, DOI 10.1046/j.1523-1747.1998.00238.x; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Whittle MC, 2015, CELL, V161, P1345, DOI 10.1016/j.cell.2015.04.048; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamano M, 2000, AM J PATHOL, V156, P2123, DOI 10.1016/S0002-9440(10)65083-3; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zaret KS, 2016, MOL CELL, V62, P665, DOI 10.1016/j.molcel.2016.05.024; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491	61	218	224	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					875	+	888.e20	10.1016/j.cell.2017.07.007	http://dx.doi.org/10.1016/j.cell.2017.07.007			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28757253	Bronze, Green Accepted			2022-12-28	WOS:000408372400008
J	Myers, RW; Guan, HP; Ehrhart, J; Petrov, A; Prahalada, S; Tozzo, E; Yang, XD; Kurtz, MM; Trujillo, M; Trotter, DG; Feng, DQ; Xu, SY; Eiermann, G; Holahan, MA; Rubins, D; Conarello, S; Niu, XD; Souza, SC; Miller, C; Liu, JQ; Lu, K; Feng, W; Li, Y; Painter, RE; Milligan, JA; He, HB; Liu, F; Ogawa, A; Wisniewski, D; Rohm, RJ; Wang, LY; Bunzel, M; Qian, Y; Zhu, W; Wang, HW; Bennet, B; Scheuch, LL; Fernandez, GE; Li, C; Klimas, M; Zhou, GC; van Heek, M; Biftu, T; Weber, A; Kelley, DE; Thornberry, N; Erion, MD; Kemp, DM; Sebhat, IK				Myers, Robert W.; Guan, Hong-Ping; Ehrhart, Juliann; Petrov, Aleksandr; Prahalada, Srinivasa; Tozzo, Effie; Yang, Xiaodong; Kurtz, Marc M.; Trujillo, Maria; Trotter, Dinko Gonzalez; Feng, Danqing; Xu, Shiyao; Eiermann, George; Holahan, Marie A.; Rubins, Daniel; Conarello, Stacey; Niu, Xiaoda; Souza, Sandra C.; Miller, Corin; Liu, Jinqi; Lu, Ku; Feng, Wen; Li, Ying; Painter, Ronald E.; Milligan, James A.; He, Huaibing; Liu, Franklin; Ogawa, Aimie; Wisniewski, Douglas; Rohm, Rory J.; Wang, Liyang; Bunzel, Michelle; Qian, Ying; Zhu, Wei; Wang, Hongwu; Bennet, Bindu; Scheuch, Lisa LaFranco; Fernandez, Guillermo E.; Li, Cai; Klimas, Michael; Zhou, Gaochao; van Heek, Margaret; Biftu, Tesfaye; Weber, Ann; Kelley, David E.; Thornberry, Nancy; Erion, Mark D.; Kemp, Daniel M.; Sebhat, Iyassu K.			Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy	SCIENCE			English	Article							PROTEIN-KINASE; ENERGY HOMEOSTASIS; METABOLIC SYNDROME; GLYCOGEN-STORAGE; MECHANISMS; EXERCISE; DISEASE; HEALTH; HEART; MICE	5'-Adenosine monophosphate-activated protein kinase (AMPK) is a master regulator of energy homeostasis in eukaryotes. Despite three decades of investigation, the biological roles of AMPK and its potential as a drug target remain incompletely understood, largely because of a lack of optimized pharmacological tools. We developed MK-8722, a potent, direct, allosteric activator of all 12 mammalian AMPK complexes. In rodents and rhesus monkeys, MK-8722-mediated AMPK activation in skeletal muscle induced robust, durable, insulin-independent glucose uptake and glycogen synthesis, with resultant improvements in glycemia and no evidence of hypoglycemia. These effects translated across species, including diabetic rhesus monkeys, but manifested with concomitant cardiac hypertrophy and increased cardiac glycogen without apparent functional sequelae.	[Myers, Robert W.; Trujillo, Maria; Conarello, Stacey; Niu, Xiaoda; Feng, Wen; Painter, Ronald E.; Milligan, James A.; Ogawa, Aimie; Wisniewski, Douglas; Wang, Liyang; Li, Cai; Zhou, Gaochao] Merck Res Labs, In Vitro Pharmacol, Kenilworth, NJ 07033 USA; [Guan, Hong-Ping; Petrov, Aleksandr; Tozzo, Effie; Yang, Xiaodong; Souza, Sandra C.; Liu, Jinqi; Lu, Ku; Li, Ying; Liu, Franklin; Rohm, Rory J.; Qian, Ying; Zhu, Wei; Kelley, David E.; Thornberry, Nancy; Erion, Mark D.; Kemp, Daniel M.] Merck Res Labs, Biol Discovery, Kenilworth, NJ 07033 USA; [Ehrhart, Juliann; Prahalada, Srinivasa; Bennet, Bindu; Scheuch, Lisa LaFranco; Fernandez, Guillermo E.] Merck Res Labs, Safety Assessment & Lab Anim Resources, West Point, PA 19486 USA; [Trotter, Dinko Gonzalez; Holahan, Marie A.; Rubins, Daniel; Miller, Corin; Klimas, Michael] Merck Res Labs, Translat Imaging & Biomarkers Dept, West Point, PA 19486 USA; [Feng, Danqing; Wang, Hongwu; Biftu, Tesfaye; Weber, Ann; Sebhat, Iyassu K.] Merck Res Labs, Med Chem, Kenilworth, NJ 07033 USA; [Xu, Shiyao] Merck Res Labs, PPDM Preclin ADME Dept, Kenilworth, NJ 07033 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Myers, RW (corresponding author), Merck Res Labs, In Vitro Pharmacol, Kenilworth, NJ 07033 USA.; Sebhat, IK (corresponding author), Merck Res Labs, Med Chem, Kenilworth, NJ 07033 USA.	robertwmyersphd@gmail.com; sandra_souza@merck.com; iyassu@kallyope.com	Wisniewski, Douglas/AAT-9198-2021	Guan, Hong-Ping/0000-0002-2282-3193; Trujillo, Maria/0000-0002-9358-5532	Merck & Co. Inc., Merck Research Laboratory	Merck & Co. Inc., Merck Research Laboratory	We thank K. Bekkari, T. Cutarelli, P. M. Dey, K. P. Ellsworth, J. N. Gorski, M. Hu, D. Kosinski, D. Leung, D. Lewis, E. Messina, L. E. Michna, L. Mixson, R. Ortiga, M. Pachanski, M. Pandya, E. M. Parker, S. Previs, D. A. Stoffregen, J. R. Strauss, A. Woods, and X. Yuan for their technical and/or intellectual support during the execution of these studies. This work was fully funded by Merck & Co. Inc., Merck Research Laboratory. Competing interests: All authors are, or were, employees of Merck & Co. Inc. and may own shares of Merck & Co. stock. MK-8722 is available from Merck under a material transfer agreement. Merck has filed patent applications for MK-8722, MK-3903, and related AMPK activators (patent application numbers WO2012116145 and WO2010036613).	Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Bailey CJ, 2016, LANCET DIABETES ENDO, V4, P350, DOI 10.1016/S2213-8587(15)00462-3; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Halseth AE, 2002, BIOCHEM BIOPH RES CO, V294, P798, DOI 10.1016/S0006-291X(02)00557-0; Hardie DG, 2014, J INTERN MED, V276, P543, DOI 10.1111/joim.12268; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harwood H James Jr, 2012, J Diabetes Sci Technol, V6, P503; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Kim M, 2014, CIRC RES, V114, P966, DOI 10.1161/CIRCRESAHA.114.302364; Lai YC, 2014, BIOCHEM J, V460, P363, DOI 10.1042/BJ20131673; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; O'Neill HM, 2013, DIABETES METAB J, V37, P1, DOI 10.4093/dmj.2013.37.1.1; Parrinello CM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0548-3; Rana S, 2015, J MED CHEM, V58, P2, DOI 10.1021/jm401994c; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sterrett JJ, 2016, AM J MED SCI, V351, P342, DOI 10.1016/j.amjms.2016.01.019; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wolf CM, 2008, CIRCULATION, V117, P144, DOI 10.1161/CIRCULATIONAHA.107.726752; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017	30	167	173	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					507	511		10.1126/science.aah5582	http://dx.doi.org/10.1126/science.aah5582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28705990				2022-12-28	WOS:000406840100039
J	Lapergue, B; Blanc, R; Gory, B; Labreuche, J; Duhamel, A; Marnat, G; Saleme, S; Costalat, V; Bracard, S; Desal, H; Mazighi, M; Consoli, A; Piotin, M				Lapergue, Bertrand; Blanc, Raphael; Gory, Benjamin; Labreuche, Julien; Duhamel, Alain; Marnat, Gautier; Saleme, Suzana; Costalat, Vincent; Bracard, Serge; Desal, Hubert; Mazighi, Mikael; Consoli, Arturo; Piotin, Michel		ASTER Trial Investigators	Effect of Endovascular Contact Aspiration vs Stent Retriever on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion The ASTER Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							1ST PASS TECHNIQUE; TICI 3; THROMBECTOMY; SUCCESS; ADAPT; MANAGEMENT; UPDATE; COST	IMPORTANCE The benefits of endovascular revascularization using the contact aspiration technique vs the stent retriever technique in patients with acute ischemic stroke remain uncertain because of lack of evidence from randomized trials. OBJECTIVE To compare efficacy and adverse events using the contact aspiration technique vs the standard stent retriever technique as a first-line endovascular treatment for successful revascularization among patients with acute ischemic stroke and large vessel occlusion. DESIGN, SETTING, AND PARTICIPANTS The Contact Aspiration vs Stent Retriever for Successful Revascularization (ASTER) study was a randomized, open-label, blinded end-point clinical trial conducted in 8 comprehensive stroke centers in France (October 2015-October 2016). Patients who presented with acute ischemic stroke and a large vessel occlusion in the anterior circulation within 6 hours of symptom onset were included. INTERVENTIONS Patients were randomly assigned to first-line contact aspiration (n = 192) or first-line stent retriever (n = 189) immediately prior to mechanical thrombectomy. MAIN OUTCOMES AND MEASURES The primary outcome was the proportion of patients with successful revascularization defined as a modified Thrombolysis in Cerebral Infarction score of 2b or 3 at the end of all endovascular procedures. Secondary outcomes included degree of disability assessed by overall distribution of the modified Rankin Scale (mRS) score at 90 days, change in National Institutes of Health Stroke Scale (NIHSS) score at 24 hours, all-cause mortality at 90 days, and procedure-related serious adverse events. RESULTS Among 381 patients randomized (mean age, 69.9 years; 174 women [45.7%]), 363 (95.3%) completed the trial. Median time from symptom onset to arterial puncture was 227 minutes (interquartile range, 180-280 minutes). For the primary outcome, the proportion of patients with successful revascularization was 85.4%(n = 164) in the contact aspiration group vs 83.1%(n = 157) in the stent retriever group (odds ratio, 1.20 [95% CI, 0.68-2.10]; P = .53; difference, 2.4%[95% CI, -5.4% to 9.7%]). For the clinical efficacy outcomes (change in NIHSS score at 24 hours, mRS score at 90 days) and adverse events, there were no significant differences between groups. CONCLUSIONS AND RELEVANCE Among patients with ischemic stroke in the anterior circulation undergoing thrombectomy, first-line thrombectomy with contact aspiration compared with stent retriever did not result in an increased successful revascularization rate at the end of the procedure.	[Lapergue, Bertrand; Consoli, Arturo] Univ Versailles & St Quentin Yvelines, Foch Hosp, Dept Stroke Ctr, Suresnes, France; [Lapergue, Bertrand; Consoli, Arturo] Univ Versailles & St Quentin Yvelines, Foch Hosp, Diagnost & Intervent Neuroradiol, Suresnes, France; [Blanc, Raphael; Mazighi, Mikael; Piotin, Michel] Rothschild Fdn, Dept Diagnost & Intervent Neuroradiol, Paris, France; [Gory, Benjamin] Hosp Civils Lyon, Dept Diagnost & Intervent Neuroradiol, Bron, France; [Labreuche, Julien; Duhamel, Alain] Univ Lille, CHU Lille, Dept Biostat, EA Sante Publ Epidemiol & Qual Soins 2694, Lille, France; [Marnat, Gautier] Univ Hosp Bordeaux, Dept Diagnost & Intervent Neuroradiol, Bordeaux, France; [Saleme, Suzana] Univ Hosp Limoges, Dept Diagnost & Intervent Neuroradiol, Limoges, France; [Costalat, Vincent] Hop Gui de Chauliac, Dept Diagnost & Intervent Neuroradiol, Montpellier, France; [Bracard, Serge] Univ Hosp Nancy, Dept Diagnost & Intervent Neuroradiol, Nancy, France; [Desal, Hubert] Guillaume & Rene Laennec Univ Hosp, Dept Diagnost & Intervent Neuroradiol, Nantes, France	Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU Bordeaux; CHU Limoges; Universite de Montpellier; CHU de Montpellier; CHU de Nancy; Universite de Lorraine; Nantes Universite; CHU de Nantes	Lapergue, B (corresponding author), Univ Versailles St Quentin Yvelines, Foch Hosp, Stroke Ctr, Div Neurol, Suresnes, France.	b.lapergue@hopital-foch.org	Gory, Benjamin/ABH-1210-2021; EKER, Omer F/H-1930-2019; Desal, Hubert/T-2089-2019; Desal, Hubert/D-3705-2015	EKER, Omer F/0000-0002-5696-5368; Desal, Hubert/0000-0002-4665-1461; MARNAT, Gaultier/0000-0002-7611-7753	Fondation Ophtalmologique Adolphe de Rothschild; Penumbra, Alameda, California	Fondation Ophtalmologique Adolphe de Rothschild; Penumbra, Alameda, California	This research was sponsored by Fondation Ophtalmologique Adolphe de Rothschild. An unrestricted research grant was provided by Penumbra, Alameda, California.	Almandoz JED, 2016, J NEUROINTERV SURG, V8, P1123, DOI 10.1136/neurintsurg-2015-012122; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Blanc R, 2017, STROKE, V48, P1588, DOI 10.1161/STROKEAHA.116.016149; Chevreul K, 2013, EUR J NEUROL, V20, P1094, DOI 10.1111/ene.12143; Dargazanli C, 2017, AM J NEURORADIOL, V38, P90, DOI 10.3174/ajnr.A4968; European Stroke Organisation; European Society for Minimally Invasive Neurological Therapy; European Society of Neuroradiology, 2014, CONS STAT MECH THROM; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Kabbasch C, 2016, INTERV NEURORADIOL, V22, P333, DOI 10.1177/1591019916632370; Kleine JF, 2017, J NEUROINTERV SURG, V9, P117, DOI 10.1136/neurintsurg-2015-012218; Kowoll A, 2016, J NEUROINTERV SURG, V8, P230, DOI 10.1136/neurintsurg-2014-011520; Lapergue B, 2016, AM J NEURORADIOL, V37, P1860, DOI 10.3174/ajnr.A4840; Lapergue B, 2018, INT J STROKE, V13, P87, DOI 10.1177/1747493017711948; Mokin M, 2015, AM J NEURORADIOL, V36, P547, DOI 10.3174/ajnr.A4149; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Rouchaud A, 2014, J NEUROINTERV SURG, V6, P139, DOI 10.1136/neurintsurg-2012-010644; Saver JL, 2014, INT J STROKE, V9, P658, DOI 10.1111/j.1747-4949.2012.00856.x; Savitz SI, 2007, STROKE, V38, P3205, DOI 10.1161/STROKEAHA.107.489351; Stapleton CJ, 2016, NEUROSURGERY S1, V63, P146, DOI [10.1227/01.neu.0000489681.90969.21, DOI 10.1227/01.neu.0000489681.90969.21]; Suh SH, 2013, STROKE, V44, P1166, DOI 10.1161/STROKEAHA.111.000399; Tomsick T, 2008, AM J NEURORADIOL, V29, P582, DOI 10.3174/ajnr.A0843; Turk AS, 2015, J NEUROINTERV SURG, V7, P666, DOI 10.1136/neurintsurg-2014-011282; Turk AS, 2014, J NEUROINTERV SURG, V6, P260, DOI 10.1136/neurintsurg-2014-011125; Turk AS, 2014, J NEUROINTERV SURG, V6, P231, DOI 10.1136/neurintsurg-2013-010713; Wahlgren N, 2016, INT J STROKE, V11, P134, DOI 10.1177/1747493015609778	26	410	432	4	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					443	452		10.1001/jama.2017.9644	http://dx.doi.org/10.1001/jama.2017.9644			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763550	Green Published			2022-12-28	WOS:000406659800015
J	Yang, Y; Lin, CX				Yang, Yang; Lin, Chenxiang			Directing reconfigurable DNA nanoarrays	SCIENCE			English	Editorial Material									[Lin, Chenxiang] Yale Univ, Dept Cell Biol, West Haven, CT 06516 USA; Yale Univ, Nanobiol Inst, West Haven, CT 06516 USA	Yale University; Yale University	Lin, CX (corresponding author), Yale Univ, Dept Cell Biol, West Haven, CT 06516 USA.	chenxiang.lin@yale.edu	Yang, Yang/S-4225-2017	Yang, Yang/0000-0002-2630-6062; Lin, Chenxiang/0000-0001-7041-1946	NIGMS NIH HHS [DP2 GM114830] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM114830] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; DU SM, 1992, BIOCHEMISTRY-US, V31, P10955, DOI 10.1021/bi00160a003; Hong F, 2017, CHEM REV, V117, P12584, DOI 10.1021/acs.chemrev.6b00825; Howorka S, 2017, NAT NANOTECHNOL, V12, P619, DOI [10.1038/NNANO.2017.99, 10.1038/nnano.2017.99]; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Marras AE, 2015, P NATL ACAD SCI USA, V112, P713, DOI 10.1073/pnas.1408869112; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Song J, 2017, SCIENCE, V357, DOI 10.1126/science.aan3377; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Zhang Z, 2017, NAT CHEM, V9, P653, DOI [10.1038/NCHEM.2802, 10.1038/nchem.2802]	12	4	4	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					352	353		10.1126/science.aao0599	http://dx.doi.org/10.1126/science.aao0599			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751594				2022-12-28	WOS:000406362300022
J	Canela, A; Maman, Y; Jung, S; Wong, N; Callen, E; Day, A; Kieffer-Kwon, KR; Pekowska, A; Zhang, HL; Rao, SSP; Huang, SC; Mckinnon, PJ; Aplan, PD; Pommier, Y; Aiden, EL; Casellas, R; Nussenzweig, A				Canela, Andres; Maman, Yaakov; Jung, Seolkyoung; Wong, Nancy; Callen, Elsa; Day, Amanda; Kieffer-Kwon, Kyong-Rim; Pekowska, Aleksandra; Zhang, Hongliang; Rao, Suhas S. P.; Huang, Su-Chen; Mckinnon, Peter J.; Aplan, Peter D.; Pommier, Yves; Aiden, Erez Lieberman; Casellas, Rafael; Nussenzweig, Andre			Genome Organization Drives Chromosome Fragility	CELL			English	Article							TOPOISOMERASE-II-BETA; DOUBLE-STRAND BREAKS; DNA BREAKS; CTCF BINDING; MOUSE GENOME; TRANSCRIPTION; TRANSLOCATIONS; WIDE; REVEALS; DOMAINS	In this study, we show that evolutionarily conserved chromosome loop anchors bound by CCCTC-binding factor (CTCF) and cohesin are vulnerable to DNA double strand breaks (DSBs) mediated by topoisomerase 2B (TOP2B). Polymorphisms in the genome that redistribute CTCF/cohesin occupancy rewire DNA cleavage sites to novel loop anchors. While transcription-and replication-coupled genomic rearrangements have been well documented, we demonstrate that DSBs formed at loop anchors are largely transcription-, replication-, and cell-type-independent. DSBs are continuously formed throughout interphase, are enriched on both sides of strong topological domain borders, and frequently occur at breakpoint clusters commonly translocated in cancer. Thus, loop anchors serve as fragile sites that generate DSBs and chromosomal rearrangements.	[Canela, Andres; Maman, Yaakov; Wong, Nancy; Callen, Elsa; Day, Amanda; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Jung, Seolkyoung; Kieffer-Kwon, Kyong-Rim; Pekowska, Aleksandra; Casellas, Rafael] NIAMSD, Genom & Immun, NIH, Bethesda, MD 20892 USA; [Zhang, Hongliang; Pommier, Yves] NIH, Dev Therapeut Branch, Bldg 10, Bethesda, MD 20892 USA; [Zhang, Hongliang; Pommier, Yves] NIH, Lab Mol Pharmacol, Bldg 10, Bethesda, MD 20892 USA; [Rao, Suhas S. P.; Huang, Su-Chen; Aiden, Erez Lieberman] Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA; [Rao, Suhas S. P.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Mckinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA; [Aplan, Peter D.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Baylor College of Medicine; Stanford University; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Aiden, Erez Lieberman/A-2908-2010; Pekowska, Aleksandra/AAC-5143-2020	Pekowska, Aleksandra/0000-0002-0425-4388	Intramural Research Program of the NIH; NIH [NS-37956, CA-21765]; CCSG [P30 CA21765]; St. Jude Children's Research Hospital; NIH Encyclopedia of DNA Elements Mapping Center Award [UM1HG009375]; President's Early Career Award in Science and Engineering; Ellison Medical Foundation Senior Scholar in Aging Award [AG-SS-2633-11]; Department of Defense Idea Expansion Award [W81XWH-15-2-006]; Department of Defense Breakthrough Award [W81XWH-16-1-0599]; Alex Lemonade Stand Foundation Award; NATIONAL CANCER INSTITUTE [P30CA021765, ZIASC010379, ZIABC010959, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG009375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCSG; St. Jude Children's Research Hospital; NIH Encyclopedia of DNA Elements Mapping Center Award; President's Early Career Award in Science and Engineering; Ellison Medical Foundation Senior Scholar in Aging Award(Lawrence Ellison Foundation); Department of Defense Idea Expansion Award; Department of Defense Breakthrough Award; Alex Lemonade Stand Foundation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Barry Sleckman, Shunichi Takeda, and Noritaka Adachi for cell lines and Xuguang Tai for assistance on T cells, Sam John, John Crispino, John Nitiss, and James Berger for stimulating discussions, and sequencing support from David Goldstein and the CCR Genomics Core. The A.N., P.D.A, Y.P., and R.C. laboratories are supported by the Intramural Research Program of the NIH. P.J.M. is supported by the NIH (NS-37956 and CA-21765), the CCSG (P30 CA21765), and St. Jude Children's Research Hospital. E.L.A. is supported by an NIH Encyclopedia of DNA Elements Mapping Center Award (UM1HG009375) and the President's Early Career Award in Science and Engineering. A.N. is supported by an Ellison Medical Foundation Senior Scholar in Aging Award (AG-SS-2633-11), the Department of Defense Idea Expansion (W81XWH-15-2-006) and Breakthrough (W81XWH-16-1-0599) Awards, and an Alex Lemonade Stand Foundation Award.	Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; Baranello L, 2014, INT J MOL SCI, V15, P13111, DOI 10.3390/ijms150713111; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Calderwood SK, 2016, TRANSCR-AUSTIN, V7, P75, DOI 10.1080/21541264.2016.1181142; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Canela A, 2016, MOL CELL, V63, P898, DOI 10.1016/j.molcel.2016.06.034; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Fisher JB, 2017, TRENDS CANCER, V3, P282, DOI 10.1016/j.trecan.2017.02.006; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Goloborodko A, 2016, ELIFE, V5, DOI 10.7554/eLife.14864; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacPherson MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-101; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Manville CM, 2015, BIOL OPEN, V4, P1436, DOI 10.1242/bio.014308; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKinnon PJ, 2016, NAT REV NEUROSCI, V17, P673, DOI 10.1038/nrn.2016.101; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Nichols MH, 2015, CELL, V162, P702, DOI 10.1016/j.cell.2015.07.053; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team R, 2008, R A LANGUAGE ENV STA; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; Uuskula-Reimand L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1043-8; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wright RL, 2014, CRIT REV ONCOL HEMAT, V91, P283, DOI 10.1016/j.critrevonc.2014.03.004; Yang F, 2015, MUTAT RES-FUND MOL M, V773, P9, DOI 10.1016/j.mrfmmm.2015.01.007; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	67	201	203	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					507	+		10.1016/j.cell.2017.06.034	http://dx.doi.org/10.1016/j.cell.2017.06.034			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28735753	Green Accepted, Bronze			2022-12-28	WOS:000406462400010
J	Stain, SC; Farquhar, M				Stain, Steven C.; Farquhar, Michael			Should doctors work 24 hour shifts?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stain, Steven C.] Albany Med Coll, Albany, NY 84449 USA	Albany Medical College	Stain, SC (corresponding author), Albany Med Coll, Albany, NY 84449 USA.	stains@mail.amc.edu; Michael.Farquhar@gstt.nhs.uk						Accreditation Council of Graduate Medical Education, 2017, ACGME COMM PROGR REQ; Akerstedt T, 2003, OCCUP MED-OXFORD, V53, P89, DOI 10.1093/occmed/kqg046; Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Bilimoria KY, 2016, NEW ENGL J MED, V374, P713, DOI 10.1056/NEJMoa1515724; Farquhar M, 2017, ARCH DIS CHILDHOOD-E, V102, P127, DOI 10.1136/archdischild-2016-312119; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Johnson S., 2016, GUARDIAN; Kecklund G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5210; Kennedy TJT, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b128; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; McClelland L, 2017, ANAESTHESIA, V72, P1069, DOI 10.1111/anae.13965; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Ong M, 2007, ARCH INTERN MED, V167, P47, DOI 10.1001/archinte.167.1.47; Philibert I, 2013, ANNU REV MED, V64, P467, DOI 10.1146/annurev-med-120711-135717; Ripp JA, 2015, ACAD MED, V90, P494, DOI 10.1097/ACM.0000000000000641; Stewart S., 2011, DAILY RECORD    1016; Thanarajasingam U, 2012, MAYO CLIN PROC, V87, P320, DOI 10.1016/j.mayocp.2011.12.012; Williamson AM, 2000, OCCUP ENVIRON MED, V57, P649, DOI 10.1136/oem.57.10.649	19	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j3522	10.1136/bmj.j3522	http://dx.doi.org/10.1136/bmj.j3522			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UW	28747488				2022-12-28	WOS:000406765900007
J	McCarthy, M				McCarthy, Michael			Large case series documents chronic brain damage in players of American football	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Rabinovici GD, 2017, JAMA-J AM MED ASSOC, V318, P338, DOI 10.1001/jama.2017.9353	2	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2017	358								j3602	10.1136/bmj.j3602	http://dx.doi.org/10.1136/bmj.j3602			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UT	28743696				2022-12-28	WOS:000406765600009
J	Choi, S; Kwon, TW; Coskun, A; Choi, JW				Choi, Sunghun; Kwon, Tae-Woo; Coskun, Ali; Choi, Jang Wook			Highly elastic binders integrating polyrotaxanes for silicon microparticle anodes in lithium ion batteries	SCIENCE			English	Article							NEGATIVE ELECTRODES; PERFORMANCE; GRAPHITE; DESIGN	Lithium-ion batteries with ever-increasing energy densities are needed for batteries for advanced devices and all-electric vehicles. Silicon has been highlighted as a promising anode material because of its superior specific capacity. During repeated charge-discharge cycles, silicon undergoes huge volume changes. This limits cycle life via particle pulverization and an unstable electrode-electrolyte interface, especially when the particle sizes are in the micrometer range. We show that the incorporation of 5 weight% polyrotaxane to conventional polyacrylic acid binder imparts extraordinary elasticity to the polymer network originating from the ring sliding motion of polyrotaxane. This binder combination keeps even pulverized silicon particles coalesced without disintegration, enabling stable cycle life for silicon microparticle anodes at commercial-level areal capacities.	[Coskun, Ali; Choi, Jang Wook] Korea Adv Inst Sci & Technol, Grad Sch Energy Environm Water & Sustainabil EEWS, Daejeon 34141, South Korea; Korea Adv Inst Sci & Technol, KAIST Inst KI NanoCentury, Daejeon 34141, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Coskun, A; Choi, JW (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Energy Environm Water & Sustainabil EEWS, Daejeon 34141, South Korea.	coskun@kaist.ac.kr; jangwookchoi@kaist.ac.kr	Choi, Jang Wook/C-1821-2011; Kwon, Tae-woo/M-2195-2017; Coskun, Ali/C-1045-2008; choi, Sunghun/G-7100-2017	Choi, Jang Wook/0000-0001-8783-0901; Kwon, Tae-woo/0000-0002-7420-5661; Coskun, Ali/0000-0002-4760-1546; choi, Sunghun/0000-0001-5139-0860	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2015R1A2A1A05001737]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	We acknowledge the support from the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF-2015R1A2A1A05001737). S.C., T.-w.K., A.C., and J.W.C. are inventors on a Korean patent application (no. 10-2016-0181036) submitted by the Korea Advanced Institute of Science and Technology that covers binder designs.	Bin Imran A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6124; Choi JW, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.13; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Goldstein J., 1981, SCANNING ELECT MICRO; Gordon J.E., 1978, STRUCTURES; Han ZJ, 2013, ECS ELECTROCHEM LETT, V2, pA17, DOI 10.1149/2.005302eel; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Ito K, 2012, POLYM J, V44, P38, DOI 10.1038/pj.2011.85; Jeong YK, 2015, ENERG ENVIRON SCI, V8, P1224, DOI 10.1039/c5ee00239g; Kasavajjula U, 2007, J POWER SOURCES, V163, P1003, DOI 10.1016/j.jpowsour.2006.09.084; Koo B, 2012, ANGEW CHEM INT EDIT, V51, P8762, DOI 10.1002/anie.201201568; Kovalenko I, 2011, SCIENCE, V334, P75, DOI 10.1126/science.1209150; Kwon TW, 2015, ACS NANO, V9, P11317, DOI 10.1021/acsnano.5b05030; Kwon TW, 2014, ADV MATER, V26, P7979, DOI 10.1002/adma.201402950; Li J, 2007, ELECTROCHEM SOLID ST, V10, pA17, DOI 10.1149/1.2398725; Li YZ, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.29; Liu XH, 2012, ACS NANO, V6, P1522, DOI 10.1021/nn204476h; Murase M, 2012, CHEMSUSCHEM, V5, P2307, DOI 10.1002/cssc.201200650; Obrovac MN, 2007, J ELECTROCHEM SOC, V154, pA849, DOI 10.1149/1.2752985; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Raymo FM, 1999, CHEM REV, V99, P1643, DOI 10.1021/cr970081q; Salem N, 2016, ENERGY TECHNOL-GER, V4, P331, DOI 10.1002/ente.201500250; Wang C, 2013, NAT CHEM, V5, P1042, DOI [10.1038/nchem.1802, 10.1038/NCHEM.1802]; Wang GP, 2005, SOLID STATE IONICS, V176, P905, DOI 10.1016/j.ssi.2004.11.009; Yoshio M, 2000, J ELECTROCHEM SOC, V147, P1245, DOI 10.1149/1.1393344; Zhao H, 2015, NANO LETT, V15, P7927, DOI 10.1021/acs.nanolett.5b03003	28	718	757	112	1028	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					279	283		10.1126/science.aal4373	http://dx.doi.org/10.1126/science.aal4373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729506				2022-12-28	WOS:000405901600035
J	Pennisi, E				Pennisi, Elizabeth			AGRICULTURE Unlocking a key to maize's amazing success	SCIENCE			English	News Item																			0	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					240	240		10.1126/science.357.6348.240	http://dx.doi.org/10.1126/science.357.6348.240			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729492				2022-12-28	WOS:000405901600016
J	Pribiag, VS				Pribiag, Vlad S.			A twist on the Majorana fermion	SCIENCE			English	Editorial Material									[Pribiag, Vlad S.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Pribiag, VS (corresponding author), Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA.	vpribiag@umn.edu						Amet F, 2016, SCIENCE, V352, P966, DOI 10.1126/science.aad6203; Beenakker C, 2016, NAT PHYS, V12, P618, DOI 10.1038/nphys3778; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; He QL, 2017, SCIENCE, V357, P294, DOI 10.1126/science.aag2792; Lee GH, 2017, NAT PHYS, V13, P693, DOI [10.1038/NPHYS4084, 10.1038/nphys4084]; Majorana E., 1937, NUOVO CIMENTO, V5, P171, DOI [10.1007/BF02961314, DOI 10.1007/BF02961314]; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Qi XL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184516; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494	10	1	2	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					252	253		10.1126/science.aao0793	http://dx.doi.org/10.1126/science.aao0793			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729499				2022-12-28	WOS:000405901600023
J	Gooth, J; Niemann, AC; Meng, T; Grushin, AG; Landsteiner, K; Gotsmann, B; Menges, F; Schmidt, M; Shekhar, C; Suss, V; Hune, R; Rellinghaus, B; Felser, C; Yan, BH; Nielsch, K				Gooth, Johannes; Niemann, Anna C.; Meng, Tobias; Grushin, Adolfo G.; Landsteiner, Karl; Gotsmann, Bernd; Menges, Fabian; Schmidt, Marcus; Shekhar, Chandra; Suess, Vicky; Huehne, Ruben; Rellinghaus, Bernd; Felser, Claudia; Yan, Binghai; Nielsch, Kornelius			Experimental signatures of the mixed axial-gravitational anomaly in the Weyl semimetal NbP	NATURE			English	Article							NEGATIVE MAGNETORESISTANCE; FERMION SEMIMETAL; THERMOPOWER; DISCOVERY; ARCS	The conservation laws, such as those of charge, energy and momentum, have a central role in physics. In some special cases, classical conservation laws are broken at the quantum level by quantum fluctuations, in which case the theory is said to have quantum anomalies(1). One of the most prominent examples is the chiral anomaly(2,3), which involves massless chiral fermions. These particles have their spin, or internal angular momentum, aligned either parallel or antiparallel with their linear momentum, labelled as left and right chirality, respectively. In three spatial dimensions, the chiral anomaly is the breakdown (as a result of externally applied parallel electric and magnetic fields(4)) of the classical conservation law that dictates that the number of massless fermions of each chirality are separately conserved. The current that measures the difference between left- and right-handed particles is called the axial current and is not conserved at the quantum level. In addition, an underlying curved space-time provides a distinct contribution to a chiral imbalance, an effect known as the mixed axial-gravitational anomaly(1), but this anomaly has yet to be confirmed experimentally. However, the presence of a mixed gauge-gravitational anomaly has recently been tied to thermoelectrical transport in a magnetic field(5,6), even in flat space-time, suggesting that such types of mixed anomaly could be experimentally probed in condensed matter systems known as Weyl semimetals(7). Here, using a temperature gradient, we observe experimentally a positive magneto-thermoelectric conductance in the Weyl semimetal niobium phosphide (NbP) for collinear temperature gradients and magnetic fields that vanishes in the ultra-quantum limit, when only a single Landau level is occupied. This observation is consistent with the presence of a mixed axial-gravitational anomaly, providing clear evidence for a theoretical concept that has so far eluded experimental detection.	[Gooth, Johannes; Niemann, Anna C.; Nielsch, Kornelius] Univ Hamburg, Inst Nanostruct & Solid State Phys, Jungiusstr 11, D-20355 Hamburg, Germany; [Gooth, Johannes; Gotsmann, Bernd; Menges, Fabian] IBM Res Zurich, Saumerstr 4, CH-8803 Ruschlikon, Switzerland; [Niemann, Anna C.; Huehne, Ruben; Rellinghaus, Bernd; Nielsch, Kornelius] Leibniz Inst Solid State & Mat Res Dresden, Inst Metall Mat, Helmholtzstr 20, D-01069 Dresden, Germany; [Meng, Tobias] Tech Univ Dresden, Inst Theoret Phys, Zellescher Weg 17, D-01062 Dresden, Germany; [Grushin, Adolfo G.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Landsteiner, Karl] Univ Autonoma Madrid, CSIC, Inst Fis Teor, Nicolas Cabrera 13-15, Madrid 28049, Spain; [Schmidt, Marcus; Shekhar, Chandra; Suess, Vicky; Felser, Claudia; Yan, Binghai] Max Planck Inst Chem Phys Solids, Nothnitzer Str 40, D-01187 Dresden, Germany; [Yan, Binghai] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-7610001 Rehovot, Israel	University of Hamburg; International Business Machines (IBM); Leibniz Institute for Solid State & Materials Research Dresden; Technische Universitat Dresden; University of California System; University of California Berkeley; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); Max Planck Society; Weizmann Institute of Science	Gooth, J (corresponding author), Univ Hamburg, Inst Nanostruct & Solid State Phys, Jungiusstr 11, D-20355 Hamburg, Germany.; Gooth, J (corresponding author), IBM Res Zurich, Saumerstr 4, CH-8803 Ruschlikon, Switzerland.	Johannes.gooth@outlook.com	Hühne, Ruben/E-5017-2011; Shekhar, Chandra/X-7472-2019; Rellinghaus, Bernd/ABG-3396-2021; Shekhar, Chandra/O-8949-2017; Gotsmann, Bernd/K-3923-2018; Meng, Tobias P/D-1147-2013; Yan, Binghai/D-2404-2013; Felser, Claudia/A-5779-2009; Nielsch, Kornelius/S-3196-2016; Grushin, Adolfo G./A-5704-2011	Hühne, Ruben/0000-0002-0030-6048; Shekhar, Chandra/0000-0002-3330-0400; Rellinghaus, Bernd/0000-0002-1367-8545; Shekhar, Chandra/0000-0002-3330-0400; Gotsmann, Bernd/0000-0001-8978-7468; Meng, Tobias P/0000-0001-5164-1287; Yan, Binghai/0000-0003-2164-5839; Felser, Claudia/0000-0002-8200-2063; Grushin, Adolfo G./0000-0001-7678-7100; Nielsch, Kornelius/0000-0003-2271-7726	DFG-RSF [NI616 22/1, SEV-2012-0249, FPA 2015-65480-P, SFB 1143]; Helmholtz association [VI-521]; DFG [ME 4844/1]	DFG-RSF; Helmholtz association(Helmholtz Association); DFG(German Research Foundation (DFG))	This work was supported by the research grant DFG-RSF (NI616 22/1) 'Contribution of topological states to the thermoelectric properties of Weyl semimetals', Severo Ochoa SEV-2012-0249, FPA 2015-65480-P and SFB 1143, by the Helmholtz association through VI-521, and by the DFG (Emmy Noether programme) via grant ME 4844/1. We thank T. Sturm and A. Pohl, for experimental support. We also acknowledge support by W. Riess, K. Moselund and H. Riel, and thank C. Bollinger for copy-editing.	ADLER SL, 1969, PHYS REV, V177, P2426, DOI 10.1103/PhysRev.177.2426; ALVAREZGAUME L, 1984, NUCL PHYS B, V234, P269, DOI 10.1016/0550-3213(84)90066-X; Arnold F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11615; BELL JS, 1969, NUOVO CIMENTO A, V60, P47, DOI 10.1007/BF02823296; Bertlmann R. A., 2000, ANOMALIEQUANTUM FI; Burkov AA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.247203; DELBOURGO R, 1972, PHYS LETT B, VB 40, P381, DOI 10.1016/0370-2693(72)90825-8; EGUCHI T, 1976, PHYS REV LETT, V37, P1251, DOI 10.1103/PhysRevLett.37.1251; Golkar S, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2016)105; Hirschberger M, 2016, NAT MATER, V15, P1161, DOI [10.1038/nmat4684, 10.1038/NMAT4684]; Huang SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8373; Huang XC, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031023; Jensen K, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2013)088; Kaminski M, 2016, PHYS LETT B, V760, P170, DOI 10.1016/j.physletb.2016.06.054; Kim KS, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.121108; Landsteiner K., 2013, LECT NOTES PHYS, V871, P433, DOI DOI 10.1007/978-3-642-37305-3_17; Landsteiner K, 2016, ACTA PHYS POL B, V47, P2617, DOI 10.5506/APhysPolB.47.2617; Landsteiner K, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2011)121; Landsteiner K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.021601; Le Bellac, 2000, THERMAL FIELD THEORY; Li H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10301; Liang T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3696; Lucas A, 2016, P NATL ACAD SCI USA, V113, P9463, DOI 10.1073/pnas.1608881113; Lundgren R, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.165115; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; NIELSEN HB, 1981, NUCL PHYS B, V185, P20, DOI 10.1016/0550-3213(81)90361-8; Niemann AC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43394; Sergelius P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33859; Sharma G, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.035116; Shekhar C., 2016, OBSERVATION CHIRAL M; Shekhar C, 2015, NAT PHYS, V11, P645, DOI [10.1038/nphys3372, 10.1038/NPHYS3372]; Son DT, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104412; Spivak BZ, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.085107; Xiong J, 2015, SCIENCE, V350, P413, DOI 10.1126/science.aac6089; Xu SY, 2015, NAT PHYS, V11, P748, DOI [10.1038/NPHYS3437, 10.1038/nphys3437]; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297	36	179	181	12	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					324	+		10.1038/nature23005	http://dx.doi.org/10.1038/nature23005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28726829	Green Submitted			2022-12-28	WOS:000405844900028
J	Hoffmann, TC; Oxman, AD; Ioannidis, JPA; Moher, D; Lasserson, TJ; Tovey, DI; Stein, K; Sutcliffe, K; Ravaud, P; Altman, DG; Perera, R; Glasziou, P				Hoffmann, Tammy C.; Oxman, Andrew D.; Ioannidis, John P. A.; Moher, David; Lasserson, Toby J.; Tovey, David I.; Stein, Ken; Sutcliffe, Katy; Ravaud, Philippe; Altman, Douglas G.; Perera, Rafael; Glasziou, Paul			Enhancing the usability of systematic reviews by improving the consideration and description of interventions	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TRIALS	The importance of adequate intervention descriptions in minimising research waste and improving research usability and reproducibility has gained attention in the past few years. Nearly all focus to date has been on intervention reporting in randomised trials. Yet clinicians are encouraged to use systematic reviews, whenever available, rather than single trials to inform their practice. This article explores the problem and implications of incomplete intervention details during the planning, conduct, and reporting of systematic reviews and makes recommendations for review authors, peer reviewers, and journal editors	[Hoffmann, Tammy C.; Ioannidis, John P. A.; Moher, David; Lasserson, Toby J.] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Bond, Qld, Australia; [Ioannidis, John P. A.; Moher, David; Tovey, David I.; Stein, Ken] Norwegian Inst Publ Hlth, Ctr Informed Hlth Choice, Oslo, Norway; [Ioannidis, John P. A.; Lasserson, Toby J.; Stein, Ken] Stanford Univ, Dept Med, Stanford, CA USA; [Oxman, Andrew D.; Lasserson, Toby J.; Stein, Ken] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Ioannidis, John P. A.; Tovey, David I.; Sutcliffe, Katy] Cochrane Editorial Unit, Cochrane Cent Execut, London, England; [Ioannidis, John P. A.; Stein, Ken; Sutcliffe, Katy] Univ Exeter Med Sch, Inst Hlth Res, Exeter, Devon, England; [Ioannidis, John P. A.; Tovey, David I.; Stein, Ken] UCL, Inst Educ, London, England; [Hoffmann, Tammy C.; Ioannidis, John P. A.; Lasserson, Toby J.; Tovey, David I.] Univ Paris 05, Sorbonne Paris Cite, INSERM U1153, Paris, France; [Oxman, Andrew D.; Ioannidis, John P. A.; Moher, David] Univ Oxford, Nuffield Dept Orthopaed, Ctr Stat Med, Rheumatol Musculoskeletal Sci, Oxford, England	Bond University; Norwegian Institute of Public Health (NIPH); Stanford University; University of Ottawa; Ottawa Hospital Research Institute; University of London; University College London; UCL Institute of Education; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford	Hoffmann, TC (corresponding author), Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Bond, Qld, Australia.	thoffmann@bond.edu.au	Glasziou, Paul/A-7832-2008; Moher, David/I-3408-2019; Ioannidis, John P. A./G-9836-2011; Hoffmann, Tammy/E-8029-2010; Oxman, Andrew/Y-3004-2019; ravaud, philippe/C-1694-2009	Glasziou, Paul/0000-0001-7564-073X; Moher, David/0000-0003-2434-4206; Hoffmann, Tammy/0000-0001-5210-8548; Oxman, Andrew/0000-0002-5608-5061; Ioannidis, John P./0000-0003-3118-6859; Perera, Rafael/0000-0003-2418-2091; Sutcliffe, Katy/0000-0002-5469-8649; Ravaud, Philippe/0000-0001-8264-9206	National Health and Medical Research Council of Australia Research Fellowship; Meta-Research Innovation Centre at Stanford (METRICS); Laura and John Arnold Foundation; University Research Chair, University of Ottawa; Cancer Research UK [16895] Funding Source: researchfish	National Health and Medical Research Council of Australia Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Meta-Research Innovation Centre at Stanford (METRICS); Laura and John Arnold Foundation; University Research Chair, University of Ottawa; Cancer Research UK(Cancer Research UK)	There was no funding for the development of this paper. PG is supported by a National Health and Medical Research Council of Australia Research Fellowship. JI is supported by the Meta-Research Innovation Centre at Stanford (METRICS), which is funded by a grant from the Laura and John Arnold Foundation. DM is supported by a University Research Chair, University of Ottawa.	Abell B, 2015, CIRC-CARDIOVASC QUAL, V8, P187, DOI 10.1161/CIRCOUTCOMES.114.001381; Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016; Baxter SK, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-62; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Cochrane Collaboration, COCHR TRAIN TEMPL IN; Cochrane Collaboration, 2016, STNAD COCHR NEW REV; Coxeter P, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010907, DOI 10.1002/14651858.CD010907]; Glasziou PP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001690; Hoffmann TC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009051; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Mosseri J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146336; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; SUN X, 2010, BMJ-BRIT MED J, V340, DOI DOI 10.1136/BMJ.C117; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063; Thomas J, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-67; Wells M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-95	19	69	73	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2017	358								j2998	10.1136/bmj.j2998	http://dx.doi.org/10.1136/bmj.j2998			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7KC	28729459	Green Submitted, Bronze			2022-12-28	WOS:000406318500001
J	Suarez, A				Suarez, Annabel			A smoker with joint pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Suarez, Annabel] Great Western Hosp, Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England		Suarez, A (corresponding author), Great Western Hosp, Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England.	annabel.suarez@nhs.net	Faber, Ben/AAU-2832-2021	Faber, Benjamin/0000-0003-4102-0190				Armstrong DJ, 2007, RHEUMATOL INT, V27, P399, DOI 10.1007/s00296-006-0224-2; Ito T, 2010, J THORAC ONCOL, V5, P976, DOI 10.1097/JTO.0b013e3181dc1f3c; Sheila N, 2011, CLIN RHEUMATOL, V30, P7, DOI 10.1007/s10067-010-1563-7; Yao QP, 2009, SEMIN ARTHRITIS RHEU, V38, P458, DOI 10.1016/j.semarthrit.2008.07.001; Yap FY, 2017, RADIOGRAPHICS, V37, P157, DOI 10.1148/rg.2017160052	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2017	358								j3149	10.1136/bmj.j3149	http://dx.doi.org/10.1136/bmj.j3149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7KC	28729330				2022-12-28	WOS:000406318500003
J	Oliver, D				Oliver, David			David Oliver: NHS doctors' licence to challenge	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						General Medical Council, 2013, GOOD MED PRACTICE; Lees Peter, 2015, Future Hosp J, V2, P208, DOI 10.7861/futurehosp.2-3-208; Lees Peter, 2015, Future Hosp J, V2, P157, DOI 10.7861/futurehosp.2-3-157; Newbold M, 2015, BMJ-BRIT MED J, V358, ph4082; Oliver D, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j3077	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2017	358								j3276	10.1136/bmj.j3276	http://dx.doi.org/10.1136/bmj.j3276			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7JY	28720690	Bronze, Green Published			2022-12-28	WOS:000406318100003
J	Wanigatunga, AA; Ambrosius, WT; Rejeski, WJ; Gill, TM; Glynn, NW; Tudor-Locke, C; Manini, TM				Wanigatunga, Amal A.; Ambrosius, Walter T.; Rejeski, W. Jack; Gill, Thomas M.; Glynn, Nancy W.; Tudor-Locke, Catrine; Manini, Todd M.			Association Between Structured Physical Activity and Sedentary Time in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							LIFE		[Wanigatunga, Amal A.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Ambrosius, Walter T.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Rejeski, W. Jack] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC USA; [Gill, Thomas M.] Yale Sch Med, Dept Med, New Haven, CT USA; [Glynn, Nancy W.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Tudor-Locke, Catrine] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, 2004 Mowry Rd, Gainesville, FL 32610 USA	Johns Hopkins University; Wake Forest University; Wake Forest University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Amherst; State University System of Florida; University of Florida	Manini, TM (corresponding author), Univ Florida, Dept Aging & Geriatr Res, 2004 Mowry Rd, Gainesville, FL 32610 USA.	tmanini@ufl.edu	Tudor-Locke, Catrine/AAC-2829-2021; Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Wanigatunga, Amal/0000-0002-5763-5184; Glynn, Nancy/0000-0003-2265-0162; Manini, Todd/0000-0002-5970-4462	National Institutes of Health (NIH) [U01AG22376]; National Institute on Aging (NIA); National Heart, Lung, and Blood Institute (NHLBI) [3U01AG022376-05A2S]; Intramural Research Program; NIH [T32AG000247, T32AG020499, P30AG028740, R01AG042525, R01HL121023, P30AG21342, K07AG043587]; NIA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000247, P30AG028740] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant U01AG22376 from the National Institutes of Health (NIH) and the National Institute on Aging (NIA); supplement 3U01AG022376-05A2S from the National Heart, Lung, and Blood Institute (NHLBI); sponsored in part by the Intramural Research Program; and supported by grants T32AG000247, T32AG020499, P30AG028740 from the NIH and NIA (Dr Wanigatunga), and grants R01AG042525 and R01HL121023 (Dr Manini) and P30AG21342 and K07AG043587 (Dr Gill) all from the NIH.	Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Dunlop DD, 2015, J PHYS ACT HEALTH, V12, P93, DOI 10.1123/jpah.2013-0311; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Fitzgerald JD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001288; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616	6	9	9	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					297	299		10.1001/jama.2017.7203	http://dx.doi.org/10.1001/jama.2017.7203			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719683	Green Published			2022-12-28	WOS:000405775000017
J	Storrs, C				Storrs, Carina			HOW POVERTY AFFECTS THE BRAIN	NATURE			English	News Item							INSTITUTIONALIZATION											Bick J, 2015, JAMA PEDIATR, V169, P211, DOI 10.1001/jamapediatrics.2014.3212; Crookston BT, 2011, MATERN CHILD NUTR, V7, P397, DOI 10.1111/j.1740-8709.2010.00255.x; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Lloyd-Fox S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04740; Marshall PJ, 2004, J COGNITIVE NEUROSCI, V16, P1327, DOI 10.1162/0898929042304723; Martorell R, 2010, J NUTR, V140, P411, DOI 10.3945/jn.109.114504; Pavlakis AE, 2015, PEDIATR NEUROL, V52, P383, DOI 10.1016/j.pediatrneurol.2014.11.005; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109	8	9	9	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					150	152		10.1038/547150a	http://dx.doi.org/10.1038/547150a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703208	Bronze			2022-12-28	WOS:000405314500014
J	Wilson, BS; Tucci, DL; Merson, MH; O'Donoghue, GM				Wilson, Blake S.; Tucci, Debara L.; Merson, Michael H.; O'Donoghue, Gerard M.			Global hearing health care: new findings and perspectives	LANCET			English	Review							HARD-OF-HEARING; COST-EFFECTIVENESS; COCHLEAR IMPLANTATION; DEAF EDUCATION; OLDER-ADULTS; IMPAIRMENT; INTERVENTIONS; CHILDREN; WORLD; RISK	In 2015, approximately half a billion people had disabling hearing loss, about 6.8% of the world's population. These numbers are substantially higher than estimates published before 2013, and point to the growing importance of hearing loss and global hearing health care. In this Review, we describe the burden of hearing loss and offer our and others' recommendations for halting and then reversing the continuing increases in this burden. Low-cost possibilities exist for prevention of hearing loss, as do unprecedented opportunities to reduce the generally high treatment costs. These possibilities and opportunities could and should be exploited. Additionally, a comprehensive worldwide initiative like VISION 2020 but for hearing could provide a focus for support and also enable and facilitate the increased efforts that are needed to reduce the burden. Success would produce major personal and societal gains, including gains that would help to fulfil the "healthy lives" and "disability inclusive" goals in the UN's new 2030 Agenda for Sustainable Development.	[Wilson, Blake S.; Tucci, Debara L.] Duke Univ, Med Ctr, Dept Surg, Div Head & Neck Surg & Commun Sci, Durham, NC 27710 USA; [Wilson, Blake S.; Tucci, Debara L.; Merson, Michael H.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Wilson, Blake S.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Wilson, Blake S.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Wilson, Blake S.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [O'Donoghue, Gerard M.] Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England; [O'Donoghue, Gerard M.] Nottingham Univ Hosp NHS Trust, Nottingham, England	Duke University; Duke University; Duke University; Duke University; University of Texas System; University of Texas Dallas; University of Nottingham; Nottingham University Hospital NHS Trust	Wilson, BS (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Head & Neck Surg & Commun Sci, Durham, NC 27710 USA.	blake.wilson@duke.edu						Ackland P, 2012, INDIAN J OPHTHALMOL, V60, P380, DOI 10.4103/0301-4738.100531; An SK, 2007, IEEE T BIO-MED ENG, V54, P973, DOI 10.1109/TBME.2007.895372; [Anonymous], 2016, LANCET, V387, P2351, DOI 10.1016/S0140-6736(16)30777-2; [Anonymous], 2014, LANCET, V383, P2185, DOI 10.1016/S0140-6736(14)61066-7; [Anonymous], 2013, INCL FUT IN INCL GRO; [Anonymous], 2016, GLOBAL INFORM TECHNO; Baltussen R, 2009, INT J AUDIOL, V48, P144, DOI 10.1080/14992020802538081; Baltussen R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e615; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bhutta Z, 2010, LANCET, V376, P1375; Binagwaho A, 2013, NEW ENGL J MED, V369, P2054, DOI 10.1056/NEJMsr1302176; Binagwaho A, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-37; Bouton Katherine, 2013, SHOUTING WONT HELP W; Burke MJ, 2012, INT J PEDIATR OTORHI, V76, P212, DOI 10.1016/j.ijporl.2011.11.004; Bush ALH, 2015, EAR HEARING, V36, P395, DOI 10.1097/AUD.0000000000000142; Clark JL, 2014, DISABIL REHABIL-ASSI, V9, P408, DOI 10.3109/17483107.2014.905642; Crisp N, 2015, HEALTHCARE, V3, P221, DOI 10.1016/j.hjdsi.2015.06.002; Crisp N, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-14; Crisp N, 2014, NEW ENGL J MED, V370, P950, DOI 10.1056/NEJMra1111610; Davis A, 2016, GERONTOLOGIST, V56, pS256, DOI 10.1093/geront/gnw033; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Emmett SD, 2016, OTOL NEUROTOL, V37, P1040, DOI 10.1097/MAO.0000000000001148; Emmett SD, 2015, OTOL NEUROTOL, V36, P1357, DOI 10.1097/MAO.0000000000000823; Fellinger J, 2012, LANCET, V379, P1037, DOI 10.1016/S0140-6736(11)61143-4; GAGNE JP, 2011, HEAR REV, V18, P16; Gladden C, 2015, J AM ACAD AUDIOL, V26, P792, DOI 10.3766/jaaa.14107; Hallam R, 2008, HEALTH-LONDON, V12, P369, DOI 10.1177/1363459308090054; Hanushek E.A., 2015, KNOWLEDGE CAPITAL NA; Huang LH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-97; Jackler RK, 2006, OTOL NEUROTOL, V27, P299, DOI 10.1097/00129492-200604000-00001; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Joint Committee on Infant Hearing of the American Academy of Pediatrics, 2013, Pediatrics, V131, pe1324, DOI 10.1542/peds.2013-0008; Kamil RJ, 2015, J AM ACAD AUDIOL, V26, P155, DOI 10.3766/jaaa.26.2.6; Kral A, 2016, LANCET NEUROL, V15, P610, DOI 10.1016/S1474-4422(16)00034-X; Kral A, 2010, NEW ENGL J MED, V363, P1438, DOI 10.1056/NEJMra0911225; Lawn JE, 2013, PEDIATR RES, V74, P1, DOI 10.1038/pr.2013.202; Lederberg AR, 2013, DEV PSYCHOL, V49, P15, DOI 10.1037/a0029558; Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Mackenzie I, 2009, ANN TROP MED PARASIT, V103, P565, DOI 10.1179/000349809X12459740922372; Marschark M, 2015, EXCEPT CHILDREN, V81, P350, DOI 10.1177/0014402914563700; Martin G, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-8; McAnany SJ, 2015, SPINE J, V15, P2254, DOI 10.1016/j.spinee.2015.06.045; Mener DJ, 2013, J AM GERIATR SOC, V61, P1627, DOI 10.1111/jgs.12429; Merson MH, 2014, NEW ENGL J MED, V370, P1676, DOI 10.1056/NEJMp1401124; Mick P, 2014, OTOLARYNG HEAD NECK, V150, P378, DOI 10.1177/0194599813518021; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; O'Donoghue GM, 2014, COCHLEAR IMPLANTS, P158; Olusanya BO, 2009, T ROY SOC TROP MED H, V103, P179, DOI 10.1016/j.trstmh.2008.07.001; Olusanya BO, 2014, B WORLD HEALTH ORGAN, V92, P367, DOI 10.2471/BLT.13.128728; Olusanya BO, 2009, INT J AUDIOL, V48, P159, DOI 10.1080/14992020802716091; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; Pimperton H, 2016, ARCH DIS CHILD, V101, P9, DOI 10.1136/archdischild-2014-307516; Qi S, 2012, J DEAF STUD DEAF EDU, V17, P1, DOI 10.1093/deafed/enr028; Rob B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-135; Ruben RJ, 2015, INT J PEDIATR OTORHI, V79, P783, DOI 10.1016/j.ijporl.2015.04.011; Saunders JE, 2015, OTOL NEUROTOL, V36, P1349, DOI 10.1097/MAO.0000000000000809; Sharma A, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6010004; Singh G., 2016, HEAR REV, V23, P16; Smith AP, 2012, GEOL SOC SPEC PUBL, V363, P107, DOI 10.1144/SP363.6; Sommer A, 2014, JAMA OPHTHALMOL, V132, P640, DOI 10.1001/jamaophthalmol.2014.84; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Stevenson J, 2015, EUR CHILD ADOLES PSY, V24, P477, DOI 10.1007/s00787-015-0697-1; Syed SB, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-17; Tan -Torres Edejer T, 2003, MAKING CHOICES HLTH; Taylor HR, 2016, ASIA-PAC J OPHTHALMO, V5, P95, DOI 10.1097/APO.0000000000000188; Tesni S, 2014, DISABIL REHABIL-ASSI, V9, P374, DOI 10.3109/17483107.2014.914981; Theunissen SCPM, 2014, JAMA PEDIATR, V168, P170, DOI 10.1001/jamapediatrics.2013.3974; Tobe RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051990; Tomblin J Bruce, 2015, Ear Hear, V36 Suppl 1, p76S, DOI 10.1097/AUD.0000000000000219; Tucci DL, 2010, OTOL NEUROTOL, V31, P31, DOI 10.1097/MAO.0b013e3181c0eaec; UN, 2015, 2030 AG SUST DEV; United Nations, 2008, CONV RIGHTS PERS DIS; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wallhagen MI, 2010, GERONTOLOGIST, V50, P66, DOI 10.1093/geront/gnp107; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2020, GLOB STRAT HUM RES H; World Health Organization, 2010, NEWB INF HEAR SCREEN; Zeng FG, 2015, HEARING RES, V322, P188, DOI 10.1016/j.heares.2014.09.013	81	268	279	5	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2017	390	10111					2503	2515		10.1016/S0140-6736(17)31073-5	http://dx.doi.org/10.1016/S0140-6736(17)31073-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO6UL	28705460				2022-12-28	WOS:000417003400028
J	Dann, GP; Liszczak, GP; Bagert, JD; Muller, MM; Nguyen, UTT; Wojcik, F; Brown, ZZ; Bos, J; Panchenko, T; Pihl, R; Pollock, SB; Diehl, KL; Allis, CD; Muir, TW				Dann, Geoffrey P.; Liszczak, Glen P.; Bagert, John D.; Mueller, Manuel M.; Nguyen, Uyen T. T.; Wojcik, Felix; Brown, Zachary Z.; Bos, Jeffrey; Panchenko, Tatyana; Pihl, Rasmus; Pollock, Samuel B.; Diehl, Katharine L.; Allis, C. David; Muir, Tom W.			ISWI chromatin remodellers sense nucleosome modifications to determine substrate preference	NATURE			English	Article							HISTONE MODIFICATIONS; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CORE PARTICLE; RECOGNITION; ACETYLATION; PEPTIDE; COMPLEX; RECONSTITUTION	ATP-dependent chromatin remodellers regulate access to genetic information by controlling nucleosome positions in vivo(1). However, the mechanism by which remodellers discriminate between different nucleosome substrates is poorly understood. Many chromatin remodelling proteins possess conserved protein domains that interact with nucleosomal features(2). Here we used a quantitative high-throughput approach, based on the use of a DNA-barcoded mononucleosome library, to profile the biochemical activity of human ISWI family remodellers in response to a diverse set of nucleosome modifications. We show that accessory (non-ATPase) subunits of ISWI remodellers can distinguish between differentially modified nucleosomes, directing remodelling activity towards specific nucleosome substrates according to their modification state. Unexpectedly, we show that the nucleosome acidic patch3 is necessary for maximum activity of all ISWI remodellers evaluated. This dependence also extends to CHD and SWI/SNF family remodellers, suggesting that the acidic patch may be generally required for chromatin remodelling. Critically, remodelling activity can be regulated by modifications neighbouring the acidic patch, signifying that it may act as a tunable interaction hotspot for ATP-dependent chromatin remodellers and, by extension, many other chromatin effectors that engage this region of the nucleosome surface(4-9).	[Dann, Geoffrey P.; Liszczak, Glen P.; Bagert, John D.; Mueller, Manuel M.; Nguyen, Uyen T. T.; Wojcik, Felix; Brown, Zachary Z.; Bos, Jeffrey; Pihl, Rasmus; Pollock, Samuel B.; Diehl, Katharine L.; Muir, Tom W.] Princeton Univ, Frick Lab, Dept Chem, Princeton, NJ 08544 USA; [Panchenko, Tatyana; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Mueller, Manuel M.] Kings Coll London, Dept Chem, 7 Trinity St, London SE1 1DB, England; [Nguyen, Uyen T. T.] Bayer Pharma AG, Berlin, Germany; [Panchenko, Tatyana] NYU, Langone Med Ctr, Perlmutter Canc Ctr, 430 East 29th St, New York, NY 10016 USA; [Pihl, Rasmus] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Pollock, Samuel B.] Univ Calif San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 USA	Princeton University; Rockefeller University; University of London; King's College London; Bayer AG; Bayer Healthcare Pharmaceuticals; New York University; NYU Langone Medical Center; Aarhus University; University of California System; University of California San Francisco	Muir, TW (corresponding author), Princeton Univ, Frick Lab, Dept Chem, Princeton, NJ 08544 USA.	muir@princeton.edu	Muir, Tom/AHD-0860-2022; Mueller, Manuel M/D-5562-2017	Muir, Tom/0000-0001-9635-0344; Mueller, Manuel M/0000-0001-6701-0893; Wojcik, Felix/0000-0003-3444-6468	German Research Foundation (DFG); US National Institutes of Health [GM112365, P01 CA196539, R37 GM086868, R01 GM107047]; NATIONAL CANCER INSTITUTE [R01CA204639, F32CA206418, P01CA196539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107047, T32GM007388, R37GM086868, F32GM112365, R01GM086868] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank current and former members of the Muir laboratory for discussions and comments; W. Wang and J. Wiggins from the Princeton Sequencing Core Facility; C. Hannon and S. Blythe for writing a custom R script for managing sequencing data; and L. Guerra and L. Beh for advice with data analysis. The SNF2h, ACF1, WSTF, CHRAC-15, and CHRAC-17 coding sequences were a gift from R. Kingston; the RSF1 coding sequence was a gift from D. Reinberg; the BPTF coding sequence was a gift from C. D. Allis; F. W. was funded by a postdoctoral fellowship from the German Research Foundation (DFG); T.P. was funded by a postdoctoral fellowship from the US National Institutes of Health (GM112365); and this research was supported by the US National Institutes of Health grants P01 CA196539, R37 GM086868 and R01 GM107047.	Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Barak O, 2004, J BIOL CHEM, V279, P45130, DOI 10.1074/jbc.M406212200; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Batjargal S, 2015, J AM CHEM SOC, V137, P1734, DOI 10.1021/ja5103019; Biron E, 2006, J PEPT SCI, V12, P213, DOI 10.1002/psc.711; Brown ZZ, 2014, J AM CHEM SOC, V136, P13498, DOI 10.1021/ja5060934; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Chatterjee N, 2015, MOL CELL BIOL, V35, P4083, DOI 10.1128/MCB.00441-15; Chatterjee N, 2011, NUCLEIC ACIDS RES, V39, P8378, DOI 10.1093/nar/gkr535; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Flaus A, 1998, J MOL BIOL, V275, P427, DOI 10.1006/jmbi.1997.1464; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Goldman JA, 2010, J BIOL CHEM, V285, P4645, DOI 10.1074/jbc.M109.072348; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Li XQ, 1998, TETRAHEDRON LETT, V39, P8669, DOI 10.1016/S0040-4039(98)01868-1; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Mitchell SA, 2001, J ORG CHEM, V66, P2327, DOI 10.1021/jo005712m; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Muller MM, 2015, CHEM REV, V115, P2296, DOI 10.1021/cr5003529; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nguyen UTT, 2014, NAT METHODS, V11, P834, DOI [10.1038/NMETH.3022, 10.1038/nmeth.3022]; North JA, 2011, NUCLEIC ACIDS RES, V39, P6465, DOI 10.1093/nar/gkr304; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Tallant C, 2015, STRUCTURE, V23, P80, DOI 10.1016/j.str.2014.10.017; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thompson RE, 2014, J AM CHEM SOC, V136, P8161, DOI 10.1021/ja502806r; Tropberger P, 2013, NAT STRUCT MOL BIOL, V20, P657, DOI 10.1038/nsmb.2581; Xiong XZ, 2016, NAT CHEM BIOL, V12, P1111, DOI [10.1038/nchembio.2218, 10.1038/NCHEMBIO.2218]; Zhao SM, 2016, P NATL ACAD SCI USA, V113, P12238, DOI 10.1073/pnas.1614120113	45	99	101	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					607	+		10.1038/nature23671	http://dx.doi.org/10.1038/nature23671			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28767641	Green Submitted, Green Accepted			2022-12-28	WOS:000408703100043
J	Dienstmann, R; Tabernero, J				Dienstmann, Rodrigo; Tabernero, Josep			CANCER A precision approach to tumour treatment	NATURE			English	Editorial Material							COLORECTAL-CANCER; MEDICINE; MODELS		[Dienstmann, Rodrigo] Vall dHebron Inst Oncol, Barcelona 08035, Spain; [Dienstmann, Rodrigo] Sage Bionetworks, Seattle, WA 98109 USA; [Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona 08035, Spain	Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO)	Dienstmann, R (corresponding author), Vall dHebron Inst Oncol, Barcelona 08035, Spain.; Dienstmann, R (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	rdienstmann@vhio.net; jtabernero@vhio.net	He, Liye/C-8843-2015; Tabernero, Josep/AAG-5026-2019	He, Liye/0000-0002-6632-2112; Tabernero, Josep/0000-0002-2495-8139				Crespo M, 2017, NAT MED, V23, P878, DOI 10.1038/nm.4355; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Pauli C, 2017, CANCER DISCOV, V7, P462, DOI 10.1158/2159-8290.CD-16-1154; Pemovska T, 2013, CANCER DISCOV, V3, P1416, DOI 10.1158/2159-8290.CD-13-0350; Schutte M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14262; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053	6	20	22	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					40	41		10.1038/nature23101	http://dx.doi.org/10.1038/nature23101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28723897				2022-12-28	WOS:000406831700032
J	Yan, Z; Zhou, Q; Wang, L; Wu, JP; Zhao, YY; Huang, GXY; Peng, W; Shen, HZ; Lei, JL; Yan, NN				Yan, Zhen; Zhou, Qiang; Wang, Lin; Wu, Jianping; Zhao, Yanyu; Huang, Gaoxingyu; Peng, Wei; Shen, Huaizong; Lei, Jianlin; Yan, Nieng			Structure of the Na(v)1.4-beta 1 Complex from Electric Eel	CELL			English	Article							SODIUM-CHANNEL INACTIVATION; AMINO-ACID-RESIDUES; BEAM-INDUCED MOTION; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; SWISS-MODEL; ELECTROPHORUS-ELECTRICUS; SLOW INACTIVATION; AUXILIARY SUBUNIT; GATING CHARGE	Voltage-gated sodium (Na-v) channels initiate and propagate action potentials. Here, we present the cryo-EM structure of EeNa(v)1.4, the Na-v channel from electric eel, in complex with the beta 1 subunit at 4.0 angstrom resolution. The immunoglobulin domain of beta 1 docks onto the extracellular L5(I) and L6(IV) loops of EeNa(v)1.4 via extensive polar interactions, and the single transmembrane helix interacts with the third voltage-sensing domain (VSDIII). The VSDs exhibit "up" conformations, while the intracellular gate of the pore domain is kept open by a digitonin-like molecule. Structural comparison with closed NavPaS shows that the outward transfer of gating charges is coupled to the iris-like pore domain dilation through intricate force transmissions involving multiple channel segments. The IFM fast inactivation motif on the III-IV linker is plugged into the corner enclosed by the outer S4-S5 and inner S6 segments in repeats III and IV, suggesting a potential allosteric blocking mechanism for fast inactivation.	[Yan, Zhen; Zhou, Qiang; Wang, Lin; Wu, Jianping; Huang, Gaoxingyu; Yan, Nieng] Tsinghua Univ, State Key Lab Membrane Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing, Peoples R China; [Yan, Zhen; Zhou, Qiang; Wang, Lin; Wu, Jianping; Huang, Gaoxingyu; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Yan, Zhen; Zhou, Qiang; Wang, Lin; Wu, Jianping; Zhao, Yanyu; Huang, Gaoxingyu; Peng, Wei; Shen, Huaizong; Lei, Jianlin; Yan, Nieng] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China; [Lei, Jianlin] Tsinghua Univ, Technol Ctr Prot Sci, Minist Educ, Key Lab Prot Sci,Sch Life Sci, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Yan, NN (corresponding author), Tsinghua Univ, State Key Lab Membrane Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing, Peoples R China.; Yan, NN (corresponding author), Tsinghua Univ, Sch Med, Beijing, Peoples R China.; Yan, NN (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China.	nyan@tsinghua.edu.cn		Yan, Zhen/0000-0002-1999-8451; Wu, Jianping/0000-0001-9869-7691; Peng, Wei/0000-0001-7541-1494	Ministry of Science and Technology of China [2015CB910101, 2016YFA0500402, 2014ZX09507003-006]; National Natural Science Foundation of China [31621092, 31630017, 31611130036]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Xiaomei Li and Xiaomin Li for technical support during EM image acquisition, Wenhao Zhang and Haiteng Deng for MS analysis, and Xiaojing Pan for critical discussions. We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the cryo-EM facility support. We thank the computational facility support on the cluster of Bio-Computing Platform (Tsinghua University Branch of China National Center for Protein Sciences Beijing) and the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the Ministry of Science and Technology of China (2015CB910101, 2016YFA0500402, and 2014ZX09507003-006) and the National Natural Science Foundation of China (projects 31621092, 31630017, and 31611130036).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CATTERALL WA, 1984, SCIENCE, V223, P653, DOI 10.1126/science.6320365; Catterall WA, 2014, ANNU REV PHARMACOL, V54, P317, DOI 10.1146/annurev-pharmtox-011112-140232; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Ching B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167589; Cronin NB, 2003, J BIOL CHEM, V278, P10675, DOI 10.1074/jbc.M208356200; Das S, 2016, ELIFE, V5, DOI 10.7554/eLife.10960; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fozzard HA, 2005, CURR PHARM DESIGN, V11, P2671, DOI 10.2174/1381612054546833; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gong X., 2015, ELIFE; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo JT, 2016, NATURE, V531, P196, DOI 10.1038/nature16446; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1945, J PHYSIOL-LONDON, V104, P176, DOI 10.1113/jphysiol.1945.sp004114; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang WY, 2017, PROTEIN CELL, V8, P401, DOI 10.1007/s13238-017-0372-z; Hung J.H., 2016, COLD SPRING HAR 1101; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; JAMES WM, 1989, BIOCHEMISTRY-US, V28, P6001, DOI 10.1021/bi00440a042; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lipkind GM, 2005, MOL PHARMACOL, V68, P1611, DOI 10.1124/mol.105.014803; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; MILLER JA, 1983, BIOCHEMISTRY-US, V22, P462, DOI 10.1021/bi00271a032; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagae M, 2013, J BIOL CHEM, V288, P33784, DOI 10.1074/jbc.M113.496224; Namadurai S, 2014, J BIOL CHEM, V289, P10797, DOI 10.1074/jbc.M113.527994; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; O'Malley HA, 2015, ANNU REV PHYSIOL, V77, P481, DOI 10.1146/annurev-physiol-021014-071846; PATTON DE, 1993, NEURON, V11, P967; PATTON DE, 1994, J BIOL CHEM, V269, P17649; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; RECIOPINTO E, 1987, J GEN PHYSIOL, V90, P375, DOI 10.1085/jgp.90.3.375; REED JK, 1976, BIOCHEMISTRY-US, V15, P944, DOI 10.1021/bi00650a002; ROSENBERG RL, 1984, P NATL ACAD SCI-BIOL, V81, P5594, DOI 10.1073/pnas.81.17.5594; ROSENBERG RL, 1984, P NATL ACAD SCI-BIOL, V81, P1239, DOI 10.1073/pnas.81.4.1239; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sanchez-Solano A, 2017, EUR BIOPHYS J BIOPHY, V46, P485, DOI 10.1007/s00249-016-1193-3; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; SHENKEL S, 1989, P NATL ACAD SCI USA, V86, P9592, DOI 10.1073/pnas.86.23.9592; SHENKEL S, 1991, J GEN PHYSIOL, V98, P465, DOI 10.1085/jgp.98.3.465; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tang LH, 1996, J GEN PHYSIOL, V108, P89, DOI 10.1085/jgp.108.2.89; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; Wang SY, 2003, BIOPHYS J, V85, P911, DOI 10.1016/S0006-3495(03)74530-5; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yarov-Yarovoy V, 2002, J BIOL CHEM, V277, P35393, DOI 10.1074/jbc.M206126200; Yu FH, 2003, J NEUROSCI, V23, P7577; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang X, 2013, CELL RES, V23, P444, DOI 10.1038/cr.2012.158; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	85	202	211	3	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					470	+		10.1016/j.cell.2017.06.039	http://dx.doi.org/10.1016/j.cell.2017.06.039			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28735751	Bronze			2022-12-28	WOS:000406462400007
J	Yu, TC; Guo, FF; Yu, YN; Sun, TT; Ma, D; Han, JX; Qian, Y; Kryczek, I; Sun, DF; Nagarsheth, N; Chen, YX; Chen, HY; Hong, J; Zou, WP; Fang, JY				Yu, TaChung; Guo, Fangfang; Yu, Yanan; Sun, Tiantian; Ma, Dan; Han, Jixuan; Qian, Yun; Kryczek, Ilona; Sun, Danfeng; Nagarsheth, Nisha; Chen, Yingxuan; Chen, Haoyan; Hong, Jie; Zou, Weiping; Fang, Jing-Yuan			Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy	CELL			English	Article							RESISTANCE; CELLS; COMMENSAL; OXALIPLATIN; SENSITIVITY; STATISTICS; MECHANISMS; MICROBIOTA; EXPRESSION; CETUXIMAB	Gut microbiota are linked to chronic inflammation and carcinogenesis. Chemotherapy failure is the major cause of recurrence and poor prognosis in colorectal cancer patients. Here, we investigated the contribution of gut microbiota to chemoresistance in patients with colorectal cancer. We found that Fusobacterium (F.) nucleatum was abundant in colorectal cancer tissues in patients with recurrence post chemotherapy, and was associated with patient clinicopathological characterisitcs. Furthermore, our bioinformatic and functional studies demonstrated that F. nucleatum promoted colorectal cancer resistance to chemotherapy. Mechanistically, F. nucleatum targeted TLR4 and MYD88 innate immune signaling and specific microRNAs to activate the autophagy pathway and alter colorectal cancer chemotherapeutic response. Thus, F. nucleatum orchestrates a molecular network of the Toll-like receptor, microRNAs, and autophagy to clinically, biologically, and mechanistically control colorectal cancer chemoresistance. Measuring and targeting F. nucleatum and its associated pathway will yield valuable insight into clinical management and may ameliorate colorectal cancer patient outcomes.	[Yu, TaChung; Guo, Fangfang; Yu, Yanan; Sun, Tiantian; Ma, Dan; Han, Jixuan; Qian, Yun; Sun, Danfeng; Chen, Yingxuan; Chen, Haoyan; Hong, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes,Shanghai, Key Lab Gastroenterol & Hepatol,Shanghai Canc Ins, Minist Hlth,Div Gastroenterol & Hepatol,Renji Hos, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China; [Kryczek, Ilona; Sun, Danfeng; Nagarsheth, Nisha; Zou, Weiping] Univ Michigan, Ctr Comprehens Canc, Grad Programs Immunol & Canc Biol, Dept Surg,Sch Med, Ann Arbor, MI 48109 USA	Shanghai Jiao Tong University; University of Michigan System; University of Michigan	Chen, YX; Chen, HY; Hong, J; Fang, JY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes,Shanghai, Key Lab Gastroenterol & Hepatol,Shanghai Canc Ins, Minist Hlth,Div Gastroenterol & Hepatol,Renji Hos, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.; Zou, WP (corresponding author), Univ Michigan, Ctr Comprehens Canc, Grad Programs Immunol & Canc Biol, Dept Surg,Sch Med, Ann Arbor, MI 48109 USA.	yingxuanchen71@126.com; haoyanchen@shsmu.edu.cn; jiehong97@shsmu.edu.cn; wzou@med.umich.edu; jingyuanfang@sjtu.edu.cn	Yu, Yan/GYV-4514-2022	Nagarsheth, Nisha/0000-0002-9508-1530; fang, jingyuan/0000-0003-2282-0248	National Natural Science Foundation of China [81421001, 81320108024, 81530072, 81522008, 31371273, 31371420, 81572303, 81001070]; National Key Technology RD Program [2014BAI09B05]; Program for Professor of Special Appointment at Shanghai Institutions of Higher Learning [201268, QD2015003]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant [20152512, 20161309]; Chenxing Project of Shanghai Jiao-Tong University; National Cancer Institute [CA211016]; NATIONAL CANCER INSTITUTE [R01CA190176, R01CA211016] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Program for Professor of Special Appointment at Shanghai Institutions of Higher Learning; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant; Chenxing Project of Shanghai Jiao-Tong University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by grants from the National Natural Science Foundation of China (81421001, 81320108024, 81530072, 81522008 31371273, 31371420, 81572303, and 81001070), the National Key Technology R&D Program (2014BAI09B05), the Program for Professor of Special Appointment (Eastern Scholar No. 201268 and 2015 Youth Eastern Scholar NO. QD2015003) at Shanghai Institutions of Higher Learning, the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (no. 20152512, 20161309), the Chenxing Project of Shanghai Jiao-Tong University (H. Chen and J. Hong), and the National Cancer Institute (CA211016, W.Z). We thank Dr. Ming Zhong for collecting colocretal cancer tissues and patient information for this work. We thank Dr. Tingting Yan for graphic abstract conception.	Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006; Abreu MT, 2014, GASTROENTEROLOGY, V146, P1534, DOI 10.1053/j.gastro.2014.01.001; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Bertotti A, 2015, CLIN CANCER RES, V21, P3377, DOI 10.1158/1078-0432.CCR-14-0848; Cartwright TH, 2012, CLIN COLORECTAL CANC, V11, P155, DOI 10.1016/j.clcc.2011.11.001; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607; Dahan L, 2009, BRIT J PHARMACOL, V158, P610, DOI 10.1111/j.1476-5381.2009.00341.x; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Nguyen HTT, 2014, GASTROENTEROLOGY, V146, P508, DOI 10.1053/j.gastro.2013.10.021; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeong H, 2007, INT J SYST EVOL MICR, V57, P1784, DOI 10.1099/ijs.0.63283-0; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101; Moutinho C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt322; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Sun TT, 2015, INT J CANCER, V136, P1053, DOI 10.1002/ijc.29061; Van Geelen CMM, 2004, DRUG RESIST UPDATE, V7, P345, DOI 10.1016/j.drup.2004.11.002; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Walko CM, 2005, CLIN THER, V27, P23, DOI 10.1016/j.clinthera.2005.01.005; Wang WM, 2016, CELL, V165, P1092, DOI 10.1016/j.cell.2016.04.009; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yu YN, 2015, ONCOTARGET, V6, P32013, DOI 10.18632/oncotarget.5166; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	47	838	881	36	414	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					548	+		10.1016/j.cell.2017.07.008	http://dx.doi.org/10.1016/j.cell.2017.07.008			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753429	Green Accepted, Bronze			2022-12-28	WOS:000406462400013
J	Goldacre, B; Lane, S; Mahtani, KR; Heneghan, C; Onakpoya, I; Bushfield, I; Smeeth, L				Goldacre, Ben; Lane, Sile; Mahtani, Kamal R.; Heneghan, Carl; Onakpoya, Igho; Bushfield, Ian; Smeeth, Liam			Pharmaceutical companies' policies on access to trial data, results, and methods: audit study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICALTRIALS.GOV RESULTS DATABASE; CLINICAL-TRIALS; INTERNATIONAL COMMITTEE; TRANSPARENCY; REGISTRATION; PUBLICATION	OBJECTIVES To identify the policies of major pharmaceutical companies on transparency of trials, to extract structured data detailing each companies' commitments, and to assess concordance with ethical and professional guidance. DESIGN Structured audit. SETTING Pharmaceutical companies, worldwide. PARTICIPANTS 42 pharmaceutical companies. MAIN OUTCOME MEASURES Companies' commitments on sharing summary results, clinical study reports (CSRs), individual patient data (IPD), and trial registration, for prospective and retrospective trials. RESULTS Policies were highly variable. Of 23 companies eligible from the top 25 companies by revenue, 21 (91%) committed to register all trials and 22 (96%) committed to share summary results; however, policies commonly lacked timelines for disclosure, and trials on unlicensed medicines and off-label uses were only included in six (26%). 17 companies (74%) committed to share the summary results of past trials. The median start date for this commitment was 2005. 22 companies (96%) had a policy on sharing CSRs, mostly on request: two committed to share only synopses and only two policies included unlicensed treatments. 22 companies (96%) had a policy to share IPD; 14 included phase IV trials (one included trials on unlicensed medicines and off-label uses). Policies in the exploratory group of smaller companies made fewer transparency commitments. Two companies fell short of industry body commitments on registration, three on summary results. Examples of contradictory and ambiguous language were documented and summarised by theme. 23/42 companies (55%) responded to feedback; 7/1806 scored policy elements were revised in light of feedback from companies (0.4%). Several companies committed to changing policy; some made changes immediately. CONCLUSIONS The commitments made by companies to transparency of trials were highly variable. Other than journal submission for all trials within 12 months, all elements of best practice were met by at least one company, showing that these commitments are realistic targets.	[Goldacre, Ben; Mahtani, Kamal R.; Heneghan, Carl; Onakpoya, Igho] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX2 6GG, England; [Lane, Sile; Bushfield, Ian] Sense Sci, London, England; [Smeeth, Liam] London Sch Hyg & Trop Med, London, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Goldacre, B (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX2 6GG, England.	ben.goldacre@phc.ox.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022	Laura and John Arnold Foundation; National Institute for Health Research [14/49/159, CL-2011-13-006] Funding Source: researchfish	Laura and John Arnold Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	BG is funded by the Laura and John Arnold Foundation to conduct work on research integrity, including this audit. The funder had no involvement in the study design or the decision to submit.	AbbVie Bodoni S., 2013, BLOOMBERG; Ali MK, 2008, LANCET, V372, P891, DOI 10.1016/S0140-6736(08)61396-3; AllTrials, 2013, ALLTRIALS CAMP; [Anonymous], 2015, PAT END LAW IS IGN; [Anonymous], 1995, STRUCTURE CONTENT CL; Begum R, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0042-8; Benjamin A, 2008, BMJ-BRIT MED J, V336, P1241, DOI 10.1136/bmj.39527.628322.AD; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Chalmers I, 2006, J ROY SOC MED, V99, P337, DOI 10.1258/jrsm.99.7.337; Chen RJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i637; Davis AL, 2017, JAMA-J AM MED ASSOC, V317, P905, DOI 10.1001/jama.2017.0918; De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Dwan K, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-66; Goldacre B, 2013, BAD PHARMA MED IS BR; Goldacre B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001821; Goldacre B, 2014, CLIN TRIALS, V11, P15, DOI 10.1177/1740774513515768; Goldacre B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f1880; Hartung DM, 2014, ANN INTERN MED, V160, P477, DOI 10.7326/M13-0480; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Kmietowicz Z, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2579; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f819; Krumholz HM, 2014, CIRC-CARDIOVASC QUAL, V7, P499, DOI 10.1161/CIRCOUTCOMES.114.001166; Laine C, 2007, ANN INTERN MED, V147, P275, DOI 10.7326/0003-4819-147-4-200708210-00166; Lo B, 2015, JAMA-J AM MED ASSOC, V313, P793, DOI 10.1001/jama.2015.292; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Miller JE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009758; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; Powell-Smith Anna, 2016, F1000Res, V5, P2629, DOI 10.12688/f1000research.10010.1; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Sydes MR, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0604-6; Taichman DB, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001950; Tompson AC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009285; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526; World Health Organisation, WHO ICTRP; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	39	32	32	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j3334	10.1136/bmj.j3334	http://dx.doi.org/10.1136/bmj.j3334			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UW	28747301	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000406765900004
J	Slomski, A				Slomski, Anita			Combination Therapy Shrinks Melanoma Brain Metastases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					323	323		10.1001/jama.2017.9525	http://dx.doi.org/10.1001/jama.2017.9525			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MY	28742907				2022-12-28	WOS:000426800100002
J	Rubin, R				Rubin, Rita			Public health commissioner appointed to lead US CDC	LANCET			English	Editorial Material													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					350	350						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28745595				2022-12-28	WOS:000405911300012
J	Ryu, J; Park, S				Ryu, Jaegeon; Park, Soojin			Sliding chains keep particles together	SCIENCE			English	Editorial Material							SILICON ANODES; BINDERS		[Ryu, Jaegeon; Park, Soojin] Ulsan Natl Inst Sci & Technol, Dept Energy Engn, Sch Energy & Chem Engn, UNIST Gil 50, Ulsan 44919, South Korea	Ulsan National Institute of Science & Technology (UNIST)	Park, S (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Energy Engn, Sch Energy & Chem Engn, UNIST Gil 50, Ulsan 44919, South Korea.	spark@unist.ac.kr	Park, Soojin/E-5899-2010; Ryu, Jaegeon/X-7462-2018	Park, Soojin/0000-0003-3878-6515; Ryu, Jaegeon/0000-0002-5290-6192				Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Choi S, 2017, SCIENCE, V357, P279, DOI 10.1126/science.aal4373; Ito K., 2012, NPG ASIA MATER, V44, P38; Jeong YK, 2015, ENERG ENVIRON SCI, V8, P1224, DOI 10.1039/c5ee00239g; Jeong YK, 2014, NANO LETT, V14, P864, DOI 10.1021/nl404237j; Koo B, 2012, ANGEW CHEM INT EDIT, V51, P8762, DOI 10.1002/anie.201201568; Kovalenko I, 2011, SCIENCE, V334, P75, DOI 10.1126/science.1209150; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Park SJ, 2015, J AM CHEM SOC, V137, P2565, DOI 10.1021/ja511181p; Raymo FM, 1999, CHEM REV, V99, P1643, DOI 10.1021/cr970081q; Ryou MH, 2013, ADV MATER, V25, P1571, DOI 10.1002/adma.201203981; Wang C, 2013, NAT CHEM, V5, P1042, DOI [10.1038/nchem.1802, 10.1038/NCHEM.1802]	12	10	10	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					250	251		10.1126/science.aan6685	http://dx.doi.org/10.1126/science.aan6685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729497				2022-12-28	WOS:000405901600021
J	You, YM; Liao, WQ; Zhao, DW; Ye, HY; Zhang, Y; Zhou, QH; Niu, XH; Wang, JL; Li, PF; Fu, DW; Wang, ZM; Gao, S; Yang, KL; Liu, JM; Li, JY; Yan, YF; Xiong, RG				You, Yu-Meng; Liao, Wei-Qiang; Zhao, Dewei; Ye, Heng-Yun; Zhang, Yi; Zhou, Qionghua; Niu, Xianghong; Wang, Jinlan; Li, Peng-Fei; Fu, Da-Wei; Wang, Zheming; Gao, Song; Yang, Kunlun; Liu, Jun-Ming; Li, Jiangyu; Yan, Yanfa; Xiong, Ren-Gen			An organic-inorganic perovskite ferroelectric with large piezoelectric response (vol 357, pg 306, 2017)	SCIENCE			English	Article							ROOM-TEMPERATURE FERROELECTRICITY; CHARGE-TRANSFER; TITANATE; CRYSTALS	Molecular piezoelectrics are highly desirable for their easy and environment-friendly processing, light weight, low processing temperature, and mechanical flexibility. However, although 136 years have passed since the discovery in 1880 of the piezoelectric effect, molecular piezoelectrics with a piezoelectric coefficient d(33) comparable with piezoceramics such as barium titanate (BTO; similar to 190 picocoulombs per newton) have not been found. We show that trimethylchloromethyl ammonium trichloromanganese(II), an organic-inorganic perovskite ferroelectric crystal processed from aqueous solution, has a large d(33) of 185 picocoulombs per newton and a high phase-transition temperature of 406 kelvin (K) (16 K above that of BTO). This makes it a competitive candidate for medical, micromechanical, and biomechanical applications.	[You, Yu-Meng; Liao, Wei-Qiang; Ye, Heng-Yun; Zhang, Yi; Li, Peng-Fei; Fu, Da-Wei; Xiong, Ren-Gen] Southeast Univ, Ordered Matter Sci Res Ctr, Nanjing 211189, Jiangsu, Peoples R China; [Zhao, Dewei; Yan, Yanfa] Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; [Zhou, Qionghua; Niu, Xianghong; Wang, Jinlan] Southeast Univ, Dept Phys, Nanjing 211189, Jiangsu, Peoples R China; [Wang, Zheming; Gao, Song] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Yang, Kunlun; Liu, Jun-Ming] Nanjing Univ, Solid State Microstruct Lab, Nanjing 210093, Jiangsu, Peoples R China; [Yang, Kunlun; Liu, Jun-Ming] Nanjing Univ, Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Li, Jiangyu] Chinese Acad Sci, Shenzhen Key Lab Nanobiomech, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China; [Li, Jiangyu] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA	Southeast University - China; University System of Ohio; University of Toledo; Southeast University - China; Peking University; Nanjing University; Nanjing University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Washington; University of Washington Seattle	You, YM; Xiong, RG (corresponding author), Southeast Univ, Ordered Matter Sci Res Ctr, Nanjing 211189, Jiangsu, Peoples R China.; Yan, YF (corresponding author), Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA.; Li, JY (corresponding author), Chinese Acad Sci, Shenzhen Key Lab Nanobiomech, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China.; Li, JY (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.	youyumeng@seu.edu.cn; jjli@u.washington.edu; yanfa.yan@utoledo.edu; xiongrg@seu.edu.cn	Wang, Jinlan/B-3503-2012; You, YuMeng/C-6821-2016; Liao, Wei-Qiang/AAY-9358-2020; Zhao, Dewei/F-5928-2010; Li, Peng-Fei/A-9047-2015	Wang, Jinlan/0000-0002-4529-874X; Zhao, Dewei/0000-0001-7914-6288; Li, Peng-Fei/0000-0001-5228-6192; Zhang, Yi/0000-0002-6375-1712; Yan, Yanfa/0000-0003-3977-5789	973 project [2014CB932103]; National Natural Science Foundation of China [21290172, 91422301, 21427801, 21290170]; National Key Research Program of China [2016YF0300101, 2016YFA0201001]	973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research Program of China	The manuscript was improved by the insightful reviews by the anonymous reviewers. This work was supported by the 973 project (grant 2014CB932103), the National Natural Science Foundation of China (grants 21290172, 91422301, 21427801, and 21290170), and the National Key Research Program of China (grants 2016YF0300101 and 2016YFA0201001). The d<INF>33</INF> data reported in this paper are tabulated in the supplementary materials. Data of crystal structures reported in this paper are deposited at the Cambridge Crystallographic Data Centre (deposition nos. CCDC 1429417-1429418 and 1515805-1515806).	AIZU K, 1969, J PHYS SOC JPN, V27, P387, DOI 10.1143/JPSJ.27.387; Akutagawa T, 2009, NAT MATER, V8, P342, DOI [10.1038/nmat2377, 10.1038/NMAT2377]; [Anonymous], 2007, SCANNING PROBE MICRO; BECHMANN R, 1956, J ACOUST SOC AM, V28, P347, DOI 10.1121/1.1908324; Bonnell DA, 2009, MRS BULL, V34, P648, DOI 10.1557/mrs2009.176; Bonnell DA, 2013, SCIENCE, V339, P401, DOI [10.1126/science.1232939, 10.1126/science.12329.39]; Bonnell DA, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.1343; CASPARI ME, 1950, PHYS REV, V80, P1082, DOI 10.1103/PhysRev.80.1082; Cho HC, 2015, SCIENCE, V350, P1222, DOI 10.1126/science.aad1818; Curie J., 1880, ACAD SCI PARIS, V91, P294; Damjanovic D, 1998, REP PROG PHYS, V61, P1267, DOI 10.1088/0034-4885/61/9/002; Fu DW, 2013, SCIENCE, V339, P425, DOI [10.1126/science.1230473, 10.1126/science.1229675]; Hao F, 2014, NAT PHOTONICS, V8, P489, DOI 10.1038/nphoton.2014.82; Heywang W, 2008, SPRINGER SER MATER S, V114, P1; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Hu L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4279; Jones JL, 2006, PHYSICA B, V385, P100, DOI 10.1016/j.physb.2006.05.115; LEVANYUK AP, 1974, USP FIZ NAUK+, V112, P561, DOI 10.1070/PU1974v017n02ABEH004336; Lu HD, 2015, ADV MATER, V27, P7832, DOI 10.1002/adma.201504019; MITZI DB, 1994, NATURE, V369, P467, DOI 10.1038/369467a0; Rodel J, 2009, J AM CERAM SOC, V92, P1153, DOI 10.1111/j.1551-2916.2009.03061.x; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Setter N., 1993, FERROELECTRIC CERAMI, P127; Shi PP, 2016, CHEM SOC REV, V45, P3811, DOI 10.1039/c5cs00308c; Tayi AS, 2012, NATURE, V488, P485, DOI 10.1038/nature11395; Tsai HH, 2016, NATURE, V536, P312, DOI 10.1038/nature18306; Valasek J, 1921, PHYS REV, V17, P475, DOI 10.1103/PhysRev.17.475; Wada S, 2005, J APPL PHYS, V98, DOI 10.1063/1.1957130; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Xu BB, 2016, SMALL, V12, P4502, DOI 10.1002/smll.201600980; Ye HY, 2016, ADV MATER, V28, P2579, DOI 10.1002/adma.201505224; Ye HY, 2015, J AM CHEM SOC, V137, P13148, DOI 10.1021/jacs.5b08290; You YM, 2017, SCIENCE, V357, P306, DOI 10.1126/science.aai8535; Zhang W, 2012, CHEM REV, V112, P1163, DOI 10.1021/cr200174w; Zhang Y, 2014, ANGEW CHEM INT EDIT, V53, P5064, DOI 10.1002/anie.201400348	35	566	575	79	1118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					306	309		10.1126/science.aai8535	http://dx.doi.org/10.1126/science.aai8535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729511				2022-12-28	WOS:000405901600042
J	Sacks, CA				Sacks, Chana A.			Severe Plantar Warts in an Immunocompromised Patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sacks, Chana A.] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Sacks, CA (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.	zinsj@ccf.org							0	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					267	267		10.1056/NEJMicm1616238	http://dx.doi.org/10.1056/NEJMicm1616238			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9PI	28723340				2022-12-28	WOS:000405777600010
J	Bushell, E; Gomes, AR; Sanderson, T; Anar, B; Girling, G; Herd, C; Metcalf, T; Modrzynska, K; Schwach, F; Martin, RE; Mather, MW; McFadden, GI; Parts, L; Rutledge, GG; Vaidya, AB; Wengelnik, K; Rayner, JC; Billker, O				Bushell, Ellen; Gomes, Ana Rita; Sanderson, Theo; Anar, Burcu; Girling, Gareth; Herd, Colin; Metcalf, Tom; Modrzynska, Katarzyna; Schwach, Frank; Martin, Rowena E.; Mather, Michael W.; McFadden, Geoffrey I.; Parts, Leopold; Rutledge, Gavin G.; Vaidya, Akhil B.; Wengelnik, Kai; Rayner, Julian C.; Billker, Oliver			Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes	CELL			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; MALARIA PARASITE; EVOLUTIONARY ANALYSIS; HUMAN ERYTHROCYTES; ACID-METABOLISM; FALCIPARUM; PROTEINS; YEAST; EXPRESSION; RESOURCE	The genomes of malaria parasites contain many genes of unknown function. To assist drug development through the identification of essential genes and pathways, we have measured competitive growth rates in mice of 2,578 barcoded Plasmodium berghei knockout mutants, representing >50% of the genome, and created a phenotype database. At a single stage of its complex life cycle, P. berghei requires two-thirds of genes for optimal growth, the highest proportion reported from any organism and a probable consequence of functional optimization necessitated by genomic reductions during the evolution of parasitism. In contrast, extreme functional redundancy has evolved among expanded gene families operating at the parasite-host interface. The level of genetic redundancy in a single-celled organism may thus reflect the degree of environmental variation it experiences. In the case of Plasmodium parasites, this helps rationalize both the relative successes of drugs and the greater difficulty of making an effective vaccine.	[Bushell, Ellen; Gomes, Ana Rita; Sanderson, Theo; Anar, Burcu; Girling, Gareth; Herd, Colin; Metcalf, Tom; Modrzynska, Katarzyna; Schwach, Frank; Parts, Leopold; Rutledge, Gavin G.; Rayner, Julian C.; Billker, Oliver] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton, Cambs, England; [Martin, Rowena E.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Mather, Michael W.; Vaidya, Akhil B.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [McFadden, Geoffrey I.] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Wengelnik, Kai] Univ Montpellier, CNRS, INSERM, DIMNP, Montpellier, France	Wellcome Trust Sanger Institute; Australian National University; Drexel University; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Rayner, JC; Billker, O (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton, Cambs, England.	julian.rayner@sanger.ac.uk; oliver.billker@sanger.ac.uk	Martin, Rowena E/C-9992-2009; Bushell, Ellen/AAA-9295-2019	Martin, Rowena E/0000-0001-7408-5295; Parts, Leopold/0000-0002-2618-670X; Mather, Michael/0000-0002-1062-0137; Gomes, Ana Rita/0000-0001-7684-8815; Rayner, Julian/0000-0002-9835-1014; Rutledge, Gavin/0000-0003-0468-0528; Wengelnik, Kai/0000-0002-4547-4205; Girling, Gareth/0000-0002-8031-1903; Sanderson, Theo/0000-0003-4177-2851	Wellcome Trust [098051]; Australian National Health and Medical Research Council [1053082]; Australian Research Council [FT160100226]; MRC [G0501670] Funding Source: UKRI; Medical Research Council [1500002] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028398, R56AI028398] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Mandy Sanders for handling sequencing samples, Thomas Dibling and Anthea Cassidy for picking and managing the genomic clone resource, and Wieslawa Johnson and Francois Meullenet for help with manuscript preparation. Work at the Sanger Institute was funded by a core grant from the Wellcome Trust (098051). R.E.M. is funded by the Australian National Health and Medical Research Council (fellowship 1053082) and the Australian Research Council (FT160100226).	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Barquist L, 2013, NUCLEIC ACIDS RES, V41, P4549, DOI 10.1093/nar/gkt148; Boisson B, 2011, MOL MICROBIOL, V81, P1343, DOI 10.1111/j.1365-2958.2011.07767.x; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Burrows JN, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1675-x; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; Csuros M, 2010, BIOINFORMATICS, V26, P1910, DOI 10.1093/bioinformatics/btq315; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gomes AR, 2015, CELL HOST MICROBE, V17, P404, DOI 10.1016/j.chom.2015.01.014; Guttery DS, 2014, CELL HOST MICROBE, V16, P128, DOI 10.1016/j.chom.2014.05.020; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Jackson AP, 2016, CURR BIOL, V26, P161, DOI 10.1016/j.cub.2015.11.055; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Ke HJ, 2015, CELL REP, V11, P164, DOI 10.1016/j.celrep.2015.03.011; Khan Shahid M, 2013, Methods Mol Biol, V923, P139; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Mann PA, 2015, ACS INFECT DIS, V1, P59, DOI 10.1021/id5000212; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Martin RE, 2009, MOL MICROBIOL, V74, P519, DOI 10.1111/j.1365-2958.2009.06863.x; Oppenheim RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004263; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Pankova-Kholmyansky I, 2006, CHEMOTHERAPY, V52, P205, DOI 10.1159/000093037; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Project MPfC, 2016, ELIFE, V5, pe08714, DOI [10.7554/eLife.08714, DOI 10.7554/ELIFE.08714]; Ramani AK, 2012, CELL, V148, P792, DOI 10.1016/j.cell.2012.01.019; Rosenthal PJ, 2013, MOL MICROBIOL, V89, P1025, DOI 10.1111/mmi.12349; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Sanderson T., 2017, Wellcome Open Research, V2, P45, DOI 10.12688/wellcomeopenres.11896.1; Saunders D, 2016, LANCET INFECT DIS, V16, P274, DOI 10.1016/S1473-3099(15)00525-3; Schwach F, 2015, NUCLEIC ACIDS RES, V43, pD1176, DOI 10.1093/nar/gku1143; Shears MJ, 2015, MOL BIOCHEM PARASIT, V199, P34, DOI 10.1016/j.molbiopara.2015.03.004; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sigala PA, 2014, ANNU REV MICROBIOL, V68, P259, DOI 10.1146/annurev-micro-091313-103537; Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Vivarest CP, 2002, CURR OPIN MICROBIOL, V5, P499, DOI 10.1016/S1369-5274(02)00356-9; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Woo YH, 2015, ELIFE, V4, DOI 10.7554/eLife.06974; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138	54	268	271	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					260	+		10.1016/j.cell.2017.06.030	http://dx.doi.org/10.1016/j.cell.2017.06.030			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708996	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000405493900007
J	Frankish, H; Horton, R				Frankish, Helen; Horton, Richard			Prevention and management of dementia: a priority for public health	LANCET			English	Editorial Material									[Frankish, Helen; Horton, Richard] The Lancet, London EC2Y 5AS, England		Frankish, H (corresponding author), The Lancet, London EC2Y 5AS, England.	helen.frankish@lancet.com			Alzheimer's Society; Economic and Social Research Council; Alzheimer's Research UK; University College London	Alzheimer's Society; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); University College London(General Electric)	We declare no competing interests. We are grateful to the Alzheimer's Society, the Economic and Social Research Council, Alzheimer's Research UK, and University College London for their financial support of the Commission. We thank Gill Livingston for chairing the Commission and all the Commissioners and peer reviewers for their help in drafting and refining the Commission.	Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Department of Health, 2009, LIVING WELL DEMENTIA; Department of Health, 2013, G8 DEM SUMM DECL; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Livingston GSA, 2017, LANCET, DOI http://dx.doi; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Prince M, 2015, WORLD ALZHEIMERS REP; Prince M, 2017, LANCET; WHO, 2017, GLOB ACT PL IN PRESS; WHO, 2015, 1 WHO MIN C GLOB ACT	10	84	87	2	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					2614	+		10.1016/S0140-6736(17)31756-7	http://dx.doi.org/10.1016/S0140-6736(17)31756-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ1FF	28735854				2022-12-28	WOS:000418101000011
J	Abbasi, J				Abbasi, Jennifer			An International Human Cell Atlas Consortium Takes Shape	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2017	318	8					685	686		10.1001/jama.2017.5640	http://dx.doi.org/10.1001/jama.2017.5640			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3DE	28768315				2022-12-28	WOS:000408095800001
J	Dahms, F; Fingerhut, BP; Nibbering, ETJ; Pines, E; Elsaesser, T				Dahms, Fabian; Fingerhut, Benjamin P.; Nibbering, Erik T. J.; Pines, Ehud; Elsaesser, Thomas			Large-amplitude transfer motion of hydrated excess protons mapped by ultrafast 2D IR spectroscopy	SCIENCE			English	Article							WATER; H5O2+; DYNAMICS; ENERGY; MECHANISM; SPECTRUM; CATION	Solvation and transport of excess protons in aqueous systems play a fundamental role in acid-base chemistry and biochemical processes. We mapped ultrafast proton excursions along the proton transfer coordinate by means of two-dimensional infrared spectroscopy, both in bulk water and in a Zundel cation (H5O2)(+) motif selectively prepared in acetonitrile. Electric fields from the environment and stochastic hydrogen bond motions induce fluctuations of the proton double-minimum potential. Within the lifetime of a particular hydration geometry, the proton explores a multitude of positions on a sub-100-femtosecond time scale. The proton transfer vibration is strongly damped by its 20- to 40-femtosecond population decay. Our results suggest a central role of Zundel-like geometries in aqueous proton solvation and transport.	[Dahms, Fabian; Fingerhut, Benjamin P.; Nibbering, Erik T. J.; Elsaesser, Thomas] Max Born Inst Nichtlineare Opt & Kurzzeitspektro, D-12489 Berlin, Germany; [Pines, Ehud] Max Born Inst Nichtlineare Opt & Kurzzeitspektro, D-12489 Berlin, Germany	Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Elsaesser, T (corresponding author), Max Born Inst Nichtlineare Opt & Kurzzeitspektro, D-12489 Berlin, Germany.	elsasser@mbi-berlin.de	Elsaesser, Thomas/P-7608-2014; Mukamel, Shaul/AAO-4196-2020; Fingerhut, Benjamin/AAE-4728-2019	Elsaesser, Thomas/0000-0003-3056-6665; Fingerhut, Benjamin/0000-0002-8532-6899	Max-Born-Institute; Deutsche Forschungsgemeinschaft [FI 2034/1-1]	Max-Born-Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research reported here has been funded by the Max-Born-Institute. B.P.F. gratefully acknowledges support through the Deutsche Forschungsgemeinschaft within the Emmy Noether Programme (grant FI 2034/1-1). The experimental data sets and calculation results generated and/or analyzed in the current study are archived at the Max-Born-Institute and available from the corresponding author upon reasonable request.	Agmon N, 2016, CHEM REV, V116, P7642, DOI 10.1021/acs.chemrev.5b00736; Ando K, 1997, J PHYS CHEM B, V101, P10464, DOI 10.1021/jp970173j; Ashihara S, 2007, J PHYS CHEM A, V111, P743, DOI 10.1021/jp0676538; Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; Bakker HJ, 2010, CHEM REV, V110, P1498, DOI 10.1021/cr9001879; Cheng HP, 1997, J CHEM PHYS, V107, P8461, DOI 10.1063/1.475046; Dahms F, 2016, ANGEW CHEM INT EDIT, V55, P10600, DOI 10.1002/anie.201602523; Hamm P., 2011, CONCEPTS METHODS 2D, V1st; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Kalish NB, 2011, J PHYS CHEM A, V115, P4063, DOI 10.1021/jp110873t; Knight C, 2012, ACCOUNTS CHEM RES, V45, P101, DOI 10.1021/ar200140h; Laage D, 2006, SCIENCE, V311, P832, DOI 10.1126/science.1122154; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Ruthmann J, 1998, J CHEM PHYS, V109, P5466, DOI 10.1063/1.477164; Stoyanov ES, 2006, J PHYS CHEM A, V110, P12992, DOI 10.1021/jp062879w; Thamer M, 2015, SCIENCE, V350, P78, DOI 10.1126/science.aab3908; Vendrell O, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2787596; Vuilleumier R, 1999, J CHEM PHYS, V111, P4251, DOI 10.1063/1.479723; Wicke E., 1954, Z PHYS CHEM, V1, P340, DOI 10.1524/ZPCH.1954.1.5_6.340; Woutersen S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138305; Yu Q, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4979601; ZUNDEL G, 1968, Z PHYS CHEM NEUE FOL, V58, P225	22	97	99	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2017	357	6350					491	494		10.1126/science.aan5144	http://dx.doi.org/10.1126/science.aan5144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4VW	28705988				2022-12-28	WOS:000406840100035
J	Sene, M; Gilmore, I; Janssen, JT				Sene, Martyn; Gilmore, Ian; Janssen, Jan-Theodoor			Metrology is key to reproducing results	NATURE			English	Editorial Material									[Sene, Martyn] NPL, Nucl Phys, Teddington, Middx, England; [Gilmore, Ian] NPL, Natl Ctr Excellence Mass Spectrometry Imaging, Teddington, Middx, England; [Gilmore, Ian] NPL, Sci, Teddington, Middx, England; [Janssen, Jan-Theodoor] NPL, Solid State Quantum Technol, Teddington, Middx, England	National Physical Laboratory - UK; National Physical Laboratory - UK; National Physical Laboratory - UK; National Physical Laboratory - UK	Janssen, JT (corresponding author), NPL, Solid State Quantum Technol, Teddington, Middx, England.	jt.janssen@npl.co.uk						Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Desrosiers M, 2013, J RES NATL INST STAN, V118, DOI 10.6028/jres.118.021; Mitchard Edward Ta, 2013, Carbon Balance Manag, V8, P10, DOI 10.1186/1750-0680-8-10; Plant AL, 2014, NAT METHODS, V11, P895, DOI 10.1038/nmeth.3076	4	20	21	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					397	399		10.1038/547397a	http://dx.doi.org/10.1038/547397a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB7ZK	28748943	Bronze			2022-12-28	WOS:000406358300013
J	Oliver, D				Oliver, David			David Oliver: When "resilience" becomes a dirty word	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Clarke R., 2017, YOUR LIFE MY HANDS; Iacobucci G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5459; Lemaire JB, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3360; Lind S., 2016, PULSE, P358; National Health Executive, 2014, GMC OFF EM RES TRAIN; Oliver D, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j17; Royal College of Physicians, 2017, NHS REAL CHECK DEL C; Royal College of Physicians, 2016, BEING JUN DOCT; Royal College of Physicians, 2016, UND UND OV NHS 2016; Smith F, 2017, J ROY SOC MED, V110, P198, DOI 10.1177/0141076817697489	10	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2017	358								j3604	10.1136/bmj.j3604	http://dx.doi.org/10.1136/bmj.j3604			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UT	28743685	Bronze, Green Published			2022-12-28	WOS:000406765600010
J	Falcone, M; Chatelain, L; Scopelliti, R; Zivkovic, I; Mazzanti, M				Falcone, Marta; Chatelain, Lucile; Scopelliti, Rosario; Zivkovic, Ivica; Mazzanti, Marinella			Nitrogen reduction and functionalization by a multimetallic uranium nitride complex	NATURE			English	Article							COORDINATED DINITROGEN; CARBON-MONOXIDE; IRON COMPLEXES; BOND FORMATION; CLEAVAGE; ACTIVATION; N-2; CO; HYDROGENATION; DEOXYGENATION	Molecular nitrogen (N-2) is cheap and widely available, but its unreactive nature is a challenge when attempting to functionalize it under mild conditions with other widely available substrates (such as carbon monoxide, CO) to produce value-added compounds. Biological N-2 fixation can do this, but the industrial Haber-Bosch process for ammonia production operates under harsh conditions (450 degrees Celsius and 300 bar), even though both processes are thought to involve multimetallic catalytic sites(1,2). And although molecular complexes capable of binding and even reducing N-2 under mild conditions are known, with co-operativity between metal centres considered crucial for the N-2 reduction step(1-14), the multimetallic species involved are usually not well defined, and further transformation of N-2-binding complexes to achieve N-H or N-C bond formation is rare(2,6,8,10,15,16). Haber noted(17), before an iron-based catalyst was adopted for the industrial Haber-Bosch process, that uranium and uranium nitride materials are very effective heterogeneous catalysts for ammonia production from N-2. However, few examples of uranium complexes binding N-2 are known(18-22), and soluble uranium complexes capable of transforming N-2 into ammonia or organonitrogen compounds have not yet been identified. Here we report the four-electron reduction of N-2 under ambient conditions by a fully characterized complex with two U-iii ions and three K+ centres held together by a nitride group and a flexible metalloligand framework. The addition of H-2 and/or protons, or CO to the resulting N-2(4-) complex results in the complete cleavage of N-2 with concomitant N-2 functionalization through N-H or N-C bond-forming reactions. These observations establish that a molecular uranium complex can promote the stoichiometric transformation of N-2 into NH3 or cyanate, and that a flexible, electron-rich, multimetallic, nitride-bridged core unit is a promising starting point for the design of molecular complexes capable of cleaving and functionalizing N-2 under mild conditions.	[Falcone, Marta; Chatelain, Lucile; Scopelliti, Rosario; Mazzanti, Marinella] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland; [Zivkovic, Ivica] Ecole Polytech Fed Lausanne, Inst Phys, Lab Quantum Magnetism, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Mazzanti, M (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland.	marinella.mazzanti@epfl.ch	Zivkovic, Ivica/A-5816-2009	Zivkovic, Ivica/0000-0003-0366-8199; Mazzanti, Marinella/0000-0002-3427-008X	Swiss National Science Foundation [200021-157158, 200021-162430]; Ecole Polytechnique Federale de Lausanne (EPFL)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne (EPFL)	We acknowledge support from the Swiss National Science Foundation (200021-157158 and 200021-162430) and from the Ecole Polytechnique Federale de Lausanne (EPFL). We thank E. Solari for carrying out the elemental analyses, and D. Kubicky (of the L. Emsley group) for assistance with EPR measurements, M. Prevot (of the K. Sivula group) for assistance with Raman and B. Rozmyslowicz (of the J. Luterbacher group) for assistance with IR and GC-MS measurements. We thank F. F. Tirani for her contribution to the X-ray single crystal structure analyses.	[Anonymous], 2011, NAT CHEM, V3, P120; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Camp C, 2013, J AM CHEM SOC, V135, P12101, DOI 10.1021/ja405815b; Chatelain L, 2016, J AM CHEM SOC, V138, P1784, DOI 10.1021/jacs.5b12620; Cleaves PA, 2014, ANGEW CHEM INT EDIT, V53, P10412, DOI 10.1002/anie.201406203; Cloke FGN, 2002, J AM CHEM SOC, V124, P9352, DOI 10.1021/ja027000e; Cooper O, 2014, J AM CHEM SOC, V136, P6716, DOI 10.1021/ja5017624; Duisenberg AJM, 2003, J APPL CRYSTALLOGR, V36, P220, DOI 10.1107/S0021889802022628; Evans WJ, 2009, J AM CHEM SOC, V131, P11195, DOI 10.1021/ja9036753; Evans WJ, 2003, J AM CHEM SOC, V125, P14264, DOI 10.1021/ja037647e; Falcone M, 2016, ANGEW CHEM INT EDIT, V55, P12290, DOI 10.1002/anie.201606796; Fryzuk MD, 1997, SCIENCE, V275, P1445, DOI 10.1126/science.275.5305.1445; Gambarotta S, 2004, ANGEW CHEM INT EDIT, V43, P5298, DOI 10.1002/anie.200301669; Grubel K, 2014, J AM CHEM SOC, V136, P16807, DOI 10.1021/ja507442b; Haber F., 1909, German patent, Patent No. [DE 229126, 229126]; Hirotsu M, 2007, J AM CHEM SOC, V129, P12690, DOI 10.1021/ja0752989; Kindra DR, 2014, CHEM REV, V114, P8865, DOI 10.1021/cr500242w; Knobloch DJ, 2010, J AM CHEM SOC, V132, P10553, DOI 10.1021/ja104025v; Knobloch DJ, 2010, NAT CHEM, V2, P30, DOI [10.1038/nchem.477, 10.1038/NCHEM.477]; LAPLAZA CE, 1995, SCIENCE, V268, P861, DOI 10.1126/science.268.5212.861; Lee Y, 2015, ANGEW CHEM INT EDIT, V54, P1499, DOI 10.1002/anie.201409676; MacKay BA, 2004, CHEM REV, V104, P385, DOI 10.1021/cr020610c; MacLeod KC, 2013, NAT CHEM, V5, P559, DOI [10.1038/NCHEM.1620, 10.1038/nchem.1620]; Mansell SM, 2011, J AM CHEM SOC, V133, P9036, DOI 10.1021/ja2019492; McWilliams SF, 2015, ACCOUNTS CHEM RES, V48, P2059, DOI 10.1021/acs.accounts.5b00213; Nishibayashi Y, 2015, INORG CHEM, V54, P9234, DOI 10.1021/acs.inorgchem.5b00881; Odom AL, 1998, J AM CHEM SOC, V120, P5836, DOI 10.1021/ja980095t; Ohki Y, 2007, ANGEW CHEM INT EDIT, V46, P3180, DOI 10.1002/anie.200605245; Pool JA, 2004, NATURE, V427, P527, DOI 10.1038/nature02274; Rodriguez MM, 2011, SCIENCE, V334, P780, DOI 10.1126/science.1211906; Roussel P, 1998, J AM CHEM SOC, V120, P1070, DOI 10.1021/ja972933+; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Spek AL, 2015, ACTA CRYSTALLOGR C, V71, P9, DOI 10.1107/S2053229614024929; Spencer LP, 2006, P NATL ACAD SCI USA, V103, P17094, DOI 10.1073/pnas.0602132103; Spencer LP, 2009, ANGEW CHEM INT EDIT, V48, P3795, DOI 10.1002/anie.200806190; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tsui EY, 2013, NAT CHEM, V5, P293, DOI [10.1038/NCHEM.1578, 10.1038/nchem.1578]	38	166	169	18	358	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					332	+		10.1038/nature23279	http://dx.doi.org/10.1038/nature23279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28726827	Green Submitted			2022-12-28	WOS:000405844900030
J	Sacks, HS				Sacks, Henry S.			Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sacks, Henry S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							AASLD-IDSA, REC TEST MAN TREAT H; Collins JM, 2015, CLIN INFECT DIS, V61, P1304, DOI 10.1093/cid/civ474; Coward S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011821; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554	4	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC3	JC3		10.7326/ACPJC-2017-167-2-003	http://dx.doi.org/10.7326/ACPJC-2017-167-2-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715825				2022-12-28	WOS:000405573400004
J	Ash, C				Ash, Caroline			OUTBREAK	SCIENCE			English	Editorial Material																			0	1	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		144	145		10.1126/science.357.6347.144	http://dx.doi.org/10.1126/science.357.6347.144			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706035				2022-12-28	WOS:000405391700032
J	Santosh, P				Santosh, Paramala			THERAPEUTICS Stimulant medication to treat attention-deficit/hyperactivity disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Santosh, Paramala] South London & Maudsley NHS Fdn Trust, Ctr Intervent Paediat Psychopharmacol & Rare Dis, London, England; [Santosh, Paramala] Kings Coll London, Dept Child Psychiat, Inst Psychiat Psychol & Neurosci, London, England	South London & Maudsley NHS Trust; University of London; King's College London	Santosh, P (corresponding author), South London & Maudsley NHS Fdn Trust, Ctr Intervent Paediat Psychopharmacol & Rare Dis, London, England.; Santosh, P (corresponding author), Kings Coll London, Dept Child Psychiat, Inst Psychiat Psychol & Neurosci, London, England.	paramala.1.santosh@kcl.ac.uk		Santosh, Paramala/0000-0003-4830-5893				Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266; Banaschewski T, 2016, EVID-BASED MENT HEAL, V19, P97, DOI 10.1136/eb-2016-102461; Bolea-Alamanac B, 2014, J PSYCHOPHARMACOL, V28, P179, DOI 10.1177/0269881113519509; Boomsma DI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010621; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Charach A, 2013, PEDIATRICS, V131, pE1584, DOI 10.1542/peds.2012-0974; Cohen SC, 2015, J AM ACAD CHILD PSY, V54, P728, DOI 10.1016/j.jaac.2015.06.011; Coughlin CG, 2015, J CHILD ADOL PSYCHOP, V25, P611, DOI 10.1089/cap.2015.0075; Daley D, 2014, J AM ACAD CHILD PSY, V53, P835, DOI 10.1016/j.jaac.2014.05.013; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; Faraone SV, 2010, EUR CHILD ADOLES PSY, V19, P353, DOI 10.1007/s00787-009-0054-3; Fridman M, 2015, EUR PSYCHIAT, V30, P521, DOI 10.1016/j.eurpsy.2015.01.001; Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6; Hechtman L, 2016, J AM ACAD CHILD PSY, V55, P945, DOI 10.1016/j.jaac.2016.07.774; Hennissen L, 2017, CNS DRUGS, V31, P199, DOI 10.1007/s40263-017-0410-7; Hinshaw SP, 2015, WIRES COGN SCI, V6, P39, DOI 10.1002/wcs.1324; Hodgkins P, 2012, EUR CHILD ADOLES PSY, V21, P477, DOI 10.1007/s00787-012-0286-5; Hoogman Martine, 2017, Lancet Psychiatry, V4, P310, DOI 10.1016/S2215-0366(17)30049-4; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1088, DOI 10.1001/archpsyc.56.12.1088; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Middeldorp CM, 2016, J AM ACAD CHILD PSY, V55, P896, DOI 10.1016/j.jaac.2016.05.025; National Institute for Health and Care Excellence, 2008, ATT DEF HYP DIS DIAG; Punja S, 2016, COCHRANE DB SYST REV, V358; Rolon-Arroyo B, 2016, J CHILD FAM STUD, V25, P65, DOI 10.1007/s10826-015-0203-x; Romanos M, 2016, JAMA-J AM MED ASSOC, V316, P994, DOI 10.1001/jama.2016.10279; Santosh PJ, 2011, CNS DRUGS, V25, P737, DOI 10.2165/11593070-000000000-00000; Santosh PJ, 2005, CLIN NEUROSCI RES, V5, P307, DOI 10.1016/j.cnr.2005.09.010; Schrantee A, 2016, JAMA PSYCHIAT, V73, P955, DOI 10.1001/jamapsychiatry.2016.1572; Schweren LJS, 2016, J AM ACAD CHILD PSY, V55, P877, DOI 10.1016/j.jaac.2016.06.013; Sharma A, 2014, ANN PHARMACOTHER, V48, P209, DOI 10.1177/1060028013510699; Shaw P, 2016, JAMA-J AM MED ASSOC, V315, P1953, DOI 10.1001/jama.2016.3427; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Storebo OJ, 2016, EVID-BASED MENT HEAL, V19, P100, DOI 10.1136/eb-2016-102499; Storebo OJ, 2015, COCHRANE DB SYST REV, V358; Storebo OJ, 2016, JAMA-J AM MED ASSOC, V316, P995, DOI 10.1001/jama.2016.10300; Storebo OJ, 2016, EUR CHILD ADOLES PSY, V25, P1037, DOI 10.1007/s00787-016-0855-0; Stuhec M, 2015, J AFFECT DISORDERS, V178, P149, DOI 10.1016/j.jad.2015.03.006; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; Volkow N D, 2001, J Neurosci, V21, pRC121; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	41	4	5	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2017	358								j2945	10.1136/bmj.j2945	http://dx.doi.org/10.1136/bmj.j2945			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA9MW	28710152				2022-12-28	WOS:000405770700001
J	Dromey, M; Nwaneri, C; Wilson, D				Dromey, Michael; Nwaneri, Chukwuemeka; Wilson, David			Severe chest pain in an asthmatic patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dromey, Michael; Nwaneri, Chukwuemeka; Wilson, David] Chester Hosp, Chester, Cheshire, England		Dromey, M (corresponding author), Chester Hosp, Chester, Cheshire, England.	mike@dromey.co.uk						Al-Mufarrej F, 2008, J CARDIOTHORAC SURG, V3, DOI 10.1186/1749-8090-3-59; Bakhos CT, 2014, J AM COLL SURGEONS, V219, P713, DOI 10.1016/j.jamcollsurg.2014.06.001; Banki F, 2013, AM J SURG, V206, P1001, DOI 10.1016/j.amjsurg.2013.08.009; Caceres M, 2008, ANN THORAC SURG, V86, P962, DOI 10.1016/j.athoracsur.2008.04.067; Caceres M, 2009, LUNG, V187, P341, DOI 10.1007/s00408-009-9164-4; Dixit R, 2012, LUNG INDIA, V29, P295, DOI 10.4103/0970-2113.99126; Levin B, 1973, Clin Radiol, V24, P337, DOI 10.1016/S0009-9260(73)80050-9; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Okada M, 2014, RESPIR INVESTIG, V52, P36, DOI 10.1016/j.resinv.2013.06.001; Stack AM, 1996, PEDIATR EMERG CARE, V12, P98, DOI 10.1097/00006565-199604000-00008; Zimmermann M, 2017, SCAND J SURG, V106, P126, DOI 10.1177/1457496916654097	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2017	358								j2972	10.1136/bmj.j2972	http://dx.doi.org/10.1136/bmj.j2972			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MU	28705904				2022-12-28	WOS:000405770500002
J	Gueroussov, S; Weatheritt, RJ; O'Hanlon, D; Lin, ZY; Narula, A; Gingras, AC; Blencowe, BJ				Gueroussov, Serge; Weatheritt, Robert J.; O'Hanlon, Dave; Lin, Zhen-Yuan; Narula, Ashrut; Gingras, Anne-Claude; Blencowe, Benjamin J.			Regulatory Expansion in Mammals of Multivalent hnRNP Assemblies that Globally Control Alternative Splicing	CELL			English	Article							WEB SERVER; BINDING MOTIFS; R PACKAGE; PROTEIN; RNA; GENE; DISORDER; REGIONS; MECHANISMS; EXPRESSION	Alternative splicing (AS) patterns have diverged rapidly during vertebrate evolution, yet the functions of most species-and lineage-specific splicing events are not known. We observe that mammalian-specific AS events are enriched in transcript sequences encoding intrinsically disordered regions (IDRs) of proteins, in particular those containing glycine/tyrosine repeats that mediate formation of higher-order protein assemblies implicated in gene regulation and human disease. These evolutionary changes impact nearly all members of the hnRNP A and D families of RNA binding proteins. Regulation of these events requires formation of unusual, long-range mammalian-specific RNA duplexes. Differential inclusion of the alternative exons controls the formation of tyrosine-dependent multivalent hnRNP assemblies that, in turn, function to globally regulate splicing. Together, our results demonstrate that AS control of IDR-mediated interactions between hnRNPs represents an important and recurring mechanism underlying splicing regulation. Furthermore, this mechanism has expanded the regulatory capacity of mammalian cells.	[Gueroussov, Serge; Weatheritt, Robert J.; O'Hanlon, Dave; Narula, Ashrut; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Gueroussov, Serge; Narula, Ashrut; Gingras, Anne-Claude; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Weatheritt, Robert J.] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge, England; [Lin, Zhen-Yuan; Gingras, Anne-Claude] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; MRC Laboratory Molecular Biology; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Gueroussov, S; Blencowe, BJ (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.; Gueroussov, S; Blencowe, BJ (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	serge.gueroussov@utoronto.ca; b.blencowe@utoronto.ca	Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Weatheritt, Robert/0000-0003-3716-1783	CIHR; NSERC; OGS scholarships; CIHR postdoctoral fellowship; Marie Curie IOF fellowship	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); OGS scholarships; CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Marie Curie IOF fellowship(European Commission)	We gratefully acknowledge T. Sterne-Weiler for sharing Whippet software in advance of publication. We also thank D. Black for sharing unpublished results and M. Babu, E. Sharma, U. Braunschweig, B. Harpur, T. Gonatopoulos-Pournatzis, and K. Ha for helpful discussions and critical review of the manuscript. This work was supported by CIHR grants to A.-C.G. and B.J.B. S.G. was supported by NSERC and OGS scholarships. R.J.W. was supported by CIHR postdoctoral and Marie Curie IOF fellowships. B.J.B holds the University of Toronto Banbury Chair in Medical Research.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Blanchette M, 1997, RNA, V3, P405; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; Chen BB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r18; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Damianov A, 2016, CELL, V165, P606, DOI 10.1016/j.cell.2016.03.040; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gueroussov S, 2015, SCIENCE, V349, P868, DOI 10.1126/science.aaa8381; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Jelen N, 2007, PLOS GENET, V3, P1838, DOI 10.1371/journal.pgen.0030173; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lai D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks241; Lambert JP, 2013, NAT METHODS, V10, P1239, DOI [10.1038/NMETH.2702, 10.1038/nmeth.2702]; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Nicolas M, 2015, CURR BIOL, V25, P1799, DOI 10.1016/j.cub.2015.05.053; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Pellegrini M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S8; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Sterne-Weiler T., 2017, BIORXIV; Sundararaman B, 2016, MOL CELL, V61, P903, DOI 10.1016/j.molcel.2016.02.012; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu H, 2016, CELL, V165, P1055, DOI 10.1016/j.cell.2016.05.004; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yoon JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6248; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	63	75	75	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					324	+		10.1016/j.cell.2017.06.037	http://dx.doi.org/10.1016/j.cell.2017.06.037			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28709000	Bronze			2022-12-28	WOS:000405493900012
J	Timpka, S; Stuart, JJ; Tanz, LJ; Rimm, EB; Franks, PW; Rich-Edwards, JW				Timpka, Simon; Stuart, Jennifer J.; Tanz, Lauren J.; Rimm, Eric B.; Franks, Paul W.; Rich-Edwards, Janet W.			Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses' Health Study II: observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR RISK-FACTORS; TYPE-2 DIABETES-MELLITUS; BLOOD-PRESSURE; INCIDENT HYPERTENSION; STOP HYPERTENSION; PHYSICAL-ACTIVITY; WEIGHT-GAIN; DISEASE; WOMEN; OBESITY	OBJECTIVES To study the association between lifestyle risk factors and chronic hypertension by history of hypertensive disorders of pregnancy (HDP: gestational hypertension and pre-eclampsia) and investigate the extent to which these risk factors modify the association between HDP and chronic hypertension. DESIGN Prospective cohort study. SETTING Nurses' Health Study II (1991-2013). PARTICIPANTS 54 588 parous women aged 32 to 59 years with data on reproductive history and without previous chronic hypertension, stroke, or myocardial infarction. MAIN OUTCOME MEASURE Chronic hypertension diagnosed by a physician and indicated through nurse participant self report. Multivariable Cox proportional hazards models were used to investigate the development of chronic hypertension contingent on history of HDP and four lifestyle risk factors: post-pregnancy body mass index, physical activity, adherence to the Dietary Approaches to Stop Hypertension (DASH) diet, and dietary sodium/potassium intake. Potential effect modification (interaction) between each lifestyle factor and previous HDP was evaluated with the relative excess risk due to interaction. RESULTS 10% (n=5520) of women had a history of HDP at baseline. 13 971 cases of chronic hypertension occurred during 689 988 person years of follow-up. Being overweight or obese was the only lifestyle factor consistently associated with higher risk of chronic hypertension. Higher body mass index, in particular, also increased the risk of chronic hypertension associated with history of HDP (relative excess risk due to interaction P<0.01 for all age strata). For example, in women aged 40-49 years with previous HDP and obesity class I (body mass index 30.0-34.9), 25% (95% confidence interval 12% to 37%) of the risk of chronic hypertension was attributable to a potential effect of obesity that was specific to women with previous HDP. There was no clear evidence of effect modification by physical activity, DASH diet, or sodium/potassium intake on the association between HDP and chronic hypertension. CONCLUSION This study suggests that the risk of chronic hypertension after HDP might be markedly reduced by adherence to a beneficial lifestyle. Compared with women without a history of HDP, keeping a healthy weight seems to be especially important with such a history.	[Timpka, Simon; Stuart, Jennifer J.; Tanz, Lauren J.; Rich-Edwards, Janet W.] Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, 75 Francis St, Boston, MA 02115 USA; [Timpka, Simon; Rimm, Eric B.; Rich-Edwards, Janet W.] Harvard Med Sch, Boston, MA 02115 USA; [Timpka, Simon; Franks, Paul W.] Lund Univ, Diabet Ctr, Dept Clin Sci Malmo, Malmo, Sweden; [Stuart, Jennifer J.; Tanz, Lauren J.; Rimm, Eric B.; Rich-Edwards, Janet W.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rimm, Eric B.; Franks, Paul W.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Rimm, Eric B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Lund University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Timpka, S (corresponding author), Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, 75 Francis St, Boston, MA 02115 USA.; Timpka, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Timpka, S (corresponding author), Lund Univ, Diabet Ctr, Dept Clin Sci Malmo, Malmo, Sweden.	simon.timpka@med.lu.se	Franks, Paul/AAA-3300-2020; Timpka, Simon/ABG-2173-2020; Tanz, Lauren/AAX-5836-2020	Timpka, Simon/0000-0001-7445-7212; Stuart, Jennifer/0000-0003-2718-8827; Franks, Paul/0000-0002-0520-7604; Tanz, Lauren/0000-0002-4191-7427	Swedish Research Council; Bundy Academy, Lund, Sweden; Folksam Research Foundation, Sweden; Swedish Heart and Lung Association; Anna Lisa and Sven Erik Lundgren's Foundation, Sweden; Hulda and E Conrad Mossfelt's Foundation, Sweden; infrastructure grant [UM1 CA176726]; National Institutes of Health [NHLBI T32 HL 098048]; Novo Nordisk Fonden [NNF16OC0021020] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bundy Academy, Lund, Sweden; Folksam Research Foundation, Sweden; Swedish Heart and Lung Association(Swedish Heart-Lung Foundation); Anna Lisa and Sven Erik Lundgren's Foundation, Sweden; Hulda and E Conrad Mossfelt's Foundation, Sweden; infrastructure grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Fonden(Novo Nordisk Foundation)	ST is supported by an international postdoctoral grant from the Swedish Research Council. Additional project funding was granted by Bundy Academy, Lund, Sweden; Folksam Research Foundation, Sweden; the Swedish Heart and Lung Association; Anna Lisa and Sven Erik Lundgren's Foundation, Sweden; Hulda and E Conrad Mossfelt's Foundation, Sweden. The Nurses' Health Study II cohort is supported by an infrastructure grant (UM1 CA176726). The study funders did not have any role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. JJS is supported by a grant from the National Institutes of Health (NHLBI T32 HL 098048). All investigators are independent from funders.	Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Callaway LK, 2007, AM J EPIDEMIOL, V166, P421, DOI 10.1093/aje/kwm099; Carnethon MR, 2010, HYPERTENSION, V56, P49, DOI 10.1161/HYPERTENSIONAHA.109.147603; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cornelissen VA, 2011, HYPERTENSION, V58, P950, DOI 10.1161/HYPERTENSIONAHA.111.177071; Feldstein C, 2009, J AM SOC HYPERTENS, V3, P353, DOI 10.1016/j.jash.2009.10.001; Forman JP, 2008, HYPERTENSION, V52, P828, DOI 10.1161/HYPERTENSIONAHA.108.117630; Fraser A, 2013, HYPERTENSION, V62, P614, DOI 10.1161/HYPERTENSIONAHA.113.01513; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Freedman LS, 2015, AM J EPIDEMIOL, V181, P473, DOI 10.1093/aje/kwu325; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Girouard J, 2007, HYPERTENSION, V49, P1056, DOI 10.1161/HYPERTENSIONAHA.107.087528; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Heida KY, 2015, HYPERTENSION, V66, P1116, DOI 10.1161/HYPERTENSIONAHA.115.06005; Kaaja RJ, 2006, J HYPERTENS, V24, P131, DOI 10.1097/01.hjh.0000194121.19851.e5; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Landsberg L, 2013, OBESITY, V21, P8, DOI 10.1002/oby.20181; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mannisto T, 2013, CIRCULATION, V127, P681, DOI 10.1161/CIRCULATIONAHA.112.128751; Magnussen EB, 2009, OBSTET GYNECOL, V114, P961, DOI 10.1097/AOG.0b013e3181bb0dfc; Moore TJ, 2001, HYPERTENSION, V38, P155, DOI 10.1161/01.HYP.38.2.155; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Nicklas JM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-23; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Quattrin T, 2014, PEDIATRICS, V134, P290, DOI 10.1542/peds.2013-4084; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Samuels-Kalow ME, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.043; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Seely EW, 2015, SEMIN PERINATOL, V39, P276, DOI 10.1053/j.semperi.2015.05.006; Skurnik G, 2016, HYPERTENS PREGNANCY, V35, P371, DOI 10.3109/10641955.2016.1154967; Spaan J, 2012, HYPERTENSION, V60, P1368, DOI 10.1161/HYPERTENSIONAHA.112.198812; Stuart JJ, 2013, J WOMENS HEALTH, V22, P37, DOI 10.1089/jwh.2012.3740; Thorsdottir I, 2002, OBSTET GYNECOL, V99, P799, DOI 10.1016/S0029-7844(02)01946-4; Tobias DK, 2012, ARCH INTERN MED, V172, P1566, DOI 10.1001/archinternmed.2012.3747; TROY LM, 1995, INT J OBESITY, V19, P570; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P713, DOI 10.1097/EDE.0b013e31821db503; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; West F, 2010, BEHAV RES THER, V48, P1170, DOI 10.1016/j.brat.2010.08.008; Wikstrom AK, 2005, BJOG-INT J OBSTET GY, V112, P1486, DOI 10.1111/j.1471-0528.2005.00733.x; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; 2013, OBSTET GYNECOL, V122, P1122	51	49	51	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2017	358								j3024	10.1136/bmj.j3024	http://dx.doi.org/10.1136/bmj.j3024			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MT	28701338	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000405770400002
J	Twomey, EC; Yelshanskaya, MV; Grassucci, RA; Frank, J; Obolevsky, AIS				Twomey, Edward C.; Yelshanskaya, Maria V.; Grassucci, Robert A.; Frank, Joachim; Obolevsky, Alexander I. S.			Channel opening and gating mechanism in AMPA-subtype glutamate receptors	NATURE			English	Article							CRYOELECTRON MICROSCOPY; ELECTRON CRYOMICROSCOPY; HIPPOCAMPAL-NEURONS; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; SEIZURE CONTROL; ACTIVATION; DESENSITIZATION; ACID	AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-subtype ionotropic glutamate receptors mediate fast excitatory neurotransmission throughout the central nervous system. Gated by the neurotransmitter glutamate, AMPA receptors are critical for synaptic strength, and dysregulation of AMPA receptor-mediated signalling is linked to numerous neurological diseases. Here we use cryo-electron microscopy to solve the structures of AMPA receptor-auxiliary subunit complexes in the apo, antagonist-and agonist-bound states and determine the iris-like mechanism of ion channel opening. The ion channel selectivity filter is formed by the extended portions of the re-entrant M2 loops, while the helical portions of M2 contribute to extensive hydrophobic interfaces between AMPA receptor subunits in the ion channel. We show how the permeation pathway changes upon channel opening and identify conformational changes throughout the entire AMPA receptor that accompany activation and desensitization. Our findings provide a framework for understanding gating across the family of ionotropic glutamate receptors and the role of AMPA receptors in excitatory neurotransmission.	[Twomey, Edward C.; Yelshanskaya, Maria V.; Grassucci, Robert A.; Frank, Joachim; Obolevsky, Alexander I. S.] Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA; [Twomey, Edward C.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, 650 West 168th St, New York, NY 10032 USA; [Grassucci, Robert A.; Frank, Joachim] Howard Hughes Med Inst, 650 West 168th St, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, 650 West 168th St, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Obolevsky, AIS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA.	as4005@cumc.columbia.edu		Twomey, Edward/0000-0002-1855-1586	National Institutes of Health (NIH) [F31 NS093838]; NIH [R01 NS083660, R01 CA206573, R01 GM029169]; Pew Scholar Award in Biomedical Sciences; Irma T. Hirschl Career Scientist Award; Howard Hughes Medical Institute; Simons Foundation [349247]; NYSTAR; NIH National Institute of General Medical Sciences [GM103310]; NATIONAL CANCER INSTITUTE [R01CA206573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, P41GM103310, T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083660, F31NS093838] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award in Biomedical Sciences; Irma T. Hirschl Career Scientist Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation; NYSTAR; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Kao for computational support, A. des Georges, I. S. Fernandez, M. Fislage and A. K. Singh for processing advice. E.C.T. is supported by National Institutes of Health (NIH) F31 NS093838. A.I.S. is supported by the NIH (R01 NS083660, R01 CA206573), the Pew Scholar Award in Biomedical Sciences, and the Irma T. Hirschl Career Scientist Award. J.F. is supported by the Howard Hughes Medical Institute and the NIH (R01 GM029169). Cryo-EM data were collected at the Columbia University Medical Center cryo-EM facility and at the Simons Electron Microscopy Center and National Resource for Automated Molecular Microscopy located at the New York Structural Biology Center, supported by grants from the Simons Foundation (349247), NYSTAR, and the NIH National Institute of General Medical Sciences (GM103310).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chang P, 2016, BRAIN, V139, P431, DOI 10.1093/brain/awv325; Chang PS, 2015, J PHARMACOL EXP THER, V352, P43, DOI 10.1124/jpet.114.218768; Chater TE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00401; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gan Q, 2016, J BIOL CHEM, V291, P6595, DOI 10.1074/jbc.M115.686246; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Henley JM, 2016, NAT REV NEUROSCI, V17, P337, DOI 10.1038/nrn.2016.37; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; Huettner JE, 2015, J PHYSIOL-LONDON, V593, P49, DOI 10.1113/jphysiol.2014.272724; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lopez MN, 2013, J GEN PHYSIOL, V142, P225, DOI 10.1085/jgp.201311000; MacLean DM, 2014, J GEN PHYSIOL, V144, P503, DOI 10.1085/jgp.201411287; Mayer ML, 2016, CURR OPIN STRUC BIOL, V41, P119, DOI 10.1016/j.sbi.2016.07.002; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530; Salussolia CL, 2013, J NEUROSCI, V33, P9840, DOI 10.1523/JNEUROSCI.2626-12.2013; Salussolia CL, 2011, J BIOL CHEM, V286, P40205, DOI 10.1074/jbc.M111.268839; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shaikh SA, 2016, CELL REP, V17, P328, DOI 10.1016/j.celrep.2016.09.014; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2015, J PHYSIOL-LONDON, V593, P29, DOI 10.1113/jphysiol.2013.264911; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Twomey EC, 2017, NEURON, V94, P569, DOI 10.1016/j.neuron.2017.04.025; Twomey EC, 2016, SCIENCE, V353, P83, DOI 10.1126/science.aaf8411; Watson JF, 2017, ELIFE, V6, DOI 10.7554/eLife.23024; Wilding TJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4349; Yelshanskaya MV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01146-z; Yelshanskaya MV, 2016, NEURON, V91, P1305, DOI 10.1016/j.neuron.2016.08.012; Yelshanskaya MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep19082; Yelshanskaya MV, 2014, SCIENCE, V345, P1070, DOI 10.1126/science.1256508; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao Y, 2016, NATURE, V536, P108, DOI 10.1038/nature18961; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	68	133	133	0	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					60	+		10.1038/nature23479	http://dx.doi.org/10.1038/nature23479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28737760	Green Accepted			2022-12-28	WOS:000409388700032
J	Myers, KR				Myers, Kimberly R.			The Paradox of Mindfulness: Seamus Heaney's "St Kevin and the Blackbird"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Myers, Kimberly R.] Penn State Coll Med, Dept Humanities, H134,500 Univ Dr, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Myers, KR (corresponding author), Penn State Coll Med, Dept Humanities, H134,500 Univ Dr, Hershey, PA 17033 USA.	krm16@psu.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					427	428		10.1001/jama.2017.6164	http://dx.doi.org/10.1001/jama.2017.6164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763553				2022-12-28	WOS:000406659800012
J	Madigan, DJ; Boustany, A; Collette, BB				Madigan, Daniel J.; Boustany, Andre; Collette, Bruce B.			East not least for Pacific bluefin tuna	SCIENCE			English	Editorial Material							POPULATION; MIGRATION; FISH		[Madigan, Daniel J.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Boustany, Andre] Monterey Bay Aquarium, Nereus Program, 886 Cannery Row, Monterey, CA 93940 USA; [Boustany, Andre] Duke Univ, Marine Geospatial Ecol Lab, Nicholas Sch Environm, Durham, NC 27708 USA; [Collette, Bruce B.] Natl Museum Nat Hist, IUCN Tuna & Billfish Specialist Grp, Washington, DC 20560 USA	Harvard University; Monterey Bay Aquarium Research Institute; Duke University; Smithsonian Institution; Smithsonian National Museum of Natural History	Madigan, DJ (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	danieljmadigan@fas.harvard.edu	Collette, Bruce B./AAA-9532-2019					Baumann H, 2015, ICES J MAR SCI, V72, P2128, DOI 10.1093/icesjms/fsv062; Bayliff W. H., 1994, FAO FISH TECH PAP, V336, P244; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Cyranoski D, 2010, NATURE, V465, P280, DOI 10.1038/465280b; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; IATTC, 2016, 14 IATTC; Madigan DJ, 2018, CAN J FISH AQUAT SCI, V75, P260, DOI 10.1139/cjfas-2016-0504; Magnuson JJ, 2001, SCIENCE, V293, P1267, DOI 10.1126/science.1064052; NOAA Fisheries, 2016, PAC BLUEF TUN LIM FI; Polovina JJ, 1996, FISH OCEANOGR, V5, P114, DOI 10.1111/j.1365-2419.1996.tb00110.x; Tawa A, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3127-8	12	10	10	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					356	357		10.1126/science.aan3710	http://dx.doi.org/10.1126/science.aan3710			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28705987				2022-12-28	WOS:000406362300025
J	Fortelny, N; Overall, CM; Pavlidis, P; Freue, GVC				Fortelny, Nikolaus; Overall, Christopher M.; Pavlidis, Paul; Freue, Gabriela V. Cohen			Can we predict protein from mRNA levels?	NATURE			English	Letter									[Fortelny, Nikolaus; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Fortelny, Nikolaus; Pavlidis, Paul] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Fortelny, Nikolaus; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC, Canada; [Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Freue, Gabriela V. Cohen] Univ British Columbia, Dept Stat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Freue, GVC (corresponding author), Univ British Columbia, Dept Stat, Vancouver, BC, Canada.	gcohen@stat.ubc.ca	Pavlidis, Paul/H-8406-2013	Pavlidis, Paul/0000-0002-0426-5028; Fortelny, Nikolaus/0000-0003-4025-9968				Berman S., 2012, SIGNIFICANCE; Edfors F, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167144; Friendly M, 2013, STAT SCI, V28, P1, DOI 10.1214/12-STS402; Hocking, 2013, METHODS APPL LINEAR; Li JJ, 2015, SCIENCE, V347, P1066, DOI 10.1126/science.aaa8332; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319	9	106	106	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					E19	E22		10.1038/nature22293	http://dx.doi.org/10.1038/nature22293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28748932				2022-12-28	WOS:000406358300001
J	Tsherniak, A; Vazquez, F; Montgomery, PG; Weir, BA; Kryukov, G; Cowley, GS; Gill, S; Harrington, WF; Pantel, S; Krill-Burger, JM; Meyers, RM; Ali, L; Goodale, A; Lee, Y; Jiang, G; Hsiao, J; Gerath, WFJ; Howell, S; Merkel, E; Ghandi, M; Garraway, LA; Root, DE; Golub, TR; Boehm, JS; Hahn, WC				Tsherniak, Aviad; Vazquez, Francisca; Montgomery, Phil G.; Weir, Barbara A.; Kryukov, Gregory; Cowley, Glenn S.; Gill, Stanley; Harrington, William F.; Pantel, Sasha; Krill-Burger, John M.; Meyers, Robin M.; Ali, Levi; Goodale, Amy; Lee, Yenarae; Jiang, Guozhi; Hsiao, Jessica; Gerath, William F. J.; Howell, Sara; Merkel, Erin; Ghandi, Mahmoud; Garraway, Levi A.; Root, David E.; Golub, Todd R.; Boehm, Jesse S.; Hahn, William C.			Defining a Cancer Dependency Map	CELL			English	Article							THERAPEUTIC VULNERABILITIES; ESSENTIAL GENES; GENOME; RNAI; EXPRESSION; BREAST; IDENTIFICATION; PREDICTION; COMPLEXES; PROMOTES	Most human epithelial tumors harbor numerous alterations, making it difficult to predict which genes are required for tumor survival. To systematically identify cancer dependencies, we analyzed 501 genome-scale loss-of-function screens performed in diverse human cancer cell lines. We developed DEMETER, an analytical framework that segregates on-from off-target effects of RNAi. 769 genes were differentially required in subsets of these cell lines at a threshold of six SDs from the mean. We found predictive models for 426 dependencies (55%) by nonlinear regression modeling considering 66,646 molecular features. Many dependencies fall into a limited number of classes, and unexpectedly, in 82% of models, the top biomarkers were expression based. We demonstrated the basis behind one such predictive model linking hypermethylation of the UBB ubiquitin gene to a dependency on UBC. Together, these observations provide a foundation for a cancer dependency map that facilitates the prioritization of therapeutic targets.	[Tsherniak, Aviad; Vazquez, Francisca; Montgomery, Phil G.; Weir, Barbara A.; Kryukov, Gregory; Cowley, Glenn S.; Gill, Stanley; Harrington, William F.; Pantel, Sasha; Krill-Burger, John M.; Meyers, Robin M.; Ali, Levi; Goodale, Amy; Lee, Yenarae; Jiang, Guozhi; Hsiao, Jessica; Gerath, William F. J.; Howell, Sara; Merkel, Erin; Ghandi, Mahmoud; Garraway, Levi A.; Root, David E.; Golub, Todd R.; Boehm, Jesse S.; Hahn, William C.] Broad Inst Harvard & MIT, 415 Main St, Cambridge, MA 02142 USA; [Vazquez, Francisca; Weir, Barbara A.; Kryukov, Gregory; Gill, Stanley; Ali, Levi; Golub, Todd R.; Hahn, William C.] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA; [Ali, Levi; Hahn, William C.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Ali, Levi; Golub, Todd R.; Hahn, William C.] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA; [Garraway, Levi A.; Golub, Todd R.] Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hahn, WC (corresponding author), Broad Inst Harvard & MIT, 415 Main St, Cambridge, MA 02142 USA.; Hahn, WC (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA.; Hahn, WC (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Hahn, WC (corresponding author), Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Vazquez, Francisca/AAA-3751-2020; Vazquez, Francisca/ABC-4620-2020	Vazquez, Francisca/0000-0002-2857-4685; Krill-Burger, John Michael/0000-0001-9614-4671; Ghandi, Mahmoud/0000-0003-1897-2265; Gill, Stanley/0000-0001-5430-4550; Tsherniak, Aviad/0000-0002-3797-1877; Kryukov, Gregory/0000-0002-6131-9483; Ali, Levi/0000-0003-1148-7355	NIH [U01 CA176058]; NIH ICBP grant [U54 CA112962]; Carlos Slim Foundation in Mexico through Slim Initiative for Genomic Medicine; Novartis; NATIONAL CANCER INSTITUTE [P01CA203655, R01CA130988, U01CA176058, U01CA199253, U54CA112962] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH ICBP grant; Carlos Slim Foundation in Mexico through Slim Initiative for Genomic Medicine; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Andrew Tubelli for help with graphical design. Screening data can be accessed at https://portals.broadinstitute.org/achilles. All analysis results and software are available at https://depmap.org/rnai. This work was funded by NIH U01 CA176058 (to W.C.H.), NIH ICBP grant U54 CA112962 (to T.R.G.), and The Carlos Slim Foundation in Mexico through the Slim Initiative for Genomic Medicine (to T.R.G.). W.C.H. and L.A.G. report receiving commercial research grants from Novartis and is a consultant/advisory board member for the same. W.C.H. is a advisory board member for KSQ Therapeutics.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Aksoy BA, 2014, BIOINFORMATICS, V30, P2051, DOI 10.1093/bioinformatics/btu164; Ashton JM, 2012, CELL STEM CELL, V11, P359, DOI 10.1016/j.stem.2012.05.024; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Buchwalter G, 2013, CANCER CELL, V23, P753, DOI 10.1016/j.ccr.2013.04.026; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; D'Antonio M, 2013, CELL REP, V5, P1519, DOI 10.1016/j.celrep.2013.11.033; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kronke J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.941742; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Laury AR, 2011, AM J SURG PATHOL, V35, P816, DOI 10.1097/PAS.0b013e318216c112; Liu YH, 2015, NATURE, V520, P697, DOI 10.1038/nature14418; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Rosenbluh J, 2016, CELL SYST, V3, P302, DOI 10.1016/j.cels.2016.09.001; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmich F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0783-1; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wagner AH, 2016, NUCLEIC ACIDS RES, V44, pD1036, DOI 10.1093/nar/gkv1165; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Yilmazel B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-192; Zhang XD, 2011, BIOINFORMATICS, V27, P2775, DOI 10.1093/bioinformatics/btr474	55	901	904	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					564	+		10.1016/j.cell.2017.06.010	http://dx.doi.org/10.1016/j.cell.2017.06.010			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753430	Bronze, Green Accepted			2022-12-28	WOS:000406462400014
J	Barr, B; Higgerson, J; Whitehead, M				Barr, Ben; Higgerson, James; Whitehead, Margaret			Investigating the impact of the English health inequalities strategy: time trend analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMIC INEQUALITIES; MENTAL-HEALTH; ENGLAND; MORTALITY; RECESSION; AUSTERITY; WALES	OBJECTIVE To investigate whether the English health inequalities strategy was associated with a decline in geographical health inequalities, compared with trends before and after the strategy. DESIGN Time trend analysis. SETTING Two groups of lower tier local authorities in England. The most deprived, bottom fifth and the rest of England. INTERVENTION The English health inequalities strategy-a cross government strategy implemented between 1997 and 2010 to reduce health inequalities in England. Trends in geographical health inequalities were assessed before (1983-2003), during (2004-12), and after (2013-15) the strategy using segmented linear regression. MAIN OUTCOME MEASURE Geographical health inequalities measured as the relative and absolute differences in male and female life expectancy at birth between the most deprived local authorities in England and the rest of the country. RESULTS Before the strategy the gap in male and female life expectancy between the most deprived local authorities in England and the rest of the country increased at a rate of 0.57 months each year (95% confidence interval 0.40 to 0.74 months) and 0.30 months each year (0.12 to 0.48 months). During the strategy period this trend reversed and the gap in life expectancy for men reduced by 0.91 months each year (0.54 to 1.27 months) and for women by 0.50 months each year (0.15 to 0.86 months). Since the end of the strategy period the inequality gap has increased again at a rate of 0.68 months each year (-0.20 to 1.56 months) for men and 0.31 months each year (-0.26 to 0.88) for women. By 2012 the gap in male life expectancy was 1.2 years smaller (95% confidence interval 0.8 to 1.5 years smaller) and the gap in female life expectancy was 0.6 years smaller (0.3 to 1.0 years smaller) than it would have been if the trends in inequalities before the strategy had continued. CONCLUSION The English health inequalities strategy was associated with a decline in geographical inequalities in life expectancy, reversing a previously increasing trend. Since the strategy ended, inequalities have started to increase again. The strategy may have reduced geographical health inequalities in life expectancy, and future approaches should learn from this experience. The concerns are that current policies are reversing the achievements of the strategy.	[Barr, Ben; Higgerson, James; Whitehead, Margaret] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Barr, B (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England.	benbarr@liverpool.ac.uk	Barr, Ben R/W-9989-2018	Barr, Ben R/0000-0002-4208-9475; Higgerson, James/0000-0002-6037-0455	DEMETRIQ project; European Communities [278511]; National Institute for Health Research (NIHR) Collaboration for Leadership in Health Research and Care (CLAHRC NWC); NIHR	DEMETRIQ project; European Communities(European Commission); National Institute for Health Research (NIHR) Collaboration for Leadership in Health Research and Care (CLAHRC NWC); NIHR(National Institute for Health Research (NIHR))	MMW and JH were supported by the DEMETRIQ project, which was funded from the Commission of the European Communities seventh framework programme under grant agreement No 278511. The study does not necessarily reflect the commission's views and in no way anticipates the commission's future policy in this area.r BB is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Health Research and Care (CLAHRC NWC). The NIHR had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This report is independent research arising from research supported by the NIHR. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Acheson SD, 1998, INDEPENDENT INQUIRY; [Anonymous], LIF EXP BIRTH AG 65; [Anonymous], TREND LIF EXP BIRTH; [Anonymous], 2010, MARMOT REV; Asaria M, 2016, J EPIDEMIOL COMMUN H, V70, P637, DOI 10.1136/jech-2015-206742; Barr B, 2016, J EPIDEMIOL COMMUN H, V70, P339, DOI 10.1136/jech-2015-206209; Barr B, 2014, BMJ-BRIT MED J, V348, P3231, DOI [10.1136/bmj.g3231, DOI 10.1136/BMJ.G3231]; Barr B, 2015, SOC SCI MED, V147, P324, DOI 10.1016/j.socscimed.2015.11.009; Barr B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3231; Barr B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g160; Barr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7831; Bartoll X, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2204-5; Buck D, 2013, IMPROVING ALLOCATION; Buck D, 2015, CHANG TIME IMPLIC PO; Crawley M. J., 2007, R BOOK, DOI [10.1002/9780470515075, DOI 10.1002/9780470515075]; Department of Health, 2009, TACKL HLTH IN 10 YEA; Department of Health, 2003, TACKL HLTH IN PROGR; Department of Health, 1999, RED HLTH IN ACT REP; Department of Health, 2009, MORT TARG MON; Department of Health, 2008, TACKL HLTH IN 2007 S; Dixon A, 2012, EUR J PUBLIC HEALTH, V22, P9, DOI 10.1093/eurpub/ckq177; Drever F, 2000, SOCIAL INEQUALITIES; Driscoll JC, 1998, REV ECON STAT, V80, P549, DOI 10.1162/003465398557825; Granados J, 2005, EUR J POPUL, V21, P393, DOI 10.1007/s10680-005-4767-9; Great Britain. Neighbourhood Renewal Unit Great Britain. Office of the Deputy Prime Minister, 2004, NEIGHB REN UN GREAT; Green M, 2017, HEALTH PLACE, V44, P77, DOI 10.1016/j.healthplace.2017.02.002; Hiam L, 2017, J ROY SOC MED, V110, P131, DOI 10.1177/0141076817693600; Hiam L, 2017, J ROY SOC MED, V110, P153, DOI 10.1177/0141076817693599; Hippisley-Cox J., HLTH INEQUALITIES PR; Hoechle D, 2007, STATA J, V7, P281, DOI 10.1177/1536867X0700700301; House of Commons Health Committee, 2008, HLTH IN 3 REP SESS 2, V1; House of Commons Health Committee, 2017, PUBL HLTH POST 2013; Hu YN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3505-z; Joyce R, 2013, OXFORD REV ECON POL, V29, P178, DOI 10.1093/oxrep/grt008; Katikireddi SV, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001790; Kunst AE, 2001, MONITORING SOCIOECON; Loopstra R, 2016, J ROY SOC MED, V109, P109, DOI 10.1177/0141076816632215; Mackenbach JP, 2011, J EPIDEMIOL COMMUN H, V65, P568, DOI 10.1136/jech.2010.128280; Mackenbach JP, 2011, LANCET, V377, P1986, DOI 10.1016/S0140-6736(10)62055-7; Maheswaran H, 2015, SOC SCI MED, V136, P135, DOI 10.1016/j.socscimed.2015.05.026; Marmot M., 2013, REV SOC DET HLTH DIV; National Audit Office, TACKL IN LIF EXP AR; Office of National Statistics, 1979, SN 3625 LOC MORT DAT; Office of the Deputy Prime Minister, 2006, LOC AR AGR GUID; ONS, 2014, NOMIS OFF LAB MARK S; ONS, 2012, EXPL DIFF 2011 CENS; Parmar D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4588; Robinson S, 2010, SMOKING DRINKING ADU; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; Suhrcke M, 2012, SOC SCI MED, V74, P647, DOI 10.1016/j.socscimed.2011.12.011; Taylor-Robinson D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7350; Taylor-Robinson D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1487; Valkonen T, 2000, EUR J PUBLIC HEALTH, V10, P274, DOI 10.1093/eurpub/10.4.274	53	56	56	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j3310	10.1136/bmj.j3310	http://dx.doi.org/10.1136/bmj.j3310			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3UW	28747304	Green Published, hybrid			2022-12-28	WOS:000406765900003
J	Horton, R				Horton, Richard			Offline: NCDs-why are we failing?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	35	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					346	346						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28745593	Bronze			2022-12-28	WOS:000405911300009
J	Compston, J				Compston, Juliet			Bone-forming agents in non-responders to bisphosphonates	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; ANTIRESORPTIVE THERAPY; TERIPARATIDE TREATMENT; MINERAL DENSITY; OSTEOPOROSIS; ROMOSOZUMAB; ALENDRONATE		[Compston, Juliet] Dept Med, Cambridge Biomed Campus, Cambridge CB2 0SL, England		Compston, J (corresponding author), Dept Med, Cambridge Biomed Campus, Cambridge CB2 0SL, England.	jec1001@cam.ac.uk			Gilead; Amgen	Gilead(Gilead Sciences); Amgen(Amgen)	I have received advisory and speaking fees from Gilead related to tenofovir alafenamide, a new antiretroviral agent for treatment of HIV infection, and speaking fees from Amgen for a talk on the treatment gap in osteoporosis.	[Anonymous], 2017, AMG UCB ANN TOP LIN; Boonen S, 2008, J CLIN ENDOCR METAB, V93, P852, DOI 10.1210/jc.2007-0711; Clark EM, 2016, OSTEOPOROSIS INT, V27, P579, DOI 10.1007/s00198-015-3271-2; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; Cosman F, 2017, J BONE MINER RES, V32, P198, DOI 10.1002/jbmr.3051; Langdahl BL, 2017, LANCET; Ma YL, 2014, BONE, V59, P139, DOI 10.1016/j.bone.2013.11.011; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Miller PD, 2008, J CLIN ENDOCR METAB, V93, P3785, DOI 10.1210/jc.2008-0353; Obermayer-Pietsch BM, 2008, J BONE MINER RES, V23, P1591, DOI 10.1359/JBMR.080506; Ominsky MS, 2014, J BONE MINER RES, V29, P1424, DOI 10.1002/jbmr.2152; Tsai JN, 2015, J BONE MINER RES, V30, P39, DOI 10.1002/jbmr.2315	12	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2017	390	10102					1565	1566		10.1016/S0140-6736(17)31824-X	http://dx.doi.org/10.1016/S0140-6736(17)31824-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI3RA	28755781				2022-12-28	WOS:000411883300005
J	Hendlin, YH; Elias, J; Ling, PM				Hendlin, Yogi Hale; Elias, Jesse; Ling, Pamela M.			The Pharmaceuticalization of the Tobacco Industry	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hendlin, Yogi Hale; Elias, Jesse; Ling, Pamela M.] Univ Calif San Francisco, 530 Parnassus Ave,Suite 366, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ling, PM (corresponding author), Univ Calif San Francisco, 530 Parnassus Ave,Suite 366, San Francisco, CA 94143 USA.	pamela.ling@ucsf.edu	Hendlin, Yogi/Q-9777-2019	Hendlin, Yogi/0000-0002-1714-6132; Ling, Pamela/0000-0001-6166-9347	National Cancer Institute at the National Institutes of Health [R01-CA141661, R01-87472]; NATIONAL CANCER INSTITUTE [R01CA087472, R01CA141661] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute at the National Institutes of Health (grants R01-CA141661 and R01-87472).	Crowley RA, 2015, ANN INTERN MED, V162, P583, DOI 10.7326/M14-2481; Euromonitor International, 2016, GLOB TOB KEY FIND PA; Food and Drug Administration, 2017, FED REG, V82, P2193; Medicines and Healthcare products Regulatory Agency, 2017, LIC PROC EL CIG OTH; Philip Morris International, 2016, ASS RISK RED; Reynolds R.J., 2008, RJRT STRATEGIC REV; Syqe Medical, 2016, THE SYQ INH; WHO, 2008, GUID IMPL ART 5 3 WH; Williams SJ, 2011, SOCIOL HEALTH ILL, V33, P710, DOI 10.1111/j.1467-9566.2011.01320.x	9	19	19	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					278	+		10.7326/M17-0759	http://dx.doi.org/10.7326/M17-0759			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28715843	Green Accepted, Green Submitted			2022-12-28	WOS:000407797500017
J	Elosua-Gonzalez, M; Garcia-Zamora, E				Elosua-Gonzalez, Marta; Garcia-Zamora, Elena			Crusted Scabies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Elosua-Gonzalez, Marta; Garcia-Zamora, Elena] Hosp Univ Fdn Alcorcon, Alcorcon, Spain	Alcorcon Foundation University Hospital	Elosua-Gonzalez, M (corresponding author), Hosp Univ Fdn Alcorcon, Alcorcon, Spain.	mgonzaleze@fhalcorcon.es	Elosua-González, Marta/F-4250-2018	Elosua-González, Marta/0000-0002-4227-9316					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					476	476		10.1056/NEJMicm1616169	http://dx.doi.org/10.1056/NEJMicm1616169			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3NW	28767353				2022-12-28	WOS:000406747100009
J	Adshead, G				Adshead, Gwen			MEDICINE AND THE MEDIA Antidepressants and murder: case not closed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adshead, Gwen] Southern Hlth NHS Fdn Trust, Ravenswood House, Southampton, Hants, England		Adshead, G (corresponding author), Southern Hlth NHS Fdn Trust, Ravenswood House, Southampton, Hants, England.	g.adshead@nhs.net							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2017	358								j3697	10.1136/bmj.j3697	http://dx.doi.org/10.1136/bmj.j3697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CG	28768656				2022-12-28	WOS:000407206800011
J	Boland, JW; Boland, EG				Boland, Jason W.; Boland, Elaine G.			THERAPEUTICS Pharmacological therapies for opioid induced constipation in adults with cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROLONGED-RELEASE OXYCODONE; MODERATE; PAIN; EFFICACY; NALOXONE; SAFETY; IMPACT		[Boland, Jason W.; Boland, Elaine G.] Univ Hull, Wolfson Palliat Care Res Ctr, Hull York Med Sch, Palliat Med, Kingston Upon Hull HU6 7RX, N Humberside, England; [Boland, Elaine G.] Hull & East Yorkshire NHS Trust, Palliat Med, Kingston Upon Hull, N Humberside, England	University of Hull; University of York - UK	Boland, JW (corresponding author), Univ Hull, Wolfson Palliat Care Res Ctr, Hull York Med Sch, Palliat Med, Kingston Upon Hull HU6 7RX, N Humberside, England.	jason.boland@hyms.ac.uk	Boland, Jason/D-9843-2015	Boland, Jason/0000-0001-5272-3057; Boland, Elaine/0000-0003-2571-5929				Agra Y, 1998, J PAIN SYMPTOM MANAG, V15, P1, DOI 10.1016/S0885-3924(97)00276-5; Ahmedzai S., 2010, CLIN EVID, V2010, P2407; Ahmedzai S. H., 2015, BMJ CLIN EVID, V2015; Ahmedzai SH, 2012, PALLIATIVE MED, V26, P50, DOI 10.1177/0269216311418869; Bell Timothy, 2009, J Opioid Manag, V5, P137; Candrilli Sean D, 2009, J Pain Palliat Care Pharmacother, V23, P231, DOI 10.1080/15360280903098440; Candy B, 2011, SAO PAULO MED J, V129, P277, DOI 10.1002/14651858.CD003448.pub3; Chey WD, 2014, NEW ENGL J MED, V370, P2387, DOI 10.1056/NEJMoa1310246; DeLuca A, 1996, PHARMACOL THERAPEUT, V69, P103, DOI 10.1016/0163-7258(95)02053-5; Dunlop William, 2012, J Med Econ, V15, P564, DOI 10.3111/13696998.2012.665279; eMC, 2017, REL 12 MG 0 6 ML SOL; eMC, 2016, MOV 12 5 M G 25MG TA; eMC, 2017, TARG 5 MG 2 5 MG 10; Ford AC, 2013, AM J GASTROENTEROL, V108, P1566, DOI 10.1038/ajg.2013.169; Freedman MD, 1997, J CLIN PHARMACOL, V37, P904, DOI 10.1002/j.1552-4604.1997.tb04264.x; Gaertner J, 2015, J CLIN GASTROENTEROL, V49, P9, DOI 10.1097/MCG.0000000000000246; Joint Formulary Committee, 2017, BRIT NAT FORM BNF 73, V73; Lazzari M, 2015, DRUG DES DEV THER, V9, P5863, DOI 10.2147/DDDT.S92998; Lowenstein O, 2009, EXPERT OPIN PHARMACO, V10, P531, DOI [10.1517/14656560902796798, 10.1517/14656560902796798 ]; McNicol ED, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006332.pub2; Meissner W, 2009, EUR J PAIN, V13, P56, DOI 10.1016/j.ejpain.2008.06.012; Morlion B, 2015, CLIN DRUG INVEST, V35, P1, DOI 10.1007/s40261-014-0254-6; National Institute for Health and Care Excellence, 2012, PALL CAR AD STRONG O; National Institute for Health and Care Excellence, 2015, NAL TREAT OP IND CON; Nelson AD, 2016, THER ADV CHRONIC DIS, V7, P121, DOI 10.1177/2040622315627801; Panchal SJ, 2007, INT J CLIN PRACT, V61, P1181, DOI 10.1111/j.1742-1241.2007.01415.x; Twycross RG, 2014, PCF5 PALLIATIVE CARE; U. S. Food and Drug Administration, 2008, DRUG APPR PACK REL M; U. S. Food and Drug Administration, 2015, NEW DRUG APPL APPR M; Vondrackova D, 2008, J PAIN, V9, P1144, DOI 10.1016/j.jpain.2008.06.014; Webster L, 2014, ALIMENT PHARM THER, V40, P771, DOI 10.1111/apt.12899	31	11	11	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2017	358								j3313	10.1136/bmj.j3313	http://dx.doi.org/10.1136/bmj.j3313			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CG	28768637				2022-12-28	WOS:000407206800001
J	Chen, LM; Epstein, AM; Orav, EJ; Filice, CE; Samson, LW; Maddox, KEJ				Chen, Lena M.; Epstein, Arnold M.; Orav, E. John; Filice, Clara E.; Samson, Lok Wong; Maddox, Karen E. Joynt			Association of Practice-Level Social and Medical Risk With Performance in the Medicare Physician Value-Based Payment Modifier Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; MULTIPLE CHRONIC CONDITIONS; READMISSIONS REDUCTION PROGRAM; SAFETY-NET HOSPITALS; HEALTH-CARE; RACIAL DISPARITIES; RANDOMIZED-TRIAL; DUAL ELIGIBLES; PAY; MULTIMORBIDITY	IMPORTANCE Medicare recently launched the Physician Value-Based Payment Modifier (PVBM) Program, a mandatory pay-for-performance program for physician practices. Little is known about performance by practices that serve socially or medically high-risk patients. OBJECTIVE To compare performance in the PVBM Program by practice characteristics. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional observational study using PVBM Program data for payments made in 2015 based on performance of large US physician practices caring for fee-for-service Medicare beneficiaries in 2013. EXPOSURES High social risk (defined as practices in the top quartile of proportion of patients dually eligible for Medicare and Medicaid) and high medical risk (defined as practices in the top quartile of mean Hierarchical Condition Category risk score among fee-for-service beneficiaries). MAIN OUTCOMES AND MEASURES Quality and cost z scores based on a composite of individual measures. Higher z scores reflect better performance on quality; lower scores, better performance on costs. RESULTS Among 899 physician practices with 5 189 880 beneficiaries, 547 practices were categorized as low risk (neither high social nor high medical risk) (mean, 7909 beneficiaries; mean, 320 clinicians), 128 were high medical risk only (mean, 3675 beneficiaries; mean, 370 clinicians), 102 were high social risk only (mean, 1635 beneficiaries; mean, 284 clinicians), and 122 were high medical and social risk (mean, 1858 beneficiaries; mean, 269 clinicians). Practices categorized as low risk performed the best on the composite quality score (z score, 0.18 [95% CI, 0.09 to 0.28]) compared with each of the practices categorized as high risk (high medical risk only: z score, -0.55 [95% CI, -0.77 to -0.32]; high social risk only: z score, -0.86 [95% CI, -1.17 to -0.54]; and high medical and social risk: -0.78 [95% CI, -1.04 to -0.51]) (P < .001 across groups). Practices categorized as high social risk only performed the best on the composite cost score (z score, -0.52 [95% CI, -0.71 to -0.33]), low risk had the next best cost score (z score, -0.18 [95% CI, -0.25 to -0.10]), then high medical and social risk (z score, 0.40 [95% CI, 0.23 to 0.57]), and then high medical risk only (z score, 0.82 [95% CI, 0.65 to 0.99]) (P < .001 across groups). Total per capita costs were $9506 for practices categorized as low risk, $13 683 for high medical risk only, $8214 for high social risk only, and $11 692 for high medical and social risk. These patterns were associated with fewer bonuses and more penalties for high-risk practices. CONCLUSIONS AND RELEVANCE During the first year of the Medicare Physician Value-Based Payment Modifier Program, physician practices that served more socially high-risk patients had lower quality and lower costs, and practices that served more medically high-risk patients had lower quality and higher costs.	[Chen, Lena M.] Univ Michigan, Dept Internal Med, Div Gen Med, Ann Arbor, MI 48109 USA; [Chen, Lena M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Chen, Lena M.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Chen, Lena M.; Samson, Lok Wong; Maddox, Karen E. Joynt] US Dept Hlth & Human Serv, Off Assistant Secretary Planning & Evaluat, Washington, DC USA; [Epstein, Arnold M.; Orav, E. John; Maddox, Karen E. Joynt] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Epstein, Arnold M.; Orav, E. John; Maddox, Karen E. Joynt] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Filice, Clara E.] Atrius Hlth, Newton, MA USA; [Filice, Clara E.] Univ Massachusetts, Sch Med, Commonwealth Med, Shrewsbury, MA USA; [Maddox, Karen E. Joynt] Washington Univ, Sch Med, St Louis, MO USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; Washington University (WUSTL)	Chen, LM (corresponding author), Univ Michigan, Div Gen Med, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA.	lenac@umich.edu			US Department of Health and Human Services; National Institute on Aging [P01 AG019783]; Agency for Healthcare Research and Quality [R01 HS024698]; Career Development Grant Award from the National Heart, Lung, and Blood Institute [K23-HL109177-03]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS024698] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	US Department of Health and Human Services; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Career Development Grant Award from the National Heart, Lung, and Blood Institute; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the US Department of Health and Human Services. Dr Chen is currently supported by grant P01 AG019783 from the National Institute on Aging and grant R01 HS024698 from the Agency for Healthcare Research and Quality. Dr Joynt Maddox is supported by Career Development Grant Award K23-HL109177-03 from the National Heart, Lung, and Blood Institute.	Allen SM, 2014, J GERONTOL B-PSYCHOL, V69, pS51, DOI 10.1093/geronb/gbu124; Alshamsan R, 2010, J HEALTH SERV RES PO, V15, P178, DOI 10.1258/jhsrp.2010.009113; Bae S, 2008, J GEN INTERN MED, V23, P1933, DOI 10.1007/s11606-008-0784-9; Bardach NS, 2013, JAMA-J AM MED ASSOC, V310, P1051, DOI 10.1001/jama.2013.277353; Bennett KJ, 2016, J RURAL HEALTH, V32, P188, DOI 10.1111/jrh.12140; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Centers for Medicare and Medicaid Services, 2015, 2015 VAL BAS PAYM MO; Centers for Medicare & Medicaid Services (CMS), 2016, FED REGISTER, V81, P77008; Coughlin TA, 2012, HEALTH AFFAIR, V31, P1083, DOI 10.1377/hlthaff.2011.0729; Dale SB, 2016, NEW ENGL J MED, V374, P2345, DOI 10.1056/NEJMsa1414953; Deswal A, 2006, AM HEART J, V152, P348, DOI 10.1016/j.ahj.2005.12.004; Fiscella K, 2016, ANNU REV PUBL HEALTH, V37, P375, DOI 10.1146/annurev-publhealth-032315-021439; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Gilman M, 2015, ANN INTERN MED, V163, P427, DOI 10.7326/M14-2813; Gilman M, 2015, HEALTH AFFAIR, V34, P398, DOI 10.1377/hlthaff.2014.1059; Hausmann LRM, 2013, MED CARE, V51, P532, DOI 10.1097/MLR.0b013e318287d6e5; Hayes S, 2016, HIGH NEED HIGH COST; Heisler M, 2003, MED CARE, V41, P1221, DOI 10.1097/01.MLR.0000093421.64618.9C; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Joynt KE, 2017, NEW ENGL J MED, V376, P510, DOI 10.1056/NEJMp1616278; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Komisar HL, 2005, INQUIRY-J HEALTH CAR, V42, P171, DOI 10.5034/inquiryjrnl_42.2.171; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Medicare Payment Advisory Commission, 2015, MARCH 2015 REP C MED; Min LL, 2014, J AM GERIATR SOC, V62, P1714, DOI 10.1111/jgs.12989; Min LC, 2007, MED CARE, V45, P480, DOI 10.1097/MLR.0b013e318030fff9; Petersen LA, 2013, JAMA-J AM MED ASSOC, V310, P1042, DOI 10.1001/jama.2013.276303; Ryan AM, 2016, LANCET, V388, P268, DOI 10.1016/S0140-6736(16)00276-2; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Sequist TD, 2008, ARCH INTERN MED, V168, P1145, DOI 10.1001/archinte.168.11.1145; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Streit S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096142; Tao WJ, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1805-8; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yoon J, 2014, MED CARE, V52, pS31, DOI 10.1097/MLR.0000000000000061; Zarabozo C., 2015, FACTORS AFFECTING VA	38	50	50	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					453	461		10.1001/jama.2017.9643	http://dx.doi.org/10.1001/jama.2017.9643			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC2HZ	28763549	Green Published			2022-12-28	WOS:000406659800016
J	Voelker, R				Voelker, Rebecca			Extended-Release ADHD Drug	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					416	416		10.1001/jama.2017.9338	http://dx.doi.org/10.1001/jama.2017.9338			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763533				2022-12-28	WOS:000406659800006
J	Cross, R				Cross, Ryan			BIOMEDICINE 'Scientific wellness' study divides researchers	SCIENCE			English	News Item																			0	2	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					345	345		10.1126/science.357.6349.345	http://dx.doi.org/10.1126/science.357.6349.345			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751591				2022-12-28	WOS:000406362300019
J	Stone, JH; Tuckwell, K; Dimonaco, S; Klearman, M; Aringer, M; Blockmans, D; Brouwer, E; Cid, MC; Dasgupta, B; Rech, J; Salvarani, C; Schett, G; Schulze-Koops, H; Spiera, R; Unizony, SH; Collinson, N				Stone, J. H.; Tuckwell, K.; Dimonaco, S.; Klearman, M.; Aringer, M.; Blockmans, D.; Brouwer, E.; Cid, M. C.; Dasgupta, B.; Rech, J.; Salvarani, C.; Schett, G.; Schulze-Koops, H.; Spiera, R.; Unizony, S. H.; Collinson, N.			Trial of Tocilizumab in Giant-Cell Arteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; POLYMYALGIA-RHEUMATICA; CORTICOSTEROID REQUIREMENTS; INTERLEUKIN-6; MULTICENTER; DURATION; THERAPY; ALPHA	BACKGROUND Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolonged use of glucocorticoids is associated with side effects. The effect of the interleukin-6 receptor alpha inhibitor tocilizumab on the rates of relapse during glucocorticoid tapering was studied in patients with giant-cell arteritis. METHODS In this 1-year trial, we randomly assigned 251 patients, in a 2: 1: 1: 1 ratio, to receive subcutaneous tocilizumab (at a dose of 162 mg) weekly or every other week, combined with a 26-week prednisone taper, or placebo combined with a prednisone taper over a period of either 26 weeks or 52 weeks. The primary outcome was the rate of sustained glucocorticoid-free remission at week 52 in each tocilizumab group as compared with the rate in the placebo group that underwent the 26-week prednisone taper. The key secondary outcome was the rate of remission in each tocilizumab group as compared with the placebo group that underwent the 52-week prednisone taper. Dosing of prednisone and safety were also assessed. RESULTS Sustained remission at week 52 occurred in 56% of the patients treated with tocilizumab weekly and in 53% of those treated with tocilizumab every other week, as compared with 14% of those in the placebo group that underwent the 26-week prednisone taper and 18% of those in the placebo group that underwent the 52-week prednisone taper (P<0.001 for the comparisons of either active treatment with placebo). The cumulative median prednisone dose over the 52-week period was 1862 mg in each tocilizumab group, as compared with 3296 mg in the placebo group that underwent the 26-week taper (P<0.001 for both comparisons) and 3818 mg in the placebo group that underwent the 52-week taper (P<0.001 for both comparisons). Serious adverse events occurred in 15% of the patients in the group that received tocilizumab weekly, 14% of those in the group that received tocilizumab every other week, 22% of those in the placebo group that underwent the 26-week taper, and 25% of those in the placebo group that underwent the 52-week taper. Anterior ischemic optic neuropathy developed in one patient in the group that received tocilizumab every other week. CONCLUSIONS Tocilizumab, received weekly or every other week, combined with a 26-week prednisone taper was superior to either 26-week or 52-week prednisone tapering plus placebo with regard to sustained glucocorticoid-free remission in patients with giant-cell arteritis. Longer follow-up is necessary to determine the durability of remission and safety of tocilizumab.	[Stone, J. H.; Unizony, S. H.] Harvard Med Sch, Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA USA; [Tuckwell, K.; Dimonaco, S.; Collinson, N.] Roche Prod, Welwyn Garden City, Herts, England; [Dasgupta, B.] Southend Univ Hosp NHS Fdn Trust, Westcliff On Sea, England; [Klearman, M.] Genentech Inc, San Francisco, CA USA; [Aringer, M.] Tech Univ Dresden, Dept Rheumatol, Univ Med Ctr, Med 3, Dresden, Germany; [Aringer, M.] Tech Univ Dresden, Fac Med, Dresden, Germany; [Rech, J.] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany; [Schett, G.] Univ Klinikum Erlangen, Inst Clin Immunol, Erlangen, Germany; [Schulze-Koops, H.] Univ Munich, Div Rheumatol & Clin Immunol, Dept Med 4, Munich, Germany; [Blockmans, D.] Univ Hosp Gasthuisberg, Dept Gen Internal Med, Leuven, Belgium; [Brouwer, E.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Cid, M. C.] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Hosp Clin, Dept Autoimmune Dis, Barcelona, Spain; [Salvarani, C.] Azienda Osped Ist Ricovero & Cura Carattere Sci R, Div Internal Med, Reggio Emilia, Italy; [Salvarani, C.] Univ Modena & Reggio Emilia, Reggio Emilia, Italy; [Spiera, R.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Roche Holding; Roche Holding; Genentech; Technische Universitat Dresden; Technische Universitat Dresden; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Munich; KU Leuven; University Hospital Leuven; University of Groningen; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universita di Modena e Reggio Emilia	Stone, JH (corresponding author), Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	jhstone@mgh.harvard.edu	Brouwer, Elisabeth/AAL-9029-2020; Aringer, Martin/AAJ-7641-2020; Salvarani, Carlo/K-2431-2018; Spiera, Robert/W-7479-2019; Cid, Maria C./J-4553-2016; Brouwer, Elisabeth/A-3198-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Aringer, Martin/0000-0003-4471-8375; Cid, Maria C./0000-0002-4730-0938; Brouwer, Elisabeth/0000-0002-5652-4423; Unizony, Sebastian/0000-0002-8935-7473	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	Funded by F. Hoffmann-La Roche; ClinicalTrials.gov number, NCT01791153.	ANDERSSON R, 1986, ACTA MED SCAND, V220, P465; Collinson N, 2015, INT J RHEUMATOL, V2015, DOI 10.1155/2015/589841; DASGUPTA B, 1990, BRIT J RHEUMATOL, V29, P456; Dejaco C, 2017, RHEUMATOLOGY, V56, P506, DOI 10.1093/rheumatology/kew273; Evans J, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000137; Fraser J Alexander, 2008, Rev Neurol Dis, V5, P140; Garcia-Martinez A, 2010, ARTHRIT CARE RES, V62, P835, DOI 10.1002/acr.20043; Genovese MC, 2013, J RHEUMATOL, V40, P768, DOI 10.3899/jrheum.120687; Gonzalez-Gay Miguel A, 2010, Curr Rheumatol Rep, V12, P436, DOI 10.1007/s11926-010-0135-9; Hayreh SS, 2003, OPHTHALMOLOGY, V110, P1204, DOI 10.1016/S0161-6420(03)00228-8; Hernandez-Rodriguez J, 2004, RHEUMATOLOGY, V43, P294, DOI 10.1093/rheumatology/keh058; Hernandez-Rodriguez J, 2002, ARTHRIT RHEUM-ARTHR, V47, P29, DOI 10.1002/art1.10161; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Kermani TA, 2015, J RHEUMATOL, V42, P1213, DOI 10.3899/jrheum.141347; Koster MJ, 2016, CURR OPIN RHEUMATOL, V28, P211, DOI 10.1097/BOR.0000000000000265; Loricera J, 2015, SEMIN ARTHRITIS RHEU, V44, P717, DOI 10.1016/j.semarthrit.2014.12.005; Oliveira F, 2014, CLIN EXP RHEUMATOL, V32, pS76; Petri H, 2015, ARTHRIT CARE RES, V67, P390, DOI 10.1002/acr.22429; Proven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388; Regent A, 2016, J RHEUMATOL, V43, P1547, DOI 10.3899/jrheum.151252; ROCHE NE, 1993, ARTHRITIS RHEUM, V36, P1286, DOI 10.1002/art.1780360913; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Salvarani C, 2012, NAT REV RHEUMATOL, V8, P509, DOI 10.1038/nrrheum.2012.97; Schmidt J, 2016, ARTHRITIS RHEUMATOL, V68, P1477, DOI 10.1002/art.39596; Seitz M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13156; Tuckwell K, 2017, SEMIN ARTHRITIS RHEU, V46, P657, DOI 10.1016/j.semarthrit.2016.11.002; Unizony S, 2012, ARTHRIT CARE RES, V64, P1720, DOI 10.1002/acr.21750; Unizony SH, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/912562; Villiger PM, 2016, LANCET, V387, P1921, DOI 10.1016/S0140-6736(16)00560-2; VINICKI J P, 2016, REUMATOL CLIN; Weyand CM, 2000, ARTHRITIS RHEUM, V43, P1041, DOI 10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7	31	646	660	3	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					317	328		10.1056/NEJMoa1613849	http://dx.doi.org/10.1056/NEJMoa1613849			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28745999	Green Published, Bronze			2022-12-28	WOS:000406295000004
J	Supek, F; Lehner, B				Supek, Fran; Lehner, Ben			Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes	CELL			English	Article							MISMATCH REPAIR; POLYMERASE-ETA; CANCER GENOMES; LIVER-CANCER; HUMAN-CELLS; REPLICATION; LANDSCAPE; HYPERMUTATION; STRESS; STRAND	Many processes can cause the same nucleotide change in a genome, making the identification of the mechanisms causing mutations a difficult challenge. Here, we show that clustered mutations provide a more precise fingerprint of mutagenic processes. Of nine clustered mutation signatures identified from > 1,000 tumor genomes, three relate to variable APOBEC activity and three are associated with tobacco smoking. An additional signature matches the spectrum of translesion DNA polymerase eta (POLH). In lymphoid cells, these mutations target promoters, consistent with AID-initiated somatic hypermutation. In solid tumors, however, they are associated with UV exposure and alcohol consumption and target the H3K36me3 chromatin of active genes in a mismatch repair (MMR)-dependent manner. These regions normally have a low mutation rate because error-freeMMR also targets H3K36me3 chromatin. Carcinogens and error-prone repair therefore redistribute mutations to the more important regions of the genome, contributing a substantial mutation load in many tumors, including driver mutations.	[Supek, Fran; Lehner, Ben] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Supek, Fran; Lehner, Ben] Univ Pompeu Fabra, Barcelona 08003, Spain; [Supek, Fran] Rudjer Boskovic Inst, Div Elect, Zagreb 10000, Croatia; [Lehner, Ben] ICREA, Barcelona 08010, Spain; [Supek, Fran] Barcelona Inst Sci & Technol, IRB Barcelona, Barcelona 08028, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Rudjer Boskovic Institute; ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Lehner, B (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain.; Lehner, B (corresponding author), Univ Pompeu Fabra, Barcelona 08003, Spain.; Lehner, B (corresponding author), ICREA, Barcelona 08010, Spain.	ben.lehner@crg.eu	Lehner, Ben/L-3413-2014; Supek, Fran/B-2359-2012	Lehner, Ben/0000-0002-8817-1124; Supek, Fran/0000-0002-7811-6711	ERC [616434]; MINECO [BFU2011-26206, SEV-2012-0208]; AXA Research Fund (AXA); Bettencourt Schueller Foundation; AGAUR [2014 SGR 831]; FP7 projects [4DCellFate 277899, MAESTRA ICT-2013-612944, InnoMol FP7-REGPOT-2012-2013-1-316289]; EMBL-CRG Systems Biology Program; CERCA program	ERC(European Research Council (ERC)European Commission); MINECO(Spanish Government); AXA Research Fund (AXA); Bettencourt Schueller Foundation; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); FP7 projects; EMBL-CRG Systems Biology Program; CERCA program	This work was supported by grants from the ERC (616434), MINECO (BFU2011-26206 and SEV-2012-0208), AXA Research Fund (AXA Chair in Risk Prediction in Age-related Diseases), Bettencourt Schueller Foundation, AGAUR (2014 SGR 831), FP7 (projects 4DCellFate 277899, MAESTRA ICT-2013-612944, and InnoMol FP7-REGPOT-2012-2013-1-316289), the EMBL-CRG Systems Biology Program, and the CERCA program.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Chahwan R, 2012, SEMIN IMMUNOL, V24, P293, DOI 10.1016/j.smim.2012.05.005; Chen JM, 2013, HUM MUTAT, V34, P1119, DOI 10.1002/humu.22341; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Dvorak K, 2007, GUT, V56, P763, DOI 10.1136/gut.2006.103697; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Satou K, 2009, DNA REPAIR, V8, P637, DOI 10.1016/j.dnarep.2008.12.009; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Seplyarskiy VB, 2016, GENOME RES, V26, P174, DOI 10.1101/gr.197046.115; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Wang Q, 2014, P NATL ACAD SCI USA, V111, P18667, DOI 10.1073/pnas.1420575111; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Yaari G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00358; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zheng CL, 2014, CELL REP, V9, P1228, DOI 10.1016/j.celrep.2014.10.031; Zlatanou A, 2011, MOL CELL, V43, P649, DOI 10.1016/j.molcel.2011.06.023	29	99	101	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					534	+		10.1016/j.cell.2017.07.003	http://dx.doi.org/10.1016/j.cell.2017.07.003			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753428	Green Published, Bronze			2022-12-28	WOS:000406462400012
J	Carroll, AE				Carroll, Aaron E.			Why Is US Maternal Mortality Rising?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Carroll, Aaron E.] Indiana Univ Sch Med, Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Carroll, AE (corresponding author), Indiana Univ Sch Med, Pediat, Indianapolis, IN 46202 USA.	aaecarro@iu.edu							0	23	23	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					321	321		10.1001/jama.2017.8390	http://dx.doi.org/10.1001/jama.2017.8390			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742896				2022-12-28	WOS:000406296700002
J	Beyrer, C; Das, P; Horton, R; Ryan, O; Bekker, LG				Beyrer, Chris; Das, Pamela; Horton, Richard; Ryan, Owen; Bekker, Linda-Gail			The International AIDS Society-Lancet Commission on the future of the HIV response and global health	LANCET			English	Editorial Material									[Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Beyrer, Chris; Ryan, Owen; Bekker, Linda-Gail] IAS, Geneva, Switzerland; [Das, Pamela; Horton, Richard] The Lancet, London, England; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Res Fdn, Cape Town, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.; Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cbeyrer@jhu.edu	Bekker, Linda-Gail/AAZ-8929-2020	BEKKER, LINDA-GAIL/0000-0002-0755-4386	Bill & Melinda Gates Foundation; Ford Foundation; US National Institutes of Health/NIAID [P30AI094189]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ford Foundation; US National Institutes of Health/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CB is immediate past president and LG-B is President of the IAS. We declare no other competing interests. The IAS-Lancet Commission on the future of the HIV response and global health is supported, in part, by grants to the International AIDS Society, and to the Center for Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health from the Bill & Melinda Gates Foundation; The Ford Foundation, and the US National Institutes of Health/NIAID to the Johns Hopkins Center for AIDS Research (P30AI094189).	Altice FL, 2016, LANCET, V388, P1228, DOI 10.1016/S0140-6736(16)30856-X; Beyrer C, 2015, LANCET, V385, P1482, DOI 10.1016/S0140-6736(15)60724-3; International Aids Society, 2015, S SESS 9 IAS SCI C V; Karim QA, 2017, JAIDS-J ACQ IMM DEF, V75, pS17, DOI [10.1097/QAI.0000000000001316, 10.1097/qai.0000000000001316]; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; UNAIDS, 2016, PREV GAP REP 2016; WHO, 2017, WHO HIV DAT	7	9	9	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					344	345						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28745592	Green Accepted			2022-12-28	WOS:000405911300008
J	Lawton, MT; Vates, GE				Lawton, Michael T.; Vates, G. Edward			Subarachnoid Hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; CEREBRAL VASOSPASM; ENDOVASCULAR COILING; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; NATURAL-HISTORY; EPIDEMIOLOGY; TRIAL; PREDICTORS; GUIDELINES	A 17-year-old boy had a sudden headache and briefly lost consciousness while at soccer practice. On arrival at the emergency department, he appeared drowsy and reported having the worst headache he had ever had. His blood pressure was 186/92 mm Hg. The neurologic examination was normal. Computed tomography (CT) of the head without contrast enhancement showed diffuse subarachnoid hemorrhage and enlargement of the temporal horns of the lateral ventricles. How should this patient be further evaluated and treated?	[Lawton, Michael T.] St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA; [Vates, G. Edward] Univ Rochester, Med Ctr, Dept Neurosurg, 601 Elmwood Ave,Box 670, Rochester, NY 14642 USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Rochester	Lawton, MT (corresponding author), St Josephs Hosp, Dept Neurosurg, Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA.; Vates, GE (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, 601 Elmwood Ave,Box 670, Rochester, NY 14642 USA.	michael.lawton@barrowbrainandspine.com; edward_vates@urmc.rochester.edu						Agid R, 2010, AM J NEURORADIOL, V31, P696, DOI 10.3174/ajnr.A1884; BASSI P, 1991, ACTA NEUROL SCAND, V84, P277, DOI 10.1111/j.1600-0404.1991.tb04954.x; Boogaarts HD, 2014, J NEUROSURG, V120, P605, DOI 10.3171/2013.9.JNS13640; Bor ASE, 2010, NEUROLOGY, V74, P1671, DOI 10.1212/WNL.0b013e3181e04297; Broderick JP, 2009, STROKE, V40, P1952, DOI 10.1161/STROKEAHA.108.542571; Brown RD, 2014, LANCET NEUROL, V13, P393, DOI 10.1016/S1474-4422(14)70015-8; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cortnum S, 2010, NEUROSURGERY, V66, P900, DOI [10.1227/01.NEU.0000367722.66098.21, 10.1227/01. NEU.0000367722.66098.21]; Czuczman AD, 2013, ACAD EMERG MED, V20, P247, DOI 10.1111/acem.12095; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000277.pub3; Dorsch N W, 1994, J Clin Neurosci, V1, P19, DOI 10.1016/0967-5868(94)90005-1; DRAKE CG, 1988, J NEUROSURG, V68, P985; Edlow JA, 2008, EUR J NEUROL, V15, P1257, DOI 10.1111/j.1468-1331.2008.02280.x; Elhadi AM, 2015, J NEUROSURG, V122, P663, DOI 10.3171/2014.10.JNS14175; Gilmore E, 2010, NEUROLOGIST, V16, P165, DOI 10.1097/NRL.0b013e3181c7cd0b; Hillman J, 2002, J NEUROSURG, V97, P771, DOI 10.3171/jns.2002.97.4.0771; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; Jane J A, 1977, Clin Neurosurg, V24, P176; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; KASSELL NF, 1983, NEUROSURGERY, V13, P479, DOI 10.1227/00006123-198311000-00001; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Kataoka K, 1999, STROKE, V30, P1396, DOI 10.1161/01.STR.30.7.1396; Korja M, 2016, NEUROLOGY, V87, P1118, DOI 10.1212/WNL.0000000000003091; Kowalski RG, 2004, JAMA-J AM MED ASSOC, V291, P866, DOI 10.1001/jama.291.7.866; Lall RR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS0921; Lennihan L, 2000, STROKE, V31, P383, DOI 10.1161/01.STR.31.2.383; Lucke-Wold BP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040497; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Matsuda Masayuki, 2007, J Stroke Cerebrovasc Dis, V16, P25, DOI 10.1016/j.jstrokecerebrovasdis.2006.09.001; McConnell ED, 2016, J CEREBR BLOOD F MET, V36, P1537, DOI 10.1177/0271678X15608389; Meurer WJ, 2016, J EMERG MED, V50, P696, DOI 10.1016/j.jemermed.2015.07.048; Mitchell P, 2008, J NEUROSURG, V108, P437, DOI 10.3171/JNS/2008/108/3/0437; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Naidech AM, 2005, ARCH NEUROL-CHICAGO, V62, P410, DOI 10.1001/archneur.62.3.410; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Nyquist P, 2017, CRIT CARE MED, V45, P476, DOI 10.1097/CCM.0000000000002247; Ortega-Gutierrez S, 2013, NEUROCRIT CARE, V18, P13, DOI 10.1007/s12028-012-9782-1; Polmear A, 2003, CEPHALALGIA, V23, P935, DOI 10.1046/j.1468-2982.2003.00596.x; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Rosenwasser Robert H, 2014, Neurosurgery, V61 Suppl 1, P121, DOI 10.1227/NEU.0000000000000377; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Samuels O, 2011, NEUROCRIT CARE, V14, P334, DOI 10.1007/s12028-011-9505-z; Sayer D, 2015, ACAD EMERG MED, V22, P1267, DOI 10.1111/acem.12811; Shea AM, 2007, NEUROSURGERY, V61, P1131, DOI 10.1227/01.neu.0000306090.30517.ae; Shimoda M, 2010, NEUROL MED-CHIR, V50, P530, DOI 10.2176/nmc.50.530; Spetzler RF, 2015, J NEUROSURG, V123, P609, DOI 10.3171/2014.9.JNS141749; Spetzler RF, 2013, J NEUROSURG, V119, P146, DOI 10.3171/2013.3.JNS12683; Starke RM, 2008, STROKE, V39, P2617, DOI 10.1161/STROKEAHA.107.506097; Taufique Z, 2016, NEUROSURGERY, V78, P256, DOI 10.1227/NEU.0000000000001042; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Zwienenberg-Lee M, 2008, STROKE, V39, P1759, DOI 10.1161/STROKEAHA.107.502666	55	218	241	4	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					257	266		10.1056/NEJMcp1605827	http://dx.doi.org/10.1056/NEJMcp1605827			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9PI	28723321				2022-12-28	WOS:000405777600009
J	Moberly, T				Moberly, Tom			UK doctors re-examine case for mandatory vaccination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tmoberly@bmj.com							0	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2017	358								j3414	10.1136/bmj.j3414	http://dx.doi.org/10.1136/bmj.j3414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7JY	28720564				2022-12-28	WOS:000406318100006
J	Burki, T				Burki, Talha			What lies in the future of the UK's medicine regulation?	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					215	215		10.1016/S0140-6736(17)31864-0	http://dx.doi.org/10.1016/S0140-6736(17)31864-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA5IZ	28721867				2022-12-28	WOS:000405477900010
J	Chandra, A; Garthwaite, C				Chandra, Amitabh; Garthwaite, Craig			The Economics of Indication-Based Drug Pricing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chandra, Amitabh] Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Garthwaite, Craig] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA	Harvard University; Northwestern University	Chandra, A (corresponding author), Harvard Kennedy Sch, Cambridge, MA 02138 USA.							Bach PB, 2014, JAMA-J AM MED ASSOC, V312, P1629, DOI 10.1001/jama.2014.13235; Dickson Virgil, 2015, MODERN HEALTHCARE; Pearson S, 2016, INDICATION SPECIFIC; Rockoff Jonathan D., 2015, WALL STREET J; Stern AD, 2017, SCIENCE, V355, P1131, DOI 10.1126/science.aai8707	5	39	39	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					103	106		10.1056/NEJMp1705035	http://dx.doi.org/10.1056/NEJMp1705035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA2PC	28700848				2022-12-28	WOS:000405282300002
J	Iacobucci, G				Iacobucci, Gareth			Three quarters of patients with diabetes in England and Wales meet blood pressure targets	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health and Social Care Information Centre, 2016, 1 HLTH SOC CAR INF C	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2016	352								i554	10.1136/bmj.i554	http://dx.doi.org/10.1136/bmj.i554			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6EX	28720582				2022-12-28	WOS:000369313700020
J	Davies, R				Davies, Rachael			Gill Livingston: transforming dementia prevention and care	LANCET			English	Biographical-Item																			0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					2619	2619		10.1016/S0140-6736(17)31913-X	http://dx.doi.org/10.1016/S0140-6736(17)31913-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ1FF	28735857				2022-12-28	WOS:000418101000014
J	Petousis-Harris, H; Paynter, J; Morgan, J; Saxton, P; McArdle, B; Goodyear-Smith, F; Black, S				Petousis-Harris, Helen; Paynter, Janine; Morgan, Jane; Saxton, Peter; McArdle, Barbara; Goodyear-Smith, Felicity; Black, Steven			Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study	LANCET			English	Article							NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; ANTIBODY-RESPONSES; MUCOSAL IMMUNITY; SEROGROUP-B; MENINGITIDIS; PREVALENCE; INFECTION; POPULATION; ANTIGENS	Background Gonorrhoea is a major global public health problem that is exacerbated by drug resistance. Effective vaccine development has been unsuccessful, but surveillance data suggest that outer membrane vesicle meningococcal group B vaccines affect the incidence of gonorrhoea. We assessed vaccine effectiveness of the outer membrane vesicle meningococcal B vaccine (MeNZB) against gonorrhoea in young adults aged 15-30 years in New Zealand. Methods We did a retrospective case-control study of patients at sexual health clinics aged 15-30 years who were born between Jan 1, 1984, and Dec 31, 1998, eligible to receive MeNZB, and diagnosed with gonorrhoea or chlamydia, or both. Demographic data, sexual health clinic data, and National Immunisation Register data were linked via patients' unique personal identifier. For primary analysis, cases were confirmed by laboratory isolation or detection of Neisseria gonorrhoeae only from a clinical specimen, and controls were individuals with a positive chlamydia test only. We estimated odds ratios (ORs) comparing disease outcomes in vaccinated versus unvaccinated participants via multivariable logistic regression. Vaccine effectiveness was calculated as 100x(1-OR). Findings 11 of 24 clinics nationally provided records. There were 14 730 cases and controls for analyses: 1241 incidences of gonorrhoea, 12 487 incidences of chlamydia, and 1002 incidences of co-infection. Vaccinated individuals were significantly less likely to be cases than controls (511 [41%] vs 6424 [51%]; adjusted OR 0.69 [95% CI 0.61-0.79]; p<0.0001). Estimate vaccine effectiveness of MeNZB against gonorrhoea after adjustment for ethnicity, deprivation, geographical area, and sex was 31% (95% CI 21-39). Interpretation Exposure to MeNZB was associated with reduced rates of gonorrhoea diagnosis, the first time a vaccine has shown any protection against gonorrhoea. These results provide a proof of principle that can inform prospective vaccine development not only for gonorrhoea but also for meningococcal vaccines.	[Petousis-Harris, Helen; Paynter, Janine; Goodyear-Smith, Felicity] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland, New Zealand; [Morgan, Jane] Univ Auckland, Sch Med, Auckland, New Zealand; [Saxton, Peter] Univ Auckland, Dept Social & Community Hlth, Auckland, New Zealand; [McArdle, Barbara] Univ Auckland, Conectus, Auckland Uniserv, Auckland, New Zealand; [Morgan, Jane] Waikato Dist Hlth Board, Sexual Hlth Serv, Hamilton, New Zealand; [Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA	University of Auckland; University of Auckland; University of Auckland; University of Auckland; Cincinnati Children's Hospital Medical Center	Petousis-Harris, H (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Gen Practice & Primary Hlth Care, PB 92019, Auckland 1142, New Zealand.	h.petousis-harris@auckland.ac.nz		Petousis-Harris, Helen/0000-0001-6098-8610	GSK Vaccines	GSK Vaccines	GSK Vaccines.	Arnold R, 2011, VACCINE, V29, P7100, DOI 10.1016/j.vaccine.2011.06.120; Barnett JR, 2000, HEALTH SOC CARE COMM, V8, P159, DOI 10.1046/j.1365-2524.2000.00239.x; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X; Bromhead C, 2013, J CLIN MICROBIOL, V51, P1505, DOI 10.1128/JCM.03223-12; CBG Health Research Limited, 2006, EV MEN B IMM NAT ROL; Clarivet B, 2014, EUR J DERMATOL, V24, P611, DOI 10.1684/ejd.2014.2413; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Craig AP, 2015, VACCINE, V33, P4520, DOI 10.1016/j.vaccine.2015.07.015; Creighton S, 2003, INT J STD AIDS, V14, P109, DOI 10.1258/095646203321156872; Davenport V, 2003, J IMMUNOL, V171, P4263, DOI 10.4049/jimmunol.171.8.4263; Davenport V, 2008, J INFECT DIS, V198, P731, DOI 10.1086/590669; Edwards JL, 2016, CRIT REV MICROBIOL, V42, P928, DOI 10.3109/1040841X.2015.1105782; Eyre JH, 1909, LANCET, V174, P76; GREENBERG L, 1971, B WORLD HEALTH ORGAN, V45, P531; GREENBERG L, 1974, CAN J PUBLIC HEALTH, V65, P29; Hadad R, 2012, APMIS, V120, P750, DOI 10.1111/j.1600-0463.2012.02903.x; Hedges SR, 1998, J INFECT DIS, V178, P742, DOI 10.1086/515372; Holst J, 2013, HUM VACC IMMUNOTHER, V9, P1241, DOI 10.4161/hv.24129; Jackson C, 2011, ARCH DIS CHILD, V96, P744, DOI 10.1136/adc.2009.180596; Jerse AE, 2014, VACCINE, V32, P1579, DOI 10.1016/j.vaccine.2013.08.067; Kirkcaldy RD, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6507a1; Lewis DA, 2014, CURR OPIN INFECT DIS, V27, P62, DOI 10.1097/QCO.0000000000000025; Manhart LE, 2004, AM J EPIDEMIOL, V160, P393, DOI 10.1093/aje/kwh220; Mehta SD, 2003, SEX TRANSM INFECT, V79, P124, DOI 10.1136/sti.79.2.124; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Paik M. C., 2013, STAT METHODS RATES P; Perez O, 2009, VACCIMONITOR, V18, P53; ROSENQVIST E, 1995, INFECT IMMUN, V63, P4642, DOI 10.1128/IAI.63.12.4642-4652.1995; *STI SURV TEAM, 2010, SEX TRANSM INF NZ AN; The Institute of Environmental Science and Research Ltd, 2015, SEX TRANSM INF NZ AN; Tinsley CR, 1996, P NATL ACAD SCI USA, V93, P11109, DOI 10.1073/pnas.93.20.11109; TRAMONT EC, 1989, CLIN MICROBIOL REV, V2, pS74, DOI 10.1128/CMR.2.Suppl.S74-S77.1989; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vonck RA, 2011, INFECT IMMUN, V79, P1566, DOI 10.1128/IAI.01155-10; Weinberg GA, 2010, J INFECT DIS, V201, P1607, DOI 10.1086/652404; Whelan J, 2016, EMERG INFECT DIS, V22, P1137, DOI 10.3201/eid2206.151093; Wind CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1878-3; Zhu WY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00124	39	183	191	2	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2017	390	10102					1603	1610		10.1016/S0140-6736(17)31449-6	http://dx.doi.org/10.1016/S0140-6736(17)31449-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI3RA	28705462				2022-12-28	WOS:000411883300024
J	Riedl, MA; Grivcheva-Panovska, V; Moldovan, D; Baker, J; Yang, WH; Giannetti, BM; Reshef, A; Andrejevic, S; Lockey, RF; Hakl, R; Kivity, S; Harper, JR; Relan, A; Cicardi, M				Riedl, Marc A.; Grivcheva-Panovska, Vesna; Moldovan, Dumitru; Baker, James; Yang, William H.; Giannetti, Bruno M.; Reshef, Avner; Andrejevic, Sladjana; Lockey, Richard F.; Hakl, Roman; Kivity, Shmuel; Harper, Joseph R.; Relan, Anurag; Cicardi, Marco			Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial	LANCET			English	Article							C1-INHIBITOR DEFICIENCY; LEUKOCYTE ADHESION; ATTACKS; PLASMA; DANAZOL; COMPLEMENT; THERAPY	Background Hereditary angio-oedema is a recurrent, oedematous disorder caused by deficiency of functional C1 inhibitor. Infusions of plasma-derived C1 esterase inhibitor deter attacks of hereditary angio-oedema, but the prophylactic effect of recombinant human C1 esterase inhibitor has not been rigorously studied. We aimed to assess the efficacy of recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema. Methods We conducted this phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial at ten centres in Canada, the Czech Republic, Israel, Italy, Macedonia, Romania, Serbia, and the USA. We enrolled patients aged 13 years or older with functional C1-inhibitor concentrations of less than 50% of normal and a history of four or more attacks of hereditary angio-oedema per month for at least 3 months before study initiation. Patients were randomly assigned centrally (1:1:1:1:1:1), via an interactive response technology system with fixed allocation, to receive one of six treatment sequences. During each sequence, patients received intravenous recombinant human C1 esterase inhibitor (50 IU/kg; maximum 4200 IU) twice weekly, recombinant human C1 esterase inhibitor once weekly and placebo once weekly, and placebo twice weekly, each for 4 weeks with a 1 week washout period between crossover. All patients, investigators, and study personnel who participated in patient care were masked to group allocation during the study. The primary efficacy endpoint was the number of attacks of hereditary angio-oedema observed in each 4 week treatment period. Attack symptoms were recorded daily. The primary efficacy analysis was done in the intention-to-treat population. Safety was assessed in all patients who received at least one injection of study medication. This study is registered with ClinicalTrials.gov, number NCT02247739. Findings Between Dec 29, 2014, and May 3, 2016, we enrolled 35 patients, of whom 32 (91%) underwent randomisation (intention-to-treat population) and 26 (81%) completed the study. The mean number of attacks of hereditary angio-oedema over 4 weeks was significantly reduced with recombinant human C1 esterase inhibitor twice weekly (2.7 attacks [SD 2.4]) and once weekly (4.4 attacks [3.2]) versus placebo (7.2 attacks [3.6]), with mean differences of -4.4 attacks (p<0.0001) and -2.8 attacks (p=0.0004), respectively. We recorded adverse events in ten (34%) of 29 patients given twice-weekly recombinant human C1 esterase inhibitor, 13 (45%) of 29 patients given the once-weekly regimen, and eight (29%) of 28 patients given placebo. Headache (twice-weekly treatment) and nasopharyngitis (once-weekly treatment) were the most common adverse events. Two (7%) adverse events (fatigue and headache) were deemed possibly related to treatment with recombinant human C1 esterase inhibitor, but both resolved without additional treatment. No thrombotic or thromboembolic events, systemic allergic reactions (including anaphylaxis), or neutralising antibodies were reported. Interpretation Prophylaxis with recombinant human C1 esterase inhibitor provided clinically relevant reductions in frequency of hereditary angio-oedema attacks and was well tolerated. In view of the pharmacokinetic profile of recombinant human C1 esterase inhibitor, our results suggest that efficacy of C1-inhibitor replacement therapy might not be a direct function of plasma trough concentrations of C1 inhibitor.	[Riedl, Marc A.] Univ Calif San Diego, Dept Med, San Diego, CA 92122 USA; [Grivcheva-Panovska, Vesna] Med Univ Skopje, Clin Dermatol, Skopje, Macedonia; [Moldovan, Dumitru] MediQuest Clin Res, Sangeorgiu De Mures, Romania; [Baker, James] Baker Allergy Asthma Dermatol, Lake Oswego, OR USA; [Yang, William H.] Ottawa Allergy Res Corp, Ottawa, ON, Canada; [Yang, William H.] Univ Ottawa, Med Sch, Ottawa, ON, Canada; [Giannetti, Bruno M.] Pharming Grp, Dept Operat, Leiden, Netherlands; [Reshef, Avner] Tel Aviv Univ, Sheba Med Ctr, Tel Hashomer, Israel; [Andrejevic, Sladjana] Clin Ctr Serbia, Belgrade, Serbia; [Lockey, Richard F.] Univ S Florida, Morsani Coll, Dept Internal Med, Tampa, FL USA; [Hakl, Roman] St Annes Univ Hosp Brno, Brno, Czech Republic; [Kivity, Shmuel] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel; [Harper, Joseph R.; Relan, Anurag] Pharming Healthcare, Dept Clin Res & Med Affairs, Berkeley Hts, NJ USA; [Cicardi, Marco] Univ Milan, Dipartimento Sci Biomed & Clin Luigi Sacco, Milan, Italy	University of California System; University of California San Diego; University of Ottawa; Chaim Sheba Medical Center; Tel Aviv University; Clinical Centre of Serbia; State University System of Florida; University of South Florida; St Anne's University Hospital Brno (FNUSA-ICRC); Tel Aviv University; Sackler Faculty of Medicine; University of Milan; Luigi Sacco Hospital	Cicardi, M (corresponding author), Univ Calif San Diego, Dept Med, Div Rheumatol Allergy & Immunol, San Diego, CA 92122 USA.	mriedl@ucsd.edu	Relan, Anurag/AAA-7372-2022; Reshef, Avner/AAL-3638-2020; cicardi, marco/K-9219-2016	Relan, Anurag/0000-0002-5521-4538; Reshef, Avner/0000-0002-3324-7072; cicardi, marco/0000-0003-1251-225X; Hakl, Roman/0000-0002-1930-4755	Pharming Technologies	Pharming Technologies	Pharming Technologies.	Bork K, 2000, MAYO CLIN PROC, V75, P349, DOI 10.4065/75.4.349; Caballero T, 2014, ALLERGY ASTHMA PROC, V35, P47, DOI 10.2500/aap.2013.34.3685; Cai SH, 2005, J IMMUNOL, V174, P6462, DOI 10.4049/jimmunol.174.10.6462; Cai SH, 2003, J IMMUNOL, V171, P4786, DOI 10.4049/jimmunol.171.9.4786; Cicardi M, 2017, J ALLERGY CLIN IMMUN, V139, pAB233, DOI 10.1016/j.jaci.2016.12.750; Craig T, 2012, WORLD ALLERGY ORGAN, V5, P182, DOI 10.1097/WOX.0b013e318279affa; Csuka D, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0351-5; GELFAND JA, 1976, NEW ENGL J MED, V295, P1444, DOI 10.1056/NEJM197612232952602; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Hack CE, 2012, ALLERGY, V67, P123, DOI 10.1111/j.1398-9995.2011.02716.x; HOSEA SW, 1980, ANN INTERN MED, V93, P809, DOI 10.7326/0003-4819-93-6-809; Jurado-Palomo J, 2013, J INVEST ALLERG CLIN, V23, P1; Keleman Z, 2010, CLIN IMMUNOL, V134, P354, DOI 10.1016/j.clim.2009.11.002; Li HH, 2015, J ALLER CL IMM-PRACT, V3, P417, DOI 10.1016/j.jaip.2014.12.013; Longhurst H, 2017, NEW ENGL J MED, V376, P1131, DOI 10.1056/NEJMoa1613627; Moldovan D, 2012, CLIN EXP ALLERGY, V42, P929, DOI 10.1111/j.1365-2222.2012.03984.x; Nussberger J, 1999, J ALLERGY CLIN IMMUN, V104, P1321, DOI 10.1016/S0091-6749(99)70030-8; Pappalardo E, 2003, IMMUNOL LETT, V86, P271, DOI 10.1016/S0165-2478(03)00029-4; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; Reshef A, 2013, ALLERGY, V68, P118, DOI 10.1111/all.12060; Riedl MA, 2014, ANN ALLERG ASTHMA IM, V112, P163, DOI 10.1016/j.anai.2013.12.004; Riedl MA, 2013, ANN ALLERG ASTHMA IM, V110, P295, DOI 10.1016/j.anai.2013.02.007; SHEFFER AL, 1981, J ALLERGY CLIN IMMUN, V68, P181, DOI 10.1016/0091-6749(81)90181-0; SMITH MA, 1985, IMMUNOLOGY, V56, P561; van Doorn MBA, 2005, J ALLERGY CLIN IMMUN, V116, P876, DOI 10.1016/j.jaci.2005.05.019; VANDERGRAAF F, 1983, J CLIN INVEST, V71, P149, DOI 10.1172/JCI110743; Zuraw B, 2010, J ALLERGY CLIN IMMUN, V126, P821, DOI 10.1016/j.jaci.2010.07.021; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977; Zuraw BL, 2013, J ALLERGY CLIN IMMUN, V131, P1491, DOI 10.1016/j.jaci.2013.03.034; Zuraw BL, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.02.020; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	31	47	47	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2017	390	10102					1595	1602		10.1016/S0140-6736(17)31963-3	http://dx.doi.org/10.1016/S0140-6736(17)31963-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI3RA	28754491				2022-12-28	WOS:000411883300023
J	Margolis, DA; Gonzalez-Garcia, J; Stellbrink, HJ; Eron, JJ; Yazdanpanah, Y; Podzamczer, D; Lutz, T; Angel, JB; Richmond, GJ; Clotet, B; Gutierrez, F; Sloan, L; St Clair, M; Murray, M; Ford, SL; Mrus, J; Patel, P; Crauwels, H; Griffith, SK; Sutton, KC; Dorey, D; Smith, KY; Williams, PE; Spreen, WR				Margolis, David A.; Gonzalez-Garcia, Juan; Stellbrink, Hans-Juergen; Eron, Joseph J.; Yazdanpanah, Yazdan; Podzamczer, Daniel; Lutz, Thomas; Angel, Jonathan B.; Richmond, Gary J.; Clotet, Bonaventura; Gutierrez, Felix; Sloan, Louis; St Clair, Marty; Murray, Miranda; Ford, Susan L.; Mrus, Joseph; Patel, Parul; Crauwels, Herta; Griffith, Sandy K.; Sutton, Kenneth C.; Dorey, David; Smith, Kimberly Y.; Williams, Peter E.; Spreen, William R.			Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial	LANCET			English	Article							BOOSTED PROTEASE INHIBITOR; ANTIRETROVIRAL THERAPY; GSK1265744; PHARMACOKINETICS; SIMPLIFICATION; PHARMACOLOGY; FORMULATION; SAFETY	Background Cabotegravir and rilpivirine are antiretroviral drugs in development as long-acting injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus rilpivirine for maintenance of HIV-1 viral suppression through 96 weeks. Methods In this randomised, phase 2b, open-label study, treatment-naive adults infected with HIV-1 initially received oral cabotegravir 30 mg plus abacavir-lamivudine 600-300 mg once daily. The objective of this study was to select an intramuscular dosing regimen based on a comparison of the antiviral activity, tolerability, and safety of the two intramuscular dosing regimens relative to oral cabotegravir plus abacavir-lamivudine. After a 20-week induction period on oral cabotegravir plus abacavir-lamivudine, patients with viral suppression (plasma HIV-1 RNA <50 copies per mL) were randomly assigned (2:2:1) to intramuscular long-acting cabotegravir plus rilpivirine at 4-week intervals (long-acting cabotegravir 400 mg plus rilpivirine 600 mg; two 2 mL injections) or 8-week intervals (long-acting cabotegravir 600 mg plus rilpivirine 900 mg; two 3 mL injections) or continued oral cabotegravir plus abacavir-lamivudine. Randomisation was computer-generated with stratification by HIV-1 RNA (<50 copies per mL, yes or no) during the first 12 weeks of the induction period. The primary endpoints were the proportion of patients with viral suppression at week 32 (as defined by the US Food and Drug Administration snapshot algorithm), protocol-defined virological failures, and safety events through 96 weeks. All randomly assigned patients who received at least one dose of study drug during the maintenance period were included in the primary efficacy and safety analyses. The primary analysis used a Bayesian approach to evaluate the hypothesis that the proportion with viral suppression for each long-acting regimen is not worse than the oral regimen proportion by more than 10% (denoted comparable) according to a prespecified decision rule (ie, posterior probability for comparability >90%). Difference in proportions and associated 95% CIs were supportive to the primary analysis. The trial is registered at ClinicalTrials.gov, number NCT02120352. Findings Among 309 enrolled patients, 286 were randomly assigned to the maintenance period ( 115 to each of the 4-week and 8-week groups and 56 to the oral treatment group). This study is currently ongoing. At 32 weeks following randomisation, both long-acting regimens met primary criteria for comparability in viral suppression relative to the oral comparator group. Viral suppression was maintained at 32 weeks in 51 (91%) of 56 patients in the oral treatment group, 108 (94%) of 115 patients in the 4-week group (difference 2.8% [95% CI -5.8 to 11.5] vs oral treatment), and 109 (95%) of 115 patients in the 8-week group (difference 3.7% [-4.8 to 12.2] vs oral treatment). At week 96, viral suppression was maintained in 47 (84%) of 56 patients receiving oral treatment, 100 (87%) of 115 patients in the 4-week group, and 108 (94%) of 115 patients in the 8-week group. Three patients (1%) experienced protocol-defined virological failure (two in the 8-week group; one in the oral treatment group). Injection-site reactions were mild (3648 [84%] of 4360 injections) or moderate (673 [15%] of 4360 injections) in intensity and rarely resulted in discontinuation (two [<1%] of 230 patients); injection-site pain was reported most frequently. Serious adverse events during maintenance were reported in 22 (10%) of 230 patients in the intramuscular groups (4-week and 8-week groups) and seven (13%) of 56 patients in the oral treatment group; none were drug related. Interpretation The two-drug combination of all-injectable, long-acting cabotegravir plus rilpivirine every 4 weeks or every 8 weeks was as effective as daily three-drug oral therapy at maintaining HIV-1 viral suppression through 96 weeks and was well accepted and tolerated.	[Margolis, David A.; St Clair, Marty; Mrus, Joseph; Patel, Parul; Griffith, Sandy K.; Sutton, Kenneth C.; Smith, Kimberly Y.; Spreen, William R.] ViiV Healthcare, 5 Moore Dr, Res Triangle Pk, NC 27709 USA; [Gonzalez-Garcia, Juan] Hosp Univ La Paz IdiPAZ, Madrid, Spain; [Stellbrink, Hans-Juergen] ICH Hamburg, Hamburg, Germany; [Eron, Joseph J.] Univ N Carolina, Chapel Hill, NC USA; [Yazdanpanah, Yazdan] Hop Bichat Claude Bernard, Paris, France; [Podzamczer, Daniel] Hosp Univ Bellvitge, Barcelona, Spain; [Lutz, Thomas] Infektiologikum, Frankfurt, Germany; [Angel, Jonathan B.] Ottawa Hosp, Ottawa, ON, Canada; [Richmond, Gary J.] Broward Gen Med Ctr, Ft Lauderdale, FL USA; [Clotet, Bonaventura] UAB, Hosp Germans Trias & Pujol, UVIC UCC, Badalona, Spain; [Gutierrez, Felix] Hosp Gen Elche, Alicante, Spain; [Gutierrez, Felix] Univ Miguel Hernandez, Alicante, Spain; [Sloan, Louis] North Texas Infect Dis Consultants, Dallas, TX USA; [Murray, Miranda] ViiV Healthcare, London, England; [Ford, Susan L.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Crauwels, Herta; Williams, Peter E.] Janssen Res & Dev, Beerse, Belgium; [Dorey, David] GlaxoSmithKline, Mississauga, ON, Canada	GlaxoSmithKline; Hospital Universitario La Paz; University of North Carolina; University of North Carolina Chapel Hill; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Ottawa; Ottawa Hospital Research Institute; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universidad Miguel Hernandez de Elche; GlaxoSmithKline; GlaxoSmithKline; Johnson & Johnson; Janssen Pharmaceuticals; GlaxoSmithKline	Margolis, DA (corresponding author), ViiV Healthcare, 5 Moore Dr, Res Triangle Pk, NC 27709 USA.	david.a.margolis@viivhealthcare.com	Rodero, Félix Gutiérrez/Q-7880-2018	Rodero, Félix Gutiérrez/0000-0002-9485-6867; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Angel, Jonathan B/0000-0003-3102-4462; Griffith, Sandy/0000-0002-3430-5131	ViiV Healthcare; Janssen RD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	ViiV Healthcare; Janssen RD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	ViiV Healthcare and Janssen R&D.	[Anonymous], 2016, ODEFSEY; [Anonymous], 2015, EDURANT; Arribas JR, 2014, LANCET INFECT DIS, V14, P581, DOI 10.1016/S1473-3099(14)70782-0; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Bolstad WM., 2017, INTRO BAYESIAN STAT; DAIDS Regulatory Support Center, DIV AIDS TABL GRAD S; Dolgin E, 2014, NAT MED, V20, P323, DOI 10.1038/nm0414-323; Ford SL, 2013, ANTIMICROB AGENTS CH, V57, P5472, DOI 10.1128/AAC.01235-13; Glass TR, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14016; Karmon SL, 2015, JAIDS-J ACQ IMM DEF, V68, pe39, DOI 10.1097/QAI.0000000000000469; Margolis DA, 2015, LANCET INFECT DIS, V15, P1145, DOI 10.1016/S1473-3099(15)00152-8; Margolis DA, 2015, CURR OPIN HIV AIDS, V10, P246, DOI 10.1097/COH.0000000000000169; Mobula L, 2015, J AIDS CLIN RES, V6, P1; Palella FJ, 2014, AIDS, V28, P335, DOI 10.1097/QAD.0000000000000087; Spreen W, 2013, HIV CLIN TRIALS, V14, P192, DOI 10.1310/hct1405-192; Spreen W, 2014, JAIDS-J ACQ IMM DEF, V67, P487, DOI 10.1097/QAI.0000000000000365; Spreen W, 2014, JAIDS-J ACQ IMM DEF, V67, P481, DOI 10.1097/QAI.0000000000000301; Spreen WR, 2013, CURR OPIN HIV AIDS, V8, P565, DOI 10.1097/COH.0000000000000002; Trezza C, 2015, CURR OPIN HIV AIDS, V10, P239, DOI 10.1097/COH.0000000000000168; Trottier B, 2017, ANTIVIR THER, V22, P295, DOI 10.3851/IMP3166; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; WHO (World Health Organization), 2016, PROGR REP 2016 PREV; Williams PE, 2015, CURR OPIN HIV AIDS, V10, P233, DOI 10.1097/COH.0000000000000164	24	302	309	2	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1499	1510		10.1016/S0140-6736(17)31917-7	http://dx.doi.org/10.1016/S0140-6736(17)31917-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7BS	28750935	Green Published			2022-12-28	WOS:000411337100025
J	Gisriel, C; Sarrou, I; Ferlez, B; Golbeck, JH; Redding, KE; Fromme, R				Gisriel, Christopher; Sarrou, Iosifina; Ferlez, Bryan; Golbeck, John H.; Redding, Kevin E.; Fromme, Raimund			Structure of a symmetric photosynthetic reaction center-photosystem	SCIENCE			English	Article							ELECTRON-TRANSFER; HELIOBACTERIUM-MODESTICALDUM; CHLAMYDOMONAS-REINHARDTII; RHODOPSEUDOMONAS-VIRIDIS; BACTERIUM; IDENTIFICATION; EVOLUTION; MEMBRANES; ORIGIN; ENERGY	Reaction centers are pigment-protein complexes that drive photosynthesis by converting light into chemical energy. It is believed that they arose once from a homodimeric protein. The symmetry of a homodimer is broken in heterodimeric reaction-center structures, such as those reported previously. The 2.2-angstrom resolution x-ray structure of the homodimeric reaction center-photosystem from the phototroph Heliobacterium modesticaldum exhibits perfect C-2 symmetry. The core polypeptide dimer and two small subunits coordinate 54 bacteriochlorophylls and 2 carotenoids that capture and transfer energy to the electron transfer chain at the center, which performs charge separation and consists of 6 (bacterio) chlorophylls and an iron-sulfur cluster; unlike other reaction centers, it lacks a bound quinone. This structure preserves characteristics of the ancestral reaction center, providing insight into the evolution of photosynthesis.	[Gisriel, Christopher; Redding, Kevin E.; Fromme, Raimund] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Sarrou, Iosifina] Deutsch Elekt Synchrotron DESY, Ctr Free Elect Laser Sci, D-22607 Hamburg, Germany; [Ferlez, Bryan; Golbeck, John H.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Redding, Kevin E.] Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA; [Fromme, Raimund] Biodesign Inst, Ctr Appl Struct Discovery, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Arizona State University; Arizona State University-Tempe	Fromme, R (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; Fromme, R (corresponding author), Biodesign Inst, Ctr Appl Struct Discovery, Tempe, AZ 85287 USA.	raimund.fromme@asu.edu	Sarrou, Iosifina/AAD-5794-2022; Redding, Kevin E/D-7308-2013; Fromme, Raimund/C-8885-2012; Fromme, Raimund/AAG-6578-2019; Fromme, Raimund/W-5838-2019	Sarrou, Iosifina/0000-0002-6963-5341; Fromme, Raimund/0000-0003-4835-1080; Fromme, Raimund/0000-0003-4835-1080	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) [DE-SC0010575]; National Institutes of Health; National Institute of General Medical Sciences; Howard Hughes Medical Institute; DOE Office of Science, Office of Biological and Environmental Research; DOE Office of Science [DE-AC02-06CH11357]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); DOE Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE))	We are grateful to J. Whitelegge for his validation of the PshX sequence by mass spectrometry and to Y. Mazor for modeling and graphical assistance. This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) through grant DE-SC0010575 to K.E.R., R.F., and J.H.G. and supported with x-ray crystallographic equipment and infrastructure provided by P. Fromme of the Biodesign Center for Applied Structural Discovery at Arizona State University. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is a DOE Scientific User Facility supported by the Director, Office of Science, Office of Basic Energy Sciences and operated for the DOE Office of Science by Lawrence Berkeley National Laboratory. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. The Structural Biology Center is funded by the DOE Office of Science, Office of Biological and Environmental Research. Argonne is operated by UChicago Argonne, LLC, for the DOE Office of Science under contract DE-AC02-06CH11357. K.E.R., J.H.G., and R.F. designed the project. I.S. and C.G. performed purifications, their subsequent optimization, and characterization. C.G., B.F., and R.F. optimized crystallization conditions. C.G. crystallized HbRC that was used in x-ray diffraction experiments. R.F. and C.G. collected x-ray diffraction data. R.F. and C.G. built models for molecular replacement phasing of diffraction data. R.F. and C.G. performed model building and refinement. C.G., K.E.R., and R.F. wrote the manuscript with input from all other authors. The HbRC structure has been deposited into the Protein Data Bank with accession code 5V8K. The authors declare no competing financial interests.	Albert I, 1998, BIOCHEMISTRY-US, V37, P9001, DOI 10.1021/bi9731347; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; BUTTNER M, 1992, BIOCHIM BIOPHYS ACTA, V1101, P154, DOI 10.1016/S0005-2728(05)80007-6; Cardona T, 2015, PHOTOSYNTH RES, V126, P111, DOI 10.1007/s11120-014-0065-x; Chauvet A, 2013, PHOTOSYNTH RES, V116, P1, DOI 10.1007/s11120-013-9871-9; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Ferlez B, 2016, BIOCHEMISTRY-US, V55, P2358, DOI 10.1021/acs.biochem.5b01320; Fromme Raimund, 2006, P320; FULLER RC, 1985, FEBS LETT, V182, P345, DOI 10.1016/0014-5793(85)80330-6; GEST H, 1983, ARCH MICROBIOL, V136, P11, DOI 10.1007/BF00415602; Gunner MR, 1996, J PHYS CHEM-US, V100, P4277, DOI 10.1021/jp9519070; Gupta RS, 2003, PHOTOSYNTH RES, V76, P173, DOI 10.1023/A:1024999314839; Hans M, 2000, EUR J BIOCHEM, V267, P7082, DOI 10.1046/j.1432-1327.2000.01809.x; Heinnickel M, 2006, BIOCHEMISTRY-US, V45, P6756, DOI 10.1021/bi060031s; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kashey TS, 2014, PHOTOSYNTH RES, V120, P291, DOI 10.1007/s11120-014-9982-y; Khadka B, 2017, PHOTOSYNTH RES, V131, P159, DOI 10.1007/s11120-016-0307-1; KIMBLE LK, 1995, ARCH MICROBIOL, V163, P259, DOI 10.1007/BF00393378; KLEINHERENBRINK FAM, 1993, BIOCHIM BIOPHYS ACTA, V1142, P69, DOI 10.1016/0005-2728(93)90085-T; KOBAYASHI M, 1991, FEBS LETT, V284, P129, DOI 10.1016/0014-5793(91)80778-2; Li YJ, 2006, P NATL ACAD SCI USA, V103, P2144, DOI 10.1073/pnas.0506537103; LIEBL U, 1993, P NATL ACAD SCI USA, V90, P7124, DOI 10.1073/pnas.90.15.7124; LIN S, 1994, BIOPHYS J, V66, P437, DOI 10.1016/S0006-3495(94)80794-5; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; Mix LJ, 2005, J MOL EVOL, V60, P153, DOI 10.1007/s00239-003-0181-2; Muller MG, 2010, P NATL ACAD SCI USA, V107, P4123, DOI 10.1073/pnas.0905407107; Muller MG, 2003, BIOPHYS J, V85, P3899, DOI 10.1016/S0006-3495(03)74804-8; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Noguchi T, 2010, PHOTOSYNTH RES, V104, P321, DOI 10.1007/s11120-009-9509-0; NUIJS AM, 1985, P NATL ACAD SCI USA, V82, P6865, DOI 10.1073/pnas.82.20.6865; Olson JM, 2004, PHOTOSYNTH RES, V80, P373, DOI 10.1023/B:PRES.0000030457.06495.83; Prokhorenko VI, 2000, J PHYS CHEM B, V104, P11563, DOI 10.1021/jp002323n; Romberger SP, 2012, PHOTOSYNTH RES, V111, P285, DOI 10.1007/s11120-012-9723-z; Romberger SP, 2010, PHOTOSYNTH RES, V104, P293, DOI 10.1007/s11120-010-9558-4; Sarrou I, 2012, PHOTOSYNTH RES, V111, P291, DOI 10.1007/s11120-012-9726-9; Sattley WM, 2008, J BACTERIOL, V190, P4687, DOI 10.1128/JB.00299-08; Schramski JR, 2015, P NATL ACAD SCI USA, V112, P9511, DOI 10.1073/pnas.1508353112; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Sommer F, 2004, J BIOL CHEM, V279, P20009, DOI 10.1074/jbc.M313986200; Sommer F, 2002, J BIOL CHEM, V277, P6573, DOI 10.1074/jbc.M110633200; TROST JT, 1989, BIOCHEMISTRY-US, V28, P9898, DOI 10.1021/bi00452a003; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; van Brederode ME, 1999, FEBS LETT, V455, P1, DOI 10.1016/S0014-5793(99)00810-8; van Brederode ME, 1999, P NATL ACAD SCI USA, V96, P2054, DOI 10.1073/pnas.96.5.2054; VanBrederode ME, 1997, BIOCHEMISTRY-US, V36, P6855, DOI 10.1021/bi9703756; VANDEMEENT EJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P356, DOI 10.1016/S0005-2728(05)80131-8	48	76	79	6	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1021	1025		10.1126/science.aan5611	http://dx.doi.org/10.1126/science.aan5611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28751471				2022-12-28	WOS:000409455700040
J	Lee, H; Lotery, A				Lee, Helena; Lotery, Andrew			Gene therapy for RPE65-mediated inherited retinal dystrophy completes phase 3	LANCET			English	Editorial Material							LEBERS CONGENITAL AMAUROSIS; ADENOASSOCIATED VIRUS; RPE65 MUTATIONS; SAFETY; TRIAL		[Lee, Helena; Lotery, Andrew] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO16 6YD, Hants, England	University of Southampton	Lotery, A (corresponding author), Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO16 6YD, Hants, England.	a.j.lotery@soton.ac.uk			Medical Research Council [NCT02781480]; National Institute for Health Research [NF-SI-0515-10020, CL-2014-26-003] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	HL declares no competing interests. AL chaired the Trial Steering Committee for a Medical Research Council-funded trial of gene therapy for RPE65 Leber congenital amaurosis (NCT02781480) from March 18, 2016, to Jan 31, 2017; the Trial Steering Committee was dissolved after a change in sponsorship.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Carvalho LS, 2015, VISION RES, V111, P124, DOI 10.1016/j.visres.2014.07.013; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P80, DOI 10.1186/1477-7525-1-80; Russell S, 2017, LANCET; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048	12	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					823	824		10.1016/S0140-6736(17)31622-7	http://dx.doi.org/10.1016/S0140-6736(17)31622-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28712536				2022-12-28	WOS:000408330700004
J	Choi, J; Huebner, AJ; Clement, K; Walsh, RM; Savol, A; Lin, KX; Gu, HC; Di Stefano, B; Brumbaugh, J; Kim, SY; Sharif, J; Rose, CM; Mohammad, A; Odajima, J; Charron, J; Shioda, T; Gnirke, A; Gygi, S; Koseki, H; Adreyev, RIS; Xiao, A; Meissner, A; Hochedlinger, K				Choi, Jiho; Huebner, Aaron J.; Clement, Kendell; Walsh, Ryan M.; Savol, Andrej; Lin, Kaixuan; Gu, Hongcang; Di Stefano, Bruno; Brumbaugh, Justin; Kim, Sang-Yong; Sharif, Jafar; Rose, Christopher M.; Mohammad, Arman; Odajima, Junko; Charron, Jean; Shioda, Toshi; Gnirke, Andreas; Gygi, Steven; Koseki, Haruhiko; Adreyev, Ruslan I. S.; Xiao, Andrew; Meissner, Alexander; Hochedlinger, Konrad			Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells	NATURE			English	Article							GROUND-STATE PLURIPOTENCY; DIFFERENTIAL EXPRESSION ANALYSIS; DNA HYPOMETHYLATION; GENOMIC STABILITY; SELF-RENEWAL; DEMETHYLATION; INHIBITION; MICE; BIOCONDUCTOR; MAINTENANCE	Concomitant activation of the Wnt pathway and suppression of Mapk signalling by two small molecule inhibitors (2i) in the presence of leukaemia inhibitory factor (LIF) (hereafter termed 2i/L) induces a naive state in mouse embryonic stem (ES) cells that resembles the inner cell mass (ICM) of the pre-implantation embryo(1). Since the ICM exists only transiently in vivo, it remains unclear how sustained propagation of naive ES cells in vitro affects their stability and functionality. Here we show that prolonged culture of male mouse ES cells in 2i/L results in irreversible epigenetic and genomic changes that impair their developmental potential. Furthermore, we find that female ES cells cultured in conventional serum plus LIF medium phenocopy male ES cells cultured in 2i/L. Mechanistically, we demonstrate that the inhibition of Mek1/2 is predominantly responsible for these effects, in part through the downregulation of DNA methyltransferases and their cofactors. Finally, we show that replacement of the Mek1/2 inhibitor with a Src inhibitor preserves the epigenetic and genomic integrity as well as the developmental potential of ES cells. Taken together, our data suggest that, although short-term suppression of Mek1/2 in ES cells helps to maintain an ICM-like epigenetic state, prolonged suppression results in irreversible changes that compromise their developmental potential.	[Choi, Jiho; Huebner, Aaron J.; Walsh, Ryan M.; Savol, Andrej; Di Stefano, Bruno; Brumbaugh, Justin; Adreyev, Ruslan I. S.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Choi, Jiho; Huebner, Aaron J.; Walsh, Ryan M.; Di Stefano, Bruno; Brumbaugh, Justin; Odajima, Junko; Shioda, Toshi; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Choi, Jiho; Huebner, Aaron J.; Walsh, Ryan M.; Di Stefano, Bruno; Brumbaugh, Justin; Odajima, Junko; Shioda, Toshi; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Choi, Jiho; Huebner, Aaron J.; Clement, Kendell; Walsh, Ryan M.; Di Stefano, Bruno; Brumbaugh, Justin; Meissner, Alexander; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Choi, Jiho; Huebner, Aaron J.; Clement, Kendell; Walsh, Ryan M.; Di Stefano, Bruno; Brumbaugh, Justin; Meissner, Alexander; Hochedlinger, Konrad] Harvard Stem Cell Inst, 1350 Massachusetts Ave, Cambridge, MA 02138 USA; [Clement, Kendell; Gu, Hongcang; Mohammad, Arman; Gnirke, Andreas; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lin, Kaixuan; Xiao, Andrew] Yale Univ, Sch Med, Dept Genet, 10 Amistad St, New Haven, CT 06519 USA; [Kim, Sang-Yong] NYU, Langone Med Ctr, New York, NY 10016 USA; [Sharif, Jafar; Koseki, Haruhiko] RIKEN, Natl Res & Dev Agcy, Ctr Integrat Med Sci, Tsurumi Ku, 1-7-22 Suehiuro Cho, Yokohama, Kanagawa 2300045, Japan; [Rose, Christopher M.; Gygi, Steven] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Charron, Jean] Univ Laval, Ctr Rech Canc, CRCHU Quebec, Hotel Dieu Quebec, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; New York University; NYU Langone Medical Center; RIKEN; Harvard University; Harvard Medical School; Laval University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.; Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.; Hochedlinger, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Hochedlinger, K (corresponding author), Harvard Stem Cell Inst, 1350 Massachusetts Ave, Cambridge, MA 02138 USA.	khochedlinger@mgh.harvard.edu	Charron, Jean/A-9792-2013; Di Stefano, Bruno/K-5020-2017; Clement, Kendell/AAZ-6854-2021	Charron, Jean/0000-0002-5133-0056; Di Stefano, Bruno/0000-0003-2532-3087; Brumbaugh, Justin/0000-0002-9605-2010; Clement, Kendell/0000-0003-3808-0811; Kim, Sang Yong/0000-0001-7326-7505; Gu, Hongcang/0000-0002-1439-7606; Choi, Jiho/0000-0001-8839-4056; Rose, Christopher/0000-0002-7502-3368	NIH [P30 CA006973, R21ES024861, 1P50HG006193, R01 HD058013-06]; American Cancer Society-New England Division-Ellison Foundation Postdoctoral Fellowship [PF-15-130-01-DDC]; EMBO [ALTF 1143-2015]; New York Stem Cell Foundation; MGH; HHMI; Gerald and Darlene Jordan Chair in Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114205] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16H02622] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-New England Division-Ellison Foundation Postdoctoral Fellowship; EMBO(European Molecular Biology Organization (EMBO)); New York Stem Cell Foundation; MGH; HHMI(Howard Hughes Medical Institute); Gerald and Darlene Jordan Chair in Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank members of the Hochedlinger laboratory for suggestions as well as L. Barrett for critical reading of the manuscript. Additionally, we thank A. Galvin, M. Gesner and M. Handley at the Massachusetts General Hospital flow cytometry core. We also thank A. L. Hawkins, S. Wang, A. Aggarwal and C. C. Morton at Brigham and Woman's Hospital CytoGenomics Core Laboratory for karyotyping analysis. We are grateful to K. Shioda from the Shioda laboratory for technical support for genome sequencing. We are also grateful to W. Yu at The Sidney Kimmel Cancer Center Microarray Core Facility at Johns Hopkins University for aCGH analysis, who was supported by NIH grant P30 CA006973 entitled Regional Oncology Research Center. We thank T. Theunissen and R. Jaenisch for sharing human OCT4-eGFP ES cell lines and T. Graf for providing the Rex1-GFP ES cells. A.J.H. is supported by an American Cancer Society-New England Division-Ellison Foundation Postdoctoral Fellowship (PF-15-130-01-DDC). B.D.S. is supported by an EMBO long-term Fellowship (ALTF 1143-2015). T. S. is supported by NIH grant R21ES024861. A. Me. is a New York Stem Cell Foundation Robertson Investigator and supported by NIH grant 1P50HG006193 and the New York Stem Cell Foundation. K.H. was supported by funds from the MGH, HHMI, NIH (R01 HD058013-06) and the Gerald and Darlene Jordan Chair in Regenerative Medicine.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen HX, 2015, P NATL ACAD SCI USA, V112, pE5936, DOI 10.1073/pnas.1516319112; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Choi J., 2017, PROTOC EXCH; Choi J, 2017, CELL STEM CELL, V20, P706, DOI 10.1016/j.stem.2017.03.002; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2013, STEM CELL REP, V1, P518, DOI 10.1016/j.stemcr.2013.11.010; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pastor WA, 2016, CELL STEM CELL, V18, P323, DOI 10.1016/j.stem.2016.01.019; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Raggioli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086691; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulz EG, 2014, CELL STEM CELL, V14, P203, DOI 10.1016/j.stem.2013.11.022; Shimizu T, 2012, STEM CELLS, V30, P1394, DOI 10.1002/stem.1119; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tamm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081156; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Treff NR, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135483; von Meyenn F, 2016, MOL CELL, V62, P848, DOI 10.1016/j.molcel.2016.04.025; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu T, 2014, CELL STEM CELL, V15, P281, DOI 10.1016/j.stem.2014.06.004; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	49	73	76	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					219	+		10.1038/nature23274	http://dx.doi.org/10.1038/nature23274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28746311	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000407284300045
J	Wu, LH; Willis, JJ; McKay, IS; Diroll, BT; Qin, J; Cargnello, M; Tassone, CJ				Wu, Liheng; Willis, Joshua J.; McKay, Ian Salmon; Diroll, Benjamin T.; Qin, Jian; Cargnello, Matteo; Tassone, Christopher J.			High-temperature crystallization of nanocrystals into three-dimensional superlattices	NATURE			English	Article							BINARY NANOPARTICLE SUPERLATTICES; IN-SITU; INTERFACE; MEMBRANES	Crystallization of colloidal nanocrystals into superlattices represents a practical bottom-up process with which to create ordered metamaterials with emergent functionalities(1-3). With precise control over the size, shape and composition of individual nanocrystals(4-6), various single-and multi-component nanocrystal superlattices have been produced, the lattice structures and chemical compositions of which can be accurately engineered(7-9). Nanocrystal superlattices are typically prepared by carefully controlling the assembly process through solvent evaporation or destabilization(2,10-15) or through DNA-guided crystallization(16-18). Slow solvent evaporation or cooling of nanocrystal solutions (over hours or days) is the key element for successful crystallization processes(10,18). Here we report the rapid growth (seconds) of micrometre-sized, face-centred-cubic, three-dimensional nanocrystal superlattices during colloidal synthesis at high temperatures (more than 230 degrees Celsius). Using in situ small-angle X-ray scattering, we observe continuous growth of individual nanocrystals within the lattices, which results in simultaneous lattice expansion and fine nanocrystal size control due to the superlattice templates. Thermodynamic models demonstrate that balanced attractive and repulsive interparticle interactions dictated by the ligand coverage on nanocrystal surfaces and nanocrystal core size are responsible for the crystallization process. The interparticle interactions can also be controlled to form different superlattice structures, such as hexagonal close-packed lattices. The rational assembly of various nanocrystal systems into novel materials is thus facilitated for both fundamental research and for practical applications in the fields of magnetics(19), electronics(3) and catalysis(20).	[Wu, Liheng; Tassone, Christopher J.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Wu, Liheng; Willis, Joshua J.; McKay, Ian Salmon; Qin, Jian; Cargnello, Matteo] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Diroll, Benjamin T.] Argonne Natl Lab, Ctr Nanoscale Mat, Lemont, IL 60439 USA; [Cargnello, Matteo] Stanford Univ, SUNCAT Ctr Interface Sci & Catalysis, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); Argonne National Laboratory; Stanford University	Tassone, CJ (corresponding author), SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA.; Cargnello, M (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Cargnello, M (corresponding author), Stanford Univ, SUNCAT Ctr Interface Sci & Catalysis, Stanford, CA 94305 USA.	mcargnello@stanford.edu; tassone@slac.stanford.edu	Wu, Liheng/L-1279-2016; Qin, Jian/C-9253-2013	Wu, Liheng/0000-0002-2649-2096; Qin, Jian/0000-0001-6271-068X; McKay, Ian Salmon/0000-0001-6598-6761; Cargnello, Matteo/0000-0002-7344-9031	US Department of Energy (DOE), Laboratory Directed Research and Development programme at SLAC National Accelerator Laboratory [DE-AC02-76SF00515]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Defense through the National Defense Science & Engineering Graduate Fellowship Program; Fannie and John Hertz Foundation through a Hertz Foundation Fellowship; School of Engineering at Stanford University; Terman Faculty Fellowship; DOE Office of Science [DE-AC02-06CH11357]	US Department of Energy (DOE), Laboratory Directed Research and Development programme at SLAC National Accelerator Laboratory; DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Defense through the National Defense Science & Engineering Graduate Fellowship Program; Fannie and John Hertz Foundation through a Hertz Foundation Fellowship; School of Engineering at Stanford University; Terman Faculty Fellowship; DOE Office of Science(United States Department of Energy (DOE))	This work was supported by the US Department of Energy (DOE), Laboratory Directed Research and Development programme at SLAC National Accelerator Laboratory, under contract DE-AC02-76SF00515. In situ SAXS experiments were performed at the Beamline 1-5 at the Stanford Synchrotron Radiation Lightsource (SSRL) of the SLAC National Accelerator Laboratory, and use of the SSRL was supported by the DOE Office of Science, Office of Basic Energy Sciences under contract number DE-AC02-76SF00515. I.S.M. was supported by the Department of Defense through the National Defense Science & Engineering Graduate Fellowship Program, and by the Fannie and John Hertz Foundation through a Hertz Foundation Fellowship. M.C. acknowledges support from the School of Engineering at Stanford University and from a Terman Faculty Fellowship. The electron microscopy characterization of nanocrystals and superlattices was performed at the Stanford Nano Shared Facilities (SNSF) at Stanford University. The work at the Center for Nanoscale Materials of Argonne National Laboratory was supported by the DOE Office of Science under contract number DE-AC02-06CH11357. L.W. thanks T.J. Dunn from SSRL for his assistance during the SAXS measurements. M. C. thanks N. Abbott (University of Wisconsin), D. Talapin (University of Chicago) and C. B. Murray (University of Pennsylvania) for discussions.	Auyeung E, 2014, NATURE, V505, P73, DOI 10.1038/nature12739; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Boles MA, 2016, CHEM REV, V116, P11220, DOI 10.1021/acs.chemrev.6b00196; Cargnello M, 2016, AICHE J, V62, P392, DOI 10.1002/aic.15063; Cargnello M, 2015, NATURE, V524, P450, DOI 10.1038/nature14872; Cargnello M, 2013, SCIENCE, V341, P771, DOI 10.1126/science.1240148; Chen J, 2013, ACS NANO, V7, P1478, DOI 10.1021/nn3052617; de Nijs B, 2015, NAT MATER, V14, P56, DOI [10.1038/NMAT4072, 10.1038/nmat4072]; Dong AG, 2010, NATURE, V466, P474, DOI 10.1038/nature09188; Erdemir D, 2009, ACCOUNTS CHEM RES, V42, P621, DOI 10.1021/ar800217x; Ganguly S, 2011, J MATER CHEM, V21, P8800, DOI 10.1039/c1jm11015b; Geuchies JJ, 2016, NAT MATER, V15, P1248, DOI [10.1038/nmat4746, 10.1038/NMAT4746]; Glicksman M, 1971, SOLID STATE PHYS, V26, P275; He GW, 2006, CRYST GROWTH DES, V6, P1746, DOI 10.1021/cg0602515; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P133, DOI 10.1016/B978-0-12-375182-9.10007-7; Jiang Z, 2015, NAT MATER, V14, P912, DOI [10.1038/NMAT4321, 10.1038/nmat4321]; JONES AG, 1974, CHEM ENG SCI, V29, P105, DOI 10.1016/0009-2509(74)85036-0; Kim JU, 2008, MACROMOLECULES, V41, P4435, DOI 10.1021/ma8002856; Kim SW, 2003, NANO LETT, V3, P1289, DOI 10.1021/nl0343405; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park J, 2005, ANGEW CHEM INT EDIT, V44, P2872, DOI 10.1002/anie.200461665; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Peng S, 2006, J AM CHEM SOC, V128, P10676, DOI 10.1021/ja063969h; Rupich SM, 2010, J AM CHEM SOC, V132, P289, DOI 10.1021/ja9074425; Shevchenko EV, 2006, J AM CHEM SOC, V128, P3620, DOI 10.1021/ja0564261; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Smith DK, 2009, J AM CHEM SOC, V131, P3281, DOI 10.1021/ja8085438; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Tian Y, 2016, NAT MATER, V15, P654, DOI [10.1038/NMAT4571, 10.1038/nmat4571]; Visser J., 1972, ADV COLLOID INTERFAC, V3, P331, DOI [10.1016/0001-8686(72)85001-2, DOI 10.1016/0001-8686(72)85001-2]; Weidman MC, 2016, NAT MATER, V15, P775, DOI [10.1038/nmat4600, 10.1038/NMAT4600]; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Yang Y, 2016, NANO LETT, V16, P2133, DOI 10.1021/acs.nanolett.6b00730; Ye XC, 2013, NAT CHEM, V5, P466, DOI [10.1038/NCHEM.1651, 10.1038/nchem.1651]; Zhao H, 2016, NAT NANOTECHNOL, V11, P82, DOI [10.1038/NNANO.2015.256, 10.1038/nnano.2015.256]	39	83	85	15	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					197	+		10.1038/nature23308	http://dx.doi.org/10.1038/nature23308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28759888	Green Submitted			2022-12-28	WOS:000407284300040
J	Butler, SM				Butler, Stuart M.			State Flexibility for Medicaid: How Much?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Butler, Stuart M.] Brookings Inst, Econ Studies, Washington, DC 20036 USA; [Butler, Stuart M.] Georgetown Univ, Grad Sch, Washington, DC 20057 USA; [Butler, Stuart M.] Convergence Ctr Policy Resolut, Washington, DC 20036 USA	Brookings Institution; Georgetown University	Butler, SM (corresponding author), Brookings Inst, Econ Studies, Washington, DC 20036 USA.; Butler, SM (corresponding author), Georgetown Univ, Grad Sch, Washington, DC 20057 USA.; Butler, SM (corresponding author), Convergence Ctr Policy Resolut, Washington, DC 20036 USA.	smbutler@brookings.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					413	414		10.1001/jama.2017.8758	http://dx.doi.org/10.1001/jama.2017.8758			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763537				2022-12-28	WOS:000406659800003
J	Chen, YY; Chen, CC				Chen, Yang-Yuan; Chen, Cheng-Che			Cholelithiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Yang-Yuan; Chen, Cheng-Che] Changhua Christian Hosp, Changhua, Taiwan	Changhua Christian Hospital	Chen, YY (corresponding author), Changhua Christian Hosp, Changhua, Taiwan.	ychen02@gmail.com							0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					371	371		10.1056/NEJMicm1612408	http://dx.doi.org/10.1056/NEJMicm1612408			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28745992				2022-12-28	WOS:000406295000009
J	Taran, S				Taran, Shaurya			The Absurd	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Taran, Shaurya] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto	Taran, S (corresponding author), Univ Hlth Network, Dept Med, 2000 Elizabeth St,Eaton Bldg 14-217, Toronto, ON M5G 2C4, Canada.	shaurya.taran@mail.utoronto.ca	Taran, Shaurya/ABF-1571-2020						0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					239	240		10.1001/jama.2017.5955	http://dx.doi.org/10.1001/jama.2017.5955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719696				2022-12-28	WOS:000405775000008
J	Horton, R				Horton, Richard			Offline: The G20 and health-platitudes and broken promises	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					214	214		10.1016/S0140-6736(17)31858-5	http://dx.doi.org/10.1016/S0140-6736(17)31858-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA5IZ	28721866				2022-12-28	WOS:000405477900009
J	Catalini, C; Tucker, C				Catalini, Christian; Tucker, Catherine			When early adopters don't adopt	SCIENCE			English	Editorial Material							ECONOMICS		[Catalini, Christian; Tucker, Catherine] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Catalini, C (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	catalini@mit.edu	Tucker, Catherine E/H-4878-2011		MIT Office of the Provost; MIT Sloan School of Management; NET Institute	MIT Office of the Provost; MIT Sloan School of Management; NET Institute	We thank D. Elitzer and J. Rubin for allowing us to study the bitcoin experiment, the MIT Office of the Provost for support, and the generous support of alumni. This research was funded by the MIT Sloan School of Management and the NET Institute.	Agrawal Ajay, 2014, INNOVATION POLICY EC, V14; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Bohme R, 2015, J ECON PERSPECT, V29, P213, DOI 10.1257/jep.29.2.213; Catalini C., 2016, 22952 NBER; Gans J., 2016, 2844843 SSRN; Gans J.S., 2015, EC ANAL DIGITAL EC, P257; Glaeser EL, 1996, Q J ECON, V111, P507, DOI 10.2307/2946686; GRILICHES Z, 1957, ECONOMETRICA, V25, P501, DOI 10.2307/1905380; Nakamoto S., 2008, DECENTRALIZED BUS RE, V4, P21260; Rogers EM, 1962, DIFFUSION INNOVATION; Von Hippel E., 1976, RES POLICY, V5, P212, DOI DOI 10.1016/0048-7333(76)90028-7; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527	12	21	21	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		135	136		10.1126/science.aal4476	http://dx.doi.org/10.1126/science.aal4476			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706029				2022-12-28	WOS:000405391700025
J	Hand, E				Hand, Eric			EARTH SCIENCE CubeSat networks hasten shift to commercial weather data	SCIENCE			English	News Item																			0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		118	119		10.1126/science.357.6347.118	http://dx.doi.org/10.1126/science.357.6347.118			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706019				2022-12-28	WOS:000405391700015
J	Jorstad, NL; Wilken, MS; Rimes, WNG; Wohl, SG; VandenBosch, LS; Yoshimatsu, T; Wong, RO; Rieke, F; Reh, TA				Jorstad, Nikolas L.; Wilken, Matthew S.; Rimes, William N. G.; Wohl, Stefanie G.; VandenBosch, Leah S.; Yoshimatsu, Takeshi; Wong, Rachel O.; Rieke, Fred; Reh, Thomas A.			Stimulation of functional neuronal regeneration from Muller glia in adult mice	NATURE			English	Article							IN-VIVO; RETINAL REGENERATION; MAMMALIAN RETINA; ZEBRAFISH RETINA; STEM-CELLS; ASCL1; PROGENITORS; ASTROCYTES; EXPRESSION; GENERATION	Many retinal diseases lead to the loss of retinal neurons and cause visual impairment. The adult mammalian retina has little capacity for regeneration. By contrast, teleost fish functionally regenerate their retina following injury, and Muller glia (MG) are the source of regenerated neurons(1-6). The proneural transcription factor Ascl1 is upregulated in MG after retinal damage(1,7) in zebrafish and is necessary for regeneration(8). Although Ascl1 is not expressed in mammalian MG after injury(9), forced expression of Ascl1 in mouse MG induces a neurogenic state in vitro(10) and in vivo after NMDA (N-methyl-d-aspartate) damage in young mice(11). However, by postnatal day 16, mouse MG lose neurogenic capacity, despite Ascl1 overexpression(11). Loss of neurogenic capacity in mature MG is accompanied by reduced chromatin accessibility, suggesting that epigenetic factors limit regeneration. Here we show that MG-specific overexpression of Ascl1, together with a histone deacetylase inhibitor, enables adult mice to generate neurons from MG after retinal injury. The MG-derived neurons express markers of inner retinal neurons, synapse with host retinal neurons, and respond to light. Using an assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq), we show that the histone deacetylase inhibitor promotes accessibility at key gene loci in the MG, and allows more effective reprogramming. Our results thus provide a new approach for the treatment of blinding retinal diseases.	[Jorstad, Nikolas L.; Wilken, Matthew S.; Wohl, Stefanie G.; VandenBosch, Leah S.; Yoshimatsu, Takeshi; Wong, Rachel O.; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Jorstad, Nikolas L.] Univ Washington, Dept Pathol, Mol Med & Mech Dis Program, Seattle, WA 98195 USA; [Rimes, William N. G.; Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Reh, TA (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	tomreh@uw.edu	Wohl, Stefanie/I-1590-2019	Wohl, Stefanie/0000-0003-2559-7678; Jorstad, Nikolas/0000-0001-7906-9470; Yoshimatsu, Takeshi/0000-0002-4939-2020	NIH NEI [1R01EY021482, EY14358]; Howard Hughes Medical Institute; Allen Distinguished Investigator award (Paul G. Allen Family Foundation); NSF [DGE-0718124]; Cellular and Molecular Biology Training Grant [T32GM007270]; Vision Core Grant [P30EY01730]; NATIONAL EYE INSTITUTE [P30EY001730, R01EY014358, R01EY021482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Allen Distinguished Investigator award (Paul G. Allen Family Foundation); NSF(National Science Foundation (NSF)); Cellular and Molecular Biology Training Grant; Vision Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the following funding sources for support of this work. NIH NEI 1R01EY021482 to T.A.R., EY14358 to R.O.W., Howard Hughes Medical Institute to F.R., Allen Distinguished Investigator award (Paul G. Allen Family Foundation) to T.A.R., F.R. and R.O.W., an NSF Fellowship to M.W. (DGE-0718124), a Cellular and Molecular Biology Training Grant (T32GM007270) to L.S.V., and the Vision Core Grant P30EY01730 for use of the imaging facilities. We thank members of the Reh and Bermingham-McDonogh laboratories for valuable discussion and technical advice. We thank O. Bermingham-McDonogh for constructive comments on the manuscript. We thank A. Wills and A. Chitsazan for their ATAC-seq protocol and data analytics suggestions. We thank J. Delrow, C. Bennett and A. Berger at the Fred Hutch Genomics Shared Resource and Flow Cytometry facilities for their contributions to our sequencing datasets. We thank the laboratory of R. D. Hawkins for the cChIP reagents and protocol (H3K27ac ChIP). We thank the laboratory of C. Trapnell, specifically D. Jackson and R. Chawla, for their help generating the 10x Genomics single-cell RNA-seq datasets. Lastly, the authors thank E. Levine (Vanderbilt University) for the Rlbp1-creER mouse line and M. Nakafuku (Cincinnati Children's) for the tetO-Ascl1-GFP mice.	Biedermann B, 2002, GLIA, V39, P217, DOI 10.1002/glia.10097; Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/NMETH.1622, 10.1038/nmeth.1622]; Brzezinski JA, 2011, DEVELOPMENT, V138, P3519, DOI 10.1242/dev.064006; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Della Santina L, 2016, CURR BIOL, V26, P2070, DOI 10.1016/j.cub.2016.06.016; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Heinrich C, 2015, NAT CELL BIOL, V17, P204, DOI 10.1038/ncb3108; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; Liu YG, 2015, J NEUROSCI, V35, P9336, DOI 10.1523/JNEUROSCI.3975-14.2015; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Newman E A, 1986, Neurosci Res Suppl, V4, pS209; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Pollak J, 2013, DEVELOPMENT, V140, P2619, DOI 10.1242/dev.091355; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Samuel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089110; Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Torper O, 2015, CELL REP, V12, P474, DOI 10.1016/j.celrep.2015.06.040; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Ueki Y, 2015, P NATL ACAD SCI USA, V112, P13717, DOI 10.1073/pnas.1510595112; Valensisi C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2285-7; Wan J, 2016, CURR OPIN GENET DEV, V40, P41, DOI 10.1016/j.gde.2016.05.009	32	238	249	5	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					103	+		10.1038/nature23283	http://dx.doi.org/10.1038/nature23283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28746305	Green Accepted			2022-12-28	WOS:000406831700045
J	Long, Y; Tahl, YS; Weidtkamp-Peters, S; Postma, M; Zhou, W; Oedhart, JG; Sanchez-Perez, MI; Adella, TWJG; Simon, R; Scheres, B; Blilou, I				Long, Yuchen; Tahl, Yvonne S.; Weidtkamp-Peters, Stefanie; Postma, Marten; Zhou, Wenkun; Oedhart, Joachim G.; Sanchez-Perez, Maria-Isabel; Adella, Theodorus W. J. G., Jr.; Simon, Ruediger; Scheres, Ben; Blilou, Ikram			In vivo FRET-FLIM reveals cell-type-specific protein interactions in Arabidopsis roots	NATURE			English	Article							STABILIZE TISSUE BOUNDARIES; TRANSCRIPTION FACTORS; FLUORESCENCE; SHR; INSTRUMENTATION; IDENTIFICATION; RESOLUTION; SCARECROW; MOVEMENT; CYAN	During multicellular development, specification of distinct cell fates is often regulated by the same transcription factors operating differently in distinct cis-regulatory modules(1-3), either through different protein complexes, conformational modification of protein complexes, or combinations of both. Direct visualization of different transcription factor complex states guiding specific gene expression programs has been challenging. Here we use in vivo FRET-FLIM (Forster resonance energy transfer measured by fluorescence lifetime microscopy) to reveal spatial partitioning of protein interactions in relation to specification of cell fate. We show that, in Arabidopsis roots, three fully functional fluorescently tagged cell fate regulators establish cell-type-specific interactions at endogenous expression levels and can form higher order complexes. We reveal that cell-type-specific in vivo FRET-FLIM distributions reflect conformational changes of these complexes to differentially regulate target genes and specify distinct cell fates.	[Long, Yuchen; Zhou, Wenkun; Scheres, Ben; Blilou, Ikram] Wageningen Univ & Res Ctr, Plant Dev Biol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [Long, Yuchen; Blilou, Ikram] Univ Utrecht, Dept Biol, Mol Genet, Padualaan 8, NL-3581 CH Utrecht, Netherlands; [Tahl, Yvonne S.; Simon, Ruediger] Heinrich Heine Univ, CEPLAS Cluster Excellence Plant Sci, Univ Str 1, D-40225 Dusseldorf, Germany; [Tahl, Yvonne S.; Simon, Ruediger] Heinrich Heine Univ, Inst Dev Genet, Univ Str 1, D-40225 Dusseldorf, Germany; [Weidtkamp-Peters, Stefanie] Heinrich Heine Univ, Ctr Adv Imaging, Univ Str 1, D-40225 Dusseldorf, Germany; [Postma, Marten; Oedhart, Joachim G.; Adella, Theodorus W. J. G., Jr.] Univ Amsterdam, van Leeuwenhoek Ctr Adv Microscopy, Sect Mol Cytol, Swammerdam Inst Life Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Sanchez-Perez, Maria-Isabel] UAM, Dept Bioquim, Inst Invest Biomed Alberto Sols, CSIC, Arturo Duperier 4, Madrid 28029, Spain; [Long, Yuchen] UCB Lyon 1, ENS Lyon, Lab Reprod & Dev Plantes RDP, CNRS,INRA, F-69342 Lyon, France	Wageningen University & Research; Utrecht University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Amsterdam; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Blilou, I (corresponding author), Wageningen Univ & Res Ctr, Plant Dev Biol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.; Blilou, I (corresponding author), Univ Utrecht, Dept Biol, Mol Genet, Padualaan 8, NL-3581 CH Utrecht, Netherlands.	ikram.blilou@wur.nl	Long, Yuchen/GZA-6989-2022; Sánchez-Pérez, Isabel/R-4107-2016; Simon, Rudiger/T-6755-2018	Long, Yuchen/0000-0001-5071-4632; Sánchez-Pérez, Isabel/0000-0002-4829-201X; Gadella, Theodorus/0000-0002-7639-219X; zhou, wenkun/0000-0002-2480-2644; Simon, Rudiger/0000-0002-1317-7716; Weidtkamp-Peters, Stefanie/0000-0001-7734-3771; Stahl, Yvonne/0000-0002-7543-5186; Blilou, Ikram/0000-0001-8003-3782	NWO VIDI grant; ERC Advanced Grant SysArc; NWO Spinoza Grant; NWO ALW-VIDI grant [864.09.015]; DFG [WE 5343/1-1]	NWO VIDI grant(Netherlands Organization for Scientific Research (NWO)); ERC Advanced Grant SysArc; NWO Spinoza Grant(Netherlands Organization for Scientific Research (NWO)); NWO ALW-VIDI grant; DFG(German Research Foundation (DFG))	We thank P. Benfey for discussions and critical reading of the manuscript, A. Akhmanova and B. P. Bouchet for providing mammalian cells lines and laboratory facilities to perform transfection assays, S. Diaz for sharing DLR protocols used in this study. This work was supported by an NWO VIDI grant to I. B. and Y.L. Y.L. was further supported by ERC Advanced Grant SysArc and NWO Spinoza Grant to B.S. M.P. was supported by an NWO ALW-VIDI grant 864.09.015 and S.W.P. was supported by DFG-project WE 5343/1-1.	Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Clark NM, 2016, ELIFE, V5, DOI 10.7554/eLife.14770; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cruz-Ramirez A, 2012, CELL, V150, P1002, DOI 10.1016/j.cell.2012.07.017; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Eggeling C, 2001, J BIOTECHNOL, V86, P163, DOI 10.1016/S0168-1656(00)00412-0; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Gerritsen HC, 2009, LAB TECH BIOCHEM MOL, V33, P95, DOI 10.1016/S0075-7535(08)00003-X; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Hejatko J, 2006, NAT PROTOC, V1, P1939, DOI 10.1038/nprot.2006.333; Hirano Y, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.10; Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kudryavtsev V, 2007, ANAL BIOANAL CHEM, V387, P71, DOI 10.1007/s00216-006-0917-0; Ladam F, 2014, DEV DYNAM, V243, P4, DOI 10.1002/dvdy.23997; LASSNER MW, 1991, PLANT MOL BIOL, V17, P229, DOI 10.1007/BF00039497; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Long YC, 2015, PLANT CELL, V27, P1185, DOI 10.1105/tpc.114.132407; Long YC, 2015, J EXP BOT, V66, P1133, DOI 10.1093/jxb/eru548; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Moreno-Risueno MA, 2015, SCIENCE, V350, P426, DOI 10.1126/science.aad1171; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Pi LM, 2015, DEV CELL, V33, P576, DOI 10.1016/j.devcel.2015.04.024; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schaffer J, 1999, J PHYS CHEM A, V103, P331, DOI 10.1021/jp9833597; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; Sparks E, 2013, NAT REV GENET, V14, P631, DOI 10.1038/nrg3541; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stahl Y, 2013, CURR BIOL, V23, P362, DOI 10.1016/j.cub.2013.01.045; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006; Verveer PJ, 2009, LAB TECH BIOCHEM MOL, V33, P59, DOI 10.1016/S0075-7535(08)00002-8; Weidtkamp-Peters S, 2009, PHOTOCH PHOTOBIO SCI, V8, P470, DOI 10.1039/b903245m; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Widengren J, 2006, ANAL CHEM, V78, P2039, DOI 10.1021/ac0522759	41	87	89	14	128	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					97	+		10.1038/nature23317	http://dx.doi.org/10.1038/nature23317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28746306	Green Accepted			2022-12-28	WOS:000406831700044
J	Zhang, CS; Hawley, SA; Zong, Y; Li, MQ; Wang, ZC; Gray, A; Ma, T; Cui, JW; Feng, JW; Zhu, MJ; Wu, YQ; Li, TY; Ye, ZY; Lin, SY; Yin, HY; Piao, HL; Hardie, DGR; Lin, SC				Zhang, Chen-Song; Hawley, Simon A.; Zong, Yue; Li, Mengqi; Wang, Zhichao; Gray, Alexander; Ma, Teng; Cui, Jiwen; Feng, Jin-Wei; Zhu, Mingjiang; Wu, Yu-Qing; Li, Terytty Yang; Ye, Zhiyun; Lin, Shu-Yong; Yin, Huiyong; Piao, Hai-Long; Hardie, D. G. Rahame; Lin, Sheng-Cai			Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK	NATURE			English	Article							VACUOLAR H+-ATPASE; ACTIVATED PROTEIN-KINASE; PHOSPHORYLATION; DISEASE; CELLS; METABOLISM; MECHANISM; AUTOPHAGY; REVEALS; COMPLEX	The major energy source for most cells is glucose, from which ATP is generated via glycolysis and/or oxidative metabolism. Glucose deprivation activates AMP-activated protein kinase (AMPK)(1), but it is unclear whether this activation occurs solely via changes in AMP or ADP, the classical activators of AMPK(2-5). Here, we describe an AMP/ADP-independent mechanism that triggers AMPK activation by sensing the absence of fructose-1,6-bisphosphate (FBP), with AMPK being progressively activated as extracellular glucose and intracellular FBP decrease. When unoccupied by FBP, aldolases promote the formation of a lysosomal complex containing at least v-ATPase, ragulator, axin, liver kinase B1 (LKB1) and AMPK, which has previously been shown to be required for AMPK activation(6,7). Knockdown of aldolases activates AMPK even in cells with abundant glucose, whereas the catalysis-defective D34S aldolase mutant, which still binds FBP, blocks AMPK activation. Cell-free reconstitution assays show that addition of FBP disrupts the association of axin and LKB1 with v-ATPase and ragulator. Importantly, in some cell types AMP/ATP and ADP/ATP ratios remain unchanged during acute glucose starvation, and intact AMP-binding sites on AMPK are not required for AMPK activation. These results establish that aldolase, as well as being a glycolytic enzyme, is a sensor of glucose availability that regulates AMPK.	[Zhang, Chen-Song; Zong, Yue; Li, Mengqi; Ma, Teng; Cui, Jiwen; Feng, Jin-Wei; Wu, Yu-Qing; Li, Terytty Yang; Ye, Zhiyun; Lin, Shu-Yong; Lin, Sheng-Cai] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; [Hawley, Simon A.; Gray, Alexander; Hardie, D. G. Rahame] Univ Dundee, Div Cell Signalling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Wang, Zhichao; Piao, Hai-Long] Chinese Acad Sci, Dalian Inst Chem Phys, Sci Res Ctr Translat Med, Dalian 116023, Liaoning, Peoples R China; [Wang, Zhichao] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian 116023, Liaoning, Peoples R China; [Wang, Zhichao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Mingjiang; Yin, Huiyong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Food Safety Res, Shanghai 200031, Peoples R China	Xiamen University; University of Dundee; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, SC (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China.; Hardie, DGR (corresponding author), Univ Dundee, Div Cell Signalling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland.	d.g.hardie@dundee.ac.uk; linsc@xmu.edu.cn	Lin, Shu-Yong/B-7726-2012; Hardie, David/Z-1979-2019; Li, Terytty Yang/HCI-2446-2022	Lin, Shu-Yong/0000-0002-4419-1713; Li, Terytty Yang/0000-0003-3684-7935; Gray, Alexander/0000-0001-9227-0363; yin, hui yong/0000-0001-7049-1560; Wang, Zhichao/0000-0002-4237-5084	Wellcome Trust [097726]; Cancer Research UK [C37030/ A15101]; National Key Research and Development Project of China [2016YFA0502001]; National Natural Science Foundation of China [31430094, 31690101, 31571214, 31601152, J1310027]; Cancer Research UK [15101] Funding Source: researchfish; Wellcome Trust [204766/Z/16/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); National Key Research and Development Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank all other members of the S.-C.L. laboratory for suggestions and technical assistance, and the proteomics team at the University of Dundee (D. Lamont, A. Atrih, W. Chen and K. Beattie) for LC-MS analyses of nucleotides. D.G.H. was supported by an Investigator Award from the Wellcome Trust (097726) and a Programme Grant from Cancer Research UK (C37030/ A15101). S.-C.L. was supported by grants from the National Key Research and Development Project of China (2016YFA0502001) and the National Natural Science Foundation of China (#31430094, #31690101, #31571214, #31601152 and #J1310027).	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Choi KH, 2001, BIOCHEMISTRY-US, V40, P13868, DOI 10.1021/bi0114877; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; ELMAGHRABI MR, 1982, J BIOL CHEM, V257, P233; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Houde VP, 2014, BIOCHEM J, V458, P41, DOI 10.1042/BJ20131324; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; KELLEY PM, 1986, PLANT PHYSIOL, V82, P1076, DOI 10.1104/pp.82.4.1076; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Langendorf CG, 2015, CELL RES, V25, P5, DOI 10.1038/cr.2014.163; Lew CR, 2012, J BIOL CHEM, V287, P42554, DOI 10.1074/jbc.M112.405969; Li TY, 2016, MOL CELL, V62, P359, DOI 10.1016/j.molcel.2016.04.009; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; MORRIS AJ, 1993, J BIOL CHEM, V268, P1095; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Rago F, 2015, J AM CHEM SOC, V137, P13876, DOI 10.1021/jacs.5b08149; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ross FA, 2016, FEBS J, V283, P2987, DOI 10.1111/febs.13698; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Sols A., 1970, CURRENT TOPICS CELLU, V2, P227; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005; Zhao J., 2014, METABOLOMICS, V10; Zhao YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16346	35	318	342	23	382	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					112	+		10.1038/nature23275	http://dx.doi.org/10.1038/nature23275			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28723898	Green Accepted, Green Submitted			2022-12-28	WOS:000406831700047
J	Yuan, KQ; Romanowicz, B				Yuan, Kaiqing; Romanowicz, Barbara			Seismic evidence for partial melting at the root of major hot spot plumes	SCIENCE			English	Article							ULTRALOW-VELOCITY ZONE; BOUNDARY-LAYER; MANTLE; BASE; SUPERPLUMES; CONSTRAINTS; HOTSPOTS; BENEATH; ULVZ	Ultralow-velocity zones are localized regions of extreme material properties detected seismologically at the base of Earth's mantle. Their nature and role in mantle dynamics are poorly understood. We used shear waves diffracted at the core-mantle boundary to illuminate the root of the Iceland plume from different directions. Through waveform modeling, we detected a large ultralow-velocity zone and constrained its shape to be axisymmetric to a very good first order. We thus attribute it to partial melting of a locally thickened, denser- and hotter-than-average layer, reflecting dynamics and elevated temperatures within the plume root. Such structures are few and far apart, and they may be characteristic of the roots of some of the broad mantle plumes tomographically imaged within the large low-shear-velocity provinces in the lower mantle.	[Yuan, Kaiqing; Romanowicz, Barbara] Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Romanowicz, Barbara] Coll France, Paris, France; [Romanowicz, Barbara] Univ Paris Diderot, Inst Phys Globe, Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Universite Paris Cite	Romanowicz, B (corresponding author), Berkeley Seismol Lab, Berkeley, CA 94720 USA.; Romanowicz, B (corresponding author), Coll France, Paris, France.; Romanowicz, B (corresponding author), Univ Paris Diderot, Inst Phys Globe, Paris, France.	barbara@seismo.berkeley.edu	romanowicz, Barbara/H-6726-2017	romanowicz, Barbara/0000-0002-6208-6044	Cooperative Studies of the Earth's Deep Interior program of the NSF [EAR-1464014]; European Research Council under the European Commission	Cooperative Studies of the Earth's Deep Interior program of the NSF(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); European Research Council under the European Commission	We thank S. Cottaar for introducing us to the 3D modeling approach used in this study and the IRIS (Incorporated Research Institutions for Seismology) data center for archiving and providing all the data. We thank three anonymous reviewers for helping improve the manuscript. This work was supported by a grant (EAR-1464014) from the Cooperative Studies of the Earth's Deep Interior program of the NSF and an Advanced Grant (WAVETOMO) from the European Research Council under the European Commission's Seventh Framework Programme. K.Y. performed the data analysis and computations and prepared the figures and technical details. B.R. provided the intellectual framework and guidance for the project and wrote the manuscript.	Ballmer MD, 2016, GEOCHEM GEOPHY GEOSY, V17, P5056, DOI 10.1002/2016GC006605; Bower DJ, 2011, EARTH PLANET SC LETT, V303, P193, DOI 10.1016/j.epsl.2010.12.035; Capdeville Y, 2003, GEOPHYS J INT, V154, P44, DOI 10.1046/j.1365-246X.2003.01959.x; Cottaar S, 2012, EARTH PLANET SC LETT, V355, P213, DOI 10.1016/j.epsl.2012.09.005; Davaille A, 2002, EARTH PLANET SC LETT, V203, P621, DOI 10.1016/S0012-821X(02)00897-X; DZIEWONSKI AM, 1987, SCIENCE, V236, P37, DOI 10.1126/science.236.4797.37; French SW, 2014, GEOPHYS J INT, V199, P1303, DOI 10.1093/gji/ggu334; French SW, 2015, NATURE, V525, P95, DOI 10.1038/nature14876; Fukao Y, 2013, J GEOPHYS RES-SOL EA, V118, P5920, DOI 10.1002/2013JB010466; Garnero EJ, 2016, NAT GEOSCI, V9, P481, DOI [10.1038/ngeo2733, 10.1038/NGEO2733]; Garnero EJ, 1998, J GEOPHYS RES-SOL EA, V103, P12495, DOI 10.1029/98JB00700; Garnero EJ, 1996, GEOPHYS RES LETT, V23, P977, DOI 10.1029/95GL03603; Garnero EJ, 2000, GEOPHYS RES LETT, V27, P2777, DOI 10.1029/2000GL008498; He YM, 2015, EARTH PLANET SC LETT, V417, P19, DOI 10.1016/j.epsl.2015.02.028; Helmberger DV, 1998, NATURE, V396, P251, DOI 10.1038/24357; Herzberg C, 2013, NATURE, V493, P393, DOI 10.1038/nature11771; Hier-Majumder S, 2010, EARTH PLANET SC LETT, V299, P382, DOI 10.1016/j.epsl.2010.09.018; Idehara K, 2011, PHYS EARTH PLANET IN, V184, P80, DOI 10.1016/j.pepi.2010.10.014; Jellinek AM, 2002, NATURE, V418, P760, DOI 10.1038/nature00979; Koelemeijer P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15241; Lay T., 2015, TREATISE GEOPHYS, P683, DOI DOI 10.1016/B978-0-444-53802-4.00019-1; Lekic V, 2012, EARTH PLANET SC LETT, V357, P68, DOI 10.1016/j.epsl.2012.09.014; Li MM, 2014, NAT GEOSCI, V7, P366, DOI [10.1038/ngeo2120, 10.1038/NGEO2120]; Liu JC, 2016, P NATL ACAD SCI USA, V113, P5547, DOI 10.1073/pnas.1519540113; Mao WL, 2006, SCIENCE, V312, P564, DOI 10.1126/science.1123442; Masson Y, 2017, GEOPHYS J INT, V208, P674, DOI 10.1093/gji/ggw412; McNamara AK, 2010, EARTH PLANET SC LETT, V299, P1, DOI 10.1016/j.epsl.2010.07.042; Mundl A, 2017, SCIENCE, V356, P66, DOI 10.1126/science.aal4179; Rost S, 2005, NATURE, V435, P666, DOI 10.1038/nature03620; Schubert G, 2004, PHYS EARTH PLANET IN, V146, P147, DOI 10.1016/j.pepi.2003.09.025; Schuberth B. S. A., 2009, J RITSEMA GEOCHEM GE, V10; Thorne MS, 2013, EARTH PLANET SC LETT, V364, P59, DOI 10.1016/j.epsl.2012.12.034; Thorne MS, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003010; Thybo H, 2003, EARTH PLANET SC LETT, V216, P693, DOI 10.1016/S0012-821X(03)00532-6; To A, 2005, EARTH PLANET SC LETT, V233, P137, DOI 10.1016/j.epsl.2005.01.037; Wen LX, 1998, SCIENCE, V279, P1701, DOI 10.1126/science.279.5357.1701; Wicks JK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043689; Williams Q, 1998, SCIENCE, V281, P546, DOI 10.1126/science.281.5376.546; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528; Zhao CP, 2017, J GEOPHYS RES-SOL EA, V122, P1198, DOI 10.1002/2016JB013449	40	58	59	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					393	396		10.1126/science.aan0760	http://dx.doi.org/10.1126/science.aan0760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751607				2022-12-28	WOS:000406362300043
J	Chen, K; Liu, J; Liu, SX; Xia, M; Zhang, XM; Han, D; Jiang, YM; Wang, CM; Cao, XT				Chen, Kun; Liu, Juan; Liu, Shuxun; Xia, Meng; Zhang, Xiaomin; Han, Dan; Jiang, Yingming; Wang, Chunmei; Cao, Xuetao			Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity	CELL			English	Article							HEPATITIS-C VIRUS; H3K36 TRIMETHYLATION; IFN-GAMMA; HISTONE; GENES; INFECTION; PROTEIN; SETD2; CELLS; DNA	Interferon-alpha (IFN alpha) signaling is essential for antiviral response via induction of IFN-stimulated genes (ISGs). Through a non-biased high-throughput RNAi screening of 711 known epigenetic modifiers in cellular models of IFN alpha-mediated inhibition of HBV replication, we identified methyltransferase SETD2 as a critical amplifier of IFN alpha-mediated antiviral immunity. Conditional knockout mice with hepatocyte-specific deletion of Setd2 exhibit enhanced HBV infection. Mechanistically, SETD2 directly mediates STAT1 methylation on lysine 525 via its methyltransferase activity, which reinforces IFN-activated STAT1 phosphorylation and antiviral cellular response. In addition, SETD2 selectively catalyzes the tri-methylation of H3K36 on promoters of some ISGs such as ISG15, leading to gene activation. Our study identifies STAT1 methylation on K525 catalyzed by the methyltransferase SETD2 as an essential signaling event for IFN alpha-dependent antiviral immunity and indicates potential of SETD2 in controlling viral infections.	[Chen, Kun; Han, Dan; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Kun; Liu, Juan; Liu, Shuxun; Zhang, Xiaomin; Jiang, Yingming; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Chen, Kun; Liu, Juan; Liu, Shuxun; Zhang, Xiaomin; Jiang, Yingming; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Xia, Meng; Wang, Chunmei; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Xia, Meng; Wang, Chunmei; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing 100005, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing 100005, Peoples R China.	caoxt@immunol.org		xia, meng/0000-0001-5223-7390	National Natural Science Foundation of China [31390431, 31622024]; National Key Basic Research Program of China [2013CB530503, 2013CB531505]; National Mega Projects of China [2017ZX10102032-001]; Merieux Research Grant; CAMS Innovation Fund for Medical Sciences [2016-I2M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Mega Projects of China; Merieux Research Grant; CAMS Innovation Fund for Medical Sciences	We thank Cong Huai for kindly providing plasmids and technical assistance and Lin Yi for the help in animal experiments. This work was supported by the National Natural Science Foundation of China (31390431, 31622024), the National Key Basic Research Program of China (2013CB530503, 2013CB531505), National Mega Projects of China (2017ZX10102032-001), a Merieux Research Grant (2016), and the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-003).	Begitt A, 2011, BLOOD, V118, P1002, DOI 10.1182/blood-2011-04-347930; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Carvalho S, 2013, NUCLEIC ACIDS RES, V41, P2881, DOI 10.1093/nar/gks1472; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dasgupta M, 2015, P NATL ACAD SCI USA, V112, P3985, DOI 10.1073/pnas.1503152112; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fusco DN, 2013, GASTROENTEROLOGY, V144, P1438, DOI 10.1053/j.gastro.2013.02.026; Ginter T, 2012, CELL SIGNAL, V24, P1453, DOI 10.1016/j.cellsig.2012.02.018; Kroetz DN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005338; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu J, 2014, NAT IMMUNOL, V15, P612, DOI 10.1038/ni.2898; Liu QY, 2014, J BIOL CHEM, V289, P11522, DOI 10.1074/jbc.M113.525014; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Mowen KA, 2014, NAT IMMUNOL, V15, P512, DOI 10.1038/ni.2873; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Pulloor N. K., 2014, PLOS PATHOG, V10; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Scaglione SJ, 2012, GASTROENTEROLOGY, V142, P1360, DOI 10.1053/j.gastro.2012.01.044; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Sung PS, 2015, P NATL ACAD SCI USA, V112, P10443, DOI 10.1073/pnas.1513341112; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yan R, 2015, J VIROL, V89, P9200, DOI 10.1128/JVI.00933-15; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Yang S, 2016, GENE DEV, V30, P1611, DOI 10.1101/gad.284323.116; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Zhang Y, 2015, NAT IMMUNOL, V16, P1215, DOI 10.1038/ni.3279; Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	54	149	162	6	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					492	+		10.1016/j.cell.2017.06.042	http://dx.doi.org/10.1016/j.cell.2017.06.042			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753426	Bronze			2022-12-28	WOS:000406462400009
J	Bradlyn, B; Elcoro, L; Cano, J; Vergniory, MG; Wang, ZJ; Felser, C; Aroyo, MI; Bernevig, BA				Bradlyn, Barry; Elcoro, L.; Cano, Jennifer; Vergniory, M. G.; Wang, Zhijun; Felser, C.; Aroyo, M. I. .; Bernevig, B. Andrei			Topological quantum chemistry	NATURE			English	Article							SINGLE DIRAC CONE; BAND REPRESENTATIONS; WANNIER FUNCTIONS; ENERGY-BANDS; SPACE-GROUPS; SEMIMETAL; SURFACE; SOLIDS; PHASE	Since the discovery of topological insulators and semimetals, there has been much research into predicting and experimentally discovering distinct classes of these materials, in which the topology of electronic states leads to robust surface states and electromagnetic responses. This apparent success, however, masks a fundamental shortcoming: topological insulators represent only a few hundred of the 200,000 stoichiometric compounds in material databases. However, it is unclear whether this low number is indicative of the esoteric nature of topological insulators or of a fundamental problem with the current approaches to finding them. Here we propose a complete electronic band theory, which builds on the conventional band theory of electrons, highlighting the link between the topology and local chemical bonding. This theory of topological quantum chemistry provides a description of the universal (across materials), global properties of all possible band structures and (weakly correlated) materials, consisting of a graph-theoretic description of momentum (reciprocal) space and a complementary group-theoretic description in real space. For all 230 crystal symmetry groups, we classify the possible band structures that arise from local atomic orbitals, and show which are topologically nontrivial. Our electronic band theory sheds new light on known topological insulators, and can be used to predict many more.	[Bradlyn, Barry; Cano, Jennifer] Princeton Univ, Princeton Ctr Theoret Sci, Princeton, NJ 08544 USA; [Elcoro, L.; Aroyo, M. I. .] Univ Basque Country, UPV EHU, Dept Condensed Matter Phys, Apartado 644, Bilbao 48080, Spain; [Vergniory, M. G.; Bernevig, B. Andrei] Donostia Int Phys Ctr, P Manuel de Lardizabal 4, Donostia San Sebastian 20018, Spain; [Vergniory, M. G.] Univ Basque Country, UPV EHU, Dept Appl Phys 2, Apartado 644, Bilbao 48080, Spain; [Vergniory, M. G.] Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany; [Wang, Zhijun; Bernevig, B. Andrei] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Felser, C.] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Bernevig, B. Andrei] Univ Paris 06, Sorbonne Univ, Univ Paris Diderot,CNRS,Sorbonne Paris Cite, Lab Pierre Aigrain,Ecole Normale Super,PSL Res Un, 24 Rue Lhomond, F-75231 Paris 05, France; [Bernevig, B. Andrei] UPMC Univ Paris 06, Sorbonne Univ, UMR 7589, LPTHE, F-75005 Paris, France	Princeton University; University of Basque Country; University of Basque Country; Max Planck Society; Princeton University; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite	Bernevig, BA (corresponding author), Donostia Int Phys Ctr, P Manuel de Lardizabal 4, Donostia San Sebastian 20018, Spain.; Bernevig, BA (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.; Bernevig, BA (corresponding author), Univ Paris 06, Sorbonne Univ, Univ Paris Diderot,CNRS,Sorbonne Paris Cite, Lab Pierre Aigrain,Ecole Normale Super,PSL Res Un, 24 Rue Lhomond, F-75231 Paris 05, France.; Bernevig, BA (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, UMR 7589, LPTHE, F-75005 Paris, France.	bernevig@princeton.edu	Elcoro, Luis/H-4584-2015; Felser, Claudia/A-5779-2009; Wang, Zhijun/O-8015-2014; Vergniory, Maia/AAB-2833-2019	Elcoro, Luis/0000-0002-5427-0984; Felser, Claudia/0000-0002-8200-2063; Wang, Zhijun/0000-0003-2169-8068; Vergniory, Maia/0000-0001-7336-3062; AROYO, MOIS ILIA/0000-0002-9083-6164; Bradlyn, Barry/0000-0001-6327-1076	Ecole Normale Superieure; Laboratoire de Physique Theorique et Hautes Energies; Spanish MINECO [FIS2016-75862-P, FIS2013-48286-C2-1-P]; Government of the Basque Country [IT779-13]; Spanish Ministry of Economy and Competitiveness; FEDER funds [MAT2015-66441-P]; Department of Energy [de-sc0016239]; Simons Investigator Award; Packard Foundation; Schmidt Fund for Innovative Research; NSF EAGER [DMR-1643312, ONR N00014-14-1-0330]; NSF-MRSEC [DMR-1420541]; NATIONAL CANCER INSTITUTE [R01CA159859, R01CA148699] Funding Source: NIH RePORTER	Ecole Normale Superieure; Laboratoire de Physique Theorique et Hautes Energies; Spanish MINECO(Spanish Government); Government of the Basque Country; Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds(European Commission); Department of Energy(United States Department of Energy (DOE)); Simons Investigator Award; Packard Foundation(The David & Lucile Packard Foundation); Schmidt Fund for Innovative Research; NSF EAGER(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	B.B. thanks I. Souza, R. Martin and I. Momennejad for discussions. M.G.V. thanks G. Lopez-Garmendia for help with computational work. B.B., J.C., Z.W. and B.A.B. acknowledge the hospitality of the Donostia International Physics Center, where parts of this work were carried out. J.C. also acknowledges the hospitality of the Kavli Institute for Theoretical Physics, and B.A.B. the hospitality and support of the Ecole Normale Superieure and Laboratoire de Physique Theorique et Hautes Energies. The work of M.V.G. was supported by the FIS2016-75862-P and FIS2013-48286-C2-1-P national projects of the Spanish MINECO. The work of L.E. and M.I.A. was supported by the Government of the Basque Country (project IT779-13) and the Spanish Ministry of Economy and Competitiveness and FEDER funds (project MAT2015-66441-P). Z.W. and B.A.B., and part of the development of the initial theory and further ab initio work, were supported by the Department of Energy de-sc0016239, a Simons Investigator Award, the Packard Foundation and the Schmidt Fund for Innovative Research. The development of the practical part of the theory, the tables, some of the code development and the ab initio work was funded by NSF EAGER grant number DMR-1643312, ONR N00014-14-1-0330 and NSF-MRSEC DMR-1420541.	Aroyo MI, 2006, ACTA CRYSTALLOGR A, V62, P115, DOI 10.1107/S0108767305040286; Atala M, 2013, NAT PHYS, V9, P795, DOI [10.1038/nphys2790, 10.1038/NPHYS2790]; BACRY H, 1993, COMMUN MATH PHYS, V153, P359, DOI 10.1007/BF02096648; Bacry H., 1988, GROUP THEORETICAL ME, P289; Benalcazar W. A., 2016, PREPRINT; Bernevig B. A, 2013, TOPOLOGICAL INSULATO, P226; Brouder C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.046402; Elcoro L., 2017, DOUBLE CRYSTALLOGRAP; Evarestov R., 1997, SITE SYMMETRY CRYSTA; FALCK L, 1978, ACTA CRYSTALLOGR B, V34, P896, DOI 10.1107/S0567740878004276; Fang C, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035119; Ferrari A., 1926, GAZZ CHIM ITAL, V56, P630; Freed DS, 2013, ANN HENRI POINCARE, V14, P1927, DOI 10.1007/s00023-013-0236-x; Fulton W., 2004, REPRESENTATION THEOR; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; HOFFMANN R, 1987, ANGEW CHEM INT EDIT, V26, P846, DOI 10.1002/anie.198708461; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; Kittel C, 1987, QUANTUM THEORY SOLID; KIVELSON S, 1982, PHYS REV B, V26, P4269, DOI 10.1103/PhysRevB.26.4269; Kruthoff J., 2016, PREPRINT; Liu ZK, 2014, NAT MATER, V13, P677, DOI [10.1038/NMAT3990, 10.1038/nmat3990]; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Marzari N, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.1419; Michel L, 2001, PHYS REP, V341, P377, DOI 10.1016/S0370-1573(00)00093-4; Morris AJ, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054111; Nakajima S, 2016, NAT PHYS, V12, P296, DOI 10.1038/NPHYS3622; Pfitzner A, 2002, Z KRISTALLOGR, V217, P51, DOI 10.1524/zkri.217.2.51.20632; Po H. C., 2017, PREPRINT; Read N, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.115309; RICE MJ, 1982, PHYS REV LETT, V49, P1455, DOI 10.1103/PhysRevLett.49.1455; Ryu S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.077002; Schoop LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11696; Soluyanov AA, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.115415; Soluyanov AA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035108; Tubman N. M., 2014, PREPRINT; Vergniory M. G., 2017, GRAPH THEORY DATA TO; Wang YJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/085017; Watanabe H, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.096404; Winkler GW, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.035453; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Xu QN, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.205310; ZAK J, 1982, PHYS REV B, V26, P3010, DOI 10.1103/PhysRevB.26.3010; ZAK J, 1989, PHYS REV LETT, V62, P2747, DOI 10.1103/PhysRevLett.62.2747; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270	47	674	683	12	380	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					298	305		10.1038/nature23268	http://dx.doi.org/10.1038/nature23268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28726818	Green Submitted			2022-12-28	WOS:000405844900024
J	Seidel, MG				Seidel, Markus G.			Baby genome screening: paving the way to genetic discrimination?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Seidel, Markus G.] Med Univ Graz, Dept Paediat & Adolescent Med, Graz, Austria	Medical University of Graz	Seidel, MG (corresponding author), Med Univ Graz, Dept Paediat & Adolescent Med, Graz, Austria.	markus.seidel@medunigraz.at	Seidel, Markus G/N-9951-2017	Seidel, Markus G/0000-0003-0981-8661	Styrian Children's Cancer Aid/Steirische Kinderkrebshilfe	Styrian Children's Cancer Aid/Steirische Kinderkrebshilfe	MGS is in part sponsored by Styrian Children's Cancer Aid/Steirische Kinderkrebshilfe.	Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Calonge N, 2010, GENET MED, V12, P153, DOI 10.1097/GIM.0b013e3181d2af04; Landau YE, 2014, J PEDIATR-US, V164, P14, DOI 10.1016/j.jpeds.2013.07.028; Levy HL, 2014, MOL GENET GENOM MED, V2, P81, DOI 10.1002/mgg3.74; Meyts I, 2016, J ALLERGY CLIN IMMUN, V138, P957, DOI 10.1016/j.jaci.2016.08.003; Miller NA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0221-8; Wilson JMG, 1968, PRINCIPLES PRACTICE	7	3	3	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2017	358								j3294	10.1136/bmj.j3294	http://dx.doi.org/10.1136/bmj.j3294			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4WT	28729238				2022-12-28	WOS:000426828600001
J	Nabet, BY; Qiu, Y; Shabason, JE; Wu, TJ; Yoon, T; Kim, BC; Benci, JL; DeMichele, AM; Tchou, J; Marcotrigiano, J; Minn, AJ				Nabet, Barzin Y.; Qiu, Yu; Shabason, Jacob E.; Wu, Tony J.; Yoon, Taewon; Kim, Brian C.; Benci, Joseph L.; DeMichele, Angela M.; Tchou, Julia; Marcotrigiano, Joseph; Minn, Andy J.			Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer	CELL			English	Article							POLYMERASE-III; METASTASIS; SELF; TRANSCRIPTION; FIBROBLASTS; RESISTANCE; RADIATION; TARGET; GENES; CELLS	Interactions between stromal fibroblasts and cancer cells generate signals for cancer progression, therapy resistance, and inflammatory responses. Although endogenous RNAs acting as damage-associated molecular patterns (DAMPs) for pattern recognition receptors (PRRs) may represent one such signal, these RNAs must remain unrecognized under non-pathological conditions. We show that triggering of stromal NOTCH-MYC by breast cancer cells results in a POL3-driven increase in RN7SL1, an endogenous RNA normally shielded by RNA binding proteins SRP9/14. This increase in RN7SL1 alters its stoichiometry with SRP9/14 and generates unshielded RN7SL1 in stromal exosomes. After exosome transfer to immune cells, unshielded RN7SL1 drives an inflammatory response. Upon transfer to breast cancer cells, unshielded RN7SL1 activates the PRR RIG-I to enhance tumor growth, metastasis, and therapy resistance. Corroborated by evidence from patient tumors and blood, these results demonstrate that regulation of RNA unshielding couples stromal activation with deployment of RNA DAMPs that promote aggressive features of cancer.	[Nabet, Barzin Y.; Qiu, Yu; Shabason, Jacob E.; Wu, Tony J.; Yoon, Taewon; Kim, Brian C.; Benci, Joseph L.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [DeMichele, Angela M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tchou, Julia] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Minn, Andy J.] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Minn, Andy J.] Univ Penn, Parker Inst Canc Immunotherapy, Perelman Sch Med, Philadelphia, PA 19104 USA; [DeMichele, Angela M.; Minn, Andy J.] Univ Penn, Basser Ctr BRCA, Perelman Sch Med, Philadelphia, PA 19104 USA; [DeMichele, Angela M.; Tchou, Julia; Minn, Andy J.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nabet, Barzin Y.; Qiu, Yu; Shabason, Jacob E.; Wu, Tony J.; Yoon, Taewon; Kim, Brian C.; Benci, Joseph L.; Minn, Andy J.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Marcotrigiano, Joseph] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Rutgers State University New Brunswick	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Perelman Sch Med, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Basser Ctr BRCA, Perelman Sch Med, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.; Minn, AJ (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	andyminn@upenn.edu		Marcotrigiano, Joseph/0000-0001-7670-7836; Nabet, Barzin/0000-0002-4824-3533; Minn, Andy/0000-0003-1418-0906; Wu, Tony James/0000-0002-5049-6986; Benci, Joseph/0000-0002-1759-4621	NIH [F31CA189707, R01GM111959]; NCI Cancer Center Support Grant [2-P30-CA-016520-35]; Breast Cancer Alliance Research Foundation; FFANY/QVC; Melanoma Research Alliance; Parker Institute for Cancer Immunotherapy; Basser Research Center for BRCA; Department of Defense [W81XWH-14-1-0450]; NIH/NCI [R01CA172651]; NATIONAL CANCER INSTITUTE [P30CA016520, F31CA189707, R25CA140116, R01CA172651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Alliance Research Foundation; FFANY/QVC; Melanoma Research Alliance; Parker Institute for Cancer Immunotherapy; Basser Research Center for BRCA; Department of Defense(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Joanna Tober and Bihui Xu for experimental assistance, and Noah Goodman and Natalie Shih for help with clinical samples (ACC Breast Program Translational Cancer Resource). B.Y.N. was supported by a grant from the NIH (F31CA189707), J.M. by a grant from the NIH (R01GM111959), J.T. by a NCI Cancer Center Support Grant (2-P30-CA-016520-35) and the Breast Cancer Alliance Research Foundation, and A.M.D. by funds from FFANY/QVC. A.J.M. was supported by the Melanoma Research Alliance, Parker Institute for Cancer Immunotherapy, and Basser Research Center for BRCA. A.J.M. is a Department of Defense Era of Hope Scholar (W81XWH-09-1-0339) and funded by the Department of Defense (W81XWH-14-1-0450) and the NIH/NCI (R01CA172651).	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Mercado-Lopez X, 2013, VACCINE, V31, P5713, DOI 10.1016/j.vaccine.2013.09.040; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Tchou J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-39; Telesnitsky A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080235; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003	36	260	271	12	124	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					352	+		10.1016/j.cell.2017.06.031	http://dx.doi.org/10.1016/j.cell.2017.06.031			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28709002	Green Accepted, Bronze			2022-12-28	WOS:000405493900014
J	Schmidt, GA; Severinghaus, J; Abe-Ouchi, A; Alley, RB; Broecker, W; Brook, E; Etheridge, D; Kawamura, K; Keeling, RF; Leinen, M; Marvel, K; Stocker, TF				Schmidt, Gavin A.; Severinghaus, Jeff; Abe-Ouchi, Ayako; Alley, Richard B.; Broecker, Wallace; Brook, Ed; Etheridge, David; Kawamura, Kenji; Keeling, Ralph F.; Leinen, Margaret; Marvel, Kate; Stocker, Thomas F.			Overestimate of committed warming	NATURE			English	Letter							TEMPERATURE; CLIMATE		[Schmidt, Gavin A.; Marvel, Kate] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Severinghaus, Jeff; Keeling, Ralph F.; Leinen, Margaret] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Abe-Ouchi, Ayako] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Abe-Ouchi, Ayako] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa 2360001, Japan; [Alley, Richard B.] Penn State Univ, Dept Geosci, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Broecker, Wallace] Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10964 USA; [Brook, Ed] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Etheridge, David] CSIRO Climate Sci Ctr, Aspendale, Vic, Australia; [Kawamura, Kenji] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Kawamura, Kenji] SOKENDAI, Dept Polar Sci, Tachikawa, Tokyo 1908518, Japan; [Kawamura, Kenji] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Marvel, Kate] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10025 USA; [Stocker, Thomas F.] Univ Bern, Phys Inst, Climate & Environm Phys, Sidlerstr 5, CH-3012 Bern, Switzerland	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Columbia University; Oregon State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Columbia University; University of Bern	Schmidt, GA (corresponding author), NASA, Goddard Inst Space Studies, New York, NY 10025 USA.	gavin.a.schmidt@nasa.gov	Etheridge, David M/B-7334-2013; Schmidt, Gavin/D-4427-2012; Marvel, Kate/K-1519-2013; Kawamura, Kenji/C-7660-2011; Abe-Ouchi, Ayako/M-6359-2013	Schmidt, Gavin/0000-0002-2258-0486; Kawamura, Kenji/0000-0003-1163-700X; Etheridge, David/0000-0001-7970-2002; Leinen, Margaret Sandra/0000-0002-7982-3661; Abe-Ouchi, Ayako/0000-0003-1745-5952				Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Bereiter B, 2015, GEOPHYS RES LETT, V42, P542, DOI 10.1002/2014GL061957; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Johnson GC, 2016, B AM METEOROL SOC, V97, pS66, DOI 10.1175/2016BAMSStateoftheClimate.1; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Paillard D, 2015, QUATERNARY SCI REV, V107, P11, DOI 10.1016/j.quascirev.2014.10.002; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Snyder CW, 2017, NATURE, V547, pE17, DOI 10.1038/nature22804; Snyder CW, 2016, NATURE, V538, P226, DOI 10.1038/nature19798; Tignor M., 2013, CLIMATE CHANGE 2013; von der Heydt AS, 2016, CURR CLIM CHANGE REP, V2, P148, DOI 10.1007/s40641-016-0049-3	15	6	6	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					E16	E17		10.1038/nature22803	http://dx.doi.org/10.1038/nature22803			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703191	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000405314500003
J	Banerjee, S				Banerjee, Susana			Bevacizumab in cervical cancer: a step forward for survival	LANCET			English	Editorial Material							GYNECOLOGIC-ONCOLOGY-GROUP; TRIAL; CARCINOMA; CISPLATIN; THERAPY		[Banerjee, Susana] Royal Marsden Natl Hlth Serv Fdn Trust, Gynaecol Unit, London SW3 6JJ, England; [Banerjee, Susana] Royal Marsden Hosp, Inst Canc Res, Div Clin Studies, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Banerjee, S (corresponding author), Royal Marsden Natl Hlth Serv Fdn Trust, Gynaecol Unit, London SW3 6JJ, England.; Banerjee, S (corresponding author), Royal Marsden Hosp, Inst Canc Res, Div Clin Studies, London SW3 6JJ, England.	susana.banerjee@rmh.nhs.uk		Banerjee, Susana/0000-0002-8840-7934				BONOMI P, 1985, J CLIN ONCOL, V3, P1079, DOI 10.1200/JCO.1985.3.8.1079; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Long HJ, 2005, J CLIN ONCOL, V23, P4626, DOI 10.1200/JCO.2005.10.021; McLachlan J, 2017, CLIN ONCOL-UK, V29, P153, DOI 10.1016/j.clon.2016.10.002; Minion LE, 2015, GYNECOL ONCOL, V137, P490, DOI 10.1016/j.ygyno.2015.02.027; Penson RT, 2015, LANCET ONCOL, V16, P301, DOI 10.1016/S1470-2045(15)70004-5; Tewari KS, 2015, CLIN CANCER RES, V21, P5480, DOI 10.1158/1078-0432.CCR-15-1346; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Tewari KS, 2017, LANCET, V240; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262	10	10	11	2	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 7	2017	390	10103					1626	1628		10.1016/S0140-6736(17)31965-7	http://dx.doi.org/10.1016/S0140-6736(17)31965-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI9TS	28756904				2022-12-28	WOS:000412352800006
J	Schneider, EC; Squires, D				Schneider, Eric C.; Squires, David			From Last to First-Could the US Health Care System Become the Best in the World?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schneider, Eric C.; Squires, David] Commonwealth Fund, New York, NY USA	Commonwealth Fund	Schneider, EC (corresponding author), Commonwealth Fund, New York, NY USA.							Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Bradley EH, 2016, HEALTH AFFAIR, V35, P760, DOI 10.1377/hlthaff.2015.0814; National Research Council Institute of Medicine, 2013, US HLTH INT SPECTIVE; Schneider EC, MIRROR MIRROR 2017IN; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645	5	34	34	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					901	904		10.1056/NEJMp1708704	http://dx.doi.org/10.1056/NEJMp1708704			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF9XU	28708020				2022-12-28	WOS:000409373100002
J	Runyan, CA; Piasini, E; Panzeri, S; Harvey, CD				Runyan, Caroline A.; Piasini, Eugenio; Panzeri, Stefano; Harvey, Christopher D.			Distinct timescales of population coding across cortex	NATURE			English	Article							PARIETAL CORTEX; SPATIAL NAVIGATION; AUDITORY-CORTEX; NEURAL BASIS; DECISION; DYNAMICS; INFORMATION; NEURONS; MOTION; CODE	The cortex represents information across widely varying timescales(1-5). For instance, sensory cortex encodes stimuli that fluctuate over few tens of milliseconds(6,7), whereas in association cortex behavioural choices can require the maintenance of information over seconds(8,9). However, it remains poorly understood whether diverse timescales result mostly from features intrinsic to individual neurons or from neuronal population activity. This question remains unanswered, because the timescales of coding in populations of neurons have not been studied extensively, and population codes have not been compared systematically across cortical regions. Here we show that population codes can be essential to achieve long coding timescales. Furthermore, we find that the properties of population codes differ between sensory and association cortices. We compared coding for sensory stimuli and behavioural choices in auditory cortex and posterior parietal cortex as mice performed a sound localization task. Auditory stimulus information was stronger in auditory cortex than in posterior parietal cortex, and both regions contained choice information. Although auditory cortex and posterior parietal cortex coded information by tiling in time neurons that were transiently informative for approximately 200 milliseconds, the areas had major differences in functional coupling between neurons, measured as activity correlations that could not be explained by task events. Coupling among posterior parietal cortex neurons was strong and extended over long time lags, whereas coupling among auditory cortex neurons was weak and short-lived. Stronger coupling in posterior parietal cortex led to a population code with long timescales and a representation of choice that remained consistent for approximately 1 second. In contrast, auditory cortex had a code with rapid fluctuations in stimulus and choice information over hundreds of milliseconds. Our results reveal that population codes differ across cortex and that coupling is a variable property of cortical populations that affects the timescale of information coding and the accuracy of behaviour.	[Runyan, Caroline A.; Harvey, Christopher D.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Piasini, Eugenio; Panzeri, Stefano] Ist Italiano Tecnol, Neural Computat Lab, I-38068 Rovereto, Italy	Harvard University; Harvard Medical School; Istituto Italiano di Tecnologia - IIT	Harvey, CD (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.; Panzeri, S (corresponding author), Ist Italiano Tecnol, Neural Computat Lab, I-38068 Rovereto, Italy.	stefano.panzeri@iit.it; harvey@hms.harvard.edu	Piasini, Eugenio/AAX-1566-2020	Piasini, Eugenio/0000-0003-0384-7699	Burroughs-Wellcome Fund Career Award at the Scientific Interface; Searle Scholars Program; New York Stem Cell Foundation; Armenise-Harvard Foundation; Alfred P. Sloan Research Foundation; NARSAD; National Institutes of Health from National Institute of Mental Health BRAINS program [R01-MH107620]; National Institute of Neurological Disorders and Stroke [R01-NS089521]; Autonomous Province of Trento (Grandi Progetti ATTEND); Fondation Bertarelli; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089521] Funding Source: NIH RePORTER	Burroughs-Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Searle Scholars Program; New York Stem Cell Foundation; Armenise-Harvard Foundation; Alfred P. Sloan Research Foundation(Alfred P. Sloan Foundation); NARSAD(NARSAD); National Institutes of Health from National Institute of Mental Health BRAINS program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autonomous Province of Trento (Grandi Progetti ATTEND); Fondation Bertarelli; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Chettih and M. Minderer for developing the cell selection software, and J. Assad, J. Drugowitsch, O. Mazor, and members of our laboratories for comments on the manuscript. We also thank the Research Instrumentation Core at Harvard Medical School. This work was supported by a Burroughs-Wellcome Fund Career Award at the Scientific Interface, the Searle Scholars Program, the New York Stem Cell Foundation, the Armenise-Harvard Foundation, the Alfred P. Sloan Research Foundation, a NARSAD Brain and Behavior Research Young Investigator Award, National Institutes of Health grants from the National Institute of Mental Health BRAINS program (R01-MH107620) and the National Institute of Neurological Disorders and Stroke (R01-NS089521), the Autonomous Province of Trento (Grandi Progetti ATTEND), and the Fondation Bertarelli. C.A.R. is a Life Sciences Research Foundation Simons Fellow. C.D.H. is a New York Stem Cell Foundation Robertson Neuroscience Investigator.	Agresti A, 2013, CATEGORICAL DATA ANA; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bathellier B, 2012, NEURON, V76, P435, DOI 10.1016/j.neuron.2012.07.008; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Carnevale F, 2013, NEURON, V80, P1532, DOI 10.1016/j.neuron.2013.09.023; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Graf ABA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7024; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Harris KD, 2011, HEARING RES, V271, P37, DOI 10.1016/j.heares.2010.06.006; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasson U, 2015, TRENDS COGN SCI, V19, P304, DOI 10.1016/j.tics.2015.04.006; Honey CJ, 2012, NEURON, V76, P423, DOI 10.1016/j.neuron.2012.08.011; Hromadka T, 2009, CURR OPIN NEUROBIOL, V19, P430, DOI 10.1016/j.conb.2009.07.009; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; Murray JD, 2014, NAT NEUROSCI, V17, P1661, DOI 10.1038/nn.3862; Nakamura K, 1999, J NEUROPHYSIOL, V82, P2503, DOI 10.1152/jn.1999.82.5.2503; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; Okun M, 2015, NATURE, V521, P511, DOI 10.1038/nature14273; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Panzeri S, 2017, NEURON, V93, P491, DOI 10.1016/j.neuron.2016.12.036; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pulkki V, 1997, J AUDIO ENG SOC, V45, P456; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Rabinowitz NC, 2015, ELIFE, V4, DOI 10.7554/eLife.08998; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Yang Y, 2008, NAT NEUROSCI, V11, P1262, DOI 10.1038/nn.2211; Yang Y, 2012, J NEUROSCI, V32, P15142, DOI 10.1523/JNEUROSCI.1411-12.2012	44	145	145	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					92	+		10.1038/nature23020	http://dx.doi.org/10.1038/nature23020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28723889	Green Accepted, Green Submitted			2022-12-28	WOS:000406831700043
J	Zhang, YL; Kim, MS; Jia, BS; Yan, JQ; Zuniga-Hertz, JP; Han, C; Cai, DS				Zhang, Yalin; Kim, Min Soo; Jia, Baosen; Yan, Jingqi; Zuniga-Hertz, Juan Pablo; Han, Cheng; Cai, Dongsheng			Hypothalamic stem cells control ageing speed partly through exosomal miRNAs	NATURE			English	Article							EXTENDS LIFE-SPAN; BETA/NF-KAPPA-B; SUBVENTRICULAR ZONE; MICRORNA REGULATION; ADULT HIPPOCAMPUS; IKK-BETA; NEUROGENESIS; MICE; OBESITY; DIFFERENTIATION	It has been proposed that the hypothalamus helps to control ageing, but the mechanisms responsible remain unclear. Here we develop several mouse models in which hypothalamic stem/progenitor cells that co-express Sox2 and Bmi1 are ablated, as we observed that ageing in mice started with a substantial loss of these hypothalamic cells. Each mouse model consistently displayed acceleration of ageing-like physiological changes or a shortened lifespan. Conversely, ageing retardation and lifespan extension were achieved in mid-aged mice that were locally implanted with healthy hypothalamic stem/progenitor cells that had been genetically engineered to survive in the ageing-related hypothalamic inflammatory microenvironment. Mechanistically, hypothalamic stem/progenitor cells contributed greatly to exosomal microRNAs (miRNAs) in the cerebrospinal fluid, and these exosomal miRNAs declined during ageing, whereas central treatment with healthy hypothalamic stem/progenitor cell-secreted exosomes led to the slowing of ageing. In conclusion, ageing speed is substantially controlled by hypothalamic stem cells, partially through the release of exosomal miRNAs.	[Zhang, Yalin; Kim, Min Soo; Jia, Baosen; Yan, Jingqi; Zuniga-Hertz, Juan Pablo; Han, Cheng; Cai, Dongsheng] Albert Einstein Coll Med, Inst Aging, Diabet Res Ctr, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), Albert Einstein Coll Med, Inst Aging, Diabet Res Ctr, Dept Mol Pharmacol, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu	Hertz, Juan Pablo Zúñiga/J-3588-2019	Hertz, Juan Pablo Zúñiga/0000-0002-8679-3456; yan, Jingqi/0000-0002-7024-6423	NIH [R01 DK078750, AG031774, HL113180, DK099136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750, R01DK099136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIH R01 DK078750, AG031774, HL113180 and DK099136 (D.C.).	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Corti S, 2007, BRAIN, V130, P1289, DOI 10.1093/brain/awm043; Dacks PA, 2013, FRONT NEUROENDOCRIN, V34, P95, DOI 10.1016/j.yfrne.2012.12.001; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Faiz M, 2015, CELL STEM CELL, V17, P624, DOI 10.1016/j.stem.2015.08.002; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Fraczek LA, 2011, MOL IMMUNOL, V49, P201, DOI 10.1016/j.molimm.2011.08.013; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Greenberg DA, 2006, NAT MED, V12, P884, DOI 10.1038/nm0806-884; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, V48, P2473, DOI DOI 10.3791/2473; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Li QT, 2008, CELL STEM CELL, V2, P195, DOI 10.1016/j.stem.2008.02.008; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Merkle FT, 2014, NAT NEUROSCI, V17, P207, DOI 10.1038/nn.3610; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Sadagurski M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12379; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Strojnik T, 2007, SURG NEUROL, V68, P133, DOI 10.1016/j.surneu.2006.10.050; Sun F, 2013, AGING CELL, V12, P978, DOI 10.1111/acel.12134; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	41	289	308	1	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					52	+		10.1038/nature23282	http://dx.doi.org/10.1038/nature23282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28746310	Green Accepted			2022-12-28	WOS:000406831700034
J	Drolet, BC; Tandon, VJ				Drolet, Brian C.; Tandon, Vickram J.			Fees for Certification and Finances of Medical Specialty Boards	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SELF-REGULATION; MAINTENANCE; ASSOCIATION; CARE		[Drolet, Brian C.] Vanderbilt Univ, Med Ctr, Dept Plast Surg, Nashville, TN 37232 USA; [Tandon, Vickram J.] Univ Michigan, Dept Plast Surg, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Michigan System; University of Michigan	Drolet, BC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Plast Surg, Med Ctr N, D-4219, Nashville, TN 37232 USA.	brian.c.drolet@gmail.com						Bauchner H, 2015, JAMA-J AM MED ASSOC, V313, P1831, DOI 10.1001/jama.2015.4569; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Gray BM, 2014, JAMA-J AM MED ASSOC, V312, P2348, DOI 10.1001/jama.2014.12716; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; Nora LM, 2015, JAMA-J AM MED ASSOC, V313, P1805, DOI 10.1001/jama.2015.4025; Teirstein PS, 2015, NEW ENGL J MED, V372, P106, DOI 10.1056/NEJMp1407422	6	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					477	479		10.1001/jama.2017.7464	http://dx.doi.org/10.1001/jama.2017.7464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763539	Green Published			2022-12-28	WOS:000406659800020
J	Voelker, R				Voelker, Rebecca			Another Fluoroquinolone Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					416	416		10.1001/jama.2017.9336	http://dx.doi.org/10.1001/jama.2017.9336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763532				2022-12-28	WOS:000406659800005
J	Pepin, CM; Geneste, G; Dewaele, A; Mezouar, M; Loubeyre, P				Pepin, C. M.; Geneste, G.; Dewaele, A.; Mezouar, M.; Loubeyre, P.			Synthesis of FeH5: A layered structure with atomic hydrogen slabs	SCIENCE			English	Article							EARTHS INNER-CORE; HIGH-PRESSURES; METALLIC HYDROGEN; IRON HYDRIDE; SUPERCONDUCTIVITY; POLYHYDRIDES; LITHIUM; GPA	High pressure promotes the formation of polyhydrides with unusually high hydrogen-to-metal ratios. These polyhydrides have complex hydrogenic sublattices. We synthesized iron pentahydride (FeH5) by a direct reaction between iron and H-2 above 130 gigapascals in a laser-heated diamond anvil cell. FeH5 exhibits a structure built of atomic hydrogen only. It consists of intercalated layers of quasicubic FeH3 units and four-plane slabs of thin atomic hydrogen. The distribution of the valence electron density indicates a bonding between hydrogen and iron atoms but none between hydrogen atoms, presenting a two-dimensional metallic character. The discovery of FeH5 suggests a low-pressure path to make materials that approach bulk dense atomic hydrogen.	[Pepin, C. M.; Geneste, G.; Dewaele, A.; Loubeyre, P.] Commissariat Energie Atom & Energies Alternat, DAM, DIF, F-91297 Arpajon, France; [Pepin, C. M.] Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, Earth & Planetary Sci Lab, CH-1015 Lausanne, Switzerland; [Mezouar, M.] European Synchrotron Radiat Facil, 6 Rue Jules Horowitz BP220, F-38043 Grenoble, France	CEA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; European Synchrotron Radiation Facility (ESRF)	Pepin, CM; Loubeyre, P (corresponding author), Commissariat Energie Atom & Energies Alternat, DAM, DIF, F-91297 Arpajon, France.; Pepin, CM (corresponding author), Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, Earth & Planetary Sci Lab, CH-1015 Lausanne, Switzerland.	charles.pepin@epfl.ch; paul.loubeyre@cea.fr		Pepin, Charles/0000-0002-9638-3303				ASHCROFT NW, 1968, PHYS REV LETT, V21, P1748, DOI 10.1103/PhysRevLett.21.1748; Ashcroft NW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187002; Babaev E, 2004, NATURE, V431, P666, DOI 10.1038/nature02910; BADDING JV, 1991, SCIENCE, V253, P421, DOI 10.1126/science.253.5018.421; Bazhanova ZG, 2012, PHYS-USP+, V55, P489, DOI 10.3367/UFNe.0182.201205c.0521; CHERTIHIN GV, 1995, J PHYS CHEM-US, V99, P12131, DOI 10.1021/j100032a013; Dewaele A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.215504; Drozdov AP, 2015, NATURE, V525, P73, DOI 10.1038/nature14964; Duan DF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06968; Feng XL, 2016, SOLID STATE COMMUN, V239, P14, DOI 10.1016/j.ssc.2016.03.025; Gagliardi L, 2004, J AM CHEM SOC, V126, P15014, DOI 10.1021/ja045991l; Goncharenko I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.045504; Gonze X, 2005, Z KRISTALLOGR, V220, P558, DOI 10.1524/zkri.220.5.558.65066; Hirao N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019380; Li B, 2011, P NATL ACAD SCI USA, V108, P18618, DOI 10.1073/pnas.1114680108; Li F, 2017, RSC ADV, V7, P12570, DOI 10.1039/c6ra25591d; Loubeyre P, 1996, NATURE, V383, P702, DOI 10.1038/383702a0; Pepin C, 2015, P NATL ACAD SCI USA, V112, P7673, DOI 10.1073/pnas.1507508112; Pepin CM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.265504; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Scheler T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.215503; Somayazulu M, 2010, NAT CHEM, V2, P50, DOI [10.1038/NCHEM.445, 10.1038/nchem.445]; Struzhkin VV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12267; Torrent M, 2008, COMP MATER SCI, V42, P337, DOI 10.1016/j.commatsci.2007.07.020; Troyan I, 2016, SCIENCE, V351, P1303, DOI 10.1126/science.aac8176; Vinet P., 1987, J PHYS CHEM, V19, pL46; Wang H, 2012, P NATL ACAD SCI USA, V109, P6463, DOI 10.1073/pnas.1118168109; Yu SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17764; Zaleski-Ejgierd P, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/15/155701; Zaleski-Ejgierd P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.059902; Zhong X, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.057002; Zurek E, 2017, COMMENT INORG CHEM, V37, P78, DOI 10.1080/02603594.2016.1196679; Zurek E, 2009, P NATL ACAD SCI USA, V106, P17640, DOI 10.1073/pnas.0908262106	33	109	113	7	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					382	+		10.1126/science.aan0961	http://dx.doi.org/10.1126/science.aan0961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751605				2022-12-28	WOS:000406362300040
J	Zhang, XP; Han, J; Plombon, JJ; Sutton, AP; Srolovitz, DJ; Boland, JJ				Zhang, Xiaopu; Han, Jian; Plombon, John J.; Sutton, Adrian P.; Srolovitz, David J.; Boland, John J.			Nanocrystalline copper films are never flat	SCIENCE			English	Article								We used scanning tunneling microscopy to study low-angle grain boundaries at the surface of nearly planar copper nanocrystalline (111) films. The presence of grain boundaries and their emergence at the film surface create valleys composed of dissociated edge dislocations and ridges where partial dislocations have recombined. Geometric analysis and simulations indicated that valleys and ridges were created by an out-of-plane grain rotation driven by reduction of grain boundary energy. These results suggest that in general, it is impossible to form flat two-dimensional nanocrystalline films of copper and other metals exhibiting small stacking fault energies and/or large elastic anisotropy, which induce a large anisotropy in the dislocation-line energy.	[Zhang, Xiaopu; Boland, John J.] Trinity Coll Dublin, Sch Chem, CRANN, Dublin 2, Ireland; [Zhang, Xiaopu; Boland, John J.] Trinity Coll Dublin, Adv Mat & Bioengn Res AMBER, Dublin 2, Ireland; [Han, Jian; Srolovitz, David J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Plombon, John J.] Intel Corp, Components Res, Hillsboro, OR 97124 USA; [Sutton, Adrian P.] Imperial Coll London, Dept Phys, Exhibit Rd, London SW7 2AZ, England; [Srolovitz, David J.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA	Trinity College Dublin; Trinity College Dublin; University of Pennsylvania; Intel Corporation; Imperial College London; University of Pennsylvania	Boland, JJ (corresponding author), Trinity Coll Dublin, Sch Chem, CRANN, Dublin 2, Ireland.; Boland, JJ (corresponding author), Trinity Coll Dublin, Adv Mat & Bioengn Res AMBER, Dublin 2, Ireland.	jboland@tcd.ie	Boland, John/AAB-8498-2022; Srolovitz, David/F-4655-2012; Han, Jian/R-1879-2019; Boland, John J/P-9740-2016	Boland, John/0000-0002-3229-8038; Srolovitz, David/0000-0001-6038-020X; Han, Jian/0000-0002-3800-9436; Boland, John J/0000-0002-3229-8038; Zhang, Xiaopu/0000-0002-3512-4586	Science Foundation Ireland (SFI) [12/IA/1482]; SFI [SFI/12/RC/2278]; National Science Foundation Division of Materials Research [1507013]	Science Foundation Ireland (SFI)(Science Foundation Ireland); SFI(Science Foundation Ireland); National Science Foundation Division of Materials Research(National Science Foundation (NSF))	J.J.B. acknowledges the Science Foundation Ireland (SFI)-funded Principal Investigator Award (grant 12/IA/1482); this work emanated from research supported in part by a research grant from SFI under grant SFI/12/RC/2278. D.J.S. acknowledges support of the National Science Foundation Division of Materials Research through award 1507013. A.P.S. is grateful to the Department of Physics at Imperial College London for the provision of laboratory facilities. All data are reported in the main paper and supplementary materials.	[Anonymous], 2013, INT TECHNOLOGY ROADM; Cahill DG, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4832615; Ceric H, 2011, MAT SCI ENG R, V71, P53, DOI 10.1016/j.mser.2010.09.001; Christiansen J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.206106; COCKAYNE DJ, 1971, PHILOS MAG, V24, P1383, DOI 10.1080/14786437108217419; Henry CR, 2005, PROG SURF SCI, V80, P92, DOI 10.1016/j.progsurf.2005.09.004; Hirth J. P., 1972, THEORY DISLOCATIONS; Josell D, 2009, ANNU REV MATER RES, V39, P231, DOI 10.1146/annurev-matsci-082908-145415; Rosenberg R, 2000, ANNU REV MATER SCI, V30, P229, DOI 10.1146/annurev.matsci.30.1.229; SAMSAVAR A, 1990, PHYS REV LETT, V65, P1607, DOI 10.1103/PhysRevLett.65.1607; Seabaugh AC, 2010, P IEEE, V98, P2095, DOI 10.1109/JPROC.2010.2070470; Sutton A., 2006, INTERFACES CRYSTALLI; Timalsina YP, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/7/075704	13	33	33	5	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					397	399		10.1126/science.aan4797	http://dx.doi.org/10.1126/science.aan4797			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751608	Green Submitted			2022-12-28	WOS:000406362300044
J	Schwartz, M				Schwartz, Michal			Can immunotherapy treat neurodegeneration?	SCIENCE			English	Editorial Material							ALZHEIMERS-DISEASE; CHOROID-PLEXUS; PATHOLOGY; BLOCKADE; MEMORY		[Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-7610001 Rehovot, Israel	Weizmann Institute of Science	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-7610001 Rehovot, Israel.	michal.schwartz@weizmann.ac.il			E.U. Seventh Framework Program HEALTH [279017]; Israel Science Foundation-Legacy Heritage Biomedical Science Partnership-research [1354/15]; ERC-ADG [741744]	E.U. Seventh Framework Program HEALTH; Israel Science Foundation-Legacy Heritage Biomedical Science Partnership-research; ERC-ADG	I thank T. Wiesel and S. Schwarzbaum for their input. This work was supported by the E.U. Seventh Framework Program HEALTH-2011 (grant 279017), the Israel Science Foundation-Legacy Heritage Biomedical Science Partnership-research (grant 1354/15), and the ERC-2016-ADG (grant 741744).	Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Breitner J, 2015, ALZHEIMERS DEMENT, V11, P216, DOI 10.1016/j.jalz.2014.03.009; Da Mesquita S, 2015, BRAIN BEHAV IMMUN, V49, P280, DOI 10.1016/j.bbi.2015.06.008; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Marsh SE, 2016, P NATL ACAD SCI USA, V113, pE1316, DOI 10.1073/pnas.1525466113; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Naert G, 2013, J MOL CELL BIOL, V5, P284, DOI 10.1093/jmcb/mjt028; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	15	32	32	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					254	255		10.1126/science.aai8231	http://dx.doi.org/10.1126/science.aai8231			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729500				2022-12-28	WOS:000405901600024
J	Arie, S				Arie, Sophie			Compulsory vaccination and growing measles threat	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 20	2017	358								j3429	10.1136/bmj.j3429	http://dx.doi.org/10.1136/bmj.j3429			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7KC	28729469				2022-12-28	WOS:000406318500010
J	Devi, S				Devi, Shamila			Staff protest against care conditions for child patients	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					216	216		10.1016/S0140-6736(17)31865-2	http://dx.doi.org/10.1016/S0140-6736(17)31865-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA5IZ	28721868				2022-12-28	WOS:000405477900011
J	Medley, GF; Vassall, A				Medley, Graham F.; Vassall, Anna			When an emerging disease becomes endemic	SCIENCE			English	Review							GOVERNANCE; DYNAMICS; AFRICA; MODEL	Epidemics, such as HIV in the early 1980s and Ebola in 2014, inspire decisive government investment and action, and individual and societal concern, sometimes bordering on panic. By contrast, endemic diseases, such as HIV in 2017 and tuberculosis, struggle to maintain the same attention. For many, the paradox is that endemic disease, in its totality, continues to impose a far higher public health burden than epidemic disease. Overall, the swift political response to epidemics has resulted in success. It has proven possible to eradicate epidemic diseases, often without the availability of vaccines and other biomedical technologies. In recent times, only HIV has made the transition from epidemic to endemic, but diseases that have existed for centuries continue to cause most of the infectious disease burden.	[Medley, Graham F.; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Medley, GF (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1E 7HT, England.	graham.medley@lshtm.ac.uk	Medley, Graham/B-7289-2008	Medley, Graham/0000-0002-0030-7278; Vassall, Anna/0000-0002-2911-1375				Brinkerhoff DW, 2016, INT J HEALTH PLAN M, V31, P470, DOI 10.1002/hpm.2330; Carslake D, 2011, PHILOS T R SOC B, V366, P1975, DOI 10.1098/rstb.2010.0396; Dieleman J, 2017, LANCET, V389, P1981, DOI 10.1016/S0140-6736(17)30874-7; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Kastelic K. H., 2015, WORKING PAPER; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Keogh-Brown MR, 2010, EUR J HEALTH ECON, V11, P543, DOI 10.1007/s10198-009-0210-1; Lau MSY, 2017, P NATL ACAD SCI USA, V114, P2337, DOI 10.1073/pnas.1614595114; Michael E, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0235-5; Ortblad KF, 2015, LANCET, V386, P2354, DOI 10.1016/S0140-6736(15)00324-4; Parkhurst JO, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17367; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; UK Department of Health, 2010, REP SWIN FLU CRIT CA; Vogus A, 2015, GLOB HEALTH-SCI PRAC, V3, P274, DOI 10.9745/GHSP-D-14-00227; W.H. Organization, 2015, WHO DRUG INF, V29, P305; Wilkinson A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0305	19	13	13	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		156	158		10.1126/science.aam8333	http://dx.doi.org/10.1126/science.aam8333			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706039	Green Accepted, Green Submitted			2022-12-28	WOS:000405391700036
J	Moller, CB; Thomas, RA; Vasilakis, G; Zeuthen, E; Tsaturyan, Y; Balabas, M; Jensen, K; Schliesser, A; Hammerer, K; Polzik, ES				Moller, Christoffer B.; Thomas, Rodrigo A.; Vasilakis, Georgios; Zeuthen, Emil; Tsaturyan, Yeghishe; Balabas, Mikhail; Jensen, Kasper; Schliesser, Albert; Hammerer, Klemens; Polzik, Eugene S.			Quantum back-action-evading measurement of motion in a negative mass reference frame	NATURE			English	Article							OSCILLATOR; OPTOMECHANICS; SYSTEM	Quantum mechanics dictates that a continuous measurement of the position of an object imposes a random quantum back-action (QBA) perturbation on its momentum. This randomness translates with time into position uncertainty, thus leading to the well known uncertainty on the measurement of motion(1,2). As a consequence of this randomness, and in accordance with the Heisenberg uncertainty principle, the QBA(3,4) puts a limitation-the so-called standard quantum limit-on the precision of sensing of position, velocity and acceleration. Here we show that QBA(5) on a macroscopic mechanical oscillator can be evaded if the measurement of motion is conducted in the reference frame of an atomic spin oscillator(6,7). The collective quantum measurement on this hybrid system of two distant and disparate oscillators is performed with light. The mechanical oscillator is a vibrational 'drum' mode of a millimetre-sized dielectric membrane(8), and the spin oscillator is an atomic ensemble in a magnetic field(9,10). The spin oriented along the field corresponds to an energetically inverted spin population and realizes a negative-effective-mass oscillator, while the opposite orientation corresponds to an oscillator with positive effective mass. The QBA is suppressed by -1.8 decibels in the negative-mass setting and enhanced by 2.4 decibels in the positive-mass case. This hybrid quantum system paves the way to entanglement generation and distant quantum communication between mechanical and spin systems and to sensing of force, motion and gravity beyond the standard quantum limit.	[Moller, Christoffer B.; Thomas, Rodrigo A.; Vasilakis, Georgios; Zeuthen, Emil; Tsaturyan, Yeghishe; Balabas, Mikhail; Jensen, Kasper; Schliesser, Albert; Polzik, Eugene S.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Vasilakis, Georgios] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion 71110, Greece; [Zeuthen, Emil] Leibniz Univ Hannover, Albert Einstein Inst, Inst Theoret Phys, Callinstr 38, D-30167 Hannover, Germany; [Zeuthen, Emil] Leibniz Univ Hannover, Albert Einstein Inst, Inst Gravitat Phys, Callinstr 38, D-30167 Hannover, Germany; [Balabas, Mikhail] St Petersburg State Univ, Dept Phys, Univ Prospekt 28, St Petersburg 198504, Russia	University of Copenhagen; Niels Bohr Institute; Foundation for Research & Technology - Hellas (FORTH); Leibniz University Hannover; Max Planck Society; Leibniz University Hannover; Max Planck Society; Saint Petersburg State University	Polzik, ES (corresponding author), Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark.	polzik@nbi.ku.dk	Jensen, Kasper/P-8359-2014; Vasilakis, Georgios/AAE-9688-2021; Hammerer, Klemens/C-3538-2008; Schliesser, Albert/C-5619-2014; Polzik, Eugene/M-4724-2014	Jensen, Kasper/0000-0002-8417-4328; Hammerer, Klemens/0000-0002-7179-0666; Schliesser, Albert/0000-0003-4317-5030; Zeuthen, Emil/0000-0002-1206-6862; Vasilakis, Georgios/0000-0002-0506-5183; Tsaturyan, Yeghishe/0000-0002-8324-5112; Moller, Christoffer/0000-0002-3123-0904; Polzik, Eugene/0000-0001-9859-6591	European Union Seventh Framework Program (ERC); European Union's Horizon 2020 research and innovation programme (ERC grant Q-CEOM) [638765]; Sapere Aude starting grant from the Danish Council for Independent Research; DARPA project QUASAR; program Science without Borders of the Brazilian Federal Government; Carlsberg Foundation; DFG [SFB 1227]	European Union Seventh Framework Program (ERC); European Union's Horizon 2020 research and innovation programme (ERC grant Q-CEOM); Sapere Aude starting grant from the Danish Council for Independent Research; DARPA project QUASAR; program Science without Borders of the Brazilian Federal Government; Carlsberg Foundation(Carlsberg Foundation); DFG(German Research Foundation (DFG))	We acknowledge discussions with F. Khalili. This work was supported by the European Union Seventh Framework Program (ERC grant INTERFACE, projects SIQS and iQUOEMS), the European Union's Horizon 2020 research and innovation programme (ERC grant Q-CEOM, grant agreement no. 638765), a Sapere Aude starting grant from the Danish Council for Independent Research, and the DARPA project QUASAR. R.A.T. is funded by the program Science without Borders of the Brazilian Federal Government. E.Z. is supported by the Carlsberg Foundation. K.H. and E.Z. acknowledge support from DFG through SFB 1227 (DQ-mat). We acknowledge help from M. Gaudesius at the early stage of the experimental development.	Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Bariani F, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.043817; Borregaard J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11356; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; Caniard T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.110801; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Corsini EP, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.022901; Danilishin SL, 2012, LIVING REV RELATIV, V15, DOI 10.12942/lrr-2012-5; Hammerer K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.020501; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Holstein T, 1940, PHYS REV, V58, P1098, DOI 10.1103/PhysRev.58.1098; Jayich AM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095008; Jensen K., 2011, THESIS; Jockel A, 2015, NAT NANOTECHNOL, V10, P55, DOI [10.1038/NNANO.2014.278, 10.1038/nnano.2014.278]; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Kimble HJ, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.022002; Kurizki G, 2015, P NATL ACAD SCI USA, V112, P3866, DOI 10.1073/pnas.1419326112; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Motazedifard A, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/7/073040; Nielsen WHP, 2017, P NATL ACAD SCI USA, V114, P62, DOI 10.1073/pnas.1608412114; Ockeloen-Korppi CF, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.140401; Polzik ES, 2015, ANN PHYS-BERLIN, V527, pA15, DOI 10.1002/andp.201400099; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Seltzer SJ, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236649; Spethmann N, 2016, NAT PHYS, V12, P27, DOI [10.1038/NPHYS3515, 10.1038/nphys3515]; Tsang M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031016; Tsang M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.123601; Tsaturyan Y., 2017, NAT NANOTECHNOL; Tsaturyan Y, 2014, OPT EXPRESS, V22, P6810, DOI 10.1364/OE.22.006810; Unruh W. G, 1983, QUANTUM OPTICS EXPT, P647; Vasilakis G, 2015, NAT PHYS, V11, P389, DOI 10.1038/nphys3280; Vasilyev DV, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/12/124007; Wasilewski W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.133601; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Wilson DJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207204; Woolley MJ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063846; Zhang KY, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043632	37	116	117	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					191	+		10.1038/nature22980	http://dx.doi.org/10.1038/nature22980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703182	Green Submitted			2022-12-28	WOS:000405314500033
J	Sotos-Prieto, M; Bhupathiraju, SN; Mattei, J; Fung, TT; Li, YP; Pan, A; Willett, WC; Rimm, EB; Hu, FB				Sotos-Prieto, Mercedes; Bhupathiraju, Shilpa N.; Mattei, Josiemer; Fung, Teresa T.; Li, Yanping; Pan, An; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.			Association of Changes in Diet Quality with Total and Cause-Specific Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; HEALTHY EATING INDEX; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; POSTMENOPAUSAL WOMEN; ALCOHOL-CONSUMPTION; PRIMARY PREVENTION; RISK; ADHERENCE	BACKGROUND Few studies have evaluated the relationship between changes in diet quality over time and the risk of death. METHODS We used Cox proportional-hazards models to calculate adjusted hazard ratios for total and cause-specific mortality among 47,994 women in the Nurses' Health Study and 25,745 men in the Health Professionals Follow-up Study from 1998 through 2010. Changes in diet quality over the preceding 12 years (1986-1998) were assessed with the use of the Alternate Healthy Eating Index-2010 score, the Alternate Mediterranean Diet score, and the Dietary Approaches to Stop Hypertension (DASH) diet score. RESULTS The pooled hazard ratios for all-cause mortality among participants who had the greatest improvement in diet quality (13 to 33% improvement), as compared with those who had a relatively stable diet quality (0 to 3% improvement), in the 12-year period were the following: 0.91 (95% confidence interval [CI], 0.85 to 0.97) according to changes in the Alternate Healthy Eating Index score, 0.84 (95 CI%, 0.78 to 0.91) according to changes in the Alternate Mediterranean Diet score, and 0.89 (95% CI, 0.84 to 0.95) according to changes in the DASH score. A 20-percentile increase in diet scores (indicating an improved quality of diet) was significantly associated with a reduction in total mortality of 8 to 17% with the use of the three diet indexes and a 7 to 15% reduction in the risk of death from cardiovascular disease with the use of the Alternate Healthy Eating Index and Alternate Mediterranean Diet. Among participants who maintained a high-quality diet over a 12-year period, the risk of death from any cause was significantly lower - by 14% (95% CI, 8 to 19) when assessed with the Alternate Healthy Eating Index score, 11% (95% CI, 5 to 18) when assessed with the Alternate Mediterranean Diet score, and 9% (95% CI, 2 to 15) when assessed with the DASH score - than the risk among participants with consistently low diet scores over time. CONCLUSIONS Improved diet quality over 12 years was consistently associated with a decreased risk of death. (Funded by the National Institutes of Health.)	[Sotos-Prieto, Mercedes; Bhupathiraju, Shilpa N.; Mattei, Josiemer; Fung, Teresa T.; Li, Yanping; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA; [Sotos-Prieto, Mercedes; Bhupathiraju, Shilpa N.; Mattei, Josiemer; Fung, Teresa T.; Li, Yanping; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bhupathiraju, Shilpa N.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Bhupathiraju, Shilpa N.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Harvard Med Sch, Boston, MA USA; [Fung, Teresa T.] Simmons Coll, Boston, MA 02115 USA; [Sotos-Prieto, Mercedes] Ohio Univ, Sch Appl Hlth Sci & Wellness, Div Food & Nutr Sci, Athens, OH 45701 USA; [Pan, An] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan, Peoples R China; [Pan, An] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Simmons University; University System of Ohio; Ohio University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, FB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.; Sotos-Prieto, M (corresponding author), Ohio Univ, Div Food & Nutr Sci, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness,Grover Ctr, Athens, OH 45701 USA.	msotosp@hsph.harvard.edu; nhbfh@channing.harvard.edu	Pan, An/C-5572-2011; Li, Yanping/H-6437-2011; Mattei, Josiemer/H-1800-2016	Pan, An/0000-0002-1089-7945; Sotos-Prieto, Mercedes/0000-0001-9127-2586; Li, Yanping/0000-0002-0412-2748; Mattei, Josiemer/0000-0001-5424-8245	National Institutes of Health; NATIONAL CANCER INSTITUTE [UM1CA167552, P01CA055075, P01CA087969, UM1CA186107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088521, R01HL060712, R01HL035464, K01HL120951, R01HL034594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health.	Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; Martinez-Gonzalez MA, 2014, CURR OPIN LIPIDOL, V25, P20, DOI 10.1097/MOL.0000000000000044; [Anonymous], 2015, SCI REP 2015 DIET GU; Atkins JL, 2014, J NUTR, V144, P673, DOI 10.3945/jn.113.186486; Aune D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0730-3; Boggs DA, 2015, J NUTR, V145, P547, DOI 10.3945/jn.114.195735; Buckland G, 2011, BRIT J NUTR, V106, P1581, DOI 10.1017/S0007114511002078; Cespedes EM, 2015, AM J CLIN NUTR, V101, P899, DOI 10.3945/ajcn.115.110213; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; George SM, 2014, AM J EPIDEMIOL, V180, P616, DOI 10.1093/aje/kwu173; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Harmon BE, 2015, AM J CLIN NUTR, V101, P587, DOI 10.3945/ajcn.114.090688; Knoops KTB, 2006, EUR J CLIN NUTR, V60, P746, DOI 10.1038/sj.ejcn.1602378; Larsson SC, 2014, AM J EPIDEMIOL, V179, P282, DOI 10.1093/aje/kwt261; Liese AD, 2015, J NUTR, V145, P393, DOI 10.3945/jn.114.205336; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mursu J, 2013, AM J CLIN NUTR, V98, P444, DOI 10.3945/ajcn.112.055681; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Sotos-Prieto M, 2015, CIRCULATION, V132, P2212, DOI 10.1161/CIRCULATIONAHA.115.017158; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yu DX, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001830	35	246	258	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					143	153		10.1056/NEJMoa1613502	http://dx.doi.org/10.1056/NEJMoa1613502			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA2PC	28700845	Green Accepted, Bronze			2022-12-28	WOS:000405282300008
J	Grilli, J; Barabas, G; Michalska-Smith, MJ; Allesina, S				Grilli, Jacopo; Barabas, Gyorgy; Michalska-Smith, Matthew J.; Allesina, Stefano			Higher-order interactions stabilize dynamics in competitive network models	NATURE			English	Article							OPTIMAL STRATEGIES; STABLE STRATEGIES; GAME; COEXISTENCE; BIODIVERSITY; COMMUNITIES; PAPER	Ecologists have long sought a way to explain how the remarkable biodiversity observed in nature is maintained. On the one hand, simple models of interacting competitors cannot produce the stable persistence of very large ecological communities(1-5). On the other hand, neutral models(6-9), in which species do not interact and diversity is maintained by immigration and speciation, yield unrealistically small fluctuations in population abundance(10), and a strong positive correlation between a species' abundance and its age(11), contrary to empirical evidence. Models allowing for the robust persistence of large communities of interacting competitors are lacking. Here we show that very diverse communities could persist thanks to the stabilizing role of higher-order interactions(12,13), in which the presence of a species influences the interaction between other species. Although higher-order interactions have been studied for decades(14-16), their role in shaping ecological communities is still unclear(5). The inclusion of higher-order interactions in competitive network models stabilizes dynamics, making species coexistence robust to the perturbation of both population abundance and parameter values. We show that higher-order interactions have strong effects in models of closed ecological communities, as well as of open communities in which new species are constantly introduced. In our framework, higher-order interactions are completely defined by pairwise interactions, facilitating empirical parameterization and validation of our models.	[Grilli, Jacopo; Barabas, Gyorgy; Michalska-Smith, Matthew J.; Allesina, Stefano] Univ Chicago, Ecol & Evolut, 1101 East 57th St, Chicago, IL 60637 USA; [Allesina, Stefano] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Allesina, Stefano] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA	University of Chicago; University of Chicago; Northwestern University	Allesina, S (corresponding author), Univ Chicago, Ecol & Evolut, 1101 East 57th St, Chicago, IL 60637 USA.; Allesina, S (corresponding author), Univ Chicago, Computat Inst, Chicago, IL 60637 USA.; Allesina, S (corresponding author), Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA.	sallesina@uchicago.edu	Michalska-Smith, Matthew J/H-3268-2019; Allesina, Stefano/A-2255-2009	Michalska-Smith, Matthew J/0000-0002-0369-412X; Allesina, Stefano/0000-0003-0313-8374; Grilli, Jacopo/0000-0002-8235-5803	Human Frontier Science Program; NSF [DEB-1148867]; US Department of Education [P200A150101]; Direct For Biological Sciences [1148867] Funding Source: National Science Foundation	Human Frontier Science Program(Human Frontier Science Program); NSF(National Science Foundation (NSF)); US Department of Education(US Department of Education); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Aljadeff, F. Brandl, J. A. Capitan, J.-F. Laslier, J. M. Levine, C. A. Marcelo Servan and E. Sander for comments and discussions. E. Leigh provided constructive feedback. J.G. was supported by the Human Frontier Science Program. S.A. and G.B. were supported by NSF grant DEB-1148867. M.J.M-S. was supported by US Department of Education grant P200A150101.	ABRAMS PA, 1983, AM NAT, V121, P887, DOI 10.1086/284111; Allesina S, 2011, P NATL ACAD SCI USA, V108, P5638, DOI 10.1073/pnas.1014428108; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Azaele S, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035003; Bairey E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12285; Barabas G, 2016, AM NAT, V188, pE1, DOI 10.1086/686901; BILLICK I, 1994, ECOLOGY, V75, P1529, DOI 10.2307/1939614; Brandl F., 2016, PREPRINT; CASE TJ, 1981, AM NAT, V118, P920, DOI 10.1086/283885; Chisholm RA, 2014, ECOL LETT, V17, P855, DOI 10.1111/ele.12296; Chisholm RA, 2014, THEOR POPUL BIOL, V93, P85, DOI 10.1016/j.tpb.2014.02.002; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; D'Andrea R, 2016, OIKOS, V125, P1369, DOI 10.1111/oik.02979; FISHER DC, 1992, AM MATH MON, V99, P935, DOI 10.2307/2324486; FISHER DC, 1995, LINEAR ALGEBRA APPL, V217, P83, DOI 10.1016/0024-3795(94)00212-V; Friedman J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0109; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; HOFBAUER J, 1979, J THEOR BIOL, V81, P609, DOI 10.1016/0022-5193(79)90058-4; Hubbell S.P., 2001, MG POP BIOL, V32; KAREIVA P, 1994, ECOLOGY, V75, P1527; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Laslier B., 2013, PREPRINT; Levine JM, 2017, NATURE, V546, P56, DOI 10.1038/nature22898; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Reichenbach T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051907; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461	30	197	200	11	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2017	548	7666					210	+		10.1038/nature23273	http://dx.doi.org/10.1038/nature23273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1GB	28746307				2022-12-28	WOS:000407284300043
J	Shah, SN; Bachur, RG; Simel, DL; Neuman, MI				Shah, Sonal N.; Bachur, Richard G.; Simel, David L.; Neuman, Mark I.			Does This Child Have Pneumonia? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RESPIRATORY-TRACT INFECTIONS; COMMUNITY-ACQUIRED PNEUMONIA; CHEST RADIOGRAPHS; BACTERIAL PNEUMONIA; CONFIRMED PNEUMONIA; PREDICTION RULE; VIRAL PNEUMONIA; DIAGNOSIS; FEATURES; GUIDELINES	IMPORTANCE Pneumonia is a leading cause of morbidity and mortality in children. It is important to identify the clinical symptoms and physical examination findings associated with pneumonia to improve timely diagnosis, prevent significant morbidity, and limit antibiotic overuse. OBJECTIVE To systematically review the accuracy of symptoms and physical examination findings in identifying children with radiographic pneumonia. DATA SOURCES AND STUDY SELECTION MEDLINE and Embase (1956 to May 2017) were searched, along with reference lists from retrieved articles, to identify diagnostic studies of pediatric pneumonia across a broad age range that had to include children younger than age 5 years (although some studies enrolled children up to age 19 years); 3644 unique articles were identified, of which 23 met inclusion criteria. DATA EXTRACTION AND SYNTHESIS Two authors independently abstracted raw data and assessed methodological quality. A third author resolved disputes. MAIN OUTCOMES AND MEASURES Likelihood ratios (LRs), sensitivity, and specificity were calculated for individual symptoms and physical examination findings for the diagnosis of pneumonia. An infiltrate on chest radiograph was considered the reference standard for the diagnosis of pneumonia. RESULTS Twenty-three prospective cohort studies of children (N = 13 833) with possible pneumonia were included (8 from North America), with a range of 78 to 2829 patients per study. The prevalence of radiographic pneumonia in North American studies was 19% (95% CI, 11%-31%) and 37%(95% CI, 26%-50%) outside of North America. No single symptom was strongly associated with pneumonia; however, the presence of chest pain in 2 studies that included adolescents was associated with pneumonia (LR, 1.5-5.5; sensitivity, 8%-14%; specificity, 94%-97%). Vital sign abnormalities such as fever (temperature >37.5 degrees C [LR range, 1.7-1.8]; sensitivity, 80%-92%; specificity, 47%-54%) and tachypnea (respiratory rate >40 breaths/min; LR, 1.5 [95% CI, 1.3-1.7]; sensitivity, 79%; specificity, 51%) were not strongly associated with pneumonia diagnosis. Similarly, auscultatory findings were not associated with pneumonia diagnosis. The presence of moderate hypoxemia (oxygen saturation <= 96%; LR, 2.8 [95% CI, 2.1-3.6]; sensitivity, 64%; specificity, 77%) and increased work of breathing (grunting, flaring, and retractions; positive LR, 2.1 [95% CI, 1.6-2.7]) were signs most associated with pneumonia. The presence of normal oxygenation (oxygen saturation >96%) decreased the likelihood of pneumonia (LR, 0.47 [95% CI, 0.32-0.67]). CONCLUSIONS AND RELEVANCE Although no single finding reliably differentiates pneumonia from other causes of childhood respiratory illness, hypoxia and increased work of breathing are more important than tachypnea and auscultatory findings.	[Shah, Sonal N.; Bachur, Richard G.; Neuman, Mark I.] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Shah, Sonal N.; Bachur, Richard G.; Neuman, Mark I.] Harvard Med Sch, Boston, MA USA; [Simel, David L.] Durham Vet Med Ctr, Durham, NC USA; [Simel, David L.] Duke Univ, Durham, NC USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Duke University	Shah, SN (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	sonal.shah@childrens.harvard.edu			Astute Medical [US20120028268 A]	Astute Medical	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bachur reports receipt of royalties from UpToDate.com (editorial duties) and Wolters-Kluwer (textbook editor); a stipend as the medical editor for the American Board of Pediatrics Sub-board of Pediatric Emergency Medicine; and research funded by Astute Medical related to biomarkers of appendicitis (patent US20120028268 A). Dr Simel reports receipt of honoraria for contributions to JAMAEvidence.com. Dr Neuman reports receipt of royalties from UpToDate.com for content unrelated to this manuscript and receives a stipend for his service as an Assistant Editor for Pediatrics. No other disclosures were reported.	Ayalon I, 2013, PEDIATR EMERG CARE, V29, P893, DOI 10.1097/PEC.0b013e31829e7d6a; Ayieko P, 2007, PEDIATR INFECT DIS J, V26, P432, DOI 10.1097/01.inf.0000260107.79355.7d; Ben Shimol S, 2012, EUR J PEDIATR, V171, P369, DOI 10.1007/s00431-011-1543-1; Berg AS, 2017, EUR J PEDIATR, V176, P629, DOI 10.1007/s00431-017-2887-y; Bilkis MD, 2010, PEDIATR EMERG CARE, V26, P399, DOI 10.1097/PEC.0b013e3181e05779; Bossuyt P., 2013, COCHRANE HDB SYSTEMA, P3; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; CAMPBELL H, 1989, LANCET, V1, P297, DOI 10.1016/S0140-6736(89)91308-1; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; DAI YH, 1995, PEDIATR INFECT DIS J, V14, P48, DOI 10.1097/00006454-199501000-00010; Davies HD, 1996, PEDIATR INFECT DIS J, V15, P600, DOI 10.1097/00006454-199607000-00008; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Elemraid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106051; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Esposito S, 2002, CLIN INFECT DIS, V35, P1345, DOI 10.1086/344191; Florin TA, 2013, PEDIATRICS, V132, P237, DOI 10.1542/peds.2013-0179; Gerber JS, 2016, JAMA-J AM MED ASSOC, V315, P558, DOI 10.1001/jama.2016.0430; Gerber JS, 2013, JAMA-J AM MED ASSOC, V309, P2345, DOI 10.1001/jama.2013.6287; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P119; GROSSMAN LK, 1988, ANN EMERG MED, V17, P43, DOI 10.1016/S0196-0644(88)80502-X; HARARI M, 1991, LANCET, V338, P928, DOI 10.1016/0140-6736(91)91785-S; Hazir T, 2006, BMJ-BRIT MED J, V333, P629; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337; Jadavji T, 1997, CAN MED ASSOC J, V156, pS703; Kelly MS, 2016, PEDIATR INFECT DIS J, V35, P257, DOI 10.1097/INF.0000000000000990; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Kosasih K, 2017, WORLD J PEDIATR, V13, P446, DOI 10.1007/s12519-017-0019-4; Kronman MP, 2011, PEDIATRICS, V127, P411, DOI 10.1542/peds.2010-2008; LEVENTHAL JM, 1982, CLIN PEDIATR, V21, P730, DOI 10.1177/000992288202101205; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; LUCERO MG, 1990, REV INFECT DIS, V12, pS1081; Lynch T, 2004, PEDIATRICS, V113, pE186, DOI 10.1542/peds.113.3.e186; Lynch Tim, 2010, PLoS One, V5, pe11989, DOI 10.1371/journal.pone.0011989; Mahabee-Gittens EM, 2005, CLIN PEDIATR, V44, P427, DOI 10.1177/000992280504400508; Margolis P, 1998, JAMA-J AM MED ASSOC, V279, P308, DOI 10.1001/jama.279.4.308; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Moreno L, 2006, PEDIATR PULM, V41, P331, DOI 10.1002/ppul.20364; Muangchana C, 2009, SE ASIAN J TROP MED, V40, P563; Mulholland K, 1999, LANCET, V354, P590, DOI 10.1016/S0140-6736(98)10238-6; Nascimento-Carvalho CM, 2015, PEDIATR INFECT DIS J, V34, P490, DOI 10.1097/INF.0000000000000622; Nash DR, 2002, ARCH PEDIAT ADOL MED, V156, P1114, DOI 10.1001/archpedi.156.11.1114; Naydenova E, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0266; Nelson KA, 2016, PEDIATR EMERG CARE, V32, P514, DOI 10.1097/PEC.0000000000000868; Neuman MI, 2012, J HOSP MED, V7, P294, DOI 10.1002/jhm.955; Neuman MI, 2011, PEDIATR EMERG CARE, V27, P606, DOI 10.1097/PEC.0b013e3182225578; Neuman MI, 2010, PEDIATR EMERG CARE, V26, P817, DOI 10.1097/PEC.0b013e3181fb0d95; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; Patel A, 2008, INT J TUBERC LUNG D, V12, P1320; Puumalainen T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-95; REDD SC, 1994, T ROY SOC TROP MED H, V88, P307, DOI 10.1016/0035-9203(94)90092-2; Rothrock SG, 2001, PEDIATR EMERG CARE, V17, P240, DOI 10.1097/00006565-200108000-00003; Seiden J., 2016, FLEISHER LUDWIGS TXB, V7th ed., P600; Shamo'on H, 2004, East Mediterr Health J, V10, P482; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simel DL, 2009, RATIONAL CLIN EXAMIN; SINGAL BM, 1989, ANN EMERG MED, V18, P13, DOI 10.1016/S0196-0644(89)80304-X; Swingler George H, 2001, BMC Med Imaging, V1, P1, DOI 10.1186/1471-2342-1-1; Swingler GH, 2000, CLIN PEDIATR, V39, P627, DOI 10.1177/000992280003901101; Test M, 2013, J HOSP MED, V8, P359, DOI 10.1002/jhm.1991; Virkki R, 2002, THORAX, V57, P438, DOI 10.1136/thorax.57.5.438; WAFULA EM, 1989, E AFR MED J, V66, P678; WAFULA EM, 1984, E AFR MED J, V61, P900; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; World Health Organization, 2012, REC MAN COMM CHILD C; Wortham JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133257; Wubbel L, 1999, PEDIATR INFECT DIS J, V18, P98, DOI 10.1097/00006454-199902000-00004; Xavier-Souza G, 2013, PEDIATR PULM, V48, P464, DOI 10.1002/ppul.22644; Zimmerman DR, 2012, PEDIATR EMERG CARE, V28, P646, DOI 10.1097/PEC.0b013e31825cfd53; ZUKIN DD, 1986, ANN EMERG MED, V15, P792	75	91	94	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					462	471		10.1001/jama.2017.9039	http://dx.doi.org/10.1001/jama.2017.9039			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763554				2022-12-28	WOS:000406659800017
J	Strum, S				Strum, Stephen			The Scientific Basis of Guideline Recommendations on Sugar Intake	ANNALS OF INTERNAL MEDICINE			English	Letter									[Strum, Stephen] Community Practice Med Oncol & Internal Med, Jacksonville, OR USA		Strum, S (corresponding author), Community Practice Med Oncol & Internal Med, Jacksonville, OR USA.							Erickson J, 2017, ANN INTERN MED, V166, P257, DOI 10.7326/M16-2020	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					218	218		10.7326/L17-0254	http://dx.doi.org/10.7326/L17-0254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28761952				2022-12-28	WOS:000406631400019
J	Reynolds, MP; Braun, HJ; Cavalieri, AJ; Chapotin, S; Davies, WJ; Ellul, P; Feuillet, C; Govaerts, B; Kropff, MJ; Lucas, H; Nelson, J; Powell, W; Quilligan, E; Rosegrant, MW; Singh, RP; Sonder, K; Tang, H; Visscher, S; Wang, R				Reynolds, M. P.; Braun, H. J.; Cavalieri, A. J.; Chapotin, S.; Davies, W. J.; Ellul, P.; Feuillet, C.; Govaerts, B.; Kropff, M. J.; Lucas, H.; Nelson, J.; Powell, W.; Quilligan, E.; Rosegrant, M. W.; Singh, Ravi P.; Sonder, K.; Tang, H.; Visscher, S.; Wang, R.			Improving global integration of crop research	SCIENCE			English	Editorial Material									[Reynolds, M. P.; Braun, H. J.; Govaerts, B.; Kropff, M. J.; Nelson, J.; Quilligan, E.; Singh, Ravi P.; Sonder, K.] Int Maize & Wheat Improvement Ctr, Mexico City, DF, Mexico; [Cavalieri, A. J.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Chapotin, S.] US Agcy Int Dev, Washington, DC 20523 USA; [Davies, W. J.] Global Plant Council, Lancaster, England; [Davies, W. J.] Univ Lancaster, Lancaster, England; [Ellul, P.] CGIAR Syst Org, Montpellier, France; [Feuillet, C.] Bayer, Crop Sci Div, Morrisville, NY USA; [Lucas, H.] Wheat Initiat, Paris, France; [Lucas, H.] Natl Inst Agr Res, Paris, France; [Powell, W.] Scotlands Rural Coll, Edinburgh, Midlothian, Scotland; [Rosegrant, M. W.] Int Food Policy Res Inst, Washington, DC 20036 USA; [Tang, H.] Chinese Acad Agr sci, Beijing, Peoples R China; [Visscher, S.] Biotechnol & Biol Sci Res Council, Swindon, Wilts, England; [Wang, R.] Food & Agr Org United Nations, Rome, Italy	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Bill & Melinda Gates Foundation; United States Agency for International Development (USAID); Lancaster University; CGIAR; Bayer AG; Bayer CropScience; INRAE; Scotland's Rural College; CGIAR; International Food Policy Research Institute (IFPRI); Chinese Academy of Agricultural Sciences; Food & Agriculture Organization of the United Nations (FAO)	Reynolds, MP (corresponding author), Int Maize & Wheat Improvement Ctr, Mexico City, DF, Mexico.	m.reynolds@cgiar.org	Singh, Ravi Prakash/I-5575-2019; Reynolds, Matthew M/S-3578-2016	Reynolds, Matthew M/0000-0002-4291-4316; Sonder, Kai/0000-0001-9672-5361; Powell, Wayne/0000-0002-5612-3398; Lucas, Helene/0000-0002-1469-0212; Govaerts, Bram/0000-0002-6109-7286	U.S. Agency for International Development (USAID); Bill AMP; Melinda Gates Foundation [OPP1052535]; CGIAR Platform for Big Data in Agriculture	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Bill AMP; Melinda Gates Foundation(CGIAR); CGIAR Platform for Big Data in Agriculture(CGIAR)	The authors acknowledge support from the U.S. Agency for International Development (USAID), the Bill & Melinda Gates Foundation (OPP1052535), and the CGIAR Platform for Big Data in Agriculture. The views and opinions in this paper are those of the authors and not necessarily those of USAID. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.	[Anonymous], 2015, NAT GENET, V47, P99; Fischer R.A., 2014, ACIAR MONOGRAPH; Gourdji SM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2190; Lantican M.A., 2016, IMPACTS INT WHEAT IM; Leeuwis C, 2018, GLOB FOOD SECUR-AGR, V16, P17, DOI 10.1016/j.gfs.2017.06.002; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pingali PL, 2012, P NATL ACAD SCI USA, V109, P12302, DOI 10.1073/pnas.0912953109; Poorter H, 2016, NEW PHYTOL, V212, P838, DOI 10.1111/nph.14243; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Reynolds MP, 2012, J EXP BOT, V63, P1, DOI 10.1093/jxb/err241; Ruiz KB, 2014, AGRON SUSTAIN DEV, V34, P349, DOI 10.1007/s13593-013-0195-0; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Stevenson JR, 2013, P NATL ACAD SCI USA, V110, P8363, DOI 10.1073/pnas.1208065110	16	23	23	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					359	+		10.1126/science.aam8559	http://dx.doi.org/10.1126/science.aam8559			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751598	Green Published			2022-12-28	WOS:000406362300027
J	Anand, P; Gold, DR				Anand, Pria; Gold, Daniel R.			Nystagmus from Wernicke's Encephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Anand, Pria; Gold, Daniel R.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Anand, P (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.	panand2@jhmi.edu		Anand, Pria/0000-0002-7421-7750					0	3	4	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					E5	E5		10.1056/NEJMicm1615499	http://dx.doi.org/10.1056/NEJMicm1615499			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28745996				2022-12-28	WOS:000406295000010
J	Inoue, A; Jiang, L; Lu, FL; Suzuki, T; Zhang, Y				Inoue, Azusa; Jiang, Lan; Lu, Falong; Suzuki, Tsukasa; Zhang, Yi			Maternal H3K27me3 controls DNA methylation-independent imprinting	NATURE			English	Article							MOUSE PREIMPLANTATION DEVELOPMENT; SEQUENCING-BASED IDENTIFICATION; REPRESSIVE HISTONE METHYLATION; GENOMIC FEATURES; RNA-SEQ; CHROMATIN; GENE; PLACENTA; EMBRYOS; EMBRYOGENESIS	Mammalian sperm and oocytes have different epigenetic landscapes and are organized in different fashions. After fertilization, the initially distinct parental epigenomes become largely equalized with the exception of certain loci, including imprinting control regions. How parental chromatin becomes equalized and how imprinting control regions escape from this reprogramming is largely unknown. Here we profile parental allele-specific DNase I hypersensitive sites in mouse zygotes and morula embryos, and investigate the epigenetic mechanisms underlying these allelic sites. Integrated analyses of DNA methylome and tri-methylation at lysine 27 of histone H3 (H3K27me3) chromatin immunoprecipitation followed by sequencing identify 76 genes with paternal allele-specific DNase I hypersensitive sites that are devoid of DNA methylation but harbour maternal allele-specific H3K27me3. Interestingly, these genes are paternally expressed in preimplantation embryos, and ectopic removal of H3K27me3 induces maternal allele expression. H3K27me3-dependent imprinting is largely lost in the embryonic cell lineage, but at least five genes maintain their imprinted expression in the extra-embryonic cell lineage. The five genes include all paternally expressed autosomal imprinted genes previously demonstrated to be independent of oocyte DNA methylation. Thus, our study identifies maternal H3K27me3 as a DNA methylation-independent imprinting mechanism.	[Inoue, Azusa; Jiang, Lan; Lu, Falong; Suzuki, Tsukasa; Zhang, Yi] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Inoue, Azusa; Jiang, Lan; Lu, Falong; Suzuki, Tsukasa; Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Inoue, Azusa; Jiang, Lan; Lu, Falong; Suzuki, Tsukasa; Zhang, Yi] Boston Childrens Hosp, Div Hematol Oncol, Dept Pediat, Boston, MA 02115 USA; [Zhang, Yi] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Lu, Falong] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhang, Y (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Dept Pediat, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Zhang, Y (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu	jiang, lan/T-3965-2019; jiang, lan/C-1077-2009; Lu, Falong/Q-3013-2016	jiang, lan/0000-0003-2008-9631; Zhang, Yi/0000-0002-2789-0811; Lu, Falong/0000-0002-8321-4818	Howard Hughes Medical Institute; Charles A. King Trust Postdoctoral Research Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Charles A. King Trust Postdoctoral Research Fellowship	We thank S. Matoba for technical advice and L. Tuesta for reading the manuscript. This project was supported by the Howard Hughes Medical Institute. F.L. is supported by a Charles A. King Trust Postdoctoral Research Fellowship. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Babak T, 2015, NAT GENET, V47, P544, DOI 10.1038/ng.3274; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Borensztein M, 2017, NAT STRUCT MOL BIOL, V24, P226, DOI 10.1038/nsmb.3365; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Duffie R., GENES DEV, V28, P463; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Henckel A, 2009, HUM MOL GENET, V18, P3375, DOI 10.1093/hmg/ddp277; Inoue A, 2008, HUM REPROD, V23, P1377, DOI 10.1093/humrep/den096; Inoue A, 2007, J REPROD DEVELOP, V53, P1043, DOI 10.1262/jrd.19064; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kobayashi H, 2012, FEBS LETT, V586, P827, DOI 10.1016/j.febslet.2012.01.059; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Kuzmin A, 2008, GENE EXPR PATTERNS, V8, P107, DOI 10.1016/j.modgep.2007.09.005; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lu FL, 2016, CELL, V165, P1375, DOI 10.1016/j.cell.2016.05.050; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Monk D, 2008, GENOME RES, V18, P1270, DOI 10.1101/gr.077115.108; Moreno-Romero J, 2016, EMBO J, V35, P1298, DOI 10.15252/embj.201593534; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; Okae H, 2014, HUM MOL GENET, V23, P992, DOI 10.1093/hmg/ddt495; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pires Nuno D, 2014, F1000Prime Rep, V6, P63, DOI 10.12703/P6-63; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Sugimoto M, 2015, STEM CELL REP, V4, P744, DOI 10.1016/j.stemcr.2015.02.014; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Varmuza S, 2015, CELL MOL LIFE SCI, V72, P51, DOI 10.1007/s00018-014-1714-0; Wang X, 2011, GENETICS, V189, P109, DOI 10.1534/genetics.111.130088; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Yamasaki-Ishizaki Y, 2007, MOL CELL BIOL, V27, P732, DOI 10.1128/MCB.01329-06; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng H, 2016, MOL CELL, V63, P1066, DOI 10.1016/j.molcel.2016.08.032; Zhou LQ, 2015, TRENDS CELL BIOL, V25, P82, DOI 10.1016/j.tcb.2014.09.006	52	219	235	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					419	+		10.1038/nature23262	http://dx.doi.org/10.1038/nature23262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28723896	Green Accepted			2022-12-28	WOS:000406358300028
J	Lui, TH				Lui, Tun Hing			SPOT DIAGNOSIS Dysphagia and choking in an older man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lui, Tun Hing] North Dist Hosp, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China		Lui, TH (corresponding author), North Dist Hosp, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	luithderek@yahoo.co.uk							0	0	0	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2017	358								j3344	10.1136/bmj.j3344	http://dx.doi.org/10.1136/bmj.j3344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UX	28751318				2022-12-28	WOS:000406766000005
J	Kirkegaard, H; Soreide, E; de Haas, I; Pettila, V; Taccone, FS; Arus, U; Storm, C; Hassager, C; Nielsen, JF; Sorensen, CA; Ilkjaer, S; Jeppesen, AN; Grejs, AM; Duez, CHV; Hjort, J; Larsen, A; Toome, V; Tiainen, M; Hastbacka, J; Laitio, T; Skrifvars, MB				Kirkegaard, Hans; Soreide, Eldar; de Haas, Inge; Pettila, Ville; Taccone, Fabio Silvio; Arus, Urmet; Storm, Christian; Hassager, Christian; Nielsen, Jorgen Feldbaek; Sorensen, Christina Ankjaer; Ilkjaer, Susanne; Jeppesen, Anni Norgaard; Grejs, Anders Morten; Duez, Christophe Henri Valdemar; Hjort, Jakob; Larsen, Alflnge; Toome, Valdo; Tiainen, Marjaana; Hastbacka, Johanna; Laitio, Timo; Skrifvars, Markus B.			Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPEUTIC HYPOTHERMIA; COMATOSE SURVIVORS; MILD HYPOTHERMIA; CARDIOPULMONARY; RESUSCITATION; INDUCTION; ADMISSION; DURATION; PROTOCOL; CARE	IMPORTANCE International resuscitation guidelines recommend targeted temperature management (TTM) at 33 degrees C to 36 degrees C in unconscious patients with out-of-hospital cardiac arrest for at least 24 hours, but the optimal duration of TTM is uncertain. OBJECTIVE To determine whether TTM at 33 degrees C for 48 hours results in better neurologic outcomes compared with currently recommended, standard, 24-hour TTM. DESIGN, SETTING, AND PARTICIPANTS This was an international, investigator-initiated, blinded-outcome-assessor, parallel, pragmatic, multicenter, randomized clinical superiority trial in 10 intensive care units (ICUs) at 10 university hospitals in 6 European countries. Three hundred fifty-five adult, unconscious patients with out-of-hospital cardiac arrest were enrolled from February 16, 2013, to June 1, 2016, with final follow-up on December 27, 2016. INTERVENTIONS Patients were randomized to TTM(33 +/- 1 degrees C) for 48 hours (n = 176) or 24 hours (n = 179), followed by gradual rewarming of 0.5 degrees C per hour until reaching 37 degrees C. MAIN OUTCOMES AND MEASURES The primary outcome was 6-month neurologic outcome, with a Cerebral Performance Categories (CPC) score of 1 or 2 used to define favorable outcome. Secondary outcomes included 6-month mortality, including time to death, the occurrence of adverse events, and intensive care unit resource use. RESULTS In 355 patients who were randomized (mean age, 60 years; 295 [83%] men), 351 (99%) completed the trial. More patients in the 48-hour group had a favorable outcome, but this was not statistically significant. Six-month mortality was not different between the groups. Adverse events were more common in the 48-hour group than in the 24-hour group. There was no significant difference in the time to mortality (hazard ratio, 0.79; 95% CI, 0.54-1.15; P = .22). The median length of ICU stay (151 vs 117 hours; P < .001), but not hospital stay (11 vs 12 days; P = .50), was longer in the 48-hour group than in the 24-hour group. [GRAPHICS] CONCLUSIONS AND RELEVANCE In unconscious survivors from out-of-hospital cardiac arrest admitted to the ICU, targeted temperature management at 33 degrees C for 48 hours did not significantly improve 6-month neurologic outcome compared with targeted temperature management at 33 degrees C for 24 hours. However, the study may have had limited power to detect clinically important differences, and further research may be warranted.	[Kirkegaard, Hans; Jeppesen, Anni Norgaard; Grejs, Anders Morten; Duez, Christophe Henri Valdemar] Aarhus Univ Hosp, Res Ctr Emergency Med, Noerrebrogade 44,Bldg 1B, DK-8000 Aarhus C, Denmark; [Kirkegaard, Hans; Jeppesen, Anni Norgaard; Grejs, Anders Morten; Duez, Christophe Henri Valdemar] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care Med, Aarhus, Denmark; [Kirkegaard, Hans; Jeppesen, Anni Norgaard; Grejs, Anders Morten; Duez, Christophe Henri Valdemar] Aarhus Univ, Aarhus, Denmark; [Soreide, Eldar] Stavanger Univ Hosp, Dept Anesthesiol & Intens Care, Stavanger, Norway; [Soreide, Eldar] Univ Bergen, Dept Clin Med, Bergen, Norway; [de Haas, Inge] Aalborg Univ Hosp, Dept Anesthesiol & Intens Care Med, Aalborg, Denmark; [de Haas, Inge] Aalborg Univ, Inst Clin, Aalborg, Denmark; [Pettila, Ville; Hastbacka, Johanna; Skrifvars, Markus B.] Univ Helsinki, Div Intens Care, Dept Anesthesiol Intens Care & Pain Med, FIN-00014 Helsinki, Finland; [Pettila, Ville; Tiainen, Marjaana; Hastbacka, Johanna; Skrifvars, Markus B.] Helsinki Univ Hosp, Helsinki, Finland; [Pettila, Ville] Univ Bern, Inselspital, Univ Hosp Bern, Bern, Switzerland; [Taccone, Fabio Silvio] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium; [Arus, Urmet] North Estonia Med Ctr, Dept Intens Cardiac Care, Tallinn, Estonia; [Storm, Christian] Charite Univ Med Berlin, Dept Internal Med Nephrol & Intens Care, Berlin, Germany; [Hassager, Christian] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Ctr Heart, Copenhagen, Denmark; [Nielsen, Jorgen Feldbaek] Aarhus Univ, Hammel Neurorehabilitat Ctr, DK-8000 Aarhus C, Denmark; [Nielsen, Jorgen Feldbaek] Aarhus Univ, Univ Res Clin, DK-8000 Aarhus C, Denmark; [Sorensen, Christina Ankjaer] Aalborg Univ Hosp, Dept Anesthesiol & Intens Care Med, Aalborg, Denmark; [Ilkjaer, Susanne] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care Med, Aarhus, Denmark; [Hjort, Jakob] Aarhus Univ, Dept Clin Med, DK-8000 Aarhus C, Denmark; [Larsen, Alflnge] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Larsen, Alflnge] Univ Bergen, Dept Clin Sci, N-5020 Bergen, Norway; [Toome, Valdo] North Estonia Med Ctr, Dept Anesthesiol Intens Care & Emergency Med, Tallinn, Estonia; [Tiainen, Marjaana] Univ Helsinki, Dept Neurol, FIN-00014 Helsinki, Finland; [Laitio, Timo] Turku Univ Hosp, Dept Anesthesiol & Intens Care, Turku, Finland; [Laitio, Timo] Univ Turku, SF-20500 Turku, Finland; [Skrifvars, Markus B.] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia	Aarhus University; Aarhus University; Aarhus University; Stavanger University Hospital; University of Bergen; Aalborg University; Aalborg University Hospital; Aalborg University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Bern; University Hospital of Bern; Universite Libre de Bruxelles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Stavanger University Hospital; University of Bergen; University of Helsinki; University of Turku; University of Turku; Monash University	Kirkegaard, H (corresponding author), Aarhus Univ Hosp, Res Ctr Emergency Med, Noerrebrogade 44,Bldg 1B, DK-8000 Aarhus C, Denmark.	hanskirkegaard@dadlnet.dk	Laitio, Timo/GQB-4976-2022; Nielsen, Jørgen Feldbæk/AAR-6384-2021; Soreide, Eldar/ABD-8141-2021	Nielsen, Jørgen Feldbæk/0000-0001-5339-171X; Hassager, Christian/0000-0002-1199-0981; Grejs, Anders/0000-0002-8850-2982; Duez, Christophe/0000-0001-7560-9214; Hastbacka, Johanna/0000-0002-3613-7231	Danish Heart Foundation; Laerdal Foundation; Scandinavian Society of Anaesthesiology and Intensive Care Medicine; Danish Society of Anaesthesiology and Intensive Care Medicine; Augustinus Foundation; Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa; Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perklens minne	Danish Heart Foundation; Laerdal Foundation; Scandinavian Society of Anaesthesiology and Intensive Care Medicine; Danish Society of Anaesthesiology and Intensive Care Medicine; Augustinus Foundation; Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa; Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perklens minne	The study was funded by independent research grants from The Danish Heart Foundation, The Laerdal Foundation, The Scandinavian Society of Anaesthesiology and Intensive Care Medicine, The Danish Society of Anaesthesiology and Intensive Care Medicine, The Augustinus Foundation, Finska Lakaresallskapet, and Medicinska Understodsforeningen Liv och Halsa and Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perklens minne.	ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; Adrie C, 2006, EUR HEART J, V27, P2840, DOI 10.1093/eurheartj/ehl335; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Becker LB, 2015, JAMA-J AM MED ASSOC, V314, P223, DOI 10.1001/jama.2015.8454; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bisschops LLA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0546-5; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Che DF, 2011, CRIT CARE MED, V39, P1423, DOI 10.1097/CCM.0b013e318212020a; Donnino MW, 2015, CIRCULATION, V132, P2448, DOI 10.1161/CIR.0000000000000313; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Grossestreuer AV, 2016, RESUSCITATION, V109, P21, DOI 10.1016/j.resuscitation.2016.09.006; Hifumi T, 2015, CIRC J, V79, P2201, DOI 10.1253/circj.CJ-15-0308; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2010, NEW ENGL J MED, V363, P1256, DOI 10.1056/NEJMct1002402; Kagawa E, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002123; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Kirkegaard H, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0334-0; Kirkegaard H, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1338-9; Legriel S, 2016, NEW ENGL J MED, V375, P2457, DOI 10.1056/NEJMoa1608193; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; Nagao K, 2010, CIRC J, V74, P77, DOI 10.1253/circj.CJ-09-0502; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Shankaran S, 2014, JAMA-J AM MED ASSOC, V312, P2629, DOI 10.1001/jama.2014.16058; Suh GJ, 2014, CRIT CARE MED, V42, pE132, DOI 10.1097/CCM.0b013e3182a668e4; TEASDALE G, 1974, LANCET, V2, P81; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	177	195	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					341	350		10.1001/jama.2017.8978	http://dx.doi.org/10.1001/jama.2017.8978			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742911	Green Published			2022-12-28	WOS:000406296700014
J	Slomski, A				Slomski, Anita			Dual Strategy Increases Colorectal Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					323	323		10.1001/jama.2017.9527	http://dx.doi.org/10.1001/jama.2017.9527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4MY	28742908				2022-12-28	WOS:000426800100003
J	Gilarranz, LJ; Rayfield, B; Linan-Cembrano, G; Bascompte, J; Gonzalez, A				Gilarranz, Luis J.; Rayfield, Bronwyn; Linan-Cembrano, Gustavo; Bascompte, Jordi; Gonzalez, Andrew			Effects of network modularity on the spread of perturbation impact in experimental metapopulations	SCIENCE			English	Article							STABILITY; COMPARTMENTALIZATION; ECOLOGY; SYSTEMS; RISKS	Networks with a modular structure are expected to have a lower risk of global failure. However, this theoretical result has remained untested until now. We used an experimental microarthropod metapopulation to test the effect of modularity on the response to perturbation. We perturbed one local population and measured the spread of the impact of this perturbation, both within and between modules. Our results show the buffering capacity of modular networks. To assess the generality of our findings, we then analyzed a dynamical model of our system. We show that in the absence of perturbations, modularity is negatively correlated with metapopulation size. However, even when a small local perturbation occurs, this negative effect is offset by a buffering effect that protects the majority of the nodes from the perturbation.	[Gilarranz, Luis J.; Bascompte, Jordi] CSIC, Estn Biol Donana, Integrat Ecol Grp, C Americo Vespucio S-N, Seville 41092, Spain; [Gilarranz, Luis J.; Bascompte, Jordi] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Rayfield, Bronwyn; Gonzalez, Andrew] McGill Univ, Dept Biol, 1205 Docteur Penfield, Montreal, PQ H3A 1B1, Canada; [Linan-Cembrano, Gustavo] Univ Seville, CSIC, Inst Microelect Sevilla, C Americo Vespucio S-N, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Zurich; McGill University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Microelectronica de Sevilla (IMS-CNM); University of Sevilla	Gonzalez, A (corresponding author), McGill Univ, Dept Biol, 1205 Docteur Penfield, Montreal, PQ H3A 1B1, Canada.	andrew.gonzalez@mcgill.ca	Gonzalez, Andrew/F-2247-2010; Cembrano, Gustavo Liñán/AAG-6742-2019; Bascompte, Jordi/B-7596-2008; Rayfield, Bronwyn/ABB-8306-2021	Gonzalez, Andrew/0000-0001-6075-8081; Cembrano, Gustavo Liñán/0000-0003-1839-555X; Bascompte, Jordi/0000-0002-0108-6411; Rayfield, Bronwyn/0000-0003-1768-1300; Gilarranz, Luis J/0000-0002-3493-1335	European Research Council; Spanish Ministry of Education through a Formacion Personal Universitario Ph.D. fellowship; Natural Sciences and Engineering and Research Council (NSERC) of Canada; NSERC; Quebec Centre for Biodiversity Science; Canada Research Chair program; Liber Ero Chair in Conservation Biology; Killam Fellowship	European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Education through a Formacion Personal Universitario Ph.D. fellowship; Natural Sciences and Engineering and Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Centre for Biodiversity Science; Canada Research Chair program(Canada Research Chairs); Liber Ero Chair in Conservation Biology; Killam Fellowship	We thank H. McIntosh, G. L'Heureux, Y. Yan, and J. Yang for help with the experiment; J. Bustamante for making the link with the microelectronics institute; and M. A. Fortuna and D. Wechsler for comments on a previous draft. We also thank Z. Lindo, C. Albert, R. Maupetit, C. Atomei, K. O'Kane, and M. F. Martinez for advice and help in the lab. Research was funded by the European Research Council through an Advanced Grant (to J. B.), the Spanish Ministry of Education through a Formacion Personal Universitario Ph.D. fellowship (to L. J. G.), the Natural Sciences and Engineering and Research Council (NSERC) of Canada through a postdoctoral fellowship (to B. R.), and a Discovery Grant (to A. G.). A. G. is supported by NSERC, the Quebec Centre for Biodiversity Science, the Canada Research Chair program, the Liber Ero Chair in Conservation Biology, and a Killam Fellowship. All experimental data are presented in table S1.	Albert CH, 2017, CONSERV BIOL, V31, P1383, DOI 10.1111/cobi.12943; Albert EM, 2013, ECOL LETT, V16, P86, DOI 10.1111/ele.12061; BEDDINGTON JR, 1974, J THEOR BIOL, V47, P65, DOI 10.1016/0022-5193(74)90099-X; Bharti N, 2010, EPIDEMIOL INFECT, V138, P1308, DOI 10.1017/S0950268809991385; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Ferrari Matthew J, 2011, Interdiscip Perspect Infect Dis, V2011, P267049, DOI 10.1155/2011/267049; Fletcher RJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3572; Fortuna MA, 2011, P NATL ACAD SCI USA, V108, P19985, DOI 10.1073/pnas.1115960108; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; GARDNER MR, 1970, NATURE, V228, P784, DOI 10.1038/228784a0; Gerber LR, 2003, ECOL APPL, V13, pS47; Grilli J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12031; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hanski I., 1999, METAPOPULATION ECOLO; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056109; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; RAFFAELLI D, 1992, J ANIM ECOL, V61, P551, DOI 10.2307/5610; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Vos CC, 2008, J APPL ECOL, V45, P1722, DOI 10.1111/j.1365-2664.2008.01569.x	30	103	104	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		199	201		10.1126/science.aal4122	http://dx.doi.org/10.1126/science.aal4122			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706071				2022-12-28	WOS:000405391700045
J	Klenerman, P; Barnes, EJ				Klenerman, Paul; Barnes, Eleanor J.			Immunology taught by rats	SCIENCE			English	Editorial Material							CHRONIC HEPATITIS-C; VIRAL-HEPATITIS; RESPONSES		[Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford OX1 3SY, England; Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford OX1 3SY, England	University of Oxford; University of Oxford	Klenerman, P (corresponding author), Univ Oxford, Nuffield Dept Med, Translat Gastroenterol Unit, Oxford OX1 3SY, England.	paul.klenerman@ndm.ox.ac.uk		klenerman, paul/0000-0003-4307-9161; Barnes, Eleanor/0000-0002-0860-0831	Medical Research Council [MR/K010239/1] Funding Source: Medline; NIAID NIH HHS [P01 AI036535] Funding Source: Medline; Wellcome Trust [109965/Z/15/Z] Funding Source: Medline; National Institute for Health Research [NF-SI-0515-10005] Funding Source: researchfish; MRC [MR/K010239/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Billerbeck E, 2017, SCIENCE, V357, P204, DOI 10.1126/science.aal1962; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Davis MM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003385; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Knolle PA, 2014, GASTROENTEROLOGY, V146, P1193, DOI 10.1053/j.gastro.2013.12.036; Law LMJ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.79; Li GD, 2017, ANTIVIR RES, V142, P83, DOI 10.1016/j.antiviral.2017.02.014; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Pybus OG, 2016, CURR OPIN VIROL, V16, P1, DOI 10.1016/j.coviro.2015.10.002; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	14	5	5	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		129	130		10.1126/science.aao0184	http://dx.doi.org/10.1126/science.aao0184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706025				2022-12-28	WOS:000405391700021
J	Woolfson, DN; Baker, EG; Bartlett, GJ				Woolfson, Derek N.; Baker, Emily G.; Bartlett, Gail J.			How do miniproteins fold?	SCIENCE			English	Editorial Material							PROTEIN DESIGN; STABILITY		[Woolfson, Derek N.; Baker, Emily G.; Bartlett, Gail J.] Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England; [Woolfson, Derek N.] Univ Bristol, Sch Biochem, Med Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England; [Woolfson, Derek N.] Univ Bristol, Bristol BioDesign Inst, Life Sci Bldg,Tyndall Ave, Bristol BS8 1TQ, Avon, England	University of Bristol; University of Bristol; University of Bristol	Woolfson, DN (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.; Woolfson, DN (corresponding author), Univ Bristol, Sch Biochem, Med Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.; Woolfson, DN (corresponding author), Univ Bristol, Bristol BioDesign Inst, Life Sci Bldg,Tyndall Ave, Bristol BS8 1TQ, Avon, England.	d.n.woolfson@bristol.ac.uk	Woolfson, Dek Neil/ABC-4338-2021	Baker, Emily Grace/0000-0002-1593-5525; Woolfson, Derek/0000-0002-0394-3202	Biotechnology and Biological Sciences Research Council-ERASynBio grant [BB/M005615/1]; European Research Council [340764]; Royal Society Wolfson Research Merit Award [WM140008]; BBSRC [BB/M005615/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M005615/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council-ERASynBio grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	D.N.W. and E.G.B. are supported by a Biotechnology and Biological Sciences Research Council-ERASynBio grant (BB/M005615/1); D.N.W. and G.J.B. are supported by the European Research Council (340764); and D.N.W. holds a Royal Society Wolfson Research Merit Award (WM140008).	Baker EG, 2017, NAT CHEM BIOL, V13, P764, DOI 10.1038/nchembio.2380; Baker EG, 2015, NAT CHEM BIOL, V11, P221, DOI 10.1038/nchembio.1739; Brunette TJ, 2015, NATURE, V528, P580, DOI 10.1038/nature16162; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Finucane MD, 1999, BIOCHEMISTRY-US, V38, P11604, DOI 10.1021/bi990765n; Gellman SH, 2002, NAT STRUCT BIOL, V9, P408, DOI 10.1038/nsb0602-408; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Rocklin GJ, 2017, SCIENCE, V357, P168, DOI 10.1126/science.aan0693; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Sun MGF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600692; Taylor WR, 2009, STRUCTURE, V17, P1244, DOI 10.1016/j.str.2009.07.012; Thomson AR, 2014, SCIENCE, V346, P485, DOI 10.1126/science.1257452	15	5	5	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		133	134		10.1126/science.aan6864	http://dx.doi.org/10.1126/science.aan6864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706028	Green Submitted			2022-12-28	WOS:000405391700024
J	D'Avino, G; Souto, M; Masino, M; Fischer, JKH; Ratera, I; Fontrodona, X; Giovannetti, G; Verstraete, MJ; Painelli, A; Lunkenheimer, P; Veciana, J; Girlando, A				D'Avino, Gabriele; Souto, Manuel; Masino, Matteo; Fischer, Jonas K. H.; Ratera, Imma; Fontrodona, Xavier; Giovannetti, Gianluca; Verstraete, Matthieu J.; Painelli, Anna; Lunkenheimer, Peter; Veciana, Jaume; Girlando, Alberto			Conflicting evidence for ferroelectricity	NATURE			English	Letter							ROOM-TEMPERATURE FERROELECTRICITY		[D'Avino, Gabriele; Verstraete, Matthieu J.] Univ Liege, Nanomat QMAT CESAM, B-4000 Liege, Belgium; [D'Avino, Gabriele; Verstraete, Matthieu J.] European Theoret Spect Facil, B-4000 Liege, Belgium; [D'Avino, Gabriele] CNRS, Inst Neel, F-38042 Grenoble, France; [D'Avino, Gabriele] Grenoble Alpes Univ, F-38042 Grenoble, France; [D'Avino, Gabriele] Univ Mons, Lab Chem Novel Mat, B-7000 Mons, Belgium; [Souto, Manuel; Ratera, Imma; Veciana, Jaume] Inst Ciencia Mat Barcelona ICMAB CSIC CIBER BBN, E-08193 Cerdanyola Del Valles, Spain; [Masino, Matteo; Painelli, Anna; Girlando, Alberto] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43124 Parma, Italy; [Masino, Matteo; Painelli, Anna; Girlando, Alberto] INSTM UdR Parma, I-43124 Parma, Italy; [Fischer, Jonas K. H.; Lunkenheimer, Peter] Univ Augsburg, Ctr Elect Correlat & Magnetism, Expt Phys 5, D-86159 Augsburg, Germany; [Fontrodona, Xavier] Univ Girona, Serv Cient Tecn, Campus Montilivi, E-17071 Girona, Spain; [Giovannetti, Gianluca] CNR IOM Democritos Natl Simulat Ctr, I-34136 Trieste, Italy; [Giovannetti, Gianluca] Int Sch Adv Studies SISSA, I-34136 Trieste, Italy	University of Liege; European Theoretical Spectroscopy Facility (ETSF); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Mons; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB); University of Parma; University of Augsburg; Universitat de Girona; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); International School for Advanced Studies (SISSA)	D'Avino, G (corresponding author), Univ Liege, Nanomat QMAT CESAM, B-4000 Liege, Belgium.; D'Avino, G (corresponding author), European Theoret Spect Facil, B-4000 Liege, Belgium.; D'Avino, G (corresponding author), CNRS, Inst Neel, F-38042 Grenoble, France.; D'Avino, G (corresponding author), Grenoble Alpes Univ, F-38042 Grenoble, France.; D'Avino, G (corresponding author), Univ Mons, Lab Chem Novel Mat, B-7000 Mons, Belgium.	gabriele.davino@neel.cnrs.fr	D'Avino, Gabriele/G-5854-2011; Lunkenheimer, Peter/C-6196-2008; Souto, Manuel/D-1014-2017; Souto, Manuel/Q-2545-2019; Verstraete, Matthieu J/A-4063-2010; Fischer, Jonas K. H./P-2505-2014; Veciana, Jaume/A-2147-2008; Painelli, Anna/AAC-4357-2022; Ratera, Imma/E-2353-2014	D'Avino, Gabriele/0000-0002-5897-2924; Lunkenheimer, Peter/0000-0002-4525-1394; Souto, Manuel/0000-0003-3491-6984; Souto, Manuel/0000-0003-3491-6984; Verstraete, Matthieu J/0000-0001-6921-5163; Fischer, Jonas K. H./0000-0001-8129-0713; Veciana, Jaume/0000-0003-1023-9923; Painelli, Anna/0000-0002-3500-3848; Ratera, Imma/0000-0002-1464-9789				Blackburn AK, 2014, J AM CHEM SOC, V136, P17224, DOI 10.1021/ja509442t; Colthup N. B., 1990, INTRO INFRARED RAMAN, V90; D'Avino G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.237602; D'Avino G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.156407; Giovannetti G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266401; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Kobayashi K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237601; Lunkenheimer P, 2012, NAT MATER, V11, P755, DOI [10.1038/NMAT3400, 10.1038/nmat3400]; PECILE C, 1989, MOL CRYST LIQ CRYST, V171, P69, DOI 10.1080/00268948908065787; Ranzieri P, 2007, J PHYS CHEM B, V111, P12844, DOI 10.1021/jp075510v; Ranzieri P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.134115; Scott JF, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/02/021001; Tayi AS, 2015, NAT CHEM, V7, P281, DOI [10.1038/NCHEM.2206, 10.1038/nchem.2206]; Tayi AS, 2012, NATURE, V488, P485, DOI 10.1038/nature11395; TAYI SA, 2017, NATURE, V547, DOI DOI 10.1038/NATURE22802	16	10	10	5	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					E9	E13		10.1038/nature22801	http://dx.doi.org/10.1038/nature22801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703195	Green Submitted			2022-12-28	WOS:000405314500001
J	Kil, J; Lobarinas, E; Spankovich, C; Griffiths, SK; Antonelli, PJ; Lynch, ED; Le Prell, CG				Kil, Jonathan; Lobarinas, Edward; Spankovich, Christopher; Griffiths, Scott K.; Antonelli, Patrick J.; Lynch, Eric D.; Le Prell, Colleen G.			Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial	LANCET			English	Article							TEMPORARY THRESHOLD SHIFT; GLUTATHIONE-PEROXIDASE; EXPOSURE; GENERATION; TINNITUS; SINGLE	Background Noise-induced hearing loss is a leading cause of occupational and recreational injury and disease, and a major determinant of age-related hearing loss. No therapeutic agent has been approved for the prevention or treatment of this disorder. In animal models, glutathione peroxidase 1 (GPx1) activity is reduced after acute noise exposure. Ebselen, a novel GPx1 mimic, has been shown to reduce both temporary and permanent noise-induced hearing loss in preclinical studies. We assessed the safety and efficacy of ebselen for the prevention of noise-induced hearing loss in young adults in a phase 2 clinical trial. Methods In this single-centre, randomised, double-blind, placebo-controlled phase 2 trial, healthy adults aged 18-31 years were randomly assigned (1:1:1:1) at the University of Florida (Gainsville, FL, USA) to receive ebselen 200 mg, 400 mg, or 600 mg, or placebo orally twice daily for 4 days, beginning 2 days before a calibrated sound challenge (4 h of pre-recorded music delivered by insert earphones). Randomisation was done with an allocation sequence generated by an independent third party. The primary outcome was mean temporary threshold shift (TTS) at 4 kHz measured 15 min after the calibrated sound challenge by pure tone audiometry; a reduction of 50% in an ebselen dose group compared with the placebo group was judged to be clinically relevant. All participants who received the calibrated sound challenge and at least one dose of study drug were included in the efficacy analysis. All randomly assigned patients were included in the safety analysis. This trial is registered with ClinicalTrials.gov, number NCT01444846. Findings Between Jan 11, 2013, and March 24, 2014, 83 participants were enrolled and randomly assigned to receive ebselen 200 mg (n=22), 400 mg (n=20), or 600 mg (n=21), or placebo (n=20). Two participants in the 200 mg ebselen group were discontinued from the study before the calibrated sound challenge because they no longer met the inclusion criteria; these participants were excluded from the efficacy analysis. Mean TTS at 4 kHz was 1.32 dB (SE 0.91) in the 400 mg ebselen group compared with 4.07 dB (0.90) in the placebo group, representing a significant reduction of 68% (difference -2.75 dB, 95% CI -4.54 to -0.97; p=0.0025). Compared with placebo, TTS at 4 kHz was non-significantly reduced by 21% in the 200 mg ebselen group (3 . 23 dB [SE 0.91] vs 4 . 07 dB [0.90] in the placebo group; difference -0.84 dB, 95% CI -2.63 to 0.94; p=0.3542) and by 7% in the 600 mg ebselen group (3.81 dB [0.90] vs 4 . 07 dB [0.90] in the placebo group; difference -0.27, 95% CI -2.03 to 1.50; p=0.7659). Ebselen treatment was well tolerated across all doses and no significant differences were seen in any haematological, serum chemistry, or radiological assessments between the ebselen groups and the placebo group. Interpretation Treatment with ebselen was safe and effective at a dose of 400 mg twice daily in preventing a noise-induced TTS. These data lend support to a role of GPx1 activity in acute noise-induced hearing loss.	[Kil, Jonathan; Lynch, Eric D.] Sound Pharmaceut, Seattle, WA USA; [Lobarinas, Edward; Spankovich, Christopher; Griffiths, Scott K.; Le Prell, Colleen G.] Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL USA; [Antonelli, Patrick J.] Univ Florida, Dept Otolaryngol, Gainesville, FL USA; [Lobarinas, Edward; Le Prell, Colleen G.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX USA; [Spankovich, Christopher] Univ Mississippi, Med Ctr, Dept Otolaryngol & Communicat Sci, Jackson, MS 39216 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Dallas; University of Mississippi; University of Mississippi Medical Center	Kil, J (corresponding author), Pharmaceut, Seattle, WA 98103 USA.	jkil@soundpharma.com		Le Prell, Colleen/0000-0002-6161-3033	Sound Pharmaceuticals	Sound Pharmaceuticals	Sound Pharmaceuticals.r Funding for this study was provided by Sound Pharmaceuticals, through a sponsored research contract to the University of Florida, with salary support for SKG, EDL, CS, PJA, and CGLP. We thank David Donley at EMB Statistical Solutions for biostatistical analysis, and Leigh Anne Marshall and Lydia Owens at the University of Florida, who provided clinical trial coordination services. We also thank Angela Fulbright, Diana Guercio, Vicki Ledon, Karlee Martin, Lindsay May, Erika Ortiz, and Caitlin Simmons for contributions to audiometric testing.	Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Campbell K, 2016, OTOL NEUROTOL, V37, pE263, DOI 10.1097/MAO.0000000000001135; Clark WW, 1999, JAMA-J AM MED ASSOC, V281, P1658, DOI 10.1001/jama.281.17.1658; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Grantham MAM, 2012, SPRINGER HANDB AUDIT, V40, P27, DOI 10.1007/978-1-4419-9523-0_3; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Jensen JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125160; Kil J, 2007, HEARING RES, V226, P44, DOI 10.1016/j.heares.2006.08.006; Kim SJ, 2009, HEARING RES, V251, P70, DOI 10.1016/j.heares.2009.03.003; Kirchner DB, 2012, J OCCUP ENVIRON MED, V54, P106, DOI 10.1097/JOM.0b013e318242677d; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Le Prell CG, 2011, J ACOUST SOC AM, V130, pEL142, DOI 10.1121/1.3630017; Le Prell CG, 2016, AUDIOLOGY NEUROTOL E, V6, P20, DOI 10.1159/000446600; Le Prell CG, 2012, EAR HEARING, V33, pE44, DOI 10.1097/AUD.0b013e31825f9d89; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; LONSBURYMARTIN BL, 1987, J ACOUST SOC AM, V81, P1507, DOI 10.1121/1.394503; Lynch ED, 2004, LARYNGOSCOPE, V114, P333, DOI 10.1097/00005537-200402000-00029; Lynch Eric, 2009, Seminars in Hearing, V30, P47, DOI 10.1055/s-0028-1111106; McFadden Sandra L., 2001, Noise Health, V3, P49; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Pourbakht A, 2003, HEARING RES, V181, P100, DOI 10.1016/S0378-5955(03)00178-3; 박용호, 2005, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V48, P1211; Ryan AF, 2016, OTOL NEUROTOL, V37, pE271, DOI 10.1097/MAO.0000000000001071; Rybak LP, 1999, LARYNGOSCOPE, V109, P1740, DOI 10.1097/00005537-199911000-00003; Swanepoel D, 2015, HEARING LOSS DUE REC; Wang Y, 2012, JARO-J ASSOC RES OTO, V13, P505, DOI 10.1007/s10162-012-0329-0; Wen Xianzhong, 2014, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V32, P568; Yamasoba T, 2005, NEUROSCI LETT, V380, P234, DOI 10.1016/j.neulet.2005.01.047	29	144	151	1	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					969	979		10.1016/S0140-6736(17)31791-9	http://dx.doi.org/10.1016/S0140-6736(17)31791-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF2SE	28716314				2022-12-28	WOS:000408746300026
J	Shyer, AE; Rodrigues, AR; Schroeder, GG; Kassianidou, E; Kumar, S; Harland, RM				Shyer, Amy E.; Rodrigues, Alan R.; Schroeder, Grant G.; Kassianidou, Elena; Kumar, Sanjay; Harland, Richard M.			Emergent cellular self-organization and mechanosensation initiate follicle pattern in the avian skin	SCIENCE			English	Article							3D COLLAGEN MATRICES; BETA-CATENIN; TISSUE MORPHOGENESIS; PERIODIC PATTERNS; INDUCTION; FIBROBLASTS; FORCES; MODEL; SHAPE	The spacing of hair in mammals and feathers in birds is one of the most apparent morphological features of the skin. This pattern arises when uniform fields of progenitor cells diversify their molecular fate while adopting higher-order structure. Using the nascent skin of the developing chicken embryo as a model system, we find that morphological and molecular symmetries are simultaneously broken by an emergent process of cellular self-organization. The key initiators of heterogeneity are dermal progenitors, which spontaneously aggregate through contractility-driven cellular pulling. Concurrently, this dermal cell aggregation triggers the mechanosensitive activation of beta-catenin in adjacent epidermal cells, initiating the follicle gene expression program. Taken together, this mechanism provides a means of integrating mechanical and molecular perspectives of organ formation.	[Shyer, Amy E.; Rodrigues, Alan R.; Schroeder, Grant G.; Harland, Richard M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rodrigues, Alan R.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Kassianidou, Elena; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; University of California System; University of California Berkeley	Shyer, AE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ashyer@berkeley.edu		Harland, Richard M./0000-0001-8247-4880	Miller Institute; Howard Hughes Medical Institute International Student fellowship; Siebel Scholars Program; University of California, Berkeley, Summer Undergraduate Research Fellowship; endowed chair funds; C. H. Li Distinguished Professor funds; NIH [R01 GM42341, R21 EB016359, R01 NS074831]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074831] Funding Source: NIH RePORTER	Miller Institute; Howard Hughes Medical Institute International Student fellowship; Siebel Scholars Program; University of California, Berkeley, Summer Undergraduate Research Fellowship; endowed chair funds; C. H. Li Distinguished Professor funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Miller and C. Exner for feedback on the manuscript; J. Tucher, H. Miller, and R. Parish for assistance with experiments; and G. Oster for his pioneering theories and thoughtful discussion. We gratefully acknowledge the support of the Miller Institute (A.E.S.); the Howard Hughes Medical Institute International Student fellowship and Siebel Scholars Program (E.K.); University of California, Berkeley, Summer Undergraduate Research Fellowship (G.G.S.); endowed chair funds; C. H. Li Distinguished Professor funds; and NIH R01 GM42341 (R.M.H.) and NIH R21 EB016359 and R01 NS074831 (S.K.). A.E.S. and A. R. R. designed the experiments, with additional contributions from G.G.S. A.E.S. and G.G.S. conducted the experiments. E.K. contributed the polyacrylamide gels, with technical and conceptual guidance from S.K. A.R.R. and A.E.S. wrote and prepared the manuscript, with assistance from G.G.S., R.M.H., and S.K.	Beningo KA, 2006, ARCH BIOCHEM BIOPHYS, V456, P224, DOI 10.1016/j.abb.2006.09.025; Brau F, 2011, NAT PHYS, V7, P56, DOI 10.1038/NPHYS1806; Brunet T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3821; CHARTIER L, 1991, CELL MOTIL CYTOSKEL, V18, P26, DOI 10.1002/cm.970180104; da Rocha-Azevedo B, 2013, EXP CELL RES, V319, P2440, DOI 10.1016/j.yexcr.2013.05.003; da Rocha-Azevedo B, 2013, EXP CELL RES, V319, P546, DOI 10.1016/j.yexcr.2012.10.005; DESBIENS X, 1992, INT J DEV BIOL, V36, P373; Fernandez-Sanchez ME, 2015, NATURE, V523, P92, DOI 10.1038/nature14329; HARRIS AK, 1984, J EMBRYOL EXP MORPH, V80, P1; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Michon F, 2008, DEVELOPMENT, V135, P2797, DOI 10.1242/dev.018341; Munjal A, 2015, NATURE, V524, P351, DOI 10.1038/nature14603; Murray J D, 1984, IMA J Math Appl Med Biol, V1, P51, DOI 10.1093/imammb/1.1.51; Noramly S, 1999, DEVELOPMENT, V126, P3509; Noramly S, 1998, DEVELOPMENT, V125, P3775; OSTER GF, 1983, J EMBRYOL EXP MORPH, V78, P83; PERELSON AS, 1986, J MATH BIOL, V24, P525, DOI 10.1007/BF00275682; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Widelitz RB, 1999, J INVEST DERM SYMP P, V4, P302, DOI 10.1038/sj.jidsp.5640234	25	123	123	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					811	815		10.1126/science.aai7868	http://dx.doi.org/10.1126/science.aai7868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28705989	Green Accepted			2022-12-28	WOS:000408327900045
J	David, SV				David, Stephen V.			COGNITION Neurons couple up to make	NATURE			English	Editorial Material							CORTEX		[David, Stephen V.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA	Oregon Health & Science University	David, SV (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	davids@ohsu.edu						Abeles M., 1982, LOCAL CORTICAL CIRCU; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Runyan CA, 2017, NATURE, V548, P92, DOI 10.1038/nature23020; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	9	0	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665					35	36		10.1038/nature23100	http://dx.doi.org/10.1038/nature23100			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC4SU	28723899				2022-12-28	WOS:000406831700028
J	Moberly, T				Moberly, Tom			Should we allow overseas visitors free access to NHS services?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tmoberly@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2017	358								j3665	10.1136/bmj.j3665	http://dx.doi.org/10.1136/bmj.j3665			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0CG	28768636				2022-12-28	WOS:000407206800007
J	Song, L; Maalouf, NM				Song, Li; Maalouf, Naim M.			24-Hour Urine Calcium in the Evaluation and Management of Nephrolithiasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPERCALCIURIA; PATHOGENESIS; RISK		[Song, Li] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA; [Maalouf, Naim M.] Univ Texas Southwestern Med Ctr Dallas, Div Mineral Metab, Dept Internal Med, Dallas, TX 75390 USA; [Maalouf, Naim M.] Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Maalouf, NM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	naim.maalouf@utsouthwestern.edu						Centers for Medicare and Medicaid Services, CLIN LAB FEE SCHED; Jones AN, 2012, OSTEOPOROSIS INT, V23, P553, DOI 10.1007/s00198-011-1580-7; Maalouf NM, 2011, J CLIN ENDOCR METAB, V96, P3733, DOI 10.1210/jc.2011-1531; Moe OW, 2005, J AM SOC NEPHROL, V16, P729, DOI 10.1681/ASN.2004100888; Pak CYC, 2011, KIDNEY INT, V80, P777, DOI 10.1038/ki.2011.227; Parvin M, 2011, UROL J, V8, P99; Pearle MS, 2014, J UROLOGY, V192, P316, DOI 10.1016/j.juro.2014.05.006; SAKHAEE K, 1993, J UROLOGY, V150, P310, DOI 10.1016/S0022-5347(17)35468-X; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Worcester EM, 2008, SEMIN NEPHROL, V28, P120, DOI 10.1016/j.semnephrol.2008.01.005	10	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					474	475		10.1001/jama.2017.7085	http://dx.doi.org/10.1001/jama.2017.7085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763529				2022-12-28	WOS:000406659800019
J	Fralick, M; Avorn, J; Kesselheim, AS				Fralick, Michael; Avorn, Jerry; Kesselheim, Aaron S.			The Price of Crossing the Border for Medications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fralick, Michael; Avorn, Jerry; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Fralick, Michael; Avorn, Jerry; Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02115 USA; [Fralick, Michael] Univ Toronto, Clinician Scientist Training Program, Toronto, ON, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto	Fralick, M (corresponding author), Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.; Fralick, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Fralick, M (corresponding author), Univ Toronto, Clinician Scientist Training Program, Toronto, ON, Canada.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Califf RM, 2017, COMMUNICATION; Health Canada, INSP PROGR ANN INSP; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Sanders B, AFFORDABLE SAFE PRES; Vega Ana D, 2016, Manag Care, V25, P41	5	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					311	313		10.1056/NEJMp1704489	http://dx.doi.org/10.1056/NEJMp1704489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28745989				2022-12-28	WOS:000406295000002
J	Peng, Y; Zhang, M; Zheng, LJ; Liang, Q; Li, HZ; Chen, JT; Guo, HY; Oshina, SY; Chen, YZ; Zhao, X; Wu, XQ; Liu, B; Mitani, S; Yu, JS; Xue, D				Peng, Yu; Zhang, Man; Zheng, Lingjun; Liang, Qian; Li, Hanzeng; Chen, Jeng-Ting; Guo, Hongyan; Oshina, Sawako Y.; Chen, Yu-Zen; Zhao, Xiang; Wu, Xiaoqi; Liu, Bin; Mitani, Shohei; Yu, Jau-Song; Xue, Ding			Cysteine protease cathepsin B mediates radiation-induced bystander effects	NATURE			English	Article							DAMAGE-INDUCED APOPTOSIS; CAENORHABDITIS-ELEGANS; C-ELEGANS; CANCER-THERAPY; DNA-DAMAGE; LIFE-SPAN; P53; HOMOLOG; PROLIFERATION; IRRADIATION	The radiation-induced bystander effect (RIBE) refers to a unique process in which factors released by irradiated cells or tissues exert effects on other parts of the animal not exposed to radiation, causing genomic instability, stress responses and altered apoptosis or cell proliferation(1-3). Although RIBEs have important implications for radioprotection, radiation safety and radiotherapy, the molecular identities of RIBE factors and their mechanisms of action remain poorly understood. Here we use Caenorhabditis elegans as a model in which to study RIBEs, and identify the cysteine protease CPR4, a homologue of human cathepsin B, as the first RIBE factor in nematodes, to our knowledge. CPR-4 is secreted from animals irradiated with ultraviolet or ionizing gamma rays, and is the major factor in the conditioned medium that leads to the inhibition of cell death and increased embryonic lethality in unirradiated animals. Moreover, CPR-4 causes these effects and stress responses at unexposed sites distal to the irradiated tissue. The activity of CPR-4 is regulated by the p53 homologue CEP-1 in response to radiation, and CPR-4 seems to exert RIBEs by acting through the insulin-like growth factor receptor DAF-2. Our study provides crucial insights into RIBEs, and will facilitate the identification of additional RIBE factors and their mechanisms of action.	[Peng, Yu; Zhang, Man; Liang, Qian; Guo, Hongyan; Zhao, Xiang; Xue, Ding] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Peng, Yu; Zhang, Man; Liang, Qian; Guo, Hongyan; Zhao, Xiang; Xue, Ding] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing 100084, Peoples R China; [Zheng, Lingjun; Li, Hanzeng; Chen, Yu-Zen; Wu, Xiaoqi; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Zheng, Lingjun; Wu, Xiaoqi; Liu, Bin] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Fujian, Peoples R China; [Chen, Jeng-Ting; Yu, Jau-Song] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan 333, Taiwan; [Chen, Jeng-Ting; Yu, Jau-Song] Chang Gung Mem Hosp Linkou, Liver Res Ctr, Taoyuan 333, Taiwan; [Oshina, Sawako Y.; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Oshina, Sawako Y.; Mitani, Shohei] Japan Sci & Technol Agcy JST, CREST, Tokyo 1628666, Japan	Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; University of Colorado System; University of Colorado Boulder; Fujian Agriculture & Forestry University; Chang Gung University; Chang Gung Memorial Hospital; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Xue, D (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Xue, D (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing 100084, Peoples R China.; Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu	Chen, Yu-Zen/Q-5671-2017; Li, Hanzeng/T-7473-2019	Chen, Yu-Zen/0000-0001-9154-2312; Yu, Jau-Song/0000-0002-4295-983X; Zhao, Xiang/0000-0003-3067-3970	National Basic Research Program of China [2013CB945602]; National Scientific and Technological Major Project of China [2013ZX10002-002]; China Scholarship Council; Fujian Agriculture and Forestry University; Tsinghua University-Peking University Center for Life Sciences; NIH [R35 GM118188]; Grants-in-Aid for Scientific Research [17K18135] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118188] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Scientific and Technological Major Project of China; China Scholarship Council(China Scholarship Council); Fujian Agriculture and Forestry University; Tsinghua University-Peking University Center for Life Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Tyler for help with localized irradiation experiments and T. Su for discussion. This work was supported by National Basic Research Program of China (2013CB945602), National Scientific and Technological Major Project of China (2013ZX10002-002), fellowships from China Scholarship Council and Fujian Agriculture and Forestry University (L.Z.) and Tsinghua University-Peking University Center for Life Sciences (Q.L. and X.Z.), and NIH grant R35 GM118188 (D.X.).	BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bertucci A, 2009, J RADIAT RES, V50, pA49, DOI 10.1269/jrr.08132S; BRENNER S, 1974, GENETICS, V77, P71; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Klokov D, 2013, ONCOGENE, V32, P479, DOI 10.1038/onc.2012.64; Koturbash I, 2008, INT J RADIAT ONCOL, V70, P554, DOI 10.1016/j.ijrobp.2007.09.039; Larminie CGC, 1996, DNA CELL BIOL, V15, P75, DOI 10.1089/dna.1996.15.75; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lorimore SA, 2013, RADIAT RES, V179, P406, DOI 10.1667/RR3158.2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Mothersill C, 2006, CURR CANCER DRUG TAR, V6, P447, DOI 10.2174/156800906777723976; Nikjoo H, 2004, HUM EXP TOXICOL, V23, P81, DOI 10.1191/0960327104ht422oa; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paquet C, 2005, LEUKEMIA, V19, P784, DOI 10.1038/sj.leu.2403717; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Pepper ASR, 2003, GENETICS, V163, P115; Perrin AJ, 2013, CELL DEATH DIFFER, V20, P97, DOI 10.1038/cdd.2012.101; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; POOLE AR, 1978, NATURE, V273, P545, DOI 10.1038/273545a0; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; RECKLIES AD, 1980, CANCER RES, V40, P550; Rzeszowska-Wolny J, 2009, EUR J PHARMACOL, V625, P156, DOI 10.1016/j.ejphar.2009.07.028; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5	39	45	52	11	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					458	+		10.1038/nature23284	http://dx.doi.org/10.1038/nature23284			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28723894	Green Accepted			2022-12-28	WOS:000406358300037
J	Moberly, T				Moberly, Tom			Advertisements for medical vacancies increase by 8% in a year	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j3610	10.1136/bmj.j3610	http://dx.doi.org/10.1136/bmj.j3610			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UW	28747310				2022-12-28	WOS:000406765900015
J	Jain, N; Hwang, T; Franklin, JM; Kesselheim, AS				Jain, Nina; Hwang, Thomas; Franklin, Jessica M.; Kesselheim, Aaron S.			Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jain, Nina; Hwang, Thomas; Franklin, Jessica M.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Kesselheim, AS (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org		Hwang, Thomas/0000-0003-0717-1497	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Engelberg Foundation	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Engelberg Foundation	This work was supported by the Laura and John Arnold Foundation. Dr Kesselheim is a Greenwall Faculty Scholar and his work is also funded by the Harvard Program in Therapeutic Science and the Engelberg Foundation.	Kesselheim AS, 2015, JAMA-J AM MED ASSOC, V314, P1687, DOI 10.1001/jama.2015.11845; Ridley DB, 2016, HEALTH AFFAIR, V35, P776, DOI 10.1377/hlthaff.2015.1314; US Food and Drug Administration, TROP DIS PRIOR REV V; US Food and Drug Administration, FDA APPR VACC PREV C	4	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					388	389		10.1001/jama.2017.7467	http://dx.doi.org/10.1001/jama.2017.7467			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742898	Green Published			2022-12-28	WOS:000406296700021
J	Granich, R; Williams, B; Montaner, J; Zuniga, JM				Granich, Reuben; Williams, Brian; Montaner, Julio; Zuniga, Jose M.			90-90-90 and ending AIDS: necessary and feasible	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY		[Granich, Reuben; Zuniga, Jose M.] Int Assoc Providers AIDS Care, Washington, DC 20036 USA; [Williams, Brian] Stellenbosch Univ, South African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa; [Montaner, Julio] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada	Stellenbosch University; B.C. Centre for Excellence in HIV/AIDS	Granich, R (corresponding author), Int Assoc Providers AIDS Care, Washington, DC 20036 USA.	rgranich@iapac.org		Williams, Brian/0000-0002-3174-4876	Public Health Agency of Canada; BC Ministry of Health; Canadian Institutes of Health Research/Genome BC; US National Institutes of Health; Johnson Johnson; Merck Canada	Public Health Agency of Canada; BC Ministry of Health; Canadian Institutes of Health Research/Genome BC(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck Canada(Merck & Company)	RG, BW, and JMZ declare no competing interests. JM has received research grants paid to his institution from the Public Health Agency of Canada, BC Ministry of Health, Canadian Institutes of Health Research/Genome BC, the US National Institutes of Health, Johnson & Johnson, and Merck Canada; and has served on the Teva Scientific advisory board participant in 2015, providing feedback as an expert in HIV.	[Anonymous], 2017, AIDSINFO ONLIN DAT; [Anonymous], 2016, FACT SHEET LAT STAT; Cahn P, 2017, CURR OPIN HIV AIDS, V12, P318, DOI 10.1097/COH.0000000000000388; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; International Association of Providers in AIDS Care, 2017, REC RAP EXP HIV SELF; Margolis DA, 2015, CURR OPIN HIV AIDS, V10, P246, DOI 10.1097/COH.0000000000000169; Medicins Sans Frontieres, 1999, PEOPL AIDS DYING BEC; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Shilts R., 1987, BAND PLAYED POLITICS; Stover J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154893; The AIDS Support Organization (TASO), 2017, TASO ACH; Treatment Action Campaign South Africa, 2010, FIGHT OUR LIV HIST T; UNAIDS, 2014, 90 90 90 AMB TREATM, P40; UNAIDS, 2015, INV HIV PREV; WHO, 2017, WHO PROGR REP HIV	17	35	37	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					341	343						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28745591				2022-12-28	WOS:000405911300007
J	Cohen, J				Cohen, Jon			PUBLIC HEALTH Zika rewrites maternal immunization ethics	SCIENCE			English	News Item																			0	8	8	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					241	241		10.1126/science.357.6348.241	http://dx.doi.org/10.1126/science.357.6348.241			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729493				2022-12-28	WOS:000405901600017
J	Mervis, J				Mervis, Jeffrey			US SCIENCE POLICY Trump's science shop is small and waiting for leadership	SCIENCE			English	News Item																			0	0	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		117	117		10.1126/science.357.6347.117	http://dx.doi.org/10.1126/science.357.6347.117			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706018				2022-12-28	WOS:000405391700014
J	Kitambi, SS; Toledo, EM; Usoskin, D; Wee, S; Harisankar, A; Svensson, R; Sigmundsson, K; Kalderen, C; Niklasson, M; Kundu, S; Aranda, S; Westermark, B; Uhrbom, L; Andang, M; Damberg, P; Nelander, S; Arenas, E; Artursson, P; Walfridsson, J; Nilsson, KF; Hammarstrom, LGJ; Ernfors, P				Kitambi, Satish Srinivas; Toledo, Enrique M.; Usoskin, Dmitry; Wee, Shimei; Harisankar, Aditya; Svensson, Richard; Sigmundsson, Kristmundur; Kalderen, Christina; Niklasson, Mia; Kundu, Soumi; Aranda, Sergi; Westermark, Bengt; Uhrbom, Lene; Andang, Michael; Damberg, Peter; Nelander, Sven; Arenas, Ernest; Artursson, Per; Walfridsson, Julian; Nilsson, Karin Forsberg; Hammarstrom, Lars G. J.; Ernfors, Patrik			RETRACTION: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule (Retraction of Vol 157, Pg 313, 2014)	CELL			English	Retraction												patrik.ernfors@ki.se	Andäng, Michael/GRE-9898-2022; Arenas, Ernest/AAO-5231-2020; Kitambi, Satish S/J-4521-2013	Arenas, Ernest/0000-0003-0197-6577; 				Kitambi SS, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.021	1	1	1	4	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					407	407		10.1016/j.cell.2017.06.044	http://dx.doi.org/10.1016/j.cell.2017.06.044			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28709005	Bronze			2022-12-28	WOS:000405493900018
J	Obrist, D; Agnan, Y; Jiskra, M; Olson, CL; Colegrove, DP; Hueber, J; Moore, CW; Sonke, JE; Helmig, D				Obrist, Daniel; Agnan, Yannick; Jiskra, Martin; Olson, Christine L.; Colegrove, Dominique P.; Hueber, Jacques; Moore, Christopher W.; Sonke, Jeroen E.; Helmig, Detlev			Tundra uptake of atmospheric elemental mercury drives Arctic mercury pollution	NATURE			English	Article							MASS-INDEPENDENT FRACTIONATION; GASEOUS MERCURY; GLOBAL CHANGE; FLUXES; DEPOSITION; DEPLETION; CLIMATE; TRENDS; SOILS; SNOW	Anthropogenic activities have led to large-scale mercury (Hg) pollution in the Arctic(1-6). It has been suggested that sea-salt-induced chemical cycling of Hg (through 'atmospheric mercury depletion events', or AMDEs) and wet deposition via precipitation are sources of Hg to the Arctic in its oxidized form (Hg(ii)). However, there is little evidence for the occurrence of AMDEs outside of coastal regions, and their importance to net Hg deposition has been questioned(2,7). Furthermore, wet-deposition measurements in the Arctic showed some of the lowest levels of Hg deposition via precipitation worldwide(8), raising questions as to the sources of high Arctic Hg loading. Here we present a comprehensive Hg-deposition mass-balance study, and show that most of the Hg (about 70%) in the interior Arctic tundra is derived from gaseous elemental Hg (Hg(0)) deposition, with only minor contributions from the deposition of Hg(ii) via precipitation or AMDEs. We find that deposition of Hg(0)-the form ubiquitously present in the global atmosphere-occurs throughout the year, and that it is enhanced in summer through the uptake of Hg(0) by vegetation. Tundra uptake of gaseous Hg(0) leads to high soil Hg concentrations, with Hg masses greatly exceeding the levels found in temperate soils. Our concurrent Hg stable isotope measurements in the atmosphere, snowpack, vegetation and soils support our finding that Hg(0) dominates as a source to the tundra. Hg concentration and stable isotope data from an inland-to-coastal transect show high soil Hg concentrations consistently derived from Hg(0), suggesting that the Arctic tundra might be a globally important Hg sink. We suggest that the high tundra soil Hg concentrations might also explain why Arctic rivers annually transport large amounts of Hg to the Arctic Ocean(9-11).	[Obrist, Daniel] Univ Massachusetts, Dept Environm Earth & Atmospher Sci, Lowell, MA 01854 USA; [Obrist, Daniel; Agnan, Yannick; Olson, Christine L.; Moore, Christopher W.] Desert Res Inst, Div Atmospher Sci, 2215 Raggio Pkwy, Reno, NV 89512 USA; [Agnan, Yannick] Sorbonne Univ, Milieux Environm Transferts & Interact Hydrosyst, UMR 7619, UPMC,CNRS,EPHE, 4 Pl Jussieu, F-75252 Paris, France; [Jiskra, Martin; Sonke, Jeroen E.] Univ Toulouse, CNRS, OMP, Geosci Environm Toulouse, 14 Ave Edouard Belin, F-31400 Toulouse, France; [Colegrove, Dominique P.; Hueber, Jacques; Helmig, Detlev] Univ Colorado, Inst Arctic & Alpine Res INSTAAR, 4001 Discovery Dr, Boulder, CO 80309 USA; [Moore, Christopher W.] GTI, 1700 South Mt Prospect Rd, Des Plaines, IL 60018 USA	University of Massachusetts System; University of Massachusetts Lowell; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Colorado System; University of Colorado Boulder	Obrist, D (corresponding author), Univ Massachusetts, Dept Environm Earth & Atmospher Sci, Lowell, MA 01854 USA.; Obrist, D (corresponding author), Desert Res Inst, Div Atmospher Sci, 2215 Raggio Pkwy, Reno, NV 89512 USA.	Daniel_obrist@uml.edu	Agnan, Yannick/E-9438-2012; Jiskra, Martin/A-5487-2013	Agnan, Yannick/0000-0002-9349-6310; Jiskra, Martin/0000-0003-4991-8122; Sonke, Jeroen/0000-0001-7146-3035	US National Science Foundation (NSF) [PLR 1304305]; NSF [CHN 1313755]; US Department of Energy [DE-SC0014275]; H2020 Marie Sklodowska-Curie grant [657195]; European Research Council [ERC-2010-StG_20091028]; CNRS-INSU-CAF (PARCS project); Office of Polar Programs (OPP) [1304202, 1739567] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); H2020 Marie Sklodowska-Curie grant; European Research Council(European Research Council (ERC)European Commission); CNRS-INSU-CAF (PARCS project); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Toolik Field Station and Polar Field Services staff for their support in setting up the field site and maintaining its operation for two years, with special thanks to J. Timm. We thank O. Dillon and C. Pearson for support with laboratory analyses; A. Steffen and S. Brooks for providing additional instrumentation; J. Chmeleff for support with inductively coupled plasma mass spectrometry; and R. Kreidberg and J. Arnone for editorial and technical assistance in manuscript preparation. The project was funded primarily by a US National Science Foundation (NSF) award (PLR 1304305), with additional support provided by further NSF (CHN 1313755) and US Department of Energy (DE-SC0014275) awards. The Hg isotope work was funded by H2020 Marie Sklodowska-Curie grant agreement no. 657195 to M. J., and European Research Council grant ERC-2010-StG_20091028 and CNRS-INSU-CAF funding (PARCS project) to J.E.S.	Agnan Y, 2016, ENVIRON SCI TECHNOL, V50, P507, DOI 10.1021/acs.est.5b04013; AMAP, 2011, MERC ARCT; Amos HM, 2015, ENVIRON SCI TECHNOL, V49, P4036, DOI 10.1021/es5058665; Arctic Climate Impact Assessment, 2004, IMP WARM ARCT ARCT C, DOI DOI 10.1371/journal.pone.0028900; Bergquist BA, 2007, SCIENCE, V318, P417, DOI 10.1126/science.1148050; Biswas A, 2008, ENVIRON SCI TECHNOL, V42, P8303, DOI 10.1021/es801444b; Castro Mark S., 2016, Atmosphere, V7, DOI 10.3390/atmos7090110; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Cole AS, 2013, ATMOS CHEM PHYS, V13, P1535, DOI 10.5194/acp-13-1535-2013; Dastoor AP, 2014, ENVIRON SCI TECHNOL, V48, P1707, DOI 10.1021/es404473e; Demers JD, 2013, GLOBAL BIOGEOCHEM CY, V27, P222, DOI 10.1002/gbc.20021; Dietz R, 2006, ENVIRON SCI TECHNOL, V40, P1120, DOI 10.1021/es051636z; Dietz R, 2006, ENVIRON SCI TECHNOL, V40, P5911, DOI 10.1021/es0609856; Douglas TA, 2008, ENVIRON SCI TECHNOL, V42, P1542, DOI 10.1021/es070502d; Douglas TA, 2012, ENVIRON CHEM, V9, P321, DOI 10.1071/EN11140; Edwards GC, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005187; Enrico M, 2016, ENVIRON SCI TECHNOL, V50, P2405, DOI 10.1021/acs.est.5b06058; Fain X, 2013, BIOGEOSCIENCES, V10, P3793, DOI 10.5194/bg-10-3793-2013; Fisher JA, 2012, NAT GEOSCI, V5, P499, DOI 10.1038/ngeo1478; Fitzgerald WF, 2005, ENVIRON SCI TECHNOL, V39, P557, DOI 10.1021/es049128x; Fritsche J, 2008, ATMOS ENVIRON, V42, P2922, DOI 10.1016/j.atmosenv.2007.12.055; Fu XW, 2014, J ANAL ATOM SPECTROM, V29, P841, DOI 10.1039/c3ja50356a; Hararuk O, 2013, BIOGEOSCIENCES, V10, P2393, DOI 10.5194/bg-10-2393-2013; Jiskra M, 2015, ENVIRON SCI TECHNOL, V49, P7188, DOI 10.1021/acs.est.5b00742; Johnson KP, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009893; Krabbenhoft DP, 2013, SCIENCE, V341, P1457, DOI 10.1126/science.1242838; Lyman SN, 2012, NAT GEOSCI, V5, P114, DOI [10.1038/NGEO1353, 10.1038/ngeo1353]; Moore CW, 2013, ATMOS ENVIRON, V69, P231, DOI 10.1016/j.atmosenv.2012.12.020; National Atmospheric Deposition Program, ANN DAT ALL MDN SIT; Obrist D, 2011, ENVIRON SCI TECHNOL, V45, P3974, DOI 10.1021/es104384m; Obrist D, 2014, ENVIRON SCI TECHNOL, V48, P2242, DOI 10.1021/es4048297; Outridge PM, 2002, ARCTIC, V55, P123; Polyakov IV, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL011111; Schuster PF, 2011, ENVIRON SCI TECHNOL, V45, P9262, DOI 10.1021/es202068b; Selin NE, 2014, ENVIRON TOXICOL CHEM, V33, P1202, DOI 10.1002/etc.2374; Seok B, 2009, BIOGEOCHEMISTRY, V95, P95, DOI 10.1007/s10533-009-9302-3; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; Sherman LS, 2010, NAT GEOSCI, V3, P173, DOI 10.1038/NGEO758; Smith D.B., 2013, DATA SERIES, V801; Smith-Downey NV, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001124; Sprovieri F, 2016, ATMOS CHEM PHYS, V16, P11915, DOI 10.5194/acp-16-11915-2016; Steffen A, 2008, ATMOS CHEM PHYS, V8, P1445, DOI 10.5194/acp-8-1445-2008; Zhang LM, 2009, ATMOS ENVIRON, V43, P5853, DOI 10.1016/j.atmosenv.2009.08.019; Zheng W, 2016, GLOBAL BIOGEOCHEM CY, V30, P1475, DOI 10.1002/2015GB005323	44	226	234	36	469	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					201	+		10.1038/nature22997	http://dx.doi.org/10.1038/nature22997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703199	Green Accepted			2022-12-28	WOS:000405314500035
J	Richner, JM; Jagger, BW; Shan, C; Fontes, CR; Dowd, KA; Cao, B; Himansu, S; Caine, EA; Nunes, BTD; Medeiros, DBA; Muruato, AE; Foreman, BM; Luo, HL; Wang, T; Barrett, AD; Weaver, SC; Vasconcelos, PFC; Rossi, SL; Ciaramella, G; Mysorekar, IU; Pierson, TC; Shi, PY; Diamond, MS				Richner, Justin M.; Jagger, Brett W.; Shan, Chao; Fontes, Camila R.; Dowd, Kimberly A.; Cao, Bin; Himansu, Sunny; Caine, Elizabeth A.; Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Muruato, Antonio E.; Foreman, Bryant M.; Luo, Huanle; Wang, Tian; Barrett, Alan D.; Weaver, Scott C.; Vasconcelos, Pedro F. C.; Rossi, Shannan L.; Ciaramella, Giuseppe; Mysorekar, Indira U.; Pierson, Theodore C.; Shi, Pei-Yong; Diamond, Michael S.			Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease	CELL			English	Article							MESSENGER-RNA VACCINES; N-LINKED GLYCOSYLATION; WEST NILE VIRUS; NS1 PROTEIN; DENGUE VIRUS; CDNA CLONE; MOUSE; ANTIBODIES; ORGANIZATION; REPLICATION	The emergence of Zika virus (ZIKV) and its association with congenital malformations has prompted the rapid development of vaccines. Although efficacy with multiple viral vaccine platforms has been established in animals, no study has addressed protection during pregnancy. We tested in mice two vaccine platforms, a lipid nanoparticle-encapsulated modified mRNA vaccine encoding ZIKV prM and E genes and a live-attenuated ZIKV strain encoding an NS1 protein without glycosylation, for their ability to protect against transmission to the fetus. Vaccinated dams challenged with a heterologous ZIKV strain at embryo day 6 (E6) and evaluated at E13 showed markedly diminished levels of viral RNA in maternal, placental, and fetal tissues, which resulted in protection against placental damage and fetal demise. As modified mRNA and live-attenuated vaccine platforms can restrict in utero transmission of ZIKV in mice, their further development in humans to prevent congenital ZIKV syndrome is warranted.	[Richner, Justin M.; Jagger, Brett W.; Caine, Elizabeth A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO USA; [Shan, Chao; Fontes, Camila R.; Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Muruato, Antonio E.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem Mol Biol, Galveston, TX USA; [Dowd, Kimberly A.; Foreman, Bryant M.; Pierson, Theodore C.] Natl Inst Hlth, Viral Pathogenesis Sect, Lab Viral Dis, Bethesda, MD USA; [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO USA; [Himansu, Sunny; Ciaramella, Giuseppe] Valera LLC, Moderna Venture, 500 Technol Sq, Cambridge, MA USA; [Nunes, Bruno T. D.; Medeiros, Daniele B. A.; Vasconcelos, Pedro F. C.] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Minist Hlth, Ananindeua, Para, Brazil; [Muruato, Antonio E.; Luo, Huanle; Rossi, Shannan L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Wang, Tian; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA; [Weaver, Scott C.; Rossi, Shannan L.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA; [Wang, Tian; Barrett, Alan D.; Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA; [Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA; [Vasconcelos, Pedro F. C.] Para State Univ, Dept Pathol, Belem, Para, Brazil; [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol Toxicol, Galveston, TX USA; [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol Mol Biophys, Galveston, TX USA; [Richner, Justin M.; Jagger, Brett W.; Shan, Chao; Fontes, Camila R.; Dowd, Kimberly A.] IIT Res Inst, Chicago, IL USA	Washington University (WUSTL); University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; Washington University (WUSTL); Instituto Evandro Chagas; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Universidade do Estado do Para (UEPA); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Illinois Institute of Technology	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem Mol Biol, Galveston, TX USA.; Pierson, TC (corresponding author), Natl Inst Hlth, Viral Pathogenesis Sect, Lab Viral Dis, Bethesda, MD USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol Toxicol, Galveston, TX USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol Mol Biophys, Galveston, TX USA.	piersontc@niaid.nih.gov; peshi@utmb.edu; diamond@wusm.wustl.edu	Vasconcelos, Pedro/AAH-3142-2019; Mysorekar, Indira U./GRS-4574-2022; Shan, Chao/AAN-8190-2021; Diamond, Michael/AAH-1733-2019	Mysorekar, Indira U./0000-0003-3917-8677; Shan, Chao/0000-0002-3953-3782; Diamond, Michael/0000-0002-8791-3165; Himansu, Sunny/0000-0002-7954-9674; Richner, Justin/0000-0002-5344-118X; Fontes-Garfias, Camila/0000-0002-1912-8413; Dowd, Kimberly/0000-0003-3641-6852	NIH-NIAID [R01 AI073755, R01 AI104972, P01 AI106695, R24AI120942, T32 AI007172]; NIH/NICHD [R01 HD091218]; intramural program of NIH-NIAID; DARPA [W911NF-13-1-0417]; Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund; Prematurity Research Initiative Investigator award from the March of Dimes [(21-FY13-28) 8]; Moderna [OTM10991]; University of Texas Medical Branch (UTMB) startup award; UTMB Innovation and Commercialization award; University of Texas STARs Award; Pan American Health Organization [SCON2016-01353]; Ministry of Health of Brazil; CNPq [303999/2016-0, 440405/2016-5]; CAPES (Zika fast track project); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011, R01HD091218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106695, ZIAAI001209, R24AI120942, R01AI104972, R01AI073755, T32AI007172] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); intramural program of NIH-NIAID; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund; Prematurity Research Initiative Investigator award from the March of Dimes; Moderna; University of Texas Medical Branch (UTMB) startup award; UTMB Innovation and Commercialization award; University of Texas STARs Award; Pan American Health Organization; Ministry of Health of Brazil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Zika fast track project)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the NIH-NIAID (R01 AI073755, R01 AI104972, and P01 AI106695 to M.S.D., R24AI120942 to S.C.W., and T32 AI007172 to B.W.J.), the NIH/NICHD (R01 HD091218 to I.U.M. and M.S.D.), the intramural program of NIH-NIAID (T.C.P), a research grant by DARPA (agreement # W911NF-13-1-0417), a Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund (to I.U.M.), a Prematurity Research Initiative Investigator award (21-FY13-28) 8 from the March of Dimes (to I.U.M.), and a research grant from Moderna (OTM10991). P.-Y.S. was supported by University of Texas Medical Branch (UTMB) startup award, UTMB Innovation and Commercialization award, University of Texas STARs Award, and a grant from Pan American Health Organization SCON2016-01353. P.F.C.V. was supported by the Ministry of Health of Brazil and by the grants from CNPq (process 303999/2016-0 and 440405/2016-5) and CAPES (Zika fast track project). We thank the Animal Resource Center and Sasha Azar at UTMB for their assistance in maintaining the A129 mouse breeding colony. M.S.D. is a consultant for Inbios, Visterra, and Takeda Pharmaceuticals and on the Scientific Advisory Boards of Moderna and OvaGene. S.C.W. is a consultant for Valera LLC, GeoVax, Inc. and Sanofi-Pasteur. S.H. and G.C. are employees of Valera LLC, a Moderna Venture focusing on the development of therapeutic approaches for Infectious Diseases, including ZIKV mRNA vaccines.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15; Durbin Anna P, 2016, Semin Reprod Med, V34, P299; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2; Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]; Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Pierson TC., 2013, FIELDS VIROLOGY, V6th ed., P747; Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352; Pryor MJ, 1998, J GEN VIROL, V79, P2631, DOI 10.1099/0022-1317-79-11-2631; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Schlake T, 2012, RNA BIOL, V9, P1319, DOI 10.4161/rna.22269; Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322; Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006; Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Shin HN, 2013, TRENDS IMMUNOL, V34, P487, DOI 10.1016/j.it.2013.08.001; Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022; Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899; Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036; Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112; Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	51	178	187	7	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					273	+		10.1016/j.cell.2017.06.040	http://dx.doi.org/10.1016/j.cell.2017.06.040			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708997	Bronze, Green Accepted			2022-12-28	WOS:000405493900008
J	Snyder, CW				Snyder, Carolyn W.			Overestimate of committed warming Reply	NATURE			English	Letter							GLACIAL CYCLES; PLEISTOCENE; TEMPERATURE; SENSITIVITY; EVOLUTION; CO2		[Snyder, Carolyn W.] Stanford Univ, Interdisciplinary Program Environm & Resources, Stanford, CA 94305 USA	Stanford University	Snyder, CW (corresponding author), Stanford Univ, Interdisciplinary Program Environm & Resources, Stanford, CA 94305 USA.	carolyn.snyder@gmail.com						Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Ganopolski A, 2011, CLIM PAST, V7, P1415, DOI 10.5194/cp-7-1415-2011; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; Huybers P, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2002PA000857; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Imbrie JZ, 2011, EARTH PLANET SC LETT, V307, P94, DOI 10.1016/j.epsl.2011.04.018; IPCC, 2013, CLIMATE CHANGE 2022; Martinez-Boti MA, 2015, NATURE, V518, P49, DOI 10.1038/nature14145; McClymont EL, 2013, EARTH-SCI REV, V123, P173, DOI 10.1016/j.earscirev.2013.04.006; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Royer DL, 2012, GEOBIOLOGY, V10, P298, DOI 10.1111/j.1472-4669.2012.00320.x; Schmidt GA, 2017, NATURE, V547, pE16, DOI 10.1038/nature22803; Snyder CW, 2016, NATURE, V538, P226, DOI 10.1038/nature19798; Tziperman E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000627	18	2	2	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					E17	E18		10.1038/nature22804	http://dx.doi.org/10.1038/nature22804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703189				2022-12-28	WOS:000405314500004
J	Behrens, I; Basit, S; Melbye, M; Lykke, JA; Wohlfahrt, J; Bundgaard, H; Thilaganathan, B; Boyd, HA				Behrens, Ida; Basit, Saima; Melbye, Mads; Lykke, Jacob A.; Wohlfahrt, Jan; Bundgaard, Henning; Thilaganathan, Baskaran; Boyd, Heather A.			Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE RISK; LONG-TERM RISK; CARE PROVIDERS; LATER LIFE; PREECLAMPSIA	OBJECTIVES To determine how soon after delivery the risk of post-pregnancy hypertension increases in women with hypertensive disorders of pregnancy and how the risk evolves over time. DESIGN Nationwide register based cohort study. SETTING Denmark. POPULATIONS 482 972 primiparous women with a first live birth or stillbirth between 1995 and 2012 (cumulative incidence analyses), and 1 025 118 women with at least one live birth or stillbirth between 1978 and 2012 (Cox regression analyses). MAIN OUTCOME MEASURES 10 year cumulative incidences of post-pregnancy hypertension requiring treatment with prescription drugs, and hazard ratios estimated using Cox regression. RESULTS Of women with a hypertensive disorder of pregnancy in a first pregnancy in their 20s, 14% developed hypertension in the first decade post partum, compared with 4% of women with normotensive first pregnancies in their 20s. The corresponding percentages for women with a first pregnancy in their 40s were 32% and 11%, respectively. In the year after delivery, women with a hypertensive disorder of pregnancy had 12-fold to 25-fold higher rates of hypertension than did women with a normotensive pregnancy. Rates in women with a hypertensive disorder of pregnancy were threefold to 10-fold higher 1-10 years post partum and remained twice as high even 20 or more years later. CONCLUSIONS The risk of hypertension associated with hypertensive disorders of pregnancy is high immediately after an affected pregnancy and persists for more than 20 years. Up to one third of women with a hypertensive disorder of pregnancy may develop hypertension within a decade of an affected pregnancy, indicating that cardiovascular disease prevention in these women should include blood pressure monitoring initiated soon after pregnancy.	[Behrens, Ida; Basit, Saima; Melbye, Mads; Wohlfahrt, Jan; Boyd, Heather A.] Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Lykke, Jacob A.] Copenhagen Univ Hosp, Dept Obstet, Rigshosp, Copenhagen, Denmark; [Bundgaard, Henning] Copenhagen Univ Hosp, Heart Ctr, Rigshosp, Copenhagen, Denmark; [Thilaganathan, Baskaran] Univ London, Fetal Med Unit, St Georges Hosp, London, England	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; St Georges University London; University of London	Boyd, HA (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	hoy@ssi.dk	Bundgaard, Henning/AAA-4381-2020	Bundgaard, Henning/0000-0002-0563-7049; Boyd, Heather/0000-0001-6849-9985; melbye, mads/0000-0001-8264-6785; Lykke, Jacob Alexander/0000-0002-3698-9792	Danish Council for Independent Research; Danish Heart Association	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Heart Association	This study was funded by the Danish Council for Independent Research and the Danish Heart Association. Neither had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. The researchers acted independently from the study sponsors in all aspects of this study.	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOL, V122, P1122, DOI [DOI 10.1097/01.AOG.0000437382.03963.88, 10.1097/01.AOG.0000437382.03963.88]; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Egeland GM, 2016, HYPERTENSION, V67, P1173, DOI 10.1161/HYPERTENSIONAHA.116.07099; Engeland A, 2015, EUR J EPIDEMIOL, V30, P501, DOI 10.1007/s10654-015-0018-5; Heidrich MB, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-61; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Knudsen LB, 1998, DAN MED BULL, V45, P320; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; MacDonald SE, 2007, J OBSTET GYNAECOL CA, V29, P705, DOI 10.1016/S1701-2163(16)32601-9; Magnussen EB, 2009, OBSTET GYNECOL, V114, P961, DOI 10.1097/AOG.0b013e3181bb0dfc; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; National Collaborating Centre for Women's and Children's Health, 2010, HYP PREGN MAN HYP DI; NISELL H, 1995, BRIT J OBSTET GYNAEC, V102, P876, DOI 10.1111/j.1471-0528.1995.tb10874.x; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Romundstad PR, 2010, CIRCULATION, V122, P579, DOI 10.1161/CIRCULATIONAHA.110.943407; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Staff AC, 2016, HYPERTENSION, V67, P251, DOI 10.1161/HYPERTENSIONAHA.115.06357; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Veerbeek JHW, 2015, HYPERTENSION, V65, P600, DOI 10.1161/HYPERTENSIONAHA.114.04850; Wilkins-Haug L, 2015, OBSTET GYNECOL, V125, P1287, DOI 10.1097/AOG.0000000000000856; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Young B, 2012, HYPERTENS PREGNANCY, V31, P50, DOI 10.3109/10641955.2010.544955	30	134	140	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2017	358								j3078	10.1136/bmj.j3078	http://dx.doi.org/10.1136/bmj.j3078			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MT	28701333	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000405770400003
J	Rubin, R				Rubin, Rita			Half-century After "Summer of Love," Free Clinics Still Play Vital Role	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					598	600		10.1001/jama.2017.8631	http://dx.doi.org/10.1001/jama.2017.8631			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28746712				2022-12-28	WOS:000407616000001
J	Jordan, SC; Lorant, T; Choi, J; Kjellman, C; Winstedt, L; Bengtsson, M; Zhang, X; Eich, T; Toyoda, M; Eriksson, BM; Ge, S; Peng, A; Jarnum, S; Wood, KJ; Lundgren, T; Wennberg, L; Backman, L; Larsson, E; Villicana, R; Kahwaji, J; Louie, S; Kang, A; Haas, M; Nast, C; Vo, A; Tufveson, G				Jordan, S. C.; Lorant, T.; Choi, J.; Kjellman, C.; Winstedt, L.; Bengtsson, M.; Zhang, X.; Eich, T.; Toyoda, M.; Eriksson, B-M; Ge, S.; Peng, A.; Jarnum, S.; Wood, K. J.; Lundgren, T.; Wennberg, L.; Backman, L.; Larsson, E.; Villicana, R.; Kahwaji, J.; Louie, S.; Kang, A.; Haas, M.; Nast, C.; Vo, A.; Tufveson, G.			IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-MEDIATED REJECTION; STAGE RENAL-DISEASE; KIDNEY-TRANSPLANTATION; HLA ANTIBODIES; INTRAVENOUS IMMUNOGLOBULIN; DESENSITIZATION; RITUXIMAB; SURVIVAL; IDES; RECIPIENTS	BACKGROUND Donor-specific antibodies create an immunologic barrier to transplantation. Current therapies to modify donor-specific antibodies are limited and ineffective in the most highly HLA-sensitized patients. The IgG-degrading enzyme derived from Streptococcus pyogenes (IdeS), an endopeptidase, cleaves human IgG into F(ab')(2) and Fc fragments inhibiting complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity, which suggests that IdeS might be useful for desensitization. We report on the combined experience of two independently performed open-label, phase 1-2 trials (conducted in Sweden and the United States) that assessed the efficacy of IdeS with regard to desensitization and transplantation of a kidney from an HLA-incompatible donor. METHODS We administered IdeS to 25 highly HLA-sensitized patients (11 patients in Uppsala or Stockholm, Sweden, and 14 in Los Angeles) before the transplantation of a kidney from an HLA-incompatible donor. Frequent monitoring for adverse events, outcomes, donor-specific antibodies, and renal function was performed, as were renal biopsies. Immunosuppression after transplantation consisted of tacrolimus, mycophenolate mofetil, and glucocorticoids. Patients in the U.S. study also received intravenous immune globulin and rituximab after transplantation to prevent antibody rebound. RESULTS Recipients in the U.S. study had a significantly longer cold ischemia time (the time elapsed between procurement of the organ and transplantation), a significantly higher rate of delayed graft function, and significantly higher levels of class I donor-specific antibodies than those in the Swedish study. A total of 38 serious adverse events occurred in 15 patients (5 events were adjudicated as being possibly related to IdeS). At transplantation, total IgG and HLA antibodies were eliminated. A total of 24 of 25 patients had perfusion of allografts after transplantation. Antibodymediated rejection occurred in 10 patients (7 patients in the U.S. study and 3 in the Swedish study) at 2 weeks to 5 months after transplantation; all these patients had a response to treatment. One graft loss, mediated by non-HLA IgM and IgA antibodies, occurred. CONCLUSIONS IdeS reduced or eliminated donor-specific antibodies and permitted HLA-incompatible transplantation in 24 of 25 patients. (Funded by Hansa Medical; ClinicalTrials.gov numbers, NCT02224820, NCT02426684, and NCT02475551.)	[Jordan, S. C.; Choi, J.; Toyoda, M.; Ge, S.; Peng, A.; Villicana, R.; Kahwaji, J.; Louie, S.; Kang, A.; Vo, A.] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, 8900 Beverly Blvd, Los Angeles, CA 90048 USA; [Jordan, S. C.; Choi, J.; Peng, A.; Villicana, R.; Kahwaji, J.; Louie, S.; Kang, A.; Vo, A.] Cedars Sinai Med Ctr, Transplant Immunotherapy Program, 8900 Beverly Blvd, Los Angeles, CA 90048 USA; [Jordan, S. C.; Toyoda, M.; Ge, S.; Vo, A.] Cedars Sinai Med Ctr, Transplant Immunol Lab, 8900 Beverly Blvd, Los Angeles, CA 90048 USA; [Zhang, X.] Cedars Sinai Med Ctr, HLA Lab, 8900 Beverly Blvd, Los Angeles, CA 90048 USA; [Haas, M.; Nast, C.] Cedars Sinai Med Ctr, Dept Pathol, 8900 Beverly Blvd, Los Angeles, CA 90048 USA; [Lorant, T.; Backman, L.; Tufveson, G.] Uppsala Univ, Dept Surg Sci, Sect Transplantat Surg, Uppsala, Sweden; [Bengtsson, M.; Larsson, E.] Uppsala Univ, Sect Mol & Morphol Pathol, Uppsala, Sweden; [Eich, T.] Uppsala Univ, Clin Immunol Sect, Uppsala, Sweden; [Eriksson, B-M] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Eriksson, B-M] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Kjellman, C.; Winstedt, L.; Jarnum, S.] Hansa Med, Lund, Sweden; [Lundgren, T.; Wennberg, L.] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Transplantat Surg, Stockholm, Sweden; [Lundgren, T.; Wennberg, L.] Karolinska Univ Hosp, Dept Transplantat Surg, Stockholm, Sweden; [Wood, K. J.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Oxford	Jordan, SC (corresponding author), Cedars Sinai Med Ctr, Comprehens Transplant Ctr, 8900 Beverly Blvd, Los Angeles, CA 90048 USA.	sjordan@cshs.org	Kahwaji, Joseph/GOJ-7788-2022; Lorant, Tomas/AAU-2490-2020; Jordan, Stan/AAI-1250-2021	Lorant, Tomas/0000-0002-2466-6259; Jordan, Stan/0000-0002-0456-8635	Hansa Medical	Hansa Medical	Funded by Hansa Medical; ClinicalTrials.gov numbers, NCT02224820, NCT02426684, and NCT02475551.	Archdeacon P, 2011, AM J TRANSPLANT, V11, P896, DOI 10.1111/j.1600-6143.2011.03525.x; Brezski RJ, 2009, P NATL ACAD SCI USA, V106, P17864, DOI 10.1073/pnas.0904174106; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cecka JM, 2011, AM J TRANSPLANT, V11, P719, DOI 10.1111/j.1600-6143.2010.03340.x; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Jarnum S, 2015, J IMMUNOL, V195, P5592, DOI 10.4049/jimmunol.1501929; JEANNET M, 1970, NEW ENGL J MED, V282, P111, DOI 10.1056/NEJM197001152820301; Jordan SC, 2004, J AM SOC NEPHROL, V15, P3256, DOI 10.1097/01.ASN.0000145878.92906.9F; Jordan SC, 2010, PEDIATR NEPHROL, V25, P2035, DOI 10.1007/s00467-009-1386-4; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; Loupy A, 2013, NAT REV NEPHROL, V9, P130, DOI 10.1038/nrneph.2013.18; Marfo K, 2011, CLIN J AM SOC NEPHRO, V6, P922, DOI 10.2215/CJN.08140910; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Orandi BJ, 2016, NEW ENGL J MED, V374, P940, DOI 10.1056/NEJMoa1508380; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Reinsmoen NL, 2008, TRANSPLANTATION, V86, P820, DOI 10.1097/TP.0b013e3181856f98; Rostaing LPE, 2016, NEW ENGL J MED, V374, P982, DOI 10.1056/NEJMe1601379; Takahashi R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10809; Toyoda M, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/5672523; U.S. Renal Data System, USRDS 2013 ANN DAT R; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Vo AA, 2014, TRANSPLANTATION, V98, P312, DOI 10.1097/TP.0000000000000064; Vo AA, 2013, TRANSPLANTATION, V95, P852, DOI 10.1097/TP.0b013e3182802f88; von Pawel-Rammingen U, 2003, CURR OPIN MICROBIOL, V6, P50, DOI 10.1016/S1369-5274(03)00003-1; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Winstedt L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132011; Zachary AA, 2013, TRANSPLANTATION, V95, P701, DOI 10.1097/TP.0b013e31827be3c1	30	140	146	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					442	453		10.1056/NEJMoa1612567	http://dx.doi.org/10.1056/NEJMoa1612567			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3NW	28767349	Green Published, Bronze			2022-12-28	WOS:000406747100006
J	Krumholz, HM				Krumholz, Harlan M.			Treatment of Cholesterol in 2017	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STATIN THERAPY		[Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Hlth, Ctr Outcomes Res & Evaluat, New Haven, CT USA	Yale University; Yale University	Krumholz, HM (corresponding author), Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020		Medtronic, through Yale; Johnson & Johnson (Janssen), through Yale; US Food and Drug Administration, through Yale	Medtronic, through Yale; Johnson & Johnson (Janssen), through Yale; US Food and Drug Administration, through Yale	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reported that he received research grants from Medtronic, Johnson & Johnson (Janssen), the US Food and Drug Administration, all through Yale; works under contract with the Centers for Medicare & Medicaid Services; chairs a cardiac scientific advisory board for UnitedHealth; is a participant and participant representative of the IBM Watson Health Life Sciences Board; is a member of the Advisory Board for Element Science and the Physician Advisory Board for Aetna; and is the founder of Hugo, a personal health information platform.	Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Green JB, 2013, JAMA INTERN MED, V173, P229, DOI 10.1001/jamainternmed.2013.1529; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Nasir K, 2015, J AM COLL CARDIOL, V66, P1657, DOI 10.1016/j.jacc.2015.07.066; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	7	24	25	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					417	418		10.1001/jama.2017.6753	http://dx.doi.org/10.1001/jama.2017.6753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28738130				2022-12-28	WOS:000406659800007
J	Torrejon, J; Riou, M; Araujo, FA; Tsunegi, S; Khalsa, G; Querlioz, D; Bortolotti, P; Cros, V; Yakushiji, K; Fukushima, A; Kubota, H; Uasa, SY; Stiles, MD; Grollier, J				Torrejon, Jacob; Riou, Mathieu; Araujo, Flavio Abreu; Tsunegi, Sumito; Khalsa, Guru; Querlioz, Damien; Bortolotti, Paolo; Cros, Vincent; Yakushiji, Kay; Fukushima, Akio; Kubota, Hitoshi; Uasa, Shinji Y.; Stiles, Mark D.; Grollier, Julie			Neuromorphic computing with nanoscale spintronic oscillators	NATURE			English	Article							DRIVEN	Neurons in the brain behave as nonlinear oscillators, which develop rhythmic activity and interact to process information(1). Taking inspiration from this behaviour to realize high-density, low-power neuromorphic computing will require very large numbers of nanoscale nonlinear oscillators. A simple estimation indicates that to fit 10(8) oscillators organized in a two-dimensional array inside a chip the size of a thumb, the lateral dimension of each oscillator must be smaller than one micrometre. However, nanoscale devices tend to be noisy and to lack the stability that is required to process data in a reliable way. For this reason, despite multiple theoretical proposals(2-5) and several candidates, including memristive(6) and superconducting(7) oscillators, a proof of concept of neuromorphic computing using nanoscale oscillators has yet to be demonstrated. Here we show experimentally that a nanoscale spintronic oscillator (a magnetic tunnel junction)(8,9) can be used to achieve spoken-digit recognition with an accuracy similar to that of state-of-the-art neural networks. We also determine the regime of magnetization dynamics that leads to the greatest performance. These results, combined with the ability of the spintronic oscillators to interact with each other, and their long lifetime and low energy consumption, open up a path to fast, parallel, on-chip computation based on networks of oscillators.	[Torrejon, Jacob; Riou, Mathieu; Araujo, Flavio Abreu; Bortolotti, Paolo; Cros, Vincent; Grollier, Julie] Univ Paris Saclay, Univ Paris Sud, Thales, CNRS,Unite Mixte Phys, F-91767 Palaiseau, France; [Tsunegi, Sumito; Yakushiji, Kay; Fukushima, Akio; Kubota, Hitoshi; Uasa, Shinji Y.; Stiles, Mark D.] Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Khalsa, Guru; Stiles, Mark D.] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Querlioz, Damien] Univ Paris Saclay, Univ Paris Sud, CNRS, Ctr Nanosci & Nanotechnol, F-91405 Orsay, France; [Khalsa, Guru] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA	Centre National de la Recherche Scientifique (CNRS); Thales Group; UDICE-French Research Universities; Universite Paris Saclay; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Standards & Technology (NIST) - USA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Cornell University	Grollier, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, Thales, CNRS,Unite Mixte Phys, F-91767 Palaiseau, France.	julie.grollier@cnrs-thales.fr	Stiles, Mark/K-2426-2012; Yakushiji, Kay/K-3040-2018; Araujo, Flavio Abreu/AAE-2128-2019; Fukushima, Akio/K-2900-2018; Kubota, Hitoshi/K-2894-2018; Yuasa, Shinji/H-2804-2016; Tsunegi, Sumito/J-9626-2018; Araujo, Flavio M Abreu/K-4532-2014	Stiles, Mark/0000-0001-8238-4156; Yakushiji, Kay/0000-0002-1616-1613; Fukushima, Akio/0000-0002-0769-7897; Kubota, Hitoshi/0000-0002-2362-3505; Yuasa, Shinji/0000-0003-1093-9057; Tsunegi, Sumito/0000-0003-3357-1507; Araujo, Flavio M Abreu/0000-0001-7157-3197; Khalsa, Guru/0000-0003-2747-0486	European Research Council (ERC) [bioSPINspired 682955]	European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by the European Research Council (ERC) under grant bioSPINspired 682955. We thank L. Larger, B. Penkovsky and F. Duport for discussions.	Aonishi T, 1999, PHYS REV LETT, V82, P2800, DOI 10.1103/PhysRevLett.82.2800; Apalkov D, 2016, P IEEE, V104, P1796, DOI 10.1109/JPROC.2016.2590142; Appeltant L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1476; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Buzsaki G, 2011, RHYTHMS BRAIN; Grimaldi E, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.104404; Grollier J, 2016, P IEEE, V104, P2024, DOI 10.1109/JPROC.2016.2597152; Hoppensteadt FC, 1999, PHYS REV LETT, V82, P2983, DOI 10.1103/PhysRevLett.82.2983; Houshang A, 2016, NAT NANOTECHNOL, V11, P280, DOI [10.1038/nnano.2015.280, 10.1038/NNANO.2015.280]; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lyon R. F., 1982, Proceedings of ICASSP 82. IEEE International Conference on Acoustics, Speech and Signal Processing, P1282; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Macia F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/9/095301; Martinenghi R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.244101; Nikonov DE, 2015, IEEE J EXPLOR SOLID-, V1, P85, DOI 10.1109/JXCDC.2015.2504049; Paquot Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00287; Pickett MD, 2013, NAT MATER, V12, P114, DOI [10.1038/nmat3510, 10.1038/NMAT3510]; Pufall MR, 2015, IEEE J EXPLOR SOLID-, V1, P76, DOI 10.1109/JXCDC.2015.2468070; Sato H, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892924; Segall K, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.032220; Slavin A, 2009, IEEE T MAGN, V45, P1875, DOI 10.1109/TMAG.2008.2009935; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Soriano MC, 2015, IEEE T NEUR NET LEAR, V26, P388, DOI 10.1109/TNNLS.2014.2311855; Texas Instruments, 1991, 46 WORD SPEAK DEP IS; Tsunegi S, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4972305; Yildiz IB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003219; Yogendra K, 2015, IEEE T MAGN, V51, DOI 10.1109/TMAG.2015.2443042	30	612	619	39	329	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					428	+		10.1038/nature23011	http://dx.doi.org/10.1038/nature23011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28748930	Green Submitted, Green Accepted			2022-12-28	WOS:000406358300030
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Charities should respect evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Cao H, 2012, PLOS ONE, V358; Charity Commission for England and Wales, 2013, GUID CHAR PURP; House of Lords Select Committee, 2000, SCI TECHN 6 REP; Kakaes K., 2016, WASHINGTON POST; MacDougall A., 2017, GLOBE MAIL; Marshall M., 2017, GUARDIAN; Roberts M., 2004, BBC NEWS; Theron I., 2017, FINANCIAL TIMES	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2017	358								j3336	10.1136/bmj.j3336	http://dx.doi.org/10.1136/bmj.j3336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UT	28743824	Green Published, Bronze			2022-12-28	WOS:000406765600001
J	Gaudet, D; Gipe, DA; Pordy, R; Ahmad, Z; Cuchel, M; Shah, PK; Chyu, KY; Sasiela, WJ; Chan, KC; Brisson, D; Khoury, E				Gaudet, Daniel; Gipe, Daniel A.; Pordy, Robert; Ahmad, Zahid; Cuchel, Marina; Shah, Prediman K.; Chyu, Kuang-Yuh; Sasiela, William J.; Chan, Kuo-Chen; Brisson, Diane; Khoury, Etienne			ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Gaudet, Daniel; Brisson, Diane; Khoury, Etienne] Univ Montreal, Chicoutimi, PQ, Canada; [Gipe, Daniel A.; Pordy, Robert; Sasiela, William J.; Chan, Kuo-Chen] Regeneron Pharmaceut, Tarrytown, NY USA; [Ahmad, Zahid] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Cuchel, Marina] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shah, Prediman K.; Chyu, Kuang-Yuh] Cedars Sinai Heart Inst, Los Angeles, CA USA	Universite de Montreal; Regeneron; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center	Gaudet, D (corresponding author), Univ Montreal, Chicoutimi, PQ, Canada.			Cuchel, Marina/0000-0001-6808-3824					0	186	191	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					296	297		10.1056/NEJMc1705994	http://dx.doi.org/10.1056/NEJMc1705994			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9PI	28723334				2022-12-28	WOS:000405777600017
J	Jackson, E; Eagle, KA				Jackson, Elizabeth; Eagle, Kim A.			Evolocumab reduced CV events in patients with atherosclerotic CV disease taking highor moderate-intensity statins	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jackson, Elizabeth; Eagle, Kim A.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jackson, E (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.								0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC7	JC7		10.7326/ACPJC-2017-167-2-007	http://dx.doi.org/10.7326/ACPJC-2017-167-2-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715829				2022-12-28	WOS:000405573400008
J	Rocklin, GJ; Chidyausiku, TM; Goreshnik, I; Ford, A; Houliston, S; Lemak, A; Carter, L; Ravichandran, R; Mulligan, VK; Chevalier, A; Arrowsmith, CH; Baker, D				Rocklin, Gabriel J.; Chidyausiku, Tamuka M.; Goreshnik, Inna; Ford, Alex; Houliston, Scott; Lemak, Alexander; Carter, Lauren; Ravichandran, Rashmi; Mulligan, Vikram K.; Chevalier, Aaron; Arrowsmith, Cheryl H.; Baker, David			Global analysis of protein folding using massively parallel design, synthesis, and testing	SCIENCE			English	Article							YEAST SURFACE DISPLAY; DE-NOVO DESIGN; VILLIN HEADPIECE; THERMODYNAMIC STABILITY; ENERGY FUNCTIONS; STRUCTURAL BASIS; ENERGETICS; SCALE; RECOGNITION; SIMULATIONS	Proteins fold into unique native structures stabilized by thousands of weak interactions that collectively overcome the entropic cost of folding. Although these forces are "encoded" in the thousands of known protein structures, "decoding" them is challenging because of the complexity of natural proteins that have evolved for function, not stability. We combined computational protein design, next-generation gene synthesis, and a high-throughput protease susceptibility assay to measure folding and stability for more than 15,000 de novo designed miniproteins, 1000 natural proteins, 10,000 point mutants, and 30,000 negative control sequences. This analysis identified more than 2500 stable designed proteins in four basic folds-a number sufficient to enable us to systematically examine how sequence determines folding and stability in uncharted protein space. Iteration between design and experiment increased the design success rate from 6% to 47%, produced stable proteins unlike those found in nature for topologies where design was initially unsuccessful, and revealed subtle contributions to stability as designs became increasingly optimized. Our approach achieves the long-standing goal of a tight feedback cycle between computation and experiment and has the potential to transform computational protein design into a data-driven science.	[Rocklin, Gabriel J.; Chidyausiku, Tamuka M.; Goreshnik, Inna; Ford, Alex; Carter, Lauren; Ravichandran, Rashmi; Mulligan, Vikram K.; Chevalier, Aaron; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Rocklin, Gabriel J.; Chidyausiku, Tamuka M.; Goreshnik, Inna; Ford, Alex; Carter, Lauren; Ravichandran, Rashmi; Mulligan, Vikram K.; Chevalier, Aaron; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Chidyausiku, Tamuka M.; Ford, Alex] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Houliston, Scott; Lemak, Alexander; Arrowsmith, Cheryl H.] Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Houliston, Scott; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Structural Genomics Consortium; University of Toronto; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@u.washington.edu		Arrowsmith, Cheryl/0000-0002-4971-3250; Rocklin, Gabriel/0000-0003-2253-5631; Chidyausiku, Tamuka/0000-0002-2561-782X; Mulligan, Vikram/0000-0001-6038-8922	Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) through ULTRA-DD [115766]; Janssen Pharmaceuticals; Merck Co.; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) through ULTRA-DD; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by the Howard Hughes Medical Institute (D.B.) and the Natural Sciences and Engineering Research Council of Canada (C.H.A.). G.J.R. is a Merck Fellow of the Life Sciences Research Foundation. C.H.A. holds a Canada Research Chair in Structural Genomics. We thank S. Rettie for mass spectrometry support; C. Lee for deep sequencing support, S. Ovchinnikov for assistance quantifying sequence conservation; V. Nguyen, A. Yehdego, T. Howard, and K. Lau for assistance with protein purification; and H. Gelman and many other members of the Baker lab for helpful discussions. This work was facilitated by the Hyak supercomputer at the University of Washington and by donations of computing time from Rosetta@Home participants. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute grant GI-055; Innovative Medicines Initiative (EU/EFPIA) through ULTRA-DD grant 115766; Janssen Pharmaceuticals; Merck & Co.; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; and the Wellcome Trust. The RosettaScripts code and blueprint files used for protein design are provided in the supplementary materials. The data for this work (designed sequences and structures, deep sequencing counts, EC<INF>50</INF> values, stability scores, and structural analysis of the designed models) are also provided in supplementary materials. The python code for inferring EC50 values and for fitting the unfolded state model is provided at https://github.com/asford/protease_experimental_analysis. G.J.R. and D.B. are inventors on provisional patent application no. 62/491,518 filed 28 April 2017 by the University of Washington that covers (i) the method described in this work for computationally designing and experimentally verifying stable miniproteins, and (ii) the 4000 most stable protein sequences designed in the work. Author contributions: G.J.R. designed the research, the experimental approach, and the proteins; G.J.R., T.M.C., I.G., S.H., L.C., R.R., and A. C. performed experiments; all authors analyzed data; G.J.R., A.F., and V.K.M. contributed new computational tools; C. H. A. and D.B. supervised research; and G.J.R. and D.B. wrote the manuscript.	Appelbaum JS, 2012, CHEM BIOL, V19, P819, DOI 10.1016/j.chembiol.2012.05.022; Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Baker EG, 2015, NAT CHEM BIOL, V11, P221, DOI 10.1038/nchembio.1739; Bhardwaj G, 2016, NATURE, V538, P329, DOI 10.1038/nature19791; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Chong PA, 2006, J BIOL CHEM, V281, P17069, DOI 10.1074/jbc.M601493200; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DAVIDSON AR, 1994, P NATL ACAD SCI USA, V91, P2146, DOI 10.1073/pnas.91.6.2146; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Finucane MD, 1999, BIOCHEMISTRY-US, V38, P11604, DOI 10.1021/bi990765n; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Nguyen H, 2014, J AM CHEM SOC, V136, P13959, DOI 10.1021/ja5032776; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Jager M, 2006, P NATL ACAD SCI USA, V103, P10648, DOI 10.1073/pnas.0600511103; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; Jiang X, 2001, PROTEIN SCI, V10, P1454, DOI 10.1110/ps.640101; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; LaRochelle JR, 2015, J AM CHEM SOC, V137, P2536, DOI 10.1021/ja510391n; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Li ZX, 2013, ANNU REV BIOPHYS, V42, P315, DOI 10.1146/annurev-biophys-083012-130315; Liang HH, 2009, ANGEW CHEM INT EDIT, V48, P3301, DOI 10.1002/anie.200805476; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Magliery TJ, 2015, CURR OPIN STRUC BIOL, V33, P161, DOI 10.1016/j.sbi.2015.09.002; Meng JM, 2005, BIOCHEMISTRY-US, V44, P11963, DOI 10.1021/bi050850x; Neuweiler H, 2009, J MOL BIOL, V390, P1060, DOI 10.1016/j.jmb.2009.05.011; Pace CN, 2014, FEBS LETT, V588, P2177, DOI 10.1016/j.febslet.2014.05.006; Pace CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/pro.2449; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Piana S, 2014, CURR OPIN STRUC BIOL, V24, P98, DOI 10.1016/j.sbi.2013.12.006; Piana S, 2012, P NATL ACAD SCI USA, V109, P17845, DOI 10.1073/pnas.1201811109; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Romero PA, 2013, P NATL ACAD SCI USA, V110, pE193, DOI 10.1073/pnas.1215251110; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Sun MGF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600692; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Xiao SF, 2013, P NATL ACAD SCI USA, V110, P11337, DOI 10.1073/pnas.1222245110; Xiao SF, 2009, BIOCHEMISTRY-US, V48, P4607, DOI 10.1021/bi8021763	52	206	213	11	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		168	174		10.1126/science.aan0693	http://dx.doi.org/10.1126/science.aan0693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706065	Green Accepted			2022-12-28	WOS:000405391700038
J	Wadman, M				Wadman, Meredith			SCIENCE AND SOCIETY A trans-Atlantic transparency gap on animal experiments	SCIENCE			English	News Item																			0	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		119	120		10.1126/science.357.6347.119	http://dx.doi.org/10.1126/science.357.6347.119			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706020				2022-12-28	WOS:000405391700016
J	Sallinen, V; Vikatmaa, P				Sallinen, Ville; Vikatmaa, Pirkka			Mobile Aortic Thrombi	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sallinen, Ville; Vikatmaa, Pirkka] Helsinki Univ Hosp, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Sallinen, V (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	ville.sallinen@helsinki.fi	Sallinen, Ville/AAG-2285-2021						0	1	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					E2	E2		10.1056/NEJMicm1702263	http://dx.doi.org/10.1056/NEJMicm1702263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA2PC	28700852				2022-12-28	WOS:000405282300012
J	Sarewitz, D				Sarewitz, Daniel			Kill the myth of the miracle machine	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC 20009 USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC 20009 USA.	daniel.sarewitz@asu.edu							0	4	4	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					139	139		10.1038/547139a	http://dx.doi.org/10.1038/547139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA3AX	28703203	Bronze			2022-12-28	WOS:000405314500008
J	Sousa, AMM; Meyer, KA; Santpere, G; Gulden, FO; Sestan, N				Sousa, Andre M. M.; Meyer, Kyle A.; Santpere, Gabriel; Gulden, Forrest O.; Sestan, Nenad			Evolution of the Human Nervous System Function, Structure, and Development	CELL			English	Review							COPY NUMBER VARIATION; DNA METHYLATION PATTERNS; HUMAN BRAIN; GENE-EXPRESSION; WHITE-MATTER; CEREBRAL-CORTEX; GREAT APES; ACCELERATED EVOLUTION; NONCODING SEQUENCES; ARCUATE FASCICULUS	The nervous system-in particular, the brain and its cognitive abilities-is among humans' most distinctive and impressive attributes. How the nervous system has changed in the human lineage and how it differs from that of closely related primates is not well understood. Here, we consider recent comparative analyses of extant species that are uncovering new evidence for evolutionary changes in the size and the number of neurons in the human nervous system, as well as the cellular and molecular reorganization of its neural circuits. We also discuss the developmental mechanisms and underlying genetic and molecular changes that generate these structural and functional differences. As relevant new information and tools materialize at an unprecedented pace, the field is now ripe for systematic and functionally relevant studies of the development and evolution of human nervous system specializations.	[Sousa, Andre M. M.; Meyer, Kyle A.; Santpere, Gabriel; Gulden, Forrest O.; Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Sect Comparat Med, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Yale Child Study Ctr, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Sestan, N (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Sect Comparat Med, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Yale Child Study Ctr, New Haven, CT 06510 USA.; Sestan, N (corresponding author), Yale Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Santpere, Gabriel/I-9437-2014; Sousa, Andre M. M./C-1203-2015	Santpere, Gabriel/0000-0001-5909-8637; Sousa, Andre M. M./0000-0003-1740-5066	NIH; Kavli Foundation; James S. McDonnell Foundation; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106934, R01MH110926, U01MH103339, U01MH105972, R01MH109904, U01MH106874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Foundation; James S. McDonnell Foundation; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of our laboratory for thoughtful discussions and comments on the manuscript and Amanda Gautier for illustrating the primate brains in Figure 1. Also, we would like to thank reviewers for their insightful comments, as these comments led to an improved manuscript. We apologize to all colleagues whose relevant studies were not cited because of space limitations, the broad scope of this review, and the emphasis on recent studies. Work in our laboratory was supported by the NIH, the Kavli Foundation, the James S. McDonnell Foundation, and the Simons Foundation.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Allman JM, 2010, BRAIN STRUCT FUNCT, V214, P495, DOI 10.1007/s00429-010-0254-0; Almecija S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3888; Alonso CR, 2005, NAT REV GENET, V6, P709, DOI 10.1038/nrg1676; Anderson JM, 1999, BRAIN LANG, V70, P1, DOI 10.1006/brln.1999.2135; Antonacci F, 2014, NAT GENET, V46, P1293, DOI 10.1038/ng.3120; Ayub Q, 2013, AM J HUM GENET, V92, P696, DOI 10.1016/j.ajhg.2013.03.019; Babbitt CC, 2011, P ROY SOC B-BIOL SCI, V278, P961, DOI 10.1098/rspb.2010.2433; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Barton RA, 2014, CURR BIOL, V24, P2440, DOI 10.1016/j.cub.2014.08.056; Bianchi S, 2013, CEREB CORTEX, V23, P2429, DOI 10.1093/cercor/bhs239; Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Bogin B., 1994, ACTA PAEDIATR, V406, P36; Borgstein J, 2002, LANCET, V359, P473, DOI 10.1016/S0140-6736(02)07676-6; Boyd JL, 2015, CURR BIOL, V25, P772, DOI 10.1016/j.cub.2015.01.041; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Brunskill EW, 2005, EUR J NEUROSCI, V22, P1265, DOI 10.1111/j.1460-9568.2005.04291.x; Buckner RL, 2013, TRENDS COGN SCI, V17, P648, DOI 10.1016/j.tics.2013.09.017; Burbano HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032877; Bush EC, 2004, P NATL ACAD SCI USA, V101, P3962, DOI 10.1073/pnas.0305760101; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Capra JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0025; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Collins CE, 2016, P NATL ACAD SCI USA, V113, P740, DOI 10.1073/pnas.1524208113; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Davis JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004241; DEACON TW, 1990, AM ZOOL, V30, P629; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Dehay C, 2015, NEURON, V85, P683, DOI 10.1016/j.neuron.2014.12.060; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Devlin AM, 2003, BRAIN, V126, P556, DOI 10.1093/brain/awg052; Doan RN, 2016, CELL, V167, P341, DOI 10.1016/j.cell.2016.08.071; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; El-Hattab AW, 2009, HUM GENET, V126, P589, DOI 10.1007/s00439-009-0706-x; Elston GN, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00002; Enard W, 2004, CURR BIOL, V14, pR148, DOI 10.1016/j.cub.2004.01.042; Enard W, 2016, CURR BIOL, V26, pR1109, DOI 10.1016/j.cub.2016.09.030; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Eriksen N, 2007, ANAT REC, V290, P83, DOI 10.1002/ar.20404; Falk D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00134; Farcas R, 2009, MOL BIOL EVOL, V26, P1379, DOI 10.1093/molbev/msp046; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feuillet L, 2007, LANCET, V370, P262, DOI 10.1016/S0140-6736(07)61127-1; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Fossati M, 2016, NEURON, V91, P356, DOI 10.1016/j.neuron.2016.06.013; Franchini LF, 2015, DEVELOPMENT, V142, P3100, DOI 10.1242/dev.120048; Furness J.B., 2006, ENTERIC NERVOUS SYST; Gazzaniga MS., 2009, HUMAN SCI WHAT MAKES; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Ghazanfar AA, 2008, NAT NEUROSCI, V11, P382, DOI 10.1038/nn0408-382; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; GLICKSTEIN M, 1994, BRAIN, V117, P1209, DOI 10.1093/brain/117.5.1209; Goidts V, 2006, HUM GENET, V120, P270, DOI 10.1007/s00439-006-0217-y; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Guerzoni D, 2016, GENOME BIOL EVOL, V8, P1222, DOI 10.1093/gbe/evw074; Gulden FO, 2014, NATURE, V515, P206, DOI 10.1038/515206a; Hammerschmidt K, 2015, Genes Brain Behav, V14, P583, DOI 10.1111/gbb.12237; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; HASLAM RHA, 1979, J PEDIATR-US, V95, P701, DOI 10.1016/S0022-3476(79)80714-3; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hecht EE, 2015, NEUROIMAGE, V108, P124, DOI 10.1016/j.neuroimage.2014.12.039; HEFFNER RS, 1983, BRAIN BEHAV EVOLUT, V23, P165, DOI 10.1159/000121494; Heissig F, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r57; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Herculano-Houzel S., 2016, HUMAN ADVANTAGE NEW; Herculano-Houzel S, 2016, J COMP NEUROL, V524, P448, DOI 10.1002/cne.23792; Herculano-Houzel S, 2015, BRAIN BEHAV EVOLUT, V86, P145, DOI 10.1159/000437413; Hernando-Herraez I, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005661; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hofman MA, 2012, PROG BRAIN RES, V195, P373, DOI 10.1016/B978-0-444-53860-4.00018-0; Holloway RL, 2002, AM J PHYS ANTHROPOL, V118, P399, DOI 10.1002/ajpa.10090; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Hrvoj-Mihic B, 2014, BIOL PSYCHIAT, V75, P929, DOI 10.1016/j.biopsych.2013.08.007; Hrvoj-Mihic B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00707; Hsieh WP, 2003, GENETICS, V165, P747; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Hubisz MJ, 2014, CURR OPIN GENET DEV, V29, P15, DOI 10.1016/j.gde.2014.07.005; Hutsler JJ, 2005, BRAIN RES, V1052, P71, DOI 10.1016/j.brainres.2005.06.015; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Isler K, 2014, EVOL ANTHROPOL, V23, P65, DOI 10.1002/evan.21403; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kamm GB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0019; Kamm GB, 2013, MOL BIOL EVOL, V30, P1088, DOI 10.1093/molbev/mst023; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Katoh S, 2016, NATURE, V530, P215, DOI 10.1038/nature16510; Keeney JG, 2015, BRAIN STRUCT FUNCT, V220, P3053, DOI 10.1007/s00429-014-0814-9; Keeney JG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00427; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Khaitovich P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r124; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kojima T., 1951, Scientific Reports of the Whales Research Institute Tokyo, V6, P49; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; Kozma C, 1996, CLIN DYSMORPHOL, V5, P49, DOI 10.1097/00019605-199601000-00007; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; KUYPERS HGJM, 1987, CIBA F SYMP, V132, P63; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lambert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017753; Lansdell H, 1999, PSYCHOL REP, V84, P209, DOI 10.2466/PR0.84.1.209-217; LASHLEY KS, 1949, Q REV BIOL, V24, P28, DOI 10.1086/396806; Li G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000900; Li ZS, 2013, RNA, V19, P1693, DOI 10.1261/rna.039206.113; Lieberman P, 2016, J ANTHROPOL SCI, V94, P127, DOI [10.4436/jass.94029, 10.4436/JASS.94029]; Liegeois F, 2010, BRAIN LANG, V114, P126, DOI 10.1016/j.bandl.2009.12.004; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu XL, 2012, GENOME RES, V22, P611, DOI 10.1101/gr.127324.111; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; MacLarnon A, 1996, J HUM EVOL, V30, P71, DOI 10.1006/jhev.1996.0005; MacLean EL, 2016, P NATL ACAD SCI USA, V113, P6348, DOI 10.1073/pnas.1521270113; Mantini D, 2013, J NEUROSCI, V33, P3259, DOI 10.1523/JNEUROSCI.4392-12.2013; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Marner L, 2003, J COMP NEUROL, V462, P144, DOI 10.1002/cne.10714; Mars RB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00298; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; McLysaght A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0332; Mesulam M, 2000, BRAIN COGNITION, V42, P4, DOI 10.1006/brcg.1999.1145; Meyer KA, 2017, MOL BIOL EVOL, V34, P1217, DOI 10.1093/molbev/msx076; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mortensen HS, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00132; Muckli L, 2009, P NATL ACAD SCI USA, V106, P13034, DOI 10.1073/pnas.0809688106; Nakajima K, 2000, J NEUROPHYSIOL, V84, P698, DOI 10.1152/jn.2000.84.2.698; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Neubauer S, 2014, BRAIN BEHAV EVOLUT, V84, P117, DOI 10.1159/000365276; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2009, EVOLUTION, V63, P2487, DOI 10.1111/j.1558-5646.2009.00799.x; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; Nuttle X, 2016, NATURE, V536, P205, DOI 10.1038/nature19075; O'Bleness M, 2012, NAT REV GENET, V13, P853, DOI 10.1038/nrg3336; O'Bleness MS, 2012, G3-GENES GENOM GENET, V2, P977, DOI 10.1534/g3.112.003061; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Olmos-Serrano JL, 2016, NEURON, V89, P1208, DOI 10.1016/j.neuron.2016.01.042; Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Paabo S, 2014, CELL, V157, P216, DOI 10.1016/j.cell.2013.12.036; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Passingham RE, 2008, WHAT IS SPECIAL HUMA; Pearce E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0168; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Pontzer H, 2016, NATURE, V533, P390, DOI 10.1038/nature17654; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Preuss TM, 2002, CEREB CORTEX, V12, P671, DOI 10.1093/cercor/12.7.671; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Pulsifer MB, 2004, EPILEPSIA, V45, P243, DOI 10.1111/j.0013-9580.2004.15303.x; Raghanti MA, 2009, NEUROSCIENCE, V158, P1551, DOI 10.1016/j.neuroscience.2008.10.058; Raghanti MA, 2008, CEREB CORTEX, V18, P584, DOI 10.1093/cercor/bhm089; Raghanti MA, 2008, J COMP NEUROL, V506, P409, DOI 10.1002/cne.21546; Raghanti MA, 2016, J COMP NEUROL, V524, P2117, DOI 10.1002/cne.23937; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Reilly SK, 2015, SCIENCE, V347, P1155, DOI 10.1126/science.1260943; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; RILLING JK, 2014, SCI ENG ETHICS, V18, P46, DOI DOI 10.1016/J.TICS.2013.09.013; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Rodenas-Cuadrado P, 2014, EUR J HUM GENET, V22, P171, DOI 10.1038/ejhg.2013.100; Rogers J, 2010, NEUROIMAGE, V53, P1103, DOI 10.1016/j.neuroimage.2010.02.020; Romero IG, 2015, ELIFE, V4, DOI 10.7554/eLife.07103; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Ruiz-Orera J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005721; Schenker NM, 2008, J COMP NEUROL, V510, P117, DOI 10.1002/cne.21792; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schneider E, 2012, CYTOGENET GENOME RES, V136, P278, DOI 10.1159/000337298; Schneider E, 2014, EPIGENETICS-US, V9, P533, DOI 10.4161/epi.27689; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Schreiweis C, 2014, P NATL ACAD SCI USA, V111, P14253, DOI 10.1073/pnas.1414542111; Seeley WW, 2012, CEREB CORTEX, V22, P245, DOI 10.1093/cercor/bhr005; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Semendeferi K, 2011, CEREB CORTEX, V21, P1485, DOI 10.1093/cercor/bhq191; Sherwood CC, 2004, BRAIN BEHAV EVOLUT, V63, P82, DOI 10.1159/000075673; Sherwood CC, 2003, BRAIN BEHAV EVOLUT, V61, P28, DOI 10.1159/000068879; Sherwood CC, 2012, PROG BRAIN RES, V195, P237, DOI 10.1016/B978-0-444-53860-4.00011-8; Shi P, 2006, TRENDS GENET, V22, P608, DOI 10.1016/j.tig.2006.09.001; Shibata M, 2015, TRENDS GENET, V31, P77, DOI 10.1016/j.tig.2014.12.004; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Sigaard RK, 2016, CEREB CORTEX, V26, P89, DOI 10.1093/cercor/bhu178; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Silver DL, 2016, BIOESSAYS, V38, P162, DOI 10.1002/bies.201500108; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Somel M, 2013, NAT REV NEUROSCI, V14, P112, DOI 10.1038/nrn3372; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Sonay TB, 2015, GENOME RES, V25, P1591, DOI 10.1101/gr.190868.115; Sousa A. M. M., 2015, COGNITIVE NEUROSCIEN, P67; Spiers H, 2015, GENOME RES, V25, P338, DOI 10.1101/gr.180273.114; Spocter MA, 2012, J COMP NEUROL, V520, P2917, DOI 10.1002/cne.23074; Squair J., 2012, U BRIT COLUMBIAS UND, V1; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Stevens CF, 1989, NEURAL COMPUT, V1, P473, DOI 10.1162/neco.1989.1.4.473; Stone JL, 2006, BRAIN, V129, P1084, DOI 10.1093/brain/awl065; Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tang Y, 2001, SYNAPSE, V41, P258, DOI 10.1002/syn.1083; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; TODOROV AB, 1974, J NEUROL NEUROSUR PS, V37, P1291, DOI 10.1136/jnnp.37.12.1291; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Uddin M, 2008, P NATL ACAD SCI USA, V105, P3215, DOI 10.1073/pnas.0712400105; van den Heuvel MP, 2016, TRENDS COGN SCI, V20, P345, DOI 10.1016/j.tics.2016.03.001; van Schaik CP., 2016, PRIMATE ORIGINS HUMA; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Vermunt MW, 2016, NAT NEUROSCI, V19, P494, DOI 10.1038/nn.4229; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Wagner GP, 2008, TRENDS ECOL EVOL, V23, P377, DOI 10.1016/j.tree.2008.03.006; Walloe S, 2010, ANAT REC, V293, P2129, DOI 10.1002/ar.21295; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watson SK, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22642; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; Wood B, 2011, ANNU REV ECOL EVOL S, V42, P47, DOI 10.1146/annurev-ecolsys-102209-144653; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Wunderlich S, 2014, STEM CELL RES, V12, P622, DOI 10.1016/j.scr.2014.02.001; Xie C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002942; Yu F, 2015, BRAIN, V138, DOI 10.1093/brain/awu239; Yu N, 2003, GENETICS, V164, P1511; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zeng J, 2012, AM J HUM GENET, V91, P455, DOI 10.1016/j.ajhg.2012.07.024; Zhang JZ, 2002, GENETICS, V162, P1825; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhang Y, 2013, BIOESSAYS, V35, P876, DOI 10.1002/bies.201300070; Zhu Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-343; Zollikofer CPE, 2013, EVOL ANTHROPOL, V22, P20, DOI 10.1002/evan.21333	264	163	165	3	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					226	247		10.1016/j.cell.2017.06.036	http://dx.doi.org/10.1016/j.cell.2017.06.036			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708995	Bronze, Green Accepted			2022-12-28	WOS:000405493900005
J	Tayi, AS; Shveyd, AK; Sue, ACH; Szarko, JM; Rolczynski, BS; Cao, D; Kennedy, TJ; Sarjeant, AA; Stern, CL; Paxton, WF; Wu, W; Dey, SK; Fahrenbach, AC; Guest, JR; Mohseni, H; Chen, LX; Wang, KL; Stoddart, JF; Stupp, SI				Tayi, Alok S.; Shveyd, Alexander K.; Sue, Andrew C. -H.; Szarko, Jodi M.; Rolczynski, Brian S.; Cao, Dennis; Kennedy, T. Jackson; Sarjeant, Amy A.; Stern, Charlotte L.; Paxton, Walter F.; Wu, Wei; Dey, Sanjeev K.; Fahrenbach, Albert C.; Guest, Jeffrey R.; Mohseni, Hooman; Chen, Lin X.; Wang, Kang L.; Stoddart, J. Fraser; Stupp, Samuel I.			Conflicting evidence for ferroelectricity Reply	NATURE			English	Letter							CHARGE-TRANSFER COMPLEXES		[Tayi, Alok S.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Shveyd, Alexander K.; Sue, Andrew C. -H.; Szarko, Jodi M.; Rolczynski, Brian S.; Cao, Dennis; Sarjeant, Amy A.; Stern, Charlotte L.; Paxton, Walter F.; Dey, Sanjeev K.; Fahrenbach, Albert C.; Chen, Lin X.; Stoddart, J. Fraser; Stupp, Samuel I.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Sue, Andrew C. -H.; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [Szarko, Jodi M.; Rolczynski, Brian S.; Chen, Lin X.] Northwestern Univ, ANSER Ctr, Evanston, IL 60208 USA; [Szarko, Jodi M.; Rolczynski, Brian S.; Chen, Lin X.] Argonne Natl Lab, Chem Sci & Engn Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Cao, Dennis; Fahrenbach, Albert C.; Stoddart, J. Fraser] Korea Adv Inst Sci & Technol, Grad Sch EEWS, Daejeon 305701, South Korea; [Kennedy, T. Jackson] Northwestern Univ, Dept Phys, Evanston, IL 60208 USA; [Wu, Wei; Mohseni, Hooman] Northwestern Univ, Dept Elect Engn, Evanston, IL 60208 USA; [Guest, Jeffrey R.] Argonne Natl Lab, Ctr Nanoscale Mat, 9700 S Cass Ave, Argonne, IL 60439 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; University of California System; University of California Los Angeles; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Korea Advanced Institute of Science & Technology (KAIST); Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.; Stupp, SI (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.; Stupp, SI (corresponding author), Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.	s-stupp@northwestern.edu	Sue, Andrew C.-H./K-1641-2015; Stupp, Samuel/B-6737-2009; Mohseni, Hooman/B-7253-2009; Paxton, Walter/AAP-8682-2021; Stupp, Samuel/AGV-1942-2022; Guest, Jeffrey R/B-2715-2009; Mohseni, Hooman/AAZ-5878-2020; Stoddart, James Fraser/H-1518-2011; Mohseni, Hooman/AAX-7824-2021	Sue, Andrew C.-H./0000-0001-9557-2658; Paxton, Walter/0000-0002-2438-4542; Guest, Jeffrey R/0000-0002-9756-8801; Mohseni, Hooman/0000-0002-0183-4213; Stoddart, James Fraser/0000-0003-3161-3697; Cao, Dennis/0000-0002-0315-1619				Blackburn AK, 2014, J AM CHEM SOC, V136, P17224, DOI 10.1021/ja509442t; D'Avino G, 2017, NATURE, V547, pE9, DOI 10.1038/nature22801; Kagawa F, 2010, NAT PHYS, V6, P169, DOI 10.1038/NPHYS1503; Marsh RE, 1995, ACTA CRYSTALLOGR B, V51, P897, DOI 10.1107/S0108768195008901; Narayanan A., J AM CHEM S IN PRESS; Scott JF, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/02/021001; Tayi AS, 2012, NATURE, V488, P485, DOI 10.1038/nature11395; TORRANCE JB, 1981, PHYS REV LETT, V47, P1747, DOI 10.1103/PhysRevLett.47.1747	8	3	3	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					E14	E15		10.1038/nature22802	http://dx.doi.org/10.1038/nature22802			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28703200				2022-12-28	WOS:000405314500002
J	Alberer, M; Gnad-Vogt, U; Hong, HS; Mehr, KT; Backert, L; Finak, G; Gottardo, R; Bica, MA; Garofano, A; Koch, SD; Fotin-Mleczek, M; Hoerr, I; Clemens, R; von Sonnenburg, F				Alberer, Martin; Gnad-Vogt, Ulrike; Hong, Henoch Sangjoon; Mehr, Keyvan Tadjalli; Backert, Linus; Finak, Greg; Gottardo, Raphael; Bica, Mihai Alexandru; Garofano, Aurelio; Koch, Sven Dominik; Fotin-Mleczek, Mariola; Hoerr, Ingmar; Clemens, Ralf; von Sonnenburg, Frank			Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial	LANCET			English	Article							INFLUENZA VACCINE; DIRECT-INJECTION; PROTECTIVE EFFICACY; INFECTION; ANTIGENS; IMMUNITY; CANCER	Background Vaccines based on mRNA coding for antigens have been shown to be safe and immunogenic in preclinical models. We aimed to report results of the first-in-human proof-of-concept clinical trial in healthy adults of a prophylactic mRNA-based vaccine encoding rabies virus glycoprotein (CV7201). Methods We did an open-label, uncontrolled, prospective, phase 1 clinical trial at one centre in Munich, Germany. Healthy male and female volunteers (aged 18-40 years) with no history of rabies vaccination were sequentially enrolled. They received three doses of CV7201 intradermally or intramuscularly by needle-syringe or one of three needle-free devices. Escalating doses were given to subsequent cohorts, and one cohort received a booster dose after 1 year. The primary endpoint was safety and tolerability. The secondary endpoint was to determine the lowest dose of CV7201 to elicit rabies virus neutralising titres equal to or greater than the WHO-specified protective antibody titre of 0.5 IU/mL. The study is continuing for long-term safety and immunogenicity follow-up. This trial is registered with ClinicalTrials.gov, number NCT02241135. Findings Between Oct 21, 2013, and Jan 11, 2016, we enrolled and vaccinated 101 participants with 306 doses of mRNA (80-640 mu g) by needle-syringe (18 intradermally and 24 intramuscularly) or needle-free devices (46 intradermally and 13 intramuscularly). In the 7 days post vaccination, 60 (94%) of 64 intradermally vaccinated participants and 36 (97%) of 37 intramuscularly vaccinated participants reported solicited injection site reactions, and 50 (78%) of 64 intradermally vaccinated participants and 29 (78%) of 37 intramuscularly vaccinated participants reported solicited systemic adverse events, including ten grade 3 events. One unexpected, possibly related, serious adverse reaction that occurred 7 days after a 640 mu g intramuscular dose resolved without sequelae. mRNA vaccination by needle-free intradermal or intramuscular device injection induced virus neutralising antibody titres of 0.5 IU/mL or more across dose levels and schedules in 32 (71%) of 45 participants given 80 mu g or 160 mu g CV7201 doses intradermally and six (46%) of 13 participants given 200 mu g or 400 mu g CV7201 doses intramuscularly. 1 year later, eight (57%) of 14 participants boosted with an 80 mu g needle-free intradermal dose of CV7201 achieved titres of 0.5 IU/mL or more. Conversely, intradermal or intramuscular needlesyringe injection was ineffective, with only one participant (who received 320 mu g intradermally) showing a detectable immune response. Interpretation This first-ever demonstration in human beings shows that a prophylactic mRNA-based candidate vaccine can induce boostable functional antibodies against a viral antigen when administered with a needle-free device, although not when injected by a needle-syringe. The vaccine was generally safe with a reasonable tolerability profile.	[Alberer, Martin; von Sonnenburg, Frank] Univ Munich, Med Ctr, Dept Infect Dis & Trop Med, Munich, Germany; [Gnad-Vogt, Ulrike; Hong, Henoch Sangjoon; Mehr, Keyvan Tadjalli; Bica, Mihai Alexandru; Garofano, Aurelio; Koch, Sven Dominik; Fotin-Mleczek, Mariola; Hoerr, Ingmar; Clemens, Ralf] CureVac AG, Tubingen, Germany; [Backert, Linus] Univ Tubingen, Quantitat Biol Ctr, Tubingen, Germany; [Backert, Linus] Univ Tubingen, Appl Bioinformat, Dept Comp Sci, Tubingen, Germany; [Finak, Greg; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA	University of Munich; CureVac N.V.; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Fred Hutchinson Cancer Center	von Sonnenburg, F (corresponding author), Univ Munich, Med Ctr, Dept Infect Dis & Trop Med, Sect Int Med & Publ Hlth, D-80802 Munich, Germany.	sonnenburg@lrz.uni-muenchen.de	Gottardo, Raphael/HCH-3169-2022	Gottardo, Raphael/0000-0002-3867-0232; Clemens, Ralf/0000-0003-4685-4207	CureVac AG	CureVac AG	CureVac AG.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P77; Carralot JP, 2004, CELL MOL LIFE SCI, V61, P2418, DOI 10.1007/s00018-004-4255-0; Cui ZR, 2003, J BIOTECHNOL, V102, P105, DOI 10.1016/S0168-1656(03)00029-4; Gedenhuys HD, 2015, VACCINE, V33, P4719, DOI 10.1016/j.vaccine.2015.03.074; Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340; Greenwood B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0433; Hoerr I, 2000, EUR J IMMUNOL, V30, P1; Jackson LA, 2001, VACCINE, V19, P4703, DOI 10.1016/S0264-410X(01)00225-0; Kis EE, 2012, VACCINE, V30, P523, DOI 10.1016/j.vaccine.2011.11.020; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Kubler H, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0068-y; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Marson AG, 2000, W J MED, V3, P573; Maruggi G, 2017, VACCINE, V35, P361, DOI 10.1016/j.vaccine.2016.11.040; McAllister L, 2014, LANCET, V384, P674, DOI 10.1016/S0140-6736(14)60524-9; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577; Schmidt T, 2012, EUR J IMMUNOL, V42, P1755, DOI 10.1002/eji.201242393; Schnee M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004746; Sebastian M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-748; Simon JK, 2011, VACCINE, V29, P9544, DOI 10.1016/j.vaccine.2011.09.097; Ulmer JB, 2012, VACCINE, V30, P4414, DOI 10.1016/j.vaccine.2012.04.060; Weide B, 2008, J IMMUNOTHER, V31, P180, DOI 10.1097/CJI.0b013e31815ce501; Weide B, 2009, J IMMUNOTHER, V32, P498, DOI 10.1097/CJI.0b013e3181a00068; WHO, WHO EXP CONS RAB 1 R	27	317	338	18	87	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1511	1520		10.1016/S0140-6736(17)31665-3	http://dx.doi.org/10.1016/S0140-6736(17)31665-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7BS	28754494				2022-12-28	WOS:000411337100026
J	Wright, AV; Liu, JJ; Knott, GJ; Doxzen, KW; Nogales, E; Doudna, JA				Wright, Addison V.; Liu, Jun-Jie; Knott, Gavin J.; Doxzen, Kevin W.; Nogales, Eva; Doudna, Jennifer A.			Structures of the CRISPR genome integration complex	SCIENCE			English	Article							SPACER ACQUISITION; HOST FACTOR; DNA; PROTEIN; ADAPTATION; REPEATS; SITE; PROTOSPACER; ELEMENTS; CAPTURE	CRISPR-Cas systems depend on the Cas1-Cas2 integrase to capture and integrate short foreign DNA fragments into the CRISPR locus, enabling adaptation to new viruses. We present crystal structures of Cas1-Cas2 bound to both donor and target DNA in intermediate and product integration complexes, as well as a cryo-electron microscopy structure of the full CRISPR locus integration complex, including the accessory protein IHF (integration host factor). The structures show unexpectedly that indirect sequence recognition dictates integration site selection by favoring deformation of the repeat and the flanking sequences. IHF binding bends the DNA sharply, bringing an upstream recognition motif into contact with Cas1 to increase both the specificity and efficiency of integration. These results explain how the Cas1-Cas2 CRISPR integrase recognizes a sequence-dependent DNA structure to ensure site-selective CRISPR array expansion during the initial step of bacterial adaptive immunity.	[Wright, Addison V.; Liu, Jun-Jie; Knott, Gavin J.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Liu, Jun-Jie; Nogales, Eva; Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Doxzen, Kevin W.; Doudna, Jennifer A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Liu, Jun-Jie/0000-0002-8982-107X; Doxzen, Kevin/0000-0002-3616-6569; Knott, Gavin J./0000-0002-9007-6273	University of California Office of the President, Multicampus Research Programs and Initiatives grant [MR-15-328599]; Sandler Foundation; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; U.S. DOE, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; U.S. National Science Foundation (NSF) grant [1244557]; National Institute of General Medical Sciences [1P50GM102706-01]; U.S. NSF Graduate Research Fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P01GM051487, P50GM102706] Funding Source: NIH RePORTER	University of California Office of the President, Multicampus Research Programs and Initiatives grant(University of California System); Sandler Foundation; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. DOE, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. National Science Foundation (NSF) grant(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. NSF Graduate Research Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Meigs and the staff of the Advanced Light Source 8.3.1 beamline and D. Tzanko, A. Gonzalez, and the staff of the Stanford Synchrotron Radiation Light Source 9-2 beamline for assistance with data collection. Beamline 8.3.1 at the Advanced Light Source is operated by the University of California Office of the President, Multicampus Research Programs and Initiatives (grant MR-15-328599), and the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. Use of the Stanford Synchrotron Radiation Lightsource (SSRL), a directorate of SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-76SF00515. The EM data were collected in the Howard Hughes Medical Institute EM facility located at the University of California, Berkeley. We thank D. B. Toso and P. Grob for expert EM assistance, A. Chintangal for computational support, and members of the Nogales laboratory for helpful discussions about EM data processing. We thank A. East-Seletsky for input on the manuscript. The SSRL Structural Molecular Biology Program is supported by the U.S. DOE, Office of Biological and Environmental Research, and the National Institutes of Health, National Institute of General Medical Sciences (including grant no. P41GM103393). This project was funded by U.S. National Science Foundation (NSF) grant no. 1244557 (to J.A.D.) and National Institute of General Medical Sciences grant no. 1P50GM102706-01 (to J. H. Cate). A.V.W. and K.W.D. are supported by a U.S. NSF Graduate Research Fellowship, and G.J.K. is funded by the Howard Hughes Medical Institute. J. A. D. and E.N. are investigators of the Howard Hughes Medical Institute and members of the Center for RNA Systems Biology. Atomic coordinates and structure factors for the reported crystal structures have been deposited in the Protein Data Bank under accession codes 5VVJ (half-site-bound), 5VVK (pseudo-full-site-bound), and 5VVL (pseudo-full-sitebound with Ni<SUP>2+</SUP>). The cryo-EM structure and map have been deposited in the Protein Data Bank under accession code 5WFE and the Electron Microscopy Data Bank under accession code EMD-8827. A patent has been filed by the University of California for the use of Cas1-Cas2 for integrating DNA into genomes. J.A.D. is a cofounder and Scientific Advisory Board member of Caribou Biosciences and Intellia Therapeutics and a cofounder of Editas Medicine, all of which develop CRISPR-based technologies.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beguin P, 2016, NUCLEIC ACIDS RES, V44, P10367, DOI 10.1093/nar/gkw821; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; Gardiner EJ, 2003, J MOL BIOL, V332, P1025, DOI 10.1016/j.jmb.2003.08.006; Goren MG, 2016, CELL REP, V16, P2811, DOI 10.1016/j.celrep.2016.08.043; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97, DOI 10.1038/72017; Hickman AB, 2015, NUCLEIC ACIDS RES, V43, P10576, DOI 10.1093/nar/gkv1180; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Laxmikanthan G, 2016, ELIFE, V5, DOI 10.7554/eLife.14313; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Moch C, 2017, NUCLEIC ACIDS RES, V45, P2714, DOI 10.1093/nar/gkw1309; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Nadler DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12266; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	34	81	85	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2017	357	6356					1113	+		10.1126/science.aao0679	http://dx.doi.org/10.1126/science.aao0679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7XX	28729350	Green Accepted, Green Submitted			2022-12-28	WOS:000410639800035
J	Ortiz-Ramirez, C; Michard, E; Simon, AA; Damineli, DSC; Hernandez-Coronado, M; Becker, JD; Feijo, JA				Ortiz-Ramirez, Carlos; Michard, Erwan; Simon, Alexander A.; Damineli, Daniel S. C.; Hernandez-Coronado, Marcela; Becker, Jorg D.; Feijo, Jose A.			GLUTAMATE RECEPTOR-LIKE channels are essential for chemotaxis and reproduction in mosses	NATURE			English	Article							PHYSCOMITRELLA-PATENS; EXPRESSION; ARABIDOPSIS; EVOLUTION; GENE; CALCIUM; SPERM; IDENTIFICATION; FAMILY; PLANTS	Glutamate receptors are well characterized channels that mediate cell-to-cell communication during neurotransmission in animals, but their functional role in organisms without a nervous system remains unclear. In plants, genes of the GLUTAMATE RECEPTOR-LIKE (GLR) family have been implicated in defence against pathogens, reproduction, control of stomata aperture and light signal transduction(1-5). However, the large number of GLR genes present in angiosperm genomes (20 to 70)(6) has prevented the observation of strong phenotypes in loss-of-function mutants. Here we show that in the basal land plant Physcomitrella patens, mutation of the GLR genes GLR1 and GLR2 causes failure of sperm cells to target the female reproductive organs. In addition, we show that GLR genes encode non-selective Ca2+-permeable channels that can regulate cytoplasmic Ca2+ and are needed to induce the expression of a BELL1-like transcription factor essential for zygote development. Our work reveals functions for GLR channels in sperm chemotaxis and transcriptional regulation. Sperm chemotaxis is essential for fertilization in both animals and early land plants such as bryophytes and pteridophytes. Therefore, our results suggest that ionotropic glutamate receptors may have been conserved throughout plant evolution to mediate cell-to-cell communication during sexual reproduction.	[Ortiz-Ramirez, Carlos; Michard, Erwan; Hernandez-Coronado, Marcela; Becker, Jorg D.; Feijo, Jose A.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Michard, Erwan; Simon, Alexander A.; Damineli, Daniel S. C.; Feijo, Jose A.] Univ Maryland, Dept Cell Biol & Mol Genet, 0118 BioSci Res Bldg, College Pk, MD 20742 USA; [Ortiz-Ramirez, Carlos; Hernandez-Coronado, Marcela] NYU, Dept Biol, Ctr Genom & Syst Biol, 12 Waverly Pl, New York, NY 10003 USA	Instituto Gulbenkian de Ciencia; University System of Maryland; University of Maryland College Park; New York University	Feijo, JA (corresponding author), Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal.; Feijo, JA (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 0118 BioSci Res Bldg, College Pk, MD 20742 USA.	jfeijo@umd.edu	Ortiz-Ramirez, Carlos/AAG-3118-2019; Damineli, Daniel S. C./P-1222-2018; Becker, Jorg/A-5930-2011; michard, erwan/GXH-1685-2022; Feijo, Jose A./ADM-0262-2022	Damineli, Daniel S. C./0000-0002-9911-2891; Becker, Jorg/0000-0002-6845-6122; Feijo, Jose A./0000-0002-1100-5478; Hernandez Coronado, Marcela/0000-0002-3841-0692; Ortiz-Ramirez, Carlos/0000-0002-5166-1955	MarieCurie ITN-Plant Origins (FP7-PEOPLE-ITN); Fundacao para a Ciencua e Tecnologia (FCT)-Portugal [BEX-BCM/0376/2012, PTDC/BIA-PLA/4018/2012]; National Science Foundation (NSF)-US [MCB 1616437/2016]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-PLA/4018/2012, PTDC/BEX-BCM/0376/2012] Funding Source: FCT; Div Of Molecular and Cellular Bioscience [1616437] Funding Source: National Science Foundation	MarieCurie ITN-Plant Origins (FP7-PEOPLE-ITN); Fundacao para a Ciencua e Tecnologia (FCT)-Portugal; National Science Foundation (NSF)-US(National Science Foundation (NSF)); Fundação para a Ciência e a Tecnologia; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. F. Perroud for the Gransden GFP and Villersexel RFP lines; L. Dolan and T. Tan for the pBNRF, pBHrev and p108GW35S vectors; M. Hasebe for the pTN83 construct; S. Rensing for providing us access to the Nimblegen_Ppat_SR_-exp_HX12 array and the Institute for Research in Biomedicine (IRB)/Functional Genomics Core (FGC) (Barcelona) for microarray processing; J. Kudla for the pEF1-YC3.6 vector. C.O.R. and M.H.C. acknowledge fellowships from MarieCurie ITN-Plant Origins (FP7-PEOPLE-ITN-2008). J. A. F. acknowledges grants from the Fundacao para a Ciencua e Tecnologia (FCT)-Portugal (BEX-BCM/0376/2012; PTDC/BIA-PLA/4018/2012) and the National Science Foundation (NSF)-US (MCB 1616437/2016).	ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Bowman JL, 2016, ANNU REV GENET, V50, P133, DOI 10.1146/annurev-genet-120215-035227; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Chiu JC, 2002, MOL BIOL EVOL, V19, P1066, DOI 10.1093/oxfordjournals.molbev.a004165; Cho D, 2009, PLANT J, V58, P437, DOI 10.1111/j.1365-313X.2009.03789.x; Damineli DSC, 2017, J EXP BOT, V68, P3267, DOI 10.1093/jxb/erx032; De Bortoli S, 2016, BIOPHYS CHEM, V218, P14, DOI 10.1016/j.bpc.2016.07.004; Forde Brian G, 2014, F1000Prime Rep, V6, P37, DOI 10.12703/P6-37; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hohe A, 2002, PLANT BIOLOGY, V4, P595, DOI 10.1055/s-2002-35440; Horst NA, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.209, 10.1038/nplants.2015.209]; Hu JH, 2004, J ANDROL, V25, P140; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Lee JH, 2008, CELL, V133, P829, DOI 10.1016/j.cell.2008.04.028; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Michard E, 2011, SCIENCE, V332, P434, DOI 10.1126/science.1201101; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Ortiz-Ramirez C, 2016, MOL PLANT, V9, P205, DOI 10.1016/j.molp.2015.12.002; Perroud PF, 2011, NEW PHYTOL, V191, P301, DOI 10.1111/j.1469-8137.2011.03668.x; REISER L, 1995, CELL, V83, P735, DOI 10.1016/0092-8674(95)90186-8; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; RESKI R, 1985, PLANTA, V165, P354, DOI 10.1007/BF00392232; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Rutjens B, 2009, PLANT J, V58, P641, DOI 10.1111/j.1365-313X.2009.03809.x; Verret F, 2010, NEW PHYTOL, V187, P23, DOI 10.1111/j.1469-8137.2010.03271.x	30	72	72	7	95	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					91	+		10.1038/nature23478	http://dx.doi.org/10.1038/nature23478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28737761	Green Published			2022-12-28	WOS:000409388700039
J	Horwitz, JA; Bar-On, Y; Lu, CL; Fera, D; Lockhart, AAK; Lorenzi, JCC; Nogueira, L; Golijanin, J; Scheid, JF; Seaman, MS; Gazumyan, A; Zolla-Pazner, S; Nussenzweig, MC				Horwitz, Joshua A.; Bar-On, Yotam; Lu, Ching-Lan; Fera, Daniela; Lockhart, Ainsley A. K.; Lorenzi, Julio C. C.; Nogueira, Lilian; Golijanin, Jovana; Scheid, Johannes F.; Seaman, Michael S.; Gazumyan, Anna; Zolla-Pazner, Susan; Nussenzweig, Michel C.			Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; VAGINAL SHIV CHALLENGE; PROTECTIVE EFFICACY; MONOCLONAL-ANTIBODY; PASSIVE-IMMUNIZATION; EFFECTOR FUNCTION; MOUSE MODEL; VACCINE; CELLS	Non-neutralizing antibodies (nnAbs) to HIV-1 show little measurable activity in prevention or therapy in animal models yet were the only correlate of protection in the RV144 vaccine trial. To investigate the role of nnAbs on HIV-1 infection in vivo, we devised a replication-competent HIV-1 reporter virus that expresses a heterologous HA-tag on the surface of infected cells and virions. Anti-HA antibodies bind to, but do not neutralize, the reporter virus in vitro. However, anti-HA protects against infection in humanized mice and strongly selects for nnAb-resistant viruses in an entirely Fc-dependent manner. Similar results were also obtained with tier 2 HIV-1 viruses using a human anti-gp41 nnAb, 246D. While nnAbs are demonstrably less effective than broadly neutralizing antibodies (bNAbs) against HIV-1 in vitro and in vivo, the data show that nnAbs can protect against and alter the course of HIV-1 infection in vivo.	[Horwitz, Joshua A.; Bar-On, Yotam; Lu, Ching-Lan; Lorenzi, Julio C. C.; Nogueira, Lilian; Golijanin, Jovana; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10065 USA; [Horwitz, Joshua A.] Harvard Med Sch, Lab Struct Cell Biol, 250 Longwood Ave, Boston, MA 02115 USA; [Horwitz, Joshua A.] Harvard Med Sch, Whelan Lab, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Lu, Ching-Lan] Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA; [Fera, Daniela] Harvard Med Sch, Boston Childrens Hosp, Lab Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA; [Lockhart, Ainsley A. K.] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10065 USA; [Scheid, Johannes F.] Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA; [Seaman, Michael S.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, 3 Blackfan Circle, Boston, MA 02115 USA; [Zolla-Pazner, Susan] Icahn Sch Med Mt Sinai, Zolla Pazner Lab, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Cornell University; Harvard University; Boston Children's Hospital; Harvard Medical School; Rockefeller University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	nussen@rockefeller.edu	Lorenzi, Julio Cesar C.C. Cetrulo/B-5264-2008; Zolla-Pazner, Susan/S-1864-2019; Lorenzi, Julio/S-2394-2019; Nussenzweig, Michel/AAE-7292-2019	Lorenzi, Julio Cesar C.C. Cetrulo/0000-0003-2492-3961; Zolla-Pazner, Susan/0000-0002-0750-2666; Lorenzi, Julio/0000-0003-2492-3961; Lockhart, Ainsley/0000-0003-0304-4618	NIH [F31 AI118555, P01 AI100151]; Howard Hughes Medical Institute at Harvard Medical School; EMBO [ALTF 661-2016]; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [OPP1033115, OPP1124068]; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663]; National Institute of Allergy and Infectious Diseases of the NIH [AI100148, AI109632]; Robertson Foundation; Rockefeller University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070084, UM1AI100663, P01AI100151, P01AI100148, U19AI109632, F31AI118555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute at Harvard Medical School; EMBO(European Molecular Biology Organization (EMBO)); Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robertson Foundation; Rockefeller University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Harry B. Gristick for assistance with structural representations of the BG505.SOSIP trimer, Drs. Jeffrey V. Ravetch and Stylianos Bournazos for helpful discussions, Neena Thomas for single cell FACS sorting, Harald Hartweger for help with experiments, Zoran Jankovic for laboratory support, and all members of the Nussenzweig Laboratory for helpful discussion and advice. J.A.H. was supported in part by the NIH (F31 AI118555) and by the Howard Hughes Medical Institute at Harvard Medical School. Y.B.-O. was supported in part by EMBO Long-Term Fellowship (ALTF 661-2016). S.Z.-P. was supported by the NIH (P01 AI100151) and by funds from the Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai. M.C.N. was supported by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (OPP1033115 and OPP1124068) the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) (1UM1 AI100663), the National Institute of Allergy and Infectious Diseases of the NIH (AI100148 and AI109632), the Robertson Foundation, and the Rockefeller University. M.C.N. is a Howard Hughes Medical Institute Investigator.	Ali A, 2006, J VIROL METHODS, V133, P41, DOI 10.1016/j.jviromet.2005.10.016; Alvarez RA, 2014, J VIROL, V88, P6031, DOI 10.1128/JVI.00449-14; ANDRIS JS, 1991, P NATL ACAD SCI USA, V88, P7783, DOI 10.1073/pnas.88.17.7783; Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; [Anonymous], AIDS, V30, P1543; Arias JF, 2014, P NATL ACAD SCI USA, V111, P6425, DOI 10.1073/pnas.1321507111; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Baum LL, 1996, J IMMUNOL, V157, P2168; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bradley T, 2016, EBIOMEDICINE, V12, P196, DOI 10.1016/j.ebiom.2016.08.045; Bruel T, 2017, J VIROL, V91, DOI 10.1128/JVI.02440-16; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chung AW, 2014, AIDS, V28, P2523, DOI 10.1097/QAD.0000000000000444; Chung AW, 2011, P NATL ACAD SCI USA, V108, P7505, DOI 10.1073/pnas.1016048108; CHURCHILL MEA, 1994, J MOL BIOL, V241, P534, DOI 10.1006/jmbi.1994.1530; Demberg T, 2007, J VIROL, V81, P3414, DOI 10.1128/JVI.02453-06; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765; Ferrari G, 2017, J INFECT DIS, V215, pS152, DOI 10.1093/infdis/jiw555; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; Holl V, 2004, J IMMUNOL, V173, P6274, DOI 10.4049/jimmunol.173.10.6274; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kramski M, 2013, CURR HIV RES, V11, P388, DOI 10.2174/15701; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Lewis GK, 2017, IMMUNOL REV, V275, P271, DOI 10.1111/imr.12510; Lewis GK, 2013, CURR HIV RES, V11, P354, DOI 10.2174/1570162X113116660060; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Margolis DM, 2017, IMMUNOL REV, V275, P313, DOI 10.1111/imr.12506; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moog C, 2014, MUCOSAL IMMUNOL, V7, P46, DOI 10.1038/mi.2013.23; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; MORAN MJ, 1993, MOL IMMUNOL, V30, P1543, DOI 10.1016/0161-5890(93)90462-K; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; Pegu A, 2017, IMMUNOL REV, V275, P296, DOI 10.1111/imr.12511; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Pham TNQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37225; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richard J, 2016, EBIOMEDICINE, V3, P122, DOI 10.1016/j.ebiom.2015.12.004; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Santra S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005042; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Song RJ, 2010, J VIROL, V84, P6935, DOI 10.1128/JVI.00453-10; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; ZOLLAPAZNER S, 1995, J VIROL, V69, P3807, DOI 10.1128/JVI.69.6.3807-3815.1995	80	90	92	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2017	170	4					637	+		10.1016/j.cell.2017.06.048	http://dx.doi.org/10.1016/j.cell.2017.06.048			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FD3PU	28757252	Green Accepted, Bronze			2022-12-28	WOS:000407445700006
J	Trounson, A				Trounson, Alan			Potential Pitfall of Pluripotent Stem Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Trounson, Alan] Hudson Inst Med Res, Canc Res Ctr, Clayton, Vic, Australia; [Trounson, Alan] Monash Univ, Clayton, Vic, Australia	Hudson Institute of Medical Research; Monash University	Trounson, A (corresponding author), Hudson Inst Med Res, Canc Res Ctr, Clayton, Vic, Australia.; Trounson, A (corresponding author), Monash Univ, Clayton, Vic, Australia.			Trounson, Alan/0000-0001-5469-0500				Garitaonandia I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118307; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Trounson A, 2016, NAT REV MOL CELL BIO, V17, P194, DOI 10.1038/nrm.2016.10; Yi L, 2012, CANCER RES, V72, P5635, DOI 10.1158/0008-5472.CAN-12-1451	4	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					490	491		10.1056/NEJMcibr1706906	http://dx.doi.org/10.1056/NEJMcibr1706906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3NW	28767348				2022-12-28	WOS:000406747100014
J	Sadeghirad, B; Johnston, BC				Sadeghirad, Behnam; Johnston, Bradley C.			The Scientific Basis of Guideline Recommendations on Sugar Intake RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sadeghirad, Behnam; Johnston, Bradley C.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Sadeghirad, B (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Sadeghirad, Behnam/A-1772-2009	Sadeghirad, Behnam/0000-0001-9422-5232				Alexander PE, 2016, J CLIN EPIDEMIOL, V72, P98, DOI 10.1016/j.jclinepi.2014.10.011; Bhutta ZA, 2015, BMC NUTR, V1, P9; Dietary Guidelines Advisory Committee, 2015, SCI REP 2015 DIET GU; Moher D, 2008, AM J CLIN NUTR, V88, P1191, DOI 10.3945/ajcn.2008.26255; US Department of Agriculture and US Department of Health and Human Services, 2015, DIET GUID AM 2015 20	5	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					219	219		10.7326/L17-0255	http://dx.doi.org/10.7326/L17-0255			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28761953				2022-12-28	WOS:000406631400021
J	Doyle, LW; Carse, E; Adams, AM; Ranganathan, S; Opie, G; Cheong, JLY				Doyle, Lex W.; Carse, Elizabeth; Adams, Anne-Marie; Ranganathan, Sarath; Opie, Gillian; Cheong, Jeanie L. Y.		Victorian Infant Collaborative	Ventilation in Extremely Preterm Infants and Respiratory Function at 8 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORTICOSTEROIDS; VICTORIA; OUTCOMES; TRIAL; RISK	BACKGROUND Assisted ventilation for extremely preterm infants (<28 weeks of gestation) has become less invasive, but it is unclear whether such developments in care are associated with improvements in short-term or long-term lung function. We compared changes over time in the use of assisted ventilation and oxygen therapy during the newborn period and in lung function at 8 years of age in children whose birth was extremely premature. METHODS We conducted longitudinal follow-up of all survivors of extremely preterm birth who were born in Victoria, Australia, in three periods - the years 1991 and 1992 (225 infants), 1997 (151 infants), and 2005 (170 infants). Perinatal data were collected prospectively, including data on the duration and type of assisted ventilation provided, the duration of oxygen therapy, and oxygen requirements at 36 weeks of age. Expiratory airflow was measured at 8 years of age, and values were converted to z scores for age, height, ethnic group, and sex. RESULTS The duration of assisted ventilation rose substantially over time, with a large increase in the duration of nasal continuous positive airway pressure. Despite the increase in the use of less invasive ventilation over time, the duration of oxygen therapy and the rate of oxygen dependence at 36 weeks rose, and airflows at 8 years of age were worse in 2005 than in earlier periods. For instance, for 2005 versus 1991-1992, the mean difference in the z scores for the ratio of forced expiratory volume in 1 second to forced vital capacity was -0.75 (95% confidence interval [CI], -1.07 to -0.44; P<0.001), and for 2005 versus 1997 the mean difference was -0.53 (95% CI, -0.86 to -0.19; P = 0.002). CONCLUSIONS Despite substantial increases in the use of less invasive ventilation after birth, there was no significant decline in oxygen dependence at 36 weeks and no significant improvement in lung function in childhood over time.	[Doyle, Lex W.; Cheong, Jeanie L. Y.] Royal Womens Hosp, Neonatal Serv, Melbourne, Vic, Australia; [Doyle, Lex W.; Cheong, Jeanie L. Y.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Doyle, Lex W.; Ranganathan, Sarath] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Carse, Elizabeth] Monash Med Ctr, Newborn Serv, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Adams, Anne-Marie; Ranganathan, Sarath] Royal Childrens Hosp, Resp & Sleep Med, Melbourne, Vic, Australia; [Opie, Gillian] Mercy Hosp Women, Neonatal Serv, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Doyle, LW (corresponding author), Royal Womens Hosp, Parkville, Vic 3052, Australia.	lwd@unimelb.edu.au	Doyle, Lex/AAJ-5205-2021	Doyle, Lex/0000-0002-7667-7312; Ranganathan, Sarath/0000-0002-6975-0307; Adams, Anne-Marie/0000-0003-0441-3796	National Health and Medical Research Council of Australia; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	Funded by the National Health and Medical Research Council of Australia and the Victorian Government's Operational Infrastructure Support Program.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Cheong JLY, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4086; Doyle LW, 2014, J PEDIATR-US, V165, P1258, DOI 10.1016/j.jpeds.2014.07.049; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Doyle LW, 2016, THORAX; Gibson AM, 2014, SEMIN FETAL NEONAT M, V19, P105, DOI 10.1016/j.siny.2013.10.006; Hacking DF, 2013, PEDIATR PULM, V48, P449, DOI 10.1002/ppul.22619; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kirpalani H, 2013, NEW ENGL J MED, V369, P611, DOI 10.1056/NEJMoa1214533; Manley BJ, 2013, NEW ENGL J MED, V369, P1425, DOI 10.1056/NEJMoa1300071; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; REYNOLDS EO, 1975, BRIT MED BULL, V31, P18, DOI 10.1093/oxfordjournals.bmb.a071235; Roberts CT, 2016, NEW ENGL J MED, V375, P1142, DOI 10.1056/NEJMoa1603694; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Soll RF, 1998, BIOL NEONATE, V74, P35, DOI 10.1159/000047033; Thomas MR, 2004, AM J RESP CRIT CARE, V169, P868, DOI 10.1164/rccm.200310-1425OC; Vollsaeter M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144243; Zivanovic S, 2014, NEW ENGL J MED, V370, P1121, DOI 10.1056/NEJMoa1309220	21	132	133	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2017	377	4					329	337		10.1056/NEJMoa1700827	http://dx.doi.org/10.1056/NEJMoa1700827			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BB	28745986	Bronze			2022-12-28	WOS:000406295000005
J	Troja, E; Lipunov, VM; Mundell, CG; Butler, NR; Watson, AM; Kobayashi, S; Cenko, SB; Marshall, FE; Ricci, R; Fruchter, A; Wieringa, MH; Gorbovskoy, ES; Kornilov, V; Kutyrev, A; Lee, WH; Toy, V; Tyurina, NV; Budnev, NM; Buckley, DAH; Gonzalez, J; Gress, O; Horesh, A; Panasyuk, MI; Prochaska, JX; Ramirez-Ruiz, E; Lopez, RR; Richer, MG; Roman-Zuniga, C; Serra-Ricart, M; Yurkov, V; Gehrels, N				Troja, E.; Lipunov, V. M.; Mundell, C. G.; Butler, N. R.; Watson, A. M.; Kobayashi, S.; Cenko, S. B.; Marshall, F. E.; Ricci, R.; Fruchter, A.; Wieringa, M. H.; Gorbovskoy, E. S.; Kornilov, V.; Kutyrev, A.; Lee, W. H.; Toy, V.; Tyurina, N. V.; Budnev, N. M.; Buckley, D. A. H.; Gonzalez, J.; Gress, O.; Horesh, A.; Panasyuk, M. I.; Prochaska, J. X.; Ramirez-Ruiz, E.; Rebolo Lopez, R.; Richer, M. G.; Roman-Zuniga, C.; Serra-Ricart, M.; Yurkov, V.; Gehrels, N.			Significant and variable linear polarization during the prompt optical flash of GRB 160625B	NATURE			English	Article							GAMMA-RAY BURST; INDUCED MAGNETIC RECONNECTION; INTERNAL SHOCKS; REVERSE SHOCK; LIGHT CURVES; EMISSION; AFTERGLOWS; 041219A; JETS; SIMULATIONS	Newly formed black holes of stellar mass launch collimated outflows (jets) of ionized matter that approach the speed of light. These outflows power prompt, brief and intense flashes of gamma-rays known as gamma-ray bursts (GRBs), followed by longer-lived afterglow radiation that is detected across the electromagnetic spectrum. Measuring the polarization of the observed GRB radiation provides a direct probe of the magnetic fields in the collimated jets. Rapid-response polarimetric observations of newly discovered bursts have probed the initial afterglow phase(1-3), and show that, minutes after the prompt emission has ended, the degree of linear polarization can be as high as 30 per cent-consistent with the idea that a stable, globally ordered magnetic field permeates the jet at large distances from the central source(3). By contrast, optical(4-6) and gamma-ray(7-9) observations during the prompt phase have led to discordant and often controversial(10-12) results, and no definitive conclusions have been reached regarding the origin of the prompt radiation or the configuration of the magnetic field. Here we report the detection of substantial (8.3 +/- 0.8 per cent from our most conservative simulation), variable linear polarization of a prompt optical flash that accompanied the extremely energetic and long-lived prompt gamma-ray emission from GRB 160625B. Our measurements probe the structure of the magnetic field at an early stage of the jet, closer to its central black hole, and show that the prompt phase is produced via fast-cooling synchrotron radiation in a large-scale magnetic field that is advected from the black hole and distorted by dissipation processes within the jet.	[Troja, E.; Cenko, S. B.; Kutyrev, A.; Toy, V.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Troja, E.; Cenko, S. B.; Marshall, F. E.; Kutyrev, A.; Gehrels, N.] NASA, Goddard Space Flight Ctr, 8800 Greenbelt Rd, Greenbelt, MD 20771 USA; [Lipunov, V. M.; Gorbovskoy, E. S.; Kornilov, V.; Tyurina, N. V.] Moscow MV Lomonosov State Univ, Dept Phys, GSP-1, Moscow 119991, Russia; [Lipunov, V. M.; Gorbovskoy, E. S.; Kornilov, V.; Tyurina, N. V.] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Univ Prospekt 13, Moscow 119234, Russia; [Mundell, C. G.] Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England; [Butler, N. R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Watson, A. M.; Lee, W. H.; Gonzalez, J.] Univ Nacl Autonoma Mexico, Inst Astron, Apartado Postal 70-264, Mexico City 04510, DF, Mexico; [Kobayashi, S.] Liverpool John Moores Univ, Astrophys Res Inst, IC2 Bldg,Liverpool Sci Pk,146 Brownlow Hill, Liverpool L3 5RF, Merseyside, England; [Ricci, R.] INAF Ist Radioastron, Via Gobetti 101, I-40129 Bologna, Italy; [Fruchter, A.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Wieringa, M. H.] CSIRO Astron & Space Sci, POB 76, Epping, NSW 1710, Australia; [Budnev, N. M.; Gress, O.] Irkutsk State Univ, Inst Appl Phys, 20 Gagarin Blvd, Irkutsk 664003, Russia; [Buckley, D. A. H.] South African Astron Observ, POB 9, ZA-7935 Cape Town, South Africa; [Horesh, A.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Panasyuk, M. I.] Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys Lomonosov, Moscow 119991, Russia; [Prochaska, J. X.; Ramirez-Ruiz, E.] Univ Calif Observ, 1156 High St, Santa Cruz, CA 95064 USA; [Rebolo Lopez, R.; Serra-Ricart, M.] Inst Astrofis Canarias, Via Lactea S-N, E-38205 Tenerife, Spain; [Richer, M. G.; Roman-Zuniga, C.] Univ Nacl Autonoma Mexico, Inst Astron, Apartado Postal 106, Ensenada 22800, Baja California, Mexico; [Yurkov, V.] Blagoveshchensk State Pedag Univ, Lenin St 104, Blagoveshchensk 675000, Amur Region, Russia	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Lomonosov Moscow State University; Lomonosov Moscow State University; University of Bath; Arizona State University; Arizona State University-Tempe; Universidad Nacional Autonoma de Mexico; Liverpool John Moores University; Istituto Nazionale Astrofisica (INAF); Space Telescope Science Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Irkutsk State University; Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; National Research Foundation - South Africa; South African Astronomical Observatory; Hebrew University of Jerusalem; Lomonosov Moscow State University; University of California System; University of California Santa Cruz; Instituto de Astrofisica de Canarias; Universidad Nacional Autonoma de Mexico	Troja, E (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.; Troja, E (corresponding author), NASA, Goddard Space Flight Ctr, 8800 Greenbelt Rd, Greenbelt, MD 20771 USA.	eleonora.troja@nasa.gov	Troja, Eleonora/I-5282-2017; Gress, Oleg/AGZ-7514-2022; Serra-Ricart, Miguel/AAB-2812-2019; González, J. Jesús/L-6687-2014; Troja, Eleonora/AAB-3604-2020; Panasyuk, Mikhail I./E-2005-2012; Gorbovskoy, Evgeny Sergeevich/O-8845-2015; Horesh, Assaf/O-9873-2016	Troja, Eleonora/0000-0002-1869-7817; Gress, Oleg/0000-0002-5070-0836; González, J. Jesús/0000-0002-3724-1583; Troja, Eleonora/0000-0002-1869-7817; Gorbovskoy, Evgeny Sergeevich/0000-0002-4368-9237; Wieringa, Mark/0000-0002-7721-8660; Rebolo, Rafael/0000-0003-3767-7085; Watson, Alan/0000-0002-2008-6927; Horesh, Assaf/0000-0002-5936-1156; Fruchter, Andrew/0000-0002-6652-9279	NASA [NNX09AH71G, NNX09AT02G, NNX10AI27G, NNX12AE66G]; CONACyT [INFR-2009-01-122785, CB-2008-101958]; UNAM PAPIIT [IN113810]; UC MEXUS-CONACyT grant [CN 09-283]; Development Program of Lomonosov Moscow State University; Moscow Union OPTICA; Russian Science Foundation [16-12-00085]; NASA Fermi grants [NNH14ZDA001N, NNH15ZDA001N]; UK Space Agency	NASA(National Aeronautics & Space Administration (NASA)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); UC MEXUS-CONACyT grant; Development Program of Lomonosov Moscow State University; Moscow Union OPTICA; Russian Science Foundation(Russian Science Foundation (RSF)); NASA Fermi grants; UK Space Agency	E.T. thanks L. Piro and K. Murase for comments. We thank the RATIR (Reionization And Transients InfraRed) project team and the staff of the Observatorio Astronomico Nacional on Sierra San Pedro Martir, and acknowledge the contribution of L. Georgiev and J.S. Bloom to the development of this observatory. RATIR is a collaboration between the University of California, the Universidad Nacional Autonoma de Mexico, the NASA Goddard Space Flight Center and Arizona State University, and benefits from the loan of an H2RG detector and hardware and software support from Teledyne Scientific and Imaging. RATIR, the automation of the Harold L. Johnson Telescope of the Observatorio Astronomico Nacional on Sierra San Pedro Martir, and the operation of both are funded through NASA grants NNX09AH71G, NNX09AT02G, NNX10AI27G and NNX12AE66G, CONACyT grants INFR-2009-01-122785 and CB-2008-101958, UNAM PAPIIT grant IN113810, and UC MEXUS-CONACyT grant CN 09-283. The MASTER project is supported in part by the Development Program of Lomonosov Moscow State University, Moscow Union OPTICA, Russian Science Foundation grant 16-12-00085. This work was supported in part by NASA Fermi grants NNH14ZDA001N and NNH15ZDA001N. This work made use of data supplied by the UK Swift Science Data Centre at the University of Leicester, funded by the UK Space Agency.	Ackermann M, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/71; Arnaud KA, 1996, ASTR SOC P, V101, P17; BAND D, 1993, ASTROPHYS J, V413, P281, DOI 10.1086/172995; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Bromberg O, 2016, MON NOT R ASTRON SOC, V456, P1739, DOI 10.1093/mnras/stv2591; Cenko SB, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/29; Chambers K. C., 2016, RAD PROCESSES ASTROP; Chambers K. C., 2016, PAN STARRS1 SURVEYS; Coburn W, 2003, NATURE, V423, P415, DOI 10.1038/nature01612; Deng W, 2016, ASTROPHYS J LETT, V821, DOI 10.3847/2041-8205/821/1/L12; Dirirsa F., 2016, GCN CIRC; Fan YZ, 2005, ASTROPHYS J, V628, pL25, DOI 10.1086/432616; Gendre B, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/59; Giannios D, 2008, ASTRON ASTROPHYS, V480, P305, DOI 10.1051/0004-6361:20079085; Giannios D, 2010, MON NOT R ASTRON SOC, V408, pL46, DOI 10.1111/j.1745-3933.2010.00925.x; Gorbovskoy ES, 2016, MON NOT R ASTRON SOC, V455, P3312, DOI 10.1093/mnras/stv2515; Gotz D, 2009, ASTROPHYS J LETT, V695, pL208, DOI 10.1088/0004-637X/695/2/L208; Granot J, 2003, ASTROPHYS J, V594, pL83, DOI 10.1086/378733; Granot J, 2002, ASTROPHYS J, V568, P820, DOI 10.1086/338966; Gruzinov A, 1999, ASTROPHYS J, V511, P852, DOI 10.1086/306720; Inoue T, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/77; Kalemci E, 2007, ASTROPHYS J SUPPL S, V169, P75, DOI 10.1086/510676; Klotz A, 2009, ASTRON J, V137, P4100, DOI 10.1088/0004-6256/137/5/4100; Kobayashi S, 2000, ASTROPHYS J, V545, P807, DOI 10.1086/317869; Kopac D, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/1; Kumar P, 2008, MON NOT R ASTRON SOC, V391, pL19, DOI 10.1111/j.1745-3933.2008.00546.x; Kumar P, 2015, PHYS REP, V561, P1, DOI 10.1016/j.physrep.2014.09.008; Li Z, 2008, ASTROPHYS J LETT, V674, pL65, DOI 10.1086/529042; Lipunov V, 2010, ADV ASTRON, V2010, DOI 10.1155/2010/349171; Lyutikov M, 2003, ASTROPHYS J, V597, P998, DOI 10.1086/378497; McGlynn S, 2007, ASTRON ASTROPHYS, V466, P895, DOI 10.1051/0004-6361:20066179; Mundell CG, 2013, NATURE, V504, P119, DOI 10.1038/nature12814; Mundell CG, 2007, SCIENCE, V315, P1822, DOI 10.1126/science.1138484; Piran T, 1999, PHYS REP, V314, P575, DOI 10.1016/S0370-1573(98)00127-6; Pruzhinskaya MV, 2014, NEW ASTRON, V29, P65, DOI 10.1016/j.newast.2013.12.003; Rutledge RE, 2004, MON NOT R ASTRON SOC, V350, P1288, DOI 10.1111/j.1365-2966.2004.07665.x; Sari R, 2000, ASTROPHYS J, V535, pL33, DOI 10.1086/312689; Sault RJ, 1995, ASTR SOC P, V77, P433; SERKOWSKI K, 1975, ASTROPHYS J, V196, P261, DOI 10.1086/153410; Shen RF, 2009, MON NOT R ASTRON SOC, V398, P1936, DOI 10.1111/j.1365-2966.2009.15212.x; Sironi L, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/75; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Steele IA, 2009, NATURE, V462, P767, DOI 10.1038/nature08590; Uhm ZL, 2014, NAT PHYS, V10, P351, DOI [10.1038/nphys2932, 10.1038/NPHYS2932]; Vestrand WT, 2005, NATURE, V435, P178, DOI 10.1038/nature03515; Wei DM, 2007, MON NOT R ASTRON SOC, V374, P525, DOI 10.1111/j.1365-2966.2006.11156.x; Yonetoku D, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/1/L1; Yu YW, 2009, ASTROPHYS J, V692, P1662, DOI 10.1088/0004-637X/692/2/1662; Zhang B, 2005, ASTROPHYS J, V628, P315, DOI 10.1086/429787; Zhang B, 2003, ASTROPHYS J, V595, P950, DOI 10.1086/377363; Zhang B. B, 2016, TRANSITION FIREBALL; Zhang B, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/90	53	74	75	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					425	+		10.1038/nature23289	http://dx.doi.org/10.1038/nature23289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28748924	Green Accepted			2022-12-28	WOS:000406358300029
J	He, QL; Pan, L; Stern, AL; Burks, EC; Che, XY; Yin, G; Wang, J; Lian, B; Zhou, Q; Choi, ES; Murata, KC; Kou, XF; Chen, ZJ; Nie, TX; Shao, QM; Fan, YB; Zhang, SC; Liu, K; Xia, J; Wang, KL				He, Qing Lin; Pan, Lei; Stern, Alexander L.; Burks, Edward C.; Che, Xiaoyu; Yin, Gen; Wang, Jing; Lian, Biao; Zhou, Quan; Choi, Eun Sang; Murata, Koichi; Kou, Xufeng; Chen, Zhijie; Nie, Tianxiao; Shao, Qiming; Fan, Yabin; Zhang, Shou-Cheng; Liu, Kai; Xia, Jing; Wang, Kang L.			Chiral Majorana fermion modes in a quantum anomalous Hall insulator-superconductor structure (Publication with Expression of Concern. See vol. 374, pg. 1454, 2021)	SCIENCE			English	Article; Publication with Expression of Concern							STATES	Majorana fermion is a hypothetical particle that is its own antiparticle. We report transport measurements that suggest the existence of one-dimensional chiral Majorana fermion modes in the hybrid system of a quantum anomalous Hall insulator thin film coupled with a superconductor. As the external magnetic field is swept, half-integer quantized conductance plateaus are observed at the locations of magnetization reversals, giving a distinct signature of the Majorana fermion modes. This transport signature is reproducible over many magnetic field sweeps and appears at different temperatures. This finding may open up an avenue to control Majorana fermions for implementing robust topological quantum computing.	[He, Qing Lin; Pan, Lei; Che, Xiaoyu; Yin, Gen; Murata, Koichi; Kou, Xufeng; Nie, Tianxiao; Shao, Qiming; Fan, Yabin; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect & Comp Engn, Dept Phys, Los Angeles, CA 90095 USA; [He, Qing Lin; Pan, Lei; Che, Xiaoyu; Yin, Gen; Murata, Koichi; Kou, Xufeng; Nie, Tianxiao; Shao, Qiming; Fan, Yabin; Wang, Kang L.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Wang, Kang L.] King Abdulaziz City Sci & Technol, Ctr Excellence Green Nanotechnol, Riyadh, Saudi Arabia; [Stern, Alexander L.; Xia, Jing] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Burks, Edward C.; Chen, Zhijie; Liu, Kai] Univ Calif Davis, Phys Dept, Davis, CA 95616 USA; [Wang, Jing] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China; [Wang, Jing; Lian, Biao; Zhou, Quan; Zhang, Shou-Cheng] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Choi, Eun Sang] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Kou, Xufeng] ShanghaiTech Univ, Sch Informat Sci & Technol, Shanghai 200031, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; King Abdulaziz City for Science & Technology; University of California System; University of California Irvine; University of California System; University of California Davis; Fudan University; Stanford University; State University System of Florida; Florida State University; ShanghaiTech University	He, QL; Kou, XF; Wang, KL (corresponding author), Univ Calif Los Angeles, Dept Elect & Comp Engn, Dept Phys, Los Angeles, CA 90095 USA.; He, QL; Kou, XF; Wang, KL (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.; Wang, KL (corresponding author), King Abdulaziz City Sci & Technol, Ctr Excellence Green Nanotechnol, Riyadh, Saudi Arabia.; Zhang, SC (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.; Kou, XF (corresponding author), ShanghaiTech Univ, Sch Informat Sci & Technol, Shanghai 200031, Peoples R China.	qlhe@ucla.edu; kouxf@shanghaitech.edu.cn; sczhang@stanford.edu; wang@ee.ucla.edu	Wang, Jing/E-5925-2012; Che, Xiaoyu/ABC-3012-2020; Shao, Qiming/AAV-5687-2020; Yin/O-2056-2018	Wang, Jing/0000-0002-4674-9485; Yin/0000-0001-5827-5101; He, Qing Lin/0000-0001-6524-1831	Spins and Heat in Nanoscale Electronic Systems (SHINES) Center, an Energy Frontier Research Center (EFRC) - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences [S000686]; Army Research Office (ARO) program [W911NF-15-1-0561:P00001]; NSF Faculty Early Career Development (CAREER) Award [DMR-1350122]; Function Accelerated nanoMaterial Engineering (FAME) Center, one of six centers of STARnet, a Semiconductor Research Corporation (SRC) program - Microelectronics Advanced Research Corporation (MARCO); Defense Advanced Research Projects Agency (DARPA); NSF [ECCS-1232275, DMR-1543582, DMR-1610060, DMR-1305677]; U.S. DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; National Science Foundation [DMR-1157490]; State of Florida; National Thousand-Young-Talents Program; Division Of Materials Research [1350122, 1610060] Funding Source: National Science Foundation	Spins and Heat in Nanoscale Electronic Systems (SHINES) Center, an Energy Frontier Research Center (EFRC) - U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Army Research Office (ARO) program; NSF Faculty Early Career Development (CAREER) Award(National Science Foundation (NSF)); Function Accelerated nanoMaterial Engineering (FAME) Center, one of six centers of STARnet, a Semiconductor Research Corporation (SRC) program - Microelectronics Advanced Research Corporation (MARCO); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); U.S. DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); State of Florida; National Thousand-Young-Talents Program; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the Spins and Heat in Nanoscale Electronic Systems (SHINES) Center, an Energy Frontier Research Center (EFRC) funded by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences under Award S000686. We are grateful for support from the Army Research Office (ARO) program under contract W911NF-15-1-0561:P00001 and NSF Faculty Early Career Development (CAREER) Award DMR-1350122. We also acknowledge support from the Function Accelerated nanoMaterial Engineering (FAME) Center, one of six centers of STARnet, a Semiconductor Research Corporation (SRC) program sponsored by Microelectronics Advanced Research Corporation (MARCO) and Defense Advanced Research Projects Agency (DARPA). Work at University of California, Davis, is supported by NSF ECCS-1232275 (K.L.), NSF DMR-1543582 (E.C.B), and NSF DMR-1610060 (Z.C.). J.W., B.L., Q.Z., and S.-C.Z. acknowledge support from the U.S. DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under contract DE-AC02-76SF00515 and from the NSF under grant DMR-1305677. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by National Science Foundation Cooperative Agreement DMR-1157490 and the State of Florida. Q.L.H. thanks B. Shen for device fabrications. Z.C. and K.L. thank P. Klavins for technical assistance with superconductivity measurements. J.W. also acknowledges support from the National Thousand-Young-Talents Program.	Akhmerov AR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216404; Alicea J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125318; Barkhausen H, 1919, PHYS Z, V20, P401; Braunecker B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.147202; Das A, 2012, NAT PHYS, V8, P887, DOI [10.1038/NPHYS2479, 10.1038/nphys2479]; Das Sarma S, 2015, NPJ QUANTUM INFORM, V1, DOI 10.1038/npjqi.2015.1; Elliott SR, 2015, REV MOD PHYS, V87, DOI 10.1103/RevModPhys.87.137; Feng Y, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.126801; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Fu L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216403; Halperin BI, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.144501; He JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4232; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Kou XF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9474; Law KT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237001; Lee PA, 2014, SCIENCE, V346, P545, DOI 10.1126/science.1260282; Lian BA, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.161401; Liu J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.267002; Maier L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186806; Majorana E., 1937, NUOVO CIMENTO, V5, P171, DOI [10.1007/BF02961314, DOI 10.1007/BF02961314]; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.020407; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184516; Qi XL, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.187001; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Sau JD, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.127003; Sau JD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040502; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Stern A, 2010, NATURE, V464, P187, DOI 10.1038/nature08915; Tanaka Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.107002; Volovik G. E., 1988, SOV PHYS JETP, V69, P9; Wang J, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.064520; Wang J, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.085106; Wang MX, 2012, SCIENCE, V336, P52, DOI 10.1126/science.1216466; Xu JP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.017001; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Zitko R, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.045441	41	416	423	28	312	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					294	299		10.1126/science.aag2792	http://dx.doi.org/10.1126/science.aag2792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729508	Green Submitted			2022-12-28	WOS:000405901600039
J	Ginsburg, PB; Patel, KK				Ginsburg, Paul B.; Patel, Kavita K.			Physician Payment Reform - Progress to Date	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE; PARTICIPATION; LEADERSHIP; MEDICARE; ACOS		[Ginsburg, Paul B.] Univ Southern Calif, Los Angeles, CA 90007 USA; [Patel, Kavita K.] Johns Hopkins Med, Baltimore, MD USA; [Ginsburg, Paul B.; Patel, Kavita K.] Brookings Inst, Washington, DC 20036 USA	University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; Brookings Institution	Ginsburg, PB (corresponding author), Univ Southern Calif, Los Angeles, CA 90007 USA.; Ginsburg, PB (corresponding author), Brookings Inst, Washington, DC 20036 USA.							[Anonymous], 2016, OR HLTH SYST TRANSF; [Anonymous], 2014, NAT SCOR PAYM REF; [Anonymous], 2016, CMS BUNDL PAYM CAR I; [Anonymous], 2013, MED HOM WHAT DO WE K; [Anonymous], 2016, REP C MED HLTH CAR D; Arkansas Health Care Payment Improvement Initiative, 2012, BUILD HLTH FUT ALL A; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Colla CH, 2014, HEALTH AFFAIR, V33, P964, DOI 10.1377/hlthaff.2013.1463; Dale SB, 2016, NEW ENGL J MED, V374, P2345, DOI 10.1056/NEJMsa1414953; Daschle T, 2013, BIPARTISAN RX PATIEN; Dummit LA, 2016, JAMA-J AM MED ASSOC, V316, P1267, DOI 10.1001/jama.2016.12717; Ginsburg PB, 2011, NEW ENGL J MED, V364, P172, DOI 10.1056/NEJMhpr1004028; Gronniger T, 2017, HLTH AFFAIRS BLOG; Kaiser Family Foundation, 2015, HLTH INS COV TOT POP; McClellan M, 2016, HLTH AFFAIRS BLOG; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; MedPAC, 2010, REP C MED HLTH CAR D; Mostashari F, 2014, JAMA-J AM MED ASSOC, V311, P1855, DOI 10.1001/jama.2014.4086; Yasaitis LC, 2016, HEALTH AFFAIR, V35, P1382, DOI 10.1377/hlthaff.2015.1635	20	15	15	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					285	292		10.1056/NEJMhpr1606353	http://dx.doi.org/10.1056/NEJMhpr1606353			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA9PI	28723320				2022-12-28	WOS:000405777600015
J	Kabadayi, C; Osvath, M				Kabadayi, Can; Osvath, Mathias			Ravens parallel great apes in flexible planning for tool-use and bartering	SCIENCE			English	Article							WESTERN SCRUB-JAYS; FUTURE-NEEDS; EXCHANGE	The ability to flexibly plan for events outside of the current sensory scope is at the core of being human and is crucial to our everyday lives and society. Studies on apes have shaped a belief that this ability evolved within the hominid lineage. Corvids, however, have shown evidence of planning their food hoarding, although this has been suggested to reflect a specific caching adaptation rather than domain-general planning. Here, we show that ravens plan for events unrelated to caching-tool-use and bartering-with delays of up to 17 hours, exert self-control, and consider temporal distance to future events. Their performance parallels that seen in apes and suggests that planning evolved independently in corvids, which opens new avenues for the study of cognitive evolution.	[Kabadayi, Can; Osvath, Mathias] Lund Univ, Dept Cognit Sci, Helgonavagen 3, S-22100 Lund, Sweden	Lund University	Osvath, M (corresponding author), Lund Univ, Dept Cognit Sci, Helgonavagen 3, S-22100 Lund, Sweden.	mathias.osvath@lucs.lu.se		Osvath, Mathias/0000-0002-7873-0930	Swedish Research Council [2012-1235, 2014-6402]; Marie Sklodowska Curie Actions, Cofund [INCA 600398]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marie Sklodowska Curie Actions, Cofund	We thank H. Osvath, I. Jacobs, A. Anikin, M. Lambert, L. Hall, C. Balkenius, P. Johansson, and T. Persson for help with the manuscript. This research was funded by the Swedish Research Council grants 2012-1235 and 2014-6402, the latter conjoined with Marie Sklodowska Curie Actions, Cofund, INCA 600398. The authors declare no conflict of interest. Data are available in the main article and supplementary materials.	Bourjade M, 2014, ANIM COGN, V17, P1329, DOI 10.1007/s10071-014-0768-6; Bourjade M, 2012, ANIM COGN, V15, P783, DOI 10.1007/s10071-012-0502-1; Cheke LG, 2012, BIOL LETTERS, V8, P171, DOI 10.1098/rsbl.2011.0909; Correia SPC, 2007, CURR BIOL, V17, P856, DOI 10.1016/j.cub.2007.03.063; Dekleva M, 2012, BEHAV PROCESS, V90, P392, DOI 10.1016/j.beproc.2012.04.003; Dufour V, 2008, BEHAV PROCESS, V79, P19, DOI 10.1016/j.beproc.2008.04.003; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Osvath M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00698; Premack D, 2007, P NATL ACAD SCI USA, V104, P13861, DOI 10.1073/pnas.0706147104; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Redshaw J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00404; Roberts WA, 2009, TRENDS COGN SCI, V13, P271, DOI 10.1016/j.tics.2009.03.003; Shettleworth S. J., 2009, COGNITION EVOLUTION; Suddendorf T, 2010, BEHAV BRAIN RES, V215, P292, DOI 10.1016/j.bbr.2009.11.044	16	87	91	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		202	+		10.1126/science.aam8138	http://dx.doi.org/10.1126/science.aam8138			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706072				2022-12-28	WOS:000405391700046
J	Strugarek, A; Beaudoin, P; Charbonneau, P; Brun, AS; do Nascimento, JD				Strugarek, A.; Beaudoin, P.; Charbonneau, P.; Brun, A. S.; do Nascimento, J. -D., Jr.			Reconciling solar and stellar magnetic cycles with nonlinear dynamo simulations	SCIENCE			English	Article							MAIN-SEQUENCE; CONVECTION; ROTATION; STARS; MODEL; SUN	The magnetic fields of solar-type stars are observed to cycle over decadal periods-11 years in the case of the Sun. The fields originate in the turbulent convective layers of stars and have a complex dependency upon stellar rotation rate. We have performed a set of turbulent global simulations that exhibit magnetic cycles varying systematically with stellar rotation and luminosity. We find that the magnetic cycle period is inversely proportional to the Rossby number, which quantifies the influence of rotation on turbulent convection. The trend relies on a fundamentally nonlinear dynamo process and is compatible with the Sun's cycle and those of other solar-type stars.	[Strugarek, A.; Beaudoin, P.; Charbonneau, P.] Univ Montreal, Dept Phys, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Strugarek, A.; Brun, A. S.] Univ Paris Diderot, CNRS,Irfu, Inst Natl Sci Univers,Commissariat Energie Atom &, Lab Astrophys,Instrumentat,Modelisat Paris Saclay, F-91191 Paris, France; [do Nascimento, J. -D., Jr.] Univ Fed Rio Grande do Norte, Dept Fis Teor & Expt, CP 1641, BR-59072970 Natal, RN, Brazil; [do Nascimento, J. -D., Jr.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA	Universite de Montreal; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Cite; Universidade Federal do Rio Grande do Norte; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Strugarek, A (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Strugarek, A (corresponding author), Univ Paris Diderot, CNRS,Irfu, Inst Natl Sci Univers,Commissariat Energie Atom &, Lab Astrophys,Instrumentat,Modelisat Paris Saclay, F-91191 Paris, France.	antoine.strugarek@cea.fr	do Nascimento, Jose-Dias/AAC-5323-2022	do Nascimento, Jose-Dias/0000-0001-7804-2145	Canada's Natural Sciences and Engineering Research Council; Institut National des Sciences de l'Univers/Programme National Soleil-Terre; Agence Nationale de la Recherche Blanc Toupies; European Research Council [STARS2 207430]; Centre National d'Etudes Spatiales Solar Orbiter grant; PLATO grant	Canada's Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Institut National des Sciences de l'Univers/Programme National Soleil-Terre; Agence Nationale de la Recherche Blanc Toupies(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Centre National d'Etudes Spatiales Solar Orbiter grant; PLATO grant	We thank P. Smolarkiewicz for help and advice on using the EULAG code, J. F. Cossette for discussions about the modeling of convection inside stars, and R. Garcia for discussions on stellar rotation. We acknowledge support from Canada's Natural Sciences and Engineering Research Council. This work was also partially supported by the Institut National des Sciences de l'Univers/Programme National Soleil-Terre, the Agence Nationale de la Recherche 2011 Blanc Toupies, European Research Council grant STARS2 207430, and Centre National d'Etudes Spatiales Solar Orbiter and PLATO grants. This work made use of the VizieR database (26), through the Astroquery package (27). This work also made use of data from the European Space Agency mission Gaia (www.cosmos.esa.int/gaia), processed by the Gaia Data Processing and Analysis Consortium (www.cosmos.esa.int/web/gaia/dpac/consortium). The EULAG-MHD code can be accessed at www.astro.umontreal.ca/similar to paulchar/grps/eulag-mhd.html (subject to U.S. export restrictions). The simulation outputs are downloadable from www.astro.umontreal.ca/sun/, and the data for the stellar sample are tabulated in the supplementary materials.	[Anonymous], 2016, AA, DOI [10.1051/0004-6361/201629272, DOI 10.1051/0004-6361/201629272]; Augustson K, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/2/149; BALIUNAS SL, 1995, ASTROPHYS J, V438, P269, DOI 10.1086/175072; Bohm-Vitense E, 2007, ASTROPHYS J, V657, P486, DOI 10.1086/510482; BRANDENBURG A, 1989, ASTRON ASTROPHYS, V213, P411; Brown AGA, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629512; Brun AS, 2015, SPACE SCI REV, V196, P303, DOI 10.1007/s11214-014-0117-8; DeRosa ML, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/96; Diaz RF, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201526729; Duarte LDV, 2016, MON NOT R ASTRON SOC, V456, P1708, DOI 10.1093/mnras/stv2726; Fletcher ST, 2010, ASTROPHYS J LETT, V718, pL19, DOI 10.1088/2041-8205/718/1/L19; Ghizaru M, 2010, ASTROPHYS J LETT, V715, pL133, DOI 10.1088/2041-8205/715/2/L133; GUBBINS D, 1993, PHYS EARTH PLANET IN, V75, P225, DOI 10.1016/0031-9201(93)90003-R; Hall JC, 2007, ASTRON J, V133, P2206, DOI 10.1086/513195; Hall JC, 2007, ASTRON J, V133, P862, DOI 10.1086/510356; Hotta H, 2016, SCIENCE, V351, P1427, DOI 10.1126/science.aad1893; Kapyla PJ, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/1/L22; Mayor M., 2003, MESSENGER, V114, P20; Metcalfe TS, 2016, ASTROPHYS J LETT, V826, DOI 10.3847/2041-8205/826/1/L2; NOYES RW, 1984, ASTROPHYS J, V287, P769, DOI 10.1086/162735; NOYES RW, 1984, ASTROPHYS J, V279, P763, DOI 10.1086/161945; Ochsenbein F, 2000, ASTRON ASTROPHYS SUP, V143, P23, DOI 10.1051/aas:2000169; Saar SH, 1999, ASTROPHYS J, V524, P295, DOI 10.1086/307794; SCHATTEN KH, 1969, SOL PHYS, V6, P442, DOI 10.1007/BF00146478; See V, 2016, MON NOT R ASTRON SOC, V462, P4442, DOI 10.1093/mnras/stw2010; Simoniello R, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/100; Smolarkiewicz PK, 2013, J COMPUT PHYS, V236, P608, DOI 10.1016/j.jcp.2012.11.008; Tobias SM, 1997, ASTRON ASTROPHYS, V322, P1007; Torres G, 2010, ASTRON J, V140, P1158, DOI 10.1088/0004-6256/140/5/1158; Ulrich RK, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/189	30	44	45	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		185	+		10.1126/science.aal3999	http://dx.doi.org/10.1126/science.aal3999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706068	Green Submitted			2022-12-28	WOS:000405391700041
J	[Anonymous]				[Anonymous]			Academia needs to confront sexism	SCIENCE			English	Editorial Material								A few years ago, I started my postdoc in a prominent biology lab at a top U.S. university, supported by a prestigious fellowship. I thought I was on track to become a professor. Instead, I am one of a number of female postdocs to leave the lab prematurely in recent years because of my supervisor's sexist behavior and the toxic lab environment she created. (Yes, she-women can be sexist, too, though I initially thought there would be little chance of facing sexism in a female professor's lab.) I am still committed to pursuing a scientific career and am transitioning to another lab. But I am driven to share my story because tolerating or fighting sexism should not be a rite of passage for female scientists.											0	0	0	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		222	222						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706076				2022-12-28	WOS:000405391700050
J	Boyd, MA; Cooper, DA				Boyd, Mark A.; Cooper, David A.			Long-acting injectable ART: next revolution in HIV?	LANCET			English	Editorial Material							REVERSE-TRANSCRIPTASE INHIBITORS; INFECTED PATIENTS; NAIVE ADULTS; DOUBLE-BLIND; TRIAL; THERAPY		[Boyd, Mark A.] Univ Adelaide, Lyell McEwin Hosp, Elizabeth Vale, SA 5112, Australia; [Boyd, Mark A.; Cooper, David A.] Univ New South Wales, Kirby Inst, Sydney, NSW 2052, Australia	Lyell McEwin Hospital; University of Adelaide; University of New South Wales Sydney; Kirby Institute	Boyd, MA (corresponding author), Univ Adelaide, Lyell McEwin Hosp, Elizabeth Vale, SA 5112, Australia.; Boyd, MA (corresponding author), Univ New South Wales, Kirby Inst, Sydney, NSW 2052, Australia.	mark.boyd@adelaide.edu.au		Boyd, Mark/0000-0002-6848-3307				Achhra AC, 2016, LANCET HIV, V3, pE351, DOI 10.1016/S2352-3018(16)30015-7; Cahn P, 2014, LANCET INFECT DIS, V14, P572, DOI 10.1016/S1473-3099(14)70736-4; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Killingley B, 2007, DRUG TODAY, V43, P427, DOI 10.1358/dot.2007.43.7.1086178; Llibre JM, 2017, 2017 C RETR OPP INF; Margolis DA, 2017, LANCET; Margolis DA, 2015, LANCET INFECT DIS, V15, P1145, DOI 10.1016/S1473-3099(15)00152-8; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975	10	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1468	1470		10.1016/S0140-6736(17)31962-1	http://dx.doi.org/10.1016/S0140-6736(17)31962-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FH7BS	28750936				2022-12-28	WOS:000411337100005
J	McDonald, CM; Campbell, C; Torricelli, RE; Finkel, RS; Flanigan, KM; Goemans, N; Heydemann, P; Kaminska, A; Kirschner, J; Muntoni, F; Osorio, AN; Schara, U; Sejersen, T; Shieh, PB; Sweeney, HL; Topaloglu, H; Tulinius, M; Vilchez, JJ; Voit, T; Wong, B; Elfring, G; Kroger, H; Luo, XH; McIntosh, J; Ong, T; Riebling, P; Souza, M; Spiegel, RJ; Peltz, SW; Mercuri, E				McDonald, Craig M.; Campbell, Craig; Erazo Torricelli, Ricardo; Finkel, Richard S.; Flanigan, Kevin M.; Goemans, Nathalie; Heydemann, Peter; Kaminska, Anna; Kirschner, Janbernd; Muntoni, Francesco; Nascimento Osorio, Andres; Schara, Ulrike; Sejersen, Thomas; Shieh, Perry B.; Sweeney, H. Lee; Topaloglu, Haluk; Tulinius, Mar; Vilchez, Juan J.; Voit, Thomas; Wong, Brenda; Elfring, Gary; Kroger, Hans; Luo, Xiaohui; McIntosh, Joseph; Ong, Tuyen; Riebling, Peter; Souza, Marcio; Spiegel, Robert J.; Peltz, Stuart W.; Mercuri, Eugenio		Clinical Evaluator Training Grp; ACT DMD Study Grp	Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							6-MINUTE WALK TEST; STAR AMBULATORY ASSESSMENT; END-POINTS; RELIABILITY; VALIDITY	Background Duchenne muscular dystrophy (DMD) is a severe, progressive, and rare neuromuscular, X-linked recessive disease. Dystrophin deficiency is the underlying cause of disease; therefore, mutation-specific therapies aimed at restoring dystrophin protein production are being explored. We aimed to assess the efficacy and safety of ataluren in ambulatory boys with nonsense mutation DMD. Methods We did this multicentre, randomised, double-blind, placebo-controlled, phase 3 trial at 54 sites in 18 countries located in North America, Europe, the Asia-Pacific region, and Latin America. Boys aged 7-16 years with nonsense mutation DMD and a baseline 6-minute walk distance (6MWD) of 150 m or more and 80% or less of the predicted normal value for age and height were randomly assigned (1:1), via permuted block randomisation (block size of four) using an interactive voice-response or web-response system, to receive ataluren orally three times daily (40 mg/kg per day) or matching placebo. Randomisation was stratified by age (<9 years vs >= 9 years), duration of previous corticosteroid use (6 months to <12 months vs >= 12 months), and baseline 6MWD (<350 m vs >= 350 m). Patients, parents and caregivers, investigational site personnel, PTC Therapeutics employees, and all other study personnel were masked to group allocation until after database lock. The primary endpoint was change in 6MWD from baseline to week 48. We additionally did a prespecified subgroup analysis of the primary endpoint, based on baseline 6MWD, which is reflective of anticipated rates of disease progression over 1 year. The primary analysis was by intention to treat. This study is registered with ClinicalTrials. gov, number NCT01826487. Findings Between March 26, 2013, and Aug 26, 2014, we randomly assigned 230 patients to receive ataluren (n=115) or placebo (n=115); 228 patients comprised the intention-to-treat population. The least-squares mean change in 6MWD from baseline to week 48 was -47.7 m (SE 9.3) for ataluren-treated patients and -60.7 m (9.3) for placebo-treated patients (difference 13.0 m [SE 10.4], 95% CI -7.4 to 33.4; p=0.213). The least-squares mean change for ataluren versus placebo in the prespecified subgroups was -7.7 m (SE 24.1, 95% CI -54.9 to 39.5; p=0.749) in the group with a 6MWD of less than 300 m, 42.9 m (15.9, 11.8-74.0; p=0.007) in the group with a 6MWD of 300 m or more to less than 400 m, and -9.5 m (17.2, -43.2 to 24.2; p=0.580) in the group with a 6MWD of 400 m or more. Ataluren was generally well tolerated and most treatment-emergent adverse events were mild to moderate in severity. Eight (3%) patients (n=4 per group) reported serious adverse events; all except one event in the placebo group (abnormal hepatic function deemed possibly related to treatment) were deemed unrelated to treatment. Interpretation Change in 6MWD did not differ significantly between patients in the ataluren group and those in the placebo group, neither in the intention-to-treat population nor in the prespecified subgroups with a baseline 6MWD of less than 300 m or 400 m or more. However, we recorded a significant effect of ataluren in the prespecified subgroup of patients with a baseline 6MWD of 300 m or more to less than 400 m. Baseline 6MWD values within this range were associated with a more predictable rate of decline over 1 year; this finding has implications for the design of future DMD trials with the 6-minute walk test as the endpoint.	[McDonald, Craig M.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Campbell, Craig] Western Univ, Schulich Sch Med & Dent, London, ON, Canada; [Erazo Torricelli, Ricardo] Hosp Ninos Luis Calvo Mackenna, Santiago, Chile; [Finkel, Richard S.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Finkel, Richard S.] Nemours Childrens Hosp, Orlando, FL USA; [Flanigan, Kevin M.] Nationwide Childrens Hosp, Columbus, OH USA; [Goemans, Nathalie] Katholieke Univ Leuven, Univ Hosp Leuven, Leuven, Belgium; [Heydemann, Peter] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Kaminska, Anna] Med Univ Warsaw, Warsaw, Poland; [Kirschner, Janbernd] Univ Freiberg, Med Ctr, Freiberg, Germany; [Muntoni, Francesco; Voit, Thomas] UCL, Inst Child Hlth, Great Ormond St, London, England; [Nascimento Osorio, Andres] Univ Barcelona, Hosp St Joan de Deu, CIBER, ISCIII, Barcelona, Spain; [Schara, Ulrike] Univ Duisburg Essen, Univ Hosp Essen, Essen, Germany; [Sejersen, Thomas] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden; [Shieh, Perry B.] Univ Calif Los Angeles, Los Angeles, CA USA; [Sweeney, H. Lee] Univ Florida, Gainesville, FL USA; [Topaloglu, Haluk] Hacettepe Childrens Hosp Med Ctr, Ankara, Turkey; [Tulinius, Mar] Gothenburg Univ, Queen Silvia Childrens Hosp, Gothenburg, Sweden; [Vilchez, Juan J.] Hosp Univ & Politecn La Fe, CIBERER, Valencia, Spain; [Voit, Thomas] UCL, Great Ormond St Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Wong, Brenda] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Elfring, Gary; Kroger, Hans; Luo, Xiaohui; McIntosh, Joseph; Ong, Tuyen; Riebling, Peter; Souza, Marcio; Spiegel, Robert J.; Peltz, Stuart W.] PTC Therapeut, South Plainfield, NJ USA; [Mercuri, Eugenio] Catholic Univ, Dept Pediat Neurol, Rome, Italy	University of California System; University of California Davis; Western University (University of Western Ontario); Universidad de Chile; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; KU Leuven; University Hospital Leuven; Rush University; Medical University of Warsaw; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; CIBER - Centro de Investigacion Biomedica en Red; Instituto de Salud Carlos III; University of Barcelona; University of Duisburg Essen; Karolinska Institutet; Karolinska University Hospital; University of California System; University of California Los Angeles; State University System of Florida; University of Florida; Hacettepe University; Queen Silvia Children's Hospital; University of Gothenburg; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cincinnati Children's Hospital Medical Center; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	McDonald, CM (corresponding author), Univ Calif Davis, Sch Med, Davis, CA 95616 USA.; McDonald, CM (corresponding author), UC Davis Childrens Hosp, Lawrence J Ellison Ambulatory Care Ctr, Phys Med & Rehabil, Sacramento, CA 95817 USA.	cmmcdonald@ucdavis.edu	TOPALOGLU, HALUK AYDIN/I-9318-2013; Bertini, Enrico/A-2284-2014; Kirschner, Janbernd/Q-1493-2019; Kirschner, Janbernd/H-7418-2016; Mercuri, Eugenio/G-1351-2015	Bertini, Enrico/0000-0001-9276-4590; Kirschner, Janbernd/0000-0003-1618-7386; Kirschner, Janbernd/0000-0003-1618-7386; Nelson, Leslie/0000-0003-3606-5757; Flanigan, Kevin/0000-0001-6440-3376; Escobar, Raul/0000-0001-9894-0727; mathews, katherine/0000-0003-4160-0435; Lowes, Linda/0000-0003-4206-0557; James, Meredith K/0000-0001-8078-7744; Mercuri, Eugenio/0000-0002-9851-5365; Vilchez, Juan J/0000-0002-0532-2872; Alfano, Lindsay/0000-0002-2263-7569	PTC Therapeutics; National Institute for Health Research [NF-SI-0515-10022] Funding Source: researchfish	PTC Therapeutics; National Institute for Health Research(National Institute for Health Research (NIHR))	PTC Therapeutics.	Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Daltroy LH, 1998, J PEDIATR ORTHOPED, V18, P561, DOI 10.1097/00004694-199809000-00001; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; European Medicines Agency, 2015, GUID CLIN INV MED PR; European Medicines Agency, TRANSL SUMM PROD CHA; Finkel RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081302; Haas M, 2015, NEUROMUSCULAR DISORD, V25, P5, DOI 10.1016/j.nmd.2014.11.011; Henricson E, 2013, PLOS CURR, V5; Manzur AY, 2008, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD14003725.PUB14651853; Mayhew A, 2011, DEV MED CHILD NEUROL, V53, P535, DOI 10.1111/j.1469-8749.2011.03939.x; Mayhew AG, 2013, DEV MED CHILD NEUROL, V55, P1046, DOI 10.1111/dmcn.12220; Mazzone E, 2010, NEUROMUSCULAR DISORD, V20, P712, DOI 10.1016/j.nmd.2010.06.014; McDonald C, 2014, NEUROMUSCULAR DISORD, V24, P861, DOI 10.1016/j.nmd.2014.06.228; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2013, MUSCLE NERVE, V48, P357, DOI 10.1002/mus.23905; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Merlini L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0408-z; Pane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108205; Pane M, 2014, NEUROMUSCULAR DISORD, V24, P201, DOI 10.1016/j.nmd.2013.11.014; Peay HL, 2014, CLIN THER, V36, P624, DOI 10.1016/j.clinthera.2014.04.011; Peltz SW, 2013, ANNU REV MED, V64, P407, DOI 10.1146/annurev-med-120611-144851; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; PTC Therapeutics, 2014, PTC THER REC COND AP; Ricotti V, 2016, J NEUROL NEUROSUR PS, V87, P149, DOI 10.1136/jnnp-2014-309405; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Scott E, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.520; Sweeney L, DEV SKELETAL MUSCLE; US Food and Drug Administration, 2015, DUCH MUSC DYSTR REL; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Willcocks RJ, 2016, ANN NEUROL, V79, P535, DOI 10.1002/ana.24599	32	232	240	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1489	1498		10.1016/S0140-6736(17)31611-2	http://dx.doi.org/10.1016/S0140-6736(17)31611-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7BS	28728956	Green Submitted			2022-12-28	WOS:000411337100024
J	Dowell, D; Haegerich, TM				Dowell, Deborah; Haegerich, Tamara M.			Changing the Conversation About Opioid Tapering	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CHRONIC PAIN; THERAPY		[Dowell, Deborah; Haegerich, Tamara M.] Ctr Dis Control & Prevent, 4770 Buford Highway NE,MS F-62, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Dowell, D (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Highway NE,MS F-62, Atlanta, GA 30341 USA.	ddowell@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Agency for Healthcare Research and Quality, 2017, NON NONPH TREATM CHR; Berna C, 2015, MAYO CLIN PROC, V90, P828, DOI 10.1016/j.mayocp.2015.04.003; Centers for Disease Control and Prevention, 2016, CDC GUID PRESCR OP C; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Dowell D, 2016, HEALTH AFFAIR, V35, P1876, DOI 10.1377/hlthaff.2016.0448; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Frank JW, 2017, ANN INTERN MED, V167, P181, DOI 10.7326/M17-0598; Rollnick S., 2008, MOTIVATIONAL INTERVI; Seal K, 2017, J GEN INTERN MED, V32, P931, DOI 10.1007/s11606-017-4047-5; US Department of Veterans Affairs & US Department of Defense, 2017, VA DOD CLIN PRACTICE	10	18	18	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					208	+		10.7326/M17-1402	http://dx.doi.org/10.7326/M17-1402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28715842	Green Accepted			2022-12-28	WOS:000406631400014
J	Li, J; Celiz, AD; Yang, J; Yang, Q; Wamala, I; Whyte, W; Seo, BR; Vasilyev, NV; Vlassak, JJ; Suo, Z; Mooney, DJ				Li, J.; Celiz, A. D.; Yang, J.; Yang, Q.; Wamala, I.; Whyte, W.; Seo, B. R.; Vasilyev, N. V.; Vlassak, J. J.; Suo, Z.; Mooney, D. J.			Tough adhesives for diverse wet surfaces	SCIENCE			English	Article							BULK PROPERTIES; DRUG-DELIVERY; REPAIR; HYDROGELS; GLUE	Adhesion to wet and dynamic surfaces, including biological tissues, is important in many fields but has proven to be extremely challenging. Existing adhesives are cytotoxic, adhere weakly to tissues, or cannot be used in wet environments. We report a bioinspired design for adhesives consisting of two layers: an adhesive surface and a dissipative matrix. The former adheres to the substrate by electrostatic interactions, covalent bonds, and physical interpenetration. The latter amplifies energy dissipation through hysteresis. The two layers synergistically lead to higher adhesion energies on wet surfaces as compared with those of existing adhesives. Adhesion occurs within minutes, independent of blood exposure and compatible with in vivo dynamic movements. This family of adhesives may be useful in many areas of application, including tissue adhesives, wound dressings, and tissue repair.	[Li, J.; Yang, J.; Yang, Q.; Whyte, W.; Seo, B. R.; Vlassak, J. J.; Suo, Z.; Mooney, D. J.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Li, J.; Celiz, A. D.; Whyte, W.; Seo, B. R.; Mooney, D. J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Li, J.] McGill Univ, Dept Mech Engn, Montreal, PQ H3A 0G4, Canada; [Celiz, A. D.] Univ Nottingham, Sch Pharm, Adv Mat & Healthcare Technol Div, Nottingham NG7 2RD, England; [Yang, J.; Yang, Q.; Suo, Z.] Harvard Univ, Kavli Inst Nanobio Sci & Technol, Cambridge, MA 02138 USA; [Yang, Q.] Tsinghua Univ, Sch Aerosp, Beijing 100084, Peoples R China; [Wamala, I.; Vasilyev, N. V.] Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA; [Whyte, W.] Royal Coll Surgeons Ireland, Adv Mat & Bioengn Res Ctr, Dublin, Ireland; [Whyte, W.] Trinity Coll Dublin, Dublin, Ireland	Harvard University; Harvard University; McGill University; University of Nottingham; Harvard University; Tsinghua University; Harvard University; Boston Children's Hospital; Royal College of Surgeons - Ireland; Trinity College Dublin	Mooney, DJ (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Mooney, DJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	mooneyd@seas.harvard.edu	Vasilyev, Nikolay/P-9254-2019; Suo, Zhigang/B-1067-2008; Li, Jianyu/ABF-1357-2020; LI, Jianyu/F-8728-2012; Seo, Bo Ri/AAO-5269-2020; Celiz, Adam/G-6841-2013	Suo, Zhigang/0000-0002-4068-4844; Li, Jianyu/0000-0002-1128-6804; Vasilyev, Nikolay/0000-0002-8181-8044; Wamala, Isaac/0000-0001-8030-9283; Yang, Jiawei/0000-0003-2446-0004; Celiz, Adam/0000-0003-4568-7734; Mooney, David/0000-0001-6299-1194; Whyte, William/0000-0002-2458-4149	NIH [R01DE0130333]; Marie Curie International Outgoing Fellowship - European Commission [629320]; Science Foundation Ireland [SFI/12/RC/2278]; Tsinghua University; NSF [CMMI-1404653]; Harvard University Materials Research Science and Engineering Center [DMR-1420570]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Outgoing Fellowship - European Commission; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Tsinghua University; NSF(National Science Foundation (NSF)); Harvard University Materials Research Science and Engineering Center; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the NIH under award R01DE0130333 and was performed, in part, at the Center for Nanoscale Systems at Harvard University. A.D.C. acknowledges support from a Marie Curie International Outgoing Fellowship funded by the European Commission (agreement 629320). W.W. acknowledges support from Science Foundation Ireland under grant SFI/12/RC/2278. Q.Y. acknowledges a scholarship from Tsinghua University. Z.S. and J.J.V. acknowledge support from the NSF under award CMMI-1404653. Z.S., J.J.V., and D.J.M. acknowledge support from the Harvard University Materials Research Science and Engineering Center (grant DMR-1420570). J.L., A.D.C., and D.J.M. are inventors on U.S. patent applications (US 62/311,646, US 62/356,939, and PCT/US2017/023538) submitted by Harvard University that cover the design of TAs.	Barrett DG, 2013, ADV HEALTHC MATER, V2, P745, DOI 10.1002/adhm.201200316; Braun M, 2013, J EXP BIOL, V216, P1475, DOI 10.1242/jeb.077149; Campbell P.K, 2005, EVALUATION ABSORBABL; Dastjerdi AK, 2012, ACTA BIOMATER, V8, P3349, DOI 10.1016/j.actbio.2012.05.005; Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171; Feiner R, 2016, NAT MATER, V15, P679, DOI [10.1038/NMAT4590, 10.1038/nmat4590]; Fernandez JG, 2017, TISSUE ENG PT A, V23, P135, DOI [10.1089/ten.TEA.2016.0266, 10.1089/ten.tea.2016.0266]; Gent AN, 1996, LANGMUIR, V12, P4492, DOI 10.1021/la950887q; Ghobril C, 2013, ANGEW CHEM INT EDIT, V52, P14070, DOI 10.1002/anie.201308007; GILLES MA, 1990, ANAL BIOCHEM, V184, P244, DOI 10.1016/0003-2697(90)90675-Y; Grinstaff MW, 2007, BIOMATERIALS, V28, P5205, DOI 10.1016/j.biomaterials.2007.08.041; HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63, DOI 10.1016/s0065-2156(08)70164-9; Lang N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006557; Li JY, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.71; Moretti M, 2005, J BIOMECH, V38, P1846, DOI 10.1016/j.jbiomech.2004.08.021; NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015; Pawlicki JM, 2004, J EXP BIOL, V207, P1127, DOI 10.1242/jeb.00859; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Roche ET, 2014, ADV MATER, V26, P1200, DOI 10.1002/adma.201304018; Rose S, 2014, NATURE, V505, P382, DOI 10.1038/nature12806; Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838; Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402; Stefanov T, 2016, INT J ADHES ADHES, V68, P142, DOI 10.1016/j.ijadhadh.2016.03.001; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Vakalopoulos KA, 2015, ANN SURG, V261, P323, DOI 10.1097/SLA.0000000000000599; VINTERS HV, 1985, NEURORADIOLOGY, V27, P279, DOI 10.1007/BF00339559; Wallace DG, 2001, J BIOMED MATER RES, V58, P545, DOI 10.1002/jbm.1053; Wilks AM, 2015, J EXP BIOL, V218, P3128, DOI 10.1242/jeb.128991; Yuk H, 2016, NAT MATER, V15, P190, DOI [10.1038/NMAT4463, 10.1038/nmat4463]	29	740	755	200	1428	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					378	381		10.1126/science.aah6362	http://dx.doi.org/10.1126/science.aah6362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751604	Green Accepted, Green Submitted			2022-12-28	WOS:000406362300039
J	Striccoli, M				Striccoli, Marinella			Photolithography based on nanocrystals	SCIENCE			English	Editorial Material									[Striccoli, Marinella] Univ Bari, Inst Phys & Chem Proc, Unit Bari CNR CNR IPCF, Chem Dept, Via Orabona 4, I-70126 Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); Universita degli Studi di Bari Aldo Moro	Striccoli, M (corresponding author), Univ Bari, Inst Phys & Chem Proc, Unit Bari CNR CNR IPCF, Chem Dept, Via Orabona 4, I-70126 Bari, Italy.	m.striccoli@ba.ipcf.cnr.it	Striccoli, Marinella/C-5456-2009	Striccoli, Marinella/0000-0002-5366-691X				Boles MA, 2016, NAT MATER, V15, P141, DOI [10.1038/NMAT4526, 10.1038/nmat4526]; Ingrosso C, 2007, ADV FUNCT MATER, V17, P2009, DOI 10.1002/adfm.200700098; Kagan CR, 2016, SCIENCE, V353, DOI 10.1126/science.aac5523; Liddle JA, 2016, ACS NANO, V10, P2995, DOI 10.1021/acsnano.5b03299; Park JS, 2016, NANO LETT, V16, P6946, DOI 10.1021/acs.nanolett.6b03007; Wang RL, 2016, ENERG ENVIRON SCI, V9, P1130, DOI 10.1039/c5ee03887a; Wang YY, 2017, SCIENCE, V357, P385, DOI 10.1126/science.aan2958; Yang J, 2016, ADV MATER, V28, P1176, DOI 10.1002/adma.201502851; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165	9	13	15	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					353	354		10.1126/science.aan8430	http://dx.doi.org/10.1126/science.aan8430			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751595				2022-12-28	WOS:000406362300023
J	Rai, D; Lee, BK; Dalman, C; Newschaffer, C; Lewis, G; Magnusson, C				Rai, Dheeraj; Lee, Brian K.; Dalman, Christina; Newschaffer, Craig; Lewis, Glyn; Magnusson, Cecilia			Antidepressants during pregnancy and autism in offspring: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; DEFICIT HYPERACTIVITY DISORDER; SPECTRUM DISORDER; RISK; EXPOSURE; CONFOUNDERS; DEPRESSION; REGISTER	Objectives To study the association between maternal use of antidepressants during pregnancy and autism spectrum disorder (ASD) in offspring. Design Observational prospective cohort study with regression methods, propensity score matching, sibling controls, and negative control comparison. Setting Stockholm County, Sweden. Participants 254 610 individuals aged 4-17, including 5378 with autism, living in Stockholm County in 2001-11 who were born to mothers who did not take antidepressants and did not have any psychiatric disorder, mothers who took antidepressants during pregnancy, or mothers with psychiatric disorders who did not take antidepressants during pregnancy. Maternal antidepressant use was recorded during first antenatal interview or determined from prescription records. Main outcome measure Offspring diagnosis of autism spectrum disorder, with and without intellectual disability. Results Of the 3342 children exposed to antidepressants during pregnancy, 4.1% (n=136) had a diagnosis of autism compared with a 2.9% prevalence (n=353) in 12 325 children not exposed to antidepressants whose mothers had a history of a psychiatric disorder (adjusted odds ratio 1.45, 95% confidence interval 1.13 to 1.85). Propensity score analysis led to similar results. The results of a sibling control analysis were in the same direction, although with wider confidence intervals. In a negative control comparison, there was no evidence of any increased risk of autism in children whose fathers were prescribed antidepressants during the mothers' pregnancy (1.13, 0.68 to 1.88). In all analyses, the risk increase concerned only autism without intellectual disability. Conclusions The association between antidepressant use during pregnancy and autism, particularly autism without intellectual disability, might not solely be a byproduct of confounding. Study of the potential underlying biological mechanisms could help the understanding of modifiable mechanisms in the aetiology of autism. Importantly, the absolute risk of autism was small, and, hypothetically, if no pregnant women took antidepressants, the number of cases that could potentially be prevented would be small.	[Rai, Dheeraj] Univ Bristol, Sch Social & Community Med, Ctr Acad Mental Hlth, Bristol BS8 2BN, Avon, England; [Rai, Dheeraj] Avon & Wiltshire Partnership NHS Mental Hlth Trus, Bristol, Avon, England; [Rai, Dheeraj; Lee, Brian K.; Dalman, Christina; Magnusson, Cecilia] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Rai, Dheeraj] Univ Bristol, NIHR Biomed Res Ctr, Bristol, Avon, England; [Lee, Brian K.; Newschaffer, Craig] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Lee, Brian K.; Newschaffer, Craig] AJ Drexel Autism Inst, Philadelphia, PA USA; [Dalman, Christina; Magnusson, Cecilia] Stockholm Hlth Care Serv, Ctr Epidemiol & Community Med, Stockholm, Sweden; [Lewis, Glyn] UCL, Div Psychiat, London, England	University of Bristol; Karolinska Institutet; University of Bristol; Drexel University; Drexel University; University of London; University College London	Rai, D (corresponding author), Univ Bristol, Sch Social & Community Med, Ctr Acad Mental Hlth, Bristol BS8 2BN, Avon, England.	Dheeraj.rai@bristol.ac.uk	Lewis, Glyn/E-9944-2012	Lewis, Glyn/0000-0001-5205-8245; Dalman, Christina/0000-0002-3579-2357; Lee, Brian/0000-0002-3635-8034; Rai, Dheeraj/0000-0002-7239-3523; Magnusson, Cecilia/0000-0002-8567-6725	Swedish Research Council [2012-3017]; NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust; University of Bristol	Swedish Research Council(Swedish Research CouncilEuropean Commission); NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust; University of Bristol	This research was funded by the Swedish Research Council (grant No 2012-3017). This research was also supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. No funder had any role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication. The views expressed are those of the authors and not necessarily those of the funders, the organisations they represent, the NHS, the National Institute for Health Research or the Department of Health.	Boukhris T, 2016, JAMA PEDIATR, V170, P117, DOI 10.1001/jamapediatrics.2015.3356; Castro VM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.190; Charlton RA, 2015, BJOG-INT J OBSTET GY, V122, P1010, DOI 10.1111/1471-0528.13143; Clements CC, 2015, MOL PSYCHIATR, V20, P727, DOI 10.1038/mp.2014.90; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; Davies NM, 2015, LANCET RESP MED, V3, pE39, DOI 10.1016/S2213-2600(15)00468-3; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Gentile S, 2015, J AFFECT DISORDERS, V182, P132, DOI 10.1016/j.jad.2015.04.048; Gidaya NB, 2014, J AUTISM DEV DISORD, V44, P2558, DOI 10.1007/s10803-014-2128-4; Harrington RA, 2014, PEDIATRICS, V133, pE1241, DOI 10.1542/peds.2013-3406; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Hviid A, 2013, NEW ENGL J MED, V369, P2406, DOI 10.1056/NEJMoa1301449; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Idring S, 2015, J AUTISM DEV DISORD, V45, P1766, DOI 10.1007/s10803-014-2336-y; Jorgensen L, 2010, ACTA PSYCHIAT SCAND, V121, P389, DOI 10.1111/j.1600-0447.2009.01500.x; Kallen B, 2011, EUR J CLIN PHARMACOL, V67, P839, DOI 10.1007/s00228-011-1021-8; Kaplan YC, 2016, REPROD TOXICOL, V66, P31, DOI 10.1016/j.reprotox.2016.09.013; Lauder J M, 1981, Adv Exp Med Biol, V133, P477; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; Lewis SJ, 2013, J CHILD PSYCHOL PSYC, V54, P1095, DOI 10.1111/jcpp.12127; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Malm H, 2016, J AM ACAD CHILD PSY, V55, P359, DOI 10.1016/j.jaac.2016.02.013; Peters Lee, 2011, AMIA Annu Symp Proc, V2011, P1117; Petersen I, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007390; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; RAI D, 2013, BMJ-BRIT MED J, V346, pf2059, DOI DOI 10.1136/BMJ.F2059; Robinson EB, 2014, P NATL ACAD SCI USA, V111, P15161, DOI 10.1073/pnas.1409204111; Smith GD, 2012, EPIDEMIOLOGY, V23, P350, DOI 10.1097/EDE.0b013e318245912c; Sorensen Merete Juul, 2013, Clin Epidemiol, V5, P449, DOI 10.2147/CLEP.S53009; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Stuart E.A, 2007, BEST PRACTICES QUANT, P155, DOI [10.4135/9781412995627.d14, DOI 10.4135/9781412995627.D14]; Thomas KH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5704; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598	34	60	60	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2017	358								j2811	10.1136/bmj.j2811	http://dx.doi.org/10.1136/bmj.j2811			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB7KA	28724519	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000406318300001
J	Friedrich, MJ				Friedrich, M. J.			Vaginal Microbiome Affects Efficacy of HIV Microbicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					231	231		10.1001/jama.2017.9091	http://dx.doi.org/10.1001/jama.2017.9091			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719701				2022-12-28	WOS:000405775000027
J	Voelker, R				Voelker, Rebecca			Expanded Use for Heart Valve	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					232	232		10.1001/jama.2017.8437	http://dx.doi.org/10.1001/jama.2017.8437			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719677				2022-12-28	WOS:000405775000028
J	Casassus, B				Casassus, Barbara			France bans sodium valproate use in case of pregnancy	LANCET			English	Editorial Material																			0	18	19	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2017	390	10091					217	217		10.1016/S0140-6736(17)31866-4	http://dx.doi.org/10.1016/S0140-6736(17)31866-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA5IZ	28721869				2022-12-28	WOS:000405477900012
J	Carson, J				Carson, Jennifer			American Eclipse	SCIENCE			English	Book Review												jenniferecarson@gmail.com						BARON D, 2017, AM ECLIPSE	1	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		137	137		10.1126/science.aan8300	http://dx.doi.org/10.1126/science.aan8300			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706030				2022-12-28	WOS:000405391700026
J	Zhou, TT; Zhu, H; Fan, ZX; Wang, F; Chen, Y; Liang, HX; Yang, ZF; Zhang, L; Lin, LN; Zhan, Y; Wang, Z; Hu, HL				Zhou, Tingting; Zhu, Hong; Fan, Zhengxiao; Wang, Fei; Chen, Yang; Liang, Hexing; Yang, Zhongfei; Zhang, Lu; Lin, Longnian; Zhan, Yang; Wang, Zheng; Hu, Hailan			History of winning remodels thalamo-PFC circuit to reinforce social dominance	SCIENCE			English	Article							MEDIAL FRONTAL-CORTEX; DECISION-MAKING; PREFRONTAL CORTEX; BEHAVIOR; HIERARCHY; MODULATION; MECHANISMS; WINNER; MOUSE; GAME	Mental strength and history of winning play an important role in the determination of social dominance. However, the neural circuits mediating these intrinsic and extrinsic factors have remained unclear. Working in mice, we identified a dorsomedial prefrontal cortex (dmPFC) neural population showing "effort"-related firing during moment-to-moment competition in the dominance tube test. Activation or inhibition of the dmPFC induces instant winning or losing, respectively. In vivo optogenetic-based long-term potentiation and depression experiments establish that the mediodorsal thalamic input to the dmPFC mediates long-lasting changes in the social dominance status that are affected by history of winning. The same neural circuit also underlies transfer of dominance between different social contests. These results provide a framework for understanding the circuit basis of adaptive and pathological social behaviors.	[Zhou, Tingting; Zhu, Hong; Wang, Fei; Chen, Yang; Yang, Zhongfei; Wang, Zheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Zhou, Tingting; Zhu, Hong; Wang, Fei; Chen, Yang; Yang, Zhongfei; Wang, Zheng] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Zhou, Tingting; Zhu, Hong; Wang, Fei] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Zhou, Tingting; Zhu, Hong; Fan, Zhengxiao; Liang, Hexing; Hu, Hailan] Zhejiang Univ, Qiushi Acad Adv Studies, Interdisciplinary Inst Neurosci & Technol, Hangzhou 310012, Zhejiang, Peoples R China; [Zhou, Tingting; Zhu, Hong; Fan, Zhengxiao; Liang, Hexing; Hu, Hailan] Zhejiang Univ, Sch Med, Minist Hlth China, Key Lab Med Neurobiol,Ctr Neurosci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Lu] Fudan Univ, Shanghai Ctr Math Sci, Shanghai 200433, Peoples R China; [Lin, Longnian] East China Normal Univ, Key Lab Brain Funct Gen, Shanghai 200062, Peoples R China; [Zhan, Yang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Brain Cognit & Brain Dis Inst, Shenzhen 518055, Peoples R China; [Hu, Hailan] Zhejiang Univ, Sch Med, Mental Hlth Ctr, Hangzhou 310013, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Zhejiang University; Zhejiang University; Fudan University; East China Normal University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Zhejiang University	Hu, HL (corresponding author), Zhejiang Univ, Qiushi Acad Adv Studies, Interdisciplinary Inst Neurosci & Technol, Hangzhou 310012, Zhejiang, Peoples R China.; Hu, HL (corresponding author), Zhejiang Univ, Sch Med, Minist Hlth China, Key Lab Med Neurobiol,Ctr Neurosci, Hangzhou 310058, Zhejiang, Peoples R China.; Hu, HL (corresponding author), Zhejiang Univ, Sch Med, Mental Hlth Ctr, Hangzhou 310013, Zhejiang, Peoples R China.	huhailan@zju.edu.cn	Wang, Zheng/GRE-7739-2022	Wang, Zheng/0000-0001-7138-8581; Hu, Hailan/0000-0002-0425-5057; Wang, Fei/0000-0002-8646-2411; Zhan, Yang/0000-0002-1150-6344; Zhang, Lu/0000-0001-7300-1037	Ministry of Science and Technology of China [2011CBA00400, 2016YFA0501000]; National Natural Science Foundation of China [91432108, 31225010, 81527901]; Strategic Priority Research Program (B) of the Chinese Academy of Sciences [XDB02030004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program (B) of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Q. Li, H. Kessels, H. Li, and W. Li for critical comments on the manuscript; D. Anderson for stimulating discussions that led to the idea of the warm spot test; J. Zhu and K. Yuan for assistance in experiments; K. Deisseroth and Z. Qiu for AAV-ChR2 constructs; B. Roth for AAV-hM4D and AAV-hM3D constructs; C. Li and X. Gu for advice on analysis of tetrode recording data; and X. Xu for Matlab code for behavior annotation. This work was supported by grants from the Ministry of Science and Technology of China (2011CBA00400 and 2016YFA0501000), the National Natural Science Foundation of China (91432108, 31225010, and 81527901), and the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB02030004) to H. H. All the data necessary to understand and assess the conclusions of this manuscript are available in the supplementary materials. Computer codes are archived at www.dropbox.com/sh/7pthozsrzj4vxr0/AACMaW9a8_5ITDumIJw_6Z_pa?dl=0. T.Z. and H. Z. conducted most optogenetic and behavioral experiments and designed the experiments with H. H. T.Z. performed in vivo tetrode recording with the help of Y.C. and Z.Y. and conducted optogenetic LTP and LTD experiments. Z.F. performed the warm spot test and dominance transfer experiments. F.W. and H.L. participated in tube test and viral injection experiments. L.Z., L.L., Y.Z., and Z. W. participated in analysis of in vivo tetrode recordings. H. H. conceived the project and wrote the manuscript with the help of T.Z. and H. Z.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bailey MR, 2016, NEUROBIOL LEARN MEM, V133, P233, DOI 10.1016/j.nlm.2016.07.015; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chou MY, 2016, SCIENCE, V352, P87, DOI 10.1126/science.aac9508; Dugatkin LA, 2004, P ROY SOC B-BIOL SCI, V271, pS488, DOI 10.1098/rsbl.2004.0235; Franklin TB, 2017, NAT NEUROSCI, V20, P260, DOI 10.1038/nn.4470; Friedman A, 2015, CELL, V161, P1320, DOI 10.1016/j.cell.2015.04.049; Fujii N, 2009, SOC NEUROSCI-UK, V4, P73, DOI 10.1080/17470910802046230; Hillman KL, 2012, NAT NEUROSCI, V15, P1290, DOI 10.1038/nn.3187; Holroyd CB, 2015, PSYCHOL REV, V122, P54, DOI 10.1037/a0038339; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hosokawa T, 2012, J NEUROSCI, V32, P7662, DOI 10.1523/JNEUROSCI.6479-11.2012; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Kura K, 2016, B MATH BIOL, V78, P1259, DOI 10.1007/s11538-016-0186-9; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mooney SJ, 2014, SOC NEUROSCI-UK, V9, P108, DOI 10.1080/17470919.2014.882862; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Rushworth MFS, 2012, CURR OPIN NEUROBIOL, V22, P946, DOI 10.1016/j.conb.2012.04.011; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Sandi C, 2015, NAT REV NEUROSCI, V16, P290, DOI 10.1038/nrn3918; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Trannoy S, 2017, FLY, V11, P129, DOI 10.1080/19336934.2016.1259041; Walton ME, 2002, J NEUROSCI, V22, P10996; Wang F, 2014, TRENDS NEUROSCI, V37, P674, DOI 10.1016/j.tins.2014.07.005; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wilson E.O., 1975, P1; Yang CR, 1996, J NEUROSCI, V16, P1922	33	132	138	29	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		162	+		10.1126/science.aak9726	http://dx.doi.org/10.1126/science.aak9726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706064				2022-12-28	WOS:000405391700037
J	Ke, YW; Xu, YA; Chen, XP; Feng, SK; Liu, ZB; Sun, YY; Yao, XL; Li, FZ; Zhu, W; Gao, L; Chen, HJ; Du, ZH; Xie, W; Xu, XC; Huang, XX; Liu, J				Ke, Yuwen; Xu, Yanan; Chen, Xuepeng; Feng, Songjie; Liu, Zhenbo; Sun, Yaoyu; Yao, Xuelong; Li, Fangzhen; Zhu, Wei; Gao, Lei; Chen, Haojie; Du, Zhenhai; Xie, Wei; Xu, Xiaocui; Huang, Xingxu; Liu, Jiang			3D Chromatin Structures of Mature Gametes and Structural Reprogramming during Mammalian Embryogenesis	CELL			English	Article							PREIMPLANTATION EMBRYOS; REGULATORY LANDSCAPE; TOPOLOGICAL DOMAINS; HUMAN GENOME; STEM-CELLS; ORGANIZATION; MOUSE; GENE; ARCHITECTURE; SPERM	High-order chromatin structure plays important roles in gene expression regulation. Knowledge of the dynamics of 3D chromatin structures during mammalian embryo development remains limited. We report the 3D chromatin architecture of mouse gametes and early embryos using an optimized Hi-C method with low-cell samples. We find that mature oocytes at the metaphase II stage do not have topologically associated domains (TADs). In sperm, extra-long-range interactions (>4 Mb) and interchromosomal interactions occur frequently. The high-order structures of both the paternal and maternal genomes in zygotes and two-cell embryos are obscure but are gradually re-established through development. The establishment of the TAD structure requires DNA replication but not zygotic genome activation. Furthermore, unmethylated CpGs are enriched in A compartment, and methylation levels are decreased to a greater extent in A compartment than in B compartment in embryos. In summary, the global reprogramming of chromatin architecture occurs during early mammalian development.	[Ke, Yuwen; Chen, Xuepeng; Liu, Zhenbo; Sun, Yaoyu; Yao, Xuelong; Li, Fangzhen; Zhu, Wei; Gao, Lei; Xu, Xiaocui; Liu, Jiang] Chinese Acad Sci, Beijing Inst Genom, Collaborat Innovat Ctr Genet & Dev, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Xu, Yanan; Feng, Songjie; Huang, Xingxu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Ke, Yuwen; Chen, Xuepeng; Feng, Songjie; Sun, Yaoyu; Yao, Xuelong; Zhu, Wei; Xu, Xiaocui; Liu, Jiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Feng, Songjie] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Chen, Haojie] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Du, Zhenhai; Xie, Wei] Tsinghua Univ, Sch Life Sci, Ctr Stem Cell Biol & Regenerat Med, MOE Key Lab Bioinformat,THU PKU Ctr Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; ShanghaiTech University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University	Liu, J (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Collaborat Innovat Ctr Genet & Dev, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.; Huang, XX (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Liu, J (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	huangxx@shanghaitech.edu.cn; liuj@big.ac.cn	Zhu, Wei/HGA-4471-2022; Gao, Lei/X-4824-2018	Zhu, Wei/0000-0003-1459-6733; Liu, Jiang/0000-0002-5687-5047; Chen, Xuepeng/0000-0001-7316-6894; Gao, Lei/0000-0002-0882-7518; huang, xingxu/0000-0001-8934-1247	CAS [XDB13040200]; National Key RD Program [2016YFA0500903]; 973 Program of China [2015CB856200]; National Natural Science Foundation of China [31630040, 31425015, 31561130152, 91519306, 81171902, 81402112]	CAS(Chinese Academy of Sciences); National Key RD Program; 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Li Lan for the language editing and the sequencing facility in BIG, CAS. This work was supported by grants from CAS funding (XDB13040200), the National Key R&D Program (2016YFA0500903), the 973 Program of China (2015CB856200), and from the National Natural Science Foundation of China (31630040, 31425015, 31561130152, 91519306, 81171902, and 81402112).	Battulin N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0642-0; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BOLTON VN, 1984, J EMBRYOL EXP MORPH, V79, P139; Carone BR, 2014, DEV CELL, V30, P11, DOI 10.1016/j.devcel.2014.05.024; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Fulka J, 1998, MOL HUM REPROD, V4, P41, DOI 10.1093/molehr/4.1.41; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Giorgetti L, 2016, NATURE, V535, P575, DOI 10.1038/nature18589; Hackett JA, 2013, CELL, V153, P737, DOI 10.1016/j.cell.2013.04.044; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Hug CB, 2017, CELL, V169, P216, DOI 10.1016/j.cell.2017.03.024; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; Jung YH, 2017, CELL REP, V18, P1366, DOI 10.1016/j.celrep.2017.01.034; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Krishnakumar R, 2016, CELL STEM CELL, V18, P104, DOI 10.1016/j.stem.2015.10.003; Krueger Felix, 2016, F1000Res, V5, P1479, DOI 10.12688/f1000research.9037.2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Dily F, 2014, GENE DEV, V28, P2151, DOI 10.1101/gad.241422.114; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Lu FL, 2016, CELL, V165, P1375, DOI 10.1016/j.cell.2016.05.050; Moreno RD, 2006, DEV BIOL, V293, P218, DOI 10.1016/j.ydbio.2006.02.001; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ooi SL, 2007, CURR OPIN CELL BIOL, V19, P257, DOI 10.1016/j.ceb.2007.04.015; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rosner M, 2013, NAT PROTOC, V8, P602, DOI 10.1038/nprot.2013.011; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Servant N, 2012, BIOINFORMATICS, V28, P2843, DOI 10.1093/bioinformatics/bts521; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng H, 2016, MOL CELL, V63, P1066, DOI 10.1016/j.molcel.2016.08.032; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440	58	243	260	12	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					367	+		10.1016/j.cell.2017.06.029	http://dx.doi.org/10.1016/j.cell.2017.06.029			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28709003	Bronze			2022-12-28	WOS:000405493900015
J	Dyer, O				Dyer, Owen			Senate committee inquiry into drug price hikes will continue despite arrest of hedge fund manager Shkreli	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		McCarthy M, 2015, BMJ-BRIT MED J, V351, ph6733; McCarthy M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5989; McCarthy M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5114	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2015	351								h6922	10.1136/bmj.h6922	http://dx.doi.org/10.1136/bmj.h6922			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ7PW	28720646				2022-12-28	WOS:000367292800003
J	Wood, CL; Cheetham, T				Wood, Claire L.; Cheetham, Tim			Treatment of Duchenne muscular dystrophy: first small steps	LANCET			English	Editorial Material							NATURAL-HISTORY		[Wood, Claire L.] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Inst Genet Med, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Cheetham, Tim] Newcastle Univ, Royal Victoria Infirm, Dept Paediat Endocrinol, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Wood, CL (corresponding author), Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Inst Genet Med, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	claire.wood@newcastle.ac.uk			MRC [MR/N020588/1] Funding Source: UKRI; Muscular Dystrophy UK [MC3/1083] Funding Source: researchfish; Medical Research Council [MR/N020588/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aartsma-Rus A, 2016, J MED GENET, V53, P145, DOI 10.1136/jmedgenet-2015-103387; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Goemans N., 2017, LANCET; Hathout Y, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9109-x; Hollingsworth KG, 2013, MUSCLE NERVE, V48, P586, DOI 10.1002/mus.23879; Lynn S, 2015, NEUROMUSCULAR DISORD, V25, P96, DOI 10.1016/j.nmd.2014.09.003; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; National Institute for Health and Care Excellence, 2016, AT TREAT DUCH MUSC D; Straub V, 2016, LANCET NEUROL, V15, P882, DOI 10.1016/S1474-4422(16)30035-7; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wood MJA, 2013, MOL THER, V21, P2131, DOI 10.1038/mt.2013.252	11	4	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1467	1468		10.1016/S0140-6736(17)31669-0	http://dx.doi.org/10.1016/S0140-6736(17)31669-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FH7BS	28728957				2022-12-28	WOS:000411337100004
J	Lasser, KE				Lasser, Karen E.			Prescription Opioid Use Among US Adults: Our Brave New World	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH; CARE; DISPARITIES		[Lasser, Karen E.] Boston Med Ctr, 801 Massachusetts Ave,2094, Boston, MA 02118 USA; [Lasser, Karen E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lasser, Karen E.] Sch Publ Hlth, Boston, MA USA	Boston Medical Center; Boston University	Lasser, KE (corresponding author), Boston Med Ctr, 801 Massachusetts Ave,2094, Boston, MA 02118 USA.	karen.lasser@bmc.org			National Institute on Drug Abuse of the National Institutes of Health [1R01 DA034252]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034252] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grant Support: Dr. Lasser is supported by grant 1R01 DA034252 from the National Institute on Drug Abuse of the National Institutes of Health.	Han B, 2017, ANN INTERN MED, V167, P293, DOI 10.7326/M17-0865; Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402; Lasser KE, 2018, HEALTH SERV RES, V53, P1727, DOI 10.1111/1475-6773.12710; Lewin ME, 2007, HEALTH AFFAIR, V26, P1490, DOI 10.1377/hlthaff.26.5.1490; Liebschutz J, 2017, JAMA INTERN IN PRESS; McCormick D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1480; Parsons JK, 2010, CANCER-AM CANCER SOC, V116, P1378, DOI 10.1002/cncr.24856; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Vance J. D., 2016, HILLBILLY ELEGY MEMO	9	7	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					351	352		10.7326/M17-1559	http://dx.doi.org/10.7326/M17-1559			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF6LC	28761948				2022-12-28	WOS:000409120400009
J	Papanicolas, I; Jha, AK				Papanicolas, Irene; Jha, Ashish K.			Challenges in International Comparison of Health Care Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Papanicolas, Irene] London Sch Econ, London, England; [Papanicolas, Irene; Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 42 Church St, Cambridge, MA 02138 USA; [Papanicolas, Irene; Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Harvard Global Hlth Inst, Cambridge, MA 02138 USA	University of London; London School Economics & Political Science; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Jha, AK (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 42 Church St, Cambridge, MA 02138 USA.	ajha@hsph.harvard.edu						Alesina A, 2005, AM ECON REV, V95, P960, DOI 10.1257/0002828054825655; Alghothani L, 2012, ARCH DERMATOL, V148, P956, DOI 10.1001/archdermatol.2012.804; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Duckett Stephen, 2012, Healthc Policy, V7, P85; Joseph KS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e746; Kociol RD, 2012, JAMA-J AM MED ASSOC, V307, P66, DOI 10.1001/jama.2011.1926; Organisation for Economic Cooperation and Development, 2015, HLTH GLANC 2015	9	19	19	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					515	516		10.1001/jama.2017.9392	http://dx.doi.org/10.1001/jama.2017.9392			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28750110				2022-12-28	WOS:000407160100010
J	Voelker, R				Voelker, Rebecca			New Hereditary Angioedema Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					416	416		10.1001/jama.2017.9334	http://dx.doi.org/10.1001/jama.2017.9334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763531				2022-12-28	WOS:000406659800004
J	Stone, R				Stone, Richard			SCIENCE DIPLOMACY Travel ban would slam university in North Korea	SCIENCE			English	News Item																			0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					342	342		10.1126/science.357.6349.342	http://dx.doi.org/10.1126/science.357.6349.342			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751588				2022-12-28	WOS:000406362300016
J	Wu, J; Bollinger, AT; He, X; Bozovic, I				Wu, J.; Bollinger, A. T.; He, X.; Bozovic, I.			Spontaneous breaking of rotational symmetry in copper oxide superconductors	NATURE			English	Article							HIGH-T-C; HIGH-TEMPERATURE SUPERCONDUCTIVITY; INTERFACE SUPERCONDUCTIVITY; ELECTRONIC NEMATICITY; TRANSVERSE VOLTAGE; MOTT INSULATOR; STATE; CUPRATE; DENSITY; MAGNETORESISTANCE	The origin of high-temperature superconductivity in copper oxides and the nature of the 'normal' state above the critical temperature are widely debated(1-3). In underdoped copper oxides, this normal state hosts a pseudogap and other anomalous features; and in the overdoped materials, the standard Bardeen-Cooper-Schrieffer description fails(4), challenging the idea that the normal state is a simple Fermi liquid. To investigate these questions, we have studied the behaviour of single-crystal La2-xSrxCuO4 films through which an electrical current is being passed. Here we report that a spontaneous voltage develops across the sample, transverse (orthogonal) to the electrical current. The dependence of this voltage on probe current, temperature, in-plane device orientation and doping shows that this behaviour is intrinsic, substantial, robust and present over a broad range of temperature and doping. If the current direction is rotated in-plane by an angle phi, the transverse voltage oscillates as sin(2 phi), breaking the four-fold rotational symmetry of the crystal. The amplitude of the oscillations is strongly peaked near the critical temperature for superconductivity and decreases with increasing doping. We find that these phenomena are manifestations of unexpected in-plane anisotropy in the electronic transport. The films are very thin and epitaxially constrained to be tetragonal (that is, with four-fold symmetry), so one expects a constant resistivity and zero transverse voltage, for every phi. The origin of this anisotropy is purely electronic-the so-called electronic nematicity. Unusually, the nematic director is not aligned with the crystal axes, unless a substantial orthorhombic distortion is imposed. The fact that this anisotropy occurs in a material that exhibits high-temperature superconductivity may not be a coincidence.	[Wu, J.; Bollinger, A. T.; He, X.; Bozovic, I.] Brookhaven Natl Lab, Upton, NY 11973 USA; [He, X.; Bozovic, I.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Yale University	Bozovic, I (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.; Bozovic, I (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	bozovic@bnl.gov		Wu, Jie/0000-0001-7314-8856	US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4410]	US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation's EPiQS Initiative	We acknowledge discussions with Z. Radovic, J. Zaanen, S. A. Kivelson, A. Gozar, I. Drozdov, P.N. Armitage and J.C. Davis. The research was done at Brookhaven and was supported by the US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. X.H. was supported by the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4410.	Abdel-Jawad M, 2006, NAT PHYS, V2, P821, DOI 10.1038/nphys449; Abdel-Jawad M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.107002; Analytis J. G., 2007, PHYS REV B, V76; Ando Y, 1999, PHYS REV LETT, V83, P2813, DOI 10.1103/PhysRevLett.83.2813; Ando Y, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.247003; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Beekman AJ, 2017, PHYS REP, V683, P1, DOI 10.1016/j.physrep.2017.03.004; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Bozovic I, 2016, NATURE, V536, P309, DOI 10.1038/nature19061; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; Butko VY, 2009, ADV MATER, V21, P3644, DOI 10.1002/adma.200803850; Carlson EW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1375; Cyr-Choiniere O, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.224502; da Luz MS, 2005, PHYSICA C, V419, P71, DOI 10.1016/j.physc.2004.12.005; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Doiron-Leyraud N, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.245136; Fernandes RM, 2014, NAT PHYS, V10, P97, DOI 10.1038/nphys2877; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; FRANCAVILLA TL, 1995, IEEE T APPL SUPERCON, V5, P1717, DOI 10.1109/77.402909; Fujita K, 2014, SCIENCE, V344, P612, DOI 10.1126/science.1248783; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; He X, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4967004; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Hussey NE, 2002, ADV PHYS, V51, P1685, DOI 10.1080/00018730210164638; Hussey NE, 2003, EUR PHYS J B, V31, P495, DOI 10.1140/epjb/e2003-00059-9; Hussey NE, 1996, PHYS REV LETT, V76, P122, DOI 10.1103/PhysRevLett.76.122; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kokalj J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045132; Kokalj J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.147001; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.277001; Lubashevsky Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.147001; Matsuda Y, 1995, PHYS REV B, V52, P15749, DOI 10.1103/PhysRevB.52.R15749; Mesaros A, 2011, SCIENCE, V333, P426, DOI 10.1126/science.1201082; Nakamae S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.100502; Narduzzo A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.220502; Oganesyan V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195109; Phillabaum B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1920; Segal A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094531; Tassini L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117002; Torchinsky DH, 2013, NAT MATER, V12, P387, DOI [10.1038/NMAT3571, 10.1038/nmat3571]; VASEK P, 1995, PHYSICA C, V247, P381, DOI 10.1016/0921-4534(95)00212-X; Wu J, 2013, NAT MATER, V12, P877, DOI [10.1038/nmat3719, 10.1038/NMAT3719]; Wu J, 2016, P NATL ACAD SCI USA, V113, P4284, DOI 10.1073/pnas.1519630113; Zaanen J, 2006, NAT PHYS, V2, P138; Zaanen J, 1996, ANN PHYS-LEIPZIG, V5, P224; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391	51	87	89	4	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					432	+		10.1038/nature23290	http://dx.doi.org/10.1038/nature23290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28748933	Green Submitted			2022-12-28	WOS:000406358300031
J	Weed, HG				Weed, Harrison G.			Preoperative geriatric assessment reduced hospital stay and complications in patients >= 65 y having vascular surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Weed, Harrison G.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Ohio State University	Weed, HG (corresponding author), Ohio State Univ, Coll Med, Columbus, OH 43210 USA.							Shields L, 2017, J AM GERIATR SOC	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC2	JC2		10.7326/ACPJC-2017-167-2-002	http://dx.doi.org/10.7326/ACPJC-2017-167-2-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715824				2022-12-28	WOS:000405573400003
J	Sales-Pardo, M				Sales-Pardo, Marta			The importance of being modular	SCIENCE			English	Editorial Material							COMPLEX NETWORKS		[Sales-Pardo, Marta] Univ Rovira & Virgili, Dept Chem Engn, E-43007 Tarragona, Spain	Universitat Rovira i Virgili	Sales-Pardo, M (corresponding author), Univ Rovira & Virgili, Dept Chem Engn, E-43007 Tarragona, Spain.	marta.sales@urv.cat	Sales-Pardo, Marta/O-9797-2019; Sales-Pardo, Marta/C-1725-2008	Sales-Pardo, Marta/0000-0002-8140-6525; Sales-Pardo, Marta/0000-0002-8140-6525				Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Bardoscia M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14416; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gilarranz LJ, 2017, SCIENCE, V357, P199, DOI 10.1126/science.aal4122; Grilli J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12031; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Levin SA, 2015, P NATL ACAD SCI USA, V112, P12543, DOI 10.1073/pnas.1518385112; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a	15	10	11	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		128	129		10.1126/science.aan8075	http://dx.doi.org/10.1126/science.aan8075			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706024				2022-12-28	WOS:000405391700020
J	Greve, J; Hahn, J				Greve, Jens; Hahn, Janina			Recombinant human C1 esterase inhibitor for hereditary angio-oedema	LANCET			English	Editorial Material									[Greve, Jens; Hahn, Janina] Ulm Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-89075 Ulm, Germany	Ulm University	Greve, J (corresponding author), Ulm Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-89075 Ulm, Germany.	jens.greve@uniklinik-ulm.de	Greve, Jens/AAF-2688-2021					Banerji A, 2015, ALLERGY ASTHMA PROC, V36, P213, DOI 10.2500/aap.2015.36.3824; Bork K, 2009, AM J MED, V122, P780, DOI 10.1016/j.amjmed.2009.02.024; Greve J, 2016, TRANSFUSION, V56, P1022, DOI 10.1111/trf.13462; Greve J, 2016, J DTSCH DERMATOL GES, V14, P266, DOI 10.1111/ddg.12856; Keleman Z, 2010, CLIN IMMUNOL, V134, P354, DOI 10.1016/j.clim.2009.11.002; Riedl MA, 2017, LANCET; SPATH P J, 1984, Complement, V1, P147; Tse KY, 2017, ANN ALLERG ASTHMA IM, V118	8	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 30	2017	390	10102					1566	1567		10.1016/S0140-6736(17)31966-9	http://dx.doi.org/10.1016/S0140-6736(17)31966-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI3RA	28754495				2022-12-28	WOS:000411883300006
J	Han, B; Compton, WM; Blanco, C; Crane, E; Lee, J; Jones, CM				Han, B.; Compton, W. M.; Blanco, C.; Crane, E.; Lee, J.; Jones, C. M.			Prescription Opioid Use, Misuse, and Use Disorders in US Adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					I24	I24		10.7326/P17-9042	http://dx.doi.org/10.7326/P17-9042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28761947				2022-12-28	WOS:000409120400001
J	Truog, RD				Truog, Robert D.			The United Kingdom Sets Limits on Experimental Treatments The Case of Charlie Gard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Truog, Robert D.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Truog, RD (corresponding author), Harvard Med Sch, Ctr Bioeth, 641 Huntington Ave, Boston, MA 02115 USA.	robert_truog@hms.harvard.edu						[Anonymous], 2017, BBC NEWS; [Anonymous], 2017, NY TIMES; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6	3	21	21	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP	2017	318	11					1001	1002		10.1001/jama.2017.10410	http://dx.doi.org/10.1001/jama.2017.10410			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7DP	28727879				2022-12-28	WOS:000411343400007
J	Lv, JC; Zhang, H; Wong, MG; Jardine, MJ; Hladunewich, M; Jha, V; Monaghan, H; Zhao, MH; Barbour, S; Reich, H; Cattran, D; Glassock, R; Levin, A; Wheeler, D; Woodward, M; Billot, L; Chan, TM; Liu, ZH; Johnson, DW; Cass, A; Feehally, J; Floege, J; Remuzzi, G; Wu, YF; Agarwal, R; Wang, HY; Perkovic, V				Lv, Jicheng; Zhang, Hong; Wong, Muh Geot; Jardine, Meg J.; Hladunewich, Michelle; Jha, Vivek; Monaghan, Helen; Zhao, Minghui; Barbour, Sean; Reich, Heather; Cattran, Daniel; Glassock, Richard; Levin, Adeera; Wheeler, David; Woodward, Mark; Billot, Laurent; Chan, Tak Mao; Liu, Zhi-Hong; Johnson, David W.; Cass, Alan; Feehally, John; Floege, Juergen; Remuzzi, Giuseppe; Wu, Yangfeng; Agarwal, Rajiv; Wang, Hai-Yan; Perkovic, Vlado		TESTING Study Grp	Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy The TESTING Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TERM-FOLLOW-UP; END-POINT; CORTICOSTEROIDS; THERAPY; PROGRESSION; INHIBITORS; PROGNOSIS; PLACEBO; RISK	IMPORTANCE Guidelines recommend corticosteroids in patients with IgA nephropathy and persistent proteinuria, but the effects remain uncertain. OBJECTIVE To evaluate the efficacy and safety of corticosteroids in patients with IgA nephropathy at risk of progression. DESIGN, SETTING, AND PARTICIPANTS The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) study was a multicenter, double-blind, randomized clinical trial designed to recruit 750 participants with IgA nephropathy (proteinuria greater than 1 g/d and estimated glomerular filtration rate [eGFR] of 20 to 120 mL/min/1.73m(2) after at least 3 months of blood pressure control with renin-angiotensin system blockade] and to provide follow-up until 335 primary outcomes occurred. INTERVENTIONS Patients were randomized 1:1 to oral methylprednisolone (0.6-0.8 mg/kg/d; maximum, 48 mg/d) (n = 136) or matching placebo (n = 126) for 2 months, with subsequent weaning over 4 to 6 months. MAIN OUTCOMES AND MEASURES The primary composite outcome was end-stage kidney disease, death due to kidney failure, or a 40% decrease in eGFR. Predefined safety outcomes were serious infection, new diabetes, gastrointestinal hemorrhage, fracture/osteonecrosis, and cardiovascular events. The mean required follow-up was estimated to be 5 years. RESULTS After randomization of 262 participants (mean age, 38.6 [SD, 11.1] years; 96 [37%] women; eGFR, 59.4 mL/min/1.73m(2); urine protein excretion, 2.40 g/d) and 2.1 years' median follow-up, recruitment was discontinued because of excess serious adverse events. Serious events occurred in 20 participants (14.7%) in the methylprednisolone group vs 4 (3.2%) in the placebo group (P = .001; risk difference, 11.5%[95% CI, 4.8%-18.2%]), mostly due to excess serious infections (11 [8.1%] vs 0; risk difference, 8.1%[95% CI, 3.5%-13.9%]; P < .001), including 2 deaths. The primary renal outcome occurred in 8 participants (5.9%) in the methylprednisolone group vs 20 (15.9%) in the placebo group (hazard ratio, 0.37 [95% CI, 0.17-0.85]; risk difference, 10.0%[95% CI, 2.5%-17.9%]; P = .02). CONCLUSIONS AND RELEVANCE Among patients with IgA nephropathy and proteinuria of 1 g/d or greater, oral methylprednisolone was associated with an increased risk of serious adverse events, primarily infections. Although the results were consistent with potential renal benefit, definitive conclusions about treatment benefit cannot be made, owing to early termination of the trial.	[Lv, Jicheng; Zhang, Hong; Zhao, Minghui; Wang, Hai-Yan] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100034, Peoples R China; [Lv, Jicheng; Wong, Muh Geot; Jardine, Meg J.; Monaghan, Helen; Woodward, Mark; Billot, Laurent; Cass, Alan; Perkovic, Vlado] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Hladunewich, Michelle] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Jha, Vivek] George Inst Global Hlth, New Delhi, India; [Jha, Vivek] Univ Oxford, Oxford, England; [Barbour, Sean; Levin, Adeera] Univ British Columbia, Vancouver, BC, Canada; [Reich, Heather; Cattran, Daniel] Univ Hlth Network, Toronto, ON, Canada; [Glassock, Richard] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Wheeler, David] Royal Free & Univ Coll, Sch Med, London, England; [Woodward, Mark] Univ Oxford, George Inst Global Hlth, Oxford, England; [Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Chan, Tak Mao] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Liu, Zhi-Hong] Jinling Hosp, Res Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Johnson, David W.] Univ Queensland, Australasian Kidney Trials Network, Brisbane, Qld, Australia; [Cass, Alan] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Feehally, John] Univ Leicester, Leicester, Leics, England; [Floege, Juergen] Rhein Westfal TH Aachen, Div Nephrol & Clin Immunol, Aachen, Germany; [Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Bergamo, Italy; [Remuzzi, Giuseppe] Clin Res Ctr Rare Dis, Bergamo, Italy; [Wu, Yangfeng] Peking Univ, Clin Res Inst, Beijing, Peoples R China; [Agarwal, Rajiv] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Peking University; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Oxford; University of British Columbia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; University College London; UCL Medical School; University of Oxford; Johns Hopkins University; University of Hong Kong; University of Queensland; Charles Darwin University; Menzies School of Health Research; University of Leicester; RWTH Aachen University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Peking University; Indiana University System; Indiana University Bloomington	Zhang, H (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100034, Peoples R China.; Perkovic, V (corresponding author), UNSW Sydney, George Inst Global Hlth, One King St,POB M201, Newtown, NSW 2042, Australia.	hongzh@bjmu.edu.cn; vperkovic@georgeinstitute.org.au	Jardine, Meg/AAS-1864-2020; Jardine, Meg/AFR-1699-2022; Agarwal, Rajiv/H-3454-2019; Woodward, Mark/L-6817-2017; Billot, Laurent/Y-1241-2019; Perkovic, Vlado/AAY-1933-2021; Johnson, David/F-2897-2011; Remuzzi, Giuseppe/V-9766-2017	Jardine, Meg/0000-0002-0160-2375; Jardine, Meg/0000-0002-0160-2375; Agarwal, Rajiv/0000-0001-8355-7100; Billot, Laurent/0000-0002-4975-9793; Chan, Tak Mao/0000-0002-3495-4051; Monaghan, Helen/0000-0001-5369-178X; Jayne, David/0000-0002-1712-0637; Johnson, David/0000-0001-5491-3460; Woodward, Mark/0000-0001-9800-5296; Remuzzi, Giuseppe/0000-0002-6194-3446; Cass, Alan/0000-0002-3923-3173; Jha, Vivekanand/0000-0002-8015-9470	National Health and Medical Research Council of Australia; Peking University Health Central Clinical Research Project; Canadian Institutes of Health Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Peking University Health Central Clinical Research Project; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the National Health and Medical Research Council of Australia, the Peking University Health Central Clinical Research Project, and the Canadian Institutes of Health Research. Study drug was provided by Pfizer Pharmaceuticals.	Barbour SJ, 2013, KIDNEY INT, V84, P1017, DOI 10.1038/ki.2013.210; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cattran DC, 2012, KIDNEY INT SUPPL, V2, P139, DOI DOI 10.1038/KISUP.2012.9; CONNELL JMC, 1987, J HYPERTENS, V5, P425; Coppo R, 2007, J AM SOC NEPHROL, V18, P1880, DOI 10.1681/ASN.2006040347; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Fellstrom BC, 2017, LANCET, V389, P2117, DOI 10.1016/S0140-6736(17)30550-0; Floege J, 2016, LANCET, V387, P2036, DOI 10.1016/S0140-6736(16)00272-5; Inker LA, 2016, AM J KIDNEY DIS, V68, P392, DOI 10.1053/j.ajkd.2016.02.042; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li XL, 2014, CLIN J AM SOC NEPHRO, V9, P484, DOI 10.2215/CJN.01990213; Lv JC, 2008, NEPHROLOGY, V13, P242, DOI 10.1111/j.1440-1797.2007.00898.x; Lv JC, 2012, J AM SOC NEPHROL, V23, P1108, DOI 10.1681/ASN.2011111112; Lv JC, 2009, AM J KIDNEY DIS, V53, P26, DOI 10.1053/j.ajkd.2008.07.029; Manno C, 2009, NEPHROL DIAL TRANSPL, V24, P3694, DOI 10.1093/ndt/gfp356; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Rauen T, 2015, NEW ENGL J MED, V373, P2225, DOI 10.1056/NEJMoa1415463; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Ruggenenti P, 1997, LANCET, V349, P1857; Smets P, 2010, GEN COMP ENDOCR, V169, P1, DOI 10.1016/j.ygcen.2010.07.004; Tesar V, 2015, J AM SOC NEPHROL, V26, P2248, DOI 10.1681/ASN.2014070697; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793	24	246	262	3	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					432	442		10.1001/jama.2017.9362	http://dx.doi.org/10.1001/jama.2017.9362			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28763548	Green Published			2022-12-28	WOS:000406659800014
J	Gibbons, A				Gibbons, Ann			BIOLOGY OF THE BOOK	SCIENCE			English	Editorial Material																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					346	349		10.1126/science.357.6349.346	http://dx.doi.org/10.1126/science.357.6349.346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751592				2022-12-28	WOS:000406362300020
J	Pulla, P				Pulla, Priyanka			Disease sleuths unmask deadly encephalitis culprit	SCIENCE			English	News Item																		2014, SCIENCE, P130	1	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					344	344		10.1126/science.357.6349.344	http://dx.doi.org/10.1126/science.357.6349.344			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751590				2022-12-28	WOS:000406362300018
J	Zar, HJ; Andronikou, S; Nicol, MP				Zar, Heather J.; Andronikou, Savvas; Nicol, Mark P.			Advances in the diagnosis of pneumonia in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCOCCAL CONJUGATE VACCINE; RADIOLOGICALLY-CONFIRMED PNEUMONIA; LOWER RESPIRATORY-INFECTIONS; POLYMERASE-CHAIN-REACTION; C-REACTIVE PROTEIN; LUNG ULTRASONOGRAPHY; HOSPITALIZED CHILDREN; CHILDHOOD PNEUMONIA; YOUNG-CHILDREN	Pneumonia remains a major cause of childhood mortality and morbidity globally. Accurate diagnosis and attribution of the causes of pneumonia are important for measuring the burden of disease, implementing appropriate preventive or treatment strategies, and developing more effective interventions. This review summarizes recent diagnostic advances in radiological techniques, specimen collection, and laboratory methods. Although chest ultrasound and chest magnetic resonance imaging are promising modalities for radiological diagnosis, their role in clinical management and their impact on outcomes need further study. Rapid, highly sensitive, multiplex laboratory tests performed on upper respiratory tract samples or induced sputum can detect nucleic acid from potential pathogens in most children with pneumonia. However, it may be difficult to attribute causality because it is often impossible to distinguish between organisms colonizing or infecting the upper respiratory tract and those causing pneumonia. Currently available host biomarkers lack accuracy for distinguishing bacterial or mixed bacterial-viral infections from viral infections. New biomarkers derived from host transcriptional profile analysis may be more accurate but require validation. Prospective studies with appropriate control populations, including studies of clinical impact, are needed to improve our understanding of the role of tests. Although progress has been made in radiological techniques and laboratory testing, current methods for diagnosing and attributing the causes of pneumonia are suboptimal.	[Zar, Heather J.; Andronikou, Savvas] Red Cross Childrens Hosp, Dept Paediat & Child Hlth, ZA-7700 Cape Town, South Africa; [Zar, Heather J.; Andronikou, Savvas] Univ Cape Town, MRC, Unit Child & Adolescent Hlth, ZA-7700 Cape Town, South Africa; [Andronikou, Savvas] Univ Bristol, Dept Radiol, Bristol, Avon, England; [Andronikou, Savvas] Bristol Royal Hosp Children, Bristol, Avon, England; [Nicol, Mark P.] Univ Cape Town, Dept Pathol, Div Med Microbiol, Cape Town, South Africa; [Nicol, Mark P.] Natl Hlth Lab Serv South Africa, Johannesburg, South Africa	University of Cape Town; University of Bristol; Bristol Royal Hospital For Children; University of Cape Town; National Health Laboratory Service	Zar, HJ (corresponding author), Red Cross Childrens Hosp, Dept Paediat & Child Hlth, ZA-7700 Cape Town, South Africa.; Zar, HJ (corresponding author), Univ Cape Town, MRC, Unit Child & Adolescent Hlth, ZA-7700 Cape Town, South Africa.	heather.zar@uct.ac.za	Andronikou, Savvas/AAF-4438-2020; Nicol, Mark/W-4149-2019; Zar, Heather/GZL-5350-2022	Nicol, Mark/0000-0002-1366-4805; Zar, Heather/0000-0002-9046-759X				Ambroggio L, 2016, J PEDIATR-US, V176, P93, DOI 10.1016/j.jpeds.2016.05.033; Andres-Terre M, 2015, IMMUNITY, V43, P1199, DOI 10.1016/j.immuni.2015.11.003; Andrews AL, 2015, J PEDIATR-US, V167, P1280, DOI 10.1016/j.jpeds.2015.09.025; Andronikou S, 2017, PEDIATR RADIOL, V47, P113, DOI 10.1007/s00247-016-3697-5; Andronikou S, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00125; Angoulvant F, 2014, CLIN INFECT DIS, V58, P918, DOI 10.1093/cid/ciu006; Anjay MA, 2008, ARCH DIS CHILD, V93, P553, DOI 10.1136/adc.2008.138958; Audette LD, 2016, EMERG MED J, V33, P589, DOI 10.1136/emermed-2016-206047.3; Baer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068419; Barger-Kamate B, 2016, CLIN INFECT DIS, V63, pS187, DOI 10.1093/cid/ciw546; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Blaschke AJ, 2014, J PEDIAT INF DIS SOC, V3, P112, DOI 10.1093/jpids/pit071; Boiselle PM, 2013, J THORAC IMAG, V28, P137, DOI 10.1097/RTI.0b013e31828cafe7; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Byington CL, 2002, ARCH PEDIAT ADOL MED, V156, P1230, DOI 10.1001/archpedi.156.12.1230; Caiulo VA, 2013, PEDIATR PULM, V48, P280, DOI 10.1002/ppul.22585; Campbell H, 2015, LANCET GLOB HEALTH, V3, pE65, DOI 10.1016/S2214-109X(14)70308-0; Cattarossi L, 2013, EARLY HUM DEV, V89, pS17, DOI 10.1016/S0378-3782(13)70006-9; Chan JYC, 2015, PEDIATRICS, V135, P607, DOI 10.1542/peds.2014-3060; Chang HY, 2014, J MICROBIOL IMMUNOL, V47, P137, DOI 10.1016/j.jmii.2013.03.015; Chang SD, 2014, CAN ASSOC RADIOL J, V65, P1, DOI 10.1016/j.carj.2013.12.001; Charkaluk ML, 2006, DIAGN MICR INFEC DIS, V55, P89, DOI 10.1016/j.diagmicrobio.2005.10.013; Chavez MA, 2015, LUNG, V193, P531, DOI 10.1007/s00408-015-9730-x; Copetti R, 2008, RADIOL MED, V113, P190, DOI 10.1007/s11547-008-0247-8; De Schutter I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089013; Deliberato RO, 2013, DIAGN MICR INFEC DIS, V76, P266, DOI 10.1016/j.diagmicrobio.2013.03.027; Dickson RP, 2014, LANCET RESP MED, V2, P238, DOI 10.1016/S2213-2600(14)70028-1; Do NTT, 2016, LANCET GLOB HEALTH, V4, pE633, DOI 10.1016/S2214-109X(16)30142-5; Doan QH, 2009, J PEDIATR-US, V154, P91, DOI 10.1016/j.jpeds.2008.07.043; Dube FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068097; Elemraid MA, 2014, DIAGN MICR INFEC DIS, V79, P458, DOI 10.1016/j.diagmicrobio.2014.04.006; Elemraid MA, 2013, EUR RESPIR J, V42, P1595, DOI 10.1183/09031936.00199112; Enarson P, 2005, MANAGEMENT CHILD COU; Esposito S, 2004, PEDIATR INFECT DIS J, V23, P365, DOI 10.1097/00006454-200404000-00021; Esposito S, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-37; Esposito S, 2011, RESP MED, V105, P1939, DOI 10.1016/j.rmed.2011.09.003; Esposito S, 2010, J MED MICROBIOL, V59, P96, DOI 10.1099/jmm.0.015305-0; Evans Ceri, 2016, Lancet Infect Dis, V16, pe92, DOI 10.1016/S1473-3099(16)00055-4; Giulia B, 2015, CLIN CHIM ACTA, V451, P215, DOI 10.1016/j.cca.2015.09.031; Global Burden of Disease Pediatrics Collaboration, 2016, JAMA Pediatr, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Gorkem SB, 2013, AM J ROENTGENOL, V200, P1352, DOI 10.2214/AJR.12.9502; Gorycki T, 2014, POL J RADIOL, V79, P1, DOI 10.12659/PJR.889952; Gray D, 2016, THORAX, DOI 10.1136/thoraxjnl-2015-207401; Greenberg D, 2015, VACCINE, V33, P4623, DOI 10.1016/j.vaccine.2015.06.062; Griggs R, 2014, PEDIATR RADIOL, V44, P648, DOI 10.1007/s00247-014-2948-6; Guerra M, 2016, EUR J PEDIATR, V175, P163, DOI 10.1007/s00431-015-2611-8; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068; Hammitt LL, 2011, J CLIN MICROBIOL, V49, P2318, DOI 10.1128/JCM.02605-10; Hansen KB, 2016, INFECT DIS-NOR, V48, P246, DOI 10.3109/23744235.2015.1096956; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hendaus MA, 2015, THER CLIN RISK MANAG, V11, P1817, DOI 10.2147/TCRM.S96222; Herberg JA, 2016, JAMA-J AM MED ASSOC, V316, P835, DOI 10.1001/jama.2016.11236; Hernes SS, 2013, EUR J CLIN MICROBIOL, V32, P381, DOI 10.1007/s10096-012-1753-0; Hirsch W, 2008, EUR J RADIOL, V68, P278, DOI 10.1016/j.ejrad.2008.05.017; Ho MC, 2015, PEDIATR NEONATOL, V56, P40, DOI 10.1016/j.pedneo.2014.03.007; Honkinen M, 2012, CLIN MICROBIOL INFEC, V18, P300, DOI 10.1111/j.1469-0691.2011.03603.x; Hoshina T, 2014, J INFECT CHEMOTHER, V20, P616, DOI 10.1016/j.jiac.2014.06.003; Howie SRC, 2014, CLIN INFECT DIS, V59, P682, DOI 10.1093/cid/ciu384; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; Iorio G, 2015, PEERJ, V3, DOI 10.7717/peerj.1374; Iuri D, 2009, RADIOL MED, V114, P321, DOI 10.1007/s11547-008-0336-8; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Johnson J, 2010, EMERG RADIOL, V17, P285, DOI 10.1007/s10140-009-0854-2; Jones BP, 2016, CHEST, V150, P131, DOI 10.1016/j.chest.2016.02.643; Kelly MS, 2016, PEDIATR INFECT DIS J, V35, P257, DOI 10.1097/INF.0000000000000990; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Kurian J, 2009, AM J ROENTGENOL, V193, P1648, DOI 10.2214/AJR.09.2791; le Roux DM, 2015, LANCET GLOB HEALTH, V3, pE95, DOI 10.1016/S2214-109X(14)70360-2; Levin D, 2010, PEDIATR CRIT CARE ME, V11, P390, DOI 10.1097/PCC.0b013e3181b809c5; Leyenaar JK, 2014, J PEDIATR-US, V165, P585, DOI 10.1016/j.jpeds.2014.04.062; Li L, 2016, J MED VIROL, V88, P211, DOI 10.1002/jmv.24338; Lichtenstein DA, 2004, INTENS CARE MED, V30, P276, DOI 10.1007/s00134-003-2075-6; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lovrenski Jovan, 2016, Acta Med Acad, V45, P39, DOI 10.5644/ama2006-124.155; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; May ML, 2012, CLIN VACCINE IMMUNOL, V19, P190, DOI 10.1128/CVI.05430-11; McCulloh RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117462; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Morpeth SC, 2017, CLIN INFECT DIS, V64, pS347, DOI 10.1093/cid/cix145; Morrow Brenda M, 2014, BMC Res Notes, V7, P26, DOI 10.1186/1756-0500-7-26; Muloiwa R, 2016, PEDIATR INFECT DIS J, V35, P611, DOI 10.1097/INF.0000000000001132; Myers AL, 2013, PEDIATR INFECT DIS J, V32, P736, DOI 10.1097/INF.0b013e318290bf63; Nascimento-Carvalho CM, 2015, PEDIATR INFECT DIS J, V34, P490, DOI 10.1097/INF.0000000000000622; National Institute for Health and Care Excellence, 2013, FEV 5S ASS IN MAN, V160; Neuman MI, 2012, J HOSP MED, V7, P294, DOI 10.1002/jhm.955; Nicol MP, 2014, LANCET GLOB HEALTH, V2, pE278, DOI 10.1016/S2214-109X(14)70195-0; Nunes MC, 2016, CLIN INFECT DIS, V63, pS181, DOI 10.1093/cid/ciw521; Oliwa JN, 2015, LANCET RESP MED, V3, P235, DOI 10.1016/S2213-2600(15)00028-4; Ozcan HN, 2017, PEDIATR RADIOL, V47, P146, DOI 10.1007/s00247-016-3729-1; Page AL, 2014, PEDIATRICS, V133, pE363, DOI 10.1542/peds.2013-2112; Peltola V, 2008, PEDIATR RADIOL, V38, P1225, DOI 10.1007/s00247-008-0987-6; Peprah KO, 2012, J THORAC IMAG, V27, P171, DOI 10.1097/RTI.0b013e318211abfb; Pride MW, 2012, CLIN VACCINE IMMUNOL, V19, P1131, DOI 10.1128/CVI.00064-12; Puderbach M, 2008, PEDIATR RADIOL, V38, pS439, DOI 10.1007/s00247-008-0844-7; Roic Goran, 2016, Acta Med Acad, V45, P82, DOI 10.5644/ama2006-124.163; Rudan I, 2013, J GLOB HEALTH, V3, DOI [10.7189/jogh.03.010101, 10.7189/jogh.03.010401]; Samson F, 2018, EUR J EMERG MED, V25, P65, DOI 10.1097/MEJ.0000000000000418; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; Shah VP, 2013, JAMA PEDIATR, V167, P119, DOI 10.1001/2013.jamapediatrics.107; Shi T, 2015, J GLOB HEALTH, V5, P122, DOI 10.7189/jogh.05.010408; Simbalista R, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0485-6; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Sodhi KS, 2016, J MAGN RESON IMAGING, V43, P1196, DOI 10.1002/jmri.25082; Spencer S, 2013, J CLIN MICROBIOL, V51, P3880, DOI 10.1128/JCM.01873-13; Spik VC, 2013, SCAND J INFECT DIS, V45, P731, DOI 10.3109/00365548.2013.804631; Spuesens EBM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001444; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Swingler GH, 1998, LANCET, V351, P404, DOI 10.1016/S0140-6736(97)07013-X; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Theodoratou E, 2014, LANCET INFECT DIS, V14, P1250, DOI 10.1016/S1473-3099(14)70990-9; Toma P, 2013, PEDIATR RADIOL, V43, P1427, DOI 10.1007/s00247-013-2756-4; Tsung JW, 2012, CRIT ULTRASOUND J, V4, DOI 10.1186/2036-7902-4-16; Tuerlinckx D, 2013, PEDIATR INFECT DIS J, V32, pE277, DOI 10.1097/INF.0b013e31828c363f; Tunsjo HS, 2015, APMIS, V123, P473, DOI 10.1111/apm.12375; Urbankowska E, 2015, RESP MED, V109, P1207, DOI 10.1016/j.rmed.2015.06.011; Valim C, 2016, AM J RESP CRIT CARE, V193, P448, DOI 10.1164/rccm.201506-1100OC; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Varshney T, 2016, EMERG MED J, V33, P603, DOI 10.1136/emermed-2015-205302; Vaz-de-Lima LRA, 2014, CLIN VACCINE IMMUNOL, V21, P636, DOI 10.1128/CVI.00760-13; Volker M, 2015, MAGN RESON MATER PHY, V28, P227, DOI 10.1007/s10334-014-0468-x; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Waris M, 2013, J CLIN VIROL, V58, P200, DOI 10.1016/j.jcv.2013.06.002; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Yikilmaz A, 2011, ACTA RADIOL, V52, P914, DOI 10.1258/ar.2011.100429; Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5; Zar HJ, 2012, CLIN INFECT DIS, V55, P1088, DOI 10.1093/cid/cis598; Zar HJ, 2005, SAMJ S AFR MED J, V95, P977	132	52	56	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2017	358								j2739	10.1136/bmj.j2739	http://dx.doi.org/10.1136/bmj.j2739			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3UW	28747379				2022-12-28	WOS:000406765900001
J	Lyon, J				Lyon, Jeff			Chikungunya Vaccine Trials Begin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					322	322		10.1001/jama.2017.8753	http://dx.doi.org/10.1001/jama.2017.8753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28742891				2022-12-28	WOS:000406296700003
J	Chu, JT; Hossain, R; Silverblatt, FJ; Hyle, EP; Turbett, SE				Chu, Jacqueline T.; Hossain, Rydhwana; Silverblatt, Frederic J.; Hyle, Emily P.; Turbett, Sarah E.			Case 22-2017: A 21-Year-Old Woman with Fever, Headache, and Myalgias	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPHOID-FEVER; LEPTOSPIROSIS		[Chu, Jacqueline T.; Hyle, Emily P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hossain, Rydhwana] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Turbett, Sarah E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Chu, Jacqueline T.; Hyle, Emily P.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Hossain, Rydhwana] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Turbett, Sarah E.] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Silverblatt, Frederic J.] Brown Univ, Dept Med, Alpert Sch Med, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Brown University	Chu, JT (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Chu, JT (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Abgueguen P, 2008, J INFECTION, V57, P171, DOI 10.1016/j.jinf.2008.06.010; Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035; [Anonymous], 2016, INF DIS REL TRAV LEP; Basnyat B, 2005, CLIN INFECT DIS, V41, P1467, DOI 10.1086/497136; Brett-Major DM, 2012, COCHRANE DATABASE SY, V2; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Craig SB, 2009, ANN TROP MED PARASIT, V103, P333, DOI 10.1179/136485909X435058; Gasem MH, 2009, EMERG INFECT DIS, V15, P975, DOI 10.3201/eid1506.081405; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Jorgenson JH, 2015, MANUAL CLIN MICROBIO; Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229; Stauffer WM, 2009, CLIN INFECT DIS, V49, P908, DOI 10.1086/605436; Thaipadunpanit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016236	13	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					268	278		10.1056/NEJMcpc1616399	http://dx.doi.org/10.1056/NEJMcpc1616399			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9PI	28723324				2022-12-28	WOS:000405777600012
J	Haymart, MR; Miller, DC; Hawley, ST				Haymart, Megan R.; Miller, David C.; Hawley, Sarah T.			Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Haymart, Megan R.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Haymart, Megan R.; Miller, David C.; Hawley, Sarah T.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Miller, David C.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Hawley, Sarah T.] Univ Michigan, Dept Internal Med, Div Gen Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Haymart, MR (corresponding author), Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.; Haymart, MR (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.			Haymart, Megan/0000-0002-1083-1575	AHRQ HHS [R01 HS024512] Funding Source: Medline; NCI NIH HHS [R01 CA201198] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS024512] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA201198] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Merrill AL, 2016, NEW ENGL J MED, V374, P390, DOI 10.1056/NEJMclde1512213; Ryser MD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv372; Vaccarella S, 2016, NEW ENGL J MED, V375, P614, DOI 10.1056/NEJMp1604412	5	44	46	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2017	377	3					203	206		10.1056/NEJMp1703787	http://dx.doi.org/10.1056/NEJMp1703787			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9PI	28723330	Green Accepted			2022-12-28	WOS:000405777600002
J	van Leeuwen, D				van Leeuwen, Danny			WHAT YOUR PATIENT IS THINKING Learning together	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												danny@health-hats.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2017	358								j3219	10.1136/bmj.j3219	http://dx.doi.org/10.1136/bmj.j3219			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7KA	28724538	Green Published, Bronze			2022-12-28	WOS:000406318300003
J	Al-Hihi, E; Badgett, RG				Al-hihi, Eyad; Badgett, Robert G.			In moderate-to-severe sciatica, pregabalin did not reduce leg pain intensity or improve quality of life	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Al-hihi, Eyad] Univ Kansas, Sch Med, Kansas City, KS 66160 USA; [Badgett, Robert G.] Univ Kansas, Sch Med, Wichita, KS 67214 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Al-Hihi, E (corresponding author), Univ Kansas, Sch Med, Kansas City, KS 66160 USA.		Badgett, Robert/AAD-3429-2021	Badgett, Robert/0000-0003-2888-3303					0	1	1	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					JC4	JC4		10.7326/ACPJC-2017-167-2-004	http://dx.doi.org/10.7326/ACPJC-2017-167-2-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28715826				2022-12-28	WOS:000405573400005
J	Aldulaimi, S; Saenz, A				Aldulaimi, Sommer; Saenz, Anthony			A Bleeding Oral Mass in a Pregnant Woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GRANULOMA		[Aldulaimi, Sommer; Saenz, Anthony] Univ Arizona, Banner Univ Med Ctr, 2800 E Ajo Way, Tucson, AZ 85713 USA	University of Arizona	Aldulaimi, S (corresponding author), Univ Arizona, Banner Univ Med Ctr, 2800 E Ajo Way, Tucson, AZ 85713 USA.	sommer.aldulaimi@bannerhealth.com						Cardoso JA, 2013, J APPL ORAL SCI, V21, P215, DOI 10.1590/1679-775720130001; Gondivkar SM, 2010, CONTEMP CLIN DENT, V1, P190, DOI 10.4103/0976-237X.72792; Gordon-Nunez MA, 2010, J ORAL MAXIL SURG, V68, P2185, DOI 10.1016/j.joms.2009.07.070; Kroumpouzos G, 2001, J AM ACAD DERMATOL, V45, P1, DOI 10.1067/mjd.2001.114595; Loes S, 2008, PATIENT SAF SURG, V2, DOI 10.1186/1754-9493-2-14; Rihani FB, 2013, BMJ CASE REP, V2013, P1, DOI [10.1136/bcr-2013-010182, DOI 10.1136/BCR-2013-010182]; Singh R. K., 2013, BMJ CASE REP, V2013	7	1	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					293	294		10.1001/jama.2017.6901	http://dx.doi.org/10.1001/jama.2017.6901			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28719673				2022-12-28	WOS:000405775000016
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Let's ditch the stuff we don't need to do	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1569; NHS Digital, 2016, GP EARN EXP 2014 15; Oliver D, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2949	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2017	358								j3457	10.1136/bmj.j3457	http://dx.doi.org/10.1136/bmj.j3457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7JY	28720573	Bronze, Green Published			2022-12-28	WOS:000406318100010
J	Dingler, FA; Patel, KJ				Dingler, Felix A.; Patel, Ketan J.			Of sizzling steaks and DNA repair	SCIENCE			English	Editorial Material							PARKINSONISM		[Dingler, Felix A.; Patel, Ketan J.] MRC, Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Patel, KJ (corresponding author), MRC, Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	kjp@mrc-lmb.cam.ac.uk			Medical Research Council [MC_U105178811] Funding Source: Medline; Cancer Research UK [23273] Funding Source: researchfish; MRC [MC_U105178811] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Pontel LB, 2015, MOL CELL, V60, P177, DOI 10.1016/j.molcel.2015.08.020; Richarme G, 2017, SCIENCE, V357, P208, DOI 10.1126/science.aag1095; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815	6	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		130	131		10.1126/science.aan8293	http://dx.doi.org/10.1126/science.aan8293			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FA4CP	28706026				2022-12-28	WOS:000405391700022
J	Kopinke, D; Roberson, EC; Reiter, JF				Kopinke, Daniel; Roberson, Elle C.; Reiter, Jeremy F.			Ciliary Hedgehog Signaling Restricts Injury-Induced Adipogenesis	CELL			English	Article							SKELETAL-MUSCLE REGENERATION; WHITE ADIPOSE-TISSUE; SONIC HEDGEHOG; FIBRO/ADIPOGENIC PROGENITORS; MATRIX-METALLOPROTEINASES; ADIPOCYTE DIFFERENTIATION; INTRAFLAGELLAR TRANSPORT; REPRESSOR FUNCTIONS; PRIMARY-CILIUM; ECTOPIC FAT	Injured skeletal muscle regenerates, but with age or in muscular dystrophies, muscle is replaced by fat. Upon injury, muscle-resident fibro/adipogenic progenitors (FAPs) proliferated and gave rise to adipocytes. These FAPs dynamically produced primary cilia, structures that transduce intercellular cues such as Hedgehog (Hh) signals. Genetically removing cilia from FAPs inhibited intramuscular adipogenesis, both after injury and in a mouse model of Duchenne muscular dystrophy. Blocking FAP ciliation also enhanced myofiber regeneration after injury and reduced myofiber size decline in the muscular dystrophy model. Hh signaling through FAP cilia regulated the expression of TIMP3, a secreted metalloproteinase inhibitor, that inhibited MMP14 to block adipogenesis. A pharmacological mimetic of TIMP3 blocked the conversion of FAPs into adipocytes, pointing to a strategy to combat fatty degeneration of skeletal muscle. We conclude that ciliary Hh signaling by FAPs orchestrates the regenerative response to skeletal muscle injury.	[Kopinke, Daniel; Roberson, Elle C.; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Reiter, JF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	jeremy.reiter@ucsf.edu	Kopinke, Daniel/AAU-9854-2021	Kopinke, Daniel/0000-0001-5148-8219; Roberson, Elle/0000-0001-7466-7447	NIH [AR054396, GM095941]; Burroughs Wellcome Fund; Packard Foundation; ARCS Foundation, Northern California Chapter; Development Grant from the Muscular Dystrophy Association [MDA294976]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK098722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095941, T32GM007810] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); ARCS Foundation, Northern California Chapter; Development Grant from the Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Yu for assistance with mouse husbandry and members of the Reiter laboratory for critical discussion; Nadja Makki, Brian Black, and Andrew Brack for helpful comments on the manuscript; Elaine Carlson for providing help with expression studies and mouse genotyping; and Ajay Chawla and members of his laboratory for assistance with MACS. We acknowledge the UCSF Functional Genomics Core Facility for assistance with RNA-seq. This work was supported by grants from the NIH (AR054396 and GM095941), the Burroughs Wellcome Fund and the Packard Foundation to J.F.R. E.C.R. was supported by the ARCS Foundation, Northern California Chapter. D.K. was supported by a Development Grant from the Muscular Dystrophy Association (MDA294976).	Bauters D, 2015, BBA-GEN SUBJECTS, V1850, P1449, DOI 10.1016/j.bbagen.2015.04.003; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Dulor JP, 1998, FEBS LETT, V439, P89, DOI 10.1016/S0014-5793(98)01216-2; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Falkenstein KN, 2014, SEMIN CELL DEV BIOL, V33, P73, DOI 10.1016/j.semcdb.2014.05.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Heine VM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002731; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hu JKH, 2012, GENE DEV, V26, P2088, DOI 10.1101/gad.187385.112; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kopinke D, 2012, DEV BIOL, V362, P57, DOI 10.1016/j.ydbio.2011.11.010; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Macaulay VM, 1999, CLIN CANCER RES, V5, P513; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Marion V, 2009, P NATL ACAD SCI USA, V106, P1820, DOI 10.1073/pnas.0812518106; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McDonald AA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12391; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Piccioni A, 2014, GENE THER, V21, P413, DOI 10.1038/gt.2014.13; Piccioni A, 2014, J GERONTOL A-BIOL, V69, P245, DOI 10.1093/gerona/glt076; Pinnick KE, 2008, OBESITY, V16, P522, DOI 10.1038/oby.2007.110; Pisani DF, 2010, BIOCHEM BIOPH RES CO, V396, P767, DOI 10.1016/j.bbrc.2010.05.021; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; PRZYBYLS.RJ, 1971, J CELL BIOL, V49, P214, DOI 10.1083/jcb.49.1.214; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Renault MA, 2013, CIRC RES, V112, P762, DOI 10.1161/CIRCRESAHA.113.300871; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Straface G, 2009, J CELL MOL MED, V13, P2424, DOI 10.1111/j.1582-4934.2008.00440.x; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Valin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004818; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	57	107	108	4	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					340	+		10.1016/j.cell.2017.06.035	http://dx.doi.org/10.1016/j.cell.2017.06.035			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28709001	Green Accepted, Bronze			2022-12-28	WOS:000405493900013
J	Ying, Y; Wang, XJ; Vuong, CK; Lin, CH; Damianov, A; Black, DL				Ying, Yi; Wang, Xiao-Jun; Vuong, Celine K.; Lin, Chia-Ho; Damianov, Andrey; Black, Douglas L.			Splicing Activation by Rbfox Requires Self-Aggregation through Its Tyrosine-Rich Domain	CELL			English	Article							PHASE-TRANSITION; STRESS GRANULES; LIQUID DROPLETS; RNA; BINDING; EXPRESSION; PROTEINS; FUS; MECHANISMS; ALS	Proteins of the Rbfox family act with a complex of proteins called the Large Assembly of Splicing Regulators (LASR). We find that Rbfox interacts with LASR via its C-terminal domain (CTD), and this domain is essential for its splicing activity. In addition to LASR recruitment, a low-complexity (LC) sequence within the CTD contains repeated tyrosines that mediate higher-order assembly of Rbfox/ LASR and are required for splicing activation by Rbfox. This sequence spontaneously aggregates in solution to form fibrous structures and hydrogels, suggesting an assembly similar to the insoluble cellular inclusions formed by FUS and other proteins in neurologic disease. Unlike the pathological aggregates, we find that assembly of the Rbfox CTD plays an essential role in its normal splicing function. Rather than simple recruitment of individual regulators to a target exon, alternative splicing choices also depend on the higher-order assembly of these regulators within the nucleus.	[Ying, Yi; Vuong, Celine K.] Univ Calif Los Angeles, Mol Biol Interdept Doctoral Program, Los Angeles, CA USA; [Wang, Xiao-Jun; Lin, Chia-Ho; Damianov, Andrey; Black, Douglas L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ying, Yi; Vuong, Celine K.; Black, Douglas L.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Black, DL (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	dougb@microbio.ucla.edu			Howard Hughes Medical Institute; NIH [R01 GM114463, F31 NS093923]; UCLA dissertation year fellowship; China Scholarship Council; Broad Center for Stem Cell Research at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM114463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS093923] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA dissertation year fellowship; China Scholarship Council(China Scholarship Council); Broad Center for Stem Cell Research at UCLA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Xiang-Dong Fu and Jinsong Qiu (UCSD) for the RASL oligos and advice on RASL-seq, Ben Blencowe and Serge Gueroussov (University of Toronto) for communicating unpublished results, and David Eisenberg and Michael Hughes (UCLA) for helpful discussions and advice. This work was supported by the Howard Hughes Medical Institute and NIH grant R01 GM114463 (to D.L.B.); UCLA dissertation year fellowship and the China Scholarship Council (to Y.Y.); NIH F31 NS093923 (to C.K.V.); and the Broad Center for Stem Cell Research at UCLA.	Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Bergeron-Sandoval LP, 2016, CELL, V165, P1067, DOI 10.1016/j.cell.2016.05.026; Bill BR, 2013, INT REV NEUROBIOL, V113, P251, DOI 10.1016/B978-0-12-418700-9.00008-3; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; Calabretta S, 2015, TRENDS BIOCHEM SCI, V40, P662, DOI 10.1016/j.tibs.2015.08.012; Conboy J.G., 2017, WILEY INTERDISCIP RE; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Courchaine EM, 2016, EMBO J, V35, P1603, DOI 10.15252/embj.201593517; Damianov A, 2016, CELL, V165, P606, DOI 10.1016/j.cell.2016.03.040; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Dent MAR, 2010, FEBS LETT, V584, P2767, DOI 10.1016/j.febslet.2010.04.073; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073323; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li Hairi, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0413s98; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Misra A, 2015, MOL CELL, V58, P819, DOI 10.1016/j.molcel.2015.03.016; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Polling S, 2015, NAT STRUCT MOL BIOL, V22, P1008, DOI 10.1038/nsmb.3127; Schwartz JC, 2015, ANNU REV BIOCHEM, V84, P355, DOI 10.1146/annurev-biochem-060614-034325; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Singh G, 2015, ANNU REV BIOCHEM, V84, P325, DOI 10.1146/annurev-biochem-080111-092106; Sleeman JE, 2014, CURR OPIN CELL BIOL, V28, P76, DOI 10.1016/j.ceb.2014.03.004; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Strzelecka M, 2010, NAT STRUCT MOL BIOL, V17, P403, DOI 10.1038/nsmb.1783; Sun SY, 2012, RNA, V18, P274, DOI 10.1261/rna.030486.111; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Wei CL, 2016, MOL CELL, V62, P875, DOI 10.1016/j.molcel.2016.04.013; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940	54	54	55	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					312	+		10.1016/j.cell.2017.06.022	http://dx.doi.org/10.1016/j.cell.2017.06.022			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708999	Green Accepted, Bronze			2022-12-28	WOS:000405493900011
J	Kearns, C; Schillinger, D				Kearns, Cristin; Schillinger, Dean			Guidelines to Limit Added Sugar Intake RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Kearns, Cristin; Schillinger, Dean] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Schillinger, Dean] San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Kearns, C (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Erickson J, 2017, ANN INTERN MED, V166, P257, DOI 10.7326/M16-2020; The AGREE Research Trust, 2013, APPR GUID RES EV 2 I	2	1	1	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					220	220		10.7326/L17-0257	http://dx.doi.org/10.7326/L17-0257			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28761955				2022-12-28	WOS:000406631400023
J	Cervenka, I; Agudelo, LZ; Ruas, JL				Cervenka, Igor; Agudelo, Leandro Z.; Ruas, Jorge L.			Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health	SCIENCE			English	Review							ARYL-HYDROCARBON RECEPTOR; AMINO-ACID TRANSPORTER; INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY; T-CELL; INTERFERON-GAMMA; QUINOLINIC ACID; ADIPOSE-TISSUE; LIFE-SPAN; CATABOLIZING ENZYMES; ENERGY HOMEOSTASIS	Kynurenine metabolites are generated by tryptophan catabolism and regulate biological processes that include host-microbiome signaling, immune cell response, and neuronal excitability. Enzymes of the kynurenine pathway are expressed in different tissues and cell types throughout the body and are regulated by cues, including nutritional and inflammatory signals. As a consequence of this systemic metabolic integration, peripheral inflammation can contribute to accumulation of kynurenine in the brain, which has been associated with depression and schizophrenia. Conversely, kynurenine accumulation can be suppressed by activating kynurenine clearance in exercised skeletal muscle. The effect of exercise training on depression through modulation of the kynurenine pathway highlights an important mechanism of interorgan cross-talk mediated by these metabolites. Here, we discuss peripheral mechanisms of tryptophan-kynurenine metabolism and their effects on inflammatory, metabolic, oncologic, and psychiatric disorders.	[Cervenka, Igor; Agudelo, Leandro Z.; Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol Mol & Cellular Exercise, SE-17177 Stockholm, Sweden	Karolinska Institutet	Ruas, JL (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol Mol & Cellular Exercise, SE-17177 Stockholm, Sweden.	jorge.ruas@ki.se	Ruas, Jorge/AAE-6094-2019	Ruas, Jorge/0000-0002-1110-2606	Swedish Research Council; Novo Nordisk Foundation (Denmark); Karolinska Institutet; Lars Hierta Memorial Foundation; Strategic Research Program (SRP) in Diabetes; SRP in Regenerative Medicine at Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation (Denmark)(Novo Nordisk Foundation); Karolinska Institutet(Karolinska Institutet); Lars Hierta Memorial Foundation; Strategic Research Program (SRP) in Diabetes; SRP in Regenerative Medicine at Karolinska Institutet	The authors acknowledge members of the Ruas laboratory for critical reading of the manuscript and funding from the Swedish Research Council, the Novo Nordisk Foundation (Denmark), Karolinska Institutet, the Lars Hierta Memorial Foundation, the Strategic Research Program (SRP) in Diabetes, and the SRP in Regenerative Medicine at Karolinska Institutet.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; Amori L, 2009, J NEUROCHEM, V109, P316, DOI 10.1111/j.1471-4159.2009.05893.x; Ananieva Elitsa, 2015, World J Biol Chem, V6, P281, DOI 10.4331/wjbc.v6.i4.281; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; AUNE TM, 1989, J CLIN INVEST, V84, P863, DOI 10.1172/JCI114247; Badawy AAB, 2017, NEUROPHARMACOLOGY, V112, P248, DOI 10.1016/j.neuropharm.2015.11.015; Badawy AAB, 2014, INT J TRYPTOPHAN RES, V7, P23, DOI 10.4137/IJTR.S18231; Ball HJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00485; Barth MC, 2009, J BIOL CHEM, V284, P19189, DOI 10.1074/jbc.M109.024042; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Beamer CA, 2012, TOXICOL SCI, V126, P554, DOI 10.1093/toxsci/kfs024; Belladonna ML, 2007, TRANSPLANTATION, V84, pS17, DOI 10.1097/01.tp.0000269199.16209.22; BENDER DA, 1983, BRIT J NUTR, V50, P25, DOI 10.1079/BJN19830068; BENDER DA, 1989, BRIT J NUTR, V61, P629, DOI 10.1079/BJN19890150; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bhutia YD, 2015, BBA-BIOMEMBRANES, V1848, P453, DOI 10.1016/j.bbamem.2014.10.021; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; BOHNEY JP, 1992, BIOCHEM PHARMACOL, V43, P1829, DOI 10.1016/0006-2952(92)90717-W; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chaves ACL, 2001, EUR J IMMUNOL, V31, P333, DOI 10.1002/1521-4141(200102)31:2&lt;333::AID-IMMU333&gt;3.0.CO;2-X; Chen JY, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0410-1; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Christmas DM, 2010, NUTR RES, V30, P678, DOI 10.1016/j.nutres.2010.09.009; CIVEN M, 1959, J BIOL CHEM, V234, P1787; Correia JC, 2015, TRENDS ENDOCRIN MET, V26, P305, DOI 10.1016/j.tem.2015.03.010; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; CREPALDI G, 1975, ACTA VITAMINOL ENZYM, V29, P140; D'Amato NC, 2015, CANCER RES, V75, P4651, DOI 10.1158/0008-5472.CAN-15-2011; Dagenais-Lussier X, 2016, J VIROL, V90, P7967, DOI 10.1128/JVI.00994-16; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Dunlop SP, 2005, CLIN GASTROENTEROL H, V3, P349, DOI 10.1016/S1542-3565(04)00726-8; Fallarini S, 2010, BIOCHEM BIOPH RES CO, V398, P420, DOI 10.1016/j.bbrc.2010.06.091; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Favennec M, 2015, OBESITY, V23, P2066, DOI 10.1002/oby.21199; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GLAVIN GB, 1989, PROG NEURO-PSYCHOPH, V13, P569, DOI 10.1016/0278-5846(89)90148-6; Granger J, 2005, SHOCK, V24, P45, DOI 10.1097/01.shk.0000191413.94461.b0; Grant RS, 1999, ARCH BIOCHEM BIOPHYS, V372, P1, DOI 10.1006/abbi.1999.1381; GREENGARD O, 1961, NATURE, V190, P446, DOI 10.1038/190446a0; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Gupta NK, 2012, INFLAMM BOWEL DIS, V18, P1214, DOI 10.1002/ibd.21849; Han Q, 2009, MOL CELL BIOL, V29, P784, DOI 10.1128/MCB.01272-08; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; HATTORI M, 1984, Acta Vitaminologica et Enzymologica, V6, P221; Hawkley LC, 2012, HORM BEHAV, V62, P314, DOI 10.1016/j.yhbeh.2012.05.011; He WR, 2011, PLANT CELL, V23, P3944, DOI 10.1105/tpc.111.089029; HERRMANN KM, 1995, PLANT CELL, V7, P907; Heyes MP, 1997, BIOCHEM J, V326, P351, DOI 10.1042/bj3260351; Hill M, 2007, EUR J IMMUNOL, V37, P3054, DOI 10.1002/eji.200636704; Inubushi T, 2012, J NUTR SCI VITAMINOL, V58, P415, DOI 10.3177/jnsv.58.415; Jenabian MA, 2015, J INFECT DIS, V212, P355, DOI 10.1093/infdis/jiv037; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Juhasz C, 2012, CLIN NUCL MED, V37, P838, DOI 10.1097/RLU.0b013e318251e458; Kanai M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-8; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lee JH, 2015, TRENDS MICROBIOL, V23, P707, DOI 10.1016/j.tim.2015.08.001; Leja-Szpak A, 2004, J PHYSIOL PHARMACOL, V55, P239; Li T, 2016, J DIABETES INVEST, V7, P32, DOI 10.1111/jdi.12406; Liu HY, 2016, ONCOTARGET, V7, P62503, DOI 10.18632/oncotarget.11526; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; MCMENAMY RH, 1958, J BIOL CHEM, V233, P1436; Mehraj V, 2015, INT J TRYPTOPHAN RES, V8, P41, DOI 10.4137/IJTR.S26862; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Mole DJ, 2008, BRIT J SURG, V95, P855, DOI 10.1002/bjs.6112; Mole DJ, 2016, NAT MED, V22, P202, DOI 10.1038/nm.4020; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Moyer BJ, 2016, TOXICOL APPL PHARM, V300, P13, DOI 10.1016/j.taap.2016.03.011; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Murray MF, 2003, LANCET INFECT DIS, V3, P644, DOI 10.1016/S1473-3099(03)00773-4; NISHIZUKA Y, 1963, J BIOL CHEM, V238, pP483; Nonaka H, 2011, INT J ONCOL, V38, P113, DOI 10.3892/ijo_00000830; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Novikov O, 2016, MOL PHARMACOL, V90, P674, DOI 10.1124/mol.116.105361; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Oh CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7794; Oh S, 2012, J APPL MICROBIOL, V113, P622, DOI 10.1111/j.1365-2672.2012.05372.x; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Oxenkrug G, 2011, FLY, V5, P307, DOI 10.4161/fly.5.4.18414; Oxenkrug GF, 2015, MOL NEUROBIOL, V52, P805, DOI 10.1007/s12035-015-9232-0; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pardridge WM, 1998, NEUROCHEM RES, V23, P635, DOI 10.1023/A:1022482604276; Patterson AD, 2011, J BIOL CHEM, V286, P19511, DOI 10.1074/jbc.M111.221739; PFEFFERKORN ER, 1984, INFECT IMMUN, V44, P211, DOI 10.1128/IAI.44.2.211-216.1984; Rios-Avila L, 2013, J NUTR, V143, P1509, DOI 10.3945/jn.113.174599; ROGERS KS, 1985, P SOC EXP BIOL MED, V178, P275, DOI 10.3181/00379727-178-42010; Romani L, 2014, EUR J IMMUNOL, V44, P3192, DOI 10.1002/eji.201344406; Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504; Sahm F, 2013, CANCER RES, V73, P3225, DOI 10.1158/0008-5472.CAN-12-3831; Schlittler M, 2016, AM J PHYSIOL-CELL PH, V310, pC836, DOI 10.1152/ajpcell.00053.2016; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schwarcz R, 2017, NEUROPHARMACOLOGY, V112, P237, DOI 10.1016/j.neuropharm.2016.08.003; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Strasser B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153617; Sugimoto S, 2016, J GASTROENTEROL, V51, P853, DOI 10.1007/s00535-016-1220-2; Suzuki Y, 2012, CLIN VACCINE IMMUNOL, V19, P436, DOI 10.1128/CVI.05402-11; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; Thaker AI, 2013, GASTROENTEROLOGY, V145, P416, DOI 10.1053/j.gastro.2013.05.002; Timosenko E, 2016, CANCER RES, V76, P6193, DOI 10.1158/0008-5472.CAN-15-3502; Tiszlavicz Z, 2011, N-S ARCH PHARMACOL, V383, P447, DOI 10.1007/s00210-011-0605-2; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Turski MP, 2013, INT J TRYPTOPHAN RES, V6, P47, DOI 10.4137/IJTR.S12536; Turski MP, 2011, PLANTA MED, V77, P858, DOI 10.1055/s-0030-1250604; Turski M, 2009, AMINO ACIDS, V36, P75, DOI 10.1007/s00726-008-0031-z; van der Goot AT, 2012, P NATL ACAD SCI USA, V109, P14912, DOI 10.1073/pnas.1203083109; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wolowczuk I., 2012, AM J PHYSIOL-REG I, V303, pR135, DOI DOI 10.1152/ajpregu.00373.2011; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073920; YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260; YATES CA, 1976, NATURE, V262, P219, DOI 10.1038/262219a0; Yeung AWS, 2015, CLIN SCI, V129, P601, DOI 10.1042/CS20140392; Yuasa HJ, 2015, J EXP ZOOL PART B, V324, P128, DOI 10.1002/jez.b.22608; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhang LS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0296-x	131	497	519	17	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349							eaaf9794	10.1126/science.aaf9794	http://dx.doi.org/10.1126/science.aaf9794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8AX	28751584				2022-12-28	WOS:000406362300034
J	Wang, YY; Fedin, I; Zhang, H; Talapin, DV				Wang, Yuanyuan; Fedin, Igor; Zhang, Hao; Talapin, Dmitri V.			Direct optical lithography of functional inorganic nanomaterials	SCIENCE			English	Article							QUANTUM-DOT SOLIDS; MATCHED MOLECULAR SOLDERS; COLLOIDAL NANOCRYSTALS; LOW-TEMPERATURE; TRANSISTORS; THIOCYANATE; COMPOSITES; LIGANDS	Photolithography is an important manufacturing process that relies on using photoresists, typically polymer formulations, that change solubility when illuminated with ultraviolet light. Here, we introduce a general chemical approach for photoresist-free, direct optical lithography of functional inorganic nanomaterials. The patterned materials can be metals, semiconductors, oxides, magnetic, or rare earth compositions. No organic impurities are present in the patterned layers, which helps achieve good electronic and optical properties. The conductivity, carrier mobility, dielectric, and luminescence properties of optically patterned layers are on par with the properties of state-of-the-art solution-processed materials. The ability to directly pattern all-inorganic layers by using a light exposure dose comparable with that of organic photoresists provides an alternate route for thin-film device manufacturing.	[Wang, Yuanyuan; Fedin, Igor; Zhang, Hao; Talapin, Dmitri V.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Wang, Yuanyuan; Fedin, Igor; Zhang, Hao; Talapin, Dmitri V.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Talapin, Dmitri V.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Talapin, DV (corresponding author), Univ Chicago, Dept Chem, Chicago, IL 60637 USA.; Talapin, DV (corresponding author), Univ Chicago, James Franck Inst, Chicago, IL 60637 USA.; Talapin, DV (corresponding author), Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA.	dvtalapin@uchicago.edu	wangwangwang, yuanyaun/HHN-6432-2022; Fedin, Igor/U-4455-2017; Lv, Yuanjie/AER-0767-2022; Wang, Yuanyuan/HCI-7034-2022; Wang, Yuan/HHC-1520-2022; Zhang, Hao/J-2858-2014	Fedin, Igor/0000-0002-3534-8336; Wang, Yuanyuan/0000-0003-3971-8362; Zhang, Hao/0000-0003-4513-0813	U.S. Department of Defense Air Force Office of Scientific Research [FA9550-14-1-0367]; NSF [CHE-1611331]; NSF Materials Research Science and Engineering Center Program [DMR-1420709]; II-VI Foundation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Division Of Chemistry [1611331] Funding Source: National Science Foundation	U.S. Department of Defense Air Force Office of Scientific Research; NSF(National Science Foundation (NSF)); NSF Materials Research Science and Engineering Center Program(National Science Foundation (NSF)); II-VI Foundation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank N. Ludwig for help with image analysis; A. Filatov for x-ray diffraction analysis; M. Hudson for providing selenocadmate ligands; and B. Tian, J. Park, V. Srivastava, and T. Shpigel for reading the manuscript. The work was supported by the U.S. Department of Defense Air Force Office of Scientific Research under grant FA9550-14-1-0367, NSF under award CHE-1611331, NSF Materials Research Science and Engineering Center Program under award DMR-1420709, and the II-VI Foundation. Use of the Center for Nanoscale Materials was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Data supporting the findings of this study are available within the article and the supplementary materials and from the corresponding authors upon reasonable request. The quantum dot samples can be provided by the authors under a materials transfer agreement with the university. Y.W., H.Z., and D.V.T. are inventors on patent application U.S. 62/486,566 submitted by the University of Chicago that covers nanocrystal patterning chemistry and methods.	Adachi MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9694; [Anonymous], 1982, NUMERICAL DATA FUNCT; Banger KK, 2011, NAT MATER, V10, P45, DOI [10.1038/nmat2914, 10.1038/NMAT2914]; Boles MA, 2016, NAT MATER, V15, P141, DOI [10.1038/NMAT4526, 10.1038/nmat4526]; Chen PE, 2017, J AM CHEM SOC, V139, P3227, DOI 10.1021/jacs.6b13234; Choi JH, 2016, SCIENCE, V352, P205, DOI 10.1126/science.aad0371; Dolzhnikov DS, 2015, SCIENCE, V347, P425, DOI 10.1126/science.1260501; Fafarman AT, 2011, J AM CHEM SOC, V133, P15753, DOI 10.1021/ja206303g; Groner MD, 2004, CHEM MATER, V16, P639, DOI 10.1021/cm0304546; Jang J, 2015, NANO LETT, V15, P6309, DOI 10.1021/acs.nanolett.5b01258; Kagan CR, 2016, SCIENCE, V353, DOI 10.1126/science.aac5523; Kagan CR, 2015, NAT NANOTECHNOL, V10, P1013, DOI [10.1038/NNANO.2015.247, 10.1038/nnano.2015.247]; Kim WJ, 2008, NANO LETT, V8, P3262, DOI 10.1021/nl8016219; Kovalenko MV, 2009, SCIENCE, V324, P1417, DOI 10.1126/science.1170524; Lhuillier E, 2013, ADV MATER, V25, P137, DOI 10.1002/adma.201203012; Liu MX, 2017, NAT MATER, V16, P258, DOI [10.1038/NMAT4800, 10.1038/nmat4800]; Llordes A, 2013, NATURE, V500, P323, DOI 10.1038/nature12398; Mack C, 2007, FUNDAMENTAL PRINCIPL; Park JS, 2016, NANO LETT, V16, P6946, DOI 10.1021/acs.nanolett.6b03007; Supran GJ, 2013, MRS BULL, V38, P703, DOI 10.1557/mrs.2013.181; Tekin E, 2007, ADV FUNCT MATER, V17, P23, DOI 10.1002/adfm.200600587; Webber DH, 2012, DALTON T, V41, P7835, DOI 10.1039/c2dt30197k; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q; Zhang H, 2016, J AM CHEM SOC, V138, P7464, DOI 10.1021/jacs.6b03240	24	149	151	32	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2017	357	6349					385	388		10.1126/science.aan2958	http://dx.doi.org/10.1126/science.aan2958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8AX	28751606				2022-12-28	WOS:000406362300041
J	Szaruga, M; Munteanu, B; Lismont, S; Veugelen, S; Horre, K; Mercken, M; Saido, TC; Ryan, NS; De Vos, T; Savvides, SN; Gallardo, R; Schymkowitz, J; Rousseau, F; Fox, NC; Hopf, C; De Strooper, B; Chavez-Gutierrez, L				Szaruga, Maria; Munteanu, Bogdan; Lismont, Sam; Veugelen, Sarah; Horre, Katrien; Mercken, Marc; Saido, Takaomi C.; Ryan, Natalie S.; De Vos, Tatjana; Savvides, Savvas N.; Gallardo, Rodrigo; Schymkowitz, Joost; Rousseau, Frederic; Fox, Nick C.; Hopf, Carsten; De Strooper, Bart; Chavez-Gutierrez, Lucia			Alzheimer's-Causing Mutations Shift A beta Length by Destabilizing gamma-Secretase-A beta n Interactions	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSMEMBRANE DOMAIN; TERMINAL FRAGMENT; SUBSTRATE DOCKING; DISEASE MUTATIONS; MEMBRANE; PEPTIDE; MODULATORS; A-BETA-42; CONFORMATION	Alzheimer's disease (AD)-linked mutations in Presenilins (PSEN) and the amyloid precursor protein (APP) lead to production of longer amyloidogenic A beta peptides. The shift in A beta length is fundamental to the disease; however, the underlying mechanism remains elusive. Here, we show that substrate shortening progressively destabilizes the consecutive enzyme-substrate (E-S) complexes that characterize the sequential gamma-secretase processing of APP. Remarkably, pathogenic PSEN or APP mutations further destabilize labile E-S complexes and thereby promote generation of longer A beta peptides. Similarly, destabilization of wild-type E-S complexes by temperature, compounds, or detergent promotes release of amyloidogenic A beta. In contrast, E-A beta n stabilizers increase gamma-secretase processivity. Our work presents a unifying model for how PSEN or APP mutations enhance amyloidogenic A beta production, suggests that environmental factors may increase AD risk, and provides the theoretical basis for the development of gamma-secretase/substrate stabilizing compounds for the prevention of AD.	[Szaruga, Maria; Lismont, Sam; Veugelen, Sarah; Horre, Katrien; Gallardo, Rodrigo; Schymkowitz, Joost; Rousseau, Frederic; De Strooper, Bart; Chavez-Gutierrez, Lucia] VIB, KU Leuven VIB Ctr Brain & Dis Res, B-3000 Leuven, Belgium; [Szaruga, Maria; Lismont, Sam; Veugelen, Sarah; Horre, Katrien; De Strooper, Bart; Chavez-Gutierrez, Lucia] Katholieke Univ Leuven, Leuven Inst Neurosci & Dis, Dept Neurosci, B-3000 Leuven, Belgium; [Munteanu, Bogdan; Hopf, Carsten] Mannheim Univ Appl Sci, Ctr Appl Res Biomed Mass Spectrometry, D-68163 Mannheim, Germany; [Mercken, Marc] Janssen Res & Dev, B-2340 Beerse, Belgium; [Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Hirosawa Wako City, Saitama 3510198, Japan; [Ryan, Natalie S.; Fox, Nick C.] UCL, Dept Neurodegenerat Dis, Dementia Res Ctr, Queen Sq, London WC1N 3BG, England; [De Vos, Tatjana; Savvides, Savvas N.] Univ Ghent, Lab Prot Biochem & Biomol Engn, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [De Vos, Tatjana; Savvides, Savvas N.] Ctr Inflammat Res, VIB UGent Technol Pk 927, B-9052 Ghent, Belgium; [Gallardo, Rodrigo; Schymkowitz, Joost; Rousseau, Frederic] Univ Leuven, Dept Cellular & Mol Med, KU Leuven, Herestr 49, B-3000 Louvain, Belgium; [De Strooper, Bart] UCL, Dementia Res Inst UK, Queen Sq, London WC1N 3BG, England	Flanders Institute for Biotechnology (VIB); KU Leuven; Johnson & Johnson; Janssen Pharmaceuticals; RIKEN; University of London; University College London; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven; University of London; University College London	De Strooper, B; Chavez-Gutierrez, L (corresponding author), VIB, KU Leuven VIB Ctr Brain & Dis Res, B-3000 Leuven, Belgium.; De Strooper, B; Chavez-Gutierrez, L (corresponding author), Katholieke Univ Leuven, Leuven Inst Neurosci & Dis, Dept Neurosci, B-3000 Leuven, Belgium.; De Strooper, B (corresponding author), UCL, Dementia Res Inst UK, Queen Sq, London WC1N 3BG, England.	Bart.DeStrooper@cme.vib-kuleuven.be; Lucia.ChavezGutierrez@cme.vib-kuleuven.be	Sado, Takaomi/AAN-2759-2021; Schymkowitz, Joost/AAV-3680-2021; Fox, Nick C/B-1319-2009; Saido, Takaomi C/N-5472-2015; de+Strooper, Bart/Z-1638-2019; Hopf, Carsten/A-3275-2015; Schymkowitz, Joost/K-7764-2016	Sado, Takaomi/0000-0003-1970-6903; Fox, Nick C/0000-0002-6660-657X; Saido, Takaomi C/0000-0003-1970-6903; Horre, Katrien/0000-0002-6801-3137; Szaruga-Bracke, Maria/0000-0003-1673-1855; Gallardo, Rodrigo/0000-0003-1584-3564; Hopf, Carsten/0000-0003-0802-6451; Schymkowitz, Joost/0000-0003-2020-0168	Stichting Alzheimer Onderzoek (SAO) [S16013]; Fund for Scientific Research Flanders (FWO) [G074115]; KU Leuven, a Methusalem grant from KU Leuven [METH/14/07]; Flemish government; Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office [P7/16]; Bax-Vanluffelen Chair for Alzheimer's Disease and "Opening the Future" of the Leuven Universiteit Fonds; Vlaams Initiatief voor Netwerken voor Dementie Onderzoek (VIND) [135043]; European Research Council under European Union [647458]; University of Leuven ("Industrieel Onderzoeksfonds") [OT/12/092]; Funds for Scientific Research Flanders [G051817N]; Flanders Agency for Innovation by Science and Technology (IWT SBO) [60839]; Federal Office for Scientific Affairs of Belgium (Belspo), IUAP grant [P7/16]; IUAPZAFH-ABIMAS; ZO IV of the Ministerium fur Wissenschaft und Kunst Baden-Wurttemberg (MWK); European Fund for Regional Development (EFRE) [Kapitel 1222 Titelgruppe 88]; Deutsche Forschungsgemeinschaft (DFG) [INST 874/7-1]; IWT [SB/131289]; Hercules foundation [AUGE/11/029]; Brain Exit fellowship; Janssen Pharmaceutica; MRC [MC_PC_17116] Funding Source: UKRI; Medical Research Council [MC_PC_17116] Funding Source: researchfish	Stichting Alzheimer Onderzoek (SAO); Fund for Scientific Research Flanders (FWO)(FWO); KU Leuven, a Methusalem grant from KU Leuven; Flemish government(European Commission); Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office; Bax-Vanluffelen Chair for Alzheimer's Disease and "Opening the Future" of the Leuven Universiteit Fonds; Vlaams Initiatief voor Netwerken voor Dementie Onderzoek (VIND); European Research Council under European Union(European Research Council (ERC)); University of Leuven ("Industrieel Onderzoeksfonds"); Funds for Scientific Research Flanders; Flanders Agency for Innovation by Science and Technology (IWT SBO)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Federal Office for Scientific Affairs of Belgium (Belspo), IUAP grant; IUAPZAFH-ABIMAS; ZO IV of the Ministerium fur Wissenschaft und Kunst Baden-Wurttemberg (MWK); European Fund for Regional Development (EFRE)(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Hercules foundation; Brain Exit fellowship; Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Queen Square Brain Bank at the Institute of Neurology, University College London, London, UK for the invaluable assistance in the collection of postmortem human brain samples. We are grateful to all donors and their relatives. We acknowledge Michel Vande Kerckhove for helpful discussions and Amantha Thathiah for the critical reading of the manuscript. We thank Janssen Pharmaceutica for anti-Ab monoclonal antibodies and GSMs. This work was funded by the Stichting Alzheimer Onderzoek (SAO; S16013), the Fund for Scientific Research Flanders (FWO; G074115), the KU Leuven, a Methusalem grant (METH/14/07) from the KU Leuven, the Flemish government, and Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office (P7/16). B.D.S. is supported by the Bax-Vanluffelen Chair for Alzheimer's Disease and "Opening the Future" of the Leuven Universiteit Fonds. This work was supported by Vlaams Initiatief voor Netwerken voor Dementie Onderzoek (VIND, Strategic Basic Research Grant 135043). The Switch Laboratory is supported by grants from the European Research Council under the European Union's Horizon 2020 Framework Programme ERC Grant agreement 647458 (MANGO) to J.S., the University of Leuven ("Industrieel Onderzoeksfonds"; OT/12/092), the Funds for Scientific Research Flanders (G051817N), the Flanders Agency for Innovation by Science and Technology (IWT, SBO grant 60839) and the Federal Office for Scientific Affairs of Belgium (Belspo), IUAP, grant number P7/16. The ABIMAS Center is funded by a joint grant (ZAFH-ABIMAS to C.H.) by ZO IV of the Ministerium fur Wissenschaft und Kunst Baden-Wurttemberg (MWK) and by the European Fund for Regional Development (EFRE), Kapitel 1222 Titelgruppe 88. The Deutsche Forschungsgemeinschaft (DFG) funded a SolariX FTICR MS (INST 874/7-1 FUGG to C.H.). S.V. is supported by a PhD fellowship from the IWT (SB/131289). T.D.V. is a FWO predoctoral fellow (1S16516N). S.N.S. acknowledges infrastructural support from the Hercules foundation (AUGE/11/029). N.S.R. is supported by a Brain Exit fellowship. M.M. is an employee of Janssen Pharmaceutica. B.D.S. receives research funding from Janssen Pharmaceutica and is a consultant for Janssen Pharmaceutica and Remynd NV.	Acx H, 2014, J BIOL CHEM, V289, P4346, DOI 10.1074/jbc.M113.530907; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2015, ANNU REV PHARMACOL, V55, P419, DOI 10.1146/annurev-pharmtox-010814-124309; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Elad N, 2015, J CELL SCI, V128, P589, DOI 10.1242/jcs.164384; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Funamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3529; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Jung JI, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0021-z; Kakuda N, 2012, EMBO MOL MED, V4, P344, DOI 10.1002/emmm.201200214; Li Y, 2014, STRUCTURE, V22, P125, DOI 10.1016/j.str.2013.09.018; Liu CY, 2017, J ALZHEIMERS DIS, V58, P1035, DOI 10.3233/JAD-161203; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; Munteanu B., 2016, ADV MALDI LASER INDU, P249; Ohki Y, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-7; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Olichon A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-7; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Potter R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005615; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Svedruzic ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032293; Szaruga M, 2015, J EXP MED, V212, P2003, DOI 10.1084/jem.20150892; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takeo K, 2014, P NATL ACAD SCI USA, V111, P10544, DOI 10.1073/pnas.1402171111; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Veugelen S, 2016, NEURON, V90, P410, DOI 10.1016/j.neuron.2016.03.010; Wahlster L, 2013, ACTA NEUROPATHOL, V125, P187, DOI 10.1007/s00401-012-1065-6; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Winkler E, 2012, J BIOL CHEM, V287, P21326, DOI 10.1074/jbc.M112.356659; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	51	136	140	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2017	170	3					443	456		10.1016/j.cell.2017.07.004	http://dx.doi.org/10.1016/j.cell.2017.07.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FB9ME	28753424	Green Submitted, Bronze			2022-12-28	WOS:000406462400005
J	Baranovskiy, AG; Babayeva, ND; Zhang, Y; Blanco, L; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Babayeva, Nigar D.; Zhang, Yinbo; Blanco, Luis; Pavlov, Youri I.; Tahirov, Tahir H.			Comment on "The [4Fe4S] cluster of human DNA primase functions as a redox switch using DNA charge transport"	SCIENCE			English	Editorial Material							C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; SUBUNIT; REPLICATION; MECHANISM; PRIMER	O'Brien et al. (Research Article, 24 February 2017, eaag1789) proposed a novel mechanism of primase function based on redox activity of the iron-sulfur cluster buried inside the C-terminal domain of the large primase subunit (p58C). Serious problems in the experimental design and data interpretation raise concerns about the validity of the conclusions.	[Baranovskiy, Andrey G.; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Blanco, Luis] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid 28049, Spain; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Blanco, Luis/I-1848-2015; Pavlov, Youri/T-7532-2017	Luis, Blanco/0000-0001-5558-4435; Tahirov, Tahir/0000-0002-1238-0069; Pavlov, Youri/0000-0003-1179-5796	National Institute of General Medical Sciences [GM101167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. C. Copeland for scientific comments and K. Jordan for editing this manuscript. Preparation of this Technical Comment was supported by National Institute of General Medical Sciences grant GM101167 to T.H.T.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Baranovskiy AG, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020062; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2016, J BIOL CHEM, V291, P4793, DOI 10.1074/jbc.M115.704064; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; KUCHTA RD, 1990, J BIOL CHEM, V265, P16158; O'Brien E, 2017, SCIENCE, V355, DOI 10.1126/science.aag1789; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333	14	33	33	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348							eaan2396	10.1126/science.aan2396	http://dx.doi.org/10.1126/science.aan2396			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB1KF	28729484	Green Accepted, Green Submitted			2022-12-28	WOS:000405901600001
J	Wadman, M				Wadman, Meredith			WOMEN IN SCIENCE Gender discrimination lawsuit at Salk ignites controversy	SCIENCE			English	News Item																			0	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348					237	238		10.1126/science.357.6348.237	http://dx.doi.org/10.1126/science.357.6348.237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28729490				2022-12-28	WOS:000405901600014
J	Kupferschmidt, K				Kupferschmidt, Kai			BIOSECURITY Labmade smallpox is possible, study shows	SCIENCE			English	News Item																			0	12	13	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		115	116		10.1126/science.357.6347.115	http://dx.doi.org/10.1126/science.357.6347.115			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706017				2022-12-28	WOS:000405391700013
J	Service, RF				Service, Robert F.			BIOFUELS A push for low-carbon fuels pays off in California	SCIENCE			English	News Item																			0	2	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2017	357	6347			SI		120	121		10.1126/science.357.6347.120	http://dx.doi.org/10.1126/science.357.6347.120			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA4CP	28706021				2022-12-28	WOS:000405391700017
J	Matei, I; Kim, HS; Lyden, D				Matei, Irina; Kim, Han Sang; Lyden, David			Unshielding Exosomal RNA Unleashes Tumor Growth And Metastasis	CELL			English	Editorial Material								Reciprocal interactions between tumor cells and their microenvironment drive cancer progression and therapy resistance. In this issue, Nabet et al. demonstrate that dynamic feedback between tumor and stroma subverts normal inflammatory responses by triggering the release of exosomes containing unshielded RNAs that activate pattern recognition receptors, thereby promoting tumor growth and metastasis.	[Matei, Irina; Kim, Han Sang; Lyden, David] Weill Cornell Med Coll, Childrens Canc & Blood Fdn Labs, Drukier Inst Childrens Hlth, Dept Pediat,Meyer Canc Ctr, New York, NY 10065 USA; [Matei, Irina; Kim, Han Sang; Lyden, David] Weill Cornell Med Coll, Childrens Canc & Blood Fdn Labs, Drukier Inst Childrens Hlth, Meyer Canc Ctr,Dept Cell & Dev Biol, New York, NY 10065 USA; [Kim, Han Sang] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol,Dept Internal Med, Seoul, South Korea; [Kim, Han Sang] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol,Dept Pharmacol, Seoul, South Korea; [Lyden, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA	Cornell University; Cornell University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Memorial Sloan Kettering Cancer Center	Matei, I; Lyden, D (corresponding author), Weill Cornell Med Coll, Childrens Canc & Blood Fdn Labs, Drukier Inst Childrens Hlth, Dept Pediat,Meyer Canc Ctr, New York, NY 10065 USA.; Matei, I; Lyden, D (corresponding author), Weill Cornell Med Coll, Childrens Canc & Blood Fdn Labs, Drukier Inst Childrens Hlth, Meyer Canc Ctr,Dept Cell & Dev Biol, New York, NY 10065 USA.; Lyden, D (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	irm2224@med.cornell.edu; dcl2001@med.cornell.edu	Kim, Han Sang/R-3768-2019	Kim, Han Sang/0000-0002-6504-9927				Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Escamilla-Tilch M, 2013, IMMUNOL CELL BIOL, V91, P601, DOI 10.1038/icb.2013.58; Huang J, 2015, AGEING RES REV, V24, P3, DOI 10.1016/j.arr.2014.10.004; Liu J, 2016, CRIT REV ONCOL HEMAT, V104, P21, DOI 10.1016/j.critrevonc.2016.05.010; Nabet BY, 2017, CELL, V170, P352, DOI 10.1016/j.cell.2017.06.031; Telesnitsky A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080235	7	28	30	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					223	225		10.1016/j.cell.2017.06.047	http://dx.doi.org/10.1016/j.cell.2017.06.047			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708994	Bronze			2022-12-28	WOS:000405493900004
J	Pawluk, A				Pawluk, April			Tiny Answers to Big Questions	CELL			English	Editorial Material														Pawluk, April/0000-0002-6136-2086				Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049	2	4	4	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					215	217		10.1016/j.cell.2017.06.033	http://dx.doi.org/10.1016/j.cell.2017.06.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28708991	Bronze			2022-12-28	WOS:000405493900001
